Citrus Sinensis ID: 002512
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 914 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LX29 | 895 | Serine/threonine-protein | yes | no | 0.969 | 0.989 | 0.697 | 0.0 | |
| O24585 | 901 | Putative receptor protein | N/A | no | 0.948 | 0.962 | 0.652 | 0.0 | |
| Q9S7D9 | 775 | Serine/threonine-protein | no | no | 0.745 | 0.878 | 0.327 | 1e-95 | |
| O80963 | 776 | Serine/threonine-protein | no | no | 0.765 | 0.902 | 0.316 | 1e-95 | |
| Q9FIJ6 | 751 | Serine/threonine-protein | no | no | 0.726 | 0.884 | 0.320 | 4e-86 | |
| C0LGI2 | 929 | Probable LRR receptor-lik | no | no | 0.304 | 0.299 | 0.480 | 1e-67 | |
| Q9LY50 | 814 | Putative serine/threonine | no | no | 0.319 | 0.358 | 0.466 | 2e-67 | |
| Q8L4H4 | 925 | Nodulation receptor kinas | N/A | no | 0.450 | 0.445 | 0.376 | 2e-66 | |
| Q8LKZ1 | 924 | Nodulation receptor kinas | N/A | no | 0.424 | 0.419 | 0.394 | 4e-66 | |
| C0LGG6 | 876 | Probable LRR receptor-lik | no | no | 0.374 | 0.390 | 0.388 | 5e-66 |
| >sp|Q9LX29|ACR4_ARATH Serine/threonine-protein kinase-like protein ACR4 OS=Arabidopsis thaliana GN=ACR4 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1293 bits (3345), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 644/923 (69%), Positives = 746/923 (80%), Gaps = 37/923 (4%)
Query: 1 MGNFSFVEGDWVLKILKTGFVVHFLMLSNLLRLVNGLGSMSSIAISYGENGPVFCGLKSD 60
M F +W+L +V ++ +++ +L + LGSMSSIAISYGE G VFCGLKSD
Sbjct: 1 MRMFETRAREWIL-------LVKLVLFTSIWQLASALGSMSSIAISYGEGGSVFCGLKSD 53
Query: 61 RSHLVTCYGSNSAIIYGTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQP 120
SHLV CYGSNSAI+YGTP H FIGLT GDGF+CGLL+ S+QPYCWG+S +IQMGVPQP
Sbjct: 54 GSHLVVCYGSNSAILYGTPGHLQFIGLTGGDGFMCGLLMLSHQPYCWGNSAFIQMGVPQP 113
Query: 121 IIKGAQYVEISAGDYHLCGLRKPLTGKWRNY-----SYVDCWGYNMTKNYVFDGQIESIS 175
+ KGA+Y+E+SAGDYHLCGLRKP+ G+ +N S VDCWGYNMT+N+VFD Q+ S+S
Sbjct: 114 MTKGAEYLEVSAGDYHLCGLRKPIVGRRKNSNIISSSLVDCWGYNMTRNFVFDKQLHSLS 173
Query: 176 AGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRC 235
AGSEFNC L S++++VFCWGDE+SS+VISLIPKE KFQK+AAGGYHVCGIL+GL+SR C
Sbjct: 174 AGSEFNCALSSKDKSVFCWGDENSSQVISLIPKEKKFQKIAAGGYHVCGILDGLESRVLC 233
Query: 236 WGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPST 295
WG+SL+ EEEV+ + + +DLPP +P+L++VGGKF+ACGIK YD +CWGF + ST
Sbjct: 234 WGKSLEFEEEVTGTSTEEKILDLPPKEPLLAVVGGKFYACGIKRYDHSAVCWGFFVNRST 293
Query: 296 PVPTGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTGFPTSLPLAVSPGLCKMTPCAPGYYE 355
P PTGI Y++AAGNYFTCGVL SM PVCWG GFP S+PLAVSPGLC TPC PG +E
Sbjct: 294 PAPTGIGFYDLAAGNYFTCGVLTGTSMSPVCWGLGFPASIPLAVSPGLCIDTPCPPGTHE 353
Query: 356 AS-QENAPCKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSS 414
S QEN+PCK +H+C+ CS CP MYQ + CT +SD+VC YNCSSC S +C NCSS
Sbjct: 354 LSNQENSPCKFTGSHICLPCSTSCPPGMYQKSVCTERSDQVCVYNCSSCSSHDCSSNCSS 413
Query: 415 QFSDGLTTKKNEKFWSMQLPVIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKS 474
+ G K+ KFWS+QLP+ AEI A+FL+ VV++ + LY+RYRLRNC+CS ++S
Sbjct: 414 SATSG--GKEKGKFWSLQLPIATAEIGFALFLVAVVSITAALYIRYRLRNCRCSENDTRS 471
Query: 475 QKTNGAGSPYQKDNGKIRPDFDDL-KIRRAQMFTYEELERATGGFKEE--VGKGSFSCVY 531
K S + KDNGKIRPD D+L K RRA++FTYEELE+A GFKEE VGKGSFSCVY
Sbjct: 472 SKD----SAFTKDNGKIRPDLDELQKRRRARVFTYEELEKAADGFKEESIVGKGSFSCVY 527
Query: 532 KGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591
KGVL+DGT VAVK+AI +SD+QKNS EF TELDLLSRLNHAHLL+LLGYCEE ERLLVY
Sbjct: 528 KGVLRDGTTVAVKRAIMSSDKQKNSNEFRTELDLLSRLNHAHLLSLLGYCEECGERLLVY 587
Query: 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 651
EFMAHGSLH HLHGK+KALKEQLDWV+RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI
Sbjct: 588 EFMAHGSLHNHLHGKNKALKEQLDWVKRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 647
Query: 652 LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL 711
LIDEEHNARVADFGLSLLGP DS SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL
Sbjct: 648 LIDEEHNARVADFGLSLLGPVDSGSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL 707
Query: 712 LLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKC 771
LLEILSGRKAIDM +EEGNIVEWAVPLIK+GDI A+LDPVLK PS+++ALKRI +VACKC
Sbjct: 708 LLEILSGRKAIDMHYEEGNIVEWAVPLIKAGDINALLDPVLKHPSEIEALKRIVSVACKC 767
Query: 772 VRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTEVVLGSNRMHKKSSQRSSNRST 831
VRMRGK+RPSMDKVTTALERALAQLMG+P SEQPILPTEVVLGS+RMHKKS + S RS
Sbjct: 768 VRMRGKDRPSMDKVTTALERALAQLMGNPSSEQPILPTEVVLGSSRMHKKSWRIGSKRSG 827
Query: 832 SETDVAEAEDQRFEFRAPSWITFPSVTSSQRRKSSVSDADVDGKNLEARNMGNAGSIGDG 891
SE EFR SWITFPSVTSSQRRKSS S+ DV + E R A
Sbjct: 828 SENT---------EFRGGSWITFPSVTSSQRRKSSASEGDVAEEEDEGRKQQEA------ 872
Query: 892 LRSLEEEIGPASPQENLYLQHNF 914
LRSLEEEIGPASP ++L+L HNF
Sbjct: 873 LRSLEEEIGPASPGQSLFLHHNF 895
|
Controls formative cell division in meristems, including root tips and lateral root initiation zones of the pericycle, in response to CLE40 signal. Acts with CLE40p peptide as a ligand-receptor pair in a signal transduction pathway, coordinating movement of the root tip and organization of cell divisions in the root meristem. Required during embryogenesis and development, probably for the differentiation of protoderm and epidermal cells. Involved in the regulation of cellular organization during the development of sepal margins and ovule integument outgrowth. Can phosphorylate ALE2. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O24585|CRI4_MAIZE Putative receptor protein kinase CRINKLY4 OS=Zea mays GN=CR4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 1175 bits (3039), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 581/890 (65%), Positives = 708/890 (79%), Gaps = 23/890 (2%)
Query: 36 GLGSMSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGTPAHFPFIGLTAGDGFVC 95
GLGSMSSIA+SYGE+GPVFCGL SD SHLV C+G++++++YG P + PF+GLTAGDGFVC
Sbjct: 24 GLGSMSSIAVSYGEDGPVFCGLNSDGSHLVACFGADASVLYGAPPNIPFLGLTAGDGFVC 83
Query: 96 GLLLDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRN---YS 152
GLLLD+ QPYCWGS+ Y++ GVPQP+++GA+Y E+SAGD HLC LR G + S
Sbjct: 84 GLLLDTRQPYCWGSNSYVKSGVPQPMVEGARYSELSAGDNHLCALRAAQDGGRGSSAATS 143
Query: 153 YVDCWGYNMTKNYVFDGQIESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKF 212
+DCWGYNMT + D + ++SAGS FNCGLF++NRTVFCWGDE+ S V+ L P+++ F
Sbjct: 144 LIDCWGYNMTATHAVDEAVSTVSAGSVFNCGLFARNRTVFCWGDETVSGVVGLAPRDLHF 203
Query: 213 QKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKF 272
Q + AGGYHVCG+LE +++ CWGRSL++++ V + G+V++ P D M ++VGG+F
Sbjct: 204 QSIGAGGYHVCGVLE--NAQVFCWGRSLEMQQVVPSSAIGDGDVNIVPMDAMSTVVGGRF 261
Query: 273 HACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTGFP 332
HACGI+S D V CWGF + ST P G+K+Y + AG+YFTCGV AE S++P CWG P
Sbjct: 262 HACGIRSLDHQVACWGFTLHNSTSPPKGLKMYALVAGDYFTCGVPAETSLMPRCWGNSGP 321
Query: 333 TSLPLAVSPGLCKMTPCAPGYYEASQEN-----APCKSPNAHVCITCSNGCPVEMYQTAE 387
+LP+AV PG+C T C+ GYYE CK N+ +C+ CS GCP +Y+++
Sbjct: 322 LALPMAVPPGICVPTACSHGYYEYVNHGEVGSIKVCKPANSRLCLPCSTGCPEGLYESSP 381
Query: 388 CTLKSDRVCEYNCSSCFSAECYKNCSSQFSDGLTTKKNEKFWSMQLPVIIAEITIAVFLI 447
C +DRVC+++C C + EC C SQ K+ K + Q+ + +AEI AV L+
Sbjct: 382 CNATADRVCQFDCLKCVTDECLSFCLSQ-----KRTKSRKLMAFQMRIFVAEIVFAVVLV 436
Query: 448 TVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFT 507
V++ + LYVR++LR+CQCS + + K+ ++KDN KI+PD +DLKIRRAQ F+
Sbjct: 437 LSVSVTTCLYVRHKLRHCQCSNRELRLAKSTAYS--FRKDNMKIQPDMEDLKIRRAQEFS 494
Query: 508 YEELERATGGFKE--EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDL 565
YEELE+ATGGF E +VGKGSFSCV+KG+L+DGTVVAVK+AI SD +K+SKEFH ELDL
Sbjct: 495 YEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKEFHNELDL 554
Query: 566 LSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQ 625
LSRLNHAHLLNLLGYCE+G ERLLVYEFMAHGSL+QHLHGK LK++L+W RRVTIAVQ
Sbjct: 555 LSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWARRVTIAVQ 614
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGT 685
AARGIEYLHGYACPPVIHRDIKSSNILIDE+HNARVADFGLS+LGPADS +PL+ELPAGT
Sbjct: 615 AARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGPADSGTPLSELPAGT 674
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745
LGYLDPEYYRLHYLTTKSDVYSFGV+LLEILSGRKAIDMQFEEGNIVEWAVPLIK+GDI
Sbjct: 675 LGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQFEEGNIVEWAVPLIKAGDIF 734
Query: 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQP 805
AILDPVL PSDL+ALK+IA+VACKCVRMRGK+RPSMDKVTTALE ALA LMGSPC EQP
Sbjct: 735 AILDPVLSPPSDLEALKKIASVACKCVRMRGKDRPSMDKVTTALEHALALLMGSPCIEQP 794
Query: 806 ILPTEVVLGSNRMHKKSSQRSSNRSTSETDVAEAEDQRFEFRAPSWITFPSVTSSQRRKS 865
ILPTEVVLGS+RMH K SQ SSN S SE ++A+ EDQ +RAPSWITFPSVTSSQRRKS
Sbjct: 795 ILPTEVVLGSSRMH-KVSQMSSNHSCSENELADGEDQGIGYRAPSWITFPSVTSSQRRKS 853
Query: 866 SVSDADVDGKN-LEARNMGNAGSIGDGLRSLEEEIGPASPQENLYLQHNF 914
S S+AD+ G+ + RN+G+ SIGDGLRSLEEEI PASPQENLYLQHNF
Sbjct: 854 SASEADIVGRRATDGRNVGS--SIGDGLRSLEEEIAPASPQENLYLQHNF 901
|
Putative receptor protein kinase. Could play a role in a differentiation signal. The CRINKLY4 (CR4) mutation affects leaf epidermis differentiation such that cell size and morphology are altered, and surface functions are compromised, allowing graft-like fusions between organs. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S7D9|ACCR1_ARATH Serine/threonine-protein kinase-like protein CCR1 OS=Arabidopsis thaliana GN=CCR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 352 bits (902), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 269/822 (32%), Positives = 390/822 (47%), Gaps = 141/822 (17%)
Query: 35 NGLGSMSSIAISYGENGPVFCGLKSDRSHLVTCYGSN-------------------SAII 75
+G GS IA S+G + FC + + V C+G N ++
Sbjct: 22 SGFGSSGPIAASFGGSA-FFCAIDASGRQDVICWGKNYSSPSSPSSSSSSSSIASSTSAS 80
Query: 76 YGTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQ-MGVPQPIIKGAQYVEISAGD 134
Y P+ L+ GDGF+CG+L +++Q +C+ S G M + + Y +I+AG+
Sbjct: 81 YNIPS---MAVLSGGDGFLCGILSNTSQAFCFSSLGSSSGMDLVPLAYRTTAYSQIAAGN 137
Query: 135 YHLCGLRKPLTGKWRNYSYVDCWGYNMT---------KNYVFDGQIES------ISAGSE 179
H+C +R + +DCW +N F QI S I +G
Sbjct: 138 SHVCAVRGAYYSD-HDSGTIDCWEITRATNNNSLIAKENPNFYDQIVSNLVFNNIVSGDG 196
Query: 180 FNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRS 239
F+CG ++ + C+G SS+ + FQ +AAG VC IL L +CWG
Sbjct: 197 FSCGGI-RDGGMLCFGPNSSN--LGFNTTSDNFQVLAAGKNSVCAILN-LSREVKCWGED 252
Query: 240 LDLEEEVSVAYSRQGNVDLPPSDP-MLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVP 298
+ V+ P +D +S+ G H CGI+ + V CWG P
Sbjct: 253 -------------ESFVNSPMNDSRFVSLTAGPRHFCGIREDNHEVECWGNSNFSLIPKG 299
Query: 299 TGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTGFPTSL----PLAV-SPGLCKMTPCAPG- 352
+G K IA+ ++ CG+ E +L CW ++L PL + SPG+C+ PC
Sbjct: 300 SGFKA--IASSDFIVCGIREEDLVLD-CWMVNGSSTLAYDPPLELCSPGMCRAGPCNEKE 356
Query: 353 -YYEASQENAP-----CKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSA 406
+ AS N P C VC C + C + ++ CT SDR+C CS C ++
Sbjct: 357 FAFNASILNEPDLTSLCVRKELMVCSPCGSDCSHGFFLSSSCTANSDRICT-PCSLCQNS 415
Query: 407 ECYKNC---SSQFSDGLTTKKNEKFW-SMQLPVIIAEITIAVFLITVVTLISILYVRYRL 462
C C +S F D K W +Q V+I + LI ++ + +
Sbjct: 416 SCSDICKLHNSNFPD--------KHWHQLQRLVLIIGSCASALLIIIIGCCVVPRI---- 463
Query: 463 RNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDFD-DLKIRR----------AQMFTYEEL 511
+ K +GA + ++ GK PD D D + AQ+F EL
Sbjct: 464 --------VTSPNKEDGAANQFKSCIGK--PDLDTDQPLENVSPAPSVTPFAQVFRLSEL 513
Query: 512 ERATGGFKE--EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
+ AT GFKE E+G+GS+ VYK VL DG VAVK+A A + N++EF TEL++L +
Sbjct: 514 KDATNGFKEFNELGRGSYGFVYKAVLADGRQVAVKRANAATIIHTNTREFETELEILCNI 573
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARG 629
H +++NLLGY E ERLLVYE+M HG+LH HLH L W R+ IA+Q A+G
Sbjct: 574 RHCNIVNLLGYSTEMGERLLVYEYMPHGTLHDHLHSGFSPLS----WSLRIKIAMQTAKG 629
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYL 689
+EYLH A P +IH D+KSSN+L+D E ARVADFGL SS+
Sbjct: 630 LEYLHNEAEPRIIHGDVKSSNVLLDSEWVARVADFGL-----VTSSNE------------ 672
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749
L K DVY FGV+LLEIL+GRK D + IVEW VP+I+ G AI+D
Sbjct: 673 -------KNLDIKRDVYDFGVVLLEILTGRKRYDRDCDPPEIVEWTVPVIREGKAAAIVD 725
Query: 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
+ LP +++ L ++A+VA CVR ++P+M ++ LE
Sbjct: 726 TYIALPRNVEPLLKLADVAELCVREDPNQQPTMSELANWLEH 767
|
Serine/threonine-protein kinase with low activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80963|ACCR2_ARATH Serine/threonine-protein kinase-like protein CCR2 OS=Arabidopsis thaliana GN=CCR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 351 bits (901), Expect = 1e-95, Method: Compositional matrix adjust.
Identities = 255/805 (31%), Positives = 399/805 (49%), Gaps = 105/805 (13%)
Query: 34 VNGLGSMSSIAISYGENGPVFCGLKSDRSHLVTCY--GSNSAIIYGTPAHF-----PFIG 86
V+ GS +IA ++GENG FC + + V C+ G+ + + P P
Sbjct: 20 VSAYGSTGTIAAAFGENG-FFCAIDASGKQEVICWDRGNTNRSLNRPPGEISGYSPPMTS 78
Query: 87 LTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTG 146
L+ G+GF+C + ++++ +CW + VP+ + Y++I++G+ H+C + L
Sbjct: 79 LSGGEGFLCAITSNTSRAFCWNLEDPSENLVPRAF-QYNSYLQIASGNNHVCAISG-LYY 136
Query: 147 KWRNYSYVDCWGYNMTKN--------------YVFDGQIESISAGSEFNCGLFSQNRTVF 192
+Y V CW Y+ N Y+ I +G F+CG+ +++ +
Sbjct: 137 SGPDYGPVHCWEYSDNTNFTSGLLWNSSFHNPYIDSLMFRKIVSGDGFSCGV-TKDGDLV 195
Query: 193 CWGDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSR 252
CWG +S+ S +F+ +A+G VCG+ + + C+G +
Sbjct: 196 CWGPKSNLLNFS---NNEEFEVLASGRNSVCGVSKD-SGQLHCFGDETEFGS-------- 243
Query: 253 QGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTP--VPTGIKVYEIAAGN 310
LP +++ G H CGI+ D GV CWG + S+ P I++ +
Sbjct: 244 -----LPNRPRFIALSAGANHYCGIREDDHGVECWGRNLNSSSSSSAPNTSGFVAISSSD 298
Query: 311 YFTCGVLAEKSMLPVCW----GTGFPTSLPLAV-SPGLCK-MTPCAPGYY-------EAS 357
TCGV E ++ CW + S PL + SPG+C C G++ + S
Sbjct: 299 STTCGV-RELDLVLDCWRVHDSSKADYSPPLELCSPGMCSPRGNCGDGWFAFNASILKES 357
Query: 358 QENAPCKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSSQFS 417
+ + C N ++C+ C C + ++ C +DRVC CS C ++ CY C + +
Sbjct: 358 ELTSLCSFHNLNICLRCGISCLEGYFPSSTCNPNADRVCT-PCSLCQNSSCYGICKIRAT 416
Query: 418 DGLTTKKNEKFWSMQLPVIIAEITIAVFLITVVTLISILYV----------RYRLRNCQC 467
++ E+ +L +II ++ FL+ ++ L I + R ++ C C
Sbjct: 417 KSKEHEQKEQREVRRLVIIIG-CSVLGFLVMLIGLSFIPKMTKGSKRDDEERSKMTCCFC 475
Query: 468 SGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKE--EVGKG 525
K S + P+Q + P + + ++F EL+ AT GFKE E+G+G
Sbjct: 476 FDKNSVEADPDPV--PHQS---VLLPT--AVSLGETKIFRLSELKDATHGFKEFNELGRG 528
Query: 526 SFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR 585
SF VYK VL DG VAVK+A A + N++ F +EL++L ++ H +++NLLGYC E
Sbjct: 529 SFGFVYKAVLSDGIHVAVKRANAATIIHSNNRGFESELEILCKIRHNNIVNLLGYCSEMG 588
Query: 586 ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRD 645
ERLLVYE+M HG+LH HLHG QLDW R+ I +QAARG++YLH PP+IHRD
Sbjct: 589 ERLLVYEYMPHGTLHDHLHGD----LSQLDWSMRLKIMLQAARGLDYLHNEVDPPIIHRD 644
Query: 646 IKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDV 705
+K+SNIL+D E AR+ADFGL DSS+ E DV
Sbjct: 645 VKTSNILLDGEMCARIADFGLVSSNERDSSNSDRE----------------------GDV 682
Query: 706 YSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIA 765
Y FG++LLEILSGRKAID + + I EWAVPLI+ G AI+D + LP +++ L ++A
Sbjct: 683 YDFGIVLLEILSGRKAIDRESDPAGIAEWAVPLIRKGKAAAIIDRNICLPRNVEPLLKLA 742
Query: 766 NVACKCVRMRGKERPSMDKVTTALE 790
+A VR ERP++ + L+
Sbjct: 743 ELAELAVRENSNERPNIRNILCFLD 767
|
Serine/threonine-protein kinase with low activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIJ6|ACCR4_ARATH Serine/threonine-protein kinase-like protein CCR4 OS=Arabidopsis thaliana GN=CCR4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 320 bits (819), Expect = 4e-86, Method: Compositional matrix adjust.
Identities = 261/814 (32%), Positives = 379/814 (46%), Gaps = 150/814 (18%)
Query: 39 SMSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSA--IIYGTPAHFPFIGLTAGDGFVCG 96
S+S+++IS+ N + C L + + + NS + G + F G+ +G+GFVCG
Sbjct: 31 SLSTVSISHISNQTLVCALNNHSYLQCSSFPLNSIPFSLTGNLRNRRFSGVVSGNGFVCG 90
Query: 97 LL--LDSNQP--YCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYS 152
L+ LDSN CW S + + I G + E+ AG++ +CG+ + ++ + R
Sbjct: 91 LISRLDSNTSTLLCWRFSVDGTNMLHKRIYHGPELEELEAGNFRICGVER-VSRRLR--- 146
Query: 153 YVDCWG-YNMTK--NYVFDGQIESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKE 209
CW Y + + NY SI+ G F CGL + C G I+ +P
Sbjct: 147 ---CWQPYYLPRPDNY------RSIALGDNFFCGLSQPPGMISCEG-------IAKVPSG 190
Query: 210 MKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVG 269
+ +AAG C I +D+ CWG++ L P + L++
Sbjct: 191 DHYIAIAAGSRQACAIT--VDNDVECWGQTQSL-----------------PREKFLALAV 231
Query: 270 GKFHACGIKSYDRGVICWGFIIKPSTP-VPTGIKVYEIAAGNYFTCGVLAEKSMLPVCWG 328
G+ CG++ + V+CWG S P I I A CGV A ++ +CWG
Sbjct: 232 GEDRGCGVRWSNGTVVCWGNNNNFSLPQTLKDIHFTSIYAKGPMFCGV-ATRNYTLICWG 290
Query: 329 ---------TGFPTSLPLAVSPGLCKMTPCAPGYYEASQENAPCKSPNAHVCITCSNGCP 379
T F + V PG C+ C SQ C N
Sbjct: 291 NENFKSGVFTPFQGLISQVVMPGPCRRE-CPYRPLSGSQS-------------LCGN--- 333
Query: 380 VEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSSQFSDGLTTKKNEKFWSMQLPVIIAE 439
+ C LK + +F D K WS +
Sbjct: 334 ----ELMICDLKRN-------------------DGEFPDTRAQNSKNKTWSRR------- 363
Query: 440 ITIAVFLITVVTLISILYV-RYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDFDDL 498
IA ++ V S+L V + + C + S + + D I D L
Sbjct: 364 -NIAFLVVGCVGTFSLLLVISFLIFKSHCRCRVHDSGRLD--------DTRTI--DIPKL 412
Query: 499 KIRRAQM-----------FTYEELERATGGF--KEEVGKGSFSCVYKGVLKDGTVVAVKK 545
+ R + F+ +EL AT GF + +G GSF VY+GVL DG VA+K+
Sbjct: 413 EKRLCTLASLGNPGQLMEFSIDELALATDGFSVRFHLGIGSFGSVYQGVLSDGRHVAIKR 472
Query: 546 AIATS----------DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595
A T+ R F EL+ +SRLNH +L+ LLG+ E+ ER+LVYE+M
Sbjct: 473 AELTNPTLSGTTMRHRRADKDSAFVNELESMSRLNHKNLVRLLGFYEDTEERILVYEYMK 532
Query: 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE 655
+GSL HLH + L W R+ IA+ AARGI+YLH + PPVIHRDIKSSNIL+D
Sbjct: 533 NGSLADHLHNPQF---DPLSWQTRLMIALDAARGIQYLHEFIVPPVIHRDIKSSNILLDA 589
Query: 656 EHNARVADFGLSLLGPA--DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLL 713
A+V+DFGLS +GP D S L+ AGTLGY+DPEYY+ LTTKSDVYSFGV+LL
Sbjct: 590 TWTAKVSDFGLSQMGPTEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTKSDVYSFGVVLL 649
Query: 714 EILSGRKAIDMQFEEG--NIVEWAVPLIKSGDITAILDPVLKLPS--DLDALKRIANVAC 769
E+LSG KAI +E N+VE+ VP I + ILD + P+ +++A+ + +A
Sbjct: 650 ELLSGHKAIHNNEDENPRNLVEYVVPYILLDEAHRILDQRIPPPTPYEIEAVAHVGYLAA 709
Query: 770 KCVRMRGKERPSMDKVTTALERALAQLMGSPCSE 803
+C+ ++RPSM +V + LE ALA + +P +E
Sbjct: 710 ECLMPCSRKRPSMVEVVSKLESALAACLTAPKTE 743
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGI2|Y1677_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g67720 OS=Arabidopsis thaliana GN=At1g67720 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (660), Expect = 1e-67, Method: Compositional matrix adjust.
Identities = 137/285 (48%), Positives = 187/285 (65%), Gaps = 7/285 (2%)
Query: 511 LERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN 570
LE AT F ++VG+GSF VY G +KDG VAVK I +++F TE+ LLSR++
Sbjct: 601 LEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVK--ITADPSSHLNRQFVTEVALLSRIH 658
Query: 571 HAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
H +L+ L+GYCEE R+LVYE+M +GSL HLHG S + LDW+ R+ IA AA+G+
Sbjct: 659 HRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDY--KPLDWLTRLQIAQDAAKGL 716
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLD 690
EYLH P +IHRD+KSSNIL+D A+V+DFGLS D + ++ + GT+GYLD
Sbjct: 717 EYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTH-VSSVAKGTVGYLD 775
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQF--EEGNIVEWAVPLIKSGDITAIL 748
PEYY LT KSDVYSFGV+L E+LSG+K + + E NIV WA LI+ GD+ I+
Sbjct: 776 PEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGII 835
Query: 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
DP + ++++ R+A VA +CV RG RP M +V A++ A+
Sbjct: 836 DPCIASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAI 880
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LY50|ACCR3_ARATH Putative serine/threonine-protein kinase-like protein CCR3 OS=Arabidopsis thaliana GN=CCR3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 258 bits (658), Expect = 2e-67, Method: Compositional matrix adjust.
Identities = 147/315 (46%), Positives = 205/315 (65%), Gaps = 23/315 (7%)
Query: 502 RAQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE- 558
+A+ F++ EL ATG F E +G GSF VY+G L DG VA+K+ + +K ++
Sbjct: 480 KAEEFSFSELASATGNFSLENKIGSGSFGVVYRGKLNDGREVAIKRGEVNAKMKKFQEKE 539
Query: 559 --FHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQL-- 614
F +E+ LSRL+H HL+ L+GYCEE E+LLVY++M +G+L+ HLH K+ K
Sbjct: 540 TAFDSEIAFLSRLHHKHLVRLVGYCEEREEKLLVYDYMKNGALYDHLHDKNNVEKHSSLI 599
Query: 615 -DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP-- 671
W R+ IA+ AARGIEYLH YA PP+IHRDIKSSNIL+D ARV+DFGLSL+GP
Sbjct: 600 NSWKMRIKIALDAARGIEYLHNYAVPPIIHRDIKSSNILLDSNWVARVSDFGLSLMGPVL 659
Query: 672 ADSSSPLAE--LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAI-----DM 724
+P AGT+GY+DPEYY L+ LT KSDVY GV+LLE+L+G++AI D+
Sbjct: 660 GKDHNPYQRPTKAAGTVGYIDPEYYSLNVLTDKSDVYGLGVVLLELLTGKRAIFRNNGDV 719
Query: 725 QFEEG----NIVEWAVPLIKSGDITAILDPVLKLPS--DLDALKRIANVACKCVRMRGKE 778
+ EEG ++V+++VP I + +++ ILDP + P + DA++ +A A CV G+
Sbjct: 720 EEEEGCVPVHLVDYSVPAITADELSTILDPRVGSPELGEGDAVELVAYTAMHCVNAEGRN 779
Query: 779 RPSMDKVTTALERAL 793
RP+M + LERAL
Sbjct: 780 RPTMTDIVGNLERAL 794
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L4H4|NORK_MEDTR Nodulation receptor kinase OS=Medicago truncatula GN=NORK PE=1 SV=2 | Back alignment and function description |
|---|
Score = 254 bits (649), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 169/449 (37%), Positives = 247/449 (55%), Gaps = 37/449 (8%)
Query: 409 YKNCSSQFSDGLTTKKNEKFWSMQL------------PVIIAEITIAVFLITVVTLISIL 456
Y C+ SD TTK N + +I IT LIT+ I +
Sbjct: 484 YFGCNPSMSDEDTTKLNSSLINTDYGRCKAKKPKFGQVFVIGAITSGSLLITLAVGI-LF 542
Query: 457 YVRYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKI--RPDFDDLKIRRAQM--FTYEELE 512
+ RYR KS G G Y I P DD I+ + FT E +E
Sbjct: 543 FCRYR----------HKSITLEGFGKTYPMATNIIFSLPSKDDFFIKSVSVKPFTLEYIE 592
Query: 513 RATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA 572
+AT +K +G+G F VY+G L DG VAVK + +S + ++EF EL+LLS + H
Sbjct: 593 QATEQYKTLIGEGGFGSVYRGTLDDGQEVAVK--VRSSTSTQGTREFDNELNLLSAIQHE 650
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+L+ LLGYC E +++LVY FM++GSL L+G++ ++ LDW R++IA+ AARG+ Y
Sbjct: 651 NLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGEASK-RKILDWPTRLSIALGAARGLAY 709
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
LH + VIHRD+KSSNIL+D+ A+VADFG S P + S ++ GT GYLDPE
Sbjct: 710 LHTFPGRSVIHRDVKSSNILLDQSMCAKVADFGFSKYAPQEGDSYVSLEVRGTAGYLDPE 769
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFE--EGNIVEWAVPLIKSGDITAILDP 750
YY+ L+ KSDV+SFGV+LLEI+SGR+ ++++ E ++VEWA P I++ + I+DP
Sbjct: 770 YYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRIEWSLVEWAKPYIRASKVDEIVDP 829
Query: 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTE 810
+K +AL R+ VA +C+ RP M + LE AL ++ + SE + +
Sbjct: 830 GIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELEDAL--IIENNASEY-MKSID 886
Query: 811 VVLGSNRMHKKSSQRS--SNRSTSETDVA 837
+ GSNR +R+ S ST+E+ +
Sbjct: 887 SLGGSNRYSIVMDKRALPSTTSTAESTIT 915
|
Involved in the perception of symbiotic fungi and bacteria. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Medicago truncatula (taxid: 3880) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LKZ1|NORK_PEA Nodulation receptor kinase OS=Pisum sativum GN=NORK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 253 bits (647), Expect = 4e-66, Method: Compositional matrix adjust.
Identities = 161/408 (39%), Positives = 237/408 (58%), Gaps = 20/408 (4%)
Query: 436 IIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDF 495
+I IT LIT+ +I + + RYR ++ G K+ P + P
Sbjct: 521 MIGAITSGSILITLAVVI-LFFCRYRHKSITLEGFGGKTY-------PMATNIIFSLPSK 572
Query: 496 DDLKIRRAQM--FTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQ 553
DD I+ + FT E +E AT +K +G+G F VY+G L DG VAVK ATS
Sbjct: 573 DDFFIKSVSVKPFTLEYIELATEKYKTLIGEGGFGSVYRGTLDDGQEVAVKVRSATS--T 630
Query: 554 KNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ 613
+ ++EF EL+LLS + H +L+ LLGYC E +++LVY FM++GSL L+G+ A ++
Sbjct: 631 QGTREFDNELNLLSAIQHENLVPLLGYCNEYDQQILVYPFMSNGSLLDRLYGE-PAKRKI 689
Query: 614 LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673
LDW R++IA+ AARG+ YLH + VIHRD+KSSNIL+D A+VADFG S P +
Sbjct: 690 LDWPTRLSIALGAARGLAYLHTFPGRSVIHRDVKSSNILLDHSMCAKVADFGFSKYAPQE 749
Query: 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFE--EGNI 731
S ++ GT GYLDPEYY+ L+ KSDV+SFGV+LLEI+SGR+ ++++ E ++
Sbjct: 750 GDSYVSLEVRGTAGYLDPEYYKTQQLSEKSDVFSFGVVLLEIVSGREPLNIKRPRVEWSL 809
Query: 732 VEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
VEWA P I++ + I+DP +K +AL R+ VA +C+ RP M + LE
Sbjct: 810 VEWAKPYIRASKVDEIVDPGIKGGYHAEALWRVVEVALQCLEPYSTYRPCMVDIVRELED 869
Query: 792 ALAQLMGSPCSEQPILPTEVVLGSNRMHKKSSQRS--SNRSTSETDVA 837
AL ++ + SE + + + GSNR +R+ S ST+E+ +
Sbjct: 870 AL--IIENNASEY-MKSIDSLGGSNRYSIVMDKRALPSTTSTAESTIT 914
|
Involved in the perception of symbiotic fungi and bacteria and required for the calcium spiking. Part of the perception/transduction system leading to nodulation or mycorrhizal infection. Pisum sativum (taxid: 3888) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG6|Y5189_ARATH Probable LRR receptor-like protein kinase At1g51890 OS=Arabidopsis thaliana GN=At1g51890 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 253 bits (646), Expect = 5e-66, Method: Compositional matrix adjust.
Identities = 141/363 (38%), Positives = 207/363 (57%), Gaps = 21/363 (5%)
Query: 435 VIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPD 494
V IA +VF + V+ I + +R K Q+TN A P G ++ D
Sbjct: 499 VAIAASVASVFAVLVILAIVFVVIR-------------KKQRTNEASGPRSFTTGTVKSD 545
Query: 495 ---FDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSD 551
I + + FTY E+ + T F+ +GKG F VY G L D T VAVK + +
Sbjct: 546 ARSSSSSIITKERKFTYSEVLKMTKNFERVLGKGGFGTVYHGNLDD-TQVAVK--MLSHS 602
Query: 552 RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALK 611
+ KEF E++LL R++H HL+ L+GYC++G L+YE+M G L +++ GK
Sbjct: 603 SAQGYKEFKAEVELLLRVHHRHLVGLVGYCDDGDNLALIYEYMEKGDLRENMSGKHSV-- 660
Query: 612 EQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671
L W R+ IAV+AA+G+EYLH PP++HRD+K +NIL++E A++ADFGLS P
Sbjct: 661 NVLSWETRMQIAVEAAQGLEYLHNGCRPPMVHRDVKPTNILLNERSQAKLADFGLSRSFP 720
Query: 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNI 731
D S + + AGT GYLDPEYYR ++L+ KSDVYSFGV+LLEI++ + ++ E +I
Sbjct: 721 VDGESHVMTVVAGTPGYLDPEYYRTNWLSEKSDVYSFGVVLLEIVTNQPVMNKNRERPHI 780
Query: 732 VEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
EW + ++ +GDI +I+DP L D + + ++ +A CV RP+M V L
Sbjct: 781 NEWVMFMLTNGDIKSIVDPKLNEDYDTNGVWKVVELALACVNPSSSRRPTMPHVVMELNE 840
Query: 792 ALA 794
LA
Sbjct: 841 CLA 843
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 914 | ||||||
| 255585507 | 920 | receptor protein kinase, putative [Ricin | 0.987 | 0.981 | 0.833 | 0.0 | |
| 449468776 | 921 | PREDICTED: serine/threonine-protein kina | 0.997 | 0.990 | 0.800 | 0.0 | |
| 224093146 | 906 | predicted protein [Populus trichocarpa] | 0.977 | 0.985 | 0.813 | 0.0 | |
| 225433874 | 926 | PREDICTED: serine/threonine-protein kina | 0.990 | 0.977 | 0.817 | 0.0 | |
| 224133142 | 878 | predicted protein [Populus trichocarpa] | 0.954 | 0.993 | 0.813 | 0.0 | |
| 356544518 | 917 | PREDICTED: serine/threonine-protein kina | 0.978 | 0.974 | 0.791 | 0.0 | |
| 356547312 | 900 | PREDICTED: serine/threonine-protein kina | 0.968 | 0.983 | 0.758 | 0.0 | |
| 357454477 | 921 | Serine/threonine protein kinase-like pro | 0.983 | 0.976 | 0.745 | 0.0 | |
| 356557366 | 857 | PREDICTED: serine/threonine-protein kina | 0.926 | 0.988 | 0.763 | 0.0 | |
| 15231681 | 895 | serine/threonine-protein kinase-like pro | 0.969 | 0.989 | 0.697 | 0.0 |
| >gi|255585507|ref|XP_002533445.1| receptor protein kinase, putative [Ricinus communis] gi|223526707|gb|EEF28941.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1576 bits (4080), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 757/908 (83%), Positives = 833/908 (91%), Gaps = 5/908 (0%)
Query: 11 WVLKI--LKTGFVVHFLMLSNLLRLVNGLGSMSSIAISYGENGPVFCGLKSDRSHLVTCY 68
WV K+ G V+ ++LS+L L +GLGSMSSIAISYGENGPVFCGLKSD SHLVTCY
Sbjct: 14 WVFKVSTWNAGTVIPIVVLSDLWWLGSGLGSMSSIAISYGENGPVFCGLKSDGSHLVTCY 73
Query: 69 GSNSAIIYGTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQPIIKGAQYV 128
GSNSAIIYGTPAHFPF+GL+AGDGFVCG+L+ SNQPYCWG+SGYIQMGVPQP++K A+Y+
Sbjct: 74 GSNSAIIYGTPAHFPFVGLSAGDGFVCGILMGSNQPYCWGNSGYIQMGVPQPMVKNAEYI 133
Query: 129 EISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQIESISAGSEFNCGLFSQN 188
EISAGDYHLCGLRKPLTG+ RNYS VDCWGYNMTKNYVFDGQI+SISAGSEFNCGLFSQN
Sbjct: 134 EISAGDYHLCGLRKPLTGRHRNYSLVDCWGYNMTKNYVFDGQIQSISAGSEFNCGLFSQN 193
Query: 189 RTVFCWGDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSV 248
R+VFCWGDE+SSRVISLIPKE++FQ++AAGGYHVCGILE ++SR CWGRSLDLEEE+SV
Sbjct: 194 RSVFCWGDETSSRVISLIPKELRFQRIAAGGYHVCGILE-INSRAYCWGRSLDLEEEISV 252
Query: 249 AYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAA 308
YS QGNVDLPPSDPMLS+VGGKFHACGIKSYD VICWGFI+KPSTP P GIKVYEIAA
Sbjct: 253 TYSGQGNVDLPPSDPMLSVVGGKFHACGIKSYDHRVICWGFIVKPSTPAPNGIKVYEIAA 312
Query: 309 GNYFTCGVLAEKSMLPVCWGTGFPTSLPLAVSPGLCKMTPCAPGYYEASQENAPCKSPNA 368
GNYF+CG+LAEKS LPVCWG GFP+SLPLAVSPGLC+ TPCA G YE S +NAPCKSP++
Sbjct: 313 GNYFSCGILAEKSFLPVCWGLGFPSSLPLAVSPGLCRSTPCALGSYEFSNDNAPCKSPSS 372
Query: 369 HVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSSQFSDGLTTKKNEKF 428
HVC+ CSNGCP EMY+ ECT K DR+C+YNCSSC+SAEC+ NCS+ + D KK+ KF
Sbjct: 373 HVCLPCSNGCPAEMYEKTECTAKLDRLCDYNCSSCYSAECFSNCSALYFDAAKGKKDNKF 432
Query: 429 WSMQLPVIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSPYQKDN 488
WS+QLPVII EI AVFL+ VV+ ++L+VRYRLRNCQCS K SKS++ G G+ + KDN
Sbjct: 433 WSLQLPVIIVEIGFAVFLMVVVSATAVLWVRYRLRNCQCSAKESKSKRNKGGGASFTKDN 492
Query: 489 GKIRPDFDDLKIRRAQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLKDGTVVAVKKA 546
GKIRPD D+LKIRRAQMF+YEELERAT GFKEE VGKGSFSCVYKGV+K+GTVVAVKKA
Sbjct: 493 GKIRPDLDELKIRRAQMFSYEELERATNGFKEESLVGKGSFSCVYKGVMKNGTVVAVKKA 552
Query: 547 IATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGK 606
I +SD+QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG ERLLVYEFMAHGSLHQHLHGK
Sbjct: 553 IVSSDKQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGGERLLVYEFMAHGSLHQHLHGK 612
Query: 607 SKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666
+K LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL
Sbjct: 613 NKVLKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 672
Query: 667 SLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQF 726
SLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGV+LLEILSGRKAIDMQ+
Sbjct: 673 SLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVMLLEILSGRKAIDMQY 732
Query: 727 EEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVT 786
EEGNIVEWAVPLIKSGDI+AILDPVLK PSDL+ALKRIANVACKCVRM+GKERPSMDKVT
Sbjct: 733 EEGNIVEWAVPLIKSGDISAILDPVLKKPSDLEALKRIANVACKCVRMKGKERPSMDKVT 792
Query: 787 TALERALAQLMGSPCSEQPILPTEVVLGSNRMHKKSSQRSSNRSTSETDVAEAEDQRFEF 846
TALER+LAQLMGSPC+EQPILPTEVVLGS+R+HKKSSQRSSNRS SETDV EAEDQRFEF
Sbjct: 793 TALERSLAQLMGSPCNEQPILPTEVVLGSSRLHKKSSQRSSNRSASETDVVEAEDQRFEF 852
Query: 847 RAPSWITFPSVTSSQRRKSSVSDADVDGKNLEARNMGNAGSIGDGLRSLEEEIGPASPQE 906
RAPSWITFPSVTSSQRRKSSVS+ADVDGKN EA+N+G + GDGLRSLEEEIGPASPQE
Sbjct: 853 RAPSWITFPSVTSSQRRKSSVSEADVDGKNSEAKNVGCVANAGDGLRSLEEEIGPASPQE 912
Query: 907 NLYLQHNF 914
+L+LQHNF
Sbjct: 913 HLFLQHNF 920
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449468776|ref|XP_004152097.1| PREDICTED: serine/threonine-protein kinase-like protein ACR4-like [Cucumis sativus] gi|449484631|ref|XP_004156935.1| PREDICTED: serine/threonine-protein kinase-like protein ACR4-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1533 bits (3970), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 739/923 (80%), Positives = 824/923 (89%), Gaps = 11/923 (1%)
Query: 1 MGNFSFVEGDWVLKILKT------GFVVHFLMLSNLLRLVNGLGSMSSIAISYGENGPVF 54
MG F V D V+ LK G V ++ +++ LV+GLGSMS +A+SYGE GPVF
Sbjct: 1 MGLFLLV--DLVVSFLKKMCGWRGGLFVELVVFADMCLLVSGLGSMSPLAVSYGEKGPVF 58
Query: 55 CGLKSDRSHLVTCYGSNSAIIYGTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQ 114
CGLKSD SHLV C+GSNSAI YGTP+HFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGY+Q
Sbjct: 59 CGLKSDGSHLVNCFGSNSAITYGTPSHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYVQ 118
Query: 115 MGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQIESI 174
MGVPQP+IKGAQY+EISAGDYHLCGLR PLTG+ RN S+VDCWGYNMT+ + FDG IESI
Sbjct: 119 MGVPQPMIKGAQYLEISAGDYHLCGLRTPLTGRRRNMSFVDCWGYNMTRTFAFDGPIESI 178
Query: 175 SAGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTR 234
SAGSEFNCGLFS NRTVFCWGDE+SSRVISLIPK+M+FQK+A+GGYHVCGILEG +SR
Sbjct: 179 SAGSEFNCGLFSLNRTVFCWGDETSSRVISLIPKDMRFQKIASGGYHVCGILEGANSRAF 238
Query: 235 CWGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPS 294
CWGRSLD+EEE+SVAYS +GNV+L P DP+ S+VGGKFHACGIKS DRGVICWGF +KPS
Sbjct: 239 CWGRSLDIEEEISVAYSGEGNVELVPVDPLASVVGGKFHACGIKSSDRGVICWGFTVKPS 298
Query: 295 TPVPTGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTGFPTSLPLAVSPGLCKMTPCAPGYY 354
TP P GIKVY+IAAG+YFTCG+LAEKS+LPVCWG G+PTSLPLAVSPG+CK TPC PG+Y
Sbjct: 299 TPPPDGIKVYDIAAGDYFTCGILAEKSLLPVCWGLGYPTSLPLAVSPGICKATPCPPGFY 358
Query: 355 EASQENAPCKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSS 414
E SQ+ A CKSPN HVC+ CS+ CP +MY EC+LKSDR CEYNCS+CFS+EC NCSS
Sbjct: 359 EISQDKARCKSPNFHVCMPCSSACPPDMYLKVECSLKSDRQCEYNCSTCFSSECLSNCSS 418
Query: 415 QFSDGLTTKKNEKFWSMQ-LPVIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASK 473
S+G+ +KN K+W +Q LPV++AEI AVFL+ +V+L +ILYVRY+LRNC CSGK K
Sbjct: 419 MLSNGMMGRKNGKYWPVQQLPVLVAEIAFAVFLVAIVSLTAILYVRYKLRNCHCSGKELK 478
Query: 474 SQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEE--VGKGSFSCVY 531
S+K G S +QK++ KIRPD D+LKIRRAQMFTYEELERAT GFKEE VGKGSFSCV+
Sbjct: 479 SKKNKGTASSFQKESYKIRPDLDELKIRRAQMFTYEELERATCGFKEESIVGKGSFSCVF 538
Query: 532 KGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591
+GVLKDGTVVAVK+AI + + QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG ERLLVY
Sbjct: 539 RGVLKDGTVVAVKRAIMSPNMQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGGERLLVY 598
Query: 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 651
EFMAHGSLHQHLHGK+ ALKEQLDW+RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI
Sbjct: 599 EFMAHGSLHQHLHGKNTALKEQLDWIRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 658
Query: 652 LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL 711
LIDEEHNARVADFGLSLLGP DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL
Sbjct: 659 LIDEEHNARVADFGLSLLGPTDSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL 718
Query: 712 LLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKC 771
LLEILSGRKAIDMQ+EEGNIVEWAVPLI+SGDI+AILDP+LK PSD +ALKRIANVACKC
Sbjct: 719 LLEILSGRKAIDMQYEEGNIVEWAVPLIRSGDISAILDPILKPPSDAEALKRIANVACKC 778
Query: 772 VRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTEVVLGSNRMHKKSSQRSSNRST 831
VRMR KERPSMDKVTTALERALAQLMGSPC+EQPILPTEVVLGS+R+HKKSSQRSSNRS
Sbjct: 779 VRMRAKERPSMDKVTTALERALAQLMGSPCNEQPILPTEVVLGSSRLHKKSSQRSSNRSV 838
Query: 832 SETDVAEAEDQRFEFRAPSWITFPSVTSSQRRKSSVSDADVDGKNLEARNMGNAGSIGDG 891
SETD+AEAEDQRFEFRAPSWITFPSVTSSQRRKSSVS+ADVDGKNLE +N+GN G +GDG
Sbjct: 839 SETDIAEAEDQRFEFRAPSWITFPSVTSSQRRKSSVSEADVDGKNLEGKNVGNCGGVGDG 898
Query: 892 LRSLEEEIGPASPQENLYLQHNF 914
L+SLEEEIGPASPQE L+L+HNF
Sbjct: 899 LKSLEEEIGPASPQEKLFLEHNF 921
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224093146|ref|XP_002309807.1| predicted protein [Populus trichocarpa] gi|222852710|gb|EEE90257.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1505 bits (3896), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 734/902 (81%), Positives = 809/902 (89%), Gaps = 9/902 (0%)
Query: 19 GFVVHFLMLSNLLRLVNGLGSMSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGT 78
G++VHF++LS+L LV+GLGSMSSIAISYGENGPVFCGLKSD SHLV CYGSNSAIIYGT
Sbjct: 8 GYLVHFVVLSDLWWLVSGLGSMSSIAISYGENGPVFCGLKSDGSHLVNCYGSNSAIIYGT 67
Query: 79 PAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLC 138
PAHF FIGLTAGDGFVCGLLL+SNQPYCWGSSGY++ GVP+P+++ A+YVEISAGDYHLC
Sbjct: 68 PAHFHFIGLTAGDGFVCGLLLESNQPYCWGSSGYLRPGVPRPMMEEAEYVEISAGDYHLC 127
Query: 139 GLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQIESISAGSEFNCGLFSQNRTVFCWGDES 198
GLRKP TG+ RN S +DCWGYNMT+N+VFDGQI+SISAGSEFNCGLFS+NRTVFCWGDE+
Sbjct: 128 GLRKPSTGRSRNLSLIDCWGYNMTRNHVFDGQIQSISAGSEFNCGLFSENRTVFCWGDEA 187
Query: 199 SSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSV---AYSRQGN 255
+SRVISLIP+EM+FQK+AAGGYHVCGILEG++SR CWGRSL LEEE+SV AY QGN
Sbjct: 188 NSRVISLIPQEMRFQKIAAGGYHVCGILEGVNSRAFCWGRSLGLEEEISVISAAYLNQGN 247
Query: 256 VDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGNYFTCG 315
VD PPSDPMLS+VGGKFHACGIKSYDR VICWG+I+K STP P+ IKVYEIAAGNYFTCG
Sbjct: 248 VDFPPSDPMLSVVGGKFHACGIKSYDREVICWGYIVKRSTPTPSAIKVYEIAAGNYFTCG 307
Query: 316 VLAEKSMLPVCWGTGFPTSLPLAVSPGLCKMTPCAPGYYEASQENAPCKSPNAHVCITCS 375
+LAEKS+ PVCWG FP+SLPLAVSPGLC+ TPC PG YE N PCKSP++H C+ CS
Sbjct: 308 ILAEKSLFPVCWGLEFPSSLPLAVSPGLCETTPCPPGSYEFFDANPPCKSPDSHACLPCS 367
Query: 376 NGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSSQFSDGLTTKKNEKFWSMQLPV 435
NGCP EMYQ ECTLKSDR C+YNCSSC+SAEC+ NCSS +S+ K +FWS++LPV
Sbjct: 368 NGCPAEMYQKMECTLKSDRQCDYNCSSCYSAECFSNCSSLYSN--NAKGKNRFWSLELPV 425
Query: 436 IIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDF 495
+IAEI +AVFL+ VVT +ILYV YRLRNCQCS K K +K NG G+ KDNGKIR D
Sbjct: 426 VIAEIGLAVFLVIVVTTTAILYVHYRLRNCQCSAKQLKPKKNNGGGTSVSKDNGKIRTDM 485
Query: 496 DDLKIRRAQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQ 553
D++K+RRA+MFTYEELE AT GFKEE VGKGSFSCVYKGVLK+GTVVAVKKAI +D+Q
Sbjct: 486 DEIKLRRARMFTYEELEGATSGFKEESIVGKGSFSCVYKGVLKNGTVVAVKKAIVCTDKQ 545
Query: 554 KNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ 613
KNSKEFHTELDLLSRLNHAHLLNLLGYCEEG ERLLVYEFMAHGSL+QHLHGK+ AL EQ
Sbjct: 546 KNSKEFHTELDLLSRLNHAHLLNLLGYCEEGGERLLVYEFMAHGSLYQHLHGKNPALIEQ 605
Query: 614 LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673
LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARV+DFGLSLLGPAD
Sbjct: 606 LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVSDFGLSLLGPAD 665
Query: 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS RKAIDMQ+EEGNIVE
Sbjct: 666 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSSRKAIDMQYEEGNIVE 725
Query: 734 WAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
WAVPLIK+GDI+AILDP LK PSD +ALKRIANVACKCVRMRGKERPSMDKVTTALERAL
Sbjct: 726 WAVPLIKAGDISAILDPALKPPSDPEALKRIANVACKCVRMRGKERPSMDKVTTALERAL 785
Query: 794 AQLMGSPCSEQPILPTEVVLGSNRMHKKSSQRSSNRS-TSETDVAEAEDQRFEFRAPSWI 852
AQLMGSPC++QPILPTEVVLGS+RMHKKSSQRSSN+S SETDV E EDQR EFRAPSWI
Sbjct: 786 AQLMGSPCNDQPILPTEVVLGSSRMHKKSSQRSSNQSAVSETDVVEGEDQRIEFRAPSWI 845
Query: 853 TFPSVTSSQRRKSSVSDADVDGKNLEARNMGNAGSIGDGLRSLEEEIGPASPQENLYLQH 912
TFPSVTSSQ RKSS SDADVDGK+ ARN+G S+GD LRSLEEEIGPASPQE L+LQH
Sbjct: 846 TFPSVTSSQGRKSSASDADVDGKS-SARNLGYVASVGDALRSLEEEIGPASPQERLFLQH 904
Query: 913 NF 914
NF
Sbjct: 905 NF 906
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225433874|ref|XP_002264936.1| PREDICTED: serine/threonine-protein kinase-like protein ACR4 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1500 bits (3883), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 747/914 (81%), Positives = 827/914 (90%), Gaps = 9/914 (0%)
Query: 10 DWVLKI--LKTGFVVH---FLMLSNLLRLVNGLGSMSSIAISYGENGPVFCGLKSDRSHL 64
+WVLKI + F+V ++ SNL LV+GLGSMSSIAISYGENGPVFCGLKSD SHL
Sbjct: 13 NWVLKIQTWQAVFLVQIRVLVVFSNLWWLVSGLGSMSSIAISYGENGPVFCGLKSDGSHL 72
Query: 65 VTCYGSNSAIIYGTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQPIIKG 124
VTCYGSNSAIIYGTPAHFPF+GLTAGDGFVCGLL+DSNQPYCWGSS Y+QMGVPQP+IKG
Sbjct: 73 VTCYGSNSAIIYGTPAHFPFMGLTAGDGFVCGLLVDSNQPYCWGSSRYVQMGVPQPMIKG 132
Query: 125 AQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQIESISAGSEFNCGL 184
A+Y+EISAGDYHLCGLR+PLTG+ RNYS VDCWGYNMT++Y FDGQ++SISAGSEFNCGL
Sbjct: 133 AEYLEISAGDYHLCGLREPLTGRLRNYSLVDCWGYNMTRSYRFDGQLQSISAGSEFNCGL 192
Query: 185 FSQNRTVFCWGDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWG-RSLDLE 243
FSQNRTVFCWGDE+SSRV SLIP+EM+FQK+AAGGYHVCGILEG +SR CWG RSLD+E
Sbjct: 193 FSQNRTVFCWGDETSSRVTSLIPQEMRFQKIAAGGYHVCGILEGANSRVFCWGGRSLDIE 252
Query: 244 EEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKV 303
EE+S AY+ QGNVD P DPMLS+VGGKFHACGI+S DRGV CWGF +K ST P GIKV
Sbjct: 253 EEISTAYTGQGNVDSAPKDPMLSVVGGKFHACGIRSSDRGVTCWGFRVKTSTLPPDGIKV 312
Query: 304 YEIAAGNYFTCGVLAEKSMLPVCWGTGFPTSLPLAVSPGLCKMTPCAPGYYEASQENAPC 363
YEIAAGNYFTCG+LAEKS+LPVCWG GFP+SLPLAVSPGLC +PC PG+YE + E+ PC
Sbjct: 313 YEIAAGNYFTCGILAEKSLLPVCWGLGFPSSLPLAVSPGLCTPSPCLPGFYEFNHESPPC 372
Query: 364 KSPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSSQ-FSDGLTT 422
KS N+HVC+ CS+ C +MYQ AECTLKSDR CE+NCS C+SAEC+ NCSS +++ +T
Sbjct: 373 KSLNSHVCLPCSSACLDDMYQKAECTLKSDRQCEFNCSGCYSAECFSNCSSSSYANAITG 432
Query: 423 KKNEKFWSMQLPVIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGS 482
+K E+FWS+QLPV++AE+ AVFL+++V+L +ILYVRY+LRNC+CS K KS+K GS
Sbjct: 433 RKTERFWSLQLPVVVAEVAFAVFLVSIVSLTTILYVRYKLRNCRCSDKGLKSKKGKANGS 492
Query: 483 PYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLKDGTV 540
+Q DN KIRPD D+LKIRRAQ FTY+ELERATGGFKEE VGKGSFSCV+KGVLKDGTV
Sbjct: 493 SFQNDNSKIRPDLDELKIRRAQTFTYDELERATGGFKEESQVGKGSFSCVFKGVLKDGTV 552
Query: 541 VAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLH 600
VAVK+A +SD +KNSKEFHTELDLLSRLNHAHLLNLLGYCEEG ERLLVYEFMAHGSLH
Sbjct: 553 VAVKRATMSSDMKKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGGERLLVYEFMAHGSLH 612
Query: 601 QHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNAR 660
QHLHGK+KALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNAR
Sbjct: 613 QHLHGKNKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNAR 672
Query: 661 VADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRK 720
VADFGLSLLGPADS SPLAE PAGT GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRK
Sbjct: 673 VADFGLSLLGPADSGSPLAEPPAGTFGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRK 732
Query: 721 AIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERP 780
AIDMQF+EGNIVEWAVPLIKSGDI+AILDPVLK PSDL+ALKRIA VA KCVRMRGKERP
Sbjct: 733 AIDMQFDEGNIVEWAVPLIKSGDISAILDPVLKPPSDLEALKRIATVAYKCVRMRGKERP 792
Query: 781 SMDKVTTALERALAQLMGSPCSEQPILPTEVVLGSNRMHKKSSQRSSNRSTSETDVAEAE 840
SMDKVTTALERALAQLMGSPC+EQPILPTEVVLGS+R+HKKSSQRSSNRS SETDVAEAE
Sbjct: 793 SMDKVTTALERALAQLMGSPCNEQPILPTEVVLGSSRLHKKSSQRSSNRSVSETDVAEAE 852
Query: 841 DQRFEFRAPSWITFPSVTSSQRRKSSVSDADVDGKNLEARNMGNAGSIGDGLRSLEEEIG 900
DQRFEFRAPSWITFPSV SSQRRKSSVS+ADVDGKNLEARN+G+ G+ GDGLRSLEEEIG
Sbjct: 853 DQRFEFRAPSWITFPSVASSQRRKSSVSEADVDGKNLEARNLGSGGNGGDGLRSLEEEIG 912
Query: 901 PASPQENLYLQHNF 914
PASPQENL+LQHNF
Sbjct: 913 PASPQENLFLQHNF 926
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224133142|ref|XP_002327971.1| predicted protein [Populus trichocarpa] gi|222837380|gb|EEE75759.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1472 bits (3811), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 717/881 (81%), Positives = 799/881 (90%), Gaps = 9/881 (1%)
Query: 40 MSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGTPAHFPFIGLTAGDGFVCGLLL 99
MSSIAISYGE GP FCG+KSD SHLV CYGSNSAII+ TPA+FPFIGLTAGDGFVCGLLL
Sbjct: 1 MSSIAISYGEKGPAFCGIKSDGSHLVNCYGSNSAIIHETPAYFPFIGLTAGDGFVCGLLL 60
Query: 100 DSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGY 159
+SN+PYCWGSSGY++ GVPQP+++ A+YVEISAGDYHLCGLRKPLTG+ RN S +DCWGY
Sbjct: 61 ESNRPYCWGSSGYLRPGVPQPMMEEAEYVEISAGDYHLCGLRKPLTGRRRNLSLIDCWGY 120
Query: 160 NMTKNYVFDGQIESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQKVAAGG 219
NMT+N+VFDGQI+SISAGS+FNCGLFS+NRTVFCWGD++SSRVISL+P+EM+FQK+AAGG
Sbjct: 121 NMTRNHVFDGQIQSISAGSDFNCGLFSENRTVFCWGDQASSRVISLVPQEMRFQKIAAGG 180
Query: 220 YHVCGILEGLDSRTRCWGRSLDLEEEVSV---AYSRQGNVDLPPSDPMLSIVGGKFHACG 276
YHVCGILEG++SR CWGRSLDLEEE+SV AY QGNVDLPPSDPMLS+VGGKFHACG
Sbjct: 181 YHVCGILEGVNSRAFCWGRSLDLEEEISVISAAYVNQGNVDLPPSDPMLSVVGGKFHACG 240
Query: 277 IKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTGFPTSLP 336
IKSY+R VICWG+I+KPSTP PTGIKVYEIAAGNYFTCG+LAEKS++PVCWG GFP+SLP
Sbjct: 241 IKSYNREVICWGYIVKPSTPTPTGIKVYEIAAGNYFTCGILAEKSLVPVCWGLGFPSSLP 300
Query: 337 LAVSPGLCKMTPCAPGYYEASQENAPCKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVC 396
LAVSPGLCK TPC PG YE + PC SP + C++CSNGCP EMYQ +CT KSDR C
Sbjct: 301 LAVSPGLCKTTPCPPGSYEFVGASTPCTSPGSRACLSCSNGCPAEMYQKTKCTSKSDRQC 360
Query: 397 EYNCSSCFSAECYKNCSSQFSDGLTTKKNEKFWSMQLPVIIAEITIAVFLITVVTLISIL 456
+YNCSSC+S+EC+ NCSS +S+ K+ +FWS+QLPVIIAEI A+FL+ VVT +IL
Sbjct: 361 DYNCSSCYSSECFSNCSSLYSN--NAKEKNRFWSLQLPVIIAEIGFAMFLVVVVTTTAIL 418
Query: 457 YVRYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATG 516
YVRYRLRNCQCS K SK++K +G+GS KDNG+IRPD D++K+RRAQMFTYEELE+AT
Sbjct: 419 YVRYRLRNCQCSAKQSKTKKNSGSGSSDSKDNGRIRPDMDEIKLRRAQMFTYEELEKATS 478
Query: 517 GFKEE--VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHL 574
GFKEE VGKGSFSCVYKGVL++GT+VAVKKAI SD+QKNSKEFHTELDLLSRLNHAHL
Sbjct: 479 GFKEESLVGKGSFSCVYKGVLRNGTLVAVKKAIVCSDKQKNSKEFHTELDLLSRLNHAHL 538
Query: 575 LNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
LNLLGYCEEG ERLLVYEFMAHGSLHQHLHGK+ ALKEQ++WVRRVTIAVQAARGIEYLH
Sbjct: 539 LNLLGYCEEGGERLLVYEFMAHGSLHQHLHGKNPALKEQMNWVRRVTIAVQAARGIEYLH 598
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
GYACPPVIHRDIKSSNILIDEEHNARV+DFGLSLLGPA+SSSPLAELPAGTLGYLDPEYY
Sbjct: 599 GYACPPVIHRDIKSSNILIDEEHNARVSDFGLSLLGPANSSSPLAELPAGTLGYLDPEYY 658
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754
RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQ+EEGNIVEWAVPLIK+GDI+AILDPVLK
Sbjct: 659 RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQYEEGNIVEWAVPLIKAGDISAILDPVLKP 718
Query: 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTEVVLG 814
PSD +ALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSP ++QPILPTEVVLG
Sbjct: 719 PSDPEALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPSNDQPILPTEVVLG 778
Query: 815 SNRMHKKSSQRSSNRS-TSETDVAEAEDQRFEFRAPSWITFPSVTSSQRRKSSVSDADVD 873
S+R+HKKSSQRSSNRS SETDV E EDQR EFRAPSWITFPSVTSSQ RKSS SDADVD
Sbjct: 779 SSRLHKKSSQRSSNRSAVSETDVVEGEDQRIEFRAPSWITFPSVTSSQGRKSSASDADVD 838
Query: 874 GKNLEARNMGNAGSIGDGLRSLEEEIGPASPQENLYLQHNF 914
GK RN+G ++GDGLRSLEEEIGPASPQE L+LQHNF
Sbjct: 839 GKT-STRNLGYVANVGDGLRSLEEEIGPASPQERLFLQHNF 878
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356544518|ref|XP_003540697.1| PREDICTED: serine/threonine-protein kinase-like protein ACR4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1439 bits (3724), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 713/901 (79%), Positives = 793/901 (88%), Gaps = 7/901 (0%)
Query: 18 TGFVVHFLMLSNLLRLVNGLGSMSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYG 77
T + ++LS+L V LGSMSSIAISYGE G VFCGLKSD SH VTCYGSNSAIIYG
Sbjct: 20 TRLLFELVILSHLWLQVTSLGSMSSIAISYGEKGSVFCGLKSDGSHTVTCYGSNSAIIYG 79
Query: 78 TPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHL 137
TP HF F+GLTAGDGFVCGLL+ SNQPYCWGSS YI+MGVPQP+IKGAQY+EISAGDYH+
Sbjct: 80 TPTHFSFLGLTAGDGFVCGLLMGSNQPYCWGSSAYIEMGVPQPMIKGAQYLEISAGDYHV 139
Query: 138 CGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQIESISAGSEFNCGLFSQNRTVFCWGDE 197
CGLRKP+TG+ RN S VDCWGYNMTKNYVF QI+SISAGSEFNCGLFSQNRTVFCWGDE
Sbjct: 140 CGLRKPMTGRHRNISLVDCWGYNMTKNYVFGAQIQSISAGSEFNCGLFSQNRTVFCWGDE 199
Query: 198 SSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVD 257
++S VISLIP +M+F K++AGGYHVCGI EG+ S+T CWGRSL+LEEE+SV+++ QGNVD
Sbjct: 200 TNSLVISLIPHDMRFHKISAGGYHVCGISEGVSSKTFCWGRSLNLEEEISVSHAGQGNVD 259
Query: 258 LPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGNYFTCGVL 317
L P+DPMLS+VGGKFHACGIKSYDRGVICWGFIIKPSTP P GIKV+E+AAG+YFTC VL
Sbjct: 260 LAPNDPMLSVVGGKFHACGIKSYDRGVICWGFIIKPSTPSPKGIKVFEVAAGDYFTCAVL 319
Query: 318 AEKSMLPVCWGTGFPTSLPLAVSPGLCKMTPCAPGYYEASQENAPCKSPNAHVCITCSNG 377
A KS++P CWG FPTSLPLAVSPG+C+ PCAPG Y Q + CKSP++ VC+ CS
Sbjct: 320 AVKSLMPSCWGVDFPTSLPLAVSPGMCQPAPCAPGSYAIDQHKSLCKSPDSRVCMRCSGA 379
Query: 378 CPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSSQFSDGLTT-KKNEKFWSMQLPVI 436
CP EM+ + C L SDRVCEYNCS C S+EC+ NCSS +S+ KK+EKFW++QLPV+
Sbjct: 380 CPPEMHLKSACNLASDRVCEYNCSCCSSSECFLNCSSSYSNAAAAEKKSEKFWALQLPVL 439
Query: 437 IAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDFD 496
IAEI AVF++++V++ ++LY+RYRLR+C+CS K S +K NG S Q +N K+RPD +
Sbjct: 440 IAEIAFAVFVVSIVSITAVLYIRYRLRDCECS-KGSMVKKLNG-NSSLQNEN-KVRPDLE 496
Query: 497 DLKIRRAQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQK 554
+LKIRRAQ FTYEELE AT GFKEE VGKGSFSCV+KGVLKDGTVVAVK+AI + + QK
Sbjct: 497 ELKIRRAQTFTYEELETATSGFKEESIVGKGSFSCVFKGVLKDGTVVAVKRAIVSPNMQK 556
Query: 555 NSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQL 614
NSKEFHTELDLLSRLNHAHLLNLLGYCEEG ERLLVYEFMAHGSLHQHLH ++ L+EQL
Sbjct: 557 NSKEFHTELDLLSRLNHAHLLNLLGYCEEGGERLLVYEFMAHGSLHQHLHATNQVLREQL 616
Query: 615 DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674
DW+RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS
Sbjct: 617 DWIRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 676
Query: 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEW 734
SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQ+EEGNIVEW
Sbjct: 677 GSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQYEEGNIVEW 736
Query: 735 AVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794
AVPLIKSGDITAILDPVLK P DL+ALKRIANVACKCVRMRGKERPSMDKVTTALER LA
Sbjct: 737 AVPLIKSGDITAILDPVLKPPPDLEALKRIANVACKCVRMRGKERPSMDKVTTALERGLA 796
Query: 795 QLMGSPCSEQPILPTEVVLGSNRMHKKSSQRSSNRSTSETDVAEAEDQRFEFRAPSWITF 854
QLMGSPC EQPILPTEVVLGSNR+HKKSSQRSSNRS SETDVAE EDQRFEFRAPSWITF
Sbjct: 797 QLMGSPCIEQPILPTEVVLGSNRLHKKSSQRSSNRSVSETDVAETEDQRFEFRAPSWITF 856
Query: 855 PSVTSSQRRKSSVSDADVDGK-NLEARNMGNAGSIGDGLRSLEEEIGPASPQENLYLQHN 913
PSVTSSQRRKSSVS+ADVDGK N E +NMGN G GD LRSLEEEIGPASP+E L+LQHN
Sbjct: 857 PSVTSSQRRKSSVSEADVDGKNNAEGKNMGNVGGGGDVLRSLEEEIGPASPRERLFLQHN 916
Query: 914 F 914
F
Sbjct: 917 F 917
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547312|ref|XP_003542059.1| PREDICTED: serine/threonine-protein kinase-like protein ACR4-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1392 bits (3603), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 685/903 (75%), Positives = 778/903 (86%), Gaps = 18/903 (1%)
Query: 19 GFVVHFLMLSNLLRLVNGLGSMSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGT 78
G + ++ S L ++ LGSMSSIA+SYG+ G VFCGLKSD SH VTCYG +SAIIYGT
Sbjct: 9 GTLFEVVVFSCLWLQISSLGSMSSIAVSYGDKGSVFCGLKSDGSHTVTCYGIDSAIIYGT 68
Query: 79 PAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLC 138
P HFPF+GLTAGDGFVCGLL+ SNQPYCWGSSG+++MGVPQP++KGAQY+EISAGDYH+C
Sbjct: 69 PTHFPFLGLTAGDGFVCGLLMSSNQPYCWGSSGHVEMGVPQPMVKGAQYLEISAGDYHVC 128
Query: 139 GLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQIESISAGSEFNCGLFSQNRTVFCWGDES 198
GLRKPLTG+ RN S VDCWGYNMT NYVFDGQ++SISAGS+FNCGLFSQNRTVFCWGDE+
Sbjct: 129 GLRKPLTGRHRNTSLVDCWGYNMTNNYVFDGQVQSISAGSQFNCGLFSQNRTVFCWGDET 188
Query: 199 SSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSL-DLEEEVSVAYSR----Q 253
SS+VIS+IP+ M+FQK++AGGYHVCGILEG++SR CWGRSL DL EE+S++ + Q
Sbjct: 189 SSQVISMIPQGMRFQKISAGGYHVCGILEGVNSRAVCWGRSLLDLREELSISLTGSGQGQ 248
Query: 254 GNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGNYFT 313
GNV+L P DPMLS+VGGKFHACGI+SYDRGV+CWG+ K TPVP+GIK +EI AGNYFT
Sbjct: 249 GNVELAPIDPMLSVVGGKFHACGIRSYDRGVVCWGYSFKAGTPVPSGIKAFEIGAGNYFT 308
Query: 314 CGVLAEKSMLPVCWGTGFPTSLPLAVSPGLCKMTPCAPGYYEASQENAPCKSPNAHVCIT 373
CGVL EKS++PVCWG GFPTSLPL VSP +C+ TPC+PGYYE +Q+N CKSP++H+C+
Sbjct: 309 CGVLVEKSLMPVCWGVGFPTSLPLPVSPRMCRSTPCSPGYYE-TQQNGLCKSPDSHICMP 367
Query: 374 CSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSSQFSDGLTTKKNEKFWSMQL 433
CS CP EMYQ + C LKSD +CEYNCS C S EC NCSS +S+ K+ E+FWSMQL
Sbjct: 368 CSAACPPEMYQRSGCNLKSDILCEYNCSICSSPECLSNCSSSYSNAAFGKRTERFWSMQL 427
Query: 434 PVIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRP 493
PV+IAEI AVFL+++V++ ++LYVRY+LRNCQCSG K +K G+ + KIRP
Sbjct: 428 PVLIAEIAFAVFLVSIVSITAVLYVRYKLRNCQCSGP--KVKKLKGSSINQKDQKCKIRP 485
Query: 494 DFDDLKIRRAQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLKDGTVVAVKKAIATSD 551
D +D KIRRAQMF YEELERAT GFKEE VGKGSFSCV+KGVLKDGTVVAVK+AI + +
Sbjct: 486 DLEDFKIRRAQMFPYEELERATSGFKEESIVGKGSFSCVFKGVLKDGTVVAVKRAIVSPN 545
Query: 552 RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALK 611
QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG ERLLVYE+MAHGSLHQHLHG +K ++
Sbjct: 546 MQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGGERLLVYEYMAHGSLHQHLHG-NKVMQ 604
Query: 612 EQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671
EQ+DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP
Sbjct: 605 EQMDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 664
Query: 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNI 731
ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNI
Sbjct: 665 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNI 724
Query: 732 VEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
V+WAVPLIKSGDI AILDPVLK P DLDAL+RIANVACK VRMRGK+RPSMDKVTT LER
Sbjct: 725 VQWAVPLIKSGDIAAILDPVLKPPPDLDALRRIANVACKSVRMRGKDRPSMDKVTTVLER 784
Query: 792 ALAQLMGSPCSEQPILPTEVVLGSNRMHKKSSQRSSNRSTSETDVAEAEDQRFEFRAPSW 851
ALAQLMGSPC EQPILPTEVVLGSNR+HKKSS S ++ TDV EDQRFEFRAPSW
Sbjct: 785 ALAQLMGSPCIEQPILPTEVVLGSNRLHKKSSSNRS--ASESTDV---EDQRFEFRAPSW 839
Query: 852 ITFPSVTSSQRRKSSVSDADVDGKNLEARNMGNAGSIGDGLRSLEEEIGPASPQENLYLQ 911
ITFPSVTSSQRR S S+A+V+GKN E RN+ N G G LRSL+EEIG ASP+E L+LQ
Sbjct: 840 ITFPSVTSSQRR--SGSEAEVEGKNAEGRNLSNVGGGGGVLRSLDEEIGLASPRERLFLQ 897
Query: 912 HNF 914
HNF
Sbjct: 898 HNF 900
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357454477|ref|XP_003597519.1| Serine/threonine protein kinase-like protein ACR4 [Medicago truncatula] gi|355486567|gb|AES67770.1| Serine/threonine protein kinase-like protein ACR4 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1364 bits (3531), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 678/910 (74%), Positives = 770/910 (84%), Gaps = 11/910 (1%)
Query: 16 LKTGFVVHFLMLSNLLRLVNGLGSMSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAII 75
L + ++ S L V GLGSMSSIA+SYG+ G FCGLKSD SH VTCYG NSAI+
Sbjct: 12 LLNTILFEVVVFSWLWSKVTGLGSMSSIAVSYGDKGSAFCGLKSDGSHTVTCYGMNSAIV 71
Query: 76 YGTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDY 135
YGTP+ FPF+GLT+GDGFVCGLL+ SNQPYCWGSS +I+MGVPQP+ K AQY+EISAGDY
Sbjct: 72 YGTPSQFPFLGLTSGDGFVCGLLMSSNQPYCWGSSSHIEMGVPQPMFKDAQYLEISAGDY 131
Query: 136 HLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQIESISAGSEFNCGLFSQNRTVFCWG 195
H+CGLRKPLTG+ RN+S+VDCWGYNMTKNYVFDGQI+SISAGSEFNCGLFSQNRTVFCWG
Sbjct: 132 HVCGLRKPLTGRHRNFSFVDCWGYNMTKNYVFDGQIQSISAGSEFNCGLFSQNRTVFCWG 191
Query: 196 DESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVA--YSRQ 253
+E S++VI LIP+ M+FQKV+ GGYHVCGILEG++SRT CWGRSL LE+E+S+ +
Sbjct: 192 NEVSTQVIRLIPQRMRFQKVSCGGYHVCGILEGVNSRTVCWGRSLGLEQEISLIPNQGQG 251
Query: 254 GNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGNYFT 313
GNV+L P+DPMLS+VGGKFHACGIKSYD VICWG +K ST VP GIKV++IAAG+YFT
Sbjct: 252 GNVELAPNDPMLSVVGGKFHACGIKSYDHVVICWGLNLKTSTKVPKGIKVFDIAAGDYFT 311
Query: 314 CGVLAEKSMLPVCWGTGFPTSLPLAVSPGL--CKMTPCAPGYYEA---SQENAPCKSPNA 368
CG+LA KS+ +CWG GFPTSLPLAVSP C PC P YYE Q C+ PN+
Sbjct: 312 CGILAAKSLESICWGVGFPTSLPLAVSPRTRKCLSAPCPPSYYEIEKDQQNGLICQDPNS 371
Query: 369 HVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSSQFSDGLTT-KKNEK 427
H+C+ CS CP EMYQ + C LKSD +CEYNCS C S EC+ NCSS S+ KKNE+
Sbjct: 372 HLCVPCSGVCPDEMYQKSGCNLKSDILCEYNCSVCSSPECFSNCSSSSSNAANGGKKNER 431
Query: 428 FWSMQLPVIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSPYQKD 487
FWSMQL VI+ EI AVF+++ V++ +++YVRY+LR+C+CS + S K S QKD
Sbjct: 432 FWSMQLIVIVGEIVFAVFIVSAVSITAVMYVRYKLRDCECSTRPLNSMKRLNVSSSVQKD 491
Query: 488 NGKIRPDFDDLKIRRAQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLKDGTVVAVKK 545
NGK+RPD +++KIRRAQ F+YEELE AT GFKEE VGKGSFSCV+KGVLKDGTVVAVK+
Sbjct: 492 NGKVRPDAEEIKIRRAQKFSYEELENATCGFKEESIVGKGSFSCVFKGVLKDGTVVAVKR 551
Query: 546 AIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHG 605
AI + + QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG ERLLVYE+MAHGSLHQHLHG
Sbjct: 552 AIMSPNMQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGGERLLVYEYMAHGSLHQHLHG 611
Query: 606 KSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665
K+K LKEQLDW+RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARV+DFG
Sbjct: 612 KNKELKEQLDWIRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVSDFG 671
Query: 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQ 725
LSLLGP DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQ
Sbjct: 672 LSLLGPTDSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQ 731
Query: 726 FEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
+EEGNIV+W+VPLIKSGDI +ILDP LK PSD++AL+RIANVACKCVRMRGK+RPSMDKV
Sbjct: 732 YEEGNIVQWSVPLIKSGDIASILDPCLKPPSDIEALRRIANVACKCVRMRGKDRPSMDKV 791
Query: 786 TTALERALAQLMGSPCSEQPILPTEVVLGSNRMHKKSSQRSSNRSTSETDVAEAEDQRFE 845
TT+LERALA LMGSPC +QPILPTEVVLGSNRMHKK+SQRSSNRS SE DV E EDQRFE
Sbjct: 792 TTSLERALAMLMGSPCIDQPILPTEVVLGSNRMHKKTSQRSSNRSASEIDVVEGEDQRFE 851
Query: 846 FRAPSWITFPSVTSSQRRKSSVSDADVDGKNLEARN-MGNAGSIGDGLRSLEEEIGPASP 904
FRAPSWITFPSVTSSQRRKSS S+ +V+ K +E RN G GD LRSLEEEIGPASP
Sbjct: 852 FRAPSWITFPSVTSSQRRKSSGSEGEVEVKIVEGRNYGNVVGGGGDVLRSLEEEIGPASP 911
Query: 905 QENLYLQHNF 914
QE L+LQHNF
Sbjct: 912 QERLFLQHNF 921
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557366|ref|XP_003546987.1| PREDICTED: serine/threonine-protein kinase-like protein ACR4-like, partial [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1345 bits (3480), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 662/867 (76%), Positives = 754/867 (86%), Gaps = 20/867 (2%)
Query: 57 LKSDRSHLVTCYGSNSAIIYGTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMG 116
L+SD SH VTCYG NSAIIYGTP HFPF+GLTAGDGFVCGLL+ SNQPYCWGSSG+++MG
Sbjct: 2 LESDGSHTVTCYGINSAIIYGTPTHFPFLGLTAGDGFVCGLLMSSNQPYCWGSSGHVEMG 61
Query: 117 VPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQIESISA 176
VPQP++KGAQY+EISAGDYH+CGLRKPLTG+ RN S VDCWGYNMT NYVFDGQ++SISA
Sbjct: 62 VPQPMVKGAQYLEISAGDYHVCGLRKPLTGRHRNTSLVDCWGYNMTNNYVFDGQVQSISA 121
Query: 177 GSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCW 236
GS+FNCGLFSQNRTVFCWGDE+SS+VI +IP+ ++FQK++AGGYHVCGILEG++SR CW
Sbjct: 122 GSQFNCGLFSQNRTVFCWGDETSSQVIYMIPQGIRFQKISAGGYHVCGILEGVNSRAVCW 181
Query: 237 GRS-LDLEEEVSVAYSR--QGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKP 293
GRS LDL EE+S++ +R QGNV+L P+DPMLS+VGGKFHACGI+S+DRGV+CWG+ K
Sbjct: 182 GRSMLDLGEELSISLTRSGQGNVELAPNDPMLSVVGGKFHACGIRSHDRGVVCWGYSFKA 241
Query: 294 STPVPTGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTGFPTSLPLAVSPGLCKMTPCAPGY 353
TPVP+GIK +EI AGNYFTCG+L EKS++PVCWG GFPTSLPL VSP +C+ PCAPGY
Sbjct: 242 GTPVPSGIKAFEIGAGNYFTCGILVEKSLMPVCWGVGFPTSLPLPVSPRMCRSAPCAPGY 301
Query: 354 YEASQENAPCKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCS 413
YE +Q+N CKSP++H+C+ CS CP EMYQ + C LKSD +CEYNCS C S EC NCS
Sbjct: 302 YE-TQQNGLCKSPDSHICMPCSAACPPEMYQRSGCNLKSDILCEYNCSLCSSPECLSNCS 360
Query: 414 SQFSDGLTTKKNEKFWSMQLPVIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASK 473
S +S+ + K++E+FWSMQLPV+IAEI AVFL+++V++ +LYVRY+LR+CQCSG K
Sbjct: 361 SSYSNAASGKRSERFWSMQLPVLIAEIAFAVFLVSIVSITVVLYVRYKLRDCQCSGP--K 418
Query: 474 SQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEE--VGKGSFSCVY 531
+K G+ S + KIRPD ++ KIRRAQMF+YEELERAT GFKEE GKGSFSCV+
Sbjct: 419 VKKLKGSSSNQKDQKCKIRPDLEEFKIRRAQMFSYEELERATSGFKEESIAGKGSFSCVF 478
Query: 532 KGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591
KGVLKDGTVVAVK+AI + + QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG ERLLVY
Sbjct: 479 KGVLKDGTVVAVKRAIVSPNMQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGGERLLVY 538
Query: 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 651
E+MAHGSLHQHLHG +K ++EQ+DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI
Sbjct: 539 EYMAHGSLHQHLHG-NKVMQEQMDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 597
Query: 652 LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL 711
LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL
Sbjct: 598 LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL 657
Query: 712 LLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKC 771
LLEILSGRKAIDMQFEEGNIV+WAVPLIKSGDI AILDP LK P DLDAL+RIANVACK
Sbjct: 658 LLEILSGRKAIDMQFEEGNIVQWAVPLIKSGDIAAILDPTLKPPPDLDALRRIANVACKS 717
Query: 772 VRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTEVVLGSNRMHKKSSQRSSNRST 831
VRMRGK+RPSMDKVTT LERALAQLMGSPC EQPILPTEVVLGSNR+HKKSS S ++
Sbjct: 718 VRMRGKDRPSMDKVTTVLERALAQLMGSPCIEQPILPTEVVLGSNRLHKKSSSNRS--AS 775
Query: 832 SETDVAEAEDQRFEFRAPSWITFPSVTSSQRRKSSVSDADVDGKNLEARNMGNA----GS 887
TDV EDQRFEFRAPSWITFPSVTSSQRR S S+ADV+GKN E RN+ N G
Sbjct: 776 ESTDV---EDQRFEFRAPSWITFPSVTSSQRR--SGSEADVEGKNAEGRNLSNVGGGGGG 830
Query: 888 IGDGLRSLEEEIGPASPQENLYLQHNF 914
GD LRSL+EEIG ASP+E L+LQHNF
Sbjct: 831 GGDVLRSLDEEIGLASPRERLFLQHNF 857
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15231681|ref|NP_191501.1| serine/threonine-protein kinase-like protein ACR4 [Arabidopsis thaliana] gi|75335599|sp|Q9LX29.1|ACR4_ARATH RecName: Full=Serine/threonine-protein kinase-like protein ACR4; AltName: Full=Protein CRINKLY 4; Short=AtCR4; Flags: Precursor gi|7801692|emb|CAB91612.1| putative protein [Arabidopsis thaliana] gi|20302590|dbj|BAB91132.1| putative receptor protein kinase ACR4 [Arabidopsis thaliana] gi|332646399|gb|AEE79920.1| serine/threonine-protein kinase-like protein ACR4 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1293 bits (3345), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 644/923 (69%), Positives = 746/923 (80%), Gaps = 37/923 (4%)
Query: 1 MGNFSFVEGDWVLKILKTGFVVHFLMLSNLLRLVNGLGSMSSIAISYGENGPVFCGLKSD 60
M F +W+L +V ++ +++ +L + LGSMSSIAISYGE G VFCGLKSD
Sbjct: 1 MRMFETRAREWIL-------LVKLVLFTSIWQLASALGSMSSIAISYGEGGSVFCGLKSD 53
Query: 61 RSHLVTCYGSNSAIIYGTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQP 120
SHLV CYGSNSAI+YGTP H FIGLT GDGF+CGLL+ S+QPYCWG+S +IQMGVPQP
Sbjct: 54 GSHLVVCYGSNSAILYGTPGHLQFIGLTGGDGFMCGLLMLSHQPYCWGNSAFIQMGVPQP 113
Query: 121 IIKGAQYVEISAGDYHLCGLRKPLTGKWRNY-----SYVDCWGYNMTKNYVFDGQIESIS 175
+ KGA+Y+E+SAGDYHLCGLRKP+ G+ +N S VDCWGYNMT+N+VFD Q+ S+S
Sbjct: 114 MTKGAEYLEVSAGDYHLCGLRKPIVGRRKNSNIISSSLVDCWGYNMTRNFVFDKQLHSLS 173
Query: 176 AGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRC 235
AGSEFNC L S++++VFCWGDE+SS+VISLIPKE KFQK+AAGGYHVCGIL+GL+SR C
Sbjct: 174 AGSEFNCALSSKDKSVFCWGDENSSQVISLIPKEKKFQKIAAGGYHVCGILDGLESRVLC 233
Query: 236 WGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPST 295
WG+SL+ EEEV+ + + +DLPP +P+L++VGGKF+ACGIK YD +CWGF + ST
Sbjct: 234 WGKSLEFEEEVTGTSTEEKILDLPPKEPLLAVVGGKFYACGIKRYDHSAVCWGFFVNRST 293
Query: 296 PVPTGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTGFPTSLPLAVSPGLCKMTPCAPGYYE 355
P PTGI Y++AAGNYFTCGVL SM PVCWG GFP S+PLAVSPGLC TPC PG +E
Sbjct: 294 PAPTGIGFYDLAAGNYFTCGVLTGTSMSPVCWGLGFPASIPLAVSPGLCIDTPCPPGTHE 353
Query: 356 AS-QENAPCKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSS 414
S QEN+PCK +H+C+ CS CP MYQ + CT +SD+VC YNCSSC S +C NCSS
Sbjct: 354 LSNQENSPCKFTGSHICLPCSTSCPPGMYQKSVCTERSDQVCVYNCSSCSSHDCSSNCSS 413
Query: 415 QFSDGLTTKKNEKFWSMQLPVIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKS 474
+ G K+ KFWS+QLP+ AEI A+FL+ VV++ + LY+RYRLRNC+CS ++S
Sbjct: 414 SATSG--GKEKGKFWSLQLPIATAEIGFALFLVAVVSITAALYIRYRLRNCRCSENDTRS 471
Query: 475 QKTNGAGSPYQKDNGKIRPDFDDL-KIRRAQMFTYEELERATGGFKEE--VGKGSFSCVY 531
K S + KDNGKIRPD D+L K RRA++FTYEELE+A GFKEE VGKGSFSCVY
Sbjct: 472 SKD----SAFTKDNGKIRPDLDELQKRRRARVFTYEELEKAADGFKEESIVGKGSFSCVY 527
Query: 532 KGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591
KGVL+DGT VAVK+AI +SD+QKNS EF TELDLLSRLNHAHLL+LLGYCEE ERLLVY
Sbjct: 528 KGVLRDGTTVAVKRAIMSSDKQKNSNEFRTELDLLSRLNHAHLLSLLGYCEECGERLLVY 587
Query: 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 651
EFMAHGSLH HLHGK+KALKEQLDWV+RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI
Sbjct: 588 EFMAHGSLHNHLHGKNKALKEQLDWVKRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 647
Query: 652 LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL 711
LIDEEHNARVADFGLSLLGP DS SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL
Sbjct: 648 LIDEEHNARVADFGLSLLGPVDSGSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL 707
Query: 712 LLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKC 771
LLEILSGRKAIDM +EEGNIVEWAVPLIK+GDI A+LDPVLK PS+++ALKRI +VACKC
Sbjct: 708 LLEILSGRKAIDMHYEEGNIVEWAVPLIKAGDINALLDPVLKHPSEIEALKRIVSVACKC 767
Query: 772 VRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTEVVLGSNRMHKKSSQRSSNRST 831
VRMRGK+RPSMDKVTTALERALAQLMG+P SEQPILPTEVVLGS+RMHKKS + S RS
Sbjct: 768 VRMRGKDRPSMDKVTTALERALAQLMGNPSSEQPILPTEVVLGSSRMHKKSWRIGSKRSG 827
Query: 832 SETDVAEAEDQRFEFRAPSWITFPSVTSSQRRKSSVSDADVDGKNLEARNMGNAGSIGDG 891
SE EFR SWITFPSVTSSQRRKSS S+ DV + E R A
Sbjct: 828 SENT---------EFRGGSWITFPSVTSSQRRKSSASEGDVAEEEDEGRKQQEA------ 872
Query: 892 LRSLEEEIGPASPQENLYLQHNF 914
LRSLEEEIGPASP ++L+L HNF
Sbjct: 873 LRSLEEEIGPASPGQSLFLHHNF 895
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 914 | ||||||
| TAIR|locus:2081227 | 895 | CR4 "crinkly4" [Arabidopsis th | 0.955 | 0.975 | 0.703 | 0.0 | |
| UNIPROTKB|O24585 | 901 | CR4 "Putative receptor protein | 0.948 | 0.962 | 0.644 | 0.0 | |
| TAIR|locus:2075074 | 775 | CCR1 "CRINKLY4 related 1" [Ara | 0.638 | 0.753 | 0.334 | 1e-92 | |
| TAIR|locus:2082033 | 814 | CCR3 "CRINKLY4 related 3" [Ara | 0.319 | 0.358 | 0.473 | 3e-91 | |
| TAIR|locus:2056033 | 776 | CCR2 "CRINKLY4 related 2" [Ara | 0.614 | 0.724 | 0.311 | 3.9e-87 | |
| TAIR|locus:2160952 | 751 | CCR4 "CRINKLY4 related 4" [Ara | 0.582 | 0.708 | 0.348 | 9.2e-86 | |
| TAIR|locus:2152312 | 880 | AT5G38990 [Arabidopsis thalian | 0.405 | 0.421 | 0.397 | 9.8e-68 | |
| TAIR|locus:2066143 | 786 | AT2G28970 [Arabidopsis thalian | 0.377 | 0.438 | 0.371 | 1.2e-64 | |
| TAIR|locus:2057991 | 934 | AT2G37050 [Arabidopsis thalian | 0.404 | 0.396 | 0.398 | 7.9e-64 | |
| TAIR|locus:2008565 | 929 | AT1G67720 [Arabidopsis thalian | 0.303 | 0.298 | 0.486 | 1e-63 |
| TAIR|locus:2081227 CR4 "crinkly4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3351 (1184.7 bits), Expect = 0., P = 0.
Identities = 635/903 (70%), Positives = 734/903 (81%)
Query: 21 VVHFLMLSNLLRLVNGLGSMSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGTPA 80
+V ++ +++ +L + LGSMSSIAISYGE G VFCGLKSD SHLV CYGSNSAI+YGTP
Sbjct: 14 LVKLVLFTSIWQLASALGSMSSIAISYGEGGSVFCGLKSDGSHLVVCYGSNSAILYGTPG 73
Query: 81 HFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGL 140
H FIGLT GDGF+CGLL+ S+QPYCWG+S +IQMGVPQP+ KGA+Y+E+SAGDYHLCGL
Sbjct: 74 HLQFIGLTGGDGFMCGLLMLSHQPYCWGNSAFIQMGVPQPMTKGAEYLEVSAGDYHLCGL 133
Query: 141 RKPLTGKWRNY-----SYVDCWGYNMTKNYVFDGQIESISAGSEFNCGLFSQNRTVFCWG 195
RKP+ G+ +N S VDCWGYNMT+N+VFD Q+ S+SAGSEFNC L S++++VFCWG
Sbjct: 134 RKPIVGRRKNSNIISSSLVDCWGYNMTRNFVFDKQLHSLSAGSEFNCALSSKDKSVFCWG 193
Query: 196 DESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGN 255
DE+SS+VISLIPKE KFQK+AAGGYHVCGIL+GL+SR CWG+SL+ EEEV+ + +
Sbjct: 194 DENSSQVISLIPKEKKFQKIAAGGYHVCGILDGLESRVLCWGKSLEFEEEVTGTSTEEKI 253
Query: 256 VDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGNYFTCG 315
+DLPP +P+L++VGGKF+ACGIK YD +CWGF + STP PTGI Y++AAGNYFTCG
Sbjct: 254 LDLPPKEPLLAVVGGKFYACGIKRYDHSAVCWGFFVNRSTPAPTGIGFYDLAAGNYFTCG 313
Query: 316 VLAEKSMLPVCWGTGFPTSLPLAVSPGLCKMTPCAPGYYEAS-QENAPCKSPNAHVCITC 374
VL SM PVCWG GFP S+PLAVSPGLC TPC PG +E S QEN+PCK +H+C+ C
Sbjct: 314 VLTGTSMSPVCWGLGFPASIPLAVSPGLCIDTPCPPGTHELSNQENSPCKFTGSHICLPC 373
Query: 375 SNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSSQFSDGLTTKKNEKFWSMQLP 434
S CP MYQ + CT +SD+VC YNCSSC S +C NCSS + G K+ KFWS+QLP
Sbjct: 374 STSCPPGMYQKSVCTERSDQVCVYNCSSCSSHDCSSNCSSSATSG--GKEKGKFWSLQLP 431
Query: 435 VIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPD 494
+ AEI A+FL+ VV++ + LY+RYRLRNC+CS ++S K S + KDNGKIRPD
Sbjct: 432 IATAEIGFALFLVAVVSITAALYIRYRLRNCRCSENDTRSSKD----SAFTKDNGKIRPD 487
Query: 495 FDDL-KIRRAQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLKDGTVVAVKKAIATSD 551
D+L K RRA++FTYEELE+A GFKEE VGKGSFSCVYKGVL+DGT VAVK+AI +SD
Sbjct: 488 LDELQKRRRARVFTYEELEKAADGFKEESIVGKGSFSCVYKGVLRDGTTVAVKRAIMSSD 547
Query: 552 RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALK 611
+QKNS EF TELDLLSRLNHAHLL+LLGYCEE ERLLVYEFMAHGSLH HLHGK+KALK
Sbjct: 548 KQKNSNEFRTELDLLSRLNHAHLLSLLGYCEECGERLLVYEFMAHGSLHNHLHGKNKALK 607
Query: 612 EQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671
EQLDWV+RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP
Sbjct: 608 EQLDWVKRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 667
Query: 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNI 731
DS SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDM +EEGNI
Sbjct: 668 VDSGSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMHYEEGNI 727
Query: 732 VEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
VEWAVPLIK+GDI A+LDPVLK PS+++ALKRI +VACKCVRMRGK+RPSMDKVTTALER
Sbjct: 728 VEWAVPLIKAGDINALLDPVLKHPSEIEALKRIVSVACKCVRMRGKDRPSMDKVTTALER 787
Query: 792 ALAQLMGSPCSEQPILPTEVVLGSNRMHKKXXXXXXXXXXXETDVAEAEDQRFEFRAPSW 851
ALAQLMG+P SEQPILPTEVVLGS+RMHKK E EFR SW
Sbjct: 788 ALAQLMGNPSSEQPILPTEVVLGSSRMHKKSWRIGSKRSGSENT---------EFRGGSW 838
Query: 852 ITFPSVTSSQRRKSSVSDADVDGKNLEARNMGNAGSIGDGLRSLEEEIGPASPQENLYLQ 911
ITFPSVTSSQRRKSS S+ DV + E R A LRSLEEEIGPASP ++L+L
Sbjct: 839 ITFPSVTSSQRRKSSASEGDVAEEEDEGRKQQEA------LRSLEEEIGPASPGQSLFLH 892
Query: 912 HNF 914
HNF
Sbjct: 893 HNF 895
|
|
| UNIPROTKB|O24585 CR4 "Putative receptor protein kinase CRINKLY4" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 3072 (1086.5 bits), Expect = 0., P = 0.
Identities = 574/890 (64%), Positives = 701/890 (78%)
Query: 36 GLGSMSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGTPAHFPFIGLTAGDGFVC 95
GLGSMSSIA+SYGE+GPVFCGL SD SHLV C+G++++++YG P + PF+GLTAGDGFVC
Sbjct: 24 GLGSMSSIAVSYGEDGPVFCGLNSDGSHLVACFGADASVLYGAPPNIPFLGLTAGDGFVC 83
Query: 96 GLLLDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNY---S 152
GLLLD+ QPYCWGS+ Y++ GVPQP+++GA+Y E+SAGD HLC LR G + S
Sbjct: 84 GLLLDTRQPYCWGSNSYVKSGVPQPMVEGARYSELSAGDNHLCALRAAQDGGRGSSAATS 143
Query: 153 YVDCWGYNMTKNYVFDGQIESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKF 212
+DCWGYNMT + D + ++SAGS FNCGLF++NRTVFCWGDE+ S V+ L P+++ F
Sbjct: 144 LIDCWGYNMTATHAVDEAVSTVSAGSVFNCGLFARNRTVFCWGDETVSGVVGLAPRDLHF 203
Query: 213 QKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKF 272
Q + AGGYHVCG+LE +++ CWGRSL++++ V + G+V++ P D M ++VGG+F
Sbjct: 204 QSIGAGGYHVCGVLE--NAQVFCWGRSLEMQQVVPSSAIGDGDVNIVPMDAMSTVVGGRF 261
Query: 273 HACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTGFP 332
HACGI+S D V CWGF + ST P G+K+Y + AG+YFTCGV AE S++P CWG P
Sbjct: 262 HACGIRSLDHQVACWGFTLHNSTSPPKGLKMYALVAGDYFTCGVPAETSLMPRCWGNSGP 321
Query: 333 TSLPLAVSPGLCKMTPCAPGYYEASQENAP-----CKSPNAHVCITCSNGCPVEMYQTAE 387
+LP+AV PG+C T C+ GYYE CK N+ +C+ CS GCP +Y+++
Sbjct: 322 LALPMAVPPGICVPTACSHGYYEYVNHGEVGSIKVCKPANSRLCLPCSTGCPEGLYESSP 381
Query: 388 CTLKSDRVCEYNCSSCFSAECYKNCSSQFSDGLTTKKNEKFWSMQLPVIIAEITIAVFLI 447
C +DRVC+++C C + EC C SQ K+ K + Q+ + +AEI AV L+
Sbjct: 382 CNATADRVCQFDCLKCVTDECLSFCLSQ-----KRTKSRKLMAFQMRIFVAEIVFAVVLV 436
Query: 448 TVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFT 507
V++ + LYVR++LR+CQCS + + K+ ++KDN KI+PD +DLKIRRAQ F+
Sbjct: 437 LSVSVTTCLYVRHKLRHCQCSNRELRLAKSTAYS--FRKDNMKIQPDMEDLKIRRAQEFS 494
Query: 508 YEELERATGGFKEE--VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDL 565
YEELE+ATGGF E+ VGKGSFSCV+KG+L+DGTVVAVK+AI SD +K+SKEFH ELDL
Sbjct: 495 YEELEQATGGFSEDSQVGKGSFSCVFKGILRDGTVVAVKRAIKASDVKKSSKEFHNELDL 554
Query: 566 LSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQ 625
LSRLNHAHLLNLLGYCE+G ERLLVYEFMAHGSL+QHLHGK LK++L+W RRVTIAVQ
Sbjct: 555 LSRLNHAHLLNLLGYCEDGSERLLVYEFMAHGSLYQHLHGKDPNLKKRLNWARRVTIAVQ 614
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGT 685
AARGIEYLHGYACPPVIHRDIKSSNILIDE+HNARVADFGLS+LGPADS +PL+ELPAGT
Sbjct: 615 AARGIEYLHGYACPPVIHRDIKSSNILIDEDHNARVADFGLSILGPADSGTPLSELPAGT 674
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745
LGYLDPEYYRLHYLTTKSDVYSFGV+LLEILSGRKAIDMQFEEGNIVEWAVPLIK+GDI
Sbjct: 675 LGYLDPEYYRLHYLTTKSDVYSFGVVLLEILSGRKAIDMQFEEGNIVEWAVPLIKAGDIF 734
Query: 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQP 805
AILDPVL PSDL+ALK+IA+VACKCVRMRGK+RPSMDKVTTALE ALA LMGSPC EQP
Sbjct: 735 AILDPVLSPPSDLEALKKIASVACKCVRMRGKDRPSMDKVTTALEHALALLMGSPCIEQP 794
Query: 806 ILPTEVVLGSNRMHKKXXXXXXXXXXXETDVAEAEDQRFEFRAPSWITFPSVTSSQRRKS 865
ILPTEVVLGS+RMHK E ++A+ EDQ +RAPSWITFPSVTSSQRRKS
Sbjct: 795 ILPTEVVLGSSRMHK-VSQMSSNHSCSENELADGEDQGIGYRAPSWITFPSVTSSQRRKS 853
Query: 866 SVSDADVDGKNL-EARNMGNAGSIGDGLRSLEEEIGPASPQENLYLQHNF 914
S S+AD+ G+ + RN+G+ SIGDGLRSLEEEI PASPQENLYLQHNF
Sbjct: 854 SASEADIVGRRATDGRNVGS--SIGDGLRSLEEEIAPASPQENLYLQHNF 901
|
|
| TAIR|locus:2075074 CCR1 "CRINKLY4 related 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 743 (266.6 bits), Expect = 1.0e-92, Sum P(2) = 1.0e-92
Identities = 226/676 (33%), Positives = 324/676 (47%)
Query: 38 GSMSSIAISYGENGPVFCGLKSDRS-HLVTCYGSNSAIIYGTPAHF--PFIG-LTAGDGF 93
GS AI V C K+ S + S+S+I T A + P + L+ GDGF
Sbjct: 36 GSAFFCAIDASGRQDVICWGKNYSSPSSPSSSSSSSSIASSTSASYNIPSMAVLSGGDGF 95
Query: 94 VCGLLLDSNQPYCWGSSGYIQ-MGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYS 152
+CG+L +++Q +C+ S G M + + Y +I+AG+ H+C +R +
Sbjct: 96 LCGILSNTSQAFCFSSLGSSSGMDLVPLAYRTTAYSQIAAGNSHVCAVRGAYYSD-HDSG 154
Query: 153 YVDCWGYNMT---------KNYVFDGQIES------ISAGSEFNCGLFSQNRTVFCWGDE 197
+DCW +N F QI S I +G F+CG ++ + C+G
Sbjct: 155 TIDCWEITRATNNNSLIAKENPNFYDQIVSNLVFNNIVSGDGFSCGGI-RDGGMLCFGPN 213
Query: 198 SSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVD 257
SS+ + FQ +AAG VC IL L +CWG E+E V+
Sbjct: 214 SSN--LGFNTTSDNFQVLAAGKNSVCAILN-LSREVKCWG-----EDE--------SFVN 257
Query: 258 LPPSDP-MLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGNYFTCGV 316
P +D +S+ G H CGI+ + V CWG P +G K IA+ ++ CG+
Sbjct: 258 SPMNDSRFVSLTAGPRHFCGIREDNHEVECWGNSNFSLIPKGSGFKA--IASSDFIVCGI 315
Query: 317 LAEKSMLPVCWGTGFPTSL----PLAV-SPGLCKMTPCAPGYY--EASQENAP-----CK 364
E +L CW ++L PL + SPG+C+ PC + AS N P C
Sbjct: 316 REEDLVLD-CWMVNGSSTLAYDPPLELCSPGMCRAGPCNEKEFAFNASILNEPDLTSLCV 374
Query: 365 SPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSSQFSDGLTTKK 424
VC C + C + ++ CT SDR+C CS C ++ C C S+
Sbjct: 375 RKELMVCSPCGSDCSHGFFLSSSCTANSDRICT-PCSLCQNSSCSDICKLHNSNF----- 428
Query: 425 NEKFW-SMQLPVIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSP 483
+K W +Q V+I + LI ++ C + K +GA +
Sbjct: 429 PDKHWHQLQRLVLIIGSCASALLIIIIGC------------CVVPRIVTSPNKEDGAANQ 476
Query: 484 YQKDNGKIRPDFD-DLKIRR----------AQMFTYEELERATGGFKE--EVGKGSFSCV 530
++ GK PD D D + AQ+F EL+ AT GFKE E+G+GS+ V
Sbjct: 477 FKSCIGK--PDLDTDQPLENVSPAPSVTPFAQVFRLSELKDATNGFKEFNELGRGSYGFV 534
Query: 531 YKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590
YK VL DG VAVK+A A + N++EF TEL++L + H +++NLLGY E ERLLV
Sbjct: 535 YKAVLADGRQVAVKRANAATIIHTNTREFETELEILCNIRHCNIVNLLGYSTEMGERLLV 594
Query: 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSN 650
YE+M HG+LH HLH L W R+ IA+Q A+G+EYLH A P +IH D+KSSN
Sbjct: 595 YEYMPHGTLHDHLHSGFSPLS----WSLRIKIAMQTAKGLEYLHNEAEPRIIHGDVKSSN 650
Query: 651 ILIDEEHNARVADFGL 666
+L+D E ARVADFGL
Sbjct: 651 VLLDSEWVARVADFGL 666
|
|
| TAIR|locus:2082033 CCR3 "CRINKLY4 related 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 689 (247.6 bits), Expect = 3.0e-91, Sum P(2) = 3.0e-91
Identities = 149/315 (47%), Positives = 205/315 (65%)
Query: 502 RAQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQK-NSKE 558
+A+ F++ EL ATG F E +G GSF VY+G L DG VA+K+ + +K KE
Sbjct: 480 KAEEFSFSELASATGNFSLENKIGSGSFGVVYRGKLNDGREVAIKRGEVNAKMKKFQEKE 539
Query: 559 --FHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQL-- 614
F +E+ LSRL+H HL+ L+GYCEE E+LLVY++M +G+L+ HLH K+ K
Sbjct: 540 TAFDSEIAFLSRLHHKHLVRLVGYCEEREEKLLVYDYMKNGALYDHLHDKNNVEKHSSLI 599
Query: 615 -DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA- 672
W R+ IA+ AARGIEYLH YA PP+IHRDIKSSNIL+D ARV+DFGLSL+GP
Sbjct: 600 NSWKMRIKIALDAARGIEYLHNYAVPPIIHRDIKSSNILLDSNWVARVSDFGLSLMGPVL 659
Query: 673 -DSSSPLAE--LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAI-----DM 724
+P AGT+GY+DPEYY L+ LT KSDVY GV+LLE+L+G++AI D+
Sbjct: 660 GKDHNPYQRPTKAAGTVGYIDPEYYSLNVLTDKSDVYGLGVVLLELLTGKRAIFRNNGDV 719
Query: 725 QFEEG----NIVEWAVPLIKSGDITAILDPVLKLPS--DLDALKRIANVACKCVRMRGKE 778
+ EEG ++V+++VP I + +++ ILDP + P + DA++ +A A CV G+
Sbjct: 720 EEEEGCVPVHLVDYSVPAITADELSTILDPRVGSPELGEGDAVELVAYTAMHCVNAEGRN 779
Query: 779 RPSMDKVTTALERAL 793
RP+M + LERAL
Sbjct: 780 RPTMTDIVGNLERAL 794
|
|
| TAIR|locus:2056033 CCR2 "CRINKLY4 related 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 691 (248.3 bits), Expect = 3.9e-87, Sum P(2) = 3.9e-87
Identities = 197/633 (31%), Positives = 320/633 (50%)
Query: 83 PFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRK 142
P L+ G+GF+C + ++++ +CW + VP+ + Y++I++G+ H+C +
Sbjct: 75 PMTSLSGGEGFLCAITSNTSRAFCWNLEDPSENLVPRAFQYNS-YLQIASGNNHVCAI-S 132
Query: 143 PLTGKWRNYSYVDCWGY----NMTKNYVFDGQ-----IES-----ISAGSEFNCGLFSQN 188
L +Y V CW Y N T +++ I+S I +G F+CG+ +++
Sbjct: 133 GLYYSGPDYGPVHCWEYSDNTNFTSGLLWNSSFHNPYIDSLMFRKIVSGDGFSCGV-TKD 191
Query: 189 RTVFCWGDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSV 248
+ CWG +S+ +++ E +F+ +A+G VCG+ + + C+G D E E
Sbjct: 192 GDLVCWGPKSN--LLNFSNNE-EFEVLASGRNSVCGVSKD-SGQLHCFG---D-ETEFGS 243
Query: 249 AYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAA 308
+R + L + H G++ + R + S P +G I++
Sbjct: 244 LPNRPRFIALSAGANHYCGIREDDH--GVECWGRNL---NSSSSSSAPNTSGFVA--ISS 296
Query: 309 GNYFTCGVLAEKSMLPVCW----GTGFPTSLPLAV-SPGLCKMTP-CAPGYY-------E 355
+ TCGV E ++ CW + S PL + SPG+C C G++ +
Sbjct: 297 SDSTTCGV-RELDLVLDCWRVHDSSKADYSPPLELCSPGMCSPRGNCGDGWFAFNASILK 355
Query: 356 ASQENAPCKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAECYKNCSSQ 415
S+ + C N ++C+ C C + ++ C +DRVC CS C ++ CY C +
Sbjct: 356 ESELTSLCSFHNLNICLRCGISCLEGYFPSSTCNPNADRVCT-PCSLCQNSSCYGICKIR 414
Query: 416 FSDGLTTKKNEKFWSMQLPVIIAEITIAVFLITVVTLISILYV----------RYRLRNC 465
+ ++ E+ +L +II ++ FL+ ++ L I + R ++ C
Sbjct: 415 ATKSKEHEQKEQREVRRLVIIIG-CSVLGFLVMLIGLSFIPKMTKGSKRDDEERSKMTCC 473
Query: 466 QCSGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKE--EVG 523
C K S + P+Q + P + + ++F EL+ AT GFKE E+G
Sbjct: 474 FCFDKNSVEADPDPV--PHQS---VLLPTA--VSLGETKIFRLSELKDATHGFKEFNELG 526
Query: 524 KGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE 583
+GSF VYK VL DG VAVK+A A + N++ F +EL++L ++ H +++NLLGYC E
Sbjct: 527 RGSFGFVYKAVLSDGIHVAVKRANAATIIHSNNRGFESELEILCKIRHNNIVNLLGYCSE 586
Query: 584 GRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIH 643
ERLLVYE+M HG+LH HLHG QLDW R+ I +QAARG++YLH PP+IH
Sbjct: 587 MGERLLVYEYMPHGTLHDHLHGDLS----QLDWSMRLKIMLQAARGLDYLHNEVDPPIIH 642
Query: 644 RDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676
RD+K+SNIL+D E AR+ADFGL DSS+
Sbjct: 643 RDVKTSNILLDGEMCARIADFGLVSSNERDSSN 675
|
|
| TAIR|locus:2160952 CCR4 "CRINKLY4 related 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 694 (249.4 bits), Expect = 9.2e-86, Sum P(2) = 9.2e-86
Identities = 204/585 (34%), Positives = 287/585 (49%)
Query: 251 SRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGN 310
S +G +P D ++I G AC I + D V CWG + +P K +A G
Sbjct: 180 SCEGIAKVPSGDHYIAIAAGSRQACAI-TVDNDVECWG----QTQSLPRE-KFLALAVGE 233
Query: 311 YFTCGVLAEKSMLPVCWGTGFPTSLPLAVSP-GLCKMTPCAPGYYEASQENAP--C-KSP 366
CGV + VCWG SLP + + P + + N C +
Sbjct: 234 DRGCGVRWSNGTV-VCWGNNNNFSLPQTLKDIHFTSIYAKGPMFCGVATRNYTLICWGNE 292
Query: 367 NAHVCI-TCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFSAEC--------YKNCSSQFS 417
N + T G ++ C R C Y S + C K +F
Sbjct: 293 NFKSGVFTPFQGLISQVVMPGPCR----RECPYRPLSGSQSLCGNELMICDLKRNDGEFP 348
Query: 418 DGLTTKKNEKFWSMQLPVIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKAS-KSQK 476
D K WS + + + F + +V IS L + +C+C S +
Sbjct: 349 DTRAQNSKNKTWSRRNIAFLVVGCVGTFSLLLV--ISFLIFK---SHCRCRVHDSGRLDD 403
Query: 477 TNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGF--KEEVGKGSFSCVYKGV 534
T P + + + F+ +EL AT GF + +G GSF VY+GV
Sbjct: 404 TRTIDIPKLEKRLCTLASLGNPG--QLMEFSIDELALATDGFSVRFHLGIGSFGSVYQGV 461
Query: 535 LKDGTVVAVKKAIATSD----------RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG 584
L DG VA+K+A T+ R F EL+ +SRLNH +L+ LLG+ E+
Sbjct: 462 LSDGRHVAIKRAELTNPTLSGTTMRHRRADKDSAFVNELESMSRLNHKNLVRLLGFYEDT 521
Query: 585 RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHR 644
ER+LVYE+M +GSL HLH + L W R+ IA+ AARGI+YLH + PPVIHR
Sbjct: 522 EERILVYEYMKNGSLADHLHNPQF---DPLSWQTRLMIALDAARGIQYLHEFIVPPVIHR 578
Query: 645 DIKSSNILIDEEHNARVADFGLSLLGPA--DSSSPLAELPAGTLGYLDPEYYRLHYLTTK 702
DIKSSNIL+D A+V+DFGLS +GP D S L+ AGTLGY+DPEYY+ LTTK
Sbjct: 579 DIKSSNILLDATWTAKVSDFGLSQMGPTEEDDVSHLSLHAAGTLGYIDPEYYKFQQLTTK 638
Query: 703 SDVYSFGVLLLEILSGRKAIDMQFEEG--NIVEWAVPLIKSGDITAILDPVLKLPS--DL 758
SDVYSFGV+LLE+LSG KAI +E N+VE+ VP I + ILD + P+ ++
Sbjct: 639 SDVYSFGVVLLELLSGHKAIHNNEDENPRNLVEYVVPYILLDEAHRILDQRIPPPTPYEI 698
Query: 759 DALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSE 803
+A+ + +A +C+ ++RPSM +V + LE ALA + +P +E
Sbjct: 699 EAVAHVGYLAAECLMPCSRKRPSMVEVVSKLESALAACLTAPKTE 743
|
|
| TAIR|locus:2152312 AT5G38990 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 668 (240.2 bits), Expect = 9.8e-68, Sum P(2) = 9.8e-68
Identities = 152/382 (39%), Positives = 224/382 (58%)
Query: 420 LTTKKNEKFWSMQLPVIIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNG 479
+T K + S LP+IIA + AV L V ++ ++ ++ + ++ + S + TN
Sbjct: 426 ITPLKGKGKSSHVLPIIIAVVGSAVALAFFVLVVVLVVMKRKKKSNESSVDTTNKPSTNS 485
Query: 480 AGSPYQKDNGKIRP-DFDDLKIRRAQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLK 536
+ P G L + F+ E++ AT F+E+ +G G F VYKG +
Sbjct: 486 SWGPLLHGTGSTNTKSASSLPSDLCRRFSIYEIKSATNDFEEKLIIGVGGFGSVYKGRID 545
Query: 537 DG-TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595
G T+VAVK+ TS++ +KEF TEL++LS+L H HL++L+GYC++ E +LVYE+M
Sbjct: 546 GGATLVAVKRLEITSNQ--GAKEFDTELEMLSKLRHVHLVSLIGYCDDDNEMVLVYEYMP 603
Query: 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE 655
HG+L HL + KA L W RR+ I + AARG++YLH A +IHRDIK++NIL+DE
Sbjct: 604 HGTLKDHLFRRDKASDPPLSWKRRLEICIGAARGLQYLHTGAKYTIIHRDIKTTNILLDE 663
Query: 656 EHNARVADFGLSLLGPADSSSP-LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLE 714
A+V+DFGLS +GP +S ++ + GT GYLDPEYYR LT KSDVYSFGV+LLE
Sbjct: 664 NFVAKVSDFGLSRVGPTSASQTHVSTVVKGTFGYLDPEYYRRQILTEKSDVYSFGVVLLE 723
Query: 715 ILSGRKAIDMQF---EEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKC 771
+L R I MQ E+ +++ W + I+D L ++++ +A +C
Sbjct: 724 VLCCRP-IRMQSVPPEQADLIRWVKSNFNKRTVDQIIDSDLTADITSTSMEKFCEIAIRC 782
Query: 772 VRMRGKERPSMDKVTTALERAL 793
V+ RG ERP M+ V ALE AL
Sbjct: 783 VQDRGMERPPMNDVVWALEFAL 804
|
|
| TAIR|locus:2066143 AT2G28970 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 618 (222.6 bits), Expect = 1.2e-64, Sum P(3) = 1.2e-64
Identities = 133/358 (37%), Positives = 207/358 (57%)
Query: 436 IIAEITIAVFLITVVTLISILYVRYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDF 495
++ + ++ + +V ++ L+ R + +A S G ++ F
Sbjct: 408 LLVPVIASISSVLIVIVVVALFFVLRKKKMPSDAQAPPSLPVEDVGQAKHSESS-----F 462
Query: 496 DDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKN 555
KIR F Y E++ T F+ +G+G F VY G + VAVK ++ S Q
Sbjct: 463 VSKKIR----FAYFEVQEMTNNFQRVLGEGGFGVVYHGCVNGTQQVAVK-LLSQSSSQ-G 516
Query: 556 SKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLD 615
K F E++LL R++H +L++L+GYC+EG L+YE+M +G L QHL GK L
Sbjct: 517 YKHFKAEVELLMRVHHKNLVSLVGYCDEGDHLALIYEYMPNGDLKQHLSGKRGGFV--LS 574
Query: 616 WVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675
W R+ +AV AA G+EYLH PP++HRDIKS+NIL+DE A++ADFGLS P ++
Sbjct: 575 WESRLRVAVDAALGLEYLHTGCKPPMVHRDIKSTNILLDERFQAKLADFGLSRSFPTENE 634
Query: 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA 735
+ ++ + AGT GYLDPEYY+ ++LT KSDVYSFG++LLEI++ R I E+ ++VEW
Sbjct: 635 THVSTVVAGTPGYLDPEYYQTNWLTEKSDVYSFGIVLLEIITNRPIIQQSREKPHLVEWV 694
Query: 736 VPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
++++GDI I+DP L D+ ++ + +A CV + RPSM +V + L+ +
Sbjct: 695 GFIVRTGDIGNIVDPNLHGAYDVGSVWKAIELAMSCVNISSARRPSMSQVVSDLKECV 752
|
|
| TAIR|locus:2057991 AT2G37050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 660 (237.4 bits), Expect = 7.9e-64, P = 7.9e-64
Identities = 155/389 (39%), Positives = 233/389 (59%)
Query: 410 KNCSSQFSDGLTTKKN-EKFWSMQLPVIIAEITIAVFLITVVTLISILYVRYRLRNCQCS 468
K+ S FS L +K+ +K +L VII ++ F++ + T+IS + + +N +
Sbjct: 507 KDVISNFSGNLNLEKSGDK--GKKLGVIIGA-SVGAFVLLIATIISCIVMCKSKKNNKL- 562
Query: 469 GKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFS 528
GK S ++ TN P Q+ + + D A FT E+E AT F++ +G G F
Sbjct: 563 GKTS-AELTNRP-LPIQRVSSTLSEAHGDA----AHCFTLYEIEEATKKFEKRIGSGGFG 616
Query: 529 CVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588
VY G ++G +AVK + ++ + +EF E+ LLSR++H +L+ LGYC+E + +
Sbjct: 617 IVYYGKTREGKEIAVK--VLANNSYQGKREFANEVTLLSRIHHRNLVQFLGYCQEEGKNM 674
Query: 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKS 648
LVYEFM +G+L +HL+G ++ W++R+ IA AARGIEYLH P +IHRD+K+
Sbjct: 675 LVYEFMHNGTLKEHLYGVVPR-DRRISWIKRLEIAEDAARGIEYLHTGCVPAIIHRDLKT 733
Query: 649 SNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSF 708
SNIL+D+ A+V+DFGLS D +S ++ + GT+GYLDPEYY LT KSDVYSF
Sbjct: 734 SNILLDKHMRAKVSDFGLSKFA-VDGTSHVSSIVRGTVGYLDPEYYISQQLTEKSDVYSF 792
Query: 709 GVLLLEILSGRKAIDMQ-FEEG--NIVEWAVPLIKSGDITAILDPVLKLPS-DLDALKRI 764
GV+LLE++SG++AI + F NIV+WA I +GDI I+DP L L ++ +I
Sbjct: 793 GVILLELMSGQEAISNESFGVNCRNIVQWAKMHIDNGDIRGIIDPALAEDDYSLQSMWKI 852
Query: 765 ANVACKCVRMRGKERPSMDKVTTALERAL 793
A A CV+ G RPSM +V ++ A+
Sbjct: 853 AEKALLCVKPHGNMRPSMSEVQKDIQDAI 881
|
|
| TAIR|locus:2008565 AT1G67720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 659 (237.0 bits), Expect = 1.0e-63, P = 1.0e-63
Identities = 139/286 (48%), Positives = 191/286 (66%)
Query: 511 LERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKN-SKEFHTELDLLSRL 569
LE AT F ++VG+GSF VY G +KDG VAVK T+D + +++F TE+ LLSR+
Sbjct: 601 LEEATDNFSKKVGRGSFGSVYYGRMKDGKEVAVK---ITADPSSHLNRQFVTEVALLSRI 657
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARG 629
+H +L+ L+GYCEE R+LVYE+M +GSL HLHG S + LDW+ R+ IA AA+G
Sbjct: 658 HHRNLVPLIGYCEEADRRILVYEYMHNGSLGDHLHGSSDY--KPLDWLTRLQIAQDAAKG 715
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYL 689
+EYLH P +IHRD+KSSNIL+D A+V+DFGLS D + ++ + GT+GYL
Sbjct: 716 LEYLHTGCNPSIIHRDVKSSNILLDINMRAKVSDFGLSRQTEEDLTH-VSSVAKGTVGYL 774
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQ-F-EEGNIVEWAVPLIKSGDITAI 747
DPEYY LT KSDVYSFGV+L E+LSG+K + + F E NIV WA LI+ GD+ I
Sbjct: 775 DPEYYASQQLTEKSDVYSFGVVLFELLSGKKPVSAEDFGPELNIVHWARSLIRKGDVCGI 834
Query: 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
+DP + ++++ R+A VA +CV RG RP M +V A++ A+
Sbjct: 835 IDPCIASNVKIESVWRVAEVANQCVEQRGHNRPRMQEVIVAIQDAI 880
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O24585 | CRI4_MAIZE | 2, ., 7, ., 1, 1, ., 1 | 0.6528 | 0.9485 | 0.9622 | N/A | no |
| Q9LX29 | ACR4_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6977 | 0.9693 | 0.9899 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 914 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-47 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-46 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-46 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-45 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 6e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-45 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-31 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-27 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-24 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-24 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-23 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-23 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-22 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-21 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-21 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-20 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-20 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-20 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-20 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 9e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-19 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-19 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-19 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-19 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-18 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-18 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-18 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-18 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-17 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-17 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-16 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-16 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-16 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-16 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 9e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-15 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 6e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-15 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-14 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-14 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 8e-14 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-13 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 3e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 9e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-12 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-12 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-12 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 9e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-11 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-11 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-10 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-10 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-10 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 5e-10 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 8e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-09 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-09 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-09 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-09 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-09 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-08 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-08 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 5e-08 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 7e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 8e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-07 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-06 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 0.001 | |
| smart00208 | 39 | smart00208, TNFR, Tumor necrosis factor receptor / | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.004 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 8e-48
Identities = 78/279 (27%), Positives = 132/279 (47%), Gaps = 31/279 (11%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA 572
+++G+G+F VYKG LK VAVK + Q +EF E ++ +L+H
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQ-QIEEFLREARIMRKLDHP 61
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+++ LLG C E +V E+M G L +L + + +L ++ A+Q ARG+EY
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEY 117
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS--SSPLAELPAGTLGYLD 690
L IHRD+ + N L+ E +++DFGLS D +LP + ++
Sbjct: 118 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLP---IRWMA 171
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750
PE + T+KSDV+SFGVLL EI + + + + E + +K+G
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTL---GEQPYPGMSNEE-VLEYLKNGYR------ 221
Query: 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789
L P + + ++ +C ++RP+ ++ L
Sbjct: 222 -LPQPP--NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-47
Identities = 77/289 (26%), Positives = 130/289 (44%), Gaps = 45/289 (15%)
Query: 520 EEVGKGSFSCVYKGVLKDG----TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLL 575
+++G+G+F VYKG LK T VAVK + ++ K+F E ++ +L H +++
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEER-KDFLKEARVMKKLGHPNVV 59
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ----LDWVRRVTIAVQAARGIE 631
LLG C E LV E+M G L +L L ++ A+Q A+G+E
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS---SSPLAELPAGTLGY 688
YL +HRD+ + N L+ E+ +++DFGLS D +LP + +
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLP---IRW 173
Query: 689 LDPEYYRLHYLTTKSDVYSFGVLLLEILS-------GRKAIDMQFEEGNIVEWAVPLIKS 741
+ PE + T+KSDV+SFGVLL EI + G ++ + ++
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-----------LEYLRK 222
Query: 742 GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
G +LP + + C ++ ++RP+ ++ LE
Sbjct: 223 G---------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 30/279 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLKDG-----TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA 572
+++G+G+F VYKG LK VAVK + Q +EF E ++ +L+H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ-QIEEFLREARIMRKLDHP 61
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+++ LLG C E ++V E+M G L +L L ++ A+Q ARG+EY
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGMEY 118
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS--SSPLAELPAGTLGYLD 690
L IHRD+ + N L+ E +++DFGLS D +LP + ++
Sbjct: 119 LESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP---IRWMA 172
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750
PE + T+KSDV+SFGVLL EI + + + G + +K G
Sbjct: 173 PESLKEGKFTSKSDVWSFGVLLWEIFTLGE----EPYPGMSNAEVLEYLKKGY------- 221
Query: 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789
+LP + + + +C ++RP+ ++ L
Sbjct: 222 --RLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 7e-46
Identities = 71/197 (36%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
+G+G F VY K G VA+K I D +E E+++L +LNH +++ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKI-IKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 581 CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640
E+ LV E+ GSL L L E D + R I +Q G+EYLH
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSE--DEILR--ILLQILEGLEYLHSN---G 112
Query: 641 VIHRDIKSSNILIDE-EHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR-LHY 698
+IHRD+K NIL+D ++ADFGLS L S L + GT Y+ PE Y
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGY 170
Query: 699 LTTKSDVYSFGVLLLEI 715
+ KSD++S GV+L E+
Sbjct: 171 YSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 1e-45
Identities = 82/270 (30%), Positives = 124/270 (45%), Gaps = 24/270 (8%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
++G GSF VYK K G +VAVK S++ K + E+ +L RL+H +++
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVR 62
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L+ E+ LV E+ G L +L + L E IA+Q RG+EYLH
Sbjct: 63 LIDAFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDE----AKKIALQILRGLEYLHSN 117
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
+IHRD+K NIL+DE ++ADFGL+ SS GT Y+ PE
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWYMAPEVLLG 172
Query: 697 H-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE--WAVPLIKSGDITAILDPVLK 753
K DV+S GV+L E+L+G+ F NI++ + I + K
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK----PPFSGENILDQLQLIRRILGPP---LEFDEPK 225
Query: 754 LPSDLDALKRIANVACKCVRMRGKERPSMD 783
S + K ++ KC+ +RP+ +
Sbjct: 226 WSSGSEEAK---DLIKKCLNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 6e-45
Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
E++G+GSF VY K G +VA+K I +K+ + E+ +L +L H +++
Sbjct: 3 ILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNIVR 61
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L E+ + LV E+ G L L K L E D R Q +EYLH
Sbjct: 62 LYDVFEDEDKLYLVMEYCEGGDLFDLLK-KRGRLSE--DEARF--YLRQILSALEYLHSK 116
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYYR 695
++HRD+K NIL+DE+ + ++ADFGL+ L P + + GT Y+ PE
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTF----VGTPEYMAPEVLL 169
Query: 696 LHYLTTKSDVYSFGVLLLEILSGR 719
D++S GV+L E+L+G+
Sbjct: 170 GKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 9e-45
Identities = 69/216 (31%), Positives = 106/216 (49%), Gaps = 33/216 (15%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA 572
+++G+G+F VYKG LK T VAVK + ++ +EF E ++ +L+H
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS-EEEREEFLEEASIMKKLSHP 61
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+++ LLG C +G +V E+M G L L E+L + +A+Q A+G+EY
Sbjct: 62 NIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKH----GEKLTLKDLLQMALQIAKGMEY 117
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS---SSPLAELP----AGT 685
L +HRD+ + N L+ E +++DFGLS D +LP A
Sbjct: 118 LESKNF---VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMA-- 172
Query: 686 LGYLDPE---YYRLHYLTTKSDVYSFGVLLLEILSG 718
PE + T+KSDV+SFGVLL EI +
Sbjct: 173 -----PESLKDGK---FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 11/203 (5%)
Query: 520 EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E +G+GSF VY + KD G ++AVK + D ++ + E+ +LS L H +++
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 579 GYC--EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
G EE + E+++ GSL L K L E + +R+ T Q G+ YLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEPV--IRKYTR--QILEGLAYLHSN 120
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
++HRDIK +NIL+D + ++ADFG + + GT ++ PE R
Sbjct: 121 G---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 697 HYLTTKSDVYSFGVLLLEILSGR 719
+D++S G ++E+ +G+
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 7e-38
Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 13/204 (6%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+ +G+G+F VYKG+ L+ G VA+K+ +++ K E+DLL L H +++
Sbjct: 4 LGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVK 63
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV-QAARGIEYLHG 635
+G E ++ E+ +GSL Q + K E L V + V Q +G+ YLH
Sbjct: 64 YIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFPESL-----VAVYVYQVLQGLAYLHE 117
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
VIHRDIK++NIL ++ ++ADFG++ S GT ++ PE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD--ASVVGTPYWMAPEVIE 172
Query: 696 LHYLTTKSDVYSFGVLLLEILSGR 719
+ +T SD++S G ++E+L+G
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 127 bits (318), Expect = 2e-31
Identities = 90/370 (24%), Positives = 148/370 (40%), Gaps = 28/370 (7%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHA-HLL 575
++G+GSF VY +D +VA+K A + K + F E+ +L+ LNH +++
Sbjct: 4 ILRKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L + ++ LV E++ GSL L + I Q +EYLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALF--ILAQILSALEYLH- 118
Query: 636 YACPPVIHRDIKSSNILIDEE-HNARVADFGLS-LLGPADSSSPLAELPA---GTLGYLD 690
+IHRDIK NIL+D + ++ DFGL+ LL S+S + LP+ GT GY+
Sbjct: 119 --SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176
Query: 691 PEYYR---LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747
PE L Y ++ SD++S G+ L E+L+G + E+ + I T
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGL--PPFEGEKNSSATSQTLKIILELPTPS 234
Query: 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPIL 807
L L + K +++ K + K R S + L L + S+ L
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSS---SDLSHDLLAHLKLKESDLSDL 291
Query: 808 PTEVVLGSNRMH------KKSSQRSSNRSTSETDVAEAEDQRFEFRAPSWITFPSVTSSQ 861
R+ S +S + + + E + P +SS
Sbjct: 292 LKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSL 351
Query: 862 RRKSSVSDAD 871
++ S
Sbjct: 352 LLSTASSKRS 361
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 519 KEEVGKGSFSCVYKG-VLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
E++GKG F VYK + G VA+K I ++ ++ E+ +L + H +++
Sbjct: 5 LEKIGKGGFGEVYKARHKRTGKEVAIKV-IKLES-KEKKEKIINEIQILKKCKHPNIVKY 62
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
G + E +V EF + GSL L ++ L E + + + +G+EYLH
Sbjct: 63 YGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES--QI--AYVCKELLKGLEYLHSNG 118
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD-SSSPLAELPAGTLGYLDPEYYRL 696
+IHRDIK++NIL+ + ++ DFGLS A S + GT ++ PE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLS----AQLSDTKARNTMVGTPYWMAPEVING 171
Query: 697 HYLTTKSDVYSFGVLLLEILSGR 719
K+D++S G+ +E+ G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 71/208 (34%), Positives = 106/208 (50%), Gaps = 26/208 (12%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+GKG F V G + G VAVK D ++ F E +++ L H +L+ L
Sbjct: 10 LGATIGKGEFGDVMLGDYR-GQKVAVKC---LKDDSTAAQAFLAEASVMTTLRHPNLVQL 65
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKA---LKEQLDWVRRVTIAVQAARGIEYLH 634
LG +G +V E+MA GSL +L + +A L +QL + V G+EYL
Sbjct: 66 LGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV------CEGMEYLE 119
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL--AELPAGTLGYLDPE 692
+HRD+ + N+L+ E+ A+V+DFGL+ ++S +LP + + PE
Sbjct: 120 E---KNFVHRDLAARNVLVSEDLVAKVSDFGLA----KEASQGQDSGKLP---VKWTAPE 169
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILS-GR 719
R +TKSDV+SFG+LL EI S GR
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 67/202 (33%), Positives = 109/202 (53%), Gaps = 14/202 (6%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
E++GKG+F VYKGVLK T VAVK +T ++F E ++L + +H +++ L+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
C + + +V E + GSL L K L + + + +++ AA G+EYL C
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK----KLLQMSLDAAAGMEYLESKNC- 114
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSL---LGPADSSSPLAELPAGTLGYLDPEYYRL 696
IHRD+ + N L+ E + +++DFG+S G S L ++P + + PE
Sbjct: 115 --IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP---IKWTAPEALNY 169
Query: 697 HYLTTKSDVYSFGVLLLEILSG 718
T++SDV+S+G+LL E S
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 22/211 (10%)
Query: 518 FKEEVGKGSFSCVYKG---VLKDGT--VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA 572
F +++G+G F V L D T VAVK + S +++ +F E+++L L+H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKS-LNHSGEEQHRSDFEREIEILRTLDHE 66
Query: 573 HLLNLLGYCEE--GRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
+++ G CE+ GR L+ E++ GSL +L ++Q++ R + + Q +G+
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQR----HRDQINLKRLLLFSSQICKGM 122
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS----SSPLAELPAGTL 686
+YL IHRD+ + NIL++ E +++DFGL+ + P D E P
Sbjct: 123 DYLGSQRY---IHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI--- 176
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ PE R ++ SDV+SFGV L E+ +
Sbjct: 177 FWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 78/281 (27%), Positives = 120/281 (42%), Gaps = 41/281 (14%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
E R + ++G G F V++G+ K+ VA+K I SD ++F E+ L RL
Sbjct: 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIK--ILKSDDLLKQQDFQKEVQALKRL 59
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL---HGKSKALKEQLDWVRRVTIAVQA 626
H HL++L C G ++ E M GSL L G+ + +D +A Q
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID------MACQV 113
Query: 627 ARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL------GPADSSSPLAE 680
A G+ YL IHRD+ + NIL+ E+ +VADFGL+ L +D P
Sbjct: 114 AEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK- 169
Query: 681 LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIK 740
+ PE +TKSDV+SFG+LL E+ + + G I
Sbjct: 170 -------WTAPEAASHGTFSTKSDVWSFGILLYEMFT-YGQVPY---PGMNNHEVYDQIT 218
Query: 741 SGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPS 781
+G ++P + I + +C ++RPS
Sbjct: 219 AG---------YRMPCPAKCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 80/279 (28%), Positives = 132/279 (47%), Gaps = 43/279 (15%)
Query: 519 KEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+++GKGSF VY DG + +K+ ++ +K ++ E+ +L +LNH N+
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHP---NI 61
Query: 578 LGYCE--EGRERLL-VYEFMAHGSLHQHLHGKSKA---LKEQ--LDWVRRVTIAVQAARG 629
+ Y E E + +L V E+ G L Q + + K E+ LDW VQ
Sbjct: 62 IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWF------VQLCLA 115
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGY 688
++YLH ++HRDIK NI + ++ DFG+S +L S+ LA+ GT Y
Sbjct: 116 LKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYY 169
Query: 689 LDPEYYR-LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747
L PE + Y KSD++S G +L E+ + + FE N++E A+ I G I
Sbjct: 170 LSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHP----FEGENLLELALK-ILKGQYPPI 223
Query: 748 LDPVLKLPSDL-DALKRIANVACKCVRMRGKERPSMDKV 785
PS L+ + + ++ +ERPS+ ++
Sbjct: 224 -------PSQYSSELRNLVS---SLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 71/217 (32%), Positives = 113/217 (52%), Gaps = 23/217 (10%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
E++R + ++G G F V++G+ + T VAVK + + K+F E ++ +L
Sbjct: 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKL 58
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHG-KSKALK-EQLDWVRRVTIAVQAA 627
H L+ L C +V E M +GSL ++L G +ALK QL + +A Q A
Sbjct: 59 RHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL-----IDMAAQVA 113
Query: 628 RGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD--SSSPLAELPA 683
G+ YL Y IHRD+ + N+L+ E + +VADFGL+ + D + A+ P
Sbjct: 114 SGMAYLEAQNY-----IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP- 167
Query: 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GR 719
+ + PE + + KSDV+SFG+LL EI++ GR
Sbjct: 168 --IKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 70/230 (30%), Positives = 111/230 (48%), Gaps = 33/230 (14%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVL------KDGTVVAVKKAIATSDRQKNSKEFHTEL 563
++R T K E+G+G+F V+ G D +VAVK T+ K+F E
Sbjct: 1 HVQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDAR-KDFEREA 59
Query: 564 DLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL--HG-------KSKALKEQL 614
+LL+ H +++ G C EG ++V+E+M HG L++ L HG + +L
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGEL 119
Query: 615 DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674
+ + IAVQ A G+ YL A +HRD+ + N L+ + ++ DFG+S D
Sbjct: 120 TLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMS----RDV 172
Query: 675 SSP-------LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ LP + ++ PE TT+SDV+SFGV+L EI +
Sbjct: 173 YTTDYYRVGGHTMLP---IRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 77/226 (34%), Positives = 118/226 (52%), Gaps = 39/226 (17%)
Query: 518 FKEEVGKGSFSCVYKGVL------KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH 571
F EE+G+G+F VYKG L T VA+K + + K +EF E +L+S L H
Sbjct: 9 FLEELGEGAFGKVYKGELTGPNERLSATSVAIK-TLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 572 AHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKS-----------KALKEQLDWVRRV 620
+++ LLG C + + +++E++AHG LH+ L S + +K LD +
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 621 TIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG-PAD-----S 674
IA+Q A G+EYL + +HRD+ + N L+ E +++DFGLS AD S
Sbjct: 128 HIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQS 184
Query: 675 SSPLAELPAGTLGYLDPE---YYRLHYLTTKSDVYSFGVLLLEILS 717
S L + ++ PE Y + TT+SD++SFGV+L EI S
Sbjct: 185 KSLLP------VRWMPPEAILYGK---FTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 13/210 (6%)
Query: 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
++GKGSF V+K V K D V A+K+ + ++ +E E +L++L+ ++++
Sbjct: 5 LNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKA-LKEQLDWVRRVTIAVQAARGIEYLHGY 636
+ + +V E+ +G LH+ L + L E W +Q G+ +LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAHLHS- 119
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYYR 695
++HRDIKS N+ +D N ++ D G++ LL ++ A GT YL PE
Sbjct: 120 --KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD---NTNFANTIVGTPYYLSPELCE 174
Query: 696 LHYLTTKSDVYSFGVLLLEILSGRKAIDMQ 725
KSDV++ GV+L E +G+ D
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 63/204 (30%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 523 GKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG-Y 580
G+GS VYK K G + A+KK I ++ K+ EL L +++ G +
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKK-IHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 581 CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640
+EG + V E+M GSL L K + E + IA Q +G++YLH
Sbjct: 69 YKEGEISI-VLEYMDGGSLAD-LLKKVGKIPEPV----LAYIARQILKGLDYLHTKR--H 120
Query: 641 VIHRDIKSSNILIDEEHNARVADFGLS-----LLGPADSSSPLAELPAGTLGYLDPEYYR 695
+IHRDIK SN+LI+ + ++ADFG+S L ++ GT+ Y+ PE +
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-------VGTVTYMSPERIQ 173
Query: 696 LHYLTTKSDVYSFGVLLLEILSGR 719
+ +D++S G+ LLE G+
Sbjct: 174 GESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 78/279 (27%), Positives = 133/279 (47%), Gaps = 32/279 (11%)
Query: 520 EEVGKGSFSCVYKGV--LKDGTVVAVK-KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+E+G G+F V KGV +K G V V K + KEF E ++++L+H ++
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSK-ALKEQLDWVRRVTIAVQAARGIEYLHG 635
L+G C+ G +LV E G L ++L + + + + + A Q A G+ YL
Sbjct: 61 LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES 113
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGT--LGYLDPEY 693
+HRD+ + N+L+ H A+++DFG+S A S A AG L + PE
Sbjct: 114 KH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT-TAGRWPLKWYAPEC 169
Query: 694 YRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752
++KSDV+S+GV L E S G K + E +K ++ A+L+
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFSYGAKP----YGE----------MKGAEVIAMLESGE 215
Query: 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
+LP + + I ++ C + R ++RP+ ++ + R
Sbjct: 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 71/224 (31%), Positives = 112/224 (50%), Gaps = 21/224 (9%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSR 568
E+ER K ++G G + VY+GV K VAVK + +EF E ++
Sbjct: 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVK---TLKEDTMEVEEFLKEAAVMKE 58
Query: 569 LNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAAR 628
+ H +L+ LLG C ++ EFM +G+L +L + +++++ V + +A Q +
Sbjct: 59 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR---ECNRQEVNAVVLLYMATQISS 115
Query: 629 GIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGT--- 685
+EYL IHRD+ + N L+ E H +VADFGLS L D+ + AG
Sbjct: 116 AMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA----HAGAKFP 168
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEI----LSGRKAIDMQ 725
+ + PE + + KSDV++FGVLL EI +S ID+
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 21/207 (10%)
Query: 523 GKGSFSCVYKGV---LKDGTVVAVK-KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
G G+F VYKGV + + V K + K +KE E +++ ++H H++ LL
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ--LDWVRRVTIAVQAARGIEYL--H 634
G C + L+ + M G L ++ + Q L+W VQ A+G+ YL
Sbjct: 76 GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYLEEK 128
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
++HRD+ + N+L+ + ++ DFGL+ L D AE + ++ E
Sbjct: 129 R-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 695 RLHYLTTKSDVYSFGVLLLEILS-GRK 720
T KSDV+S+GV + E+++ G K
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 88/307 (28%), Positives = 146/307 (47%), Gaps = 44/307 (14%)
Query: 510 ELERATGGFKEEVGKGSFSCVYK----GVL--KDGTVVAVK--KAIATSDRQKNSKEFHT 561
E R + ++G+G+F V++ G+L + T+VAVK K A++D Q +F
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA---DFQR 57
Query: 562 ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL------------HGKSKA 609
E L++ +H +++ LLG C G+ L++E+MA+G L++ L H S A
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSA 117
Query: 610 LKE-----QLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADF 664
K L ++ IA Q A G+ YL + +HRD+ + N L+ E ++ADF
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADF 174
Query: 665 GLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDM 724
GLS + +E A + ++ PE + TT+SDV+++GV+L EI S M
Sbjct: 175 GLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS----YGM 230
Query: 725 QFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDK 784
Q G E + ++ G++ + D P +L L R+ C +RPS
Sbjct: 231 QPYYGMAHEEVIYYVRDGNVLSCPD---NCPLELYNLMRL------CWSKLPSDRPSFAS 281
Query: 785 VTTALER 791
+ L+R
Sbjct: 282 INRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 67/204 (32%), Positives = 99/204 (48%), Gaps = 20/204 (9%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAV----KKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+GKGSF V KD G + A+ KK I +++ TE ++LSR+NH ++
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL---TERNILSRINHPFIVK 57
Query: 577 LLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L Y + E+L LV E+ G L HL K E + R A + +EYLH
Sbjct: 58 LH-YAFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSE--ERARF--YAAEIVLALEYLHS 111
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
+I+RD+K NIL+D + + ++ DFGL+ ++ S GT YL PE
Sbjct: 112 LG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--TNTFCGTPEYLAPEVLL 166
Query: 696 LHYLTTKSDVYSFGVLLLEILSGR 719
D +S GVLL E+L+G+
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 75/216 (34%), Positives = 106/216 (49%), Gaps = 21/216 (9%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE-FHTELDLLSR 568
E+ R + + ++G G F V+ G T VAVK T S E F E ++ +
Sbjct: 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVK----TLKPGTMSPEAFLQEAQIMKK 57
Query: 569 LNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLH-GKSKALK-EQLDWVRRVTIAVQA 626
L H L+ L C E +V E+M+ GSL L G+ K L+ QL V +A Q
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-----VDMAAQI 112
Query: 627 ARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL--AELPAG 684
A G+ YL IHRD+ + NIL+ E ++ADFGL+ L D + A+ P
Sbjct: 113 AEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP-- 167
Query: 685 TLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GR 719
+ + PE T KSDV+SFG+LL EI++ GR
Sbjct: 168 -IKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 74/270 (27%), Positives = 123/270 (45%), Gaps = 36/270 (13%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+E+G G F V+ G + VA+K + + ++F E ++ +L+H L+ L
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIK---TIREGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKAL-KEQLDWVRRVTIAVQAARGIEYLHGY 636
G C E LV+EFM HG L +L + +E L + + + G+ YL
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETL-----LGMCLDVCEGMAYLES- 118
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEYY 694
+ VIHRD+ + N L+ E +V+DFG++ +L +SS + P + + PE +
Sbjct: 119 SN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP---VKWSSPEVF 173
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITA---ILDPV 751
++KSDV+SFGVL+ E+ S K +VE I A + P
Sbjct: 174 SFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE---------TINAGFRLYKPR 224
Query: 752 LKLPSDLDALKRIANVACKCVRMRGKERPS 781
L A + + + C + R ++RPS
Sbjct: 225 L-------ASQSVYELMQHCWKERPEDRPS 247
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 72/276 (26%), Positives = 130/276 (47%), Gaps = 32/276 (11%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
F +E+G G F V+ G + VA+K + + +F E ++ +L+H +L+ L
Sbjct: 8 FLKELGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL--HG 635
G C + R +V E+MA+G L +L + L + + + +EYL +G
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEW----LLDMCSDVCEAMEYLESNG 120
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEY 693
+ IHRD+ + N L+ E++ +V+DFGL+ +L +SS + P + + PE
Sbjct: 121 F-----IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP---VKWAPPEV 172
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753
+ ++KSDV+SFGVL+ E+ S K +F +VE + +G +
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVE----SVSAG---------YR 219
Query: 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789
L A + + C + ++RP+ K+ + L
Sbjct: 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 71/230 (30%), Positives = 111/230 (48%), Gaps = 19/230 (8%)
Query: 518 FKEEVGKGSFSCVYKGVL------KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH 571
K E+G+G+F V+ +D +VAVK SD + K+FH E +LL+ L H
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQH 66
Query: 572 AHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKAL------KEQLDWVRRVTIA 623
H++ G C EG ++V+E+M HG L++ L HG L +L + + IA
Sbjct: 67 EHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126
Query: 624 VQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA 683
Q A G+ YL A +HRD+ + N L+ E ++ DFG+S + +
Sbjct: 127 QQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTM 183
Query: 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
+ ++ PE TT+SDV+S GV+L EI + K Q ++E
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 233
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 27/279 (9%)
Query: 522 VGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLL 575
+G+G F V+ K T+V VK A+ + + EF ELD+ +L+H +++
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVK-ALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHL---HGKSKALKEQ-LDWVRRVTIAVQAARGIE 631
LLG C E ++ E+ G L Q L K + LK L ++V + Q A G++
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
+L + +HRD+ + N L+ + +V+ LS L L +L P
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 692 EYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751
E + +TKSDV+SFGVL+ E+ + + + F + E + +++G
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGE---LPFYGLSDEE-VLNRLQAGK-------- 235
Query: 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
L+LP R+ + +C + K+RPS ++ +AL
Sbjct: 236 LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 70/202 (34%), Positives = 110/202 (54%), Gaps = 22/202 (10%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
+GKG F V G + G VAVK K AT+ + F E ++++L H++L+ LLG
Sbjct: 14 IGKGEFGDVMLGDYR-GNKVAVKCIKNDATA------QAFLAEASVMTQLRHSNLVQLLG 66
Query: 580 YCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
E + L +V E+MA GSL +L + +++ L + ++ +EYL
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAMEYLEANN- 122
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
+HRD+ + N+L+ E++ A+V+DFGL+ A S+ +LP + + PE R
Sbjct: 123 --FVHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKLP---VKWTAPEALREKK 175
Query: 699 LTTKSDVYSFGVLLLEILS-GR 719
+TKSDV+SFG+LL EI S GR
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLG 579
+G G+F VY V L G ++AVK+ I D K KE E+ +L L H NL+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKE-IRIQDNDPKTIKEIADEMKVLELLKHP---NLVK 63
Query: 580 Y--CEEGRERLLVY-EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
Y E RE++ ++ E+ + G+L + L +R T+ Q G+ YLH +
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRI---LDEHVIRVYTL--QLLEGLAYLHSH 118
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLG---YLDPEY 693
++HRDIK +NI +D ++ DFG ++ ++++ + E G Y+ PE
Sbjct: 119 G---IVHRDIKPANIFLDHNGVIKLGDFGCAVK-LKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 694 YRLHYLTTK---SDVYSFGVLLLEILSGRK 720
+D++S G ++LE+ +G++
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 67/201 (33%), Positives = 107/201 (53%), Gaps = 15/201 (7%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSK-EFHTELDLLSRLNHAHLLNLL 578
E +GKG+F V+KG LKD T VAVK D + K +F +E +L + +H +++ L+
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPVAVKT--CKEDLPQELKIKFLSEARILKQYDHPNIVKLI 58
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
G C + + +V E + G L K K++L + V A+ AA G+ YL C
Sbjct: 59 GVCTQRQPIYIVMELVPGGDFLSFLRKK----KDELKTKQLVKFALDAAAGMAYLESKNC 114
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLL--GPADSSSPLAELPAGTLGYLDPEYYRL 696
IHRD+ + N L+ E + +++DFG+S SSS L ++P + + PE
Sbjct: 115 ---IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP---IKWTAPEALNY 168
Query: 697 HYLTTKSDVYSFGVLLLEILS 717
+++SDV+S+G+LL E S
Sbjct: 169 GRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 67/241 (27%), Positives = 103/241 (42%), Gaps = 20/241 (8%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSD--RQKNSKEFHTELDLLSRLNHAHLLNLLG 579
+GKG+F V +D + K + + + + E +L LNH L+NL
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW- 66
Query: 580 YCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
Y + E + LV + + G L HL K K +EQ V+ + +EYLH
Sbjct: 67 YSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ---VK--FWICEIVLALEYLHSKG- 120
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
+IHRDIK NIL+DE+ + + DF ++ D+ L +GT GY+ PE
Sbjct: 121 --IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQG 175
Query: 699 LTTKSDVYSFGVLLLEILSGR---KAIDMQFEEG--NIVEWAVPLIKSGDITAILDPVLK 753
+ D +S GV E L G+ + + E A L + T +D + K
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINK 235
Query: 754 L 754
L
Sbjct: 236 L 236
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 68/218 (31%), Positives = 107/218 (49%), Gaps = 25/218 (11%)
Query: 518 FKEEVGKGSFSCVYKGVL------KDGTVVAVK--KAIATSDRQKNSKEFHTELDLLSRL 569
K E+G+G+F V+ +D +VAVK K + S RQ +F E +LL+ L
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ----DFQREAELLTVL 64
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKE--------QLDWVRR 619
H H++ G C EGR L+V+E+M HG L++ L HG + QL +
Sbjct: 65 QHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM 124
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679
+ IA Q A G+ YL +HRD+ + N L+ + ++ DFG+S + +
Sbjct: 125 LAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181
Query: 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ ++ PE TT+SD++SFGV+L EI +
Sbjct: 182 GRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 4e-22
Identities = 86/325 (26%), Positives = 135/325 (41%), Gaps = 79/325 (24%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKD------GTVVAVK--KAIATSDRQKNSKEFHT 561
EL R + +G+G+F V K + VAVK K AT +K+ + +
Sbjct: 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT---EKDLSDLVS 64
Query: 562 ELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGK-----------SKA 609
E++++ + H +++NLLG C + +V E+ AHG+L L + +
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124
Query: 610 LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669
+E L V+ A Q ARG+E+L C IHRD+ + N+L+ E+H ++ADFGL
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKC---IHRDLAARNVLVTEDHVMKIADFGL--- 178
Query: 670 GPADSSSPLAELPAGTLGYLDPEYYRLH------------------YLTTKSDVYSFGVL 711
A + ++D YYR T +SDV+SFGVL
Sbjct: 179 -------------ARDIHHID--YYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 223
Query: 712 LLEI--LSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVAC 769
L EI L G + EE L+K G ++ +L L
Sbjct: 224 LWEIFTLGGSPYPGIPVEE------LFKLLKEGY---RMEKPQNCTQELYHL------MR 268
Query: 770 KCVRMRGKERPSMDKVTTALERALA 794
C +RP+ ++ L+R L
Sbjct: 269 DCWHEVPSQRPTFKQLVEDLDRMLT 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 55/223 (24%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE---FHTELDLLSRLNHAHLLNLL 578
+GKG F CVY G L D + A+ + +R + +E F E ++ +H ++L+LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 579 GYC--EEGRERLLVYEFMAHGSLHQHLHGKSK--ALKEQLDWVRRVTIAVQAARGIEYLH 634
G C EG L+V +M HG L + ++ +K+ + +Q A+G+EYL
Sbjct: 63 GICLPSEGSP-LVVLPYMKHGDLRNFIRSETHNPTVKDL------IGFGLQVAKGMEYL- 114
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
A +HRD+ + N ++DE +VADFGL+ D EYY
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLAR------------------DIYDKEYY 154
Query: 695 RLH--------------------YLTTKSDVYSFGVLLLEILS 717
+H TTKSDV+SFGVLL E+++
Sbjct: 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 74/274 (27%), Positives = 132/274 (48%), Gaps = 28/274 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
F +E+G G F V+ G + VA+K A ++ + ++F E ++ +L+H L+ L
Sbjct: 8 FMKELGSGQFGVVHLGKWRAQIKVAIK---AINEGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
G C + + +V EFM +G L +L + L + + +++ G+EYL +
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDM----LLSMCQDVCEGMEYLERNS 120
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEYYR 695
IHRD+ + N L+ +V+DFG++ +L +SS A+ P + + PE +
Sbjct: 121 ---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFP---VKWSPPEVFN 174
Query: 696 LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755
++KSDV+SFGVL+ E+ + K M FE+ + E V +I G + P L
Sbjct: 175 FSKYSSKSDVWSFGVLMWEVFTEGK---MPFEKKSNYE-VVEMISRGF--RLYRPKL--- 225
Query: 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789
A + V C + + RP+ ++ A+
Sbjct: 226 ----ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 7e-22
Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 10/206 (4%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
E +G G+ + VY + L + VA+K+ I Q + E E+ +S+ NH +++
Sbjct: 5 LIEVIGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHPNVVK 63
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
G E LV +++ GSL + KS + LD T+ + +G+EYLH
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPE-Y 693
IHRDIK+ NIL+ E+ + ++ADFG+S L D + + + GT ++ PE
Sbjct: 122 G---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGR 719
++H K+D++SFG+ +E+ +G
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
E++G+G+ VYK G VA+KK ++ E+ ++ H ++++
Sbjct: 23 NLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVD 79
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKE-QLDWVRRVTIAVQAARGIEYLHG 635
G E +V E+M GSL + + E Q+ +V R + +G+EYLH
Sbjct: 80 YYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL-----QGLEYLHS 134
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA---------GTL 686
VIHRDIKS NIL+ ++ + ++ADFG + A+L GT
Sbjct: 135 Q---NVIHRDIKSDNILLSKDGSVKLADFGFA-----------AQLTKEKSKRNSVVGTP 180
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
++ PE + K D++S G++ +E+ G
Sbjct: 181 YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 520 EEVGKGSFSCVYKGVL----KDGTVVAVKKAIAT-SDRQKNSKEFHTELDLLSRLNHAHL 574
+ +G G F V +G L K VA+K A SD+Q+ +F TE ++ + +H ++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR--LDFLTEASIMGQFDHPNI 67
Query: 575 LNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL- 633
+ L G + R +++ E+M +GSL + L + + V + A G++YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLS 123
Query: 634 -HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAG--TLGYLD 690
Y +HRD+ + NIL++ +V+DFGLS + S G + +
Sbjct: 124 EMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYTTKGGKIPIRWTA 176
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEILS 717
PE T+ SDV+SFG+++ E++S
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 85/295 (28%), Positives = 137/295 (46%), Gaps = 39/295 (13%)
Query: 518 FKEEVGKGSFSCVYKG-VLKDGTVV-AVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHL 574
F++ +G+G+F V K + KDG + A K + + + ++F EL++L +L H ++
Sbjct: 11 FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 575 LNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALK------------EQLDWVRRVTI 622
+NLLG CE L E+ HG+L L KS+ L+ L + +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHF 129
Query: 623 AVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP 682
A ARG++YL + IHRD+ + NIL+ E + A++ADFGLS + LP
Sbjct: 130 AADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186
Query: 683 AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS--GRKAIDMQFEEGNIVEWAVPLIK 740
+ ++ E TT SDV+S+GVLL EI+S G M E
Sbjct: 187 ---VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------------ 231
Query: 741 SGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795
+ L +L L+ + ++ +C R + ERPS ++ +L R L +
Sbjct: 232 ---LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 83/286 (29%), Positives = 135/286 (47%), Gaps = 58/286 (20%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
E +G+G F V +G G VAVK K T+ + F E ++++L+H +L+ L
Sbjct: 12 EIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTA------QAFLEETAVMTKLHHKNLVRL 64
Query: 578 LGYC-EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
LG G +V E M+ G+L L + +AL + ++ ++ A G+EYL
Sbjct: 65 LGVILHNGLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQ---FSLDVAEGMEYLES- 118
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP--ADSSSPLAELPAGTLGYLDPEYY 694
++HRD+ + NIL+ E+ A+V+DFGL+ +G D+S +LP + + PE
Sbjct: 119 --KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS----KLP---VKWTAPEAL 169
Query: 695 RLHYLTTKSDVYSFGVLLLEILS-GR--------KAIDMQFEEGNIVEWAVPLIKSGDIT 745
+ ++KSDV+S+GVLL E+ S GR K + E+G
Sbjct: 170 KHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG---------------- 213
Query: 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
++P P+D+ L C K+RPS K+ LE+
Sbjct: 214 YRMEPPEGCPADVYVLMT------SCWETEPKKRPSFHKLREKLEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 59/204 (28%), Positives = 107/204 (52%), Gaps = 12/204 (5%)
Query: 521 EVGKGSFSCVYKGV--LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E+G G+F CV KGV ++ + K + + + E E +++ +L++ +++ ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
G CE +LV E + G L++ L GK K+++ V + Q + G++YL G
Sbjct: 62 GVCE-AEALMLVMEMASGGPLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEG--- 113
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
+HRD+ + N+L+ +H A+++DFGLS LG DS L + PE
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 698 YLTTKSDVYSFGVLLLEILS-GRK 720
+++SDV+S+G+ + E S G+K
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 5e-21
Identities = 67/209 (32%), Positives = 110/209 (52%), Gaps = 19/209 (9%)
Query: 518 FKEEVGKGSFS----CVYKGVLKDGT--VVAVKKAIATSDRQKNSKEFHTELDLLSRLNH 571
F +++GKG+F C Y L+D T VVAVKK ++ ++F E+++L L H
Sbjct: 8 FIQQLGKGNFGSVELCRYDP-LQDNTGEVVAVKKLQHSTAEHL--RDFEREIEILKSLQH 64
Query: 572 AHLLNLLGYC-EEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARG 629
+++ G C GR L LV E++ +GSL +L +E+LD + + A Q +G
Sbjct: 65 DNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKG 120
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGT-LGY 688
+EYL +HRD+ + NIL++ E+ ++ DFGL+ + P D P + + +
Sbjct: 121 MEYLGSKRY---VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFW 177
Query: 689 LDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
PE + SDV+SFGV+L E+ +
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 7e-21
Identities = 73/280 (26%), Positives = 126/280 (45%), Gaps = 25/280 (8%)
Query: 519 KEE--VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
KEE + +G YKG + V K I + +S E+ + +L H +++
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS-----EIADMGKLQHPNIVK 747
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L+G C + L++E++ +L + L L W RR IA+ A+ + +LH
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCR 799
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
P V+ ++ I+ID + + LSL G + + A Y+ PE
Sbjct: 800 CSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGLLCTDTKCFISSA----YVAPETRET 852
Query: 697 HYLTTKSDVYSFGVLLLEILSGRKAIDMQFE-EGNIVEWAVPLIKSGDITAILDPVLK-- 753
+T KSD+Y FG++L+E+L+G+ D +F G+IVEWA + +DP ++
Sbjct: 853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD 912
Query: 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
+ + + + + N+A C RP + V LE A
Sbjct: 913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS 952
|
Length = 968 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 69/228 (30%), Positives = 118/228 (51%), Gaps = 27/228 (11%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVL-----KDGTVVAVKKAIATSDRQKNSKEFHTELD 564
EL + F EE+G+ +F +YKG L +VA+K ++ Q+ EF E
Sbjct: 1 ELPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWG-EFQQEAS 59
Query: 565 LLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSK------------ALKE 612
L++ L+H +++ LLG + + +++E++ G LH+ L +S +K
Sbjct: 60 LMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKS 119
Query: 613 QLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL-LGP 671
LD + IA+Q A G+EYL + +H+D+ + NILI E+ + +++D GLS +
Sbjct: 120 SLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYS 176
Query: 672 AD--SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
AD P + LP + ++ PE ++ SD++SFGV+L EI S
Sbjct: 177 ADYYRVQPKSLLP---IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 67/218 (30%), Positives = 107/218 (49%), Gaps = 20/218 (9%)
Query: 510 ELERATGGFKEEVGKGSFSCVYK----GVLKDGTV--VAVKKAIATSDRQKNSKEFHTEL 563
E R F + +G G+F V + G+ K V VAVK T+ + + +EL
Sbjct: 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSE-REALMSEL 89
Query: 564 DLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI 622
++S L NH +++NLLG C G L++ E+ +G L L K ++ D + +
Sbjct: 90 KIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLL---SF 146
Query: 623 AVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS---SSPLA 679
+ Q A+G+ +L C IHRD+ + N+L+ ++ DFGL+ DS A
Sbjct: 147 SYQVAKGMAFLASKNC---IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNA 203
Query: 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
LP + ++ PE T +SDV+S+G+LL EI S
Sbjct: 204 RLP---VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 1e-20
Identities = 78/286 (27%), Positives = 127/286 (44%), Gaps = 33/286 (11%)
Query: 522 VGKGSFSCVYKGVLK--DGTV--VAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+G+G F V +G L DG+ VAVK +EF +E + +H +++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 578 LGYCEEGRER------LLVYEFMAHGSLHQHL-HGKSKALKEQLDWVRRVTIAVQAARGI 630
+G C E +++ FM HG LH L + + L E+L + V A G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS---LLGPADSSSPLAELPAGTLG 687
EYL + IHRD+ + N ++ E+ VADFGLS G +A++P +
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMP---VK 180
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747
++ E T+KSDV++FGV + EI + + P +++ +I
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT-------------PYPGVENHEIYDY 227
Query: 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
L +L D L + ++ C R K+RP+ K+ LE L
Sbjct: 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENIL 273
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 35/272 (12%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKN---SKEFHTELDLLSRLNHAHLL 575
E +G GSF VY+G+ L DG AVK+ D Q K+ E+ LLS+L H +++
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 576 NLLGYCEEGRERLLVY-EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
LG E + L ++ E + GSL + L K + E + +R T Q G+EYLH
Sbjct: 66 QYLGTEREE-DNLYIFLELVPGGSLAK-LLKKYGSFPEPV--IRLYT--RQILLGLEYLH 119
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA--GTLGYLDPE 692
+HRDIK +NIL+D ++ADFG+ A + + G+ ++ PE
Sbjct: 120 DRN---TVHRDIKGANILVDTNGVVKLADFGM-----AKQVVEFSFAKSFKGSPYWMAPE 171
Query: 693 YY-RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751
+ +D++S G +LE+ +G+ + + + +S ++ I
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPI---- 223
Query: 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMD 783
P L + + KC++ RP+
Sbjct: 224 ---PDHLSDEAK--DFILKCLQRDPSLRPTAA 250
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-20
Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 26/235 (11%)
Query: 518 FKEEVGKGSF------SCVYKGVLKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLSRL 569
K E+G+G+F C KD +VAVK K + R K+F E +LL+ L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR----KDFQREAELLTNL 64
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLH-----------GKSKALKEQLDWVR 618
H H++ G C +G ++V+E+M HG L++ L G+ + K +L +
Sbjct: 65 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124
Query: 619 RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678
+ IA Q A G+ YL A +HRD+ + N L+ ++ DFG+S + +
Sbjct: 125 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRV 181
Query: 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
+ ++ PE TT+SDV+SFGV+L EI + K Q ++E
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE 236
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIAT---SDRQKNSKEFHTELDLL 566
E++R +G+G F VY+GV + A+ T ++F E ++
Sbjct: 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIM 61
Query: 567 SRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQA 626
+ +H H++ L+G E +V E G L +L + K LD + + Q
Sbjct: 62 RQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQL 116
Query: 627 ARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS--SSPLAELPAG 684
+ + YL +HRDI + N+L+ ++ DFGLS +S + +LP
Sbjct: 117 STALAYLESKRF---VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLP-- 171
Query: 685 TLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ ++ PE T+ SDV+ FGV + EIL
Sbjct: 172 -IKWMAPESINFRRFTSASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 69/212 (32%), Positives = 111/212 (52%), Gaps = 24/212 (11%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKA----IATSDRQKNSKEFHTELDLLSRLNHAHL 574
+++G G+FS Y+ +K GT++AVK+ +S++++ + E+ L++RLNH H+
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 575 LNLLG-YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV--QAARGIE 631
+ +LG CE+ L V E+MA GS+ L K A KE V I Q RG+
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLS-KYGAFKEA------VIINYTEQLLRGLS 117
Query: 632 YLHGYACPPVIHRDIKSSNILIDEE-HNARVADFGLSLLGPADSSSPLAELPA---GTLG 687
YLH +IHRD+K +N+LID R+ADFG + A + E GT+
Sbjct: 118 YLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGA-GEFQGQLLGTIA 173
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
++ PE R DV+S G +++E+ + +
Sbjct: 174 FMAPEVLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 5e-20
Identities = 73/277 (26%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSK---EFHTELDLLSRLNHAHLLNL 577
+G G+F VYKG+ + +G V + AI + K EF E +++ ++H HL+ L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQL--DWVRRVTIAVQAARGIEYLHG 635
LG C +L V + M HG L ++H + QL +W VQ A+G+ YL
Sbjct: 75 LGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE 127
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
++HRD+ + N+L+ ++ ++ DFGL+ L D A+ + ++ E
Sbjct: 128 RR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 696 LHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754
T +SDV+S+GV + E+++ G K D I + +I +L+ +L
Sbjct: 185 YRKFTHQSDVWSYGVTIWELMTFGGKPYDG--------------IPTREIPDLLEKGERL 230
Query: 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
P + V KC + RP ++ R
Sbjct: 231 PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 35/226 (15%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLN-HA 572
F + +G+GSFS V K A+K K ++K K E ++L+RLN H
Sbjct: 5 FGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI--KEKKVKYVKIEKEVLTRLNGHP 62
Query: 573 HLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
++ L Y + E L V E+ +G L Q++ K +L E R A + +E
Sbjct: 63 GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDE--KCTR--FYAAEILLALE 116
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA-------- 683
YLH +IHRD+K NIL+D++ + ++ DFG + + +SS + A
Sbjct: 117 YLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 684 ----------GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
GT Y+ PE SD+++ G ++ ++L+G+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 5e-20
Identities = 65/213 (30%), Positives = 106/213 (49%), Gaps = 24/213 (11%)
Query: 523 GKGSFSCVYK-GVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYC 581
GKGS+ VYK L D A+K+ S QK ++ E+ +L+ +NH N++ Y
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHP---NIISYK 65
Query: 582 E---EGRERLLVYEFMAHGSLHQHL---HGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
E +G + +V E+ G L + + K K + EQ W I +Q RG++ LH
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGLQALHE 121
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
++HRD+KS+NIL+ ++ D G+S + +A+ GT Y+ PE ++
Sbjct: 122 QK---ILHRDLKSANILLVANDLVKIGDLGISKV----LKKNMAKTQIGTPHYMAPEVWK 174
Query: 696 LHYLTTKSDVYSFGVLLLEILSGR---KAIDMQ 725
+ KSD++S G LL E+ + +A MQ
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 9e-20
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 47/221 (21%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
++G+G++ VYK K G +VA+KK ++++ E+ LL +L H +++ L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 579 G-YCEEGRERL-LVYEFMAH---GSLHQHLH----GKSKALKEQLDWVRRVTIAVQAARG 629
+G+ + +V+E+M H G L + K +QL G
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQL------------LEG 112
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL----SLLGPADSSSPLAELPAGT 685
++YLH ++HRDIK SNILI+ + ++ADFGL + AD ++ + T
Sbjct: 113 LQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-----T 164
Query: 686 LGYLDPE-------YYRLHYLTTKSDVYSFGVLLLEILSGR 719
L Y PE Y + D++S G +L E+ G+
Sbjct: 165 LWYRPPELLLGATRY------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
++G+G++ VYK G +VA+KK + + K E+ LL LNH +++ LL
Sbjct: 5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
+ LV+EFM L++ + + + L E L ++ + Q +G+ + H +
Sbjct: 65 DVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESL--IK--SYLYQLLQGLAFCHSHGI 119
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPE-YYRL 696
+HRD+K N+LI+ E ++ADFGL+ G P T Y PE
Sbjct: 120 ---LHRDLKPENLLINTEGVLKLADFGLARSFGS--PVRPYTHYVV-TRWYRAPELLLGD 173
Query: 697 HYLTTKSDVYSFGVLLLEILSGR 719
+T D++S G + E+LS R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 521 EVGKGSFSCVYKGVLKD------GTVVAVKKAIAT-SDRQKNSKEFHTELDLLSRLNHAH 573
E+G+GSF VY+G+ K T VA+K S R++ EF E ++ N H
Sbjct: 13 ELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMKEFNCHH 70
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI---------AV 624
++ LLG G+ L+V E MA G L +L ++ + + + + A
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYL----RSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 625 QAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAE--L 681
+ A G+ YL +HRD+ + N ++ E+ ++ DFG++ + D + L
Sbjct: 127 EIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 682 PAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
P + ++ PE + TTKSDV+SFGV+L E+ +
Sbjct: 184 P---VRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 70/213 (32%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 515 TGGFKEE--VGKGSFSCVYKGV-LKDGTVVAVKKA-----IATSDRQKNSKEFHTELDLL 566
G FK E +GKG FS VYK + L DG VVA+KK + RQ KE +DLL
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKE----IDLL 56
Query: 567 SRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQ---HLHGKSKALKEQLDWVRRVTIA 623
+L+H +++ L E E +V E G L + H + + + E+ W
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW----KYF 112
Query: 624 VQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP- 682
VQ +E++H ++HRDIK +N+ I ++ D G LG SS A
Sbjct: 113 VQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLG---LGRFFSSKTTAAHSL 166
Query: 683 AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEI 715
GT Y+ PE + KSD++S G LL E+
Sbjct: 167 VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 1e-19
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 21/221 (9%)
Query: 503 AQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHT 561
A++ EL + + +G G F V+KG+ + +G + + AI T + + F
Sbjct: 1 ARILKETELRKL-----KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQE 55
Query: 562 ELD---LLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ--LDW 616
D + L+HA+++ LLG C G LV + GSL H+ +L Q L+W
Sbjct: 56 ITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW 114
Query: 617 VRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676
VQ A+G+ YL + ++HR++ + NIL+ + ++ADFG++ L D
Sbjct: 115 ------CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKK 165
Query: 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ ++ E T +SDV+S+GV + E++S
Sbjct: 166 YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 34/286 (11%)
Query: 522 VGKGSFSCVYKGVL-KDGTV--VAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+G+G F V +G L +D ++ VAVK IA R + ++F +E + +H +++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE-MEDFLSEAVCMKEFDHPNVMRL 65
Query: 578 LGYCEEGRER------LLVYEFMAHGSLHQHL-HGKSKALKEQLDWVRRVTIAVQAARGI 630
+G C + E +++ FM HG LH L + + + L V A G+
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS---LLGPADSSSPLAELPAGTLG 687
EYL + IHRD+ + N +++E N VADFGLS G +A++P +
Sbjct: 126 EYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP---VK 179
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747
++ E TTKSDV+SFGV + EI + + P +++ +I
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT-------------PYPGVENSEIYDY 226
Query: 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
L +L D L + ++ C + K+RPS + + LE+AL
Sbjct: 227 LRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 66/218 (30%), Positives = 110/218 (50%), Gaps = 28/218 (12%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGT-VVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHL 574
F++ +G+G+F V + ++K DG + A K + + + ++F EL++L +L +H ++
Sbjct: 6 FEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNI 65
Query: 575 LNLLGYCEEGRERLLVYEFMAHGSLHQHL---------------HGKSKALKEQLDWVRR 619
+NLLG CE + E+ +G+L L HG + L Q +
Sbjct: 66 INLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ----QL 121
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679
+ A A G++YL + IHRD+ + N+L+ E +++ADFGLS +
Sbjct: 122 LQFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178
Query: 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
LP + ++ E TTKSDV+SFGVLL EI+S
Sbjct: 179 RLP---VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 61/202 (30%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E +G+G+F V+ G L+ D T VAVK T +K F E +L + +H +++ L+
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLI 59
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
G C + + +V E + G L + LK + + + AA G+EYL C
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVK----ELIQMVENAAAGMEYLESKHC 115
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLL---GPADSSSPLAELPAGTLGYLDPEYYR 695
IHRD+ + N L+ E++ +++DFG+S G S+ + ++P + + PE
Sbjct: 116 ---IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP---VKWTAPEALN 169
Query: 696 LHYLTTKSDVYSFGVLLLEILS 717
+++SDV+SFG+LL E S
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 71/275 (25%), Positives = 127/275 (46%), Gaps = 30/275 (10%)
Query: 521 EVGKGSFSCVYKGVL---KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
E+G G+F V KG+ K VAVK ++ E E +++ +L++ +++ +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV-QAARGIEYLHGY 636
+G CE +LV E G L++ L K+K + E + +T V Q + G++YL
Sbjct: 62 IGICE-AESWMLVMELAELGPLNKFLQ-KNKHVTE-----KNITELVHQVSMGMKYLEET 114
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAG-TLGYLDPEYYR 695
+HRD+ + N+L+ +H A+++DFGLS AD + A+ + + PE
Sbjct: 115 N---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN 171
Query: 696 LHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754
+ ++KSDV+SFGVL+ E S G+K +K ++T +++ ++
Sbjct: 172 YYKFSSKSDVWSFGVLMWEAFSYGQKPYKG--------------MKGNEVTQMIESGERM 217
Query: 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789
+ ++ C ERP V L
Sbjct: 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRL 252
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (220), Expect = 4e-19
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 36/215 (16%)
Query: 519 KEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHT-----ELDLLSRLNHA 572
E++G+G++ VYK K G +VA+KK R N +E E+ LL L H
Sbjct: 4 LEKLGEGTYGVVYKARDKKTGEIVALKKI-----RLDNEEEGIPSTALREISLLKELKHP 58
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+++ LL R+ LV+E+ L ++L + L L ++ I Q RG+ Y
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL--IKS--IMYQLLRGLAY 113
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAG--TLGYLD 690
H + ++HRD+K NILI+ + ++ADFGL+ PL TL Y
Sbjct: 114 CHSHR---ILHRDLKPQNILINRDGVLKLADFGLA----RAFGIPLRTYTHEVVTLWYRA 166
Query: 691 PE------YYRLHYLTTKSDVYSFGVLLLEILSGR 719
PE +Y +T D++S G + E+++G+
Sbjct: 167 PEILLGSKHY-----STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-18
Identities = 75/286 (26%), Positives = 136/286 (47%), Gaps = 34/286 (11%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
E+ R T +++G G F V+ G T VA+K S + + F E +L+ +L
Sbjct: 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQL 58
Query: 570 NHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAAR 628
H L+ L Y +E + ++ E+M +GSL L +L + + +A Q A
Sbjct: 59 QHPRLVRL--YAVVTQEPIYIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAE 113
Query: 629 GIEYLH--GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD--SSSPLAELPAG 684
G+ ++ Y IHRD++++NIL+ E ++ADFGL+ L + ++ A+ P
Sbjct: 114 GMAFIERKNY-----IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFP-- 166
Query: 685 TLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDI 744
+ + PE T KSDV+SFG+LL EI++ G I P + + ++
Sbjct: 167 -IKWTAPEAINYGTFTIKSDVWSFGILLTEIVT----------YGRI---PYPGMTNPEV 212
Query: 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
L+ ++P + + + + C + + +ERP+ + + + LE
Sbjct: 213 IQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 62/206 (30%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
E++G+GS+ VYK + K+ G VVA+K D Q+ KE + +L + + +++
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKE----ISILKQCDSPYIVK 62
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV---QAARGIEYL 633
G + + +V E+ GS+ + +K L E+ IA Q +G+EYL
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEE-------IAAILYQTLKGLEYL 115
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
H IHRDIK+ NIL++EE A++ADFG+S G + GT ++ PE
Sbjct: 116 HSNK---KIHRDIKAGNILLNEEGQAKLADFGVS--GQLTDTMAKRNTVIGTPFWMAPEV 170
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGR 719
+ K+D++S G+ +E+ G+
Sbjct: 171 IQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 58/208 (27%), Positives = 91/208 (43%), Gaps = 23/208 (11%)
Query: 520 EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
VG+G++ V K K G +VA+KK + D + K E+ +L +L H +++NL
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
LV+E++ +L + L L VR Q + I Y H +
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDA--VRSYIW--QLLQAIAYCHSHNI 121
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
IHRDIK NIL+ E ++ DFG + A +SPL + Y+ +YR
Sbjct: 122 ---IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD-------YVATRWYRAPE 171
Query: 699 LTTKS-------DVYSFGVLLLEILSGR 719
L DV++ G ++ E+L G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 78/295 (26%), Positives = 137/295 (46%), Gaps = 34/295 (11%)
Query: 510 ELERATGGFKEEVGKGSFSCVY----KGVLKDG--TVVAVKKAIATSDRQKNSKEFHTEL 563
E+ R E+G+GSF VY KGV+KD T VA+K + + + EF E
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIK-TVNEAASMRERIEFLNEA 60
Query: 564 DLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHG-----KSKALKEQLDWVR 618
++ N H++ LLG +G+ L++ E M G L +L ++ ++ +
Sbjct: 61 SVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKK 120
Query: 619 RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL-LGPADSSSP 677
+ +A + A G+ YL+ +HRD+ + N ++ E+ ++ DFG++ + D
Sbjct: 121 MIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 177
Query: 678 LAE--LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA 735
+ LP + ++ PE + TT SDV+SFGV+L EI + + Q +G E
Sbjct: 178 GGKGLLP---VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----LAEQPYQGMSNEQV 230
Query: 736 VPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
+ + G +LD P L L R+ C + K RPS ++ ++++
Sbjct: 231 LRFVMEG---GLLDKPDNCPDMLFELMRM------CWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 71/283 (25%), Positives = 132/283 (46%), Gaps = 27/283 (9%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
E+ R + +++G G F V+ G + T VAVK + + + F E +L+ L
Sbjct: 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTL 58
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARG 629
H L+ L + ++ E+MA GSL L KS ++ + + + Q A G
Sbjct: 59 QHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFL--KSDE-GGKVLLPKLIDFSAQIAEG 115
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD--SSSPLAELPAGTLG 687
+ Y+ IHRD++++N+L+ E ++ADFGL+ + + ++ A+ P +
Sbjct: 116 MAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP---IK 169
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747
+ PE T KSDV+SFG+LL EI++ K P + + D+ +
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKI-------------PYPGMSNSDVMSA 216
Query: 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
L ++P + + ++ C + + +ERP+ D + + L+
Sbjct: 217 LQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 68/211 (32%), Positives = 107/211 (50%), Gaps = 22/211 (10%)
Query: 522 VGKGSFSCVYKGVLK-DGTVV-AVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLL 578
+G+G+F V K +K DG + A K + + + ++F EL++L +L +H +++NLL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR------------VTIAVQA 626
G CE L E+ HG+L L KS+ L+ + + A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 627 ARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTL 686
ARG++YL + IHRD+ + NIL+ E + A++ADFGLS + LP +
Sbjct: 122 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP---V 175
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
++ E TT SDV+S+GVLL EI+S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 54/216 (25%), Positives = 92/216 (42%), Gaps = 21/216 (9%)
Query: 507 TYEELERATGGFKEEVGKGSFSCVYK-GVLKDGTVVAVKKAIATSDRQKNSKEFHTELDL 565
Y+ L R +G+G+ V+K + G VA+KK + E+
Sbjct: 1 RYKILGR--------IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKA 52
Query: 566 LSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQ 625
L H +++ LL G +LV E+M L + L + + L E V+
Sbjct: 53 LQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQ--VKSYMR--M 107
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGT 685
+G+ Y+H ++HRD+K +N+LI + ++ADFGL+ L + + T
Sbjct: 108 LLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH-QVAT 163
Query: 686 LGYLDPE--YYRLHYLTTKSDVYSFGVLLLEILSGR 719
Y PE Y Y D+++ G + E+L+G
Sbjct: 164 RWYRAPELLYGARKY-DPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 16/208 (7%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKK-AIATSDRQKNSKEF---HTELDLLSRLNHAHLL 575
E +GKG++ VY G+ G ++AVK+ + TS+ KE+ E+DLL L H +++
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
LG C + + EF+ GS+ L+ + L E + + T Q G+ YLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPV--FCKYT--KQILDGVAYLHN 120
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFG----LSLLGPADSSSPLAELPAGTLGYLDP 691
V+HRDIK +N+++ ++ DFG L+ +G + S + + GT ++ P
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 692 EYYRLHYLTTKSDVYSFGVLLLEILSGR 719
E KSD++S G + E+ +G+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 80/274 (29%), Positives = 121/274 (44%), Gaps = 36/274 (13%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHT---ELDLLSRLNHAHLLNL 577
+G+G+F VY D G +AVK+ D + KE + E+ LL L H ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 578 LGYCEEGRERLLVY-EFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
G C E L ++ E+M GS+ L +G AL E + R+ T Q G+EYLH
Sbjct: 70 YG-CLRDDETLSIFMEYMPGGSVKDQLKAYG---ALTETV--TRKYT--RQILEGVEYLH 121
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEY 693
++HRDIK +NIL D N ++ DFG S L SS + GT ++ PE
Sbjct: 122 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV 178
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA--VPLIKSGDITAILDPV 751
K+DV+S G ++E+L+ + WA + I A
Sbjct: 179 ISGEGYGRKADVWSVGCTVVEMLTEKPP------------WAEFEAMAAIFKI-ATQPTN 225
Query: 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
+LPS + R N + K+RPS +++
Sbjct: 226 PQLPSHVSPDAR--NFLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 26/222 (11%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLL 566
YE LE +GKGSF V K K DG ++ K+ + +K ++ +E+++L
Sbjct: 2 YEVLE--------TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNIL 53
Query: 567 SRLNHAHLLNLLGYCEE--GRERLLVY---EFMAHGSLHQHLHGKSKALKEQL--DWVRR 619
L H N++ Y + R +Y E+ G L Q L K K ++ + +++ R
Sbjct: 54 RELKHP---NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWR 109
Query: 620 VTIAVQAARGIEYLH--GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677
+ Q + H V+HRD+K +NI +D +N ++ DFGL+ + DSS
Sbjct: 110 ILT--QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS-- 165
Query: 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
A+ GT Y+ PE KSD++S G L+ E+ +
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 65/267 (24%), Positives = 118/267 (44%), Gaps = 34/267 (12%)
Query: 538 GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRER--LLVYEFMA 595
G +VAVK + Q+N+ + E+++L L H +++ G C E + L+ E++
Sbjct: 33 GEMVAVK-TLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91
Query: 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE 655
GSL +L L + L A Q G+ YLH IHRD+ + N+L+D
Sbjct: 92 LGSLRDYLPKHKLNLAQLL------LFAQQICEGMAYLHSQH---YIHRDLAARNVLLDN 142
Query: 656 EHNARVADFGLSLLGPA---------DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVY 706
+ ++ DFGL+ P D SP+ + E + + + SDV+
Sbjct: 143 DRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF--------WYAVECLKENKFSYASDVW 194
Query: 707 SFGVLLLEILS---GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKR 763
SFGV L E+L+ +++ +FEE ++ + + +L+ ++LP + +
Sbjct: 195 SFGVTLYELLTHCDSKQSPPKKFEE--MIGPKQGQMTVVRLIELLERGMRLPCPKNCPQE 252
Query: 764 IANVACKCVRMRGKERPSMDKVTTALE 790
+ + C K RP+ + L+
Sbjct: 253 VYILMKNCWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-18
Identities = 56/197 (28%), Positives = 102/197 (51%), Gaps = 22/197 (11%)
Query: 536 KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFM 594
K+ VAVK + +K+ + +E++++ + H +++NLLG C + ++ E+
Sbjct: 45 KEAVTVAVK-MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 103
Query: 595 AHGSLHQHLHGK-----------SKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIH 643
+ G+L ++L + ++ EQ+ + V+ Q ARG+EYL C IH
Sbjct: 104 SKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKC---IH 160
Query: 644 RDIKSSNILIDEEHNARVADFGLSL-LGPAD--SSSPLAELPAGTLGYLDPEYYRLHYLT 700
RD+ + N+L+ E + ++ADFGL+ + D + LP + ++ PE T
Sbjct: 161 RDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLP---VKWMAPEALFDRVYT 217
Query: 701 TKSDVYSFGVLLLEILS 717
+SDV+SFGVL+ EI +
Sbjct: 218 HQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 7e-18
Identities = 73/283 (25%), Positives = 134/283 (47%), Gaps = 28/283 (9%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
E+ R + + ++G+G F V+ G T VA+K + + + F E ++ +L
Sbjct: 2 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKL 58
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARG 629
H L+ L E +V E+M+ GSL L G+ L + V +A Q A G
Sbjct: 59 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKY---LRLPQLVDMAAQIASG 114
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD--SSSPLAELPAGTLG 687
+ Y+ +HRD++++NIL+ E +VADFGL+ L + ++ A+ P +
Sbjct: 115 MAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP---IK 168
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747
+ PE T KSDV+SFG+LL E+ + +G + P + + ++
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTT----------KGRV---PYPGMVNREVLDQ 215
Query: 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
++ ++P + + + ++ C+C R +ERP+ + + LE
Sbjct: 216 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 18/203 (8%)
Query: 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
E+G G+ V K + + G ++AVK + K+ ELD+L + N +++ G
Sbjct: 8 ELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQ-KQILRELDILHKCNSPYIVGFYG 66
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
+ + E+M GSL + L + E++ + ++ +AV +G+ YLH
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEVQGRIPERI--LGKIAVAV--LKGLTYLHEKH-- 120
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEYYR-L 696
+IHRD+K SNIL++ ++ DFG+S L+ +S LA+ GT Y+ PE +
Sbjct: 121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV---NS---LAKTFVGTSSYMAPERIQGN 174
Query: 697 HYLTTKSDVYSFGVLLLEILSGR 719
Y + KSD++S G+ L+E+ +GR
Sbjct: 175 DY-SVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 34/291 (11%)
Query: 519 KEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE----FHTELDLLSRLNHAHL 574
+ + +G+F ++ G+L D ++ + + S+ E LL L+H ++
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 575 LNLLGYCEEGRERLLV-YEFMAHGSLHQHLH-------GKSKALKEQLDWVRRVTIAVQA 626
L +L C E E V Y +M G+L L +AL Q + V +A+Q
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ----QLVHMAIQI 126
Query: 627 ARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL-LGPADSSSPLAELPAGT 685
A G+ YLH VIH+DI + N +IDEE ++ D LS L P D L +
Sbjct: 127 ACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC-LGDNENRP 182
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745
+ ++ E ++ SDV+SFGVLL E+++ + + E + E A +K G
Sbjct: 183 VKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ---TPYVEIDPFEMAA-YLKDG--Y 236
Query: 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796
+ P+ P +L A+ +AC C + +ERPS ++ L AQL
Sbjct: 237 RLAQPI-NCPDELFAV-----MAC-CWALDPEERPSFSQLVQCLTDFHAQL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 69/231 (29%), Positives = 115/231 (49%), Gaps = 30/231 (12%)
Query: 510 ELERATGGFKEEVGKGSFSCVYK----GVLKD----GTVVAVKKAIATSDRQKNSKEFHT 561
EL R + +G+G F V G+ KD VAVK + K+ + +
Sbjct: 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVK-MLKDDATDKDLSDLVS 66
Query: 562 ELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKS-----------KA 609
E++++ + H +++NLLG C + ++ E+ + G+L ++L + K
Sbjct: 67 EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126
Query: 610 LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL- 668
+EQL + V+ A Q ARG+EYL C IHRD+ + N+L+ E++ ++ADFGL+
Sbjct: 127 PEEQLTFKDLVSCAYQVARGMEYLASQKC---IHRDLAARNVLVTEDNVMKIADFGLARD 183
Query: 669 LGPAD--SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ D + LP + ++ PE T +SDV+SFGVLL EI +
Sbjct: 184 VHNIDYYKKTTNGRLP---VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 2e-17
Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 47/300 (15%)
Query: 522 VGKGSFSCVYK----GVLK---DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAH 573
+G+G F V + G+ K D TV K + + K+ + +E++L+ + H +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGK-----------SKALKEQLDWVRRVTI 622
++NLLG C + ++ E+ A G+L + L + +K +EQL + V+
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 623 AVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD----SSSPL 678
A Q ARG+EYL C IHRD+ + N+L+ E++ ++ADFGL+ G D +
Sbjct: 140 AYQVARGMEYLESRRC---IHRDLAARNVLVTEDNVMKIADFGLA-RGVHDIDYYKKTSN 195
Query: 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEI--LSGRKAIDMQFEEGNIVEWAV 736
LP + ++ PE T +SDV+SFG+L+ EI L G + EE
Sbjct: 196 GRLP---VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE------LF 246
Query: 737 PLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796
L++ G +D +L L R +C +RP+ ++ AL++ LA +
Sbjct: 247 KLLREGH---RMDKPSNCTHELYMLMR------ECWHAVPTQRPTFKQLVEALDKVLAAV 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 32/285 (11%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
E+ R + +++G G F V+ G T VAVK + + + F E ++ +L
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT---MSPESFLEEAQIMKKL 58
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLH-GKSKALK-EQLDWVRRVTIAVQAA 627
H L+ L E +V E+M+ GSL L G+ +ALK L V +A Q A
Sbjct: 59 RHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-----VDMAAQVA 112
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD--SSSPLAELPAGT 685
G+ Y+ IHRD++S+NIL+ + ++ADFGL+ L + ++ A+ P
Sbjct: 113 AGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFP--- 166
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745
+ + PE T KSDV+SFG+LL E+++ +G + P + + ++
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVT----------KGRV---PYPGMNNREVL 213
Query: 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
++ ++P D + + +C + +ERP+ + + + LE
Sbjct: 214 EQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 29/221 (13%)
Query: 522 VGKGSFSCVYKGV------LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLL 575
+G+G F V K T VAVK + + ++ +E +LL ++NH H++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVK-MLKENASSSELRDLLSEFNLLKQVNHPHVI 66
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLH-------------GKSKALKEQLDWVRRVTI 622
L G C + LL+ E+ +GSL L G + R +T+
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 623 ------AVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676
A Q +RG++YL A ++HRD+ + N+L+ E +++DFGLS + S
Sbjct: 127 GDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY 183
Query: 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ ++ E H TT+SDV+SFGVLL EI++
Sbjct: 184 VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 69/246 (28%), Positives = 108/246 (43%), Gaps = 44/246 (17%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
VG+GS+ V K K+ G +VA+KK + + D + K E+ +L +L H +L+NL+
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 581 CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640
+ LV+EF+ H L L L E VR+ Q RGIE+ H +
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDD-LEKYPNGLDESR--VRKYLF--QILRGIEFCHSHN--- 120
Query: 641 VIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
+IHRDIK NIL+ + ++ DFG + L P + + Y+ +YR
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT----------DYVATRWYRAPE 170
Query: 699 LTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758
L Y +A+D+ WAV + + +T +P+ SD+
Sbjct: 171 LLVGDTKYG------------RAVDI---------WAVGCLVTEMLTG--EPLFPGDSDI 207
Query: 759 DALKRI 764
D L I
Sbjct: 208 DQLYHI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 69/232 (29%), Positives = 119/232 (51%), Gaps = 33/232 (14%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKK-------AIATSDRQKNS-KEFHTELDLLSRLN 570
E +GKG++ VY + + G ++AVK+ A RQK+ K +E++ L L+
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 571 HAHLLNLLGYCEEGRERLLVY-EFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAA 627
H +++ LG E E L ++ E++ GS+ L +G+ +EQL VR T Q
Sbjct: 67 HLNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQL--VRFFT--EQVL 118
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLG 687
G+ YLH ++HRD+K+ N+L+D + +++DFG+S + G++
Sbjct: 119 EGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVF 175
Query: 688 YLDPEY---YRLHYLTTKSDVYSFGVLLLEILSGRK------AIDMQFEEGN 730
++ PE Y Y + K D++S G ++LE+ +GR+ AI F+ GN
Sbjct: 176 WMAPEVIHSYSQGY-SAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGN 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 4e-17
Identities = 68/220 (30%), Positives = 108/220 (49%), Gaps = 19/220 (8%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
F +E+G G F V G + VA+K S + EF E ++ +L+H L+ L
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
G C + R +V E+M++G L +L HGK + L+ + V G+ YL
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV------CEGMAYLES 118
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEY 693
IHRD+ + N L+D++ +V+DFGLS +L +SS ++ P + + PE
Sbjct: 119 KQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP---VRWSPPEV 172
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
++KSDV++FGVL+ E+ S K +F VE
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVE 212
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 65/228 (28%), Positives = 105/228 (46%), Gaps = 33/228 (14%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTEL 563
E+ R E+G+GSF VY+G +D T VAVK + S + EF E
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVK-TVNESASLRERIEFLNEA 60
Query: 564 DLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHG-----------KSKALKE 612
++ H++ LLG +G+ L+V E MAHG L +L L+E
Sbjct: 61 SVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQE 120
Query: 613 QLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL-LGP 671
+ +A + A G+ YL+ +HRD+ + N ++ + ++ DFG++ +
Sbjct: 121 M------IQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171
Query: 672 ADSSSPLAE--LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
D + LP + ++ PE + TT SD++SFGV+L EI S
Sbjct: 172 TDYYRKGGKGLLP---VRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 64/216 (29%), Positives = 112/216 (51%), Gaps = 32/216 (14%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATS------DRQKNSKE-FHTELDLLSRLNHAH 573
+G GSF VY G+ G ++AVK+ S DR+++ + E+ LL L H +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 574 LLNLLGYCEEGRERLLVY-EFMAHGSLHQHLHGKSKALKEQL--DWVRRVTIAVQAARGI 630
++ LG + L ++ E++ GS+ L A +E L ++VR Q +G+
Sbjct: 68 IVQYLG-SSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETLVRNFVR------QILKGL 119
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-------LLGPADSSSPLAELPA 683
YLH +IHRDIK +NIL+D + +++DFG+S L + + P +
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQ--- 173
Query: 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
G++ ++ PE + T K+D++S G L++E+L+G+
Sbjct: 174 GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-17
Identities = 59/194 (30%), Positives = 105/194 (54%), Gaps = 22/194 (11%)
Query: 539 TVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHG 597
T VAVK + + +K+ + +E++++ + H +++NLLG C + ++ E+ + G
Sbjct: 51 TKVAVK-MLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 109
Query: 598 SLHQHLHGK-----------SKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDI 646
+L ++L + ++ +EQL + V+ A Q ARG+EYL C IHRD+
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKC---IHRDL 166
Query: 647 KSSNILIDEEHNARVADFGLSL-LGPAD--SSSPLAELPAGTLGYLDPEYYRLHYLTTKS 703
+ N+L+ E++ ++ADFGL+ + D + LP + ++ PE T +S
Sbjct: 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP---VKWMAPEALFDRIYTHQS 223
Query: 704 DVYSFGVLLLEILS 717
DV+SFGVLL EI +
Sbjct: 224 DVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 5e-17
Identities = 79/284 (27%), Positives = 124/284 (43%), Gaps = 35/284 (12%)
Query: 522 VGKGSFSCVYKGVLK--DGTV--VAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+GKG F V + LK DG+ VAVK A + +EF E + +H +++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 578 LGYCEEGRER------LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI--AVQAARG 629
+G R + +++ FM HG LH L S+ +E + + + A G
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS---LLGPADSSSPLAELPAGTL 686
+EYL + IHRD+ + N +++E VADFGLS G ++LP +
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP---V 179
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITA 746
+L E + TT SDV++FGV + EI++ + E I + LIK
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY---LIKGN---- 232
Query: 747 ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
+L D L+ + + C+C K RPS + LE
Sbjct: 233 ------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 38/221 (17%)
Query: 519 KEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
E +G+G++ VYK K G +VA+K D ++ KE E ++L + ++ N+
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKE---EYNILRKYSNHP--NI 65
Query: 578 LGY---------CEEGRERLLVYEFMAHGS---LHQHLHGKSKALKEQLDWVRRVTIAVQ 625
+ + LV E GS L + L K K LKE +W+ I +
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKE--EWI--AYILRE 121
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA-- 683
RG+ YLH VIHRDIK NIL+ + ++ DFG+S A S L
Sbjct: 122 TLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVS----AQLDSTLGRRNTFI 174
Query: 684 GTLGYLDPE------YYRLHYLTTKSDVYSFGVLLLEILSG 718
GT ++ PE Y +SDV+S G+ +E+ G
Sbjct: 175 GTPYWMAPEVIACDEQPDASY-DARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 48/227 (21%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLL 566
YE+L + +G+GS+ V+K ++ G +VA+KK + + D K E+ +L
Sbjct: 3 YEKLSK--------IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRML 54
Query: 567 SRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLH---QHLHGKSKALKEQLDWVRRVTIA 623
+L H +L+NL+ R+ LV+E+ H L+ ++ G + E L ++++
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG----VPEHL--IKKIIW- 107
Query: 624 VQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADS------- 674
Q + + + H + C IHRD+K NILI ++ ++ DFG + L GP D
Sbjct: 108 -QTLQAVNFCHKHNC---IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVAT 163
Query: 675 ---SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
+P EL G Y P DV++ G + E+L+G
Sbjct: 164 RWYRAP--ELLVGDTQYGPP-----------VDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 7e-17
Identities = 63/208 (30%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 522 VGKGSFSCVY---KGVLKDGTVVAVKKAIATSDRQKNSKE-FHTELDLLSRLNHAHLLNL 577
+ KG++ V+ K D + A+K +KN + TE D+LS+ +++ L
Sbjct: 1 ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
Y +G++ L LV E++ G L L +L E V R+ IA + +EYLH
Sbjct: 59 Y-YSFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDED---VARIYIA-EIVLALEYLHSN 112
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA------GTLGYLD 690
IHRD+K NILID + ++ DFGLS +G L + GT Y+
Sbjct: 113 GI---IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEILSG 718
PE + D +S G +L E L G
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 68/288 (23%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 519 KEEVGKGSFSCVYKGVLKDGTVVAVKKAIAT-----SDRQKNSKEFHTELDLLSRLNHAH 573
+E +G G F V +G LK + AI T +++Q+ ++F +E ++ + +H +
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR--RDFLSEASIMGQFDHPN 66
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
+++L G + R +++ EFM +G+L L Q ++ V + A G++YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYL 122
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLG------ 687
+HRD+ + NIL++ +V+DFGLS D+S P +LG
Sbjct: 123 SEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTY---TSSLGGKIPIR 176
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILS--GRKAIDMQFEEGNIVEWAVPLIKSGDIT 745
+ PE T+ SDV+S+G+++ E++S R DM + D+
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---------------DVI 221
Query: 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
++ +LP +D + + C + RP ++ + L++ +
Sbjct: 222 NAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 19/206 (9%)
Query: 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL-G 579
E+G G+F VYK K+ + A K I ++ ++F E+D+LS H +++ L
Sbjct: 12 ELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKE-QLDWVRRVTIAVQAARGIEYLHGYAC 638
Y E + +L+ EF G+L + + L E Q+ +V R Q + +LH +
Sbjct: 71 YFYENKLWILI-EFCDGGALDSIMLELERGLTEPQIRYVCR-----QMLEALNFLHSHK- 123
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY----- 693
VIHRD+K+ NIL+ + + ++ADFG+S S+ + GT ++ PE
Sbjct: 124 --VIHRDLKAGNILLTLDGDVKLADFGVSAKN--KSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGR 719
++ + K+D++S G+ L+E+
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 83/310 (26%), Positives = 135/310 (43%), Gaps = 46/310 (14%)
Query: 510 ELERATGGFKEEVGKGSFS----CVYKGVLK-------------DGTVVAVKKAIATSDR 552
E R FKE++G+G F C +G+ K +VAVK + D
Sbjct: 1 EFPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVK--MLREDA 58
Query: 553 QKNSK-EFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALK 611
KN++ +F E+ ++SRL +++ LL C ++ E+M +G L+Q L +
Sbjct: 59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFL--SRHEPQ 116
Query: 612 EQLDWVRRVTI--------AVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVAD 663
E + VTI A Q A G++YL +HRD+ + N L+ + + ++AD
Sbjct: 117 EAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIAD 173
Query: 664 FGLS---LLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GR 719
FG+S G A LP + ++ E L TT SDV++FGV L EIL+ +
Sbjct: 174 FGMSRNLYSGDYYRIQGRAVLP---IRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK 230
Query: 720 KAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKER 779
+ Q + ++E +G+ + LP + + C R KER
Sbjct: 231 EQPYSQLSDEQVIE------NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKER 284
Query: 780 PSMDKVTTAL 789
PS ++ L
Sbjct: 285 PSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 63/227 (27%), Positives = 112/227 (49%), Gaps = 25/227 (11%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATS---DRQKNS--KEFHTELD 564
E+ +T F EE+G+ F VYKG L +A+A D+ + +EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAM 60
Query: 565 LLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKS-----------KALKEQ 613
+ SRL H +++ LLG + + +++ + +H LH+ L +S K +K
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 614 LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL-SLLGPA 672
L+ V I Q A G+E+L + V+H+D+ + N+L+ ++ N +++D GL + A
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 673 DSSSPLAE--LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
D + LP + ++ PE + SD++S+GV+L E+ S
Sbjct: 178 DYYKLMGNSLLP---IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 73/286 (25%), Positives = 134/286 (46%), Gaps = 34/286 (11%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
E+ R + ++++G G F V+ T VAVK S + + F E +++ L
Sbjct: 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTL 58
Query: 570 NHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHL---HGKSKALKEQLDWVRRVTIAVQ 625
H L+ L +E + ++ EFMA GSL L G + L + +D+ + Q
Sbjct: 59 QHDKLVKLHAVVT--KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF------SAQ 110
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGT 685
A G+ ++ IHRD++++NIL+ ++ADFGL+ + D+ E
Sbjct: 111 IAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFP 166
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDI 744
+ + PE T KSDV+SFG+LL+EI++ GR P + + ++
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI--------------PYPGMSNPEV 212
Query: 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
L+ ++P + + + N+ +C + R +ERP+ + + + L+
Sbjct: 213 IRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 520 EEVGKGSFSCVYKGVLKD--GTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLN 576
+++G GSF V +G G V+ V SD+ +F E ++ L+H +L+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI---AVQAARGIEYL 633
L G ++V E GSL L K+ L T+ AVQ A G+ YL
Sbjct: 61 LYGVVLT-HPLMMVTELAPLGSLLDRLR------KDALGHFLISTLCDYAVQIANGMRYL 113
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADS---SSPLAELPAGTLGYL 689
IHRD+ + NIL+ + ++ DFGL L + ++P +
Sbjct: 114 ESKRF---IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP---FAWC 167
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILS 717
PE R + SDV+ FGV L E+ +
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 69/243 (28%), Positives = 104/243 (42%), Gaps = 59/243 (24%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKE-FHT---- 561
YE L + +G+G+F VYK +K G VVA+KK + N K+ F
Sbjct: 10 YEILGK--------LGEGTFGEVYKARQIKTGRVVALKKIL-----MHNEKDGFPITALR 56
Query: 562 ELDLLSRLNHAHLLNLLGYC-----EEGRERLLVY---EFMAH---GSLHQ---HL-HGK 606
E+ +L +L H +++ L+ + R+R VY +M H G L L +
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ 116
Query: 607 SKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666
K QL GI YLH ++HRDIK++NILID + ++ADFGL
Sbjct: 117 IKCYMLQL------------LEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL 161
Query: 667 SLLGPADSSSPLAELPAGTLGYLD---PEYYRLHYL-------TTKSDVYSFGVLLLEIL 716
+ +P GT Y + +YR L TT D++ G + E+
Sbjct: 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221
Query: 717 SGR 719
+ R
Sbjct: 222 TRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 520 EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E +GKGSF VYK + K VVA+K I + + ++ E+ LS+ ++
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQVVAIKV-IDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV---QAARGIEYLHG 635
G +G + ++ E+ GS L K L E IA + G+EYLH
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDET-------YIAFILREVLLGLEYLHE 116
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
IHRDIK++NIL+ EE + ++ADFG+S G S+ GT ++ PE +
Sbjct: 117 EG---KIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 696 LHYLTTKSDVYSFGVLLLEILSG 718
K+D++S G+ +E+ G
Sbjct: 172 QSGYDEKADIWSLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 3e-16
Identities = 65/234 (27%), Positives = 109/234 (46%), Gaps = 34/234 (14%)
Query: 510 ELERATGGFKEEVGKGSFS----CVYKGVLK---------DGTVVAVKKAIATSDRQKNS 556
E R KE++G+G F C +G+ + DG V V + +D K +
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTA 60
Query: 557 K-EFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLD 615
+ +F E+ ++SRL + +++ LLG C ++ E+M +G L+Q L + ++
Sbjct: 61 RNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFL--SQREIESTFT 118
Query: 616 WVRRVT---------IAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666
+ +AVQ A G++YL A +HRD+ + N L+ + ++ADFG+
Sbjct: 119 HANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGM 175
Query: 667 SL-LGPAD--SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
S L D A LP + + E L TT SDV++FGV L E+ +
Sbjct: 176 SRNLYSGDYYRIQGRAVLPIRWMAW---ESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 523 GKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYC- 581
G+G+ V K LK+ ++ K I T K+ EL++ +++ G
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL 69
Query: 582 -EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640
E + E+ GSL ++ K K ++ IA +G+ YLH
Sbjct: 70 DESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--- 125
Query: 641 VIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLT 700
+IHRDIK SNIL+ + ++ DFG+S G +S LA GT Y+ PE + +
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVS--GELVNS--LAGTFTGTSFYMAPERIQGKPYS 181
Query: 701 TKSDVYSFGVLLLEILSGR 719
SDV+S G+ LLE+ R
Sbjct: 182 ITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 51/199 (25%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
E +GKGSF V+KG+ V K I + + ++ E+ +LS+ + ++ G
Sbjct: 10 ERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
+G + ++ E++ GS L D + T+ + +G++YLH
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGP------FDEFQIATMLKEILKGLDYLHS---E 120
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYL 699
IHRDIK++N+L+ E+ + ++ADFG++ G + GT ++ PE +
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178
Query: 700 TTKSDVYSFGVLLLEILSG 718
+K+D++S G+ +E+ G
Sbjct: 179 DSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 66/288 (22%), Positives = 129/288 (44%), Gaps = 48/288 (16%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIAT-----SDRQKNSKEFHTELDLLSRLNHAHLLN 576
+G G F V++G+LK V AI T +++Q+ +F +E ++ + +H +++
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQ--DFLSEASIMGQFSHHNIIR 70
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L G + + +++ E+M +G+L ++L + + V + A G++YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSDM 126
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGT---------LG 687
+HRD+ + NIL++ +V+DFGLS + L + P GT +
Sbjct: 127 N---YVHRDLAARNILVNSNLECKVSDFGLSRV--------LEDDPEGTYTTSGGKIPIR 175
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILS--GRKAIDMQFEEGNIVEWAVPLIKSGDIT 745
+ PE T+ SDV+SFG+++ E++S R DM E +
Sbjct: 176 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---------------VM 220
Query: 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
++ +LP+ +D + + +C + RP + L++ L
Sbjct: 221 KAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 84/334 (25%), Positives = 145/334 (43%), Gaps = 50/334 (14%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAI-----ATSDRQKNSKEFHTELDLLSRLNHAHLL 575
+G G+F VYKG+ + +G V + AI ATS K +KE E +++ +++ H+
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVC 72
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ--LDWVRRVTIAVQAARGIEYL 633
LLG C +L + + M G L ++ + Q L+W VQ A+G+ YL
Sbjct: 73 RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYL 125
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
++HRD+ + N+L+ + ++ DFGL+ L AD AE + ++ E
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182
Query: 694 YRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752
T +SDV+S+GV + E+++ G K D I + +I++IL+
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG--------------IPASEISSILEKGE 228
Query: 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTEVV 812
+LP + + KC + RP + L +++ P V+
Sbjct: 229 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRE----LIIEFSKMARDPQRYL------VI 278
Query: 813 LGSNRMHKKSSQRSSNR-----STSETDVAEAED 841
G RMH S S+ DV +A++
Sbjct: 279 QGDERMHLPSPTDSNFYRALMDEEDMDDVVDADE 312
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 61/227 (26%), Positives = 98/227 (43%), Gaps = 56/227 (24%)
Query: 517 GFKEEVGKGSFSCVYKGVLKDGTV-VAVKKAIATSDRQKNSK-EFHTELDLLSRLNHAHL 574
F E+ + + D V VAVK + N++ +F E+ +LSRL+ ++
Sbjct: 31 DFSEKAFAENDN-------ADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81
Query: 575 LNLLGYCEEGRERLLVYEFMAHGSLHQHLH---GKSKALKEQLDWVRRVT---IAVQAAR 628
LLG C ++ E+M +G L+Q L ++ L + T +A Q A
Sbjct: 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIAS 141
Query: 629 GIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGY 688
G+ YL +HRD+ + N L+ + + ++ADFG+S L +
Sbjct: 142 GMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMS-----------RNLYSS---- 183
Query: 689 LDPEYYRLH---------------YL---TTKSDVYSFGVLLLEILS 717
+YYR+ L TTKSDV++FGV L EIL+
Sbjct: 184 ---DYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 7e-16
Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 38/224 (16%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLS 567
ELER +G G+ VYK + + + K I + ++ E+++L
Sbjct: 73 LSELERV-----NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127
Query: 568 RLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAA 627
+NH +++ + E ++ EFM GSL + L + +A Q
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD---------VARQIL 178
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-----LLGPADSSSPLAELP 682
GI YLH ++HRDIK SN+LI+ N ++ADFG+S + P +SS
Sbjct: 179 SGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS------- 228
Query: 683 AGTLGYLDPEYYRLH-------YLTTKSDVYSFGVLLLEILSGR 719
GT+ Y+ PE R++ Y D++S GV +LE GR
Sbjct: 229 VGTIAYMSPE--RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 7e-16
Identities = 74/225 (32%), Positives = 111/225 (49%), Gaps = 25/225 (11%)
Query: 503 AQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSK--EF 559
A++F+ ++ E+ +E +G GSF VY ++ VVA+KK ++ S +Q N K +
Sbjct: 5 AELFSKDDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKK-MSYSGKQSNEKWQDI 62
Query: 560 HTELDLLSRLNHAHLLNLLG-YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVR 618
E+ L +L H + + G Y E LV E+ GS L K L+E V
Sbjct: 63 IKEVRFLQQLRHPNTIEYKGCYLRE-HTAWLVMEYCL-GSASDILEVHKKPLQE----VE 116
Query: 619 RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG-LSLLGPADS--S 675
I A +G+ YLH + IHRDIK+ NIL+ E ++ADFG SL+ PA+S
Sbjct: 117 IAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVG 173
Query: 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRK 720
+P P L + +Y K DV+S G+ +E L+ RK
Sbjct: 174 TPYWMAPEVILAMDEGQY------DGKVDVWSLGITCIE-LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 60/202 (29%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 519 KEEVGKGSFSCVYKGV-LKDGTVVAVKKA-IATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
++++G+G FS VY+ L DG VA+KK I K + E+DLL +LNH +++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIK 66
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQ---HLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
E E +V E G L + H + + + E+ W VQ +E++
Sbjct: 67 YYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW----KYFVQLCSALEHM 122
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
H V+HRDIK +N+ I ++ D GL + +++ A GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPER 177
Query: 694 YRLHYLTTKSDVYSFGVLLLEI 715
+ KSD++S G LL E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 519 KEEVGKGSFSCVYKGV-LKDGTVVAVKKA-IATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
++++G+G FS VY+ L D VA+KK I K ++ E+DLL +LNH +++
Sbjct: 7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIK 66
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQ---HLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
L E E +V E G L Q + + + + E+ W VQ +E++
Sbjct: 67 YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW----KYFVQLCSAVEHM 122
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
H V+HRDIK +N+ I ++ D GL + +++ A GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYYMSPER 177
Query: 694 YRLHYLTTKSDVYSFGVLLLEI 715
+ KSD++S G LL E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-15
Identities = 55/199 (27%), Positives = 98/199 (49%), Gaps = 11/199 (5%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
E +GKGSF VYKG+ V K I + + ++ E+ +LS+ + ++ G
Sbjct: 10 ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
+G + ++ E++ GS L K L+E TI + +G++YLH
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETY----IATILREILKGLDYLHS---E 120
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYL 699
IHRDIK++N+L+ E+ + ++ADFG++ G + GT ++ PE +
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 700 TTKSDVYSFGVLLLEILSG 718
K+D++S G+ +E+ G
Sbjct: 179 DFKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 48/220 (21%)
Query: 520 EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHT--------ELDLLSRLN 570
+++G G+F VY K+ G +VA+KK K+F++ E+ L +LN
Sbjct: 5 KQLGDGTFGSVYLARNKETGELVAIKKMK---------KKFYSWEECMNLREVKSLRKLN 55
Query: 571 -HAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL-HGKSKALKEQLDWVRRVTIAVQAAR 628
H +++ L E E V+E+M G+L+Q + K K E + +R +I Q +
Sbjct: 56 EHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESV--IR--SIIYQILQ 110
Query: 629 GIEYLH--GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTL 686
G+ ++H G+ HRD+K N+L+ ++ADFGL+ S P +
Sbjct: 111 GLAHIHKHGF-----FHRDLKPENLLVSGPEVVKIADFGLA--REIRSRPPYTD------ 157
Query: 687 GYLDPEYYR-----LH--YLTTKSDVYSFGVLLLEILSGR 719
Y+ +YR L ++ D+++ G ++ E+ + R
Sbjct: 158 -YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 59/206 (28%), Positives = 103/206 (50%), Gaps = 21/206 (10%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E +G+G++ VY+G + G VVA+K + S + E+ LLS+L + N+
Sbjct: 7 ELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQPPNIT 65
Query: 579 GY--CE-EGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWV--RRVTIAVQAARGIEYL 633
Y +G ++ E+ GS+ + K+ + E+ V R V +A ++Y+
Sbjct: 66 KYYGSYLKGPRLWIIMEYAEGGSVRTLM--KAGPIAEKYISVIIREVLVA------LKYI 117
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
H VIHRDIK++NIL+ N ++ DFG++ L + +S GT ++ PE
Sbjct: 118 HK---VGVIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWMAPEV 172
Query: 694 YR-LHYLTTKSDVYSFGVLLLEILSG 718
Y TK+D++S G+ + E+ +G
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-15
Identities = 66/241 (27%), Positives = 109/241 (45%), Gaps = 39/241 (16%)
Query: 510 ELERATGGFKEEVGKGSFSCV---------------YKGVLKDGTVVAVKKAIATSDRQK 554
+ R FKE++G+G F V + ++ G + V I D K
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60
Query: 555 NSK-EFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ 613
N++ +F E+ +LSRL +++ LLG C + ++ E+M +G L+Q L KE+
Sbjct: 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 614 --------------LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA 659
+ + + +A+Q A G++YL + +HRD+ + N L+ E
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTI 177
Query: 660 RVADFGLS---LLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEIL 716
++ADFG+S G A LP + + E + TT SDV++FGV L EIL
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGRAVLPIRWMAW---ECILMGKFTTASDVWAFGVTLWEIL 234
Query: 717 S 717
Sbjct: 235 M 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 71/221 (32%), Positives = 102/221 (46%), Gaps = 40/221 (18%)
Query: 522 VGKGSFSCVYKGVLKD----GT---VVAVK--KAIATSDRQKNSKEFHTELDLLSRLNHA 572
+G G+F VY+G D G+ VAVK + AT +K EF E L+S NH
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK---EFLKEAHLMSNFNHP 59
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKA--------LKEQLDWVRRVTIAV 624
+++ LLG C + ++ E M G L +L LKE LD I +
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLD------ICL 113
Query: 625 QAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNAR-----VADFGLSL-LGPADSSSPL 678
A+G YL IHRD+ + N L+ E+ + DFGL+ + +D
Sbjct: 114 DVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170
Query: 679 AE--LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
E LP + ++ PE TT+SDV+SFGVL+ EIL+
Sbjct: 171 GEGLLP---VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 54/207 (26%), Positives = 103/207 (49%), Gaps = 17/207 (8%)
Query: 522 VGKGSF--SCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
+GKG+F + +Y+ +D ++V K+ T +K ++ E+ +LS L H +++
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKAL--KEQLDWVRRVTIAVQAARGIEYLHGYA 637
+ + L+ E+ G+L+ + + L +E + W Q + Y+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY-----LFQIVSAVSYIHKAG 121
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYYRL 696
++HRDIK+ NI + + ++ DFG+S +LG S +AE GT Y+ PE +
Sbjct: 122 ---ILHRDIKTLNIFLTKAGLIKLGDFGISKILG---SEYSMAETVVGTPYYMSPELCQG 175
Query: 697 HYLTTKSDVYSFGVLLLEILSGRKAID 723
KSD+++ G +L E+L+ ++ D
Sbjct: 176 VKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 15/203 (7%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYC 581
+GKG++ VY V K I D + + H E+ L S L H +++ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY-VQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 582 EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPV 641
E + E + GSL L K LK+ + T Q G++YLH +
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT--KQILEGLKYLHDNQ---I 129
Query: 642 IHRDIKSSNILIDEEHNA-RVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEY--YRL 696
+HRDIK N+L++ +++DFG S L G +P E GTL Y+ PE
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG----INPCTETFTGTLQYMAPEVIDKGP 185
Query: 697 HYLTTKSDVYSFGVLLLEILSGR 719
+D++S G ++E+ +G+
Sbjct: 186 RGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 69/255 (27%), Positives = 114/255 (44%), Gaps = 30/255 (11%)
Query: 535 LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594
+ GTV+A KK + + K+ EL ++ ++++ G + EFM
Sbjct: 27 IPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85
Query: 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID 654
GSL + K ++ + ++ +AV G+ YL Y ++HRDIK SNIL++
Sbjct: 86 DCGSLDRIY---KKGGPIPVEILGKIAVAV--VEGLTYL--YNVHRIMHRDIKPSNILVN 138
Query: 655 EEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLE 714
++ DFG+S G +S +A+ GT Y+ PE + T KSDV+S G+ ++E
Sbjct: 139 SRGQIKLCDFGVS--GELINS--IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIE 194
Query: 715 ILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD--------PVLKLPSDLDALKRIAN 766
+ G+ F NI + D ILD P +LPS D + + +
Sbjct: 195 LALGK----FPFAFSNIDDDG-----QDDPMGILDLLQQIVQEPPPRLPSS-DFPEDLRD 244
Query: 767 VACKCVRMRGKERPS 781
C+ ERP+
Sbjct: 245 FVDACLLKDPTERPT 259
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 14/153 (9%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+ +G G++ VYK + G +VA+K + + + + E+ +L H +++
Sbjct: 7 LIQRIGSGTYGDVYKARDIATGELVAIK--VIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 577 LLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKE-QLDWVRRVTIAVQAARGIEYLH 634
G R++L +V E+ GSL L E Q+ +V R + +G+ YLH
Sbjct: 65 YFG-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLH 118
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
IHRDIK +NIL+ E+ + ++ADFG+S
Sbjct: 119 ETG---KIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 11/199 (5%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
E++GKGSF V+KG+ V K I + + ++ E+ +LS+ + ++ G
Sbjct: 10 EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
+ + ++ E++ GS L LD + TI + +G++YLH
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLLE------PGPLDETQIATILREILKGLDYLHS---E 120
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYL 699
IHRDIK++N+L+ E ++ADFG++ G + GT ++ PE +
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 700 TTKSDVYSFGVLLLEILSG 718
+K+D++S G+ +E+ G
Sbjct: 179 DSKADIWSLGITAIELAKG 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 32/208 (15%)
Query: 522 VGKGSFS--CVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
VG G+F C + L G VA+KK + +K + EL LL L H ++++L
Sbjct: 18 VGMGAFGLVCSARDQLT-GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 580 YCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
E + V E + LH+ L S+ L++Q Q RG++Y+H
Sbjct: 77 IFISPLEDIYFVTELLG-TDLHRLL--TSRPLEKQFIQY----FLYQILRGLKYVHSAG- 128
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH- 697
V+HRD+K SNILI+E + ++ DFGL+ D GY+ YYR
Sbjct: 129 --VVHRDLKPSNILINENCDLKICDFGLAR--IQDPQ---------MTGYVSTRYYRAPE 175
Query: 698 -YLT-----TKSDVYSFGVLLLEILSGR 719
LT + D++S G + E+L G+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 60/212 (28%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E +G G++ V + + G VA+KK D +K EL +L H +++ +
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70
Query: 579 GYC----EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
+ ++ +V + M LH +H + L E+ +R Q RG++Y+H
Sbjct: 71 DILRPPGADFKDVYVVMDLM-ESDLHHIIHS-DQPLTEEH--IR--YFLYQLLRGLKYIH 124
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL---GPADSSSPLAELPAGTLGYLDP 691
A VIHRD+K SN+L++E+ R+ DFG++ P + + E A T Y P
Sbjct: 125 S-AN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRWYRAP 180
Query: 692 E-YYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722
E L TT D++S G + E+L GR+ +
Sbjct: 181 ELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 68/277 (24%), Positives = 124/277 (44%), Gaps = 31/277 (11%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIAT---SDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+G G+F VYKG+ + DG V + AI + K +KE E +++ + ++ L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ--LDWVRRVTIAVQAARGIEYLHG 635
LG C +L V + M +G L ++ + Q L+W VQ A+G+ YL
Sbjct: 75 LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLEE 127
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
++HRD+ + N+L+ ++ ++ DFGL+ L D + A+ + ++ E
Sbjct: 128 VR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 696 LHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754
T +SDV+S+GV + E+++ G K D I + +I +L+ +L
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDG--------------IPAREIPDLLEKGERL 230
Query: 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
P + + KC + + RP ++ R
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 7e-15
Identities = 75/285 (26%), Positives = 130/285 (45%), Gaps = 32/285 (11%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
E+ R + ++G+G F V+ G T VA+K + + F E ++ +L
Sbjct: 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKL 58
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL-HGKSKALK-EQLDWVRRVTIAVQAA 627
H L+ L E +V EFM GSL L G K LK QL V +A Q A
Sbjct: 59 RHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL-----VDMAAQIA 112
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD--SSSPLAELPAGT 685
G+ Y+ IHRD++++NIL+ + ++ADFGL+ L + ++ A+ P
Sbjct: 113 DGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFP--- 166
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745
+ + PE T KSDV+SFG+LL E+++ +G + P + + ++
Sbjct: 167 IKWTAPEAALYGRFTIKSDVWSFGILLTELVT----------KGRV---PYPGMVNREVL 213
Query: 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
++ ++P + + + C + ERP+ + + + LE
Sbjct: 214 EQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-15
Identities = 55/204 (26%), Positives = 105/204 (51%), Gaps = 23/204 (11%)
Query: 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG- 579
E+G G+F VYK K+ +A K I T ++ +++ E+++L+ NH +++ LLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE-LEDYMVEIEILATCNHPYIVKLLGA 77
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKE-QLDWVRRVTIAVQAARGIEYLHGYAC 638
+ +G+ +++ EF G++ + + L E Q+ I Q ++YLH
Sbjct: 78 FYWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQ-----VICRQMLEALQYLHSMK- 130
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA--GTLGYLDPEYYRL 696
+IHRD+K+ N+L+ + + ++ADFG+S A + L + GT ++ PE
Sbjct: 131 --IIHRDLKAGNVLLTLDGDIKLADFGVS----AKNVKTLQRRDSFIGTPYWMAPEVVMC 184
Query: 697 HYLTT-----KSDVYSFGVLLLEI 715
+ K+D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 9e-15
Identities = 66/281 (23%), Positives = 133/281 (47%), Gaps = 38/281 (13%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIAT-----SDRQKNSKEFHTELDLLSRLNHAHLLN 576
+G G F V G LK + AI T +++Q+ ++F +E ++ + +H ++++
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR--RDFLSEASIMGQFDHPNIIH 69
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH-- 634
L G + + ++V E+M +GSL L + Q ++ V + A G++YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQLVGMLRGIASGMKYLSDM 125
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL----AELPAGTLGYLD 690
GY +HRD+ + NIL++ +V+DFGLS + D + ++P + +
Sbjct: 126 GY-----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP---IRWTA 177
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750
PE T+ SDV+S+G+++ E++S G W + + D+ ++
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMS----------YGERPYWE---MSNQDVIKAIEE 224
Query: 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
+LP+ +D + + C + ERP +++ + L++
Sbjct: 225 GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (187), Expect = 2e-14
Identities = 57/214 (26%), Positives = 90/214 (42%), Gaps = 33/214 (15%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL-- 578
+G G++ V V + G VA+KK D ++K E+ LL L H +++ LL
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 579 ---GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH- 634
E+ + +V E M LH+ + L Q RG++YLH
Sbjct: 68 LRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP-----LTDDHIQYFLYQILRGLKYLHS 121
Query: 635 -GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
VIHRD+K SNIL++ + ++ DFGL A P + Y+ +
Sbjct: 122 AN-----VIHRDLKPSNILVNSNCDLKICDFGL-----ARGVDPDEDEKGFLTEYVVTRW 171
Query: 694 YR--------LHYLTTKSDVYSFGVLLLEILSGR 719
YR Y T D++S G + E+L+ +
Sbjct: 172 YRAPELLLSSSRY-TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 73/224 (32%), Positives = 104/224 (46%), Gaps = 23/224 (10%)
Query: 503 AQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSK--EF 559
A +F ++ E G E+G GSF VY VVAVKK ++ S +Q N K +
Sbjct: 11 ADLFYKDDPEEIFVGL-HEIGHGSFGAVYFATNSHTNEVVAVKK-MSYSGKQTNEKWQDI 68
Query: 560 HTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR 619
E+ L +L H + + G + LV E+ GS L K L+E V
Sbjct: 69 IKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQE----VEI 123
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG-LSLLGPADS--SS 676
I A +G+ YLH + +IHRDIK+ NIL+ E ++ADFG S PA+S +
Sbjct: 124 AAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGT 180
Query: 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRK 720
P P L + +Y K DV+S G+ +E L+ RK
Sbjct: 181 PYWMAPEVILAMDEGQY------DGKVDVWSLGITCIE-LAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-14
Identities = 60/228 (26%), Positives = 113/228 (49%), Gaps = 25/228 (10%)
Query: 520 EEVGKGSFSCVYKGVL----KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLL 575
+++G+GSF K +L +DG +K+ + K +E E+ +LS + H +++
Sbjct: 6 KKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIV 62
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKAL--KEQ-LDWVRRVTIAVQAARGIEY 632
EE +V ++ G L++ ++ + L ++Q LDW VQ +++
Sbjct: 63 QYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF------VQICLALKH 116
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
+H ++HRDIKS NI + ++ ++ DFG++ + +S+ LA GT YL PE
Sbjct: 117 VHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPE 171
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIK 740
KSD+++ G +L E+ + + A FE GN+ + +I+
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHA----FEAGNMKNLVLKIIR 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 2e-14
Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 41/216 (18%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFH----TELDLLSRLNHAHLLN 576
+G+G+++ VYK + G +VA+KK I +R++ + E+ LL L H +++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKK-IKLGERKEAKDGINFTALREIKLLQELKHPNIIG 66
Query: 577 LLG-YCEEGRERLLVYEFMAHGSLHQHLHGKS--------KALKEQLDWVRRVTIAVQAA 627
LL + + L V+EFM L + + KS K+ +
Sbjct: 67 LLDVFGHKSNINL-VFEFM-ETDLEKVIKDKSIVLTPADIKS------------YMLMTL 112
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAG--T 685
RG+EYLH ++HRD+K +N+LI + ++ADFGL+ SP ++ T
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLA----RSFGSPNRKMTHQVVT 165
Query: 686 LGYLDPE--YYRLHYLTTKSDVYSFGVLLLEILSGR 719
Y PE + HY D++S G + E+L
Sbjct: 166 RWYRAPELLFGARHY-GVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 19/209 (9%)
Query: 522 VGKGSFSCVYKGVLK----DGTVVAVK-KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+G G+F VY+G+ + D + V K + S +++ +F E ++S+ NH +++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHL-HGKSKALK-EQLDWVRRVTIAVQAARGIEYLH 634
L+G E R ++ E MA G L L + + + L + A A+G +YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVA---DFGLSL-LGPAD--SSSPLAELPAGTLGY 688
IHRDI + N L+ + RVA DFG++ + A A LP + +
Sbjct: 134 ENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLP---IKW 187
Query: 689 LDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ PE + T+K+DV+SFGVLL EI S
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 3e-14
Identities = 72/224 (32%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 503 AQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSK--EF 559
A++F E+ E+ +E +G GSF VY ++ VVA+KK ++ S +Q N K +
Sbjct: 15 AELFFKEDPEKLFTDLRE-IGHGSFGAVYFARDVRTNEVVAIKK-MSYSGKQSNEKWQDI 72
Query: 560 HTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR 619
E+ L R+ H + + G LV E+ GS L K L+E V
Sbjct: 73 IKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE----VEI 127
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG-LSLLGPADS--SS 676
I A +G+ YLH + +IHRDIK+ NIL+ E ++ADFG S+ PA+S +
Sbjct: 128 AAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGT 184
Query: 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRK 720
P P L + +Y K DV+S G+ +E L+ RK
Sbjct: 185 PYWMAPEVILAMDEGQY------DGKVDVWSLGITCIE-LAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 4e-14
Identities = 62/213 (29%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+G++ VYK G VVA+KK ++ + E+ LL LNH +++ LL
Sbjct: 6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV--------QAARGI 630
+ LV+EF LHQ L K+ +D I + Q +G+
Sbjct: 66 DVIHTENKLYLVFEF-----LHQDL-------KKFMDASPLSGIPLPLIKSYLFQLLQGL 113
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLD 690
+ H + V+HRD+K N+LI+ E ++ADFGL+ + E+ TL Y
Sbjct: 114 AFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV--TLWYRA 168
Query: 691 PE-YYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722
PE Y +T D++S G + E+++ R+A+
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 77/277 (27%), Positives = 115/277 (41%), Gaps = 78/277 (28%)
Query: 510 ELERATGGFKEEVGKGSFSCVYK----GVLKDGT--VVAVK--KAIATSDRQKNSKEFHT 561
E R + +G+G+F V + G+ K + VAVK K AT+ K T
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYK---ALMT 59
Query: 562 ELDLLSRL-NHAHLLNLLGYCEEGRERLLV-YEFMAHGSLHQHLHGK------------- 606
EL +L + +H +++NLLG C + L+V E+ G+L +L K
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTR 119
Query: 607 ------SKALKEQLDWVRR-------------------------------------VTIA 623
+ K++LD V ++ +
Sbjct: 120 KREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYS 179
Query: 624 VQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS---LLGPADSSSPLAE 680
Q ARG+E+L C IHRD+ + NIL+ E + ++ DFGL+ P A
Sbjct: 180 FQVARGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236
Query: 681 LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
LP L ++ PE TT+SDV+SFGVLL EI S
Sbjct: 237 LP---LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 5e-14
Identities = 58/186 (31%), Positives = 92/186 (49%), Gaps = 17/186 (9%)
Query: 538 GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE--GRERLLVYEFMA 595
G VAVK ++ + + E+++L L H +++ G C E G L+ EF+
Sbjct: 33 GEQVAVK-SLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 91
Query: 596 HGSLHQHL-HGKSKA-LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 653
GSL ++L K+K LK+QL + AVQ +G++YL +HRD+ + N+L+
Sbjct: 92 SGSLKEYLPRNKNKINLKQQLKY------AVQICKGMDYL---GSRQYVHRDLAARNVLV 142
Query: 654 DEEHNARVADFGLSLLGPADSSSPLA--ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL 711
+ EH ++ DFGL+ D +L + Y PE SDV+SFGV
Sbjct: 143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA-PECLIQSKFYIASDVWSFGVT 201
Query: 712 LLEILS 717
L E+L+
Sbjct: 202 LYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 8e-14
Identities = 64/217 (29%), Positives = 106/217 (48%), Gaps = 34/217 (15%)
Query: 519 KEEVGKGSFSCVYKGVLKD-GTVVAVKKAI-ATSDRQKNSKEFHTELDLLSRLNHAH--- 573
+++GKG++ V+K + + VVA+KK A + + F E+ L L H
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGD-HPNI 69
Query: 574 --LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
LLN++ E ++ LV+E+M LH + ++ L++ V + I Q + ++
Sbjct: 70 VKLLNVI-KAENDKDIYLVFEYM-ETDLHAVI--RANILED----VHKRYIMYQLLKALK 121
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTL--GYL 689
Y+H VIHRD+K SNIL++ + ++ADFGL A S S L E P + Y+
Sbjct: 122 YIHSGN---VIHRDLKPSNILLNSDCRVKLADFGL-----ARSLSELEENPENPVLTDYV 173
Query: 690 DPEYYRL-------HYLTTKSDVYSFGVLLLEILSGR 719
+YR T D++S G +L E+L G+
Sbjct: 174 ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 8e-14
Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 23/224 (10%)
Query: 503 AQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSK--EF 559
A++F ++ E+ +E +G GSF VY +++ VVA+KK ++ S +Q N K +
Sbjct: 5 AELFFKDDPEKLFSDLRE-IGHGSFGAVYFARDVRNSEVVAIKK-MSYSGKQSNEKWQDI 62
Query: 560 HTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR 619
E+ L +L H + + G LV E+ GS L K L+E V
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQE----VEI 117
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG-LSLLGPADS--SS 676
+ A +G+ YLH + +IHRD+K+ NIL+ E ++ DFG S++ PA+ +
Sbjct: 118 AAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 174
Query: 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRK 720
P P L + +Y K DV+S G+ +E L+ RK
Sbjct: 175 PYWMAPEVILAMDEGQY------DGKVDVWSLGITCIE-LAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 61/232 (26%), Positives = 95/232 (40%), Gaps = 49/232 (21%)
Query: 522 VGKGSFSCVYKGVLKD---GTVVAVKKAIATSD--RQKNSKEFHTELDLLSRLNHAHLLN 576
+G+G+F V+ +++D G V A+K + SD ++ E D+L+ + ++
Sbjct: 9 IGRGAFGEVW--LVRDKDTGQVYAMKV-LRKSDMIKRNQIAHVRAERDILADADSPWIVK 65
Query: 577 LLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH- 634
L Y + E L LV E+M G L L + E + R + A ++ +H
Sbjct: 66 LY-YSFQDEEHLYLVMEYMPGGDLMNLLI-RKDVFPE--ETARFYIAELVLA--LDSVHK 119
Query: 635 -GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP---------------- 677
G+ IHRDIK NILID + + ++ADFGL
Sbjct: 120 LGF-----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 678 -----------LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
A GT Y+ PE R + D +S GV+L E+L G
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 61/200 (30%), Positives = 92/200 (46%), Gaps = 14/200 (7%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHT--ELDLLSRLNHAHLLNLLG 579
+GKGSF V + +D + K I + S+ HT E +L+++N ++ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 580 YCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
+ + E+L LV F+ G L HL + + D R + +E LH +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGR-----FDLSRARFYTAELLCALENLHKFN- 113
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
VI+RD+K NIL+D + + + DFGL L D GT YL PE H
Sbjct: 114 --VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLGHG 169
Query: 699 LTTKSDVYSFGVLLLEILSG 718
T D ++ GVLL E+L+G
Sbjct: 170 YTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 1e-13
Identities = 68/294 (23%), Positives = 125/294 (42%), Gaps = 62/294 (21%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE-FHTELDLLSRLNHAHLLNLLGY 580
VG+G+F V+ K + + K I K+ + E +L L+H N++ Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHP---NIIEY 64
Query: 581 CE---EGRERLLVYEFMAHGSLHQHLHGKSKAL---KEQLDWVRRVTIAVQAARGIEYLH 634
E E + ++V E+ G+L +++ + +L L + ++ +A+ ++H
Sbjct: 65 YENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH------HVH 118
Query: 635 GYACPPVIHRDIKSSNILIDEEHN-ARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
++HRD+K+ NIL+D+ ++ DFG+S + SS A GT Y+ PE
Sbjct: 119 TKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPEL 172
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753
KSD+++ G +L E+ S ++A FE N+ P + VLK
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLKRA----FEAANL-----PAL-----------VLK 212
Query: 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPIL 807
+ M G P D+ + L + + ++ S++P L
Sbjct: 213 I-------------------MSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQL 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-13
Identities = 48/176 (27%), Positives = 80/176 (45%), Gaps = 19/176 (10%)
Query: 557 KEFHTELDLLSRLNHAHLLNLL--GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQL 614
F E L +RL H +++ LL G G V+E++ +L + L A L
Sbjct: 23 ARFRRETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVL-----AADGAL 76
Query: 615 DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGP 671
+ +Q + H ++HRD+K NI++ +A+V DFG+ L P
Sbjct: 77 PAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLP 133
Query: 672 ADSSSPLAELPA-----GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722
+ +A L GT Y PE R +T SD+Y++G++ LE L+G++ +
Sbjct: 134 GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
E+G G+ V K + + ++ +K I + + EL +L N +++ G
Sbjct: 8 ELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGA 67
Query: 581 CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL---HGYA 637
E + E M GSL Q L K+ + E + + +++IAV RG+ YL H
Sbjct: 68 FYSDGEISICMEHMDGGSLDQVLK-KAGRIPENI--LGKISIAV--LRGLTYLREKHK-- 120
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEYYR 695
++HRD+K SNIL++ ++ DFG+S L+ DS +A GT Y+ PE R
Sbjct: 121 ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DS---MANSFVGTRSYMSPE--R 169
Query: 696 L---HYLTTKSDVYSFGVLLLEILSGRKAI 722
L HY T +SD++S G+ L+E+ GR I
Sbjct: 170 LQGTHY-TVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 522 VGKGSFSCV----YKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+GKGSF V KG + V +KK + D + L+ H L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQL 61
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
C + ++RL V E++ G L H+ +S E R A + G+++LH
Sbjct: 62 HS-CFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFDEP----RARFYAAEIVLGLQFLHER 115
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSL--LGPADSSSPLAELPAGTLGYLDPEYY 694
+I+RD+K N+L+D E + ++ADFG+ + ++S GT Y+ PE
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTF----CGTPDYIAPEIL 168
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE 728
D ++ GVLL E+L+G+ + E+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED 202
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHT---ELDLLSRLNHAHLLNL 577
+G+G+F VY D G +AVK+ D Q+ SKE + E+ LL L H ++
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 578 LGYCEEGRERLL--VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
G + E+ L E+M GS+ L AL E + RR T Q +G+ YLH
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENV--TRRYT--RQILQGVSYLHS 124
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYY 694
++HRDIK +NIL D N ++ DFG S + S + GT ++ PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 695 RLHYLTTKSDVYSFGVLLLEILS 717
K+DV+S ++E+L+
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 50/235 (21%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKK-AIATSD--------RQKNSK 557
YEEL E+G+G++ VYK L G VA+KK + S+ R
Sbjct: 1 YEELA--------EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR----- 47
Query: 558 EFHTELDLLSRL---NHAHLLNLLGYC-----EEGRERLLVYEFMAHGSLHQHL--HGKS 607
E+ LL +L H +++ LL C + + LV+E + L +L K
Sbjct: 48 ----EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKP 102
Query: 608 KALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
E + + R Q RG+++LH + ++HRD+K NIL+ + ++ADFGL+
Sbjct: 103 GLPPETIKDLMR-----QLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154
Query: 668 LLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722
+ L + TL Y PE T D++S G + E L R+ +
Sbjct: 155 RI--YSFEMALTSVVV-TLWYRAPEVLLQSSYATPVDMWSVGCIFAE-LFRRRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG- 579
VG G++ V G VA+KK ++K + EL LL ++H +++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDV 82
Query: 580 YC-----EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV-QAARGIEYL 633
+ E+ ++ LV M L+ + K + L + + V Q RG++Y+
Sbjct: 83 FTPASSLEDFQDVYLVTHLMG-ADLNNIV--KCQKLSDD-----HIQFLVYQILRGLKYI 134
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE- 692
H +IHRD+K SNI ++E+ ++ DFGL+ + + +A T Y PE
Sbjct: 135 HSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVA-----TRWYRAPEI 186
Query: 693 -YYRLHYLTTKSDVYSFGVLLLEILSGR 719
+HY D++S G ++ E+L+G+
Sbjct: 187 MLNWMHY-NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
E+G G+ V+K K ++ +K I + + EL +L N +++ G
Sbjct: 12 ELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 581 CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640
E + E M GSL Q L K+ + EQ+ + +V+IAV +G+ YL
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLK-KAGRIPEQI--LGKVSIAV--IKGLTYLREKH--K 124
Query: 641 VIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLT 700
++HRD+K SNIL++ ++ DFG+S +A GT Y+ PE + + +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYS 180
Query: 701 TKSDVYSFGVLLLEILSGRKAI 722
+SD++S G+ L+E+ GR I
Sbjct: 181 VQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 4e-13
Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEF-HTELDLLSRLNHAHLLNLLGY 580
+G+GSF +Y K + V K I + KE E+ LL+++ H +++
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 581 CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ---LDWVRRVTIAVQAARGIEYLHGYA 637
+E +V E+ G L + ++ + L + L W VQ + G++++H
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWF------VQISLGLKHIHDRK 121
Query: 638 CPPVIHRDIKSSNILIDEEHN-ARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
++HRDIKS NI + + A++ DFG++ + S LA GT YL PE +
Sbjct: 122 ---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEICQN 176
Query: 697 HYLTTKSDVYSFGVLLLEI 715
K+D++S G +L E+
Sbjct: 177 RPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 4e-13
Identities = 58/202 (28%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
E+G G+ V K K ++ +K I + + EL +L N +++ G
Sbjct: 12 ELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 71
Query: 581 CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640
E + E M GSL Q L ++K + E++ + +V+IAV RG+ YL
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLK-EAKRIPEEI--LGKVSIAV--LRGLAYLREKH--Q 124
Query: 641 VIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLT 700
++HRD+K SNIL++ ++ DFG+S +A GT Y+ PE + + +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHYS 180
Query: 701 TKSDVYSFGVLLLEILSGRKAI 722
+SD++S G+ L+E+ GR I
Sbjct: 181 VQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 6e-13
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 21/203 (10%)
Query: 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
E+G G+F VYK K+ V+A K I T ++ +++ E+D+L+ +H +++ LL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHPNIVKLLDA 70
Query: 581 CEEGRERLLVYEFMAHGSLHQHLHGKSKALKE-QLDWVRRVTIAVQAARGIEYLHGYACP 639
++ EF A G++ + + L E Q+ V + T+ + YLH
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTL-----EALNYLHE---N 122
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA--GTLGYLDPEYYRLH 697
+IHRD+K+ NIL + + ++ADFG+S A ++ + + GT ++ PE
Sbjct: 123 KIIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 698 Y-----LTTKSDVYSFGVLLLEI 715
K+DV+S G+ L+E+
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 6e-13
Identities = 73/281 (25%), Positives = 122/281 (43%), Gaps = 46/281 (16%)
Query: 518 FKEEVGKGSFSCVYKGVLK---DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHL 574
F VGKGS+ V +++ DG +KK + ++ K E LLS+L H
Sbjct: 4 FVRVVGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHP-- 59
Query: 575 LNLLGYCE--EGRERLL--VYEFMAHGSLHQHL-HGKSKALKEQ--LDWVRRVTIAVQAA 627
N++ Y E EG + LL V F G L+ L K K L E ++W VQ A
Sbjct: 60 -NIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF------VQIA 112
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLG 687
++YLH ++HRD+K+ N+ + + +V D G++ + ++ +A GT
Sbjct: 113 MALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAI---DMQFEEGNIVEWAVPLIKSGDI 744
Y+ PE + KSDV++ G + E+ + + A DM I+E +P
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP------- 220
Query: 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
+P D + + + R ++RPS+ +
Sbjct: 221 --------PMPKDYS--PELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 7e-13
Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 27/217 (12%)
Query: 522 VGKGSFSCVYKGVLKDG----TVVAVKKAIATSDRQKNSKEFHTELDLLS-RLNHAHLLN 576
+GKGSF V+ LK + A+KK + D E +LS H L +
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECT--MVEKRVLSLAWEHPFLTH 60
Query: 577 LLGYCE-EGRERLL-VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
L YC + +E L V E++ G L H+ K D R A + G+++LH
Sbjct: 61 L--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHK-----FDLPRATFYAAEIICGLQFLH 113
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGL---SLLGPADSSSPLAELPAGTLGYLDP 691
+++RD+K NIL+D + + ++ADFG+ ++LG A + + GT Y+ P
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-----FCGTPDYIAP 165
Query: 692 EYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE 728
E T D +SFGVLL E+L G+ EE
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 7e-13
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 19/204 (9%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSR----LNHAHLLN 576
+GKG F V +K G + A KK D+++ K ++ L + + +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL----DKKRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 577 LLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L Y E ++ L LV M G L H++ + R + A Q G+E+LH
Sbjct: 57 SLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPG---FPEARAIFYAAQIICGLEHLHQ 113
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
+++RD+K N+L+D+ N R++D GL++ AGT GY+ PE +
Sbjct: 114 RR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK-GGKKIKGR--AGTPGYMAPEVLQ 167
Query: 696 LHYLTTKSDVYSFGVLLLEILSGR 719
D ++ G L E+++GR
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKE---FHTELDLLSRLNHAHLLNL 577
+G+G+F VY D G +AVK+ + + SKE E+ LL L H ++
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 578 LGYCEEGRERLL--VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
G + ER L E M GS+ L AL E + R+ T Q G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENV--TRKYT--RQILEGVSYLHS 124
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEY 693
++HRDIK +NIL D N ++ DFG S L S + + + GT ++ PE
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV-TGTPYWMSPEV 180
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGR 719
K+D++S G ++E+L+ +
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 62/206 (30%), Positives = 101/206 (49%), Gaps = 24/206 (11%)
Query: 522 VGKGSFSCVY---KGVLKD-GTVVAVK---KA-IATSDRQKNSKEFHTELDLLSRLNHAH 573
+G+GSF V+ K D G + A+K KA + DR + E D+L+ +NH
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKME----RDILAEVNHPF 59
Query: 574 LLNL-LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
++ L + EG+ L+ +F+ G L L + +E + + + A +++
Sbjct: 60 IVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKEVMFTEEDVKFY-----LAELALALDH 113
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
LH +I+RD+K NIL+DEE + ++ DFGLS D GT+ Y+ PE
Sbjct: 114 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLS-KESIDHEKKAYSF-CGTVEYMAPE 168
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSG 718
T +D +SFGVL+ E+L+G
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 69/225 (30%), Positives = 106/225 (47%), Gaps = 49/225 (21%)
Query: 521 EVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKE-FHT----ELDLLSRLNHAHL 574
++G+G++ VYK KD G +VA+KK R N KE F E+ +L +LNH ++
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKV-----RLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 575 LNL----------LGYCEEGRERLLVYEFMAH---GSLHQHL------HGKSKALKEQLD 615
+NL L + ++ LV+E+M H G L L H KS +K+ L+
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS-FMKQLLE 127
Query: 616 WVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675
G+ Y H +HRDIK SNIL++ + ++ADFGL+ L ++ S
Sbjct: 128 -------------GLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 676 SPLAELPAGTLGYLDPEYYRLHYLTTKS-DVYSFGVLLLEILSGR 719
P TL Y PE + DV+S G +L E+ + +
Sbjct: 172 RPYTN-KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+E+GKG++ VYK + + V K I + + ELD+L + ++++
Sbjct: 5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDF 64
Query: 578 LG-YCEEGRERLLVY---EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIA-VQAARGIEY 632
G + EG VY E+M GSL + G D +RR+T A V+ + ++
Sbjct: 65 YGAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE 120
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
H +IHRD+K +N+L++ ++ DFG+S G +S LA+ G Y+ PE
Sbjct: 121 EHN-----IIHRDVKPTNVLVNGNGQVKLCDFGVS--GNLVAS--LAKTNIGCQSYMAPE 171
Query: 693 YYR-------LHYLTTKSDVYSFGVLLLEILSGR 719
+ Y T +SDV+S G+ +LE+ GR
Sbjct: 172 RIKSGGPNQNPTY-TVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 65/211 (30%), Positives = 96/211 (45%), Gaps = 15/211 (7%)
Query: 522 VGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKE-FHTELDLLSRLNHAH-LLNLL 578
+GKGSF V LK G + AVK Q + E TE +LS L H L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILS-LARNHPFLTQL 61
Query: 579 GYCEEGRERLL-VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
C + +RL V EF+ G L H+ KS+ + D R A + + +LH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSR----RFDEARARFYAAEITSALMFLHDKG 116
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
+I+RD+K N+L+D E + ++ADFG+ G + GT Y+ PE +
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEM 171
Query: 698 YLTTKSDVYSFGVLLLEILSGRKAIDMQFEE 728
D ++ GVLL E+L G + + E+
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFEAENED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 49/160 (30%), Positives = 73/160 (45%), Gaps = 27/160 (16%)
Query: 567 SRLNHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQ 625
+ H L+NL C + + + V E+ A G L H+H + R V A
Sbjct: 57 NSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIH------TDVFSEPRAVFYAAC 109
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL--LGPADSSSPLAELPA 683
G++YLH +++RD+K N+L+D E ++ADFGL +G D +S
Sbjct: 110 VVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTF----C 162
Query: 684 GTLGYLDPEYYRLHYLTTKS-----DVYSFGVLLLEILSG 718
GT +L PE LT S D + GVL+ E+L G
Sbjct: 163 GTPEFLAPE-----VLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 36/217 (16%)
Query: 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH----AHL 574
EE+G+G++ V K GT++AVK+ AT + Q+ K +LD+ R
Sbjct: 7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ-KRLLMDLDISMRSVDCPYTVTF 65
Query: 575 LNLLGYCEEGRERLLVYEFM-----AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARG 629
L EG V+ M + ++ ++ K + E D + + IAV +
Sbjct: 66 YGAL--FREGD----VWICMEVMDTSLDKFYKKVYDKGLTIPE--DILGK--IAVSIVKA 115
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLG 687
+EYLH + VIHRD+K SN+LI+ ++ DFG+S L+ DS + + AG
Sbjct: 116 LEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV---DSVAKTID--AGCKP 168
Query: 688 YL-----DPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
Y+ +PE + Y KSDV+S G+ ++E+ +GR
Sbjct: 169 YMAPERINPELNQKGY-DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 17/206 (8%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKE---FHTELDLLSRLNHAHLLNL 577
+G+G+F VY D G +A K+ + + SKE E+ LL L H ++
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 578 LGYCEEGRERLLV--YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
G + E+ L E+M GS+ L AL E + R+ T Q G+ YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESV--TRKYT--RQILEGMSYLHS 124
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEY 693
++HRDIK +NIL D N ++ DFG S L S + + + GT ++ PE
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV-TGTPYWMSPEV 180
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGR 719
K+DV+S G ++E+L+ +
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 46/149 (30%), Positives = 75/149 (50%), Gaps = 10/149 (6%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+G++ VYK G +VA+KK ++ + E+ LL LNH +++ LL
Sbjct: 5 EKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL 64
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSK-ALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
+ LV+EF+ L +++ L L ++ Q +GI Y H +
Sbjct: 65 DVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPL--IKSYL--YQLLQGIAYCHSHR 119
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGL 666
V+HRD+K N+LID E ++ADFGL
Sbjct: 120 ---VLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 28/210 (13%)
Query: 523 GKGSFSCVY----KGVLKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
G G++ V+ G G + A+K K + K ++ TE +L + L
Sbjct: 9 GTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLV 68
Query: 577 LLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L Y + +L L+ +++ G L HL+ + + ++ RV IA + +++LH
Sbjct: 69 TLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEV----RVYIA-EIVLALDHLHQ 123
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
+I+RDIK NIL+D E + + DFGLS A+ A GT+ Y+ PE R
Sbjct: 124 LG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIEYMAPEVIR 179
Query: 696 LHYLTTKS-------DVYSFGVLLLEILSG 718
S D +S GVL E+L+G
Sbjct: 180 -----GGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 6e-12
Identities = 73/264 (27%), Positives = 107/264 (40%), Gaps = 72/264 (27%)
Query: 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHL 574
G F + V +F + K + V + K AT+ K +EL +L + NH ++
Sbjct: 18 GAFGKVVEASAFG-IDKKSSCNTVAVKMLKEGATASEHK---ALMSELKILIHIGNHLNV 73
Query: 575 LNLLGYCEEGRERLLV-YEFMAHGSLHQHL-----------------HGKSKALKEQLDW 616
+NLLG C + L+V EF +G+L L G+ +A+ EQ
Sbjct: 74 VNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRV 133
Query: 617 VRR----------------------------------------VTIAVQAARGIEYLHGY 636
RR + + Q ARG+E+L
Sbjct: 134 DRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLS---LLGPADSSSPLAELPAGTLGYLDPEY 693
C IHRD+ + NIL+ E + ++ DFGL+ P A LP L ++ PE
Sbjct: 194 KC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP---LKWMAPES 247
Query: 694 YRLHYLTTKSDVYSFGVLLLEILS 717
TT+SDV+SFGVLL EI S
Sbjct: 248 IFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 521 EVGKGSFSCVYKG-VLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
++G+GS V G VAVKK +Q+ + E+ ++ H +++ +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYS 83
Query: 580 YCEEGRERLLVYEFMAHGSL-----HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
G E +V EF+ G+L H ++ +EQ+ T+ + + + +LH
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMN------EEQI-----ATVCLAVLKALSFLH 132
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
VIHRDIKS +IL+ + +++DFG P + GT ++ PE
Sbjct: 133 AQG---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPEVI 187
Query: 695 -RLHYLTTKSDVYSFGVLLLEILSG 718
RL Y T+ D++S G++++E++ G
Sbjct: 188 SRLPY-GTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 64/295 (21%), Positives = 130/295 (44%), Gaps = 40/295 (13%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVL----KDGTVVAVKKAIAT-SDRQKNSKEFHTELD 564
EL+ + + +G G F + +G L K VA+ A SD+Q+ F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG--FLAEAL 58
Query: 565 LLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV 624
L + +H++++ L G G ++V E+M++G+L L + + QL + + +
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL----RKHEGQLVAGQLMGMLP 114
Query: 625 QAARGIEYLH--GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP 682
A G++YL GY +H+ + + +L++ + +++ F D S +
Sbjct: 115 GLASGMKYLSEMGY-----VHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTM 166
Query: 683 AGTLGYL--DPEYYRLHYLTTKSDVYSFGVLLLEILS--GRKAIDMQFEEGNIVEWAVPL 738
+G L PE + H+ ++ SDV+SFG+++ E++S R DM +
Sbjct: 167 SGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----------- 215
Query: 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
D+ ++ +LP+ + + + C + ERP ++ + L + +
Sbjct: 216 ----DVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 12/205 (5%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVA--VKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+E+G G F V G G A V K + S F E+ LNH ++L
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
LG C E LLV EF G L +L + + +A + A G+ +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD 120
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
IH D+ N + + + ++ D+GL+L + + A L +L PE +
Sbjct: 121 ---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177
Query: 698 Y-------LTTKSDVYSFGVLLLEI 715
T KS+++S GV + E+
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 45/149 (30%), Positives = 77/149 (51%), Gaps = 7/149 (4%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+G++ VYKG K G +VA+KK S+ + E+ LL L H +++ L
Sbjct: 6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ 65
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
+ L++EF++ L ++L K + +D + Q +GI + H
Sbjct: 66 DVLMQESRLYLIFEFLSM-DLKKYLDSLPKG--QYMDAELVKSYLYQILQGILFCHSRR- 121
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLS 667
V+HRD+K N+LID + ++ADFGL+
Sbjct: 122 --VLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 9e-12
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 20/204 (9%)
Query: 518 FKEEVGKGSFSCVYKG-VLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
++E +G G+ VYK L ++AVK I + K+ +EL++L + + +++
Sbjct: 5 YQEILGHGNGGTVYKAYHLLTRRILAVK-VIPLDITVELQKQIMSELEILYKCDSPYIIG 63
Query: 577 LLG-YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
G + E R + EFM GSL + + + E + + R+ +AV +G+ YL
Sbjct: 64 FYGAFFVENRISICT-EFMDGGSLDVY-----RKIPEHV--LGRIAVAV--VKGLTYLWS 113
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
++HRD+K SN+L++ ++ DFG+S + +A+ GT Y+ PE
Sbjct: 114 LK---ILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERIS 166
Query: 696 LHYLTTKSDVYSFGVLLLEILSGR 719
SDV+S G+ +E+ GR
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 1e-11
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 27/210 (12%)
Query: 522 VGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL-- 578
+G+G++ V K G VA+KK I+ + Q + E+ +L R H +++ +L
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKK-ISPFEHQTFCQRTLREIKILRRFKHENIIGILDI 71
Query: 579 ---GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQL---DWVRRVTIAVQAARGIEY 632
E + +V E M L+ K +K Q D ++ Q RG++Y
Sbjct: 72 IRPPSFESFNDVYIVQELM-ETDLY-------KLIKTQHLSNDHIQYFL--YQILRGLKY 121
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGL--SLLGPADSSSPLAELPAGTLGYLD 690
+H V+HRD+K SN+L++ + ++ DFGL D + L E A T Y
Sbjct: 122 IHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA-TRWYRA 177
Query: 691 PEYYRLHYLTTKS-DVYSFGVLLLEILSGR 719
PE TK+ D++S G +L E+LS R
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 1e-11
Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 27/209 (12%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK-----KAIATSDRQKNSKEFHTELDLLSRLNH 571
F + +G GSF V K G A+K K + + K + E +L + H
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIV----KLKQVEHVLNEKRILQSIRH 60
Query: 572 AHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
L+NL G ++ LV E++ G L HL KS E V R A Q +E
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLR-KSGRFPEP---VARF-YAAQVVLALE 115
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYL 689
YLH +++RD+K N+L+D + ++ DFG + + G + GT YL
Sbjct: 116 YLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC-------GTPEYL 165
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
PE D ++ G+L+ E+L+G
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 30/215 (13%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E VG G++ VYKG +K G + A+K T D ++ E E+++L + ++H N+
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE---EIKLEINMLKK--YSHHRNIA 76
Query: 579 GY---------CEEGRERLLVYEFMAHGSLHQHL-HGKSKALKEQLDWVRRVTIAVQAAR 628
Y + LV EF GS+ + + K ALKE DW+ I + R
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE--DWI--AYICREILR 132
Query: 629 GIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGY 688
G+ +LH + VIHRDIK N+L+ E ++ DFG+S D + GT +
Sbjct: 133 GLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYW 187
Query: 689 LDPEYYRLH-----YLTTKSDVYSFGVLLLEILSG 718
+ PE +SD++S G+ +E+ G
Sbjct: 188 MAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 522 VGKGSFSCVYKGVLKDGTVV----AVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+G+GS++ V LK + VKK + D ++ TE + + ++ L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDD--EDIDWVQTEKHVFEQASNHPFLVG 60
Query: 578 LGYCEEGRERLL-VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L C + RL V E++ G L H+ + K +E + + + + + YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY-----SAEISLALNYLHER 115
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG--PADSSSPLAELPAGTLGYLDPEYY 694
+I+RD+K N+L+D E + ++ D+G+ G P D++S GT Y+ PE
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----CGTPNYIAPEIL 168
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGRKAIDM 724
R D ++ GVL+ E+++GR D+
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 40/211 (18%)
Query: 523 GKGSFSCVYKG-VLKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLL 578
G+G+FS V K K G A+K K S Q N+ E+ L RL+ H ++L L
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRL- 63
Query: 579 GYCEEGRERL-----LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRV-TIAVQAARGIEY 632
E +R LV+E M +L++ + G+ + L E+ RV + Q + +++
Sbjct: 64 --IEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEK-----RVKSYMYQLLKSLDH 115
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
+H + HRDIK NILI ++ ++ADFG S G S P E + T Y PE
Sbjct: 116 MHRNG---IFHRDIKPENILIKDDI-LKLADFG-SCRG-IYSKPPYTEYIS-TRWYRAPE 168
Query: 693 ------YYRLHYLTTKSDVYSFGVLLLEILS 717
YY K D+++ G + EILS
Sbjct: 169 CLLTDGYY-----GPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 56/201 (27%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 522 VGKGSFSCVYK-GVLKDGTVVAVKKAIATSDRQKNSKEFH-TELDLLSRLNHAHLLNLLG 579
+GKG F V V G + A KK +++ + E +L ++N +++L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL-A 66
Query: 580 YCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
Y E ++ L LV M G L H++ +A + R V A + G+E LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYHMGEA---GFEEGRAVFYAAEICCGLEDLHQ--- 120
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
+++RD+K NIL+D+ + R++D GL++ P + + GT+GY+ PE +
Sbjct: 121 ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNER 177
Query: 699 LTTKSDVYSFGVLLLEILSGR 719
T D ++ G LL E+++G+
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 55/271 (20%), Positives = 109/271 (40%), Gaps = 49/271 (18%)
Query: 530 VYKGVLKDGTVVAVKKAIATSDRQKNSK----EFHTELDLLSRLNHAHLLNLLGYCEEGR 585
+YKG+ + V ++ K K E+ L R++ ++L + G+ +
Sbjct: 36 IYKGIF-NNKEVIIR---TFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV 91
Query: 586 ERL----LVYEFMAHGSLHQHLHGKSKALKEQ-LDWVRRVTIAVQAARGIEYLHGYACPP 640
+ L L+ E+ G L + L KE+ L + ++ +A+ +G+ L+ Y P
Sbjct: 92 DDLPRLSLILEYCTRGYLREVLD------KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP 145
Query: 641 VIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR--LHY 698
++++ S + L+ E + ++ GL + SS P + + Y +
Sbjct: 146 --YKNLTSVSFLVTENYKLKIICHGLEKIL---SSPPFKNV--NFMVYFSYKMLNDIFSE 198
Query: 699 LTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK----L 754
T K D+YS GV+L EI +G+ +P ++ I D ++ L
Sbjct: 199 YTIKDDIYSLGVVLWEIFTGK----------------IPF-ENLTTKEIYDLIINKNNSL 241
Query: 755 PSDLDALKRIANVACKCVRMRGKERPSMDKV 785
LD I + C +RP++ ++
Sbjct: 242 KLPLDCPLEIKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 41/217 (18%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
++VG G++ V + + G VA+KK + +K + EL LL + H +++ LL
Sbjct: 21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 579 GY--CEEGRERL----LVYEFMAH--GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
+ +R LV FM G L +H E+L R + Q +G+
Sbjct: 81 DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH---------EKLSEDRIQFLVYQMLKGL 131
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLD 690
+Y+H +IHRD+K N+ ++E+ ++ DFGL+ DS GY+
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSE---------MTGYVV 177
Query: 691 PEYYR--------LHYLTTKSDVYSFGVLLLEILSGR 719
+YR +HY T D++S G ++ E+L+G+
Sbjct: 178 TRWYRAPEVILNWMHY-TQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 51/202 (25%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+G+ V+ + + G VA+K+ +Q + E+ ++ L + +++N L
Sbjct: 25 EKIGQGASGTVFTAIDVATGQEVAIKQI--NLQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ-LDWVRRVTIAVQAARGIEYLHGYA 637
G E +V E++A GSL + + E +D + + + + +E+LH
Sbjct: 83 DSFLVGDELFVVMEYLAGGSL-------TDVVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGL-SLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
VIHRDIKS N+L+ + + ++ DFG + + P S GT ++ PE
Sbjct: 136 ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTR 189
Query: 697 HYLTTKSDVYSFGVLLLEILSG 718
K D++S G++ +E++ G
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E VG G++ VYKG +K G + A+K T D ++ K+ E+++L + ++H N+
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKK--YSHHRNIA 66
Query: 579 GYCEEGRER---------LLVYEFMAHGSLHQHL-HGKSKALKEQLDWVRRVTIAVQAAR 628
Y ++ LV EF GS+ + + K LKE+ W+ I + R
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE--WI--AYICREILR 122
Query: 629 GIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGY 688
G+ +LH + VIHRDIK N+L+ E ++ DFG+S D + GT +
Sbjct: 123 GLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVGRRNTFIGTPYW 177
Query: 689 LDPEYYRLH-----YLTTKSDVYSFGVLLLEILSG 718
+ PE KSD++S G+ +E+ G
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 75/273 (27%), Positives = 122/273 (44%), Gaps = 50/273 (18%)
Query: 519 KEEVGKGSFSCVYKGVLKDGTVVA-----VKKAIATSDRQKNSK-EFHTELDLLSRLNHA 572
++ +GKGSF VY ++KD VA V K I + N + + E LLS+L+H
Sbjct: 5 QQRLGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHP 62
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLH-----GKSKALKEQLDWVRRVTIAVQAA 627
++ E ++ E+ L L GK+ + + +W +Q
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWF------IQLL 116
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGT 685
G+ Y+H ++HRD+K+ NI + + + ++ DFG+S L+G D LA GT
Sbjct: 117 LGVHYMHQRR---ILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCD----LATTFTGT 168
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGN-------IVEWAVPL 738
Y+ PE + +KSD++S G +L E+ A FE N IVE P
Sbjct: 169 PYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHA----FEGQNFLSVVLRIVEGPTPS 224
Query: 739 IK---SGDITAIL------DPVLKLPSDLDALK 762
+ S + +I+ DP L+ PS + L+
Sbjct: 225 LPETYSRQLNSIMQSMLNKDPSLR-PSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 66/283 (23%), Positives = 128/283 (45%), Gaps = 40/283 (14%)
Query: 520 EEVGKGSFSCVYKGVLKDG--TVVAVKKAIATS--------DRQKNSKEFHTELDLL-SR 568
E +G G+F CVYK K+ ++A+K+ + +R K+ + +E+ ++ +
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 569 LNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQH---LHGKSKALKEQLDWVRRVTIAVQ 625
L H +++ E +V + + L +H L K + E+ W I VQ
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIW----NIFVQ 121
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP--A 683
+ YLH ++HRD+ +NI++ E+ + DFGL A P ++L
Sbjct: 122 MVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGL-----AKQKQPESKLTSVV 174
Query: 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD 743
GT+ Y PE + K+DV++FG +L ++ + F N++ A +++
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMC----TLQPPFYSTNMLSLATKIVE--- 227
Query: 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVT 786
A+ +P LP + + + + +V C+ + RP + +V+
Sbjct: 228 --AVYEP---LPEGMYS-EDVTDVITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 522 VGKGSFSCVYKGVLKDGTVV----AVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+G+GS++ V LK + VKK + D ++ TE + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDD--EDIDWVQTEKHVFEQASSNPFLVG 60
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L C + RL LV E++ G L H+ + K +E + A + + +LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY-----AAEICIALNFLHER 115
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSL--LGPADSSSPLAELPAGTLGYLDPEYY 694
+I+RD+K N+L+D + + ++ D+G+ LGP D++S GT Y+ PE
Sbjct: 116 G---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC----GTPNYIAPEIL 168
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGRKAIDM 724
R D ++ GVL+ E+++GR D+
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHT-ELDLLSRLNHAHLLNLLG 579
+GKG F V +K+ G + A KK ++K+ ++ E ++L ++N ++NL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 580 YCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
Y E + L LV M G L H++ + L+ R + + Q GI +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNVGE---RGLEMERVIHYSAQITCGILHLHSMD- 115
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
+++RD+K N+L+D++ N R++D GL++ + AGT GY+ PE +
Sbjct: 116 --IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR---AGTNGYMAPEILKEEP 170
Query: 699 LTTKSDVYSFGVLLLEILSGR 719
+ D ++ G + E+++GR
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 56/235 (23%)
Query: 520 EEVGKGSFSCVYKG-VLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA-HLLNL 577
E+G G+ VYK K G V+AVK+ T ++++N K +LD++ + + +++
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRILMDLDVVLKSHDCPYIVKC 79
Query: 578 LGYCEEGRERLLVYEFMA----------HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAA 627
GY + + E M+ G + + + GK + V
Sbjct: 80 YGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGK---------------MTVAIV 124
Query: 628 RGIEYL---HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS---LLGPADSSSPLAEL 681
+ + YL HG VIHRD+K SNIL+D N ++ DFG+S + A + S
Sbjct: 125 KALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS----- 174
Query: 682 PAGTLGYLDPEYYRLHYLTTK------SDVYSFGVLLLEILSGR---KAIDMQFE 727
AG Y+ PE R+ +DV+S G+ L+E+ +G+ K +FE
Sbjct: 175 -AGCAAYMAPE--RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE 226
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 60/209 (28%), Positives = 109/209 (52%), Gaps = 25/209 (11%)
Query: 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+G+++ VYKG + G +VA+K+ ++ S E+ L+ L H +++ L
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLH 64
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
+ +LV+E+M L +++ HG AL V+ T Q +GI + H
Sbjct: 65 DVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNT--VKSFTY--QLLKGIAFCHEN 119
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLG-PADS-SSPLAELPAGTLGYLDPEY 693
V+HRD+K N+LI++ ++ADFGL+ G P ++ S+ + TL Y P+
Sbjct: 120 R---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-----TLWYRAPDV 171
Query: 694 Y---RLHYLTTKSDVYSFGVLLLEILSGR 719
R + +T D++S G ++ E+++GR
Sbjct: 172 LLGSRTY--STSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 61/203 (30%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 522 VGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKN-SKEFHTELD-LLSRLNHAHLLNLL 578
+GKGSF V K DG AVK + +K K E + LL + H L+ L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL- 61
Query: 579 GYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
Y + ++L V +++ G L HL + ++ E R A + A + YLH
Sbjct: 62 HYSFQTADKLYFVLDYVNGGELFFHLQ-RERSFPE----PRARFYAAEIASALGYLHSLN 116
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLG--PADSSSPLAELPAGTLGYLDPEYYR 695
+I+RD+K NIL+D + + + DFGL G + ++S GT YL PE R
Sbjct: 117 ---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTF----CGTPEYLAPEVLR 169
Query: 696 LHYLTTKSDVYSFGVLLLEILSG 718
D + G +L E+L G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 51/236 (21%)
Query: 506 FTYEELERATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELD 564
FT E+L+ E+G+G+F V K + K GT++AVK+ +T D +K K +LD
Sbjct: 1 FTAEDLKD-----LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-EKEQKRLLMDLD 54
Query: 565 LLSRLNHAHLLNLLGYCE-----------EGRERLLVYEFM--AHGSLHQHLHGKSKA-L 610
++ R + C EG + + E M + +++++ K+ +
Sbjct: 55 VVMRSSD---------CPYIVKFYGALFREG-DCWICMELMDISLDKFYKYVYEVLKSVI 104
Query: 611 KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--L 668
E++ + ++ +A + + YL +IHRD+K SNIL+D N ++ DFG+S L
Sbjct: 105 PEEI--LGKIAVAT--VKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQL 158
Query: 669 LGPADSSSPLAELPAGTLGYLDPEYYRLHYLTT-----KSDVYSFGVLLLEILSGR 719
+ DS + + AG Y+ PE R+ +SDV+S G+ L E+ +G+
Sbjct: 159 V---DSIAKTRD--AGCRPYMAPE--RIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-11
Identities = 55/200 (27%), Positives = 99/200 (49%), Gaps = 16/200 (8%)
Query: 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
++G+GS V K G VAVKK +Q+ + E+ ++ +H +++++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
G E +V EF+ G+L + ++ +EQ+ T+ + R + YLH
Sbjct: 87 SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQG-- 138
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY-RLHY 698
VIHRDIKS +IL+ + +++DFG P + GT ++ PE RL Y
Sbjct: 139 -VIHRDIKSDSILLTSDGRIKLSDFGFC--AQVSKEVPKRKSLVGTPYWMAPEVISRLPY 195
Query: 699 LTTKSDVYSFGVLLLEILSG 718
T+ D++S G++++E++ G
Sbjct: 196 -GTEVDIWSLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 7e-11
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 40/221 (18%)
Query: 521 EVGKGSFSCVYKGVLK---DGTVVAVKKAIATSDRQKN-SKEFHTELDLLSRLNHAHLLN 576
+G+G++ VYK K DG A+KK ++ S+ E+ LL L H ++++
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 577 LLGYCEEGRERL--LVYEFMAH---GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
L+ E ++ L++++ H + H K ++ + V+ + Q G+
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSM--VKSLLW--QILNGVH 122
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNAR----VADFGLSLLGPADSSSPLAELPAG--- 684
YLH V+HRD+K +NIL+ E R + D GL+ L ++PL L
Sbjct: 123 YLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL----FNAPLKPLADLDPV 175
Query: 685 --TLGYLDPEYYRL-----HYLTTKS-DVYSFGVLLLEILS 717
T+ Y PE L HY TK+ D+++ G + E+L+
Sbjct: 176 VVTIWYRAPE---LLLGARHY--TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 9e-11
Identities = 56/202 (27%), Positives = 98/202 (48%), Gaps = 18/202 (8%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNL 577
E++G+G+ VY + + G VA+K+ + +Q+ KE L+ R N H +++N
Sbjct: 25 EKIGQGASGTVYTAIDVATGQEVAIKQ---MNLQQQPKKELIINEILVMRENKHPNIVNY 81
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
L G E +V E++A GSL + +D + + + + +E+LH
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 135
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGL-SLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
VIHRDIKS NIL+ + + ++ DFG + + P S GT ++ PE
Sbjct: 136 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTR 189
Query: 697 HYLTTKSDVYSFGVLLLEILSG 718
K D++S G++ +E++ G
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 59/228 (25%), Positives = 98/228 (42%), Gaps = 43/228 (18%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKK-------AIATSDRQKNSK---EFHT--ELDLLSR 568
+G+G++ V K G +VA+KK T DRQ F T EL +++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 569 LNHAHLLNLLG-YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAA 627
+ H +++ L+ Y E L V + M L + + K + + Q+ I +Q
Sbjct: 77 IKHENIMGLVDVYVEGDFINL-VMDIM-ASDLKKVVDRKIRLTESQVK-----CILLQIL 129
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL-LGPADSSSPLAELPAG-- 684
G+ LH + +HRD+ +NI I+ + ++ADFGL+ G S L++
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 685 ---------TLGYLDPEYYRLHYLTTK----SDVYSFGVLLLEILSGR 719
TL Y PE L K D++S G + E+L+G+
Sbjct: 187 REEMTSKVVTLWYRAPE---LLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 25/232 (10%)
Query: 502 RAQMFTYEELERATGGFK--EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKE 558
+ M E L T ++ E +GKG++ VYK KDG++ AVK SD +E
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV---DEE 64
Query: 559 FHTELDLLSRL-NHAHLLNLLGYCEE-----GRERLLVYEFMAHGSLHQHLHGKSKALKE 612
E ++L L NH +++ G + G + LV E GS+ + + G +
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQ 123
Query: 613 QLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672
+LD I A G+++LH +IHRD+K +NIL+ E ++ DFG+S
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVS--AQL 178
Query: 673 DSSSPLAELPAGTLGYLDPEY------YRLHYLTTKSDVYSFGVLLLEILSG 718
S+ GT ++ PE Y Y + DV+S G+ +E+ G
Sbjct: 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSY-DARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 77/261 (29%), Positives = 111/261 (42%), Gaps = 44/261 (16%)
Query: 522 VGKGSFSCVYKGVLK-DGTVVAVK----KAIATSDRQKNSKEFHTELD-LLSRLNHAHLL 575
+GKGSF V K DG+ AVK K I ++K E + LL L H L+
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTIL---KKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 576 NLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
L Y + E+L V +++ G L HL + + E R A + A I YLH
Sbjct: 60 GL-HYSFQTAEKLYFVLDYVNGGELFFHLQ-RERCFLEP----RARFYAAEVASAIGYLH 113
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG--PADSSSPLAELPAGTLGYLDPE 692
+I+RD+K NIL+D + + + DFGL G P +++S GT YL PE
Sbjct: 114 SLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF----CGTPEYLAPE 166
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752
R D + G +L E+L G +P S D++ + D +L
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG-----------------LPPFYSRDVSQMYDNIL 209
Query: 753 KLPSDLDALKRIANVACKCVR 773
P L K +A AC +
Sbjct: 210 HKPLQLPGGKTVA--ACDLLV 228
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 31/207 (14%)
Query: 522 VGKGSFSCVYKGVLK-DGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
VG G+F V+ + A+K AI R K + H E +L ++H ++ L
Sbjct: 9 VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66
Query: 580 YCEEGRERLL--VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVT------IAVQAARGIE 631
+ E +R L + E++ G L +L R + A + +E
Sbjct: 67 FWTEHDQRFLYMLMEYVPGGELFSYLRNS-----------GRFSNSTGLFYASEIVCALE 115
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
YLH +++RD+K NIL+D+E + ++ DFG A GT YL P
Sbjct: 116 YLHSKE---IVYRDLKPENILLDKEGHIKLTDFGF-----AKKLRDRTWTLCGTPEYLAP 167
Query: 692 EYYRLHYLTTKSDVYSFGVLLLEILSG 718
E + D ++ G+L+ E+L G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNL 577
E++G+G+ VY + + G VA+++ + +Q+ KE L+ R N + +++N
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQ---MNLQQQPKKELIINEILVMRENKNPNIVNY 82
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ-LDWVRRVTIAVQAARGIEYLHGY 636
L G E +V E++A GSL + + E +D + + + + +E+LH
Sbjct: 83 LDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGL-SLLGPADSSSPLAELPAGTLGYLDPEYYR 695
VIHRDIKS NIL+ + + ++ DFG + + P S + + GT ++ PE
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STM-VGTPYWMAPEVVT 189
Query: 696 LHYLTTKSDVYSFGVLLLEILSG 718
K D++S G++ +E++ G
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 2e-10
Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 520 EEVGKGSFSCVYKGV---LKDG-----TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH 571
E +G+G+F+ ++KG+ + D T V +K + + S+ F ++S+L+H
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLK--VLDKSHRNYSESFFEAASMMSQLSH 58
Query: 572 AHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
HL+ G C G E ++V E++ GSL +L K + W ++ +A Q A +
Sbjct: 59 KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISW--KLEVAKQLAWALH 114
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVAD--FGLSLLGPADSSSPLA-ELPAGTLGY 688
+L + H ++ + N+L+ E + + + F + L P S + L E+ + +
Sbjct: 115 FLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPF-IKLSDPGISITVLPKEILLERIPW 170
Query: 689 LDPEYYR-LHYLTTKSDVYSFGVLLLEILSG 718
+ PE L+ +D +SFG L EI SG
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 23/218 (10%)
Query: 507 TYEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDL 565
+YE+LE+ +G+GS++ VYKG K +G +VA+K I + + E L
Sbjct: 6 SYEKLEK--------LGEGSYATVYKGKSKVNGKLVALK-VIRLQEEEGTPFTAIREASL 56
Query: 566 LSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQ 625
L L HA+++ L LV+E++ H L Q++ L + V+ Q
Sbjct: 57 LKGLKHANIVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHP--ENVK--LFLFQ 111
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGT 685
RG+ Y+H ++HRD+K N+LI + ++ADFGL+ S + E+ T
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV--T 166
Query: 686 LGYLDPEYY--RLHYLTTKSDVYSFGVLLLEILSGRKA 721
L Y P+ Y +T D++ G + +E++ G A
Sbjct: 167 LWYRPPDVLLGSTEY-STCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 72/272 (26%), Positives = 115/272 (42%), Gaps = 55/272 (20%)
Query: 522 VGKGSFSCVYKGVLKD---GTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
VG+G F V V+++ G + A+K + Q+ F E D+LS N + L
Sbjct: 9 VGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLD--WVRRVTIAVQAARGIEYLH 634
Y + ++ L LV E+ G L L+ E + ++ + +A+ + +
Sbjct: 67 Q-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSV----HQM 121
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
GY +HRDIK N+LID + ++ADFG + A+ ++LP GT Y+ PE
Sbjct: 122 GY-----VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPE-- 173
Query: 695 RLHYLTTKS-----------DVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD 743
LTT + D +S GV+ E++ GR F EG +
Sbjct: 174 ---VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP----FHEGTSAK---------T 217
Query: 744 ITAILD--PVLKLPSDL----DALKRIANVAC 769
I++ LK P D D L I ++ C
Sbjct: 218 YNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC 249
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 25/207 (12%)
Query: 522 VGKGSFSCVYKGVLKDGT----VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+GKGSF V LK + A+KK + D + L+ H L +L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLTHL 61
Query: 578 LGYCE-EGRERLL-VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
+C + +E L V E++ G L H+ + D R A + G+++LH
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-----FDEARARFYAAEIICGLQFLHK 114
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGL---SLLGPADSSSPLAELPAGTLGYLDPE 692
+I+RD+K N+L+D++ + ++ADFG+ ++ G +S+ GT Y+ PE
Sbjct: 115 KG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-----FCGTPDYIAPE 166
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSGR 719
+ D +SFGVLL E+L G+
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 62/239 (25%), Positives = 101/239 (42%), Gaps = 66/239 (27%)
Query: 507 TYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKE-----FH 560
+E+L R +G+G++ VY+ G +VA+KK R N ++
Sbjct: 8 EFEKLNR--------IGEGTYGIVYRARDTTSGEIVALKKV-----RMDNERDGIPISSL 54
Query: 561 TELDLLSRLNHAHLLNLL---------------GYCEEGRERLLVYEFMAHGSLHQHLHG 605
E+ LL L H +++ L YCE+ LL S Q
Sbjct: 55 REITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLL-DNMPTPFSESQ---- 109
Query: 606 KSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665
V+ + +Q RG++YLH +IHRD+K SN+L+ ++ ++ADFG
Sbjct: 110 -----------VK--CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFG 153
Query: 666 LSLL--GPADSSSPLAELPAGTLGYLDPEYY---RLHYLTTKSDVYSFGVLLLEILSGR 719
L+ PA +P TL Y PE + TT D+++ G +L E+L+ +
Sbjct: 154 LARTYGLPAKPMTPKVV----TLWYRAPELLLGCTTY--TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 59/219 (26%), Positives = 91/219 (41%), Gaps = 45/219 (20%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
+G G+F V+ +DG VA+KK + K EL +L H ++L+ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 581 CEEG-----RERLLVYEFMAHGSLH------QHLHGKSKALKEQLDWVRRVTIAVQAARG 629
+ E +V E M LH Q L D V+ Q RG
Sbjct: 68 LQPPHIDPFEEIYVVTELM-QSDLHKIIVSPQPLSS---------DHVKVFL--YQILRG 115
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL-AELPAGTLGY 688
++YLH ++HRDIK N+L++ ++ DFGL+ + D S + E+
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVT----- 167
Query: 689 LDPEYYRL--------HYLTTKSDVYSFGVLLLEILSGR 719
+YYR HY T+ D++S G + E+L R
Sbjct: 168 ---QYYRAPEILMGSRHY-TSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 37/213 (17%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
VG G++ V K G VAVKK ++K + EL LL + H +++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 581 ------CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
EE + LV M L+ K K D V+ + Q RG++Y+H
Sbjct: 85 FTPARSLEEFNDVYLVTHLMG-----ADLNNIVKCQKLTDDHVQ--FLIYQILRGLKYIH 137
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
+IHRD+K SN+ ++E+ ++ DFGL+ + + GY+ +Y
Sbjct: 138 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----------GYVATRWY 183
Query: 695 R--------LHYLTTKSDVYSFGVLLLEILSGR 719
R +HY T D++S G ++ E+L+GR
Sbjct: 184 RAPEIMLNWMHYNQT-VDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 35/108 (32%), Positives = 47/108 (43%), Gaps = 17/108 (15%)
Query: 614 LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673
DW + + G+E LH +IHRDIK N+LID+ + ++ DFGLS G
Sbjct: 96 EDWAK--QYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNG--- 147
Query: 674 SSSPLAELP---AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
GT YL PE SD +S G ++ E L G
Sbjct: 148 ------LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 522 VGKGSFSCVYKGVLKDG----TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH--AHLL 575
+GKGSF V LK V A+KK + D + L+ N HL
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL- 61
Query: 576 NLLGYCE-EGRERLL-VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
YC + +E L V EF+ G L H+ K + D R A + G+++L
Sbjct: 62 ----YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR-----FDLYRATFYAAEIVCGLQFL 112
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGL---SLLGPADSSSPLAELPAGTLGYLD 690
H +I+RD+K N+++D + + ++ADFG+ ++ G +S+ GT Y+
Sbjct: 113 HSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-----FCGTPDYIA 164
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
PE + T D +SFGVLL E+L G+
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 20/203 (9%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNL 577
E++G+G+ VY + + G VA+K+ + +Q+ KE L+ R N + +++N
Sbjct: 25 EKIGQGASGTVYTAIDIATGQEVAIKQ---MNLQQQPKKELIINEILVMRENKNPNIVNY 81
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ-LDWVRRVTIAVQAARGIEYLHGY 636
L G E +V E++A GSL + + E +D + + + + +++LH
Sbjct: 82 LDSYLVGDELWVVMEYLAGGSL-------TDVVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGL-SLLGPADSSSPLAELPAGTLGYLDPEYYR 695
VIHRDIKS NIL+ + + ++ DFG + + P S GT ++ PE
Sbjct: 135 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVT 188
Query: 696 LHYLTTKSDVYSFGVLLLEILSG 718
K D++S G++ +E++ G
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 14/203 (6%)
Query: 522 VGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFH---TELDLLSRLNHAHLLNL 577
+GKG F V ++ G + A KK R K K + E +L+++ H+ +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKL--NKKRLKKRKGYEGAMVEKRILAKV-HSRFIVS 57
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L Y + + L LV M G L H++ + R Q G+E+LH
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEE-NPGFPEPRACFYTAQIISGLEHLHQR 116
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
+I+RD+K N+L+D + N R++D GL++ S AGT G++ PE +
Sbjct: 117 R---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY--AGTPGFMAPELLQG 171
Query: 697 HYLTTKSDVYSFGVLLLEILSGR 719
D ++ GV L E+++ R
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 45/231 (19%)
Query: 503 AQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTE 562
+M TY +LE+ +G+G+++ V+KG K + K I + E
Sbjct: 3 GKMETYIKLEK--------LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIRE 54
Query: 563 LDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLD------W 616
+ LL L HA+++ L + LV+E++ K LK+ +D
Sbjct: 55 VSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL------------DKDLKQYMDDCGNIMS 102
Query: 617 VRRVTIAV-QAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675
+ V I + Q RG+ Y H V+HRD+K N+LI+E ++ADFGL+ +
Sbjct: 103 MHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159
Query: 676 SPLAELPAGTLGYLDP-------EYYRLHYLTTKSDVYSFGVLLLEILSGR 719
+ E+ TL Y P EY +T+ D++ G + E+ SGR
Sbjct: 160 TYSNEVV--TLWYRPPDVLLGSSEY------STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 522 VGKGSFSCVYK-GVLKDGTVVAVKKAIATSDRQKNSKEFH-TELDLLSRLNHAHLLNLLG 579
+GKG F V V G + A K+ +++ + E +L ++N ++NL
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL-A 66
Query: 580 YCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
Y E ++ L LV M G L H++ E+ R + A + G+E LH
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEE---ERALFYAAEILCGLEDLHREN- 122
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
++RD+K NIL+D+ + R++D GL++ P GT+GY+ PE
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIP---EGESIRGRVGTVGYMAPEVLNNQR 177
Query: 699 LTTKSDVYSFGVLLLEILSGR 719
T D + G L+ E++ G+
Sbjct: 178 YTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-10
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 522 VGKGSFSCVYKGVLKDGTVV----AVKKAIATSDR-----QKNSKEFHTELDLLSRLNHA 572
+G+GS++ V LK + +KK + D Q F T NH
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETAS------NHP 56
Query: 573 HLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
L+ L C + RL V EF++ G L H+ + K +E + + + + +
Sbjct: 57 FLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFY-----SAEISLALN 110
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL--LGPADSSSPLAELPAGTLGYL 689
+LH +I+RD+K N+L+D E + ++ D+G+ + P D++S GT Y+
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTF----CGTPNYI 163
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDM 724
PE R D ++ GVL+ E+++GR D+
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-10
Identities = 38/96 (39%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 625 QAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS---LLGPADSSSPLAEL 681
Q A+G+E+L C IHRD+ + NIL+ E + ++ DFGL+ P A L
Sbjct: 187 QVAKGMEFLASRKC---IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 682 PAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
P L ++ PE T +SDV+SFGVLL EI S
Sbjct: 244 P---LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 6e-10
Identities = 51/200 (25%), Positives = 96/200 (48%), Gaps = 16/200 (8%)
Query: 521 EVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
++G+GS V +K G +VAVKK +Q+ + E+ ++ H +++ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
G E +V EF+ G+L + ++ +EQ+ + + + + LH
Sbjct: 85 SYLVGDELWVVMEFLEGGAL-TDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQG-- 136
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY-RLHY 698
VIHRDIKS +IL+ + +++DFG P + GT ++ PE RL Y
Sbjct: 137 -VIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPY 193
Query: 699 LTTKSDVYSFGVLLLEILSG 718
+ D++S G++++E++ G
Sbjct: 194 -GPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 6e-10
Identities = 32/83 (38%), Positives = 49/83 (59%)
Query: 641 VIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLT 700
+IHRDIKS+NIL+ ++ DFG S + A S + GT Y+ PE +R +
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223
Query: 701 TKSDVYSFGVLLLEILSGRKAID 723
K+D++S GVLL E+L+ ++ D
Sbjct: 224 KKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+GS++ VYKG+ + +G +VA+K I+ + E LL L HA+++ LL
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHANIV-LL 68
Query: 579 GYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
+E L V+E+M H L Q++ L Q RG+ Y+HG
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPY----NVRLFMFQLLRGLAYIHGQH 123
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY--R 695
++HRD+K N+LI ++ADFGL+ S + +E+ TL Y P+
Sbjct: 124 ---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGA 178
Query: 696 LHYLTTKSDVYSFGVLLLEILSGRKA 721
Y ++ D++ G + +E+L G+ A
Sbjct: 179 TDY-SSALDIWGAGCIFIEMLQGQPA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 28/222 (12%)
Query: 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLKD---GTVVAVKKAIATSDRQKNSKEFHT 561
M YE++E+ G+G++ VYK +D +A+KK + +
Sbjct: 1 MDQYEKVEKI--------GEGTYGVVYKA--RDRVTNETIALKKIRLEQEDEGVPSTAIR 50
Query: 562 ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRV- 620
E+ LL + H +++ L + LV+E++ L +H+ K R +
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNP----RLIK 105
Query: 621 TIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA-RVADFGLSLLGPADSSSPLA 679
T Q RGI Y H + V+HRD+K N+LID NA ++ADFGL+ +
Sbjct: 106 TYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTH 162
Query: 680 ELPAGTLGYLDPEYY--RLHYLTTKSDVYSFGVLLLEILSGR 719
E+ TL Y PE HY +T D++S G + E+++ +
Sbjct: 163 EVV--TLWYRAPEILLGSRHY-STPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 36/236 (15%)
Query: 534 VLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL-LVYE 592
VLK T+V + K ++ TE +L + + L L Y + +L L+ +
Sbjct: 35 VLKKATIV---------QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILD 85
Query: 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV-QAARGIEYLHGYACPPVIHRDIKSSNI 651
++ G L HL + + KEQ V I + +E+LH +I+RDIK NI
Sbjct: 86 YINGGELFTHLSQRER-FKEQ-----EVQIYSGEIVLALEHLHKLG---IIYRDIKLENI 136
Query: 652 LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR----LHYLTTKSDVYS 707
L+D + + DFGLS D GT+ Y+ P+ R H D +S
Sbjct: 137 LLDSNGHVVLTDFGLSKEFHEDEVERAYSF-CGTIEYMAPDIVRGGDGGH--DKAVDWWS 193
Query: 708 FGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKR 763
GVL+ E+L+G + E+ + E + ++KS +P P ++ AL +
Sbjct: 194 MGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------EP--PYPQEMSALAK 240
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLL 566
YE+LE+ +G+G++ VYK G +VA+KK D + E+ LL
Sbjct: 3 YEKLEK--------IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLL 54
Query: 567 SRLNHA-HLLNLLG--YCEE--GRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRV 620
L+ + +++ LL + EE G+ L LV+E++ L + + + L
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIK 113
Query: 621 TIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA-RVADFGLSLLGPADSSSPLA 679
+ Q +G+ + H + V+HRD+K N+L+D++ ++AD GL S
Sbjct: 114 SFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 680 ELPAGTLGYLDPEYY--RLHYLTTKSDVYSFGVLLLEILSG 718
E+ TL Y PE HY +T D++S G + E+
Sbjct: 171 EIV--TLWYRAPEVLLGSTHY-STPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 522 VGKGSFSCVY----KGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+GKGSF V KG + + +KK + D E +L+ L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECT--MVEKRVLALPGKPPFLTQ 65
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L C + +RL V E++ G L H+ K KE V A + A G+ +LH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK-FKEP----HAVFYAAEIAIGLFFLHSK 120
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGL---SLLGPADSSSPLAELPAGTLGYLDPEY 693
+I+RD+K N+++D E + ++ADFG+ ++ G + + GT Y+ PE
Sbjct: 121 G---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT-----FCGTPDYIAPEI 172
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE 728
D ++FGVLL E+L+G+ D + E+
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 49/231 (21%)
Query: 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKK--------AIATSDRQKN 555
+ TY++L++ +G+GS++ VYKG K G +VA+K+ A T+ R
Sbjct: 4 LETYKKLDK--------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR--- 52
Query: 556 SKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLD 615
E LL L HA+++ L + LV+E++ L Q++ L +
Sbjct: 53 ------EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGL--SMH 103
Query: 616 WVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675
VR Q RG+ Y H V+HRD+K N+LI E ++ADFGL+ S
Sbjct: 104 NVRLFLF--QLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158
Query: 676 SPLAELPAGTLGYLDP-------EYYRLHYLTTKSDVYSFGVLLLEILSGR 719
+ E+ TL Y P EY +T D++ G + E+ +GR
Sbjct: 159 TYSNEVV--TLWYRPPDVLLGSTEY------STSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 521 EVGKGSFSCVYKGVLKDGT---VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+VG+G++ VYK KDG A+K+ T +E + LL L H +++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIAL 63
Query: 578 --LGYCEEGRERLLVYEFMAHGSLHQ-HLHGKSKALKEQLDWVRRV--TIAVQAARGIEY 632
+ R+ L++++ H H H SKA K+ + R + ++ Q GI Y
Sbjct: 64 QKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123
Query: 633 LHGYACPPVIHRDIKSSNILI----DEEHNARVADFGLSLLGPADSSSPLAELP--AGTL 686
LH V+HRD+K +NIL+ E ++AD G + L + PLA+L T
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS-PLKPLADLDPVVVTF 179
Query: 687 GYLDPEYY--RLHYLTTKSDVYSFGVLLLEILS 717
Y PE HY T D+++ G + E+L+
Sbjct: 180 WYRAPELLLGARHY-TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 64/203 (31%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 522 VGKGSFSCVYKGVLK-DGTVVAVK---KAIATSDRQKNSKEFHTELD-LLSRLNHAHLLN 576
+GKGSF V K DG AVK K I + +++ K E + LL + H L+
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ--KHIMAERNVLLKNVKHPFLVG 60
Query: 577 LLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L Y + E+L V +F+ G L HL + ++ E R A + A + YLH
Sbjct: 61 L-HYSFQTTEKLYFVLDFVNGGELFFHLQ-RERSFPEP----RARFYAAEIASALGYLHS 114
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
+++RD+K NIL+D + + + DFGL G A S + GT YL PE R
Sbjct: 115 IN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTF--CGTPEYLAPEVIR 169
Query: 696 LHYLTTKSDVYSFGVLLLEILSG 718
D + G +L E+L G
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 80/335 (23%), Positives = 126/335 (37%), Gaps = 66/335 (19%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFH--TELDLLSRLNHAHLLNL 577
+ +GKG V+ LK + K + + K +K TE ++L+ L+H L L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKS-KALKEQLDWVRRVTIA-VQAARGIEYLHG 635
+ LV ++ G L + L + K L E+ V R A V A +EYLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE---VARFYAAEVLLA--LEYLH- 120
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLS-------------LLGPADSSSPLAELP 682
+++RD+K NIL+ E + ++DF LS L + SS +
Sbjct: 121 --LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 683 --------------AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR-----KAID 723
GT Y+ PE + D ++ G+LL E+L G D
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238
Query: 724 MQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRG----KER 779
F NI++ V S +++ +++ D KR+ K RG K+
Sbjct: 239 ETFS--NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRL---GSK----RGAAEIKQH 289
Query: 780 PSMDKVTTALERALAQLMGSPCSEQPILPTEVVLG 814
P V AL R + PI+P
Sbjct: 290 PFFRGVNWALIR---------HTTPPIIPRPDDGI 315
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 34/194 (17%)
Query: 538 GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY------CEEGRERLLVY 591
G VAVKK Q ++K + EL LL +NH ++++LL EE ++ LV
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 651
E M +L Q +H +LD R + Q GI++LH +IHRD+K SNI
Sbjct: 106 ELM-DANLCQVIH-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNI 154
Query: 652 LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR-------LHYLTTKSD 704
++ + ++ DFGL+ + + P Y+ YYR + Y D
Sbjct: 155 VVKSDCTLKILDFGLA----RTACTNFMMTP-----YVVTRYYRAPEVILGMGY-KENVD 204
Query: 705 VYSFGVLLLEILSG 718
++S G ++ E++ G
Sbjct: 205 IWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 63/222 (28%), Positives = 98/222 (44%), Gaps = 37/222 (16%)
Query: 520 EEVGKGSFSCVYKGVLKD---------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN 570
E +G+G+F+ +YKGVL+ G V+V + SD ++S F L+S+L+
Sbjct: 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD-HRDSLAFFETASLMSQLS 59
Query: 571 HAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
H HL+ L G C E ++V E++ G L LH + + L W ++ +A Q A +
Sbjct: 60 HKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNV--SLHW--KLDVAKQLASAL 114
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS--SSPLAELPAGTLGY 688
YL +H ++ NIL VA +GL+ S P + +
Sbjct: 115 HYLEDKKL---VHGNVCGKNIL--------VARYGLNEGYVPFIKLSDPGIPITVLSREE 163
Query: 689 -------LDPEYYR--LHYLTTKSDVYSFGVLLLEILSGRKA 721
+ PE R LT +D +SFG LLEI S +
Sbjct: 164 RVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 25/213 (11%)
Query: 521 EVGKGSFSCVYKGVLKDGTV---VAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+VG+G++ VYK KDG A+K+ T +E + LL L H ++++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNVISL 63
Query: 578 --LGYCEEGRERLLVYEFMAHGSLHQ-HLHGKSKALKEQLDWVRRV--TIAVQAARGIEY 632
+ R+ L++++ H H H SKA K+ + R + ++ Q GI Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 633 LHGYACPPVIHRDIKSSNILI----DEEHNARVADFGLSLLGPADSSSPLAELP--AGTL 686
LH V+HRD+K +NIL+ E ++AD G + L + PLA+L T
Sbjct: 124 LHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS-PLKPLADLDPVVVTF 179
Query: 687 GYLDPEYY--RLHYLTTKSDVYSFGVLLLEILS 717
Y PE HY T D+++ G + E+L+
Sbjct: 180 WYRAPELLLGARHY-TKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 519 KEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSD--RQKNSKEFHTELDLLSRLNHAHLLN 576
E +G GSF V K K + + + K + E +L L+H ++N
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVN 82
Query: 577 LL-GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
++ + +E R L+ EF+ G L HL KA + D + + A EYLH
Sbjct: 83 MMCSFQDENRVYFLL-EFVVGGELFTHLR---KAGRFPNDVAKFYHAELVLA--FEYLHS 136
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
+I+RD+K N+L+D + + +V DFG + P D + L GT YL PE +
Sbjct: 137 KD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-DRTFTL----CGTPEYLAPEVIQ 188
Query: 696 LHYLTTKSDVYSFGVLLLEILSG 718
D ++ GVLL E ++G
Sbjct: 189 SKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 17/216 (7%)
Query: 518 FKEEVGKGSFSCVY----KGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAH 573
F +GKGSF V KG + + +KK + D E +L+
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECT--MVEKRVLALSGKPP 61
Query: 574 LLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
L L C + +RL V E++ G L + + KE V A + A G+ +
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR-FKEP----HAVFYAAEIAIGLFF 116
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
LH +I+RD+K N+++D E + ++ADFG+ D + + GT Y+ PE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPE 171
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE 728
D ++FGVLL E+L+G+ + + E+
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 48/195 (24%), Positives = 81/195 (41%), Gaps = 23/195 (11%)
Query: 536 KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595
T+VAVKK S +++ K E+ +L H ++L + E +V MA
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 596 HGSLHQHL--HGKSKALKEQLDWVRRVTIAV---QAARGIEYLHGYACPPVIHRDIKSSN 650
+GS L H L E + IA ++Y+H IHR +K+S+
Sbjct: 83 YGSCEDLLKTHFPE-GLPE-------LAIAFILKDVLNALDYIHSKGF---IHRSVKASH 131
Query: 651 ILIDEEHNARVADF--GLSLLGPADSSSPLAELPAGT---LGYLDPE--YYRLHYLTTKS 703
IL+ + ++ +S++ + + P + L +L PE L KS
Sbjct: 132 ILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKS 191
Query: 704 DVYSFGVLLLEILSG 718
D+YS G+ E+ +G
Sbjct: 192 DIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 27/209 (12%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
+++G+G+++ VYKG K + K I + E+ LL L HA+++ L
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLD------WVRRVTIAV-QAARGIEY 632
+ LV+E++ K LK+ LD + V + + Q RG+ Y
Sbjct: 72 IIHTEKSLTLVFEYL------------DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
H V+HRD+K N+LI+E ++ADFGL+ + + E+ TL Y P+
Sbjct: 120 CHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPD 174
Query: 693 YY--RLHYLTTKSDVYSFGVLLLEILSGR 719
Y +T+ D++ G + E+ +GR
Sbjct: 175 ILLGSTDY-STQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 3e-09
Identities = 56/204 (27%), Positives = 99/204 (48%), Gaps = 17/204 (8%)
Query: 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
+++G+G+++ V+KG K +VA+K+ + E+ LL L HA+++ L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV-QAARGIEYLHGYA 637
R LV+E++ L Q+L + + V I + Q RG+ Y H
Sbjct: 70 DIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMS-----MHNVKIFMFQLLRGLSYCHKRK 123
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY--R 695
++HRD+K N+LI+E+ ++ADFGL+ + + E+ TL Y P+
Sbjct: 124 ---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGS 178
Query: 696 LHYLTTKSDVYSFGVLLLEILSGR 719
Y +T D++ G +L E+ +GR
Sbjct: 179 TEY-STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 46/178 (25%), Positives = 85/178 (47%), Gaps = 33/178 (18%)
Query: 625 QAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL---AEL 681
Q A+G+++L C IHRD+ + N+L+ + A++ DFGL+ DS+ + A L
Sbjct: 220 QVAQGMDFLASKNC---IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276
Query: 682 PAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK-----AIDMQFEEGNIVEWA 735
P + ++ PE T +SDV+S+G+LL EI S G+ ++ +F +
Sbjct: 277 P---VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK------- 326
Query: 736 VPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
++K G ++ A I ++ C + ERP+ +++ ++R L
Sbjct: 327 --MVKRG---------YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 27/196 (13%)
Query: 538 GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597
GT+V V+ + +++ K E+ L H +++ G ++ FMA+G
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 598 SLHQHL-----HGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNIL 652
S + L G S+AL I A RG+ YLH IHR+IK+S+IL
Sbjct: 85 SANSLLKTYFPEGMSEALIG--------NILFGALRGLNYLHQNGY---IHRNIKASHIL 133
Query: 653 IDEEHNARVADFGLS----LLGPADSSSPLAELP---AGTLGYLDPEYYR--LHYLTTKS 703
I + V+ GLS L+ + + + P L +L PE R L+ KS
Sbjct: 134 ISGD--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS 191
Query: 704 DVYSFGVLLLEILSGR 719
D+YS G+ E+ +GR
Sbjct: 192 DIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 5e-09
Identities = 44/156 (28%), Positives = 71/156 (45%), Gaps = 9/156 (5%)
Query: 561 TELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRV 620
E+D+L ++H ++NL+ +V L ++ EQ +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-----I 188
Query: 621 TIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAE 680
TI + + YLHG +IHRD+K+ NI +DE NA + DFG + A +P
Sbjct: 189 TIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245
Query: 681 LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEIL 716
+GTL PE L K+D++S G++L E+
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 58/217 (26%), Positives = 96/217 (44%), Gaps = 17/217 (7%)
Query: 517 GFKEEVGKGSFSCVY----KGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA 572
F +GKGSF V KG + + +KK + D E +L+ +
Sbjct: 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECT--MVEKRVLALQDKP 60
Query: 573 HLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
L L C + +RL V E++ G L H+ K + Q V A + + G+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQ-----AVFYAAEISVGLF 115
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
+LH +I+RD+K N+++D E + ++ADFG+ D + GT Y+ P
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAP 170
Query: 692 EYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE 728
E D +++GVLL E+L+G+ D + E+
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 56/213 (26%), Positives = 93/213 (43%), Gaps = 37/213 (17%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
VG G++ V + VAVKK +++ + EL LL + H +++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 581 ------CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
E E LV M L+ K K + V+ + Q RG++Y+H
Sbjct: 83 FTPATSIENFNEVYLVTNLMG-----ADLNNIVKCQKLSDEHVQ--FLIYQLLRGLKYIH 135
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
+IHRD+K SN+ ++E+ R+ DFGL+ + + GY+ +Y
Sbjct: 136 SAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-----------GYVATRWY 181
Query: 695 R--------LHYLTTKSDVYSFGVLLLEILSGR 719
R +HY T D++S G ++ E+L G+
Sbjct: 182 RAPEIMLNWMHYNQT-VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 37/149 (24%), Positives = 72/149 (48%), Gaps = 9/149 (6%)
Query: 520 EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+G++ V+K ++ +VA+K+ D + E+ LL L H +++ L
Sbjct: 6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
++ LV+E+ Q L + +D + Q +G+ + H +
Sbjct: 66 DVLHSDKKLTLVFEY-----CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN- 119
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLS 667
V+HRD+K N+LI++ ++ADFGL+
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 36/193 (18%)
Query: 541 VAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY------CEEGRERLLVYEFM 594
VA+KK ++K + EL L+ +NH +++ LL EE ++ LV E M
Sbjct: 44 VAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM 103
Query: 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID 654
+L Q + LD R + Q GI++LH +IHRD+K SNI++
Sbjct: 104 DA-NLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 152
Query: 655 EEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYYR-------LHYLTTKSDVY 706
+ ++ DFGL+ G + +P Y+ YYR + Y D++
Sbjct: 153 SDCTLKILDFGLARTAGTSFMMTP----------YVVTRYYRAPEVILGMGY-KENVDIW 201
Query: 707 SFGVLLLEILSGR 719
S G ++ E++ G
Sbjct: 202 SVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 18/199 (9%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYC 581
VG+GSF + K I ++ E LL+++ H +++
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67
Query: 582 EEGRERLLVYEFMAHGSLHQHLH-GKSKALKEQ--LDWVRRVTIAVQAARGIEYLHGYAC 638
E +V E+ G L Q + + K E L W VQ G++++H
Sbjct: 68 EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWF------VQMCLGVQHIHE--- 118
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA--GTLGYLDPEYYRL 696
V+HRDIKS NI + + ++ DFG + L +SP A GT Y+ PE +
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL----LTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 697 HYLTTKSDVYSFGVLLLEI 715
KSD++S G +L E+
Sbjct: 175 MPYNNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 1e-08
Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 562 ELDLLSRLNHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRV 620
E +L ++N +++L Y E ++ L LV M G L H++ D R V
Sbjct: 50 EKQILEKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNP---GFDEERAV 105
Query: 621 TIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAE 680
A + G+E LH +++RD+K NIL+D+ + R++D GL++ P
Sbjct: 106 FYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIP---EGETIR 159
Query: 681 LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
GT+GY+ PE + T D + G L+ E++ G+
Sbjct: 160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 52/193 (26%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 543 VKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQ 601
V + A + K + TE ++L + + L L Y + +L L+ ++++ G +
Sbjct: 35 VLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFT 94
Query: 602 HLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARV 661
HL+ + E D VR + + A +E+LH +++RDIK NIL+D E + +
Sbjct: 95 HLYQRDN-FSE--DEVRFYSGEIILA--LEHLHKLG---IVYRDIKLENILLDSEGHVVL 146
Query: 662 ADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKS-DVYSFGVLLLEILSGRK 720
DFGLS ++ GT+ Y+ PE R K+ D +S G+L+ E+L+G
Sbjct: 147 TDFGLSKEFLSEEKERTYSF-CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGAS 205
Query: 721 AIDMQFEEGNIVE 733
++ E E
Sbjct: 206 PFTLEGERNTQSE 218
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHT--ELDLLSRLNHAHLLNLLG 579
+GKG+F VY+ KD + K ++ + + HT E ++L R ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 580 Y---CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
+ + LV ++M+ G L HL + + +++ + IA + +E+LH Y
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR----AKFYIA-ELVLALEHLHKY 115
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
+++RD+K NIL+D + + DFGLS + + GT YL PE
Sbjct: 116 ---DIVYRDLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLD 170
Query: 697 HYLTTKS-DVYSFGVLLLEILSG 718
TK D +S GVL+ E+ G
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 37/131 (28%), Positives = 65/131 (49%), Gaps = 13/131 (9%)
Query: 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKS 648
+ + M G LH HL ++++ + A + G+E++H V++RD+K
Sbjct: 74 FILDLMNGGDLHYHLSQHGVFSEKEMRFY-----ATEIILGLEHMHNRF---VVYRDLKP 125
Query: 649 SNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYS 707
+NIL+DE + R++D GL+ D S GT GY+ PE + + +D +S
Sbjct: 126 ANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFS 181
Query: 708 FGVLLLEILSG 718
G +L ++L G
Sbjct: 182 LGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 19/134 (14%)
Query: 589 LVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDI 646
+ + M G LH HL HG E A + G+E++H V++RD+
Sbjct: 74 FILDLMNGGDLHYHLSQHG---VFSEA----EMRFYAAEIILGLEHMHNRF---VVYRDL 123
Query: 647 KSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR--LHYLTTKSD 704
K +NIL+DE + R++D GL+ D S GT GY+ PE + + Y + +D
Sbjct: 124 KPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPEVLQKGVAY-DSSAD 178
Query: 705 VYSFGVLLLEILSG 718
+S G +L ++L G
Sbjct: 179 WFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 48/175 (27%), Positives = 79/175 (45%), Gaps = 35/175 (20%)
Query: 507 TYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKE-FHT--- 561
YE+L + +G+G+F V+K K +VA+KK +N KE F
Sbjct: 13 KYEKLAK--------IGQGTFGEVFKARHKKTKQIVALKKV-----LMENEKEGFPITAL 59
Query: 562 -ELDLLSRLNHAHLLNLLGYCE-----EGRER---LLVYEFMAHGSLHQHLHGKSKALKE 612
E+ +L L H +++NL+ C R + LV+EF H L G
Sbjct: 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-----DLAGLLSNKNV 114
Query: 613 QLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
+ + G+ Y+H ++HRD+K++NILI ++ ++ADFGL+
Sbjct: 115 KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 73/292 (25%), Positives = 128/292 (43%), Gaps = 37/292 (12%)
Query: 543 VKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQH 602
V K + +D ++ + +EL L+ +H ++ + + LL+ E+ + G L++
Sbjct: 97 VAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155
Query: 603 LHGKSKALKEQLDWVRRVT--IAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNAR 660
+ + LKE L + + Q ++ +H ++HRD+KS+NI + +
Sbjct: 156 I---KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIK 209
Query: 661 VADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS--- 717
+ DFG S S +A GT YL PE + + K+D++S GV+L E+L+
Sbjct: 210 LGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269
Query: 718 -----GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL-KLPSD---------LDALK 762
++ I Q G + P+ S + A+LDP+L K P+ + LK
Sbjct: 270 PFKGPSQREIMQQVLYGKYDPFPCPV--SSGMKALLDPLLSKNPALRPTTQQLLHTEFLK 327
Query: 763 RIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTEVVLG 814
+AN+ VR P D+ E L QL S E+ P+ + G
Sbjct: 328 YVANLFQDIVRHSETISPH-DR-----EEILRQLQES--GERAPPPSSIRYG 371
|
Length = 478 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 42/160 (26%), Positives = 71/160 (44%), Gaps = 15/160 (9%)
Query: 565 LLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS--LHQHLHGKSKALKEQLDWVRRVTI 622
LL +NH ++ + G +V + H S L+ +L +S+ L + + I
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSR----PLPIDQALII 162
Query: 623 AVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP 682
Q G+ YLH +IHRD+K+ NI I++ + D G + P
Sbjct: 163 EKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA---PAFLGL 216
Query: 683 AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722
AGT+ PE +K+D++S G++L E+L+ I
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256
|
Length = 357 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 562 ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVT 621
E LL RL+H +L LL G LV L+ +L + + L +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLP-KYRSDLYTYLGARLRPL----GLAQVTA 264
Query: 622 IAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAEL 681
+A Q I+Y+HG +IHRDIK+ N+L++ + + DFG + S+P
Sbjct: 265 VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 682 PAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLE 714
AGT+ PE T D++S G+++ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 64/256 (25%), Positives = 107/256 (41%), Gaps = 31/256 (12%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSD--RQKNSKEFHTELDLLSRLNHAHLLNLLG 579
+G+G+F V K V K ++ + ++ +S F E D+++ N ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
++ R +V E+M G L + K W R T V A ++ +H
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK----WARFYTAEVVLA--LDAIHSMG-- 162
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH-- 697
IHRD+K N+L+D+ + ++ADFG + + + GT Y+ PE +
Sbjct: 163 -FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGG 220
Query: 698 --YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD--PVLK 753
Y + D +S GV L E+L G D F ++V G + I++ L
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVG----DTPFYADSLV---------GTYSKIMNHKNSLT 267
Query: 754 LPSDLDALKRIANVAC 769
P D D K N+ C
Sbjct: 268 FPDDNDISKEAKNLIC 283
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 35/172 (20%)
Query: 559 FHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVR 618
F L+S+++H HL + G C G E ++V EF+ HG L L + + + + W
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCL--RKEKGRVPVAW-- 118
Query: 619 RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678
++T+A Q A + YL ++H ++ + NIL L+ LG A+ +SP
Sbjct: 119 KITVAQQLASALSYLEDKN---LVHGNVCAKNIL-------------LARLGLAEGTSPF 162
Query: 679 AEL--PAGTLG------------YLDPEYYR-LHYLTTKSDVYSFGVLLLEI 715
+L P + ++ PE + L+T +D +SFG LLEI
Sbjct: 163 IKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 53/201 (26%), Positives = 91/201 (45%), Gaps = 13/201 (6%)
Query: 522 VGKGSFSCVYK-GVLKDGTVVAVKKAIATSDRQKNSKEFH-TELDLLSRLNHAHLLNLLG 579
+GKG F V V G + A KK +++ + E +L ++N +++L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL-A 66
Query: 580 YCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
Y E ++ L LV M G L H++ D R + A + G+E L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNMGNP---GFDEQRAIFYAAELCCGLEDLQR--- 120
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
+++RD+K NIL+D+ + R++D GL++ P + GT+GY+ PE
Sbjct: 121 ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEVINNEK 177
Query: 699 LTTKSDVYSFGVLLLEILSGR 719
T D + G L+ E++ G+
Sbjct: 178 YTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 62/256 (24%), Positives = 111/256 (43%), Gaps = 31/256 (12%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSD--RQKNSKEFHTELDLLSRLNHAHLLNLLG 579
+G+G+F V K V K ++ + ++ +S F E D+++ N ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFC 110
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
++ + +V E+M G L + K W + T V A ++ +H
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK----WAKFYTAEVVLA--LDAIHSMG-- 162
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH-- 697
+IHRD+K N+L+D+ + ++ADFG + + ++ + GT Y+ PE +
Sbjct: 163 -LIHRDVKPDNMLLDKHGHLKLADFG-TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 698 --YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD--PVLK 753
Y + D +S GV L E+L G D F ++V G + I+D L
Sbjct: 221 DGYYGRECDWWSVGVFLFEMLVG----DTPFYADSLV---------GTYSKIMDHKNSLN 267
Query: 754 LPSDLDALKRIANVAC 769
P D++ K N+ C
Sbjct: 268 FPEDVEISKHAKNLIC 283
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 49/228 (21%)
Query: 522 VGKGSFSCVYKGVLKDGT-VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
+G GSF VY+ + D + VA+KK + D Q ++E L ++ LNH +++ L Y
Sbjct: 74 IGNGSFGVVYEAICIDTSEKVAIKKVL--QDPQYKNRE----LLIMKNLNHINIIFLKDY 127
Query: 581 ----CEEGRERLL----VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
C + E+ + V EF+ ++H+++ ++ L + Q R + Y
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN-NHALPLFLVKLYSYQLCRALAY 185
Query: 633 LHG-YACPPVIHRDIKSSNILID-EEHNARVADFGLS--LLGPADSSSPLAELPAGTLGY 688
+H + C HRD+K N+LID H ++ DFG + LL S S Y
Sbjct: 186 IHSKFIC----HRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS-----------Y 230
Query: 689 LDPEYYRLHYL-------TTKSDVYSFGVLLLE------ILSGRKAID 723
+ +YR L TT D++S G ++ E I SG+ ++D
Sbjct: 231 ICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 22/203 (10%)
Query: 523 GKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY-- 580
+G Y +L+ VA+KK Q ++K + EL L+ +NH +++ LL
Sbjct: 36 AQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFT 93
Query: 581 ----CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
EE ++ +V E M +L Q ++ +LD R + Q GI++LH
Sbjct: 94 PQKSLEEFQDVYIVMELM-DANLCQ-------VIQMELDHERMSYLLYQMLCGIKHLHSA 145
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
+IHRD+K SNI++ + ++ DFGL+ +S + T Y PE
Sbjct: 146 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILG 199
Query: 697 HYLTTKSDVYSFGVLLLEILSGR 719
D++S G ++ E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 31/214 (14%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
+G+G++ V + VA+KK D + ++K E+ LL L+H +++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 581 CE-EGRERL----LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
RE +VYE M LHQ + S+ L + D + Q RG++Y+H
Sbjct: 73 MPPPHREAFNDVYIVYELM-DTDLHQIIR-SSQTLSD--DHCQ--YFLYQLLRGLKYIHS 126
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
V+HRD+K SN+L++ + ++ DFGL A ++S + Y+ +YR
Sbjct: 127 ---ANVLHRDLKPSNLLLNANCDLKICDFGL-----ARTTSEKGDF---MTEYVVTRWYR 175
Query: 696 LHYL-------TTKSDVYSFGVLLLEILSGRKAI 722
L TT DV+S G + E+L GRK +
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 12/160 (7%)
Query: 561 TELDLLSRLNHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRR 619
TE +L H L L Y + +RL V E+ G L HL + + E+ R
Sbjct: 44 TESRVLQNTRHP-FLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEE----RA 97
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679
+ +EYLH V++RDIK N+++D++ + ++ DFGL G +D ++
Sbjct: 98 RFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 152
Query: 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
+ GT YL PE + D + GV++ E++ GR
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
++G+GS V K G VAVK + +Q+ + E+ ++ H +++ +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
G E ++ EF+ G+L + +++ +EQ+ T+ + + YLH
Sbjct: 86 SYLVGEELWVLMEFLQGGAL-TDIVSQTRLNEEQI-----ATVCESVLQALCYLHSQG-- 137
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYL 699
VIHRDIKS +IL+ + +++DFG D P + GT ++ PE
Sbjct: 138 -VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKSLVGTPYWMAPEVISRTPY 194
Query: 700 TTKSDVYSFGVLLLEILSG 718
T+ D++S G++++E++ G
Sbjct: 195 GTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 3e-08
Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 521 EVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL---NHAHLLN 576
E+G G++ VYK G VA+K ++ E+ LL RL +H +++
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 577 LLGYCEEGR-----ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
L+ C R + LV+E + L +L K + ++ + Q RG++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLD-KVPPPGLPAETIK--DLMRQFLRGLD 122
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP-AGTLGYLD 690
+LH ++HRD+K NIL+ ++ADFGL+ + S +A P TL Y
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARI----YSCQMALTPVVVTLWYRA 175
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEIL 716
PE T D++S G + E+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 15/211 (7%)
Query: 522 VGKGSFSCVYKGVLKDGT--VVAVKKAIATSDRQKNSKE-FHTELDLLSRLNHAHLLNLL 578
+GKGSF V LK GT V A+K Q + + TE +L+ L L
Sbjct: 3 LGKGSFGKVMLAELK-GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 579 GYCEEGRERLL-VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
C + ++RL V E++ G L + K D R A + + +LH +
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK-----FDEPRSRFYAAEVTLALMFLHRHG 116
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
VI+RD+K NIL+D E + ++ADFG+ G + GT Y+ PE +
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQEL 171
Query: 698 YLTTKSDVYSFGVLLLEILSGRKAIDMQFEE 728
D ++ GVL+ E+++G+ + E+
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFEADNED 202
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.9 bits (134), Expect = 5e-08
Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 523 GKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY-- 580
+G Y VL VA+KK Q ++K + EL L+ +NH ++++LL
Sbjct: 29 AQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFT 86
Query: 581 ----CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
EE ++ LV E M +L Q ++ +LD R + Q GI++LH
Sbjct: 87 PQKSLEEFQDVYLVMELM-DANLCQ-------VIQMELDHERMSYLLYQMLCGIKHLHSA 138
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYYR 695
+IHRD+K SNI++ + ++ DFGL+ G + +P T Y PE
Sbjct: 139 G---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV----TRYYRAPEVIL 191
Query: 696 LHYLTTKSDVYSFGVLLLEILS------GRKAID 723
D++S G ++ E++ GR ID
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 5e-08
Identities = 43/160 (26%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 561 TELDLLSRLNHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRR 619
TE +L H L +L Y + ++RL V E++ G L HL + + E R
Sbjct: 44 TESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSED----RT 97
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679
+ ++YLH +++RD+K N+++D++ + ++ DFGL G D+++
Sbjct: 98 RFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT--M 152
Query: 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
+ GT YL PE + D + GV++ E++ GR
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-08
Identities = 52/213 (24%), Positives = 95/213 (44%), Gaps = 38/213 (17%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
VG G++ V + + G VA+KK + +K + EL LL + H +++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 581 ------CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
+E ++ LV +M K + L + + Q G++Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYM--------QTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH 134
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
+IHRD+K N+ ++E+ ++ DFGL+ A+ + GY+ +Y
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMT-----------GYVVTRWY 180
Query: 695 R--------LHYLTTKSDVYSFGVLLLEILSGR 719
R +HY T D++S G ++ E+L+G+
Sbjct: 181 RAPEVILNWMHYNQT-VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 39/107 (36%), Positives = 57/107 (53%), Gaps = 9/107 (8%)
Query: 614 LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673
L ++ V + Q A G+E+L C +HRD+ + N+LI E ++ DFGL+ D
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNC---VHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 674 S---SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
S S LP L ++ PE + TT SDV+SFG+LL EI +
Sbjct: 293 SNYISKGSTFLP---LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 57/223 (25%), Positives = 93/223 (41%), Gaps = 41/223 (18%)
Query: 521 EVGKGSFSCV----YKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLL 575
E+G+G++ V + VA+KK ++ +K EL LL H ++
Sbjct: 7 ELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNIT 65
Query: 576 NLL--------GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAA 627
L + E L +YE + LHQ + + L + Q
Sbjct: 66 CLYDMDIVFPGNFNE-----LYLYEELMEADLHQIIRSG-----QPLTDAHFQSFIYQIL 115
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTL- 686
G++Y+H V+HRD+K N+L++ + ++ DFGL A S AG +
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL-----ARGFSENPGENAGFMT 167
Query: 687 GYLDPEYYR-----LHY--LTTKSDVYSFGVLLLEILSGRKAI 722
Y+ +YR L + T DV+S G +L E+L GRK +
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 48/170 (28%), Positives = 80/170 (47%), Gaps = 21/170 (12%)
Query: 500 IRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKE 558
+RR YE ++R VG G++ VYK L G + AVK I + +
Sbjct: 3 LRRNPQHDYELIQR--------VGSGTYGDVYKARNLHTGELAAVK--IIKLEPGDDFSL 52
Query: 559 FHTELDLLSRLNHAHLLNLLGYCEEGRERLLV-YEFMAHGSLHQHLHGKSKALKEQLDWV 617
E+ ++ H +++ G RE+L + E+ GSL H + Q+ +V
Sbjct: 53 IQQEIFMVKECKHCNIVAYFG-SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYV 111
Query: 618 RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
R T+ +G+ YLH +HRDIK +NIL+ + + ++ADFG++
Sbjct: 112 CRETL-----QGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 47/151 (31%), Positives = 67/151 (44%), Gaps = 7/151 (4%)
Query: 520 EEVGKGSFSCVYKGVLKDG---TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+E+G G F V G + G V VK+ ++ Q+ K F E L H++LL
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQ 59
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
LG C E LLV EF G L +L KA D +A + A G+ +LH
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
IH D+ N L+ + ++ D+GLS
Sbjct: 120 N---FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 2e-07
Identities = 60/247 (24%), Positives = 106/247 (42%), Gaps = 70/247 (28%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKE---FHT-- 561
YE+L R + +G++ VY+ K G +VA+KK K KE F
Sbjct: 7 YEKLNR--------IEEGTYGVVYRARDKKTGEIVALKKL-------KMEKEKEGFPITS 51
Query: 562 --ELDLLSRLNHAHLLNLLGYCEEGRERL---------LVYEFMAHGSLHQHLHGKSKAL 610
E+++L +L H +++ + +E + +V E++ H L + +
Sbjct: 52 LREINILLKLQHPNIVTV-------KEVVVGSNLDKIYMVMEYVEH-----DLKSLMETM 99
Query: 611 KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670
K+ + +Q G+ +LH ++HRD+K+SN+L++ ++ DFGL+
Sbjct: 100 KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLA--- 153
Query: 671 PADSSSPLAELPAG--TLGYLDPE------YYRLHYLTTKSDVYSFGVLLLEILS----- 717
+ SPL TL Y PE Y +T D++S G + E+L+
Sbjct: 154 -REYGSPLKPYTQLVVTLWYRAPELLLGAKEY-----STAIDMWSVGCIFAELLTKKPLF 207
Query: 718 -GRKAID 723
G+ ID
Sbjct: 208 PGKSEID 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 53/216 (24%), Positives = 89/216 (41%), Gaps = 32/216 (14%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E +GKGS+ V + G VA+KK + ++ E+ LL L H ++ +
Sbjct: 6 EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 579 GYC-----EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
E ++ +V+E M LHQ + E + Q R ++Y+
Sbjct: 66 HIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQF-----FLYQLLRALKYI 119
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTL--GYLDP 691
H V HRD+K NIL + + ++ DFGL+ + D+ P Y+
Sbjct: 120 HTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDT-------PTAIFWTDYVAT 169
Query: 692 EYYRLHYL--------TTKSDVYSFGVLLLEILSGR 719
+YR L T D++S G + E+L+G+
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 44/176 (25%), Positives = 85/176 (48%), Gaps = 17/176 (9%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
+ +G G++ VYK + G + A+K + + ++ E+ ++ H++++
Sbjct: 15 QRIGSGTYGDVYKARNVNTGELAAIK--VIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
G + + EF GSL H + Q+ +V R T+ +G+ YLH
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKG- 126
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA--GTLGYLDPE 692
+HRDIK +NIL+ + + ++ADFG+S A ++ +A+ + GT ++ PE
Sbjct: 127 --KMHRDIKGANILLTDNGHVKLADFGVS----AQITATIAKRKSFIGTPYWMAPE 176
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 36/107 (33%), Positives = 57/107 (53%), Gaps = 9/107 (8%)
Query: 614 LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673
LD ++ + Q A+G+ +L C IHRD+ + NIL+ ++ DFGL+ D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNC---IHRDLAARNILLTHGRITKICDFGLARDIRND 267
Query: 674 SSSPL---AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
S+ + A LP + ++ PE T +SDV+S+G+LL EI S
Sbjct: 268 SNYVVKGNARLP---VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 35/101 (34%), Positives = 55/101 (54%), Gaps = 9/101 (8%)
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS---SS 676
++ Q ARG+E+L C +HRD+ + N+L+ + ++ DFGL+ DS S
Sbjct: 240 LSFTYQVARGMEFLASKNC---VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
LP + ++ PE + TT SDV+S+G+LL EI S
Sbjct: 297 GSTFLP---VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 41/155 (26%), Positives = 65/155 (41%), Gaps = 18/155 (11%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVA--VKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+E+G G F V + T VA V K + + K EF + D L H ++L
Sbjct: 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60
Query: 578 LGYCEEGRERLLVYEFMAHGSL------HQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
LG C E LLV+E+ G L Q S+ L Q +A + A G+
Sbjct: 61 LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-------RMACEIAAGVT 113
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666
++H + +H D+ N + + +V D+G+
Sbjct: 114 HMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 44/160 (27%), Positives = 74/160 (46%), Gaps = 11/160 (6%)
Query: 561 TELDLLSRLNHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRR 619
TE +L H L L Y + +RL V E+ G L HL + + E R
Sbjct: 44 TENRVLQNSRHP-FLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSED----RA 97
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679
+ ++YLH + V++RD+K N+++D++ + ++ DFGL G D ++
Sbjct: 98 RFYGAEIVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--M 153
Query: 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
+ GT YL PE + D + GV++ E++ GR
Sbjct: 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 522 VGKGSFSCVYKGVLKDGTV-----VAVKKAIATSDRQKNSKEFHTELD-LLSRLNHAHLL 575
+GKGSF V K V KKAI ++K K +E + LL + H L+
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAIL---KKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L + + V +++ G L HL + L+ R A + A + YLH
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEP-----RARFYAAEIASALGYLHS 114
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSL--LGPADSSSPLAELPAGTLGYLDPEY 693
+++RD+K NIL+D + + + DFGL + ++S GT YL PE
Sbjct: 115 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTF----CGTPEYLAPEV 167
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSG 718
D + G +L E+L G
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 44/160 (27%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 561 TELDLLSRLNHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRR 619
TE +L H L L Y + +RL V E+ G L HL + + E R
Sbjct: 44 TESRVLQNTRHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSED----RA 97
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679
+ + YLH V++RD+K N+++D++ + ++ DFGL G +D ++
Sbjct: 98 RFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--M 152
Query: 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
+ GT YL PE + D + GV++ E++ GR
Sbjct: 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 8e-07
Identities = 31/102 (30%), Positives = 47/102 (46%), Gaps = 16/102 (15%)
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAE--------- 680
+EYLH Y ++HRD+K N+LI + ++ DFGLS +G ++ L E
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTRE 170
Query: 681 ----LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
GT Y+ PE D ++ G++L E L G
Sbjct: 171 FLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 21/221 (9%)
Query: 501 RRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTV--VAVKKAIATSD-RQKNSK 557
+R YE+ F +G GSF V K+ VA+K+ + +QK
Sbjct: 22 KRKNKMKYEDFN-----FIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76
Query: 558 EFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWV 617
+E +L+ +NH +NL G ++ LV EF+ G L ++K +
Sbjct: 77 HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPNDVG-- 133
Query: 618 RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677
A Q EYL +++RD+K N+L+D++ ++ DFG + + + +
Sbjct: 134 --CFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYT- 187
Query: 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
GT Y+ PE +D ++ G+ + EIL G
Sbjct: 188 ----LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 19/206 (9%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE--FHTELDLLSRLNHAHLLNLLG 579
+G+G+F V LK+ V K + + K ++ F E D+L ++ + L
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLD--WVRRVTIAVQAARGIEYLHGYA 637
++ LV ++ G L L L E + ++ + IA+ + + Y
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY----- 123
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
+HRDIK NIL+D + R+ADFG S L + + + + GT Y+ PE +
Sbjct: 124 ----VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAM 178
Query: 698 -----YLTTKSDVYSFGVLLLEILSG 718
+ D +S GV + E+L G
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 23/212 (10%)
Query: 520 EEVGKGSFSCVYKGVL--KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLN 576
E +GKG++ V+K VL K+G+ AVK D +E E ++L L +H +++
Sbjct: 24 ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDI---DEEIEAEYNILKALSDHPNVVK 79
Query: 577 LLGY-----CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
G + G + LV E GS+ + G K E+++ I +A G++
Sbjct: 80 FYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQ 138
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
+LH IHRD+K +NIL+ E ++ DFG+S S+ GT ++ P
Sbjct: 139 HLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVS--AQLTSTRLRRNTSVGTPFWMAP 193
Query: 692 EYYRLHY-----LTTKSDVYSFGVLLLEILSG 718
E + DV+S G+ +E+ G
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 67/285 (23%), Positives = 120/285 (42%), Gaps = 36/285 (12%)
Query: 521 EVGKGSFSCVYKGV-LKDG-TVVAVKKAIATSDRQKNSKEFHTELDLLSRLN---HAHLL 575
E+G+G++ V+K LK+G VA+K+ + + E+ +L L H +++
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 576 NLLGYCEEGR-----ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
L C R + LV+E + L +L K + + + Q RG+
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETIKDMMFQLLRGL 123
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLD 690
++LH + V+HRD+K NIL+ ++ADFGL+ + S TL Y
Sbjct: 124 DFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRA 177
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLE------ILSGRKAIDMQFEEGNIV------EWA--V 736
PE T D++S G + E + G +D + +++ +W V
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 237
Query: 737 PLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPS 781
L + + P+ K +D+D L + ++ KC+ +R S
Sbjct: 238 ALPRQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRIS 280
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 520 EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNS-KEFHTELDLLSRLNHAHLLNL 577
+VG+G + V+ KD G +VA+K+ + + N + TE D+L+ L+ L
Sbjct: 7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL 66
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH-- 634
L Y + E L L E++ G L+ L E D R + A ++ LH
Sbjct: 67 L-YAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSE--DHARFYMAEMFEA--VDALHEL 120
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
GY IHRD+K N LID + ++ DFGLS ++S + G+ Y+ PE
Sbjct: 121 GY-----IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV-----GSPDYMAPEVL 170
Query: 695 RLHYLTTKSDVYSFGVLLLEILSG 718
R D +S G +L E L G
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 53/233 (22%), Positives = 93/233 (39%), Gaps = 45/233 (19%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFH--TELDLLSRLNHAHLLNLLG 579
+G+G+F V KD + K + +D + + H E D+L + A ++ +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFY 68
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLD-WVRRVTIAVQAARGIEYLHGYAC 638
++ R L+ EF+ G + L K +E ++ +A+ A + +
Sbjct: 69 SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF------ 122
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFG----------------LSLLGPADSS------- 675
IHRDIK N+L+D + + +++DFG L+ P+D S
Sbjct: 123 ---IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 676 ----------SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
LA GT Y+ PE + D +S GV++ E+L G
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 52/206 (25%), Positives = 82/206 (39%), Gaps = 25/206 (12%)
Query: 522 VGKGSFSCVYKGVLK-DGTVVA---VKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+G G F V +K A VKK Q+ + +E ++L NH ++ L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58
Query: 578 LGYCEEGRERLLVY---EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
+++ +Y E+ G L L + + R IA EYLH
Sbjct: 59 YRTF---KDKKYIYMLMEYCLGGELWTILRDRGLFDEYT----ARFYIA-CVVLAFEYLH 110
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEY 693
+I+RD+K N+L+D ++ DFG + L + GT Y+ PE
Sbjct: 111 NRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF----CGTPEYVAPEI 163
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGR 719
D +S G+LL E+L+GR
Sbjct: 164 ILNKGYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 37/140 (26%), Positives = 70/140 (50%), Gaps = 13/140 (9%)
Query: 625 QAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA-RVADFGLS-LLGPADSSSPLAELP 682
Q RG++Y+H V+HRD+K +N+ I+ E ++ DFGL+ ++ P S
Sbjct: 122 QLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 683 AGTLGYLDPE--YYRLHYLTTKSDVYSFGVLLLEILSGRK--AIDMQFEEGNIVEWAVPL 738
T Y P +Y T D+++ G + E+L+G+ A + E+ ++ +VP+
Sbjct: 179 LVTKWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237
Query: 739 IKSGDITAILDPVLKLPSDL 758
++ D +L+ +PS +
Sbjct: 238 VREEDRNELLN---VIPSFV 254
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 5e-06
Identities = 51/197 (25%), Positives = 81/197 (41%), Gaps = 24/197 (12%)
Query: 525 GSFSCVYKGVLKDGTV--VAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCE 582
G F V VLK + V+K I + N+ E L+ ++ + + L
Sbjct: 27 GKFGKVS--VLKHKPTQKLFVQKII--KAKNFNAIEPMVH-QLMK--DNPNFIKLYYSVT 79
Query: 583 EGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVI 642
+ +L+ +++ G L L K L E V++ I Q + LH + +I
Sbjct: 80 TLKGHVLIMDYIKDGDLFDLLK-KEGKLSEAE--VKK--IIRQLVEALNDLHKHN---II 131
Query: 643 HRDIKSSNILIDE-EHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTT 701
H DIK N+L D + + D+GL + S GTL Y PE + H
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLC--KIIGTPS----CYDGTLDYFSPEKIKGHNYDV 185
Query: 702 KSDVYSFGVLLLEILSG 718
D ++ GVL E+L+G
Sbjct: 186 SFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 64/257 (24%), Positives = 110/257 (42%), Gaps = 31/257 (12%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE--FHTELDLLSRLNHAHLLNLLG 579
+G+G+F V K V K ++ + K S F E D+++ N ++ L
Sbjct: 51 IGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHY 110
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
++ + +V E+M G L + + + E W R T V A ++ +H
Sbjct: 111 AFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPE--KWARFYTAEVVLA--LDAIHSMG-- 162
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH-- 697
IHRD+K N+L+D+ + ++ADFG + A+ + GT Y+ PE +
Sbjct: 163 -FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEVLKSQGG 220
Query: 698 --YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD--PVLK 753
Y + D +S GV L E+L G D F ++V G + I+D L
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVG----DTPFYADSLV---------GTYSKIMDHKNSLT 267
Query: 754 LPSDLDALKRIANVACK 770
P D++ K+ ++ C
Sbjct: 268 FPDDIEISKQAKDLICA 284
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 8e-06
Identities = 55/224 (24%), Positives = 90/224 (40%), Gaps = 50/224 (22%)
Query: 520 EEVGKGSFSCVYKGVLKDGT------------VVAVKKAIATSDRQKNSKEFHTELDLLS 567
E +G+G+ + +Y G+L + + K + S R + F T ++
Sbjct: 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETA-SMMR 59
Query: 568 RLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAA 627
+++H H++ L G C E ++V EF+ G L +H KS L W + +A Q A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP--W--KFKVAKQLA 115
Query: 628 RGIEYL------HGYACPPVIHRDIKSSNILIDEEHNARVADFGL-SLLGP----ADSSS 676
+ YL HG C + NIL+ E G+ GP +D
Sbjct: 116 SALSYLEDKDLVHGNVC---------TKNILLARE--------GIDGECGPFIKLSDPGI 158
Query: 677 PLAELP----AGTLGYLDPEYYR-LHYLTTKSDVYSFGVLLLEI 715
P+ L + ++ PE L+ +D +SFG L EI
Sbjct: 159 PITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 9e-06
Identities = 59/240 (24%), Positives = 98/240 (40%), Gaps = 56/240 (23%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFH--TELDLLSRLNHAHLLNLL 578
+G+G+F V KD G + A+KK + S+ + + H E D+L+ ++ ++ L
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKK-LRKSEMLEKEQVAHVRAERDILAEADNPWVVKL- 66
Query: 579 GYC--EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH-- 634
Y ++ L+ E++ G + L K E+ R IA + I+ +H
Sbjct: 67 -YYSFQDENYLYLIMEYLPGGDMMTLLM-KKDTFTEE---ETRFYIA-ETILAIDSIHKL 120
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGL--------------------SLLGPADS 674
GY IHRDIK N+L+D + + +++DFGL
Sbjct: 121 GY-----IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 675 SSP----------------LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
S P LA GT Y+ PE + + D +S GV++ E+L G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 52/226 (23%), Positives = 104/226 (46%), Gaps = 43/226 (19%)
Query: 522 VGKGSFSCVYKGVLKDGT--------VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAH 573
+GKG + V++ G V K I + QK++ E ++L + H
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRN--QKDTAHTKAERNILEAVKHPF 61
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLD-WVRRVTIAVQAARGIEY 632
+++L+ + G + L+ E+++ G L HL + +++ ++ +++A +E+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA------LEH 115
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
LH +I+RD+K NIL+D + + ++ DFGL + + + GT+ Y+ PE
Sbjct: 116 LHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPE 170
Query: 693 YYRLHYLTTKS------DVYSFGVLLLEILSG---------RKAID 723
+ +S D +S G L+ ++L+G +K ID
Sbjct: 171 ------ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 29/95 (30%), Positives = 47/95 (49%), Gaps = 4/95 (4%)
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLG 687
R I+YLH +IHRDIK+ NI I+ + + DFG + P D ++ AGT+
Sbjct: 193 RAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACF-PVDINANKYYGWAGTIA 248
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722
PE D++S G++L E+ + ++
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 28/83 (33%), Positives = 43/83 (51%), Gaps = 8/83 (9%)
Query: 642 IHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL----- 696
+HRDIK N+L+D+ + R+ADFG S L + + + GT Y+ PE +
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182
Query: 697 -HYLTTKSDVYSFGVLLLEILSG 718
Y + D +S GV + E+L G
Sbjct: 183 GRY-GPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 46/151 (30%), Positives = 74/151 (49%), Gaps = 16/151 (10%)
Query: 522 VGKGSFSCVYKGVLK--DGTVVAVKKAIATSDRQKNS-KEFHTELDLLSRLNHAHLLNLL 578
+GKG+F V + V K G + A+K + + +K+ E D+L+ + +++L
Sbjct: 9 IGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLY 67
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH--GY 636
++ + L+ EF+ G L L K E V R +A + IE +H G+
Sbjct: 68 YSFQDAQYLYLIMEFLPGGDLMTMLI-KYDTFSED---VTRFYMA-ECVLAIEAVHKLGF 122
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
IHRDIK NILID + +++DFGLS
Sbjct: 123 -----IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-05
Identities = 31/127 (24%), Positives = 53/127 (41%), Gaps = 19/127 (14%)
Query: 607 SKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666
SK L E+ ++I + IEY+H V+HRD+K NIL+ + D+G
Sbjct: 103 SKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA 159
Query: 667 SLLGPA------DSSSPLAELP----------AGTLGYLDPEYYRLHYLTTKSDVYSFGV 710
++ D + GT Y+ PE + +D+Y+ GV
Sbjct: 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGV 219
Query: 711 LLLEILS 717
+L ++L+
Sbjct: 220 ILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 6e-05
Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 21/207 (10%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE--FHTELDLLSRLNHAHLLNLLG 579
+G+G+F V +K + K + + K ++ F E ++L + L
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-GDCQWITTLH 67
Query: 580 YCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLD--WVRRVTIAVQAARGIEYLHGY 636
Y + L LV ++ G L L L E + ++ + +A+ + + Y
Sbjct: 68 YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHY---- 123
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR- 695
+HRDIK N+L+D + R+ADFG S L + + + GT Y+ PE +
Sbjct: 124 -----VHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSSVAVGTPDYISPEILQA 177
Query: 696 ----LHYLTTKSDVYSFGVLLLEILSG 718
+ + D +S GV + E+L G
Sbjct: 178 MEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 36/113 (31%), Positives = 56/113 (49%), Gaps = 12/113 (10%)
Query: 510 ELERATGGFKEEVGKGSFSCVYK----GVLKDGTV--VAVK--KAIATSDRQKNSKEFHT 561
E R F + +G G+F V + G+ K+ V VAVK KA A +D ++ +
Sbjct: 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDERE---ALMS 90
Query: 562 ELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ 613
EL +LS L H +++NLLG C G L++ E+ +G L L K++
Sbjct: 91 ELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNF 143
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 52/235 (22%), Positives = 93/235 (39%), Gaps = 49/235 (20%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFH--TELDLLSRLNHAHLLNLLG 579
+G+G+F V KD V K + +D + + H E D+L + ++ +
Sbjct: 9 IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFY 68
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLD-WVRRVTIAVQAARGIEYLHGYAC 638
++ L+ EF+ G + L K +E+ ++ +A+ + + +
Sbjct: 69 SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF------ 122
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGL------------------SLLGPAD------- 673
IHRDIK N+L+D + + +++DFGL SL P+D
Sbjct: 123 ---IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSL--PSDFTFQNMN 177
Query: 674 ----------SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
+ LA GT Y+ PE + D +S GV++ E+L G
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 37/133 (27%), Positives = 48/133 (36%), Gaps = 48/133 (36%)
Query: 630 IEYLH--GYACPPVIHRDIKSSNILIDEEHNARVADFGL----------SLLGPA----- 672
IE +H G+ IHRDIK NILID + + ++ DFGL
Sbjct: 114 IESVHKMGF-----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQ 168
Query: 673 DSSSPLAELPA--------------------------GTLGYLDPEYYRLHYLTTKSDVY 706
DS P E GT Y+ PE T D +
Sbjct: 169 DSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 228
Query: 707 SFGVLLLEILSGR 719
S GV+L E+L G+
Sbjct: 229 SVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 9e-04
Identities = 27/84 (32%), Positives = 43/84 (51%), Gaps = 18/84 (21%)
Query: 589 LVYEFMAHGSLHQHLH-----GKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIH 643
LV E++ G + LH + A+K ++ V +A+ YLH + +IH
Sbjct: 81 LVMEYLIGGDVKSLLHIYGYFDEEMAVK----YISEVALALD------YLHRHG---IIH 127
Query: 644 RDIKSSNILIDEEHNARVADFGLS 667
RD+K N+LI E + ++ DFGLS
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 47/199 (23%), Positives = 85/199 (42%), Gaps = 10/199 (5%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
VG+G++ V K K+ +VA+KK + + ++ + EL +L L +++ L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 581 CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640
+ LV+E++ L + E++ + Q + I + H
Sbjct: 69 FRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR-----SYIYQLIKAIHWCHKND--- 120
Query: 641 VIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLT 700
++HRDIK N+LI ++ DFG + S++ E A T Y PE
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVA-TRWYRSPELLLGAPYG 179
Query: 701 TKSDVYSFGVLLLEILSGR 719
D++S G +L E+ G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|214558 smart00208, TNFR, Tumor necrosis factor receptor / nerve growth factor receptor repeats | Back alignment and domain information |
|---|
Score = 35.9 bits (83), Expect = 0.003
Identities = 15/48 (31%), Positives = 17/48 (35%), Gaps = 9/48 (18%)
Query: 349 CAPGYYEASQENAPCKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVC 396
C G Y C N C+ C CP + CT SD VC
Sbjct: 1 CKEGTY--------CSDGNHSSCLRCRR-CPPGLVVKQPCTATSDTVC 39
|
Repeats in growth factor receptors that are involved in growth factor binding. TNF/TNFR. Length = 39 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 31/103 (30%), Positives = 48/103 (46%), Gaps = 6/103 (5%)
Query: 510 ELERATGGFKEEVGKGSFSCVYK----GVLKDGTVVAVK-KAIATSDRQKNSKEFHTELD 564
E R F + +G G+F V + G+ K + V K + S + +EL
Sbjct: 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELK 90
Query: 565 LLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGK 606
+LS L NH +++NLLG C G L++ E+ +G L L K
Sbjct: 91 VLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRK 133
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 42/172 (24%), Positives = 72/172 (41%), Gaps = 23/172 (13%)
Query: 559 FHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVR 618
EL + NH +++ E +V FMA+GS K +D +
Sbjct: 46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS------AKDLICTHFMDGMS 99
Query: 619 RVTIA---VQAARGIEYLH--GYACPPVIHRDIKSSNILIDEEHNARVADF--GLSLLGP 671
+ IA + ++Y+H GY +HR +K+S+ILI + ++ LS++
Sbjct: 100 ELAIAYILQGVLKALDYIHHMGY-----VHRSVKASHILISVDGKVYLSGLRSNLSMINH 154
Query: 672 ADSSSPLAELP---AGTLGYLDPEYYR--LHYLTTKSDVYSFGVLLLEILSG 718
+ + P L +L PE + L KSD+YS G+ E+ +G
Sbjct: 155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.004
Identities = 67/289 (23%), Positives = 124/289 (42%), Gaps = 46/289 (15%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLL 578
+++G G F V+ K KAI+ +++ + E++++ L H +++ +
Sbjct: 19 KKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI 78
Query: 579 G-YCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
+ + ++L ++ EF G L +++ K + +++ V I Q + Y H
Sbjct: 79 DRFLNKANQKLYILMEFCDAGDLSRNIQ-KCYKMFGKIEEHAIVDITRQLLHALAYCHNL 137
Query: 637 ACPP----VIHRDIKSSNILID-----------EEHN------ARVADFGLSLLGPADSS 675
P V+HRD+K NI + + +N A++ DFGLS +S
Sbjct: 138 KDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES- 196
Query: 676 SPLAELPAGTLGYLDPEYYRLHYLTT---KSDVYSFGVLLLEILSGRKAIDMQFEEGNIV 732
+A GT Y PE LH + KSD+++ G ++ E+ SG+ F + N
Sbjct: 197 --MAHSCVGTPYYWSPELL-LHETKSYDDKSDMWALGCIIYELCSGKTP----FHKANNF 249
Query: 733 EWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPS 781
+ +K G P+ +L+ L I N+ + + KERPS
Sbjct: 250 SQLISELKRGPDL----PIKGKSKELNIL--IKNL----LNLSAKERPS 288
|
Length = 1021 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 914 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.98 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.98 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| COG5184 | 476 | ATS1 Alpha-tubulin suppressor and related RCC1 dom | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| COG5184 | 476 | ATS1 Alpha-tubulin suppressor and related RCC1 dom | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.92 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.88 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| KOG1427 | 443 | consensus Uncharacterized conserved protein, conta | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.67 | |
| KOG1427 | 443 | consensus Uncharacterized conserved protein, conta | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.58 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.56 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG1428 | 3738 | consensus Inhibitor of type V adenylyl cyclases/Ne | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| KOG0783 | 1267 | consensus Uncharacterized conserved protein, conta | 99.3 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| KOG0783 | 1267 | consensus Uncharacterized conserved protein, conta | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG1428 | 3738 | consensus Inhibitor of type V adenylyl cyclases/Ne | 99.01 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.98 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.93 | |
| PF13540 | 30 | RCC1_2: Regulator of chromosome condensation (RCC1 | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| PF13540 | 30 | RCC1_2: Regulator of chromosome condensation (RCC1 | 98.74 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.73 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.47 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.41 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.37 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.22 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.21 | |
| PF00415 | 51 | RCC1: Regulator of chromosome condensation (RCC1) | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.12 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.06 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.02 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.99 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.97 | |
| PF00415 | 51 | RCC1: Regulator of chromosome condensation (RCC1) | 97.92 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.89 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.84 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.7 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.68 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.63 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.57 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.54 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.53 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.27 | |
| KOG0941 | 850 | consensus E3 ubiquitin protein ligase [Posttransla | 97.23 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.14 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.05 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.94 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.92 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.9 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.76 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.75 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.75 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.54 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.49 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.44 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.44 | |
| PLN02236 | 344 | choline kinase | 96.14 | |
| KOG0941 | 850 | consensus E3 ubiquitin protein ligase [Posttransla | 96.0 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.65 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-55 Score=489.10 Aligned_cols=284 Identities=52% Similarity=0.883 Sum_probs=250.9
Q ss_pred ccccCCHHHHHHHhccccc--ccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeec
Q 002512 502 RAQMFTYEELERATGGFKE--EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579 (914)
Q Consensus 502 ~~~~~~~~el~~~t~~~~~--~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g 579 (914)
....|++.||.++|++|.+ .||+|+||.||+|.+.+++.||||++....... .++|.+|+.++.+++|||||+|+|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 4567999999999999995 699999999999999999999999775544322 467999999999999999999999
Q ss_pred eeecCC-eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCc
Q 002512 580 YCEEGR-ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHN 658 (914)
Q Consensus 580 ~~~~~~-~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~ 658 (914)
||.+.+ +++||||||++|+|.++|+..... .++|..|++||.++|+||+|||+...|+||||||||+|||||++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999999 599999999999999999976532 7899999999999999999999999899999999999999999999
Q ss_pred EEEeecCCcccCCC-CCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCccccc--ccccHHHHH
Q 002512 659 ARVADFGLSLLGPA-DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQF--EEGNIVEWA 735 (914)
Q Consensus 659 ~kl~DFGla~~~~~-~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~--~~~~l~~~~ 735 (914)
+||+|||+|+..+. ....... ..||.+|+|||++..+..+.|+|||||||+|+||+||+++.+... .+..+++|+
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~--~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~ 293 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTT--VMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA 293 (361)
T ss_pred EEccCccCcccCCccccceeee--cCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence 99999999977654 2221111 179999999999999999999999999999999999999987543 445689999
Q ss_pred HhhhhcCCcccccccccC-CCCCH-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 736 VPLIKSGDITAILDPVLK-LPSDL-DALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 736 ~~~~~~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
.+.+..+.+.+++|+.+. ..... +...++..++.+|++.+|++||+|.||+++|+.+
T Consensus 294 ~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 294 KPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred HHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 999999999999999987 44443 6888999999999999999999999999999554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=417.81 Aligned_cols=259 Identities=35% Similarity=0.523 Sum_probs=213.8
Q ss_pred ccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC-eEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR-ERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-~~~LV~Ey~~~g 597 (914)
.+.||+|+||+||+|.++....||||++..........++|.+|+.+|.+++|||||+|+|+|.+.. ...||||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 4559999999999999985555999998765544444679999999999999999999999999988 789999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC-cEEEeecCCcccCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-NARVADFGLSLLGPADSSS 676 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kl~DFGla~~~~~~~~~ 676 (914)
+|.++|+.. .+..+++..+++|+.|||+||.|||+++. ||||||||+||||+.++ ++||+|||+++......
T Consensus 126 sL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-- 198 (362)
T KOG0192|consen 126 SLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-- 198 (362)
T ss_pred cHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--
Confidence 999999874 13469999999999999999999999883 99999999999999997 99999999998754432
Q ss_pred CCccCCCCcCCccChhhhh--cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 677 PLAELPAGTLGYLDPEYYR--LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~--~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||..... .+.+......+.. .
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~~v~~~~~R---------p 265 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVASAVVVGGLR---------P 265 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhcCCC---------C
Confidence 2233367999999999999 66999999999999999999999999975432 1112222222221 1
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHc
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLM 797 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~~~ 797 (914)
+.+......+..|+.+||+.||..||++.+++..|+.+.....
T Consensus 266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 1122255688999999999999999999999999998877654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=416.35 Aligned_cols=260 Identities=28% Similarity=0.456 Sum_probs=218.2
Q ss_pred HHHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEE
Q 002512 511 LERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 511 l~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
+.+....+.++||+|.||.||+|.++....||+|.+..... ..++|.+|+++|++|+|+|||+|+++|..++..+||
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m---~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV 279 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM---SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV 279 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc---ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence 33334446778999999999999999888999998866532 337899999999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
||||+.|+|.+||+... ...+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+..
T Consensus 280 tE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 280 TEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred EEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEccccccccc
Confidence 99999999999998732 246788899999999999999999999 999999999999999999999999999954
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
..+. ........-++.|.|||.+....++.|||||||||+||||+| |+.|+... ...+ +.+.++
T Consensus 354 ~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-sn~e-------------v~~~le 418 (468)
T KOG0197|consen 354 GDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-SNEE-------------VLELLE 418 (468)
T ss_pred CCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC-CHHH-------------HHHHHh
Confidence 4333 333334456789999999999999999999999999999999 56665432 2211 123345
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
...+++.+..++.++++||..||+.+|++|||++.+...|++...
T Consensus 419 ~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 419 RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 566777888899999999999999999999999998888887643
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=430.49 Aligned_cols=268 Identities=30% Similarity=0.477 Sum_probs=225.7
Q ss_pred HHHHHHhcccccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceee
Q 002512 509 EELERATGGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCE 582 (914)
Q Consensus 509 ~el~~~t~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~ 582 (914)
.++.+....|.++||+|.||+||+|+.. +...||||.++...+. +..++|++|+++|..|+|||||+|+|+|.
T Consensus 481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-QARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 3455555567889999999999999853 3567999988765543 34589999999999999999999999999
Q ss_pred cCCeEEEEEeeCCCCCHHHhhhcCccch---------hcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE
Q 002512 583 EGRERLLVYEFMAHGSLHQHLHGKSKAL---------KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 653 (914)
Q Consensus 583 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~---------~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl 653 (914)
+++..+||+|||..|||.+||+...+.. +.+|+..+.+.||.|||.||+||-++. +|||||..+|+||
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLV 636 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLV 636 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhcee
Confidence 9999999999999999999998554432 233888999999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHH
Q 002512 654 DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIV 732 (914)
Q Consensus 654 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~ 732 (914)
.++..+||+||||++.....++........-.++||+||.+..++||.+||||||||+|||++| |+.|+.... +.
T Consensus 637 ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS-n~--- 712 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS-NQ--- 712 (774)
T ss_pred ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc-hH---
Confidence 9999999999999998776666655545556789999999999999999999999999999999 888876432 22
Q ss_pred HHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 733 EWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
.+...++++.+ ++.+..++.+++.||..||+.+|++||+++||-..|+....
T Consensus 713 -EVIe~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 713 -EVIECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -HHHHHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 23345555543 34455778899999999999999999999999999987643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=381.72 Aligned_cols=257 Identities=28% Similarity=0.386 Sum_probs=210.4
Q ss_pred cCCHHHHHHHhcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec
Q 002512 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE 583 (914)
Q Consensus 505 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~ 583 (914)
.+++.||++ .+.||+|..|+|||++++ +++.+|+|.+.... .....+++.+|++++.+.+||+||+++|.|..
T Consensus 75 ~i~~~dle~-----~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~-~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 75 GISLSDLER-----LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI-DPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred ccCHHHhhh-----hhhcccCCCcEEEEEEEcCCCeEEEEEeecccC-CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 367778875 356999999999999987 58889999884333 33445789999999999999999999999999
Q ss_pred CC-eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceEEcCCCcEEE
Q 002512 584 GR-ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNILIDEEHNARV 661 (914)
Q Consensus 584 ~~-~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NILl~~~~~~kl 661 (914)
.. ...|+||||.+|||++++...+ .+++...-+|+.++++||.|||+ .+ ||||||||+|||++..|++||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKi 220 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKI 220 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEe
Confidence 88 5999999999999999998653 47888889999999999999996 66 999999999999999999999
Q ss_pred eecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccc-cccHHHHHHhhhh
Q 002512 662 ADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFE-EGNIVEWAVPLIK 740 (914)
Q Consensus 662 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~-~~~l~~~~~~~~~ 740 (914)
+|||.++.+-.. ......||..|||||.+.+..|+.++||||||++|+|+.+|+.|+..... .....+.+ ..+.
T Consensus 221 cDFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll-~~Iv 295 (364)
T KOG0581|consen 221 CDFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELL-CAIV 295 (364)
T ss_pred ccccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHH-HHHh
Confidence 999999876543 45667899999999999999999999999999999999999999865311 11222211 1222
Q ss_pred cCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 741 SGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.+ +....|.. ....++..++..||+.||.+||+++|+++.
T Consensus 296 ~~-------ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 296 DE-------PPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred cC-------CCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 21 22222222 466789999999999999999999998753
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=374.34 Aligned_cols=197 Identities=30% Similarity=0.495 Sum_probs=176.9
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.++||+|+|++||+|+++ ++..||||.+.......+..+.+..|+.+|+.|+|||||+|+++++.++..|||||||.+
T Consensus 14 ~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~g 93 (429)
T KOG0595|consen 14 LSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNG 93 (429)
T ss_pred ehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCC
Confidence 3456999999999999986 589999999876654555667789999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC------CcEEEeecCCcccC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE------HNARVADFGLSLLG 670 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~------~~~kl~DFGla~~~ 670 (914)
|||.+||+..+ .++......++.|||.||++||+++ ||||||||.||||+.+ -.+||+|||+|+.+
T Consensus 94 GDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 94 GDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 99999999765 4788888999999999999999999 9999999999999764 45899999999988
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccc
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQ 725 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~ 725 (914)
.... +..+.+|++.|||||+++..+|+.|+|+||.|+||||+++|+.||+..
T Consensus 166 ~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 166 QPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred Cchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 7443 455678999999999999999999999999999999999999998743
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=376.18 Aligned_cols=255 Identities=22% Similarity=0.347 Sum_probs=206.5
Q ss_pred HHHhcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccc----c-chHHHHHHHHHHHhccCCceeeeeceeecCC
Q 002512 512 ERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQ----K-NSKEFHTELDLLSRLNHAHLLNLLGYCEEGR 585 (914)
Q Consensus 512 ~~~t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~----~-~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~ 585 (914)
.+..+-+.+.||+|+||.|-+|..+ +++.||||.+....... . ......+|+++|++|+|||||+++++|+..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4455667788999999999999965 69999999886543221 1 1233479999999999999999999999999
Q ss_pred eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC---CcEEEe
Q 002512 586 ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE---HNARVA 662 (914)
Q Consensus 586 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~---~~~kl~ 662 (914)
..|||||||+||+|.+++-.+.. +.......++.|++.|+.|||+++ |+||||||+||||..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEec
Confidence 99999999999999999976543 555566778999999999999999 9999999999999765 679999
Q ss_pred ecCCcccCCCCCCCCCccCCCCcCCccChhhhhcC---CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhh
Q 002512 663 DFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH---YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLI 739 (914)
Q Consensus 663 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~ 739 (914)
|||+|+.... ...+.+.+||+.|.|||++..+ .+..|.|+||+|||||-+|||.+||........+.+ .+
T Consensus 322 DFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~e----QI 394 (475)
T KOG0615|consen 322 DFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKE----QI 394 (475)
T ss_pred ccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHH----HH
Confidence 9999998653 2356778999999999999765 344588999999999999999999987655554443 33
Q ss_pred hcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 740 KSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+.+... .+...+..++..+|+.++|..||++|||+.|++.
T Consensus 395 ~~G~y~f~------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 395 LKGRYAFG------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred hcCccccc------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 33433221 1223456788999999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=408.38 Aligned_cols=264 Identities=23% Similarity=0.446 Sum_probs=224.6
Q ss_pred HHHHHhcccccccCcccceEEEEEEEcC----CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC
Q 002512 510 ELERATGGFKEEVGKGSFSCVYKGVLKD----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR 585 (914)
Q Consensus 510 el~~~t~~~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~ 585 (914)
||......+.+.||.|.||.||+|+++- ...||||.++.. ..++...+|+.|+.||.+++||||++|.|+....+
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~ 703 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK 703 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence 4444445566779999999999999862 457999987654 34556689999999999999999999999999999
Q ss_pred eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecC
Q 002512 586 ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 586 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFG 665 (914)
..+||.|||+||+|+.||+.+.. ++++.+.+-++.+||.||.||-+.+ +|||||.++|||++.+..+||+|||
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFG 776 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFG 776 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEecccc
Confidence 99999999999999999998753 5899999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCCCCCcc-CCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCC
Q 002512 666 LSLLGPADSSSPLAE-LPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGD 743 (914)
Q Consensus 666 la~~~~~~~~~~~~~-~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 743 (914)
|++.+.++.....++ .-.-.++|.|||.+..++++.+||||||||||||.++ |++|+.+..+. +
T Consensus 777 LSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQ--------------d 842 (996)
T KOG0196|consen 777 LSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--------------D 842 (996)
T ss_pred ceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchH--------------H
Confidence 999887665322221 1223579999999999999999999999999999887 88887543221 2
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 002512 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~ 795 (914)
+.+-++..+++|++.+++..|.+||..||++|-.+||.+.+|+..|.+++++
T Consensus 843 VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 843 VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 2233455678899999999999999999999999999999999999887654
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=388.56 Aligned_cols=248 Identities=26% Similarity=0.424 Sum_probs=208.1
Q ss_pred cccccccCcccceEEEEEEE-cCCcEEEEEEeeecc-ccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 516 GGFKEEVGKGSFSCVYKGVL-KDGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+...+.||+|||+.||+++. ..|+.||+|++.+.. ......+...+||+|.++|+|||||+++++|++.++.|||.|+
T Consensus 20 Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLEL 99 (592)
T KOG0575|consen 20 YKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLEL 99 (592)
T ss_pred eeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEe
Confidence 34456799999999999997 679999999886643 2334457899999999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
|++++|.+++++. +++++.+...+..||+.||.|||+++ |||||||..|+||+++.++||+|||||..+..+
T Consensus 100 C~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 100 CHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred cCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999844 36899999999999999999999999 999999999999999999999999999887655
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.. ...+.+|||.|+|||++.....+..+||||+|||||-||+|++||+... +.+ ....++..+. .
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~----vke-ty~~Ik~~~Y--------~ 236 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT----VKE-TYNKIKLNEY--------S 236 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch----HHH-HHHHHHhcCc--------c
Confidence 43 3345689999999999999999999999999999999999999996432 111 2222322221 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.|. ....+..+||.++|+.+|.+|||+++|+..
T Consensus 237 ~P~--~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 237 MPS--HLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ccc--ccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 222 334567899999999999999999999853
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=357.20 Aligned_cols=257 Identities=26% Similarity=0.362 Sum_probs=210.5
Q ss_pred cccccCcccceEEEEEE-EcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeec-eeecCCe-EEEEEeeC
Q 002512 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG-YCEEGRE-RLLVYEFM 594 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g-~~~~~~~-~~LV~Ey~ 594 (914)
+.++||+|+||+|||+. +.++..||.|++.-.....+..+....|+.+|++|+|||||++++ -+.++.+ .+|||||+
T Consensus 23 Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c 102 (375)
T KOG0591|consen 23 ILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELC 102 (375)
T ss_pred HHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhh
Confidence 45679999999999998 458999999998755555566788999999999999999999998 4545444 88999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccC-CCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA-CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~-~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
..|+|.+.++.... .++.++...++++..|+++||.++|++- ...|+||||||.||+|+.+|.+||+||||++.+..+
T Consensus 103 ~~GDLsqmIk~~K~-qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~ 181 (375)
T KOG0591|consen 103 DAGDLSQMIKHFKK-QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK 181 (375)
T ss_pred cccCHHHHHHHHHh-ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch
Confidence 99999999875422 3456899999999999999999999832 123999999999999999999999999999987654
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
. ......+|||.||+||.+....|+.||||||+||++|||..-..||... ++.+ ....+..++...+.+
T Consensus 182 ~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~-L~~KI~qgd~~~~p~---- 250 (375)
T KOG0591|consen 182 T--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLS-LCKKIEQGDYPPLPD---- 250 (375)
T ss_pred h--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHH-HHHHHHcCCCCCCcH----
Confidence 3 3455678999999999999999999999999999999999999999754 3433 233455554433322
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
...+..+..|+..|+..||+.||+.-.++..+.
T Consensus 251 ----~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 251 ----EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 355678999999999999999999655554444
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=405.27 Aligned_cols=275 Identities=27% Similarity=0.430 Sum_probs=223.4
Q ss_pred HHHHHHHhcccccccCcccceEEEEEEEcC--Cc----EEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeecee
Q 002512 508 YEELERATGGFKEEVGKGSFSCVYKGVLKD--GT----VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYC 581 (914)
Q Consensus 508 ~~el~~~t~~~~~~LG~G~fG~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~ 581 (914)
+.++.+....+.+.||+|.||.||.|...+ +. .||||.+.+..+ .+...+|.+|..+|++++|||||+++|.|
T Consensus 686 lp~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~ 764 (1025)
T KOG1095|consen 686 LPEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVC 764 (1025)
T ss_pred cccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEee
Confidence 344556666677889999999999999764 43 489998866543 44568999999999999999999999999
Q ss_pred ecCCeEEEEEeeCCCCCHHHhhhcCccch--hcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcE
Q 002512 582 EEGRERLLVYEFMAHGSLHQHLHGKSKAL--KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA 659 (914)
Q Consensus 582 ~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~--~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 659 (914)
.+...++|++|||++|+|..||++.+... ...++....+.|+.|||+|+.||++++ +|||||.++|+||++...+
T Consensus 765 l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~V 841 (1025)
T KOG1095|consen 765 LDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVV 841 (1025)
T ss_pred cCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcE
Confidence 99999999999999999999998764322 345888899999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhh
Q 002512 660 RVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPL 738 (914)
Q Consensus 660 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~ 738 (914)
||+|||||+.+...++........-..+|||||.++.+.++.|+|||||||+|||++| |..||...... + .....
T Consensus 842 KIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~---v~~~~ 917 (1025)
T KOG1095|consen 842 KIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-E---VLLDV 917 (1025)
T ss_pred EEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH-H---HHHHH
Confidence 9999999996555444433333345689999999999999999999999999999999 55666432221 1 11122
Q ss_pred hhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHcCCC
Q 002512 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSP 800 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~~~~~~ 800 (914)
...+ +++.+..+++.+++||..||+.+|++||++..|++.++.+.......+
T Consensus 918 ~~gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 918 LEGG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred HhCC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 2222 344556677899999999999999999999999999988877665443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=376.74 Aligned_cols=266 Identities=29% Similarity=0.501 Sum_probs=214.6
Q ss_pred HHHHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEE
Q 002512 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLL 589 (914)
Q Consensus 510 el~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 589 (914)
|+......+.+.||+|.||+||+|++. ..||||++......+...+.|++|+..+++-+|.||+-|.|||..... .|
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AI 464 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AI 464 (678)
T ss_pred ccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-ee
Confidence 333333345678999999999999986 349999998777777778999999999999999999999999999877 99
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
|..+++|-+|+.+||... ..++....++|+.|||+||.|||.++ |||||||+.||||.++++|||+||||+..
T Consensus 465 iTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv 537 (678)
T KOG0193|consen 465 ITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV 537 (678)
T ss_pred eehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence 999999999999999653 46888899999999999999999999 99999999999999999999999999966
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhhcC---CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccc
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRLH---YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITA 746 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 746 (914)
...-..........|...|||||++++. +|+..+||||||+|+|||+||..||.....+..+ | .+-.|.+
T Consensus 538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi--f---mVGrG~l-- 610 (678)
T KOG0193|consen 538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII--F---MVGRGYL-- 610 (678)
T ss_pred eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE--E---Eeccccc--
Confidence 4433333334456689999999999754 7999999999999999999999998732221111 1 1111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 002512 747 ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~ 795 (914)
..|.. .....+..+|.+|+..||..++++||.+.+|+..|+.++..
T Consensus 611 ~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 611 MPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred Cccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 11111 11235567899999999999999999999999999876653
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=367.28 Aligned_cols=274 Identities=26% Similarity=0.402 Sum_probs=225.0
Q ss_pred cCCHHHHHHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC
Q 002512 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG 584 (914)
Q Consensus 505 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~ 584 (914)
.-.++|+.+....|.++||+|-||.|.+........||||+++..... ....+|.+|+++|.+|+|||||+|+|+|..+
T Consensus 529 ~~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~-~~r~~F~kEIkiLsqLkhPNIveLvGVC~~D 607 (807)
T KOG1094|consen 529 GPALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK-NARNDFLKEIKILSRLKHPNIVELLGVCVQD 607 (807)
T ss_pred CcchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch-hHHHHHHHHHHHHhccCCCCeeEEEeeeecC
Confidence 345678888888899999999999999999988899999998765533 3358999999999999999999999999999
Q ss_pred CeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeec
Q 002512 585 RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADF 664 (914)
Q Consensus 585 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DF 664 (914)
+..+||+|||++|+|.+||..+... .+.-...++|+.|||.||+||.+.+ +|||||.++|+|+|.++++||+||
T Consensus 608 ePicmI~EYmEnGDLnqFl~aheap---t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadf 681 (807)
T KOG1094|consen 608 DPLCMITEYMENGDLNQFLSAHELP---TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADF 681 (807)
T ss_pred CchHHHHHHHhcCcHHHHHHhccCc---ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCc
Confidence 9999999999999999999876432 1344556789999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh--CCCCcccccccccHHHHHHhhhhcC
Q 002512 665 GLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS--GRKAIDMQFEEGNIVEWAVPLIKSG 742 (914)
Q Consensus 665 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt--G~~p~~~~~~~~~l~~~~~~~~~~~ 742 (914)
|+++-+............+-.++|||||.+..++++.+||||+||++|||+++ ..+||... .++..++..-..+..+
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~l-t~e~vven~~~~~~~~ 760 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQL-TDEQVVENAGEFFRDQ 760 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhh-hHHHHHHhhhhhcCCC
Confidence 99997776666666656667899999999999999999999999999999865 66787543 2233333333333322
Q ss_pred CcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 743 DITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
....+ ++.+.-++..++++|.+||+.+-++||+++++...|++.
T Consensus 761 ~~~~~------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 761 GRQVV------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred Cccee------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22221 223335567889999999999999999999999888653
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=367.52 Aligned_cols=253 Identities=28% Similarity=0.400 Sum_probs=211.1
Q ss_pred cccCCHHHHHHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceee
Q 002512 503 AQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCE 582 (914)
Q Consensus 503 ~~~~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~ 582 (914)
...+.|++|....+ ||.|+-|.||+|+++ ++.|||||+.... ..+|+.|++|+||||+.|.|+|.
T Consensus 118 ~WeiPFe~IsELeW-----lGSGaQGAVF~Grl~-netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCt 182 (904)
T KOG4721|consen 118 LWEIPFEEISELEW-----LGSGAQGAVFLGRLH-NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCT 182 (904)
T ss_pred hccCCHHHhhhhhh-----hccCcccceeeeecc-CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeec
Confidence 34567777765443 999999999999997 7899999874322 25789999999999999999999
Q ss_pred cCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEe
Q 002512 583 EGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVA 662 (914)
Q Consensus 583 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~ 662 (914)
....++||||||+.|-|++.|+... .++....+.+..+||.||.|||.+. |||||||+-||||..+..+||+
T Consensus 183 qsPcyCIiMEfCa~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIs 254 (904)
T KOG4721|consen 183 QSPCYCIIMEFCAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKIS 254 (904)
T ss_pred CCceeEEeeeccccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEec
Confidence 9999999999999999999998754 4677778899999999999999999 9999999999999999999999
Q ss_pred ecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC
Q 002512 663 DFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG 742 (914)
Q Consensus 663 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~ 742 (914)
|||-++..... .......||..|||||+++..+.++|.|||||||||||||||+.||........
T Consensus 255 DFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------------ 319 (904)
T KOG4721|consen 255 DFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------------ 319 (904)
T ss_pred cccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------------
Confidence 99999876543 233445799999999999999999999999999999999999999853222110
Q ss_pred CcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 743 DITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
+.-+=...+.++.+..+++-+.-|+.+||+..|..||++.+++..|+-+-.
T Consensus 320 -IwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 320 -IWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred -EEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 111222345566677788888899999999999999999999998854433
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=354.88 Aligned_cols=260 Identities=29% Similarity=0.445 Sum_probs=201.9
Q ss_pred cccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhc--cCCceeeeeceeecCC----eEEEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL--NHAHLLNLLGYCEEGR----ERLLVY 591 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l--~HpnIv~l~g~~~~~~----~~~LV~ 591 (914)
+.+.||+|.||.||||+++ ++.||||++.. ++.+.|.+|-+|++.. +|+||++|+++-+... +++||+
T Consensus 214 l~eli~~Grfg~V~KaqL~-~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt 287 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLD-NRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT 287 (534)
T ss_pred hHHHhhcCccceeehhhcc-CceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence 3456999999999999997 69999998843 2347799988888754 8999999999987666 889999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc------cCCCCeeccCCCccceEEcCCCcEEEeecC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG------YACPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~------~~~~~iiHrDIKp~NILl~~~~~~kl~DFG 665 (914)
||.++|+|.+||..+ .++|....+|+..+++||+|||+ +.+|+|+|||||++||||.+|+++.|+|||
T Consensus 288 ~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 288 EFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred eeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999865 58999999999999999999995 446899999999999999999999999999
Q ss_pred CcccCCCCCCCCCccCCCCcCCccChhhhhcCC-C-----CCcchHHHHHHHHHHHHhCCCCcc--------ccccc---
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY-L-----TTKSDVYSFGVLLLEILSGRKAID--------MQFEE--- 728 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~-----s~ksDV~S~GvvL~ElltG~~p~~--------~~~~~--- 728 (914)
||..+............+||.+|||||++.+.. + -.+.||||+|.|||||+++...++ ..++.
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 998877665554445578999999999997642 2 236899999999999999765442 11111
Q ss_pred -ccHHHHHHhhhh-cCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 729 -GNIVEWAVPLIK-SGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 729 -~~l~~~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
..-.+.+...+. ......+.+.-... ..+..+.+.+..||..||+.|.|+.=+.+++.++.
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h----~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKH----AGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcC----ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 011122222222 22222222222222 34567889999999999999999999988887643
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=372.00 Aligned_cols=263 Identities=29% Similarity=0.390 Sum_probs=204.5
Q ss_pred hcccccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCC-e
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGR-E 586 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~-~ 586 (914)
.+.+.++||+|+||.||++.+. +++.||||++.... .....+.|.+|+.++.++ +||||++++++|...+ .
T Consensus 8 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (338)
T cd05102 8 RLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGP 86 (338)
T ss_pred HceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCc
Confidence 3456788999999999999742 35689999875432 223346799999999999 8999999999887644 5
Q ss_pred EEEEEeeCCCCCHHHhhhcCccc---------------------------------------------------------
Q 002512 587 RLLVYEFMAHGSLHQHLHGKSKA--------------------------------------------------------- 609 (914)
Q Consensus 587 ~~LV~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------- 609 (914)
.++||||+++|+|.++|+.....
T Consensus 87 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (338)
T cd05102 87 LMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDL 166 (338)
T ss_pred eEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccc
Confidence 78999999999999999753210
Q ss_pred hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCcc
Q 002512 610 LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYL 689 (914)
Q Consensus 610 ~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~ 689 (914)
....+++...+.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............+++.||
T Consensus 167 ~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 167 WKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 0134778888999999999999999998 9999999999999999999999999997654333222223345678999
Q ss_pred ChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHH
Q 002512 690 DPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVA 768 (914)
Q Consensus 690 aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 768 (914)
|||++....++.++||||||++||||++ |..||........+ ...+..+.... .+......+.+|+
T Consensus 244 aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~----~~~~~~~~~~~---------~~~~~~~~l~~li 310 (338)
T cd05102 244 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF----CQRLKDGTRMR---------APENATPEIYRIM 310 (338)
T ss_pred CcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH----HHHHhcCCCCC---------CCCCCCHHHHHHH
Confidence 9999999999999999999999999997 99998653322211 12222221111 1112345788999
Q ss_pred HHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 769 CKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 769 ~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
.+||+.+|++|||+.|+++.|++++.
T Consensus 311 ~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 311 LACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=376.55 Aligned_cols=265 Identities=31% Similarity=0.448 Sum_probs=212.9
Q ss_pred HHHHHhcccccccCcccceEEEEEEEcC--C--cE-EEEEEeeecc-ccccchHHHHHHHHHHHhccCCceeeeeceeec
Q 002512 510 ELERATGGFKEEVGKGSFSCVYKGVLKD--G--TV-VAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE 583 (914)
Q Consensus 510 el~~~t~~~~~~LG~G~fG~Vy~~~~~~--~--~~-vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~ 583 (914)
||......+.++||+|+||.||+|+++. + .. ||||...... .......+|++|+++|++++|||||+|+|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 4444444566889999999999999763 2 23 8999876422 344567899999999999999999999999999
Q ss_pred CCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEee
Q 002512 584 GRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVAD 663 (914)
Q Consensus 584 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~D 663 (914)
..+.|||||+|+||+|.+||++... .++..++++++.++|.||+|||+++ +|||||.++|+|++.++.+||+|
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence 9999999999999999999987643 5899999999999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcC
Q 002512 664 FGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSG 742 (914)
Q Consensus 664 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~ 742 (914)
|||++........ .....-..+|+|||.+....++.++|||||||++||+.+ |..|+...... .+...+.
T Consensus 306 FGLs~~~~~~~~~--~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-----~v~~kI~-- 376 (474)
T KOG0194|consen 306 FGLSRAGSQYVMK--KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-----EVKAKIV-- 376 (474)
T ss_pred cccccCCcceeec--cccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-----HHHHHHH--
Confidence 9999765421111 112235689999999999999999999999999999999 77787543211 1112221
Q ss_pred CcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 002512 743 DITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~~ 796 (914)
....+.+.+...+.++..++.+||..+|++||+|.++.+.|+.+....
T Consensus 377 ------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 377 ------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred ------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 112233333456678889999999999999999999999999876553
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=348.23 Aligned_cols=239 Identities=26% Similarity=0.370 Sum_probs=196.3
Q ss_pred cccccCcccceEEEEEEEcC-CcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.||+|+||+||+++.++ ++.+|+|++.+..-. ..+.+....|..+|.+++||.||+|+..|++.+.+|||+||+.
T Consensus 29 ~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~ 108 (357)
T KOG0598|consen 29 ILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLN 108 (357)
T ss_pred eeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccC
Confidence 46789999999999999765 889999988665432 2345778899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
||.|..+|++.+. ++.....-++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++.......
T Consensus 109 GGeLf~hL~~eg~-----F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 109 GGELFYHLQREGR-----FSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred CccHHHHHHhcCC-----cchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 9999999987653 777777788999999999999999 99999999999999999999999999986544332
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
.+...+||+.|||||++....|+..+|.||||++|||||+|.+||..... ..+.. .+..+. +..+
T Consensus 181 --~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~----~~~~~-~I~~~k--------~~~~ 245 (357)
T KOG0598|consen 181 --ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV----KKMYD-KILKGK--------LPLP 245 (357)
T ss_pred --ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH----HHHHH-HHhcCc--------CCCC
Confidence 23446899999999999999999999999999999999999999864321 12211 122221 1111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCC
Q 002512 756 SDLDALKRIANVACKCVRMRGKERP 780 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RP 780 (914)
+.-...+..+++...|+.+|++|.
T Consensus 246 -p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 246 -PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CccCCHHHHHHHHHHhccCHHHhc
Confidence 111335678999999999999996
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=373.97 Aligned_cols=254 Identities=27% Similarity=0.431 Sum_probs=215.0
Q ss_pred ccccCcccceEEEEEEEc-CC----cEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 519 KEEVGKGSFSCVYKGVLK-DG----TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~----~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
.++||+|+||+||||.+- ++ -+||||++.... ..+..++|++|+.+|.+|+|||++||+++|.... +.||++|
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 457999999999999863 33 468999876544 3445689999999999999999999999999876 8899999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
||.|+|.||++.++ ..+-.+..+.|..|||+||.|||++. ++||||.++|||+.+-..+||.|||+++++..+
T Consensus 779 mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred cccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 99999999998753 46777888999999999999999999 999999999999999999999999999998887
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
..........-.+.|||-|.+....++.++|||||||++|||+| |.+|++.... .++.+++....
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~--------------~eI~dlle~ge 917 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA--------------EEIPDLLEKGE 917 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH--------------HHhhHHHhccc
Confidence 76655555555688999999999999999999999999999999 7788754321 12233444445
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~ 795 (914)
+++.++-+..+++.+|.+||..|+..||+++++...+.+..+.
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 5667777888999999999999999999999999999876654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=351.33 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=198.1
Q ss_pred cccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC--eEEEEEeeC
Q 002512 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR--ERLLVYEFM 594 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--~~~LV~Ey~ 594 (914)
..+.||+|+||.||++...+ |+..|||.+...... ..+.+.+|+.+|++|+|||||+.+|.....+ ..+|.|||+
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~ 98 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYA 98 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeecc
Confidence 35679999999999999765 899999987554221 1577899999999999999999999854444 688999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC-CCcEEEeecCCcccCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE-EHNARVADFGLSLLGPAD 673 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kl~DFGla~~~~~~ 673 (914)
++|+|.+++.+.+. .|+...+.++..||++||+|||+++ ||||||||+||||+. ++.+||+|||+++.....
T Consensus 99 ~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 99 PGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred CCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999987642 4889999999999999999999999 999999999999999 799999999999876531
Q ss_pred C-CCCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 674 S-SSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 674 ~-~~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
. .........||+.|||||++..+ ....++|||||||+++||+||++||... ....++............
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~~~P~----- 243 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGREDSLPE----- 243 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccCCCCC-----
Confidence 1 11223346799999999999964 3335999999999999999999998643 111222222222221111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
.+...+.+..+++.+|++.+|++|||++++++..
T Consensus 244 ----ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 244 ----IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred ----CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1122446788999999999999999999998655
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=335.28 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=203.6
Q ss_pred cccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
.++|+|+||.|||.+.++ |+.||||++....+.+...+-.++|+++|++|+|||+|.|+.+|......+||+||++. +
T Consensus 8 gkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-T 86 (396)
T KOG0593|consen 8 GKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-T 86 (396)
T ss_pred hccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-H
Confidence 369999999999999875 99999999988776666667788999999999999999999999999999999999987 4
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
+.+.|.... .-++.....+++.|+++|+.|+|+++ +|||||||+||||+.++.+||+|||+|+.+.... ..
T Consensus 87 vL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg--d~ 157 (396)
T KOG0593|consen 87 VLHELERYP----NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPG--DN 157 (396)
T ss_pred HHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCc--ch
Confidence 444454432 24778888999999999999999999 9999999999999999999999999999876422 23
Q ss_pred ccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHH----------HhhhhcC-Cccc
Q 002512 679 AELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA----------VPLIKSG-DITA 746 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~----------~~~~~~~-~~~~ 746 (914)
.+..+.|..|.|||.+.+ ..|....|||+.||++.||++|.+.|....+-+.+.-.. ...+... .+..
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 445578999999999987 689999999999999999999998887654443322211 1111111 1111
Q ss_pred ccccccCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 747 ILDPVLKLPSD-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 747 ~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+.-|....+.+ +....-+.+++..||++||.+|++-++++.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 21122222222 223457889999999999999999998864
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=357.61 Aligned_cols=263 Identities=28% Similarity=0.438 Sum_probs=222.7
Q ss_pred CHHHHHHHhcccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC
Q 002512 507 TYEELERATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR 585 (914)
Q Consensus 507 ~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~ 585 (914)
...|+++....+.++||-|.||.||.|.++. .-.||||.++.. ....++|+.|+.+|+.++|||+|+|+|+|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 4567777777788999999999999999875 567999987543 335689999999999999999999999999999
Q ss_pred eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecC
Q 002512 586 ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 586 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFG 665 (914)
.+|||.|||.+|+|.+||++..+ +.++-...+.++.||+.||+||..++ +|||||.++|+|+.++..+||+|||
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccc
Confidence 99999999999999999997654 45777788999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCc
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDI 744 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 744 (914)
|++++..+.+... ....-.+.|.|||.+....++.|+|||+|||+|||+.| |..|+... ++ ..+.
T Consensus 411 LsRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi----dl-SqVY-------- 476 (1157)
T KOG4278|consen 411 LSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI----DL-SQVY-------- 476 (1157)
T ss_pred hhhhhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc----cH-HHHH--------
Confidence 9999877655432 22345789999999999999999999999999999998 66666432 11 1122
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
.+++..++...+..++..+++||+.||+.+|.+||++.|+-+.+|.++
T Consensus 477 -~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 477 -GLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred -HHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 334445556666678889999999999999999999999999997654
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=345.56 Aligned_cols=270 Identities=22% Similarity=0.335 Sum_probs=208.9
Q ss_pred HHHHHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhc--cCCceeeeeceeecCC-
Q 002512 509 EELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL--NHAHLLNLLGYCEEGR- 585 (914)
Q Consensus 509 ~el~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l--~HpnIv~l~g~~~~~~- 585 (914)
+.-...+..+.+.||+|.||+||+|.++ |+.||||++... +++.+.+|.+|++-+ +|+||+.|++.-..++
T Consensus 206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred HHhhhheeEEEEEecCccccceeecccc-CCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 3334455667889999999999999997 899999988533 236788888888754 9999999998875543
Q ss_pred ---eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhh-----ccCCCCeeccCCCccceEEcCCC
Q 002512 586 ---ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH-----GYACPPVIHRDIKSSNILIDEEH 657 (914)
Q Consensus 586 ---~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH-----~~~~~~iiHrDIKp~NILl~~~~ 657 (914)
+++||.||.++|||+|||.+. .++-...+++++.+|.||+||| .+++|.|.|||||+.|||+.+|+
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 679999999999999999864 5778888999999999999999 57889999999999999999999
Q ss_pred cEEEeecCCcccCCCCCC--CCCccCCCCcCCccChhhhhcCC------CCCcchHHHHHHHHHHHHhC----------C
Q 002512 658 NARVADFGLSLLGPADSS--SPLAELPAGTLGYLDPEYYRLHY------LTTKSDVYSFGVLLLEILSG----------R 719 (914)
Q Consensus 658 ~~kl~DFGla~~~~~~~~--~~~~~~~~Gt~~y~aPE~l~~~~------~s~ksDV~S~GvvL~ElltG----------~ 719 (914)
++.|+|+|||.....+.. ....+..+||.+|||||++.... .-..+||||||+||||+.-+ +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 999999999976655432 22334557999999999995431 11468999999999999864 2
Q ss_pred CCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 720 KAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 720 ~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
.||+.-...+.-.+.+.+.+-...+...++... .+.+.+..+.+||..||..+|..|-|+-.+.+.|.++.
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CCcccCCCCCCCHHHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 555543333333343444443333333322222 23478889999999999999999999999988887654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=351.13 Aligned_cols=261 Identities=18% Similarity=0.302 Sum_probs=204.9
Q ss_pred cccCCHHHHHHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccc-cchHHHHHHHHHHHhccCCceeeeecee
Q 002512 503 AQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQ-KNSKEFHTELDLLSRLNHAHLLNLLGYC 581 (914)
Q Consensus 503 ~~~~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~ 581 (914)
.+.++.++++..+ ...|++|+++.||+|.+ +++.||||++....... ...+.|.+|+.+|.+++|||||++++++
T Consensus 12 ~~~i~~~~i~~~~---~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~ 87 (283)
T PHA02988 12 IKCIESDDIDKYT---SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFI 87 (283)
T ss_pred ceecCHHHcCCCC---CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeE
Confidence 4455666664322 13599999999999998 58999999886543222 1246788999999999999999999998
Q ss_pred ec----CCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhcc-CCCCeeccCCCccceEEcCC
Q 002512 582 EE----GRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY-ACPPVIHRDIKSSNILIDEE 656 (914)
Q Consensus 582 ~~----~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~-~~~~iiHrDIKp~NILl~~~ 656 (914)
.+ ....+|||||+++|+|.+++.... .+++...++++.|++.||.|||+. + ++||||||+|||++++
T Consensus 88 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~ 159 (283)
T PHA02988 88 IDIVDDLPRLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTEN 159 (283)
T ss_pred EecccCCCceEEEEEeCCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCC
Confidence 77 346789999999999999997642 578999999999999999999985 6 8899999999999999
Q ss_pred CcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhc--CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHH
Q 002512 657 HNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL--HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEW 734 (914)
Q Consensus 657 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~ 734 (914)
+.+||+|||+++...... ....|+..|+|||++.. ..++.++|||||||++|||++|+.||...... .+.
T Consensus 160 ~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-~~~-- 231 (283)
T PHA02988 160 YKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-EIY-- 231 (283)
T ss_pred CcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-HHH--
Confidence 999999999987653321 12358899999999976 67899999999999999999999999643211 111
Q ss_pred HHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 735 AVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
......+ . +.+.+...+..+.+|+.+||+.||++|||++|+++.|++..
T Consensus 232 -~~i~~~~-~--------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 232 -DLIINKN-N--------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred -HHHHhcC-C--------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 1111111 1 11111234567899999999999999999999999998653
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=352.37 Aligned_cols=265 Identities=25% Similarity=0.376 Sum_probs=201.5
Q ss_pred hcccccccCcccceEEEEEEEcC-----------------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeee
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKD-----------------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l 577 (914)
.+.+.++||+|+||.||++.+++ +..||+|.+.... ......+|.+|++++.+++||||+++
T Consensus 6 ~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 6 HLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 34567889999999999998643 3369999875432 22334679999999999999999999
Q ss_pred eceeecCCeEEEEEeeCCCCCHHHhhhcCccc--------------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeec
Q 002512 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKA--------------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIH 643 (914)
Q Consensus 578 ~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~--------------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiH 643 (914)
++++.+.+..+|||||+++|+|.+++...... ....++|...++++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 99999999999999999999999998653211 1134788889999999999999999999 999
Q ss_pred cCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhC--CCC
Q 002512 644 RDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG--RKA 721 (914)
Q Consensus 644 rDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG--~~p 721 (914)
|||||+|||+++++.+||+|||+++...............++..|||||++....++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 999999999999999999999999765433222223334568899999999988999999999999999999974 456
Q ss_pred cccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 722 IDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 722 ~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
|.... .................... ...+...+..+.+|+.+||+.+|++|||+.+|.+.|+
T Consensus 242 ~~~~~-~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELT-DEQVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCC-HHHHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 64322 22222222222211110000 0111123457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=365.47 Aligned_cols=260 Identities=27% Similarity=0.394 Sum_probs=203.4
Q ss_pred cccccccCcccceEEEEEEE------cCCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVL------KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~ 588 (914)
..+.+.||+|+||.||+++. ..+..||||++.... .....+.+.+|++++..+ +||||++++++|.+.+..+
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~ 115 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTL 115 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcce
Confidence 44678899999999999974 235689999875432 223446789999999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhcCccc-----------------------------------------------------------
Q 002512 589 LVYEFMAHGSLHQHLHGKSKA----------------------------------------------------------- 609 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~----------------------------------------------------------- 609 (914)
+||||+++|+|.++++.....
T Consensus 116 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (375)
T cd05104 116 VITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYI 195 (375)
T ss_pred eeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceec
Confidence 999999999999999753210
Q ss_pred -----------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 610 -----------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 610 -----------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
....+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..........
T Consensus 196 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 196 DQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred ccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 0124788889999999999999999998 99999999999999999999999999976544332222
Q ss_pred ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
.....++..|+|||++....++.++||||||++||||++ |..||........+.. .+..+... ..+
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~----~~~~~~~~---------~~~ 339 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK----MIKEGYRM---------LSP 339 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHH----HHHhCccC---------CCC
Confidence 223345678999999999999999999999999999998 8888754322222222 22222110 001
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
...+.++.+|+.+||+.+|++||++.||++.|++.
T Consensus 340 ~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 340 ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=352.57 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=202.8
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
|.+.||.|+|++||+|+.+ .++.+|||++.+.-- +++..+-...|-.+|.+| .||.|++|+-.|.++..+|+|+||+
T Consensus 77 Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A 156 (604)
T KOG0592|consen 77 FGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYA 156 (604)
T ss_pred hhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEec
Confidence 6778999999999999966 589999998754321 222334567899999999 8999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
+||+|.++|++.+. ++..-...++.+|+.||+|||+.+ ||||||||+|||||+|+++||+|||-|+.+....
T Consensus 157 ~nGdll~~i~K~Gs-----fde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 157 PNGDLLDLIKKYGS-----FDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred CCCcHHHHHHHhCc-----chHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999997753 777777889999999999999999 9999999999999999999999999999876543
Q ss_pred CC---------CC--ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC
Q 002512 675 SS---------PL--AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD 743 (914)
Q Consensus 675 ~~---------~~--~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~ 743 (914)
.. .. ....+||..|.+||+|.....+..+|+|+||||||.||.|.+||....+-- .+..
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl----iFqk------ 298 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL----IFQK------ 298 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH----HHHH------
Confidence 22 11 134679999999999999999999999999999999999999997532211 1111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
|++-.+..+ ...++.+.+|+.+.|..||.+|+|.++|.+..
T Consensus 299 ---I~~l~y~fp--~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 299 ---IQALDYEFP--EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ---HHHhcccCC--CCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 111112222 23336788999999999999999998887654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=345.67 Aligned_cols=258 Identities=26% Similarity=0.369 Sum_probs=203.8
Q ss_pred cccCcccceEEEEEEE-cCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC--CeEEEEEeeCCC
Q 002512 520 EEVGKGSFSCVYKGVL-KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RERLLVYEFMAH 596 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey~~~ 596 (914)
++||+|.||.|||++. .+|+.||+|+++.....+....-..+||.||++|+||||++|.+...+. ..+|||+|||++
T Consensus 123 ~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 123 EKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 4699999999999995 4699999999987776666666778999999999999999999988776 689999999987
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
||.-++..... .|+..++..++.|++.||+|+|+++ |+|||||.+|||||.+|.+||+|||||+++......
T Consensus 203 -DL~GLl~~p~v----kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~ 274 (560)
T KOG0600|consen 203 -DLSGLLSSPGV----KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSA 274 (560)
T ss_pred -hhhhhhcCCCc----ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCCc
Confidence 88888876433 5889999999999999999999999 999999999999999999999999999987766554
Q ss_pred CCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC--------Ccc--
Q 002512 677 PLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG--------DIT-- 745 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~--------~~~-- 745 (914)
. .+..+-|.-|.|||.+.+. .|+.+.|+||.||||.||++|++.|....+.+.+...+. +.-.. ++.
T Consensus 275 ~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk-lcGSP~e~~W~~~kLP~~ 352 (560)
T KOG0600|consen 275 P-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK-LCGSPTEDYWPVSKLPHA 352 (560)
T ss_pred c-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH-HhCCCChhccccccCCcc
Confidence 4 3445679999999999875 799999999999999999999998876554443322211 11110 000
Q ss_pred cccccccCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 746 AILDPVLKLPSD-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 746 ~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+.+....... ........+|+..+|..||.+|.|+.+++.
T Consensus 353 ~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 353 TIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111111100000 112356778999999999999999988764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=340.56 Aligned_cols=261 Identities=24% Similarity=0.327 Sum_probs=205.4
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.++||.|..++||+|+.. .++.||||++....... ..+.+.+|+..|+.++||||++++..|..++.+|+||.||
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfM 106 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFM 106 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhh
Confidence 456788999999999999954 58999999987655433 3688999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
.+||+.+.++..-+ .-+.+..+..|+.++++||.|||.++ .||||||+.||||+.+|.+||+|||.+..+....
T Consensus 107 a~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 107 AGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred cCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999986543 34888889999999999999999999 9999999999999999999999999886544332
Q ss_pred C-CCCc-cCCCCcCCccChhhhh--cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 675 S-SPLA-ELPAGTLGYLDPEYYR--LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 675 ~-~~~~-~~~~Gt~~y~aPE~l~--~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
. .... ....||+.|||||++. ...|+.|+|||||||+..||.+|..||.....-.-+. ..++ +......-.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl----~tLq-n~pp~~~t~ 255 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL----LTLQ-NDPPTLLTS 255 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH----HHhc-CCCCCcccc
Confidence 1 1112 5568999999999964 3468999999999999999999999997543222111 1111 111111111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.+...........+.+++..||+.||++|||++++++.
T Consensus 256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11111122334578899999999999999999998753
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=350.40 Aligned_cols=244 Identities=25% Similarity=0.352 Sum_probs=207.9
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.+.||+|+||.||||+.+ +.+.||+|.+.+....+++.+.+.+|++|+++|+|||||.++++|+...+.++|.||+.+
T Consensus 7 ~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g- 85 (808)
T KOG0597|consen 7 YEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG- 85 (808)
T ss_pred HHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-
Confidence 467999999999999976 478999998877766677788899999999999999999999999999999999999987
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|+.+|.... .++...+..|+.+++.||.|||+.. |+|||+||.||||+.++++|++|||+|+..... ..
T Consensus 86 ~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~ 155 (808)
T KOG0597|consen 86 DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TS 155 (808)
T ss_pred hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC--ce
Confidence 9999998765 4888889999999999999999999 999999999999999999999999999876543 33
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
..+...|||.|||||.+.+.+|+..+|.||+|||||||.+|++||... .+.+.+ ..+...+. ..+
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~----si~~Lv-~~I~~d~v----------~~p 220 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR----SITQLV-KSILKDPV----------KPP 220 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH----HHHHHH-HHHhcCCC----------CCc
Confidence 455678999999999999999999999999999999999999998632 222222 22222111 112
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
......+.+++...|..||..|.+..+++..
T Consensus 221 ~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 221 STASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 2566788999999999999999999988753
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=362.37 Aligned_cols=262 Identities=27% Similarity=0.422 Sum_probs=203.7
Q ss_pred hcccccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeE
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRER 587 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~ 587 (914)
...+.+.||+|+||.||+++.. ++..||+|++..... ....+.+.+|+++++.+ +|||||+++++|.+....
T Consensus 39 ~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 3446788999999999998842 245799998864332 22346789999999999 899999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhcCcc-----------------------------------------------------------
Q 002512 588 LLVYEFMAHGSLHQHLHGKSK----------------------------------------------------------- 608 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 608 (914)
+|||||+++|+|.++++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 999999999999999864321
Q ss_pred ------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCccCC
Q 002512 609 ------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP 682 (914)
Q Consensus 609 ------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~ 682 (914)
.....+++...++|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 00124778888999999999999999998 999999999999999999999999999765433222222233
Q ss_pred CCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHH
Q 002512 683 AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDAL 761 (914)
Q Consensus 683 ~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 761 (914)
.++..|||||++....++.++||||||++||||++ |+.||........+.. ....+. ....+...+
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~----~~~~~~---------~~~~~~~~~ 341 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK----MVKRGY---------QMSRPDFAP 341 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHH----HHHccc---------CccCCCCCC
Confidence 46678999999998899999999999999999997 9999865332221111 111110 000111123
Q ss_pred HHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 762 KRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 762 ~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
.++.+++.+||+.+|++||++.+|++.|++++
T Consensus 342 ~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 342 PEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 57889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=353.43 Aligned_cols=244 Identities=23% Similarity=0.377 Sum_probs=203.8
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
++||+|..|.||.+... .++.||||++...... ..+-+.+|+.+|+.++|+|||++++.|...++.++|||||++|+
T Consensus 279 ~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggs 356 (550)
T KOG0578|consen 279 KKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGS 356 (550)
T ss_pred hhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCc
Confidence 46999999999999854 6889999998765543 33668899999999999999999999999999999999999999
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
|.|.+... .+++.++..|+.++++||+|||.++ |||||||.+||||+.++.+||+|||++..+..... .
T Consensus 357 LTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~--K 425 (550)
T KOG0578|consen 357 LTDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS--K 425 (550)
T ss_pred hhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--c
Confidence 99998754 4788899999999999999999999 99999999999999999999999999977655443 3
Q ss_pred ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
....+||+.|||||++....|..|.||||||++++||+-|++||.. +..+.. ..++..... + ++....
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln---E~PlrA--lyLIa~ng~-----P--~lk~~~ 493 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN---ENPLRA--LYLIATNGT-----P--KLKNPE 493 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC---CChHHH--HHHHhhcCC-----C--CcCCcc
Confidence 4456899999999999999999999999999999999999999853 222221 122222211 1 122233
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.....+.+++.+||+.|+++||++.|+++.
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 455789999999999999999999999864
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=352.03 Aligned_cols=261 Identities=28% Similarity=0.460 Sum_probs=221.8
Q ss_pred HHHHHhcccccccCcccceEEEEEEEcC---C--cEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC
Q 002512 510 ELERATGGFKEEVGKGSFSCVYKGVLKD---G--TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG 584 (914)
Q Consensus 510 el~~~t~~~~~~LG~G~fG~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~ 584 (914)
+|.+....+.+.||.|.||.||+|.+.+ | -.||||..+..... ...+.|++|..+|++++|||||+|+|.|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 4556666677889999999999999643 3 35888877654433 3468899999999999999999999999874
Q ss_pred CeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeec
Q 002512 585 RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADF 664 (914)
Q Consensus 585 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DF 664 (914)
..+||||.++.|.|..||+.+.. .|+....+.++.||..+|+|||+.. +|||||..+|||+.....+||+||
T Consensus 464 -P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDF 535 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADF 535 (974)
T ss_pred -ceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeeccc
Confidence 67999999999999999987643 5788888999999999999999999 999999999999999999999999
Q ss_pred CCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCC
Q 002512 665 GLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGD 743 (914)
Q Consensus 665 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 743 (914)
||++.+..+...... ...-.+.|||||.+.-++++.+||||-|||.+||++. |.+||..-. +.+
T Consensus 536 GLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk--------------NsD 600 (974)
T KOG4257|consen 536 GLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK--------------NSD 600 (974)
T ss_pred chhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc--------------ccc
Confidence 999988776654433 4456789999999999999999999999999999987 889987432 223
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
+.-.++..-+.|.++.++..|+.|+.+||..+|.+||++.|+...|..++.
T Consensus 601 VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 601 VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 334445556777888899999999999999999999999999999988776
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.08 Aligned_cols=258 Identities=20% Similarity=0.379 Sum_probs=204.2
Q ss_pred HHHhcccccccCcccceEEEEEEEc----CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeE
Q 002512 512 ERATGGFKEEVGKGSFSCVYKGVLK----DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRER 587 (914)
Q Consensus 512 ~~~t~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 587 (914)
......+.+.||+|+||.||+|.++ .+..||+|++..... ......|.+|+.++.+++||||+++++++...+..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 3445567888999999999999864 356899998764422 23346799999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCc
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla 667 (914)
+|||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccc
Confidence 99999999999999997542 25889999999999999999999999 999999999999999999999999987
Q ss_pred ccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccc
Q 002512 668 LLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITA 746 (914)
Q Consensus 668 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 746 (914)
........ .......++..|+|||.+....++.++||||||+++|||++ |+.||...... .+ ...+..+.
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~-~~----~~~~~~~~--- 225 (266)
T cd05064 155 QEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ-DV----IKAVEDGF--- 225 (266)
T ss_pred ccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-HH----HHHHHCCC---
Confidence 65322211 11112235678999999999999999999999999999875 99998643221 11 11222211
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 747 ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
..+.+...+..+.+++.+||+.+|++||++++|.+.|++.
T Consensus 226 ------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1112223456788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=350.18 Aligned_cols=247 Identities=27% Similarity=0.386 Sum_probs=199.9
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc---cccchHHHHHHHHHHHhcc-CCceeeeeceeecCCeEEEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD---RQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV 590 (914)
+.+.+.||+|+||+||+|... .++.||+|.+..... .....+.+.+|+.++++++ ||||++++.++......|+|
T Consensus 19 y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~iv 98 (370)
T KOG0583|consen 19 YELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIV 98 (370)
T ss_pred eeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEE
Confidence 445678999999999999865 589999995544311 1123456678999999998 99999999999999999999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC-CcEEEeecCCccc
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE-HNARVADFGLSLL 669 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kl~DFGla~~ 669 (914)
|||+.+|+|++++.... .+......+++.|++.|++|+|+++ |+||||||+||||+.+ +++||+|||++..
T Consensus 99 mEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 99 MEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 99999999999998743 4677888899999999999999999 9999999999999999 9999999999988
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhhcCC-CC-CcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccc
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRLHY-LT-TKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~-~s-~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 747 (914)
.. ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.. +....... +..+.
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~----~~~~l~~k-i~~~~---- 239 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS----NVPNLYRK-IRKGE---- 239 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc----cHHHHHHH-HhcCC----
Confidence 74 1223445668999999999999866 65 7899999999999999999999752 22221111 22222
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVT 786 (914)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~ 786 (914)
...|.... ..++..|+.+|+..+|.+|+++.+|+
T Consensus 240 ----~~~p~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 240 ----FKIPSYLL-SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ----ccCCCCcC-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 22222211 56788999999999999999999998
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=346.28 Aligned_cols=251 Identities=34% Similarity=0.550 Sum_probs=194.7
Q ss_pred cccccCcccceEEEEEEEc-----CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 518 FKEEVGKGSFSCVYKGVLK-----DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
+.+.||.|.||.||+|.+. .+..|+||.+... ......++|.+|++++++++||||++++|++.+.+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4678999999999999987 2568999988432 233346889999999999999999999999998888999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|+++|+|.++|+... ...+++..+++|+.||++||+|||+.+ |+|+||+++|||+++++.+||+|||++.....
T Consensus 82 ~~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred ccccccccccccccc---ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc
Confidence 999999999998762 235899999999999999999999998 99999999999999999999999999987633
Q ss_pred CCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
...............|+|||.+....++.++||||||+++|||++ |+.|+... ....+.. .+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~~----~~~~~~~------- 223 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEIIE----KLKQGQR------- 223 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHHH----HHHTTEE-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccc----ccccccc-------
Confidence 222222333457789999999999989999999999999999999 67776533 2222221 2222211
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
.+.+...+..+.+++.+||..+|++||+|.++++.|
T Consensus 224 --~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 --LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp --TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred --ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111122346788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.12 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=203.1
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhcc-CCceeeeeceeecCC-eEEEEEe
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGR-ERLLVYE 592 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~-~~~LV~E 592 (914)
+...++||.|.||.||+|+.+ .++.||||+++......++ -.=++|++.|++|+ |||||+|.+++.+.+ .+|+|||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE 90 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE 90 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence 334678999999999999954 6899999998765543221 22468999999998 999999999998888 9999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
||+ -+|+++++++. ..++...+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+||||||....
T Consensus 91 ~Md-~NLYqLmK~R~----r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 91 FMD-CNLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred hhh-hhHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 996 49999998774 46899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCCCCccCCCCcCCccChhhhh-cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC--------
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYR-LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD-------- 743 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~-------- 743 (914)
.. -.+..+-|.-|.|||++. ...|+.+.|+|++|||++|+.+-++.|.+..+.+.+.... ..+-...
T Consensus 163 kp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc-~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 163 KP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKIC-EVLGTPDKDSWPEGY 238 (538)
T ss_pred CC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHH-HHhCCCccccchhHH
Confidence 32 234456789999999884 5689999999999999999999998887655544433211 1111100
Q ss_pred ---------cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 744 ---------ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 744 ---------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
+..+....+..-. .....+..+++.+|+..||.+|||+.|.++.-
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~-p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLL-PNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhC-cccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 0111110111001 12567889999999999999999999987653
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=344.86 Aligned_cols=257 Identities=32% Similarity=0.509 Sum_probs=205.0
Q ss_pred ccccccCcccceEEEEEEEcC------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
.+.+.||+|+||.||+|.... ...|++|.+.... ......+|.+|++++.+++||||+++++++.+.+..+++
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 86 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCML 86 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEE
Confidence 356789999999999998653 2578999875432 223346799999999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhcCccchh-----------cccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcE
Q 002512 591 YEFMAHGSLHQHLHGKSKALK-----------EQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA 659 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~-----------~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 659 (914)
|||+++++|.+++........ ..+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05048 87 FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTV 163 (283)
T ss_pred EecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcE
Confidence 999999999999976432211 45788889999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhh
Q 002512 660 RVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPL 738 (914)
Q Consensus 660 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~ 738 (914)
||+|||+++...............+++.|+|||++....++.++||||||++||||++ |..||...... .+. ..
T Consensus 164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~-~~~----~~ 238 (283)
T cd05048 164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ-EVI----EM 238 (283)
T ss_pred EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHH----HH
Confidence 9999999976543332223334457889999999998899999999999999999998 99998643221 111 12
Q ss_pred hhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
+..+... +.+...+.++.+|+.+||+.+|.+||++.||++.|+.
T Consensus 239 i~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 2222111 1122345789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=340.67 Aligned_cols=250 Identities=23% Similarity=0.298 Sum_probs=197.5
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
..+.||+|+||.||++... +++.||+|++...... ......+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05631 4 HYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecC
Confidence 4567999999999999965 6899999987543321 2233568899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 84 GGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred CCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999988864322 25788899999999999999999999 9999999999999999999999999997654322
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......||..|||||++....++.++|||||||+||||++|+.||......... +.....+... .. .
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~~~~~~--------~~--~ 223 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDRRVKED--------QE--E 223 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHHHhhcc--------cc--c
Confidence 122346899999999999999999999999999999999999999754322111 1111111111 00 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPS-----MDKVTT 787 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~ 787 (914)
........+.+|+.+||+.||++||+ ++++++
T Consensus 224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11223457889999999999999997 566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=357.76 Aligned_cols=262 Identities=27% Similarity=0.394 Sum_probs=204.9
Q ss_pred hcccccccCcccceEEEEEEEcC------CcEEEEEEeeeccccccchHHHHHHHHHHHhcc-CCceeeeeceeecCCeE
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRER 587 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~ 587 (914)
...+.+.||+|+||.||+|+... ...||||++.... .....+.|.+|+++|+++. |||||++++++.+....
T Consensus 38 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 38 GLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred ceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 34456789999999999998531 3469999885432 2333467999999999995 99999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhcCccc----------------------------------------------------------
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKA---------------------------------------------------------- 609 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~---------------------------------------------------------- 609 (914)
+|||||+++|+|.++|+.....
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 9999999999999998753210
Q ss_pred ---------------------------------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC
Q 002512 610 ---------------------------------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE 656 (914)
Q Consensus 610 ---------------------------------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~ 656 (914)
....+++..+++++.||++||+|||+.+ |+||||||+|||++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~ 273 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCC
Confidence 0124778888999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHH
Q 002512 657 HNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWA 735 (914)
Q Consensus 657 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~ 735 (914)
+.+||+|||+++...............++..|||||.+....++.++||||||++||||++ |..||........+.
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~--- 350 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY--- 350 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH---
Confidence 9999999999976543332222233457789999999998889999999999999999997 888886432222111
Q ss_pred HhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 736 VPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 736 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
..+..+. ..+.+...+..+.+++.+||+.+|++||++.+|.+.|++++
T Consensus 351 -~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 351 -NKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred -HHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1122211 11112234567899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=348.46 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=199.8
Q ss_pred cccccccCcccceEEEEEEEc-CCc----EEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGT----VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
+...+.||+|+||.||+|++. +++ .||+|++.... .....++|.+|+.+++.++||||++++++|... ..++|
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v 86 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 86 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceee
Confidence 344567999999999999864 333 38999875332 233457899999999999999999999999875 56799
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
+||+++|+|.++++... ..+++...++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 87 ~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 87 TQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999998643 24788889999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
..............+..|+|||++....++.++||||||++||||++ |+.||...... .+ ...+..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-~~----~~~~~~~~------ 228 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EI----SSILEKGE------ 228 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-HH----HHHHhCCC------
Confidence 54333222222335678999999999999999999999999999998 99988542111 11 11111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
..+.+......+.+++.+||+.+|.+||++.+++..|.++..
T Consensus 229 ---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 111112233568899999999999999999999999877643
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.42 Aligned_cols=258 Identities=22% Similarity=0.308 Sum_probs=203.1
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.++||+|.||.||+|++. .|+.||||++......+.-.....+|++.|+.++||||+.|+++|.+.+...||+|||+-
T Consensus 7 ~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t- 85 (318)
T KOG0659|consen 7 LEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT- 85 (318)
T ss_pred hhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-
Confidence 356999999999999964 699999999987755544456789999999999999999999999999999999999974
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|+..|+.... .++...+..++.++++||+|||++. |+||||||.|+|+++++.+||+|||+++.+.......
T Consensus 86 dLe~vIkd~~i----~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 86 DLEVVIKDKNI----ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred cHHHHhccccc----ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 99999987643 5788889999999999999999999 9999999999999999999999999999876554332
Q ss_pred CccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC------Ccccccc-
Q 002512 678 LAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG------DITAILD- 749 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~------~~~~~~d- 749 (914)
.. .+-|.-|.|||.+-+ +.|+...||||.|||+.||+-|.+-|....+-+.+...+. .+-.. ++..+.|
T Consensus 159 ~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~-~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 159 TH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFR-ALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred cc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHH-HcCCCCcccCccccccccH
Confidence 22 267899999999876 4789999999999999999999876665444333332221 11100 1111111
Q ss_pred --------cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 750 --------PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 750 --------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
+.+.. .-..+.....+|+..++..||.+|+++.|.+++
T Consensus 236 ~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 236 VKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11110 111344567899999999999999999988753
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=393.91 Aligned_cols=267 Identities=25% Similarity=0.465 Sum_probs=214.4
Q ss_pred CCHHHHHHHhcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC
Q 002512 506 FTYEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG 584 (914)
Q Consensus 506 ~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~ 584 (914)
++++++.... ...+.||+|+||.||+|+.. +++.||||++..... ....|++++++++|||||+++++|.+.
T Consensus 683 ~~~~~~~~~~-~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDILSSL-KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHHhhC-CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 5566665432 23457999999999999974 689999998753221 123568899999999999999999999
Q ss_pred CeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeec
Q 002512 585 RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADF 664 (914)
Q Consensus 585 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DF 664 (914)
+..+|||||+++|+|.++++ .++|..+.+|+.|+++||+|||....++|+||||||+|||++.+..+++. |
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~ 826 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L 826 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence 99999999999999999995 27899999999999999999997655669999999999999999988875 6
Q ss_pred CCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCccccc-ccccHHHHHHhhhhcCC
Q 002512 665 GLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQF-EEGNIVEWAVPLIKSGD 743 (914)
Q Consensus 665 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~-~~~~l~~~~~~~~~~~~ 743 (914)
+.......+ ....+|+.|||||++....++.|+|||||||++|||+||+.|++... ....+.+|+........
T Consensus 827 ~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 900 (968)
T PLN00113 827 SLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH 900 (968)
T ss_pred ccccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc
Confidence 665433221 12357899999999999999999999999999999999999986433 23456666665554444
Q ss_pred cccccccccCC--CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 744 ITAILDPVLKL--PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 744 ~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
...++|+.+.. +...+...++.+++.+||+.+|++||+|+||++.|+++.+
T Consensus 901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 55566665533 3345667789999999999999999999999999987654
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=340.35 Aligned_cols=258 Identities=27% Similarity=0.456 Sum_probs=205.4
Q ss_pred hcccccccCcccceEEEEEEEcC------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEE
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 588 (914)
+..+.+.||+|+||.||+|...+ ++.||+|.+..... ....+.|.+|++++++++||||+++++++......+
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 34566789999999999998643 47899998754332 223478999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhcCcc---------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcE
Q 002512 589 LVYEFMAHGSLHQHLHGKSK---------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA 659 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~---------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 659 (914)
+||||+++++|.++|+.... .....+++.....++.|++.+|+|||+++ |+||||||+|||++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 99999999999999976432 12245788899999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhh
Q 002512 660 RVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPL 738 (914)
Q Consensus 660 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~ 738 (914)
||+|||+++...............+++.|+|||++....++.++||||||+++|||++ |+.||...... ... ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~~~----~~ 236 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EVI----EC 236 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHH----HH
Confidence 9999999976433322222233346789999999999999999999999999999999 99998643221 111 22
Q ss_pred hhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
+..+..... +...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 237 ~~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 237 ITQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 222221111 1123467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=330.68 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=207.6
Q ss_pred hcccccccCcccceEEEEEEE-cCCcEEEEEEeeecc-ccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 515 TGGFKEEVGKGSFSCVYKGVL-KDGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
.+.|.+.||+|.||.|-++.. ..|+.||||.+.+.. ..+++.-.+.+|++||+.|+||||+.++.+|++.+...||||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 344567899999999999985 679999999876543 334455678899999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|..+|.|+||+.+.. .|+......|+.||..|+.|.|.+. ++|||||.+|||||+|+++||+||||+.++..
T Consensus 134 YaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 134 YASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred ecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999998764 4888889999999999999999999 99999999999999999999999999987765
Q ss_pred CCCCCCccCCCCcCCccChhhhhcCCC-CCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYL-TTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
.. ...+.+|++-|.+||++.+.+| .+..|-|||||+||.|+.|..||+...- . .+...+..|.+.+.
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-k----~lvrQIs~GaYrEP---- 273 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-K----RLVRQISRGAYREP---- 273 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-H----HHHHHhhcccccCC----
Confidence 43 4456689999999999998865 4789999999999999999999975321 1 22334555544332
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
+.+....-||.+||..+|++|.|+.+|+...
T Consensus 274 -------~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 -------ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred -------CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1123456789999999999999999998765
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=334.79 Aligned_cols=257 Identities=28% Similarity=0.470 Sum_probs=205.7
Q ss_pred HHHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEE
Q 002512 511 LERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 511 l~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
+.+....+.+.||+|+||.||++.+.+++.||+|.+.... ...++|.+|+.++++++||||+++++++...+..++|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 3344566778899999999999998888899999875432 2346799999999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
|||+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 80 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 153 (261)
T cd05068 80 TELMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVI 153 (261)
T ss_pred eecccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEc
Confidence 99999999999997643 235789999999999999999999999 999999999999999999999999999776
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
...... .......+..|+|||++....++.++||||||+++|||+| |+.||...... . ....+....
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~----~~~~~~~~~------ 221 (261)
T cd05068 154 KEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA-E----VLQQVDQGY------ 221 (261)
T ss_pred cCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH-H----HHHHHHcCC------
Confidence 532211 1111223468999999999899999999999999999999 88888532211 1 111121110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
..+........+.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 222 ---RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111122334678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.59 Aligned_cols=249 Identities=27% Similarity=0.448 Sum_probs=196.6
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
+.||+|+||.||+++++ +++.+|+|...... .......|.+|++++++++||||+++++++...+..+|||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 36999999999999975 68899999765332 22234679999999999999999999999999999999999999999
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++...........
T Consensus 80 L~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRTEG----PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 999997542 24788899999999999999999999 99999999999999999999999999875433211111
Q ss_pred ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
......+..|+|||.+....++.++||||||+++|||++ |..||...... . ....+... ...+.+
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~-~----~~~~~~~~---------~~~~~~ 218 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ-Q----TREAIEQG---------VRLPCP 218 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH-H----HHHHHHcC---------CCCCCc
Confidence 112223567999999998889999999999999999998 88887532211 1 11111111 011112
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
...+..+.+++.+||+.+|++||++.++.++|+
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 233467889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=335.23 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=203.0
Q ss_pred cccccccCcccceEEEEEEEcC----CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
..+.+.||+|+||.||+|.++. ...||||++.... ......+|.+|+.++++++||||+++++++.+.+..++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 84 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIIT 84 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEE
Confidence 3456789999999999999753 4578999775433 2333467999999999999999999999999999999999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+++++|.+++.... ..+++..+++++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 85 EYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999997643 25889999999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 672 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
............++..|+|||.+....++.++||||||+++|||++ |..||..... ..+ ...+....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-~~~----~~~~~~~~------- 225 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-QDV----IKAVEDGY------- 225 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-HHH----HHHHHcCC-------
Confidence 2222112222345678999999998899999999999999999998 9988753221 111 11121111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
..+.....+..+.+++.+||+.+|++||+++||++.|+++
T Consensus 226 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 --RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111223446788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=335.90 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=199.9
Q ss_pred cccccCcccceEEEEEEEcCCc---EEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC------CeEE
Q 002512 518 FKEEVGKGSFSCVYKGVLKDGT---VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG------RERL 588 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~ 588 (914)
+.+.||+|+||.||+|++.+.. .+|+|.+..........+.|.+|++++++++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 4578999999999999976532 589997755433444567899999999999999999999987432 2468
Q ss_pred EEEeeCCCCCHHHhhhcCcc-chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCc
Q 002512 589 LVYEFMAHGSLHQHLHGKSK-ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~-~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla 667 (914)
+||||+++|+|.+++..... .....+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred EEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCcc
Confidence 99999999999998853221 11235789999999999999999999998 999999999999999999999999999
Q ss_pred ccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccc
Q 002512 668 LLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITA 746 (914)
Q Consensus 668 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 746 (914)
+...............+++.|++||++....++.++||||||+++|||++ |+.||..... .. ....+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~----~~~~~~~~~~~~ 234 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-SE----IYDYLRQGNRLK 234 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH-HH----HHHHHHcCCCCC
Confidence 86543322112223346778999999999999999999999999999999 7888754211 11 112222222111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 747 ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
.....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 235 ---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 235 ---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1113345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=352.22 Aligned_cols=263 Identities=27% Similarity=0.393 Sum_probs=204.5
Q ss_pred HhcccccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhcc-CCceeeeeceeecCCe
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRE 586 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 586 (914)
....+.+.||+|+||.||++++. .++.||+|++.... .....+.|.+|+++|.++. |||||++++++.....
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 33445678999999999999864 24689999986432 2223457999999999997 9999999999999999
Q ss_pred EEEEEeeCCCCCHHHhhhcCccc---------------------------------------------------------
Q 002512 587 RLLVYEFMAHGSLHQHLHGKSKA--------------------------------------------------------- 609 (914)
Q Consensus 587 ~~LV~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------- 609 (914)
.+|||||+++|+|.++|++....
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 99999999999999999754210
Q ss_pred ------------------------------------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE
Q 002512 610 ------------------------------------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 653 (914)
Q Consensus 610 ------------------------------------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl 653 (914)
....+++...++|+.||+.||+|||+.+ |+||||||+|||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl 272 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLI 272 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEE
Confidence 0123677788999999999999999988 9999999999999
Q ss_pred cCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHH
Q 002512 654 DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIV 732 (914)
Q Consensus 654 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~ 732 (914)
++++.+||+|||+++...............++..|||||.+....++.++||||||++||||++ |+.||........+
T Consensus 273 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~- 351 (401)
T cd05107 273 CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF- 351 (401)
T ss_pred eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH-
Confidence 9999999999999976533222112223357889999999998889999999999999999998 88887543222111
Q ss_pred HHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 733 EWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
...+..+. +.+.+.....++.+|+.+||..+|.+||+++||++.|++++
T Consensus 352 ---~~~~~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 352 ---YNAIKRGY---------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred ---HHHHHcCC---------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11122211 11111223467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=339.17 Aligned_cols=257 Identities=27% Similarity=0.467 Sum_probs=201.6
Q ss_pred cccccccCcccceEEEEEEE-----cCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVL-----KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
..+.+.||+|+||.||+|.. .+++.+++|.+..... .....+|.+|++++++++||||+++++++...+..++|
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 85 (283)
T cd05090 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCML 85 (283)
T ss_pred ceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEE
Confidence 34668899999999999985 2467899998764332 23346799999999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhcCcc------------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCc
Q 002512 591 YEFMAHGSLHQHLHGKSK------------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHN 658 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~------------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~ 658 (914)
|||+++++|.+++..... .....+++...+.++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 86 FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCc
Confidence 999999999999864321 11235788889999999999999999999 999999999999999999
Q ss_pred EEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHh
Q 002512 659 ARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVP 737 (914)
Q Consensus 659 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~ 737 (914)
+||+|||+++...............++..|+|||++....++.++||||||++||||++ |..||..... ..+ ..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-~~~----~~ 237 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEV----IE 237 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-HHH----HH
Confidence 99999999976543322222233346778999999998889999999999999999999 8888753211 111 11
Q ss_pred hhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 738 LIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
.+...... +.+.....++.+++.+||+.+|++||++.+|.+.|.
T Consensus 238 ~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 281 (283)
T cd05090 238 MVRKRQLL---------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLR 281 (283)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhh
Confidence 22221111 111223457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=333.77 Aligned_cols=252 Identities=25% Similarity=0.448 Sum_probs=203.1
Q ss_pred cccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
..+.++||+|+||.||+|...+++.||+|++.... ...+.|.+|+.++++++||||+++++++.+.+..+|||||++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 44668899999999999998888899999865322 234789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.++++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||++........
T Consensus 85 ~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 85 KGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999997542 235788889999999999999999998 99999999999999999999999999976543322
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. ......++..|+|||++....++.++||||||+++|||+| |+.||...... ... ..+.... ..
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~----~~~~~~~---------~~ 223 (261)
T cd05072 159 T-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS-DVM----SALQRGY---------RM 223 (261)
T ss_pred e-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH-HHH----HHHHcCC---------CC
Confidence 1 1222346778999999998889999999999999999999 88888542211 111 1111111 11
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
+.....+..+.+++.+||..+|++||+++++.+.|++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=334.48 Aligned_cols=262 Identities=18% Similarity=0.227 Sum_probs=198.6
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||+++.+ +++.||+|++..........+.+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 83 (287)
T cd07848 4 EVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83 (287)
T ss_pred eEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCC
Confidence 45678999999999999986 57889999886554444445778999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|..+.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 84 KNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred CCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 87776554322 24788888999999999999999999 99999999999999999999999999976543222
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHH-----------HhhhhcCCc
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA-----------VPLIKSGDI 744 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~-----------~~~~~~~~~ 744 (914)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||........+.... .........
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 A-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred c-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 1 1223468999999999998889999999999999999999999986532221111100 000000000
Q ss_pred ccccccccCCCCC------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 TAILDPVLKLPSD------LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 ~~~~d~~l~~~~~------~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....+....+.. ......+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000011111110 113457899999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=346.07 Aligned_cols=262 Identities=28% Similarity=0.393 Sum_probs=204.0
Q ss_pred cccccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecC-CeE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEG-RER 587 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~-~~~ 587 (914)
+.+.+.||+|+||.||+|... .++.||+|++.... .....+.+.+|+.++.++ +||||++++++|... ...
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~ 87 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPL 87 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCE
Confidence 446678999999999999743 24789999875432 223346788999999999 899999999988654 567
Q ss_pred EEEEeeCCCCCHHHhhhcCccc--------------------------------------------------------hh
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKA--------------------------------------------------------LK 611 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------~~ 611 (914)
+++|||+++++|.++|...... ..
T Consensus 88 ~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (337)
T cd05054 88 MVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYK 167 (337)
T ss_pred EEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhh
Confidence 8999999999999998643210 12
Q ss_pred cccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccCh
Q 002512 612 EQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691 (914)
Q Consensus 612 ~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aP 691 (914)
..++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..||||
T Consensus 168 ~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 168 EPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 36899999999999999999999998 999999999999999999999999999875443322223334567889999
Q ss_pred hhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHH
Q 002512 692 EYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACK 770 (914)
Q Consensus 692 E~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~ 770 (914)
|++....++.++|||||||+||||++ |+.||......+.+. ..+..+... ..+.....++.+|+.+
T Consensus 245 E~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 245 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFC----RRLKEGTRM---------RAPEYATPEIYSIMLD 311 (337)
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHH----HHHhccCCC---------CCCccCCHHHHHHHHH
Confidence 99999999999999999999999998 998986432222111 122222111 1111234678999999
Q ss_pred hhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 771 CVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 771 Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
||+.+|++||++.||++.|++++.
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=343.66 Aligned_cols=243 Identities=24% Similarity=0.314 Sum_probs=194.7
Q ss_pred cCcccceEEEEEEEc-CCcEEEEEEeeecc-ccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 522 VGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
||+|+||.||+++.. +++.||+|++.... ........+.+|+.++.+++||||+++++++.+.+..+|||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999976 47899999876432 1223456788999999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCc
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 679 (914)
.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~ 150 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKT 150 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccc
Confidence 99997543 4788888999999999999999999 9999999999999999999999999987543222 122
Q ss_pred cCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHH
Q 002512 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLD 759 (914)
Q Consensus 680 ~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 759 (914)
....||+.|+|||++....++.++|||||||++|||++|+.||..... .+...... ... ...+ ..
T Consensus 151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----~~~~~~~~-~~~--------~~~~--~~ 215 (312)
T cd05585 151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----NEMYRKIL-QEP--------LRFP--DG 215 (312)
T ss_pred ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----HHHHHHHH-cCC--------CCCC--Cc
Confidence 345699999999999999999999999999999999999999864321 11111111 111 1111 12
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 760 ALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 760 ~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
...++.+++.+||+.||++||++..+.+.|
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 345788999999999999999765544444
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=336.10 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=197.6
Q ss_pred cccccCcccceEEEEEEEc-CCc----EEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGT----VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
+.+.||+|+||.||+|.+. +++ .+++|++.... ......++..|+.++++++||||+++++++.. ...++|+|
T Consensus 11 ~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e 88 (279)
T cd05111 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQ 88 (279)
T ss_pred eccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEE
Confidence 4567999999999999974 344 36667653221 22334678889999999999999999999864 45789999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|+++|+|.++++... ..+++...+.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++....
T Consensus 89 ~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 89 LSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred eCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999997543 25889999999999999999999998 99999999999999999999999999986544
Q ss_pred CCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
...........++..|+|||++....++.++||||||+++|||++ |+.||...... .+ ...+..+... ..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-~~----~~~~~~~~~~--~~~- 233 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-EV----PDLLEKGERL--AQP- 233 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HH----HHHHHCCCcC--CCC-
Confidence 333223334457789999999998889999999999999999998 99888643211 11 1122222111 111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
......+.+++.+||..+|.+|||+.|+++.|+.+.+
T Consensus 234 ------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 234 ------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1123467889999999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=337.96 Aligned_cols=261 Identities=27% Similarity=0.441 Sum_probs=205.3
Q ss_pred hcccccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEE
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 588 (914)
...+.+.||+|+||.||++... ++..+|+|.+.... ....+.|.+|++++++++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 3446678999999999999852 24568888775432 233467999999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhcCcc--------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEE
Q 002512 589 LVYEFMAHGSLHQHLHGKSK--------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNAR 660 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~--------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~k 660 (914)
+||||+++++|.+++..... .....+++..++.++.|++.+|+|||+.+ |+||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 99999999999999975431 11234899999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhh
Q 002512 661 VADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLI 739 (914)
Q Consensus 661 l~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~ 739 (914)
|+|||+++...............++..|+|||++....++.++||||||+++|||++ |+.||...... .. ...+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~-~~----~~~i 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN-EV----IECI 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HH----HHHH
Confidence 999999976543322222233446789999999998899999999999999999999 88887543221 11 1122
Q ss_pred hcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 740 KSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
..+..... +...+..+.+|+.+||+.+|.+|||+.|+.+.|+++..
T Consensus 236 ~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 TQGRVLQR---------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HcCCcCCC---------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 22221111 11123568999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=337.47 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=203.1
Q ss_pred cccccCcccceEEEEEEEcC------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
+.+.||+|+||.||+|+... ...+++|.+..... ....++|.+|+.++++++||||+++++++...+..++||
T Consensus 4 ~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred ccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45679999999999998642 35688887654332 233467999999999999999999999999999999999
Q ss_pred eeCCCCCHHHhhhcCcc-------------------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceE
Q 002512 592 EFMAHGSLHQHLHGKSK-------------------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNIL 652 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NIL 652 (914)
||+++++|.+++..... .....+++...+.++.|++.||+|||+.+ |+||||||+|||
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEE
Confidence 99999999999864321 11235788999999999999999999998 999999999999
Q ss_pred EcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccH
Q 002512 653 IDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNI 731 (914)
Q Consensus 653 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l 731 (914)
+++++.+||+|||+++...............++..|+|||++....++.++||||||+++|||+| |+.||..... ..+
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~ 238 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERL 238 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-HHH
Confidence 99999999999999976543322222233346778999999998889999999999999999999 9888853221 111
Q ss_pred HHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 732 VEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 732 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
. ...... ...+.+.....++.+++.+||+.+|++||++.|+++.|++++.
T Consensus 239 ~----~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 239 F----NLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H----HHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 122111 1111122334678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=331.49 Aligned_cols=248 Identities=26% Similarity=0.453 Sum_probs=199.0
Q ss_pred ccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
.+.+.||+|+||.||++.++++..+|+|.+.... ...++|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~ 83 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMEN 83 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCC
Confidence 4567899999999999999888899999764322 2346799999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
|+|.++++... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 84 GCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999997543 24789999999999999999999999 999999999999999999999999998764322211
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......++..|+|||++....++.++||||||++||||++ |+.||...... ... ..+..+.. ...+
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-~~~----~~i~~~~~--~~~~----- 223 (256)
T cd05114 157 -SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVV----EMISRGFR--LYRP----- 223 (256)
T ss_pred -ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-HHH----HHHHCCCC--CCCC-----
Confidence 1122235678999999998889999999999999999999 88888543211 111 11222211 1111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
......+.+++.+||+.+|++||+++++++.|
T Consensus 224 --~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 --KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11235789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=333.71 Aligned_cols=258 Identities=28% Similarity=0.427 Sum_probs=202.2
Q ss_pred cccccCcccceEEEEEEEcC----CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCe------E
Q 002512 518 FKEEVGKGSFSCVYKGVLKD----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRE------R 587 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~------~ 587 (914)
+.+.||+|+||.||+|.+.. +..||+|++............|.+|+++++.++||||+++++++.+.+. .
T Consensus 3 ~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05035 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82 (273)
T ss_pred cccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCccc
Confidence 45779999999999999753 3679999876544334445789999999999999999999998876554 7
Q ss_pred EEEEeeCCCCCHHHhhhcCcc-chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCC
Q 002512 588 LLVYEFMAHGSLHQHLHGKSK-ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~-~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGl 666 (914)
++||||+++++|.+++..... .....+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 83 ~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 83 MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred EEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccc
Confidence 999999999999999864321 12245888899999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcc
Q 002512 667 SLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDIT 745 (914)
Q Consensus 667 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 745 (914)
++...............++..|+|||++....++.++||||||+++|||++ |..||..... ..+. ..+..+...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~-~~~~----~~~~~~~~~ 234 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIY----DYLRHGNRL 234 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH-HHHH----HHHHcCCCC
Confidence 976544332222222345678999999998899999999999999999999 8888754321 1111 122222111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
. .+.....++.+++.+||+.+|++||++.|+++.|+++
T Consensus 235 ~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 235 K---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1123346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.48 Aligned_cols=243 Identities=25% Similarity=0.375 Sum_probs=199.9
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
+.||+|.||.||||... .++.||+|.+.... ...+.+++.+|+.+|.+++++||.++|+.+..+..++++|||+.+|+
T Consensus 19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGs 97 (467)
T KOG0201|consen 19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGS 97 (467)
T ss_pred hhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcc
Confidence 56999999999999975 58899999886544 34456889999999999999999999999999999999999999999
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
+.+.|+.... ++.....-|..+++.||.|||+++ .+|||||+.||||..++.+||+|||.+-.+.......
T Consensus 98 v~~lL~~~~~-----~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr- 168 (467)
T KOG0201|consen 98 VLDLLKSGNI-----LDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR- 168 (467)
T ss_pred hhhhhccCCC-----CccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc-
Confidence 9999986543 345555567889999999999999 9999999999999999999999999997766554332
Q ss_pred ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
...+||+.|||||+++...|+.|+||||||++.+||++|.+|+.......-+. .+.+-..|.+..
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf----------lIpk~~PP~L~~---- 233 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF----------LIPKSAPPRLDG---- 233 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE----------eccCCCCCcccc----
Confidence 55689999999999998899999999999999999999999986443311100 011111222222
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....+.+++..||..+|+.||++.++++
T Consensus 234 ~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 234 DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 34467889999999999999999998865
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=345.12 Aligned_cols=242 Identities=23% Similarity=0.301 Sum_probs=194.7
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
.||+|+||.||+++.+ +++.||+|++..... .......+.+|+.++++++||||+++++++.+.+..+|||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 5999999999999975 688999998865322 22334678899999999999999999999999999999999999999
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 82 LFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 999997543 4788888999999999999999999 9999999999999999999999999987532221 12
Q ss_pred ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
.....||+.|+|||++....++.++|||||||+||||++|+.||...... .+. ..+..+.. .. +.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-~~~----~~~~~~~~--------~~--p~ 216 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLF----ELILMEEI--------RF--PR 216 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-HHH----HHHHcCCC--------CC--CC
Confidence 23346999999999999999999999999999999999999998643211 111 11111111 11 11
Q ss_pred HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERP-----SMDKVTT 787 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~ 787 (914)
....++.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 2345788999999999999999 6777653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=332.11 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=202.8
Q ss_pred hcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
...+.++||+|+||.||++..+ .++.||+|++... .....+|.+|++++++++||||+++++++..++..++||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 3456778999999999999976 4788999976432 22346799999999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++++|.+++..... ..+++..++.++.|++++|+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~L~~~~~~~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 84 MTYGNLLDYLRECNR---QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred CCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 999999999975432 35788999999999999999999998 999999999999999999999999999765433
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
... ......++..|+|||.+....++.++||||||+++|||++ |..|+..... ... ...+... .
T Consensus 158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-~~~----~~~~~~~---------~ 222 (263)
T cd05052 158 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQV----YELLEKG---------Y 222 (263)
T ss_pred eee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHH----HHHHHCC---------C
Confidence 221 1112234678999999999999999999999999999998 8888753211 111 1111111 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
..+.+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1111123346788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=342.93 Aligned_cols=260 Identities=23% Similarity=0.281 Sum_probs=198.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||+++.+ ++..+|+|.+.... .....++|.+|+++|++++||||+++++++.+.+..+|||||++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 8 ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred eEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 34567999999999999976 47788888775432 22334679999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++.... .+++..+..++.|++.||.|||+.+ .|+||||||+|||+++++.+||+|||++......
T Consensus 87 ~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 87 GGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999997543 4788888999999999999999853 2999999999999999999999999998755332
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC--c-c-------
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD--I-T------- 745 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~--~-~------- 745 (914)
......||+.|+|||++.+..++.++||||||++||||+||+.||...... .+..........+. . .
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVDGEEGEPHSISPRPR 234 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccccCCccccCcccc
Confidence 123346899999999999989999999999999999999999998643211 11111000000000 0 0
Q ss_pred --------------------c----ccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 746 --------------------A----ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 746 --------------------~----~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
+ +...............++.+|+.+||+.||++|||++|+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0 0000000000112346789999999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=337.54 Aligned_cols=260 Identities=26% Similarity=0.432 Sum_probs=205.6
Q ss_pred cccccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLL 589 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 589 (914)
..+.+.||+|+||.||+++.. +...+++|++.... ....+.|.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 7 IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred eEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 345678999999999999853 34568888764332 2334679999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHhhhcCcc-----------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCc
Q 002512 590 VYEFMAHGSLHQHLHGKSK-----------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHN 658 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~ 658 (914)
||||+++++|.+++..... .....+++..++.++.||+.||+|||+++ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975432 11235789999999999999999999999 999999999999999999
Q ss_pred EEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHh
Q 002512 659 ARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVP 737 (914)
Q Consensus 659 ~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~ 737 (914)
+||+|||++................++..|+|||++....++.++||||||+++|||+| |+.||...... ... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~----~ 236 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-EVI----E 236 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-HHH----H
Confidence 99999999976544332222333457889999999999999999999999999999999 99987543221 111 1
Q ss_pred hhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 738 LIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
.+..+..... ....+..+.+++.+||+.+|++||++.+|+++|+++..
T Consensus 237 ~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 2222221111 11234578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=331.09 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=196.7
Q ss_pred ccCcccceEEEEEEEc---CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLK---DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
+||+|+||.||+|.++ +++.+|+|++..........++|.+|+.++++++||||+++++++.. +..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 5999999999999753 57889999875444333445789999999999999999999999864 5678999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... .+++...+.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 9999997542 4788889999999999999999999 9999999999999999999999999997654332211
Q ss_pred -CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 678 -LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 678 -~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+ ...+..+... +
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~----~~~i~~~~~~---------~ 218 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEV----TQMIESGERM---------E 218 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHH----HHHHHCCCCC---------C
Confidence 1122235679999999988889999999999999999998 8999864321 111 1122222111 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
.+...+.++.+++.+||+.+|++||++.+|.+.|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 112334678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=338.71 Aligned_cols=237 Identities=22% Similarity=0.288 Sum_probs=192.6
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||++..+ +++.||+|++..... ..+..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 83 (291)
T cd05612 4 ERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYV 83 (291)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCC
Confidence 35678999999999999976 588999998754321 1223467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.+++.... .+++.....++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 84 ~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 84 PGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999997543 4788888999999999999999999 999999999999999999999999998765332
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
.....||+.|+|||++....++.++||||||++||||++|+.||...... + ....+..+.. ..
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~----~-~~~~i~~~~~--------~~ 217 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF----G-IYEKILAGKL--------EF 217 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----H-HHHHHHhCCc--------CC
Confidence 12346899999999999988999999999999999999999998643211 1 1111212111 11
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPS 781 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs 781 (914)
+ ......+.+|+.+||+.||.+||+
T Consensus 218 ~--~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 218 P--RHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred C--ccCCHHHHHHHHHHcCCCHHHccC
Confidence 1 112356789999999999999995
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=336.33 Aligned_cols=257 Identities=24% Similarity=0.411 Sum_probs=200.4
Q ss_pred cccccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLL 589 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 589 (914)
+.+.+.||+|+||.||+|.++ .+..||+|++.... ......+|.+|+.++++++||||+++++++.+....++
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~l 86 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLV 86 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEE
Confidence 456678999999999999864 24679999874432 22334679999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHhhhcCccch-----hcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeec
Q 002512 590 VYEFMAHGSLHQHLHGKSKAL-----KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADF 664 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~-----~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DF 664 (914)
||||+++++|.++++...... ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+||
T Consensus 87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~df 163 (277)
T cd05062 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDF 163 (277)
T ss_pred EEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCC
Confidence 999999999999997533211 224678888999999999999999998 999999999999999999999999
Q ss_pred CCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCC
Q 002512 665 GLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGD 743 (914)
Q Consensus 665 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 743 (914)
|+++...............+++.|||||++....++.++||||||+++|||++ |..||...... .. ...+....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-~~----~~~~~~~~ 238 (277)
T cd05062 164 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-QV----LRFVMEGG 238 (277)
T ss_pred CCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HH----HHHHHcCC
Confidence 99875543322222222346788999999999899999999999999999999 67787543211 11 11222221
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
.... +...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 239 ~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 239 LLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred cCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111 1123457889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=345.30 Aligned_cols=252 Identities=22% Similarity=0.285 Sum_probs=200.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||+++.. +++.||+|++..... .....+.+.+|++++.+++||||+++++++.+.+..+|||||+
T Consensus 4 ~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 83 (333)
T cd05600 4 QILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYV 83 (333)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCC
Confidence 45678999999999999986 488999998865422 1223467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 84 ~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 84 PGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999997543 4778888899999999999999999 99999999999999999999999999875433
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
......||+.|+|||++....++.++|||||||+||||++|+.||........ .. .+... ...+......
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~----~i~~~--~~~~~~~~~~ 223 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WE----NLKYW--KETLQRPVYD 223 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HH----HHHhc--cccccCCCCC
Confidence 22334689999999999999999999999999999999999999864322111 11 11110 0001100000
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
........++.+++.+||..+|++||+++++++.
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0112334678899999999999999999988754
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=333.81 Aligned_cols=267 Identities=24% Similarity=0.380 Sum_probs=201.9
Q ss_pred ccccccCcccceEEEEEEE-----cCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC--CeEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVL-----KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RERLL 589 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~L 589 (914)
.+.+.||+|+||+||++.. .+++.||+|.+.... .......|.+|++++++++||||+++++++... ...++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 4567899999999988653 357889999875432 223456789999999999999999999988654 46789
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||+++++|.+++... .+++..++.++.|+++||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~ 156 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA 156 (283)
T ss_pred EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccc
Confidence 99999999999999643 4889999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCC-CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCccccccc-ccHHHHHHhhhhcCCcccc
Q 002512 670 GPADSSS-PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE-GNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 670 ~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~~ 747 (914)
....... .......++..|+|||++....++.++||||||+++|||+||+.|+...... ...............+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 5433221 1112234567799999999888999999999999999999999997543211 0000000000000111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
.+.....+.+...+.++.+++.+||+.+|++|||++++++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2222222223344578999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=340.06 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=194.2
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
.||+|+||.||+++.+ +++.||+|++..... .......+.+|++++++++||||+++++++...+..+|||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 5999999999999975 589999998865422 22334678899999999999999999999999999999999999999
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
|.+++.... .+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 82 L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~ 151 (323)
T cd05595 82 LFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--T 151 (323)
T ss_pred HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--c
Confidence 999987543 4788899999999999999999999 99999999999999999999999999875322211 1
Q ss_pred ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
.....||+.|+|||++....++.++|||||||+||||++|+.||....... .. ..+.... ...+ .
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~----~~~~~~~--------~~~p--~ 216 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LF----ELILMEE--------IRFP--R 216 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH-HH----HHHhcCC--------CCCC--C
Confidence 223468999999999999899999999999999999999999986432211 11 1111111 1111 1
Q ss_pred HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERP-----SMDKVTT 787 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~ 787 (914)
....++.+++.+||+.+|++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 2345778999999999999998 6777664
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=336.78 Aligned_cols=256 Identities=26% Similarity=0.417 Sum_probs=201.6
Q ss_pred ccccccCcccceEEEEEEEcC------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
.+.++||+|+||.||+|...+ ++.||+|++..... ....+.|.+|+.++.+++||||+++++++.+.+..+++
T Consensus 8 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 456789999999999998643 57899998764332 22346789999999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhcCcc-----------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcE
Q 002512 591 YEFMAHGSLHQHLHGKSK-----------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA 659 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 659 (914)
+||+++++|.+++..... .....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 999999999999853211 11235788889999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhh
Q 002512 660 RVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPL 738 (914)
Q Consensus 660 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~ 738 (914)
||+|||+++...............+++.|+|||++....++.++||||||+++|||++ |..||..... ... ...
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~----~~~ 238 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-QDV----IEM 238 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-HHH----HHH
Confidence 9999999876543332222333456789999999988889999999999999999998 7777753221 111 122
Q ss_pred hhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
+..+... +.+...+..+.+|+.+||+.+|++||++++|+..|+
T Consensus 239 i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 239 IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 2222211 112234567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=339.21 Aligned_cols=264 Identities=27% Similarity=0.397 Sum_probs=206.1
Q ss_pred HhcccccccCcccceEEEEEEEc--------CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecC
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLK--------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEG 584 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~ 584 (914)
..+.+.+.||+|+||.||+++.. +...+|+|.+.... ......++.+|+.++.++ +||||+++++++.+.
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 44567788999999999999853 23469999875432 233446788999999999 899999999999999
Q ss_pred CeEEEEEeeCCCCCHHHhhhcCccc-----------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE
Q 002512 585 RERLLVYEFMAHGSLHQHLHGKSKA-----------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 653 (914)
Q Consensus 585 ~~~~LV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl 653 (914)
+..++||||+++|+|.+++...... ....+++..+++++.|++.||+|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 9999999999999999999764321 1235889999999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHH
Q 002512 654 DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIV 732 (914)
Q Consensus 654 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~ 732 (914)
++++.+||+|||+++...............+++.|+|||++....++.++||||||+++|||++ |+.||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 9999999999999876543221111222234578999999998889999999999999999998 7788753211
Q ss_pred HHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 002512 733 EWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~ 795 (914)
+.....+..+.. .+.+.....++.+|+.+||+.+|++||+|.+|++.|++++..
T Consensus 249 ~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 249 EELFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHcCCC---------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 111112222211 111123346788999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=343.36 Aligned_cols=246 Identities=25% Similarity=0.392 Sum_probs=205.3
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeecc-ccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.||+|+-|.|-+|++. .|+.+|||.+.... ..+.....+.+|+.+|+.|.||||++||+++++..++|||.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 4567999999999999965 69999999886652 233344668899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+|.|+++|-.++ .++..+..+++.||+.|+.|.|..+ |+||||||+|+|||..+++||+|||+|.+-..+.
T Consensus 96 gGELFdylv~kG-----~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 96 GGELFDYLVRKG-----PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred CchhHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 999999998765 4788889999999999999999999 9999999999999999999999999997755443
Q ss_pred CCCccCCCCcCCccChhhhhcCCC-CCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYL-TTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~-s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
.-.+.+|++.|.+||++.+.+| ..++||||.|||||.||||+.||++ +++.... ..++.|.+. .
T Consensus 167 --lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LL-lKV~~G~f~--------M 231 (786)
T KOG0588|consen 167 --LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLL-LKVQRGVFE--------M 231 (786)
T ss_pred --cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHH-HHHHcCccc--------C
Confidence 3455689999999999998865 5789999999999999999999973 2333222 223333321 1
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
| ...+.+..+|+.+|+..||+.|.|++||++.-
T Consensus 232 P--s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 232 P--SNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred C--CcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 1 23446788999999999999999999998753
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=312.45 Aligned_cols=263 Identities=22% Similarity=0.363 Sum_probs=211.9
Q ss_pred hcccccccCcccceEEEEEE-EcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC-----eEE
Q 002512 515 TGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR-----ERL 588 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~ 588 (914)
.+.+.+.||+|||+.||+++ +.+++.+|+|++.-.. .+..+..++|++..++++||||++++++...+. ..|
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 35567889999999999998 4568899999986544 445688999999999999999999999986554 489
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
|+++|...|||.+++..... ....++..+.+.|+.+|.+||++||+.. ||++||||||.|||+.+++.++|.|||.+.
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 99999999999999976533 2346899999999999999999999988 689999999999999999999999999886
Q ss_pred cCCCCCCCCC-------ccCCCCcCCccChhhhhc---CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhh
Q 002512 669 LGPADSSSPL-------AELPAGTLGYLDPEYYRL---HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPL 738 (914)
Q Consensus 669 ~~~~~~~~~~-------~~~~~Gt~~y~aPE~l~~---~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~ 738 (914)
..+..-.... .....-|..|.|||.+.- ...++++|||||||+||+|+.|..||+...+.+.-+.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla----- 252 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA----- 252 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----
Confidence 5432211110 111236889999999853 4678999999999999999999999975433322111
Q ss_pred hhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
..+....+..|.....++.+.+++.+|++.||.+||++.+++..++.+
T Consensus 253 ------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 253 ------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 233344455555556778999999999999999999999999988754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=331.82 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=200.3
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeecccc------------ccchHHHHHHHHHHHhccCCceeeeeceee
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR------------QKNSKEFHTELDLLSRLNHAHLLNLLGYCE 582 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~------------~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~ 582 (914)
+.+.++||+|.||.|-+|+.. +++.||||++.+.... ....+...+|+.+|++++|||||+|+.+..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 345677999999999999965 6999999987654221 112357889999999999999999999987
Q ss_pred c--CCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEE
Q 002512 583 E--GRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNAR 660 (914)
Q Consensus 583 ~--~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~k 660 (914)
+ .+..|||+|||..|.+...=.. ...++..+..+++.++..||+|||.++ ||||||||+|+||++++++|
T Consensus 179 DP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VK 250 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVK 250 (576)
T ss_pred CcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEE
Confidence 6 4588999999998887543221 123888999999999999999999999 99999999999999999999
Q ss_pred EeecCCcccCCCCCCC---CCccCCCCcCCccChhhhhcC----CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHH
Q 002512 661 VADFGLSLLGPADSSS---PLAELPAGTLGYLDPEYYRLH----YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733 (914)
Q Consensus 661 l~DFGla~~~~~~~~~---~~~~~~~Gt~~y~aPE~l~~~----~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~ 733 (914)
|+|||.+......... .......||+.|||||...++ ..+.+.||||+||+||-|+.|+.||...+.- +
T Consensus 251 IsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~----~ 326 (576)
T KOG0585|consen 251 ISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL----E 326 (576)
T ss_pred eeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----H
Confidence 9999999765332111 112235799999999998763 3567899999999999999999999654321 1
Q ss_pred HHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 734 WAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 734 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
.. ..|+...+..|..++.-+++.+|+.++|..||+.|.+..+|....
T Consensus 327 l~---------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 327 LF---------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred HH---------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 11 134444556666667778899999999999999999999987655
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.20 Aligned_cols=261 Identities=21% Similarity=0.296 Sum_probs=194.0
Q ss_pred cccccccCcccceEEEEEEEc--CCcEEEEEEeeeccccccchHHHHHHHHHHHhc---cCCceeeeeceee-----cCC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK--DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL---NHAHLLNLLGYCE-----EGR 585 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~-----~~~ 585 (914)
+.+.+.||+|+||.||+++.. +++.||+|++............+.+|+.+++++ +||||+++++++. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 345678999999999999863 467899998765443333345677888887776 6999999999885 345
Q ss_pred eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecC
Q 002512 586 ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 586 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFG 665 (914)
..++||||++ ++|.+++..... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 6899999996 699999975432 34788899999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC---
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG--- 742 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~--- 742 (914)
+++..... .......||+.|+|||++....++.++||||||+++|||++|++||........+... .......
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i-~~~~~~~~~~ 231 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI-LDVIGLPGEE 231 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHH-HHHhCCCChh
Confidence 99765432 1223446899999999999888999999999999999999999998754332222111 1110000
Q ss_pred Ccc-------cccccccCCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 743 DIT-------AILDPVLKLPS---DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 743 ~~~-------~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+.. ..+.+....+. .......+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 00000000000 0122356789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=328.82 Aligned_cols=248 Identities=27% Similarity=0.458 Sum_probs=198.6
Q ss_pred ccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
.+.+.||+|+||.||++.++++..+|+|.+.... ....+|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 3567899999999999998877889999874322 2336799999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~ 156 (256)
T cd05059 84 GCLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT 156 (256)
T ss_pred CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence 999999975432 5789999999999999999999999 999999999999999999999999998764322111
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......++..|+|||.+....++.++||||||++||||++ |+.||...... ... ..+.... ..+
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-~~~----~~~~~~~---------~~~ 221 (256)
T cd05059 157 -SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS-EVV----ESVSAGY---------RLY 221 (256)
T ss_pred -ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH-HHH----HHHHcCC---------cCC
Confidence 1112234568999999998899999999999999999999 78888543221 111 1111110 011
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
.+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1122456789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=329.71 Aligned_cols=256 Identities=27% Similarity=0.353 Sum_probs=193.8
Q ss_pred ccCcccceEEEEEEEcC---CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLKD---GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.||+|+||.||+|...+ +..+|+|++..... ......|.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 59999999999998653 45789998754432 223457899999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.++++..........++..++.++.|+++||+|||+.+ ++||||||+|||+++++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999997543322234567778889999999999999999 9999999999999999999999999987544332222
Q ss_pred CccCCCCcCCccChhhhhcC-------CCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 678 LAELPAGTLGYLDPEYYRLH-------YLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~-------~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
......++..|+|||++... .++.++||||||+++|||++ |+.||....... ... .........+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-~~~----~~~~~~~~~~~~ 232 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ-VLT----YTVREQQLKLPK 232 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH-HHH----HHhhcccCCCCC
Confidence 22334578899999998642 35789999999999999996 999986432221 111 111111122222
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
+.+... ....+.+++..|+ .+|++|||++||+..|+
T Consensus 233 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 233 PRLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 222211 2345778999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=335.75 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=203.7
Q ss_pred cccccccCcccceEEEEEEEcC-----------------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeee
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD-----------------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~ 578 (914)
+.+.+.||+|+||.||++...+ +..||+|++..... ....++|.+|++++++++||||++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~ 85 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS-DNAREDFLKEVKILSRLSDPNIARLL 85 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC-HHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 4456789999999999998653 24588898754432 23457899999999999999999999
Q ss_pred ceeecCCeEEEEEeeCCCCCHHHhhhcCccc------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceE
Q 002512 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKA------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNIL 652 (914)
Q Consensus 579 g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NIL 652 (914)
+++..++..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ |+||||||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nil 162 (296)
T cd05051 86 GVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCL 162 (296)
T ss_pred EEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhcee
Confidence 9999999999999999999999999765421 1225889999999999999999999999 999999999999
Q ss_pred EcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh--CCCCccccccccc
Q 002512 653 IDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS--GRKAIDMQFEEGN 730 (914)
Q Consensus 653 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt--G~~p~~~~~~~~~ 730 (914)
+++++.+||+|||+++...............+++.|||||++....++.++||||||+++|||++ +..|+..... ..
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~-~~ 241 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD-QQ 241 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-HH
Confidence 99999999999999976544333233334457789999999998889999999999999999998 5666643221 11
Q ss_pred HHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 731 IVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 731 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
................ ..+.+...+.++.+++.+||+.+|++|||+.||++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 242 VIENAGHFFRDDGRQI------YLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHhccccccccc------cCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 2221111111111111 11112233467899999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=343.55 Aligned_cols=238 Identities=24% Similarity=0.322 Sum_probs=193.3
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.+.||+|+||.||+++.+ +++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 345678999999999999986 588999998764321 223446789999999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++|+|.+++.... .+++.....++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++.....
T Consensus 100 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 100 VVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred CCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999997643 4677778889999999999999999 999999999999999999999999999765432
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
. ....||+.|+|||++....++.++|||||||+||||++|+.||...... + ....+..+. +.
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~-~~~~i~~~~--------~~ 233 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF----R-IYEKILAGR--------LK 233 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH----H-HHHHHhcCC--------cC
Confidence 1 2246899999999999999999999999999999999999998643211 1 111122221 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPS 781 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 781 (914)
.+. ....++.+|+.+||+.||.+||+
T Consensus 234 ~p~--~~~~~~~~li~~~L~~dP~~R~~ 259 (329)
T PTZ00263 234 FPN--WFDGRARDLVKGLLQTDHTKRLG 259 (329)
T ss_pred CCC--CCCHHHHHHHHHHhhcCHHHcCC
Confidence 111 12346789999999999999997
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=333.53 Aligned_cols=264 Identities=27% Similarity=0.369 Sum_probs=207.2
Q ss_pred HhcccccccCcccceEEEEEEEcC-----CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec-CCeE
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLKD-----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE-GRER 587 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~ 587 (914)
..+.+.+.||+|+||.||+|.+.+ +..|++|++... ......+.+.+|+.++++++||||+++++++.+ ....
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 344567889999999999999876 678888876533 233345779999999999999999999998766 4678
Q ss_pred EEEEeeCCCCCHHHhhhcCccc---hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeec
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKA---LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADF 664 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~---~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DF 664 (914)
++++||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999999754221 1245889999999999999999999998 999999999999999999999999
Q ss_pred CCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCC
Q 002512 665 GLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGD 743 (914)
Q Consensus 665 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 743 (914)
|+++.+.............++..|+|||++....++.++||||||+++|||++ |+.||..... ..+.. .+..+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~----~~~~~~ 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-FEMAA----YLKDGY 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-HHHHH----HHHcCC
Confidence 99986544332222223346788999999998889999999999999999999 9999864311 11111 111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 002512 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~ 795 (914)
..+.....+.++.+++.+||+.+|++|||+.++++.|+.+..+
T Consensus 237 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 ---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1111112345788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=328.00 Aligned_cols=249 Identities=27% Similarity=0.485 Sum_probs=195.9
Q ss_pred ccCcccceEEEEEEEc---CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLK---DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.||+|+||.||+|.+. .+..||+|++.... .....++|.+|+.++++++||||+++++++.. +..++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 3899999999999864 35568999875432 23334679999999999999999999998864 5789999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... ..+++..+++++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++.........
T Consensus 80 ~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 9999997532 25889999999999999999999999 9999999999999999999999999997654332211
Q ss_pred -CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 678 -LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 678 -~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......++..|+|||++....++.++||||||+++|||++ |..||...... . +...+..+.. .+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~----~~~~~~~~~~---------~~ 218 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-E----VMSFIEQGKR---------LD 218 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-H----HHHHHHCCCC---------CC
Confidence 1122234678999999998889999999999999999996 99998643211 1 1112222211 11
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
.+.....++.+++.+||+.+|++||++.+|.+.|+..
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1223346788999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=330.19 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=204.6
Q ss_pred cccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.++||.|+||.||+|..++++.+++|.+.... .....++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 85 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELME 85 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecc
Confidence 34567899999999999999889999999875433 2234679999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.++++.... ..+++..+++++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 86 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 86 KGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999976432 35789999999999999999999999 99999999999999999999999999976543322
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. .....++..|+|||.+....++.++||||||+++|||++ |+.||...... .... .+..+ ...
T Consensus 160 ~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~-~~~~----~~~~~---------~~~ 223 (261)
T cd05148 160 L--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH-EVYD----QITAG---------YRM 223 (261)
T ss_pred c--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH-HHHH----HHHhC---------CcC
Confidence 1 113346778999999998899999999999999999999 78888543211 1111 11111 111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
+.+...+..+.+++.+||+.+|++|||+.++++.|+.
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1222344678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=336.45 Aligned_cols=240 Identities=25% Similarity=0.355 Sum_probs=195.2
Q ss_pred ccccCcccceEEEEEEEcC-CcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 519 KEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
...||+|+||.||+++-++ |..+|+|++.+.... ....+..+.|-.+|...++|+||+|+..|++.+++||||||+||
T Consensus 146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG 225 (550)
T KOG0605|consen 146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG 225 (550)
T ss_pred heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence 4579999999999999765 999999998776532 23456788999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC----
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA---- 672 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~---- 672 (914)
|++..+|...+ .|+......++.+++-|++-||..+ ||||||||+|+|||..|++||+||||+.-+..
T Consensus 226 GD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~ 297 (550)
T KOG0605|consen 226 GDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI 297 (550)
T ss_pred ccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence 99999998764 4777778889999999999999999 99999999999999999999999999852211
Q ss_pred ------------------CCCCC-----------------------CccCCCCcCCccChhhhhcCCCCCcchHHHHHHH
Q 002512 673 ------------------DSSSP-----------------------LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL 711 (914)
Q Consensus 673 ------------------~~~~~-----------------------~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~Gvv 711 (914)
..... .....+|||.|||||++.+..|+..+|.||||||
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I 377 (550)
T KOG0605|consen 298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI 377 (550)
T ss_pred hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence 00000 0012359999999999999999999999999999
Q ss_pred HHHHHhCCCCccccccccc---HHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 002512 712 LLEILSGRKAIDMQFEEGN---IVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPS 781 (914)
Q Consensus 712 L~ElltG~~p~~~~~~~~~---l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 781 (914)
|||||.|.+||........ ++.|- ..+..|.......+..+||.+|+. ||+.|.-
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr--------------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWR--------------ETLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHh--------------hhccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999975433321 22221 123344444455788899999999 9999976
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=313.94 Aligned_cols=241 Identities=24% Similarity=0.342 Sum_probs=196.9
Q ss_pred CCHHHHHHHhcccccccCcccceEEEEEEEc-CCcEEEEEEeeecc-ccccchHHHHHHHHHHHhccCCceeeeeceeec
Q 002512 506 FTYEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE 583 (914)
Q Consensus 506 ~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~ 583 (914)
+++++.+ +...||.|+||.|.+++.+ ++..+|+|++.+.. -+.+..+...+|..+|+.+.||.+++|++.|.+
T Consensus 41 ~~l~dfe-----~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFE-----RLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhh-----heeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 5555554 3456999999999999987 47889999875432 223445678899999999999999999999999
Q ss_pred CCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEee
Q 002512 584 GRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVAD 663 (914)
Q Consensus 584 ~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~D 663 (914)
.+..||||||++||.|..+|++.+ .++......++.||+.||+|||+.+ |++|||||+|||||.+|.+||.|
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitD 187 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITD 187 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEe
Confidence 999999999999999999998765 4788888899999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC
Q 002512 664 FGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD 743 (914)
Q Consensus 664 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~ 743 (914)
||+|+..... +-+.+|||.|+|||.++.+.+..++|.|+|||++|||+.|.+||...... .....+.++
T Consensus 188 FGFAK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~-----~iY~KI~~~- 256 (355)
T KOG0616|consen 188 FGFAKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI-----QIYEKILEG- 256 (355)
T ss_pred ccceEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH-----HHHHHHHhC-
Confidence 9999876543 34568999999999999999999999999999999999999999754321 112222232
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCC
Q 002512 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKER 779 (914)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R 779 (914)
.++.|. -...++.+|+...|+.|-.+|
T Consensus 257 -------~v~fP~--~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 257 -------KVKFPS--YFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -------cccCCc--ccCHHHHHHHHHHHhhhhHhh
Confidence 233332 222466778888888887776
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=329.50 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=200.0
Q ss_pred cccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.+.||+|+||.||++..+++..+|+|.+.... ...++|.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred eEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 35677899999999999998877789999875332 234679999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++..... .+++..+++++.||+.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.......
T Consensus 83 ~~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 83 NGCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 9999999975432 5789999999999999999999999 99999999999999999999999999876543321
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. ......++..|+|||++....++.++||||||+++|||++ |+.||..... .... ..+..+...
T Consensus 156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~----~~~~~~~~~--------- 220 (256)
T cd05113 156 T-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN-SETV----EKVSQGLRL--------- 220 (256)
T ss_pred e-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHH----HHHhcCCCC---------
Confidence 1 1112235678999999998889999999999999999999 8888753221 1111 112221111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
+........+.+++.+||+.+|.+||++.++++.|+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 011122467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=335.77 Aligned_cols=249 Identities=24% Similarity=0.334 Sum_probs=211.8
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCe-EEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRE-RLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~LV~Ey~~ 595 (914)
+.+.||+|+||.+++.+++ +.+.+++|++..........+..++|+.++++++|||||.+.+.+.+++. .+|||+|++
T Consensus 8 ~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~e 87 (426)
T KOG0589|consen 8 VLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCE 87 (426)
T ss_pred hhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecC
Confidence 3567999999999999876 57899999998877767767788999999999999999999999998887 899999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
||+|.+.|.+.. ...++...+..++.|++.|+.|||++. |+|||||++|||++.+..+||+|||+|+.+..+.
T Consensus 88 Gg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 88 GGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred CCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 999999998654 246888899999999999999999888 9999999999999999999999999999887654
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
.......||+.||.||.+.+.+|..|+|||||||++|||++-+++|...... .++. +.. .. . -.|
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-~Li~---ki~-~~----~-----~~P 225 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-ELIL---KIN-RG----L-----YSP 225 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-HHHH---HHh-hc----c-----CCC
Confidence 2455678999999999999999999999999999999999999998643221 1221 111 11 1 123
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.+.....++..++..|++.+|+.||++.+++..
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 334556789999999999999999999999987
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=334.89 Aligned_cols=266 Identities=24% Similarity=0.366 Sum_probs=200.6
Q ss_pred HhcccccccCcccceEEEEEEEcC---------------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeee
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLKD---------------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~ 578 (914)
..+.+.+.||+|+||.||+++..+ ...||+|++.... .......|.+|++++++++||||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 345567889999999999987642 1248999875432 223346799999999999999999999
Q ss_pred ceeecCCeEEEEEeeCCCCCHHHhhhcCccc-------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccce
Q 002512 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKA-------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 651 (914)
Q Consensus 579 g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~-------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NI 651 (914)
+++...+..++||||+++++|.+++...... ....+++..++.++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 9999999999999999999999999653211 0123688889999999999999999999 99999999999
Q ss_pred EEcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh--CCCCcccccccc
Q 002512 652 LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS--GRKAIDMQFEEG 729 (914)
Q Consensus 652 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt--G~~p~~~~~~~~ 729 (914)
|+++++.+||+|||++................++..|+|||++....++.++||||||+++|||++ +..||..... .
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~ 239 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-E 239 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-H
Confidence 999999999999999976543322222333446789999999998889999999999999999998 4556643221 1
Q ss_pred cHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 730 NIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 730 ~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
.................. ...+...+..+.+|+.+||+.+|++||+|.+|++.|+
T Consensus 240 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 240 QVIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 222211111111110000 0111123457899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=350.43 Aligned_cols=257 Identities=21% Similarity=0.303 Sum_probs=211.3
Q ss_pred cccccccCcccceEEEEEEEcCC-cEEEEEEeeeccccccchHHHHHHHHHHHhcc-CCceeeeece-eec------CCe
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDG-TVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGY-CEE------GRE 586 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~-~~~------~~~ 586 (914)
..+.+.|-+|||+.||++.+..+ ..+|+|++... .+...+...+|+++|++|+ |||||.+++. ... .-+
T Consensus 39 v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 39 VTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 34567799999999999998766 99999998765 3455688999999999995 9999999993 322 126
Q ss_pred EEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCC
Q 002512 587 RLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666 (914)
Q Consensus 587 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGl 666 (914)
.+|.||||++|.|-|++..+.. ..|+..++++|+.|+++|+++||... |||||||||-+||||+.+++.||||||-
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 7899999999999999986532 34899999999999999999999987 8899999999999999999999999998
Q ss_pred cccCCCCC--CCCCc-----cCCCCcCCccChhhh---hcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH
Q 002512 667 SLLGPADS--SSPLA-----ELPAGTLGYLDPEYY---RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV 736 (914)
Q Consensus 667 a~~~~~~~--~~~~~-----~~~~Gt~~y~aPE~l---~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~ 736 (914)
+...-... ..... -...-|+.|.|||.+ .+..+++|+|||+|||+||-|+....||+...
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 85322111 10000 011258999999987 56789999999999999999999999996431
Q ss_pred hhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 002512 737 PLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 737 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~ 795 (914)
-..|++-.+..|........|..||..||+.+|.+||++.+|++.+.+++..
T Consensus 263 -------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 -------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred -------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1246666777787788999999999999999999999999999998776543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=341.49 Aligned_cols=261 Identities=22% Similarity=0.337 Sum_probs=194.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC-----CeEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG-----RERLLV 590 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~LV 590 (914)
.+.+.||+|+||.||+++.+ +++.||||++...........++.+|++++++++||||+++++++... ...++|
T Consensus 3 ~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv 82 (338)
T cd07859 3 KIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVV 82 (338)
T ss_pred EEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEE
Confidence 45678999999999999975 589999998864433334446789999999999999999999988543 257999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
|||+. ++|.+++.... .+++..+..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 83 ~e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 83 FELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 99995 69999887543 4788999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCC-CCCccCCCCcCCccChhhhhc--CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH-----------
Q 002512 671 PADSS-SPLAELPAGTLGYLDPEYYRL--HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV----------- 736 (914)
Q Consensus 671 ~~~~~-~~~~~~~~Gt~~y~aPE~l~~--~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~----------- 736 (914)
..... ........||+.|+|||++.. ..++.++|||||||++|||+||+.||........ .....
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ-LDLITDLLGTPSPETI 232 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH-HHHHHHHhCCCCHHHH
Confidence 32221 112233468999999999876 6789999999999999999999999864321110 00000
Q ss_pred hhhhcCCcccccccc---cCCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 737 PLIKSGDITAILDPV---LKLPS---DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 737 ~~~~~~~~~~~~d~~---l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+........++.. ...+. .......+.+++.+||+.+|++|||++|+++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 000000000000000 00000 0112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=330.06 Aligned_cols=244 Identities=23% Similarity=0.287 Sum_probs=192.0
Q ss_pred cCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 522 VGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
||+|+||+||++..+ +++.+|+|++...... ....+.|..|++++++++||||+++++++......+|||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999976 5889999987643221 22346688999999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCc
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 679 (914)
.+++..... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++........ ..
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~ 154 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KT 154 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cc
Confidence 988854321 1235889999999999999999999999 99999999999999999999999999876543322 12
Q ss_pred cCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHH
Q 002512 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLD 759 (914)
Q Consensus 680 ~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 759 (914)
....||+.|+|||++....++.++||||||+++|||++|+.||............. ..+ ...... .+..
T Consensus 155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~-~~~--------~~~~~~--~~~~ 223 (280)
T cd05608 155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK-QRI--------LNDSVT--YPDK 223 (280)
T ss_pred cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH-Hhh--------cccCCC--Cccc
Confidence 33468999999999999999999999999999999999999986432221111111 111 111111 1123
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCH
Q 002512 760 ALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 760 ~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
....+.+++.+||+.+|++||++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~ 246 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGF 246 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCC
Confidence 44678899999999999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=336.84 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=206.5
Q ss_pred HhcccccccCcccceEEEEEEEc--------CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecC
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLK--------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEG 584 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~ 584 (914)
..+.+.+.||+|+||.||+++.. ++..||+|.+.... .....+++.+|+.+++.+ +||||+++++++...
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 33456678999999999999742 24578999775432 233457799999999999 899999999999999
Q ss_pred CeEEEEEeeCCCCCHHHhhhcCccc-----------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE
Q 002512 585 RERLLVYEFMAHGSLHQHLHGKSKA-----------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 653 (914)
Q Consensus 585 ~~~~LV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl 653 (914)
...++||||+++|+|.+++...... ....+++..++.++.||++||+|||+++ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 9999999999999999999764321 1245788899999999999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHH
Q 002512 654 DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIV 732 (914)
Q Consensus 654 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~ 732 (914)
++++.+||+|||+++...............+++.|+|||++....++.++||||||++||||++ |..||.... ..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~ 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP----VE 246 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC----HH
Confidence 9999999999999976544332222333346788999999998889999999999999999998 777764321 11
Q ss_pred HHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHH
Q 002512 733 EWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~ 795 (914)
+ ....+..+... ..+......+.+++.+||+.+|++||++.|+++.|++++..
T Consensus 247 ~-~~~~~~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 E-LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred H-HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1 11122222111 11123446788999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=358.14 Aligned_cols=256 Identities=22% Similarity=0.276 Sum_probs=203.3
Q ss_pred hcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC--------
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR-------- 585 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-------- 585 (914)
.+.+.+.||+|+||+||+++.. +++.||||++............+.+|+.++..++|+||++++..+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 3456778999999999999865 6899999988655444445577899999999999999999988775432
Q ss_pred eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecC
Q 002512 586 ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 586 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFG 665 (914)
..+|||||+++|+|.++|+.... ....+++.....++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecc
Confidence 36799999999999999975432 2245788889999999999999999998 9999999999999999999999999
Q ss_pred CcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcc
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 745 (914)
+++...............||+.|+|||++....++.++||||||++||||++|+.||.... ..+.... ...+...
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~----~~~~~~~-~~~~~~~ 263 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN----MEEVMHK-TLAGRYD 263 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHH-HhcCCCC
Confidence 9987554333333344579999999999999999999999999999999999999986431 1111111 1111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
. .+.....++.+++.+||+.+|.+||++.+++..
T Consensus 264 ~---------~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 P---------LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C---------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 112334678899999999999999999999764
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=338.12 Aligned_cols=198 Identities=26% Similarity=0.359 Sum_probs=169.4
Q ss_pred HhcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
..+.+.++||+|+||.||++.++ ++..+|+|.+.... .....+.|.+|++++++++||||++++++|.+.+..+||||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 33455678999999999999987 57788888765432 22334679999999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhcc-CCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY-ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~-~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
|+++++|.+++.... .+++.....++.|++.||.|||+. + |+||||||+|||+++++.+||+|||++....
T Consensus 84 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999997543 477888889999999999999974 5 9999999999999999999999999987543
Q ss_pred CCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 002512 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDM 724 (914)
Q Consensus 672 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~ 724 (914)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 156 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 156 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred hh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 22 12234689999999999988899999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=356.18 Aligned_cols=252 Identities=19% Similarity=0.253 Sum_probs=199.7
Q ss_pred cccccccCcccceEEEEEEEc-C-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-D-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.+.||+|+||.||++... + ++.||+|++.... ......+.+|+.+|++++|||||++++++...+..||||||
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 456778999999999999865 3 5778888664332 23345688899999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++|+|.++|+.... ....+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 147 ~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 147 GSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 999999998864321 1235788888999999999999999998 999999999999999999999999999875443
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
..........||+.|||||++....++.++|||||||++|||++|+.||..... .+.... +..+....
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~~~~~~-~~~~~~~~------- 290 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----REIMQQ-VLYGKYDP------- 290 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHH-HHhCCCCC-------
Confidence 322233445699999999999999999999999999999999999999864321 111111 11111111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+......+.+++.+||+.+|++||++.+++.
T Consensus 291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11123357889999999999999999999864
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=334.78 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=204.6
Q ss_pred cccccccCcccceEEEEEEEcC------CcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~ 588 (914)
..+.+.||+|+||.||++...+ ...+|+|.+.... ..+...++.+|++++.++ +||||+++++++......+
T Consensus 14 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (293)
T cd05053 14 LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLY 92 (293)
T ss_pred eEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeE
Confidence 3456789999999999998642 3678999875432 233446789999999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhcCcc-----------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC
Q 002512 589 LVYEFMAHGSLHQHLHGKSK-----------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH 657 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~ 657 (914)
+||||+++|+|.++++.... .....+++..+++++.|++.||+|||+.+ |+||||||+|||+++++
T Consensus 93 li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~ 169 (293)
T cd05053 93 VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDH 169 (293)
T ss_pred EEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCC
Confidence 99999999999999975321 12346889999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHH
Q 002512 658 NARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAV 736 (914)
Q Consensus 658 ~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~ 736 (914)
.+||+|||+++...............++..|+|||++....++.++||||||+++|||++ |..||...... . ..
T Consensus 170 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~----~~ 244 (293)
T cd05053 170 VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE-E----LF 244 (293)
T ss_pred eEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH-H----HH
Confidence 999999999986554332222223345678999999998899999999999999999998 88887532111 1 11
Q ss_pred hhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 737 PLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 737 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
..+..+.. .+.+......+.+|+.+||+.+|++|||+.|+++.|+.++
T Consensus 245 ~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 KLLKEGYR---------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 12222111 1112233457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=340.70 Aligned_cols=243 Identities=23% Similarity=0.294 Sum_probs=195.1
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
.||+|+||.||+++.+ +++.||+|++..... .......+.+|++++++++||||+++++++.+.+..+|||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 5899999999999975 589999998865422 22344678899999999999999999999999999999999999999
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
|.+++.... .+++.....++.||+.||+|||+++ |+||||||+||||++++.+||+|||+++...... ..
T Consensus 82 L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 82 LFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 999987542 4788889999999999999999999 9999999999999999999999999987533221 12
Q ss_pred ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
.....||+.|+|||++....++.++|||||||+||||++|+.||...... .+. ..+.... ... +.
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-~~~----~~~~~~~--------~~~--p~ 216 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLF----ELILMED--------IKF--PR 216 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-HHH----HHhccCC--------ccC--CC
Confidence 23346999999999999889999999999999999999999998643211 111 1111111 011 11
Q ss_pred HHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERP-----SMDKVTTA 788 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 788 (914)
....++.+++.+||+.+|++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2345788999999999999997 77777643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=332.56 Aligned_cols=261 Identities=24% Similarity=0.314 Sum_probs=194.3
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||.||+++.+ +++.||+|++..... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 85 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYV 85 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECC
Confidence 345678999999999999986 588999998754432 223356789999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
+ ++|.+++.... ..++...+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 86 ~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 86 H-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred C-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 5 68888886542 24777888899999999999999999 9999999999999999999999999987543221
Q ss_pred CCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC---c------
Q 002512 675 SSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD---I------ 744 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~---~------ 744 (914)
.......+|+.|+|||++.+ ..++.++|||||||+||||++|+.||..........+.......... .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T cd07869 158 --HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235 (303)
T ss_pred --ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhc
Confidence 12233468999999999865 46789999999999999999999999753222111111111110000 0
Q ss_pred ccccccccC--CCCCH-------HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 TAILDPVLK--LPSDL-------DALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 ~~~~d~~l~--~~~~~-------~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
......... .+... .....+.+++.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000 01100 11246779999999999999999998874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=329.89 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=195.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.++||+|+||.||+++.+ +++.||+|++..... ......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 8 VKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred eEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 45678999999999999976 588999998754332 2234578899999999999999999999999999999999997
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+ +|.+++.... ..+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 87 ~-~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 87 S-DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred c-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 5 9999987543 24678888999999999999999999 99999999999999999999999999875432221
Q ss_pred CCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhh------------cC
Q 002512 676 SPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIK------------SG 742 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~------------~~ 742 (914)
......+++.|+|||++.+ ..++.++||||||+++|||+||+.||........+.. ....+. ..
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL-IFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChHHhhccccch
Confidence 1223458999999999865 5689999999999999999999999864332221111 111000 00
Q ss_pred CcccccccccCCCC----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 743 DITAILDPVLKLPS----DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 743 ~~~~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.......+...... ......+..+++.+||+.||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 01111111110000 0112356789999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.33 Aligned_cols=264 Identities=25% Similarity=0.394 Sum_probs=200.8
Q ss_pred cccccccCcccceEEEEEEEc-----------------CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeee
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-----------------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~ 578 (914)
+.+.++||+|+||.||++... +...+|+|++.... .....++|.+|++++++++||||++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~ 85 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIRLL 85 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEE
Confidence 456778999999999998643 23468899875432 223346899999999999999999999
Q ss_pred ceeecCCeEEEEEeeCCCCCHHHhhhcCccch------hcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceE
Q 002512 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKAL------KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNIL 652 (914)
Q Consensus 579 g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~------~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NIL 652 (914)
+++.+.+..++||||+++++|.+++....... ...+++...+.++.|++.||+|||+.+ |+||||||+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nil 162 (296)
T cd05095 86 AVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCL 162 (296)
T ss_pred EEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEE
Confidence 99999999999999999999999997643211 124778889999999999999999999 999999999999
Q ss_pred EcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh--CCCCccccccccc
Q 002512 653 IDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS--GRKAIDMQFEEGN 730 (914)
Q Consensus 653 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt--G~~p~~~~~~~~~ 730 (914)
+++++.+||+|||+++...............++..|++||......++.++||||||+++|||++ |..||...... .
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~-~ 241 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE-Q 241 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-H
Confidence 99999999999999976543322222233345688999999988889999999999999999998 66777532221 1
Q ss_pred HHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 731 IVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 731 l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
................ ..+.+...+..+.+|+.+||+.+|++||++.||.+.|+
T Consensus 242 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 242 VIENTGEFFRDQGRQV------YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHhhccccc------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1111111111111100 11111223467889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=331.46 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=198.6
Q ss_pred ccccccCcccceEEEEEEEc-CCc----EEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGT----VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
.+.+.||+|+||.||+|++. +++ .||+|++.... .....+++.+|+.++++++||||+++++++... ..+++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~ 87 (279)
T cd05109 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVT 87 (279)
T ss_pred eeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEE
Confidence 35678999999999999854 444 47888775432 233356799999999999999999999999764 578999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+++|+|.++++... ..+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 88 ~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 88 QLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999997642 25788999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 672 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
............+++.|+|||.+....++.++||||||+++|||++ |..||..... ..+.. .+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~~----~~~~~~~------ 229 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-REIPD----LLEKGER------ 229 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HHHHH----HHHCCCc------
Confidence 4332222222345678999999998889999999999999999998 8888753211 11211 1222111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
.+........+.+++.+||+.||++||++.++++.|++..
T Consensus 230 ---~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 230 ---LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred ---CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1111223457889999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=327.42 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=191.2
Q ss_pred ccCcccceEEEEEEEcC---CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLKD---GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
+||+|+||.||+|...+ ...+++|.+.... .......|.+|+.+++.++||||+++++++.+....+|||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 59999999999998643 3467888664332 2333467899999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++...........++...+.++.||+.||+|||+.+ |+||||||+|||+++++++||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997654332334567778899999999999999999 9999999999999999999999999986543332222
Q ss_pred CccCCCCcCCccChhhhhc-------CCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 678 LAELPAGTLGYLDPEYYRL-------HYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~-------~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
......+++.|+|||++.. ..++.++||||||+++|||++ |..||........+ ...+... ...+.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~~-~~~~~~ 232 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVL----KQVVREQ-DIKLPK 232 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHH----HHHhhcc-CccCCC
Confidence 2233346778999999753 356889999999999999999 67777533221111 1111111 112222
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
+.+. ......+.+++..|+ .||++|||+++|++.|
T Consensus 233 ~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 233 PQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred Cccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 2111 123356677888888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.43 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=204.6
Q ss_pred HHHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEE
Q 002512 511 LERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 511 l~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
+.+.++.+.++||+|+||.||++..++++.||+|.+.... ...++|.+|+.++++++||||+++++++. .+..++|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS---MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC---CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 4456677888999999999999999889999999875432 23468999999999999999999999874 4568999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
|||+++++|.+++..... ..+++..++.++.|++.+|+|||+.+ ++||||||+||++++++.++|+|||++...
T Consensus 79 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 152 (260)
T cd05067 79 TEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLI 152 (260)
T ss_pred EEcCCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeec
Confidence 999999999999875432 35788999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
...... ......++..|+|||++....++.++||||||+++|||++ |+.||..... ..+.. .+..+.
T Consensus 153 ~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~~~----~~~~~~------ 220 (260)
T cd05067 153 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEVIQ----NLERGY------ 220 (260)
T ss_pred CCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHHHH----HHHcCC------
Confidence 432211 1222346788999999998889999999999999999999 9999864321 11111 111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
..+.....+.++.+++.+||..+|++||+++++...|+.
T Consensus 221 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 ---RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111112234578999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=334.04 Aligned_cols=257 Identities=26% Similarity=0.403 Sum_probs=203.0
Q ss_pred cccccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~ 588 (914)
..+.+.||+|+||.||++... .+..||+|++..... ....+.|.+|+++++++ +||||+++++++...+..+
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 115 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPIL 115 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceE
Confidence 456678999999999999752 245799998754322 23346799999999999 8999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
|||||+++|+|.++++.... ..+++..++.++.|++.||+|||+++ |+|+||||+|||+++++.+||+|||+++
T Consensus 116 lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 116 VITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999975432 23789999999999999999999998 9999999999999999999999999997
Q ss_pred cCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccc
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 747 (914)
...............++..|+|||++....++.++||||||+++|||++ |+.||........+. ..+..+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~----~~~~~~~---- 261 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY----KLIKEGY---- 261 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH----HHHHcCC----
Confidence 6543322212223346788999999998889999999999999999998 898886433222211 1122111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
....+.....++.+++.+||+.+|++||++.|+++.|+++
T Consensus 262 -----~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 262 -----RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111112235788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=344.73 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=200.8
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||+++.. +++.||+|++...... ......|.+|++++..++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (350)
T cd05573 4 EVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYM 83 (350)
T ss_pred eEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCC
Confidence 45678999999999999976 6899999988654322 234567899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++... ..+++.....++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 84 PGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred CCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999765 24788888999999999999999998 9999999999999999999999999997654332
Q ss_pred ---------------------------CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccc
Q 002512 675 ---------------------------SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFE 727 (914)
Q Consensus 675 ---------------------------~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~ 727 (914)
.........||+.|+|||++....++.++|||||||+||||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00122334699999999999999999999999999999999999999864322
Q ss_pred cccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 002512 728 EGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPS-MDKVTTA 788 (914)
Q Consensus 728 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs-~~ev~~~ 788 (914)
.. ......... ..+..+.......++.+++.+|+. +|.+||+ ++++++.
T Consensus 236 ~~----~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 QE----TYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH----HHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11 111111100 111122222234678899999997 9999999 9888753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=325.79 Aligned_cols=251 Identities=28% Similarity=0.453 Sum_probs=199.9
Q ss_pred cccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.++||+|+||.||++..+++..+|+|.+..... ..+.|.+|+.++++++||||+++++++.+ +..++||||++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~ 83 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMS 83 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecC
Confidence 345678999999999999988888899998754322 23679999999999999999999998854 56789999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.++++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 84 KGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 9999999975422 34789999999999999999999999 99999999999999999999999999976543321
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. ......++..|+|||++....++.++||||||+++|||++ |+.||..... ..... .+... ...
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-~~~~~----~~~~~---------~~~ 222 (260)
T cd05070 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-REVLE----QVERG---------YRM 222 (260)
T ss_pred c-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-HHHHH----HHHcC---------CCC
Confidence 1 1122235678999999998889999999999999999999 8888854221 11111 11111 111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
+.+...+..+.+|+.+|+..+|++|||+.++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1222344678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=305.07 Aligned_cols=254 Identities=28% Similarity=0.415 Sum_probs=205.7
Q ss_pred cCCHHHHHHHhcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceee
Q 002512 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCE 582 (914)
Q Consensus 505 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~ 582 (914)
.+++++++ +.+.||+|-||.||+|+.+ ++..||+|++.+..- .......+.+|++|-+.|+||||+++++||.
T Consensus 18 ~~~l~dfe-----igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 18 TWTLDDFE-----IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred ccchhhcc-----ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 45555554 4677999999999999976 578999998866542 2223467899999999999999999999999
Q ss_pred cCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEe
Q 002512 583 EGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVA 662 (914)
Q Consensus 583 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~ 662 (914)
+....||++||.+.|+|+..|..... ..++......+..|+|.||.|+|..+ ||||||||+|+|++.++.+||+
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiA 166 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIA 166 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeecc
Confidence 99999999999999999999985432 34666677789999999999999999 9999999999999999999999
Q ss_pred ecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC
Q 002512 663 DFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG 742 (914)
Q Consensus 663 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~ 742 (914)
|||-+...+. ....+..||..|.+||...+...+.+.|+|++|++.||+|.|.+||......+.+. .+..
T Consensus 167 dfGwsV~~p~----~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk-----rI~k- 236 (281)
T KOG0580|consen 167 DFGWSVHAPS----NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK-----RIRK- 236 (281)
T ss_pred CCCceeecCC----CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH-----HHHH-
Confidence 9999865442 23345679999999999999999999999999999999999999997544222111 1111
Q ss_pred CcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 743 DITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
..+..| ........+++.+|+..+|.+|.+..|+++.
T Consensus 237 -------~~~~~p--~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 -------VDLKFP--STISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------ccccCC--cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111111 2344577899999999999999999998764
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=331.37 Aligned_cols=256 Identities=27% Similarity=0.437 Sum_probs=200.1
Q ss_pred cccccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLL 589 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 589 (914)
..+.++||+|+||.||++... ++..+++|.+.... ....+.|.+|++++++++||||+++++++.+.+..++
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 7 IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred ceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 345678999999999999742 35678888765432 2334689999999999999999999999999999999
Q ss_pred EEeeCCCCCHHHhhhcCccc----------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcE
Q 002512 590 VYEFMAHGSLHQHLHGKSKA----------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA 659 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~----------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 659 (914)
||||+++++|.++++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 99999999999999754321 1134788999999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhh
Q 002512 660 RVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPL 738 (914)
Q Consensus 660 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~ 738 (914)
||+|||+++...............+++.|+|||++....++.++||||||+++|||++ |+.||...... ... ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-~~~----~~ 236 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT-EAI----EC 236 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH-HHH----HH
Confidence 9999999875543322222223345788999999999999999999999999999998 88887532211 111 11
Q ss_pred hhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
+..+... ..+...+..+.+|+.+||+.+|.+||+++||++.|+
T Consensus 237 ~~~~~~~---------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 237 ITQGREL---------ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHcCccC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111100 111123356889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=340.14 Aligned_cols=263 Identities=26% Similarity=0.373 Sum_probs=201.7
Q ss_pred hcccccccCcccceEEEEEEE------cCCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecC-Ce
Q 002512 515 TGGFKEEVGKGSFSCVYKGVL------KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEG-RE 586 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~-~~ 586 (914)
.+.+.+.||+|+||.||+|.. .+++.||||++..... ......+.+|+.++.++ +||||+++++++... ..
T Consensus 8 ~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 8 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred HhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 345678899999999999974 3478899998854322 23346788999999999 789999999988654 46
Q ss_pred EEEEEeeCCCCCHHHhhhcCccc---------------------------------------------------------
Q 002512 587 RLLVYEFMAHGSLHQHLHGKSKA--------------------------------------------------------- 609 (914)
Q Consensus 587 ~~LV~Ey~~~gsL~~~l~~~~~~--------------------------------------------------------- 609 (914)
.++||||+++|+|.++++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 78999999999999998753210
Q ss_pred -----hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCccCCCC
Q 002512 610 -----LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAG 684 (914)
Q Consensus 610 -----~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 684 (914)
....+++..+++++.||++||+|||+++ |+||||||+|||+++++++||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 0124688888999999999999999999 99999999999999999999999999976533322222223346
Q ss_pred cCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHH
Q 002512 685 TLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKR 763 (914)
Q Consensus 685 t~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 763 (914)
+..|+|||.+....++.++||||||+++|||++ |..||........+ ...+..+..... + .....+
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----~~~~~~~~~~~~-------~--~~~~~~ 310 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----CRRLKEGTRMRA-------P--DYTTPE 310 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH----HHHHhccCCCCC-------C--CCCCHH
Confidence 678999999998889999999999999999997 88887543222111 111222211111 1 112346
Q ss_pred HHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 764 IANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 764 l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
+.+++.+||+.+|++||++.||++.|+.++.
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.62 Aligned_cols=256 Identities=25% Similarity=0.411 Sum_probs=198.3
Q ss_pred ccccccCcccceEEEEEEEcC------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
.+.+.||+|+||.||++.+.+ ...|++|...... .......|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred EeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 345789999999999999764 4678888764332 222346799999999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhcCccc--hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC---cEEEeecC
Q 002512 591 YEFMAHGSLHQHLHGKSKA--LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH---NARVADFG 665 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~--~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~---~~kl~DFG 665 (914)
|||+++++|.++++..... ....+++..+++++.||+.||+|||+.+ ++||||||+|||++.++ .+||+|||
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCc
Confidence 9999999999999765321 1235889999999999999999999999 99999999999998654 59999999
Q ss_pred CcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCc
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDI 744 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 744 (914)
+++................+..|+|||++....++.++|||||||++|||++ |+.||...... .+. ..+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~~~----~~~~~~~- 238 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-EVM----EFVTGGG- 238 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-HHH----HHHHcCC-
Confidence 9986533222111222234578999999998899999999999999999997 88888643221 111 1111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
....+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 239 --------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 239 --------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 01111223467889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=326.37 Aligned_cols=253 Identities=28% Similarity=0.474 Sum_probs=201.5
Q ss_pred hcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.++||+|+||.||+|++++...||+|++.... ...++|.+|++++++++||||+++++++.+ +..++||||+
T Consensus 7 ~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~---~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc---cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 356778899999999999998877789999875422 234679999999999999999999998754 5679999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.+++.+... ..+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 83 SKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999975321 35788999999999999999999999 9999999999999999999999999997654332
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.. ......++..|+|||++....++.++||||||+++|||+| |+.||...... .. ...+... ..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~-~~----~~~~~~~---------~~ 221 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-EV----LDQVERG---------YR 221 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH-HH----HHHHhcC---------CC
Confidence 21 1223346778999999998889999999999999999999 77777533211 11 1111111 01
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
.+...+.+..+.+|+.+|++.+|++||++.++.+.|+..
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 112234456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=344.62 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=192.7
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.||+|+||+||+++.. +++.||+|++..... .....+.+.+|++++.+++||||+++++++.+.+..+|||||++
T Consensus 5 ~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~ 84 (381)
T cd05626 5 KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIP 84 (381)
T ss_pred EEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCC
Confidence 4567999999999999875 578999998865432 22334678999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+|+|.+++.+.. .+++.....++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.......
T Consensus 85 gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 85 GGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999997543 4777888889999999999999999 99999999999999999999999999754311000
Q ss_pred C---------------------------------------------CCccCCCCcCCccChhhhhcCCCCCcchHHHHHH
Q 002512 676 S---------------------------------------------PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGV 710 (914)
Q Consensus 676 ~---------------------------------------------~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~Gv 710 (914)
. .......||+.|||||++....++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0 0012346999999999999888999999999999
Q ss_pred HHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHH--hhhcCCCCCCCHHHHHH
Q 002512 711 LLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACK--CVRMRGKERPSMDKVTT 787 (914)
Q Consensus 711 vL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~~p~~RPs~~ev~~ 787 (914)
+||||+||+.||.......... ..+... ..+..+.......++.+++.+ |+..++..||++.|++.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~----~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~ 304 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQL----KVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA 304 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHH----HHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 9999999999996532211111 111100 011111111233466677776 55666777999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=337.89 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=192.5
Q ss_pred cccCcccceEEEEEEEc----CCcEEEEEEeeeccc--cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 520 EEVGKGSFSCVYKGVLK----DGTVVAVKKAIATSD--RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.||+|+||.||+++.. .++.||+|.+..... .......+.+|+.+|++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 46999999999999853 578999998764321 222345678999999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++++|.+++.... .+.+.....++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 99999999997543 3667777889999999999999999 999999999999999999999999998653222
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
. .......||+.|+|||++....++.++||||||++||||++|+.||...... ... ..+..+. ..
T Consensus 154 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----~~~-~~~~~~~--------~~ 218 (323)
T cd05584 154 G--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----KTI-DKILKGK--------LN 218 (323)
T ss_pred C--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH----HHH-HHHHcCC--------CC
Confidence 2 1223346999999999999888999999999999999999999998643211 111 1111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERP-----SMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~ 787 (914)
.+ ......+.+++.+||+.+|++|| +++++++
T Consensus 219 ~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 LP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CC--CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11 12235678999999999999999 6666654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=341.35 Aligned_cols=244 Identities=23% Similarity=0.289 Sum_probs=195.8
Q ss_pred cccccccCcccceEEEEEEEcC--CcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD--GTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
+.+.+.||+|+||.||+|.+++ +..||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..+||||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 4456789999999999998654 36899998754322 22345678999999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 112 y~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 112 FVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999997543 4788888999999999999999999 99999999999999999999999999976532
Q ss_pred CCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||...... .....+..+..
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~i~~~~~-------- 245 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----LIYQKILEGII-------- 245 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----HHHHHHhcCCC--------
Confidence 2 12346899999999999988999999999999999999999999643211 11111222111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERP-----SMDKVTT 787 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~ 787 (914)
..+. .....+.+++.+||+.+|++|+ +++++++
T Consensus 246 ~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 YFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred CCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 1111 1234678999999999999995 6766653
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.82 Aligned_cols=254 Identities=24% Similarity=0.462 Sum_probs=201.0
Q ss_pred ccccccCcccceEEEEEEEcC-C---cEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-G---TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
.+.+.||+|+||.||+++++. + ..+++|++.... .....++|.+|++++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 8 TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred eEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 346779999999999999753 3 368998775432 22335679999999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 87 YMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred cCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999997542 25789999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCCc-cCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 673 DSSSPLA-ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 673 ~~~~~~~-~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
....... .....+..|+|||++....++.++||||||+++|||++ |+.||...... . ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-~----~~~~i~~~-------- 226 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-E----VMKAINDG-------- 226 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-H----HHHHHhcC--------
Confidence 2221111 11223567999999998889999999999999999998 99998543221 1 11122211
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
...+...+.+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 -~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 -FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11122223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=341.10 Aligned_cols=240 Identities=24% Similarity=0.323 Sum_probs=193.7
Q ss_pred cccCcccceEEEEEEE----cCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 520 EEVGKGSFSCVYKGVL----KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.||+|+||.||+++. .+++.+|+|++............+.+|++++++++||||+++++++.+.+..||||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999875 257899999886544333344667889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+|+|.+++.... .+++.....++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 999999996542 4788899999999999999999999 99999999999999999999999999876433211
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......||+.|+|||.+....++.++||||||++||||++|+.||....... . . ..+.... ...+
T Consensus 154 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~-~---~-~~i~~~~--------~~~p 218 (318)
T cd05582 154 --KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE-T---M-TMILKAK--------LGMP 218 (318)
T ss_pred --ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH-H---H-HHHHcCC--------CCCC
Confidence 2223468999999999998888999999999999999999999986432111 1 1 1111111 1111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDK 784 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 784 (914)
......+.+++.+||+.||++||++.+
T Consensus 219 --~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 --QFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 123356789999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.01 Aligned_cols=248 Identities=27% Similarity=0.448 Sum_probs=198.3
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
+.||+|+||.||++.+.+++.+|+|++..... ......|.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 36999999999999988899999998754332 22345799999999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCc
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 679 (914)
.+++.... ..+++..++.++.|++.+|.|||+.+ ++||||||+||++++++.+||+|||++........ ...
T Consensus 80 ~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~ 151 (250)
T cd05085 80 LSFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSS 151 (250)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccC
Confidence 99987543 24788999999999999999999999 99999999999999999999999999865433221 111
Q ss_pred cCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 680 ~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
....++..|+|||++....++.++||||||+++|||++ |..||...... . ....+..+.. .....
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~-~----~~~~~~~~~~---------~~~~~ 217 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ-Q----AREQVEKGYR---------MSCPQ 217 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH-H----HHHHHHcCCC---------CCCCC
Confidence 22235678999999998889999999999999999999 88888543111 1 1111211111 11112
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
..+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 23467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.39 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=201.2
Q ss_pred hcccccccCcccceEEEEEEEcC------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEE
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 588 (914)
.+.+.+.||+|+||.||+|..++ +..||+|.+.... ......+|.+|+.++++++||||+++++++.+.+..+
T Consensus 7 ~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 85 (288)
T cd05061 7 KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTL 85 (288)
T ss_pred HceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 44567789999999999997642 4579999765332 2223456889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhcCccch-----hcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEee
Q 002512 589 LVYEFMAHGSLHQHLHGKSKAL-----KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVAD 663 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~-----~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~D 663 (914)
+||||+++|+|.++++...... ...+++...++++.|++.||.|||+++ |+||||||+|||+++++.+||+|
T Consensus 86 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 86 VVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECc
Confidence 9999999999999997532211 123466778899999999999999999 99999999999999999999999
Q ss_pred cCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcC
Q 002512 664 FGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSG 742 (914)
Q Consensus 664 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~ 742 (914)
||+++...............++..|+|||.+....++.++||||||+++|||++ |..||.....+ .. ...+..+
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-~~----~~~~~~~ 237 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-QV----LKFVMDG 237 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-HH----HHHHHcC
Confidence 999876543322222222345778999999998899999999999999999999 67787543221 11 1112222
Q ss_pred CcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 743 DITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
.... .+......+.+++.+||+.+|++|||+.++++.|+..+
T Consensus 238 ~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 238 GYLD---------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred CCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111 11122357899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=340.11 Aligned_cols=243 Identities=26% Similarity=0.391 Sum_probs=188.9
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.++||+|+||.||++++. +++.||||++.... .....+.|.+|++++++++|+||+++++++.+.+..++||||++++
T Consensus 79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 467999999999999976 58999999875432 2233467999999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+.. .+.+.....++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 158 ~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 158 SLEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred cccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 996542 2345567789999999999999999 99999999999999999999999999976543221
Q ss_pred CccCCCCcCCccChhhhhc-----CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 678 LAELPAGTLGYLDPEYYRL-----HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~-----~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
......||..|+|||++.. ...+.++|||||||+||||++|+.||..... ........ .+....
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-~~~~~~~~-~~~~~~--------- 292 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-GDWASLMC-AICMSQ--------- 292 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-ccHHHHHH-HHhccC---------
Confidence 1233468999999998843 3455799999999999999999999863221 11111111 111000
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..........++.+|+.+||+.+|++||++.|+++
T Consensus 293 ~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 293 PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00111233457899999999999999999999875
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.45 Aligned_cols=259 Identities=30% Similarity=0.478 Sum_probs=200.3
Q ss_pred ccccccCcccceEEEEEEEcC-Cc--EEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEe
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GT--VVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
.+.+.||+|+||.||+|.+++ +. .+++|++.... ......+|.+|++++.++ +||||+++++++.+.+..++|||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e 88 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 88 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEE
Confidence 456789999999999999753 44 45777654322 223346789999999999 89999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccc-----------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEE
Q 002512 593 FMAHGSLHQHLHGKSKA-----------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARV 661 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~-----------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl 661 (914)
|+++++|.++++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 89 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl 165 (303)
T cd05088 89 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKI 165 (303)
T ss_pred eCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEe
Confidence 99999999999754321 1235788899999999999999999999 999999999999999999999
Q ss_pred eecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhh
Q 002512 662 ADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIK 740 (914)
Q Consensus 662 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~ 740 (914)
+|||+++...... ......++..|+|||++....++.++||||||++||||+| |..||...... .... .+.
T Consensus 166 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~----~~~ 237 (303)
T cd05088 166 ADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYE----KLP 237 (303)
T ss_pred CccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-HHHH----HHh
Confidence 9999986422111 1112234678999999988889999999999999999998 99998533221 1111 111
Q ss_pred cCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 002512 741 SGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~~ 796 (914)
.+ ...+.+......+.+|+.+||+.+|++||++++++..|++++...
T Consensus 238 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 238 QG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred cC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 011111123457889999999999999999999999998877654
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=321.58 Aligned_cols=249 Identities=30% Similarity=0.493 Sum_probs=198.8
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
++||+|+||.||++.+++++.|++|++...... ...+.|.+|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 369999999999999877999999987554332 3457899999999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCc
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 679 (914)
.+++.... ..+++..++.++.+++.+|+|||+++ ++||||||+|||++.++.+||+|||++............
T Consensus 80 ~~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 99997542 24788888999999999999999999 999999999999999999999999998764422211111
Q ss_pred cCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 680 ~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
.....+..|+|||.+....++.++||||||+++|||+| |..||...... .... .+... ...+.+.
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~-~~~~----~~~~~---------~~~~~~~ 218 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ-QTRE----RIESG---------YRMPAPQ 218 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH-HHHH----HHhcC---------CCCCCCc
Confidence 22234677999999998899999999999999999999 77777533211 1111 11111 0111122
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
..+.++.+++.+||+.+|++||++.|+++.|+
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 34467899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=342.04 Aligned_cols=251 Identities=25% Similarity=0.301 Sum_probs=198.5
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||+++.+ +++.||+|++..... .....+.|.+|+.+++.++||||+++++++.+.+..+|||||+
T Consensus 4 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (330)
T cd05601 4 DVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQ 83 (330)
T ss_pred eEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCC
Confidence 45678999999999999976 588999998865432 2234467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.+++.... ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 84 PGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999997642 25788888999999999999999999 9999999999999999999999999997654332
Q ss_pred CCCCccCCCCcCCccChhhhh------cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccc
Q 002512 675 SSPLAELPAGTLGYLDPEYYR------LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~------~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 748 (914)
.. ......||+.|+|||++. ...++.++||||||++||||++|+.||....... ..........
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~----~~~~i~~~~~----- 226 (330)
T cd05601 157 MV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK----TYNNIMNFQR----- 226 (330)
T ss_pred ce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH----HHHHHHcCCC-----
Confidence 21 223346899999999987 4567899999999999999999999986432211 1111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+..+........+.+|+..|++ +|.+||++++++.
T Consensus 227 --~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 --FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred --ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 11122222344577889999998 9999999988763
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=326.11 Aligned_cols=253 Identities=30% Similarity=0.477 Sum_probs=195.9
Q ss_pred cccCcccceEEEEEEEcC-Cc--EEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCC
Q 002512 520 EEVGKGSFSCVYKGVLKD-GT--VVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.||+|+||.||++++++ +. .+++|.+.... .....+.|.+|++++.++ +||||+++++++...+..++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 358999999999999864 43 46777665322 223346799999999999 89999999999999999999999999
Q ss_pred CCCHHHhhhcCccc-----------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeec
Q 002512 596 HGSLHQHLHGKSKA-----------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADF 664 (914)
Q Consensus 596 ~gsL~~~l~~~~~~-----------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DF 664 (914)
+|+|.++++..... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence 99999999754311 1234788999999999999999999998 999999999999999999999999
Q ss_pred CCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCC
Q 002512 665 GLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGD 743 (914)
Q Consensus 665 Gla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~ 743 (914)
|++....... .......+..|+|||++....++.++||||||+++|||++ |..||...... .+.. .+..+.
T Consensus 157 gl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~----~~~~~~ 228 (270)
T cd05047 157 GLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-ELYE----KLPQGY 228 (270)
T ss_pred CCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-HHHH----HHhCCC
Confidence 9985322111 1111234568999999998899999999999999999997 99998542211 1111 111111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
..+.......++.+++.+||+.+|.+|||+.+++..|++++
T Consensus 229 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 ---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---------CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11111123457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.32 Aligned_cols=255 Identities=25% Similarity=0.487 Sum_probs=201.1
Q ss_pred cccccccCcccceEEEEEEEcC-C---cEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD-G---TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
..+.+.||+|+||.||+|.++. + ..||+|.+.... .....++|..|+.++++++||||+++++++.++...++||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4567889999999999999753 3 369999875432 2334578999999999999999999999999999999999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||+|||++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 85 EFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred ecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999997543 25788999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCCCCccC-CC--CcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccc
Q 002512 672 ADSSSPLAEL-PA--GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 672 ~~~~~~~~~~-~~--Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 747 (914)
.......... .. .+..|+|||++....++.++||||||+++|||++ |..||...... .... .+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~-~~~~----~i~~~----- 227 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ-DVIN----AIEQD----- 227 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH-HHHH----HHHcC-----
Confidence 3322111111 11 2457999999998899999999999999999987 99998643211 1111 11111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
...+.+.+.+..+.+++.+||+.+|.+||++++|+..|+.+
T Consensus 228 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 ----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11112223446788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=336.69 Aligned_cols=246 Identities=22% Similarity=0.279 Sum_probs=191.7
Q ss_pred ccccccCcccceEEEEEEEc----CCcEEEEEEeeeccc--cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK----DGTVVAVKKAIATSD--RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLL 589 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~L 589 (914)
.+.+.||+|+||.||+++.. +++.||+|++..... .....+.+.+|+.++.++ +||||+++++++.+.+..+|
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 45678999999999998853 578999998764321 223346688999999999 59999999999999999999
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||+++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 v~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999997543 4788888999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccc
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 748 (914)
....... ......||+.|||||++.+. .++.++||||||++||||+||+.||........... +...+...
T Consensus 155 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~~~------ 226 (332)
T cd05614 155 FLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSE-VSRRILKC------ 226 (332)
T ss_pred ccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHH-HHHHHhcC------
Confidence 4332221 22234699999999999865 478899999999999999999999964322222111 11111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002512 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
++. .+......+.+++.+||+.||++||++
T Consensus 227 ~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~ 256 (332)
T cd05614 227 DPP----FPSFIGPEAQDLLHKLLRKDPKKRLGA 256 (332)
T ss_pred CCC----CCCCCCHHHHHHHHHHcCCCHHHcCCC
Confidence 111 111234567899999999999999943
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=335.74 Aligned_cols=242 Identities=23% Similarity=0.361 Sum_probs=191.3
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.||+|+||.||+++.+ +++.+|+|.+..... .....+.+.+|+.++.++ +||||+++++++.+.+..+|||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 5999999999999976 578999998865422 223345688899998887 8999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-- 151 (329)
T cd05618 82 DLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-- 151 (329)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--
Confidence 9999886543 4788889999999999999999999 99999999999999999999999999875322211
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccc----cccHHHHHHhhhhcCCcccccccccC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFE----EGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~----~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ......+....+.... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~~ 223 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------IR 223 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--------CC
Confidence 22334689999999999999999999999999999999999999953211 1111222222222211 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
.+ ......+.+++.+||+.||++||+.
T Consensus 224 ~p--~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IP--RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CC--CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 11 1233567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=328.44 Aligned_cols=259 Identities=24% Similarity=0.405 Sum_probs=203.6
Q ss_pred HhcccccccCcccceEEEEEEEcC------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeE
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRER 587 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 587 (914)
....+.+.||+|+||.||++..++ +..||+|.+.... .......|.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 344566789999999999998753 3689999874332 223346799999999999999999999999999999
Q ss_pred EEEEeeCCCCCHHHhhhcCccch-----hcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEe
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKAL-----KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVA 662 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~~-----~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~ 662 (914)
++||||+++++|.+++....... ...+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 99999999999999997543211 124688899999999999999999998 9999999999999999999999
Q ss_pred ecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhc
Q 002512 663 DFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKS 741 (914)
Q Consensus 663 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~ 741 (914)
|||+++...............++..|+|||.+....++.++||||||+++|||+| |+.||..... ..+. ..+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~-~~~~----~~~~~ 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-EEVL----KFVID 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH-HHHH----HHHhc
Confidence 9999876544332222333457889999999998889999999999999999998 8888753221 1111 12222
Q ss_pred CCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 742 GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
+..... +...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 237 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 237 GGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCC---------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 211111 1122467889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=318.45 Aligned_cols=249 Identities=26% Similarity=0.395 Sum_probs=202.7
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||+++.+ +++.|++|.+..........+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 35678999999999999976 58899999876544344556789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.++++... ...+++..++.++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 83 NGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 999999997642 235888899999999999999999998 99999999999999999999999999876543322
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......|++.|+|||++....++.++||||||+++|||++|+.||..... ... ...+..+....+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~----~~~~~~~~~~~~-------- 221 (256)
T cd08529 157 --FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-GAL----ILKIIRGVFPPV-------- 221 (256)
T ss_pred --hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHH----HHHHHcCCCCCC--------
Confidence 12334588999999999999899999999999999999999999864321 111 111112111111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.......+.+++.+||+.+|++||++.++++
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 222 -SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred -ccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 1133467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=337.60 Aligned_cols=267 Identities=27% Similarity=0.411 Sum_probs=207.2
Q ss_pred HHHHHhcccccccCcccceEEEEEEEcC--------CcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeece
Q 002512 510 ELERATGGFKEEVGKGSFSCVYKGVLKD--------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGY 580 (914)
Q Consensus 510 el~~~t~~~~~~LG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~ 580 (914)
++....+.+.+.||+|+||.||++.... ...||+|.+.... .....++|.+|++++.++ +||||++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3444556778899999999999997531 2368999765322 233457899999999999 89999999999
Q ss_pred eecCCeEEEEEeeCCCCCHHHhhhcCcc-----------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 002512 581 CEEGRERLLVYEFMAHGSLHQHLHGKSK-----------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSS 649 (914)
Q Consensus 581 ~~~~~~~~LV~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~ 649 (914)
+.+.+..++||||+++|+|.++|..... .....+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~ 163 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAAR 163 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccc
Confidence 9999999999999999999999975421 12345889999999999999999999999 999999999
Q ss_pred ceEEcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCccccccc
Q 002512 650 NILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEE 728 (914)
Q Consensus 650 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~ 728 (914)
|||+++++.+||+|||+++...............++..|||||++....++.++||||||++||||++ |..||.....
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~- 242 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV- 242 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 99999999999999999876543222222222335678999999999999999999999999999999 7888753221
Q ss_pred ccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 729 GNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 729 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
.+ ....+..+... +.......++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 243 ---~~-~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 243 ---EE-LFKLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred ---HH-HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 11 11222221111 1111234578899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=322.58 Aligned_cols=249 Identities=29% Similarity=0.485 Sum_probs=196.5
Q ss_pred cccCcccceEEEEEEEcC----CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 520 EEVGKGSFSCVYKGVLKD----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
++||+|+||.||+|++.. +..+|+|.+...... ...++|.+|++++++++||||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 369999999999998542 268999987644332 34578999999999999999999999876 456799999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.++|.... .+++..++.++.|++.+|+|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 999999997643 4789999999999999999999999 99999999999999999999999999976543322
Q ss_pred CC-CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 676 SP-LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 676 ~~-~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.. ......++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+.. .+.....
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~~----~~~~~~~--------- 216 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVIA----MLESGER--------- 216 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHHH----HHHcCCc---------
Confidence 11 1111224568999999998899999999999999999998 8999864321 11221 2222111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
.+.+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 111122345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=325.36 Aligned_cols=249 Identities=23% Similarity=0.322 Sum_probs=194.7
Q ss_pred cCcccceEEEEEEEc-CCcEEEEEEeeeccccc-cchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 522 VGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQ-KNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
||+|+||.||+++.+ +++.+|+|++....... .....+..|++++++++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999976 58999999885432221 1234566799999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCc
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 679 (914)
.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++....... ..
T Consensus 81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~ 151 (277)
T cd05607 81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TI 151 (277)
T ss_pred HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---ee
Confidence 998865432 34788888999999999999999999 9999999999999999999999999987654322 12
Q ss_pred cCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHH
Q 002512 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLD 759 (914)
Q Consensus 680 ~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 759 (914)
....|+..|+|||++....++.++|||||||+||||++|+.||..........+.. ....... .... ...
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~--------~~~~-~~~ 221 (277)
T cd05607 152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK-RRTLEDE--------VKFE-HQN 221 (277)
T ss_pred eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH-HHhhccc--------cccc-ccc
Confidence 23468999999999998889999999999999999999999986432221111111 1111111 1100 112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 760 ALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 760 ~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
...++.+|+.+||+.+|++||+++|+++.+
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~ 251 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDDP 251 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence 345688999999999999999998876443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=333.98 Aligned_cols=238 Identities=25% Similarity=0.352 Sum_probs=188.6
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.||+|+||.||+++.+ +++.||+|.+..... .....+.+..|..++..+ +||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5999999999999976 478899998865321 222345567777777755 8999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... .++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 82 DLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 9999997543 4778888899999999999999999 9999999999999999999999999997543222 2
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..+.... + . .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-~~~----~~i~~~~------~--~--~~ 216 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-ELF----DSILNDR------P--H--FP 216 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-HHH----HHHHcCC------C--C--CC
Confidence 233456999999999999989999999999999999999999998643221 111 1111110 0 0 11
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSMD 783 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ 783 (914)
.....++.+++.+||+.+|++||++.
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~ 242 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVD 242 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCh
Confidence 12335678999999999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=330.00 Aligned_cols=261 Identities=28% Similarity=0.462 Sum_probs=198.0
Q ss_pred ccccccCcccceEEEEEEEc-----CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec--CCeEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-----DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE--GRERLL 589 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~L 589 (914)
.+.+.||+|+||.||++..+ +++.||+|++.... ....+.|.+|++++++++||||+++++++.. ....++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 7 KFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred eeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 45678999999999999753 47899999875432 2334689999999999999999999998753 346889
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 85 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999997542 24789999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCCC-CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC-----
Q 002512 670 GPADSSSP-LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD----- 743 (914)
Q Consensus 670 ~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~----- 743 (914)
........ ......++..|+|||++....++.++||||||+++|||++|..++...... +. .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~----~~~~~~~~~~~~ 231 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--FM----RMMGNDKQGQMI 231 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--hh----hhcccccccccc
Confidence 64432211 111122445699999999888999999999999999999988765322110 00 0000000
Q ss_pred ---cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 744 ---ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 744 ---~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
+.+.+......+.....+.++.+|+.+||..+|++|||++||++.|+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 232 VYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred hHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 0011111111222233456789999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=330.78 Aligned_cols=259 Identities=28% Similarity=0.451 Sum_probs=200.0
Q ss_pred ccccccCcccceEEEEEEEcC-Cc--EEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEe
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GT--VVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
.+.+.||+|+||.||++.+++ +. .+++|.+.... .....+.|.+|++++.++ +||||+++++++.+....++|||
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 5 KFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred eeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 356789999999999999764 33 46887664322 223346799999999999 79999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccc-----------hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEE
Q 002512 593 FMAHGSLHQHLHGKSKA-----------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARV 661 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~-----------~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl 661 (914)
|+++++|.++++..... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEE
Confidence 99999999999754211 1134788899999999999999999998 999999999999999999999
Q ss_pred eecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhh
Q 002512 662 ADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIK 740 (914)
Q Consensus 662 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~ 740 (914)
+|||++........ ......+..|+|||++....++.++||||||+++|||++ |..||...... ++.+ .+.
T Consensus 161 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-~~~~----~~~ 232 (297)
T cd05089 161 ADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-ELYE----KLP 232 (297)
T ss_pred CCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-HHHH----HHh
Confidence 99999864321111 111223567999999998889999999999999999998 99998543211 1111 111
Q ss_pred cCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 002512 741 SGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 741 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~~ 796 (914)
.+ ...+.+......+.+|+.+||+.+|.+||+++++++.|+.++...
T Consensus 233 ~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 233 QG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred cC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 011111223457889999999999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=335.01 Aligned_cols=237 Identities=24% Similarity=0.334 Sum_probs=189.4
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.||+|+||.||+++.+ +++.||+|++..... .....+.+..|.+++..+ +||||+++++++.+.+..+|||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5999999999999976 478999998865321 223346688899999876 8999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... .+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 82 DLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 9999987543 4788888999999999999999999 9999999999999999999999999987533222 1
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
......||+.|+|||++....++.++||||||+++|||++|+.||....... +. ..+..+.. ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-~~----~~i~~~~~--------~~p-- 216 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-LF----ESILHDDV--------LYP-- 216 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-HH----HHHHcCCC--------CCC--
Confidence 2233468999999999999899999999999999999999999996432211 11 11111111 011
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
.....++.+++.+||+.+|++||+.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~ 241 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGC 241 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCC
Confidence 1123577899999999999999943
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=326.73 Aligned_cols=251 Identities=23% Similarity=0.308 Sum_probs=197.2
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
...+.||+|+||.||++... +++.||+|++...... ......+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05605 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEecc
Confidence 34567999999999999975 5889999988643322 222356788999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.+++..... ..+++.....++.|++.||+|||+.+ |+||||||+|||+++++.++|+|||++.......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 83 NGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred CCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999998865321 35889999999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. .....|++.|+|||++....++.++||||||+++|||++|+.||........ .+.+...+.... .
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~----------~ 222 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-REEVERRVKEDQ----------E 222 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-HHHHHHHhhhcc----------c
Confidence 1 1234689999999999988899999999999999999999999964322211 111111111100 0
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERP-----SMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~ 787 (914)
..+......+.+|+.+||+.||++|| ++++++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 11123446788999999999999999 6666643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.97 Aligned_cols=259 Identities=25% Similarity=0.342 Sum_probs=204.2
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||+++.+ +++.||||++..... .......|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 5 ~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08228 5 QIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELA 84 (267)
T ss_pred eeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEec
Confidence 45678999999999999975 689999998754322 2233467899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++..... ....++....+.++.|+++||+|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 85 DAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred CCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 99999998864321 1234788888999999999999999999 9999999999999999999999999987654322
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. ......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... ...... ..+.......
T Consensus 161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~--~~~~~~-~~~~~~~~~~-------- 227 (267)
T cd08228 161 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLFSLC-QKIEQCDYPP-------- 227 (267)
T ss_pred H--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc--cHHHHH-HHHhcCCCCC--------
Confidence 1 12234588899999999988899999999999999999999999854321 111111 1111111100
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
.........+.+++.+||..+|++||++.+|++.|+++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01123446789999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=330.31 Aligned_cols=257 Identities=28% Similarity=0.450 Sum_probs=200.7
Q ss_pred ccccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
.+.+.||+|+||.||++..+ ++..||+|++.... ......+|.+|+.++++++||||+++++++.+++..++|
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred eecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 34567999999999999864 46789999875432 223346799999999999999999999999999999999
Q ss_pred EeeCCCCCHHHhhhcCcc-----------------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE
Q 002512 591 YEFMAHGSLHQHLHGKSK-----------------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 653 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl 653 (914)
|||+++++|.+++..... .....+++..++.++.|++.||+|||+.+ ++||||||+|||+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEe
Confidence 999999999999974321 11124788889999999999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHH
Q 002512 654 DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIV 732 (914)
Q Consensus 654 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~ 732 (914)
++++.+||+|||++.................+..|+|||.+....++.++||||||+++|||++ |..||......
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~---- 239 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE---- 239 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 9999999999999875433322222222335678999999998899999999999999999998 77787532111
Q ss_pred HHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 733 EWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
+ ....+..+.... .+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ~-~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 E-VIYYVRDGNVLS---------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H-HHHHHhcCCCCC---------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 112222222211 111234678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=321.38 Aligned_cols=253 Identities=30% Similarity=0.482 Sum_probs=204.0
Q ss_pred cccCcccceEEEEEEEcC----CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 520 EEVGKGSFSCVYKGVLKD----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.||+|+||.||++...+ +..+++|.+....... ..+.+.+|++++.+++|+||+++++++.+....++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 369999999999999764 7889999876544332 45789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccc----hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 596 HGSLHQHLHGKSKA----LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 596 ~gsL~~~l~~~~~~----~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
+++|.+++...... ....+++..+..++.|+++||+|||+++ |+||||||+|||+++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999865211 1246899999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 672 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
............++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+. ..+..+..
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~----~~~~~~~~------ 225 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN-EEVL----EYLRKGYR------ 225 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH-HHHH----HHHHcCCC------
Confidence 5432223334457889999999998889999999999999999999 5888864411 1111 12221111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
...+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 226 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 226 ---LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111223568889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=322.35 Aligned_cols=252 Identities=27% Similarity=0.443 Sum_probs=199.9
Q ss_pred hcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.++||+|+||.||++.++++..+|+|++.... ...+.|.+|++++++++|||++++++++.. +..++||||+
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 345677899999999999998877789999765332 234679999999999999999999998754 5688999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.++++.... ..+++..++.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 83 GKGSLLDFLKEGDG---KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 99999999975432 34788999999999999999999998 9999999999999999999999999997654322
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.. ......++..|+|||++....++.++||||||+++|||+| |+.||...... .... .+..+. .
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~----~~~~~~---------~ 221 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR-EVLE----QVERGY---------R 221 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH----HHHcCC---------C
Confidence 11 1122346778999999998889999999999999999999 88888643221 1111 111110 0
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
.+.+...+..+.+++.+||..+|++||++++|.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 11122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=334.16 Aligned_cols=242 Identities=23% Similarity=0.352 Sum_probs=192.3
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.||+|+||.||+++.+ +++.||+|.+..... .....+.+.+|..++.++ +||||+++++++.+.+..+|||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 5899999999999976 588999998865322 223345688999999999 7999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~ 151 (329)
T cd05588 82 DLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--D 151 (329)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--C
Confidence 9999886542 4888999999999999999999999 9999999999999999999999999986422211 1
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccc----cccHHHHHHhhhhcCCcccccccccC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFE----EGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~----~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
......||+.|+|||++.+..++.++||||||+++|||++|+.||+.... ......+....+.... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 223 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ--------IR 223 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------CC
Confidence 22334689999999999999999999999999999999999999963211 1112222222222221 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
.+. ....++.+++.+||+.+|.+||+.
T Consensus 224 ~p~--~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 224 IPR--SLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCC--CCCHHHHHHHHHHhccCHHHcCCC
Confidence 111 223567899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=321.06 Aligned_cols=250 Identities=27% Similarity=0.404 Sum_probs=199.1
Q ss_pred cccCcccceEEEEEEEcC--C--cEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 520 EEVGKGSFSCVYKGVLKD--G--TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.||+|+||.||++.+.+ + ..||+|.+...... ...++|.+|+.++++++||||+++++++.+ ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 368999999999999753 2 36899987654432 445789999999999999999999999988 88999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++..... ..+++.....++.|+++||+|||+.+ ++|+||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999986532 35889999999999999999999999 99999999999999999999999999987644222
Q ss_pred C-CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 676 S-PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 676 ~-~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
. .......++..|+|||++....++.++||||||+++|||++ |+.||....... ... ........
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~---~~~~~~~~--------- 219 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ-ILK---KIDKEGER--------- 219 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH-HHH---HHHhcCCc---------
Confidence 1 12223457889999999999899999999999999999999 999985332211 111 11111110
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
.+.+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 1111123467889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=334.26 Aligned_cols=239 Identities=26% Similarity=0.355 Sum_probs=191.7
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.||+|+||.||+++.+ +++.||+|++..... .....+.+..|..++..+ +||||+++++++.+.+..+|||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 5999999999999976 478999998764321 223446788899999877 7999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 82 DLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred hHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 9999987543 4788888999999999999999999 9999999999999999999999999987532221 1
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
......||+.|||||++....++.++||||||+++|||++|+.||...... .+. ..+..+.. ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-~~~----~~i~~~~~--------~~~-- 216 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-DLF----EAILNDEV--------VYP-- 216 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-HHH----HHHhcCCC--------CCC--
Confidence 223346999999999999989999999999999999999999998643221 111 11211111 111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSMDK 784 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~~e 784 (914)
.....++.+++.+||+.||++||++.+
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 123357789999999999999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=343.32 Aligned_cols=252 Identities=22% Similarity=0.305 Sum_probs=193.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.++||+|+||.||++..+ +++.||||++..... .....+.+.+|++++++++||||+++++++.+.+..||||||+
T Consensus 4 ~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~ 83 (377)
T cd05629 4 HTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFL 83 (377)
T ss_pred eEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCC
Confidence 34578999999999999865 688999998865321 2233467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 84 PGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999997543 4677788889999999999999999 9999999999999999999999999986332110
Q ss_pred CC---------------------------------------------CCccCCCCcCCccChhhhhcCCCCCcchHHHHH
Q 002512 675 SS---------------------------------------------PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFG 709 (914)
Q Consensus 675 ~~---------------------------------------------~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~G 709 (914)
.. .......||+.|+|||++....++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000123599999999999998999999999999
Q ss_pred HHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCC---CCHHHHH
Q 002512 710 VLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKER---PSMDKVT 786 (914)
Q Consensus 710 vvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R---Ps~~ev~ 786 (914)
|+||||++|+.||........ ........ ..+..+.......++.+++.+|+. +|.+| |++.|++
T Consensus 236 vil~elltG~~Pf~~~~~~~~----~~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHET----YRKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHH----HHHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 999999999999864322111 11111100 011112222234567889999997 67665 5887776
Q ss_pred HH
Q 002512 787 TA 788 (914)
Q Consensus 787 ~~ 788 (914)
..
T Consensus 304 ~h 305 (377)
T cd05629 304 SH 305 (377)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=337.79 Aligned_cols=242 Identities=23% Similarity=0.309 Sum_probs=193.5
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
.||+|+||.||+++.+ +++.||+|.+..... ......++.+|++++.+++||||+++++++.+.+..+|||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 5999999999999965 588999998865322 22334678899999999999999999999999999999999999999
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
|.+++.... .+++.....++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-- 151 (325)
T cd05594 82 LFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-- 151 (325)
T ss_pred HHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--
Confidence 999987543 47888999999999999999997 67 99999999999999999999999999875332211
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
......||+.|||||++.+..++.++||||||++||||+||+.||...... ... ..+.... ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-~~~----~~i~~~~--------~~~p-- 216 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-KLF----ELILMEE--------IRFP-- 216 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-HHH----HHHhcCC--------CCCC--
Confidence 122346999999999999999999999999999999999999998643211 111 1111111 1111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002512 758 LDALKRIANVACKCVRMRGKERP-----SMDKVTT 787 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~ 787 (914)
.....++.+++.+||+.||++|+ ++.++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 12235688999999999999997 7877764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.43 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=192.8
Q ss_pred cccCcccceEEEEEEEcC----CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceee-cCCeEEEEEeeC
Q 002512 520 EEVGKGSFSCVYKGVLKD----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCE-EGRERLLVYEFM 594 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~-~~~~~~LV~Ey~ 594 (914)
+.||+|+||.||+|.+.+ ...+|+|++.... .....+.|.+|+.+++.++||||+++++++. .+...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 358999999999998642 3578999864322 2233568899999999999999999999775 455689999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.++++.... .+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 99999999975432 3567778899999999999999998 9999999999999999999999999987543322
Q ss_pred CC--CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCC-CcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 675 SS--PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRK-AIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 675 ~~--~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~-p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
.. .......++..|+|||++....++.++||||||+++|||++|.. |+... ....+.. .+..+..
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~----~~~~~~~------- 220 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITV----YLLQGRR------- 220 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHH----HHhcCCC-------
Confidence 11 11123346778999999998899999999999999999999654 44321 1111111 1111110
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l 793 (914)
.+.+...+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 221 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 221 --LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred --CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 0111122357889999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=338.76 Aligned_cols=200 Identities=24% Similarity=0.341 Sum_probs=170.3
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.||+|+||+||+++.+ +++.||+|++..... .......+.+|+.++.+++||||+++++++.+....+|||||++
T Consensus 5 ~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (363)
T cd05628 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLP 84 (363)
T ss_pred EeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCC
Confidence 4577999999999999876 488999998865322 12234568899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+|+|.+++.... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 85 GGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999997543 4788889999999999999999999 99999999999999999999999999875432110
Q ss_pred C---------------------------------CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCc
Q 002512 676 S---------------------------------PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722 (914)
Q Consensus 676 ~---------------------------------~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~ 722 (914)
. .......||+.|+|||++....++.++|||||||+||||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0 0112346999999999999999999999999999999999999999
Q ss_pred ccc
Q 002512 723 DMQ 725 (914)
Q Consensus 723 ~~~ 725 (914)
...
T Consensus 237 ~~~ 239 (363)
T cd05628 237 CSE 239 (363)
T ss_pred CCC
Confidence 643
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=330.71 Aligned_cols=263 Identities=26% Similarity=0.407 Sum_probs=204.1
Q ss_pred cccccccCcccceEEEEEEEc--------CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCe
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK--------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRE 586 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~ 586 (914)
..+.++||+|+||.||+++.. ....+|+|.+.... ......+|.+|+++++++ +||||+++++++.+...
T Consensus 14 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 92 (314)
T cd05099 14 LVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGP 92 (314)
T ss_pred eeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCc
Confidence 346678999999999999752 24568888765432 233456789999999999 69999999999999999
Q ss_pred EEEEEeeCCCCCHHHhhhcCcc-----------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC
Q 002512 587 RLLVYEFMAHGSLHQHLHGKSK-----------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE 655 (914)
Q Consensus 587 ~~LV~Ey~~~gsL~~~l~~~~~-----------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~ 655 (914)
.++||||+++|+|.+++..... .....+++..+++++.|++.||.|||+.+ |+||||||+|||+++
T Consensus 93 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~ 169 (314)
T cd05099 93 LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTE 169 (314)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcC
Confidence 9999999999999999975421 11245889999999999999999999999 999999999999999
Q ss_pred CCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHH
Q 002512 656 EHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEW 734 (914)
Q Consensus 656 ~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~ 734 (914)
++.+||+|||+++...............++..|||||++....++.++||||||+++|||++ |..||..... . .
T Consensus 170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-~----~ 244 (314)
T cd05099 170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-E----E 244 (314)
T ss_pred CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-H----H
Confidence 99999999999976543222222222234568999999998899999999999999999999 8888753211 1 1
Q ss_pred HHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 002512 735 AVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~~ 796 (914)
....+..+... ..+.....++.+++.+||+.+|++||++.++++.|+++....
T Consensus 245 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 245 LFKLLREGHRM---------DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11222222111 111223457889999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=325.06 Aligned_cols=255 Identities=25% Similarity=0.471 Sum_probs=201.3
Q ss_pred cccccccCcccceEEEEEEEc----CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK----DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
+.+.+.||+|+||.||+|.+. .+..+|+|.+.... .....+.|.+|+.++.+++||||+++++++.+++..++||
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (267)
T cd05066 6 IKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVT 84 (267)
T ss_pred eEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 345678999999999999864 23478999775432 2233568999999999999999999999999999999999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+++++|.+++.... ..+++...+.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 85 EYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999997543 25788999999999999999999999 9999999999999999999999999997654
Q ss_pred CCCCCCC-ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 672 ADSSSPL-AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 672 ~~~~~~~-~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
....... .....++..|+|||++....++.++||||||+++||+++ |+.||...... ... ..+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~-~~~----~~~~~~~------ 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ-DVI----KAIEEGY------ 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH-HHH----HHHhCCC------
Confidence 3322111 111224578999999998889999999999999999887 99998643221 111 1121110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
..+.....+..+.+++.+|++.+|.+||+|.++++.|+++
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ---RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1111223345788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=341.66 Aligned_cols=255 Identities=20% Similarity=0.247 Sum_probs=193.2
Q ss_pred hcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
.+.+.+.||+|+||.||++... .++.||+|+.. ...+.+|++++++|+|||||++++++......++||||
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3556788999999999999975 58899999642 24578999999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+. ++|.+++.... .+++...+.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 165 ~~-~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 165 YK-TDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred CC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 95 79999886542 4788889999999999999999999 999999999999999999999999999753322
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCccccccc------ccHHHHHHhhhhc------
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE------GNIVEWAVPLIKS------ 741 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~------~~l~~~~~~~~~~------ 741 (914)
.. .......||+.|+|||++....++.++|||||||+||||+||+.|+...... .............
T Consensus 236 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 236 NA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred cc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 11 1223346999999999999989999999999999999999999886432110 0001000000000
Q ss_pred ----CCcccc---------cccccCC--CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 742 ----GDITAI---------LDPVLKL--PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 742 ----~~~~~~---------~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+..+ ..+..+. ......+.++.+|+.+||+.||++|||++|+++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 0000000 001123457889999999999999999999875
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=321.10 Aligned_cols=258 Identities=25% Similarity=0.334 Sum_probs=204.5
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.||+|+||.||++..+ +++.++||++..... ......+|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 6 ~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 85 (267)
T cd08229 6 IEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85 (267)
T ss_pred hhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecC
Confidence 4567999999999999964 789999998755332 22334689999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++..... ....+++...+.++.||++||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 86 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 86 AGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred CCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 9999999874322 1235789999999999999999999999 99999999999999999999999999876543321
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......++..|+|||++....++.++||||||+++|||++|..||...... ..+.. ..+... ..+ ..
T Consensus 162 --~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~-~~~~~~-----~~~---~~ 228 (267)
T cd08229 162 --AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYSLC-KKIEQC-----DYP---PL 228 (267)
T ss_pred --ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--HHHHh-hhhhcC-----CCC---CC
Confidence 122345889999999999888999999999999999999999998532211 11111 111110 001 01
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
........+.+++.+||..+|++||||.+|++.+++.
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1123456789999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.35 Aligned_cols=260 Identities=25% Similarity=0.363 Sum_probs=206.3
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.+.||+|+||.||++... +++.+|+|.+...... ....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 346678999999999999987 7899999987543222 23357899999999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++++|.+++..... ....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.++|+|||+++.....
T Consensus 84 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~ 159 (267)
T cd08224 84 ADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred CCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence 999999999865321 1235788999999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.||.... ....+.. ..+..+....+
T Consensus 160 ~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~-~~~~~~~~~~~------ 228 (267)
T cd08224 160 TT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLC-KKIEKCDYPPL------ 228 (267)
T ss_pred Cc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC--ccHHHHH-hhhhcCCCCCC------
Confidence 21 1223458889999999998889999999999999999999999985322 1111111 11111111111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
+.......+.+++.+||..+|++||++.+|+++|+++
T Consensus 229 --~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 229 --PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 1113446788999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=323.95 Aligned_cols=261 Identities=24% Similarity=0.407 Sum_probs=201.6
Q ss_pred hcccccccCcccceEEEEEEEc-----CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC--CeE
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-----DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RER 587 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~ 587 (914)
+....+.||+|+||.||++++. +++.||+|.+.... .....+.|.+|++++++++||||+++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3345567999999999999842 47889999875443 233456899999999999999999999998775 568
Q ss_pred EEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCc
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla 667 (914)
++||||+++++|.+++.+.. ..+++..++.++.|++.+|+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccc
Confidence 99999999999999996542 24789999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCC-CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCccccccc----------ccHHHHHH
Q 002512 668 LLGPADSSS-PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE----------GNIVEWAV 736 (914)
Q Consensus 668 ~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~----------~~l~~~~~ 736 (914)
+........ .......++..|+|||++....++.++||||||+++|||+|++.|....... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 765433221 1122345777899999998888999999999999999999988764321110 00011111
Q ss_pred hhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 737 PLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 737 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
..+..+. ..+........+.+|+.+||+.+|++||+++++++.|+.+
T Consensus 237 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 237 RVLEEGK---------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHcCc---------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111 1111223456899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=340.36 Aligned_cols=251 Identities=20% Similarity=0.306 Sum_probs=194.8
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||+++.+ +++.||||++..... .......+.+|++++..++||||+++++++.+.+..+|||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (364)
T cd05599 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYL 83 (364)
T ss_pred eEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCC
Confidence 34578999999999999976 588999998865321 1223456889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 84 PGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999997543 4788889999999999999999999 9999999999999999999999999986543211
Q ss_pred CCC------------------------------------CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhC
Q 002512 675 SSP------------------------------------LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718 (914)
Q Consensus 675 ~~~------------------------------------~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG 718 (914)
... ......||+.|||||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 000 01123599999999999999999999999999999999999
Q ss_pred CCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 002512 719 RKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPS---MDKVTT 787 (914)
Q Consensus 719 ~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~ev~~ 787 (914)
+.||....... ......... ..+..+........+.+++.+|+. +|.+|++ ++|++.
T Consensus 236 ~~Pf~~~~~~~----~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 236 YPPFCSDNPQE----TYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCHHH----HHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99986432211 111111110 011111111234567788889986 9999998 666654
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=340.07 Aligned_cols=253 Identities=22% Similarity=0.335 Sum_probs=197.1
Q ss_pred hcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
.+.+.+.||+|+||.||+++.+ +++.||+|++..... .......|.+|+.+++.++||||+++++++.+.+..+||||
T Consensus 44 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05596 44 DFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVME 123 (370)
T ss_pred HcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEc
Confidence 3456678999999999999976 588999998854321 22233568899999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|+++|+|.++++.. .++......++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 124 y~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 124 YMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999998653 3566777889999999999999999 99999999999999999999999999976543
Q ss_pred CCCCCCccCCCCcCCccChhhhhcC----CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccc
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLH----YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~~----~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 748 (914)
.... ......||+.|||||.+... .++.++|||||||+||||++|+.||...... ..... +....
T Consensus 195 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~-i~~~~----- 263 (370)
T cd05596 195 NGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV----GTYSK-IMDHK----- 263 (370)
T ss_pred CCcc-cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH----HHHHH-HHcCC-----
Confidence 2211 22345699999999998653 4789999999999999999999998643221 11111 11110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 002512 749 DPVLKLPSDLDALKRIANVACKCVRMRGKE--RPSMDKVTTA 788 (914)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~--RPs~~ev~~~ 788 (914)
..+..+.......++.+++.+||+.+|++ ||+++|++..
T Consensus 264 -~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 264 -NSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -CcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 01122222234567889999999999987 9999988653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=332.75 Aligned_cols=242 Identities=24% Similarity=0.337 Sum_probs=190.2
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHH---HhccCCceeeeeceeecCCeEEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLL---SRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l---~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
.+.+.||+|+||.||++..+ +++.||||++..... .....+.+.+|++++ ++++||||+++++++.+.+..+|||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 35678999999999999976 588999998864321 122345677776665 5668999999999999999999999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+++++|..+++.. .+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 82 E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 82 EYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred cCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988642 4888999999999999999999999 9999999999999999999999999986532
Q ss_pred CCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 672 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
... .......|++.|||||++....++.++||||||++||||++|+.||....... .. ..+..+..
T Consensus 153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~----~~-~~i~~~~~------- 218 (324)
T cd05589 153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE----VF-DSIVNDEV------- 218 (324)
T ss_pred CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH----HH-HHHHhCCC-------
Confidence 221 12234569999999999999999999999999999999999999986432211 11 11111111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDK 784 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 784 (914)
..+ ......+.+++.+||+.+|.+||++.+
T Consensus 219 -~~p--~~~~~~~~~li~~~L~~dP~~R~~~~~ 248 (324)
T cd05589 219 -RYP--RFLSREAISIMRRLLRRNPERRLGSGE 248 (324)
T ss_pred -CCC--CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 111 123456789999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.55 Aligned_cols=255 Identities=29% Similarity=0.481 Sum_probs=203.7
Q ss_pred HHhcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 513 RATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 513 ~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
+....+.+.||+|+||.||++..++++.+|||.+.... ...++|.+|+.++++++||||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 34455678899999999999998888899999875432 234789999999999999999999999999899999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|+++++|.+++..... ..+++..++.++.|++.||+|||+++ |+|+||||+||++++++.+||+|||++.....
T Consensus 82 ~~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccc
Confidence 9999999999976431 35789999999999999999999999 99999999999999999999999999876543
Q ss_pred CCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
.... .......+..|+|||.+....++.++||||||+++|||++ |+.||...... .... .+..+
T Consensus 156 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~-~~~~----~~~~~--------- 220 (261)
T cd05034 156 DEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR-EVLE----QVERG--------- 220 (261)
T ss_pred hhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHH----HHHcC---------
Confidence 2111 1112234678999999998889999999999999999999 89888533211 1111 11111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
...+.+...+.++.+++.+|++.+|++||+++++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111112234678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.45 Aligned_cols=259 Identities=25% Similarity=0.386 Sum_probs=212.1
Q ss_pred cCCHHHHHHHhcccccccCcccceEEEEEEEcC--Cc--EEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeece
Q 002512 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLKD--GT--VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580 (914)
Q Consensus 505 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~~--~~--~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~ 580 (914)
.+..++|. +.|+||+|.||.|++|.++. |+ .||||.+....... ...+|++|+.+|.+|+|||+++|||.
T Consensus 106 lIpee~i~-----l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 106 LIPEEQIK-----LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred eccHHHHH-----HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeee
Confidence 44555554 35689999999999999873 44 58999886655433 56899999999999999999999999
Q ss_pred eecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEE
Q 002512 581 CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNAR 660 (914)
Q Consensus 581 ~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~k 660 (914)
..+ ...+||||+++.|+|.+.|++.. +..|-......++.|||.||+||.+++ +|||||..+|+||-....+|
T Consensus 180 Vl~-qp~mMV~ELaplGSLldrLrka~---~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVK 252 (1039)
T KOG0199|consen 180 VLD-QPAMMVFELAPLGSLLDRLRKAK---KAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVK 252 (1039)
T ss_pred ecc-chhhHHhhhcccchHHHHHhhcc---ccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceee
Confidence 988 77889999999999999998722 345777778899999999999999999 99999999999999999999
Q ss_pred EeecCCcccCCCCCCC-CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhh
Q 002512 661 VADFGLSLLGPADSSS-PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPL 738 (914)
Q Consensus 661 l~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~ 738 (914)
|+||||.+-+...... .+.....-.+.|.|||.++...++.+||||+|||+||||+| |+.||-.....
T Consensus 253 I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~---------- 322 (1039)
T KOG0199|consen 253 ICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI---------- 322 (1039)
T ss_pred eecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------
Confidence 9999999877654433 33333345678999999999999999999999999999999 56787532111
Q ss_pred hhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
.+.+.+|...+++.+..++++|+++|.+||.++|.+|||+..|.+.+-
T Consensus 323 ----qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 323 ----QILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ----HHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 111234455566777788999999999999999999999999986653
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=324.67 Aligned_cols=255 Identities=26% Similarity=0.424 Sum_probs=201.2
Q ss_pred ccccccCcccceEEEEEEEcC-Cc----EEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GT----VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
.+.+.||+|+||.||+|.+++ ++ .+|+|....... .....+|.+|+.++++++||||+++++++.. ...++||
T Consensus 10 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred EEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 456789999999999999753 33 588887654432 3344679999999999999999999999987 7889999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+++|+|.++++.... .+++...+.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 88 e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 88 QLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred ecCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999976432 4889999999999999999999988 9999999999999999999999999998765
Q ss_pred CCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 672 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
............++..|+|||.+....++.++||||||+++|||++ |+.||...... ++. ..+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~----~~~~~~~~------ 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV-EIP----DLLEKGER------ 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH-HHH----HHHhCCCC------
Confidence 3332222222234678999999988889999999999999999999 99998643211 111 12222111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
.+.+......+.+++.+||..+|.+||++.++++.|+++++
T Consensus 230 ---~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 ---LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111223467899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=320.48 Aligned_cols=246 Identities=29% Similarity=0.476 Sum_probs=200.4
Q ss_pred ccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
.+.+.||+|+||.||++... ++.||+|++..... ..++|.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus 9 ~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 9 KLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred cceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 45678999999999999876 78999998854432 457899999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++..... ..+++..+..++.|++.+|.|||+.+ |+|+||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 85 GSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 999999975432 25899999999999999999999999 99999999999999999999999999976532211
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
....+..|+|||++....++.++||||||+++|||++ |+.||.... ...+. ..+..+.. ..
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~~~~~----~~~~~~~~---------~~ 219 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVV----PHVEKGYR---------ME 219 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHHH----HHHhcCCC---------CC
Confidence 2235678999999998889999999999999999997 888875331 11111 11211111 01
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
.+...+..+.+++.+||..+|++||++.|++++|++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 220 APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111234678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=357.01 Aligned_cols=263 Identities=22% Similarity=0.311 Sum_probs=202.7
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.++||+|+||.||+|+.. .++.||+|++..... .....++|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 5 eIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~ 84 (932)
T PRK13184 5 DIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYI 84 (932)
T ss_pred EEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcC
Confidence 35678999999999999976 488999998864322 2233467999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCcc------chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 595 AHGSLHQHLHGKSK------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 595 ~~gsL~~~l~~~~~------~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
++++|.+++..... .....+++...++++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 85 eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 85 EGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred CCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcce
Confidence 99999999864211 11234567788999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCC----------------CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHH
Q 002512 669 LGPADSS----------------SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIV 732 (914)
Q Consensus 669 ~~~~~~~----------------~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~ 732 (914)
....... ........||+.|||||++.+..++.++|||||||++|||+||+.||....... ..
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k-i~ 240 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK-IS 240 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh-hh
Confidence 6521110 001122459999999999999999999999999999999999999986422111 00
Q ss_pred HHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHHHHHH
Q 002512 733 EWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERP-SMDKVTTALERALA 794 (914)
Q Consensus 733 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP-s~~ev~~~L~~~l~ 794 (914)
. .. .+.++. ......+.+..+.+++.+|++.+|++|| +++++.+.|+..+.
T Consensus 241 ---~----~~---~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 241 ---Y----RD---VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ---h----hh---hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0 00 001110 0111123345788999999999999996 67788888887654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=336.05 Aligned_cols=240 Identities=25% Similarity=0.347 Sum_probs=198.4
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeecc-ccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEee
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+|...||+|+||+|+++.++ +++.+|||.+.+.. -...+.+..+.|.+|+... +||-++.|+.+|+..++.|.||||
T Consensus 371 ~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey 450 (694)
T KOG0694|consen 371 RLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEY 450 (694)
T ss_pred EEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEe
Confidence 36788999999999999987 47899999887654 2334567788999999888 599999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+.||++..+++. ..++.....-++..|+.||+|||+++ |||||||.+|||||.+|.+||+||||++..-..
T Consensus 451 ~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 451 VAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred cCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCC
Confidence 999995444432 25888888999999999999999999 999999999999999999999999999864422
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
. ..+.+..||+.|||||++....|+...|.|||||+|||||.|..||....+++-+- .+...+
T Consensus 522 g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd-----sI~~d~---------- 584 (694)
T KOG0694|consen 522 G--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD-----SIVNDE---------- 584 (694)
T ss_pred C--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-----HHhcCC----------
Confidence 2 24566789999999999999999999999999999999999999998654443211 122211
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
...+.-...+.++|+.+.|..+|++|.-+
T Consensus 585 ~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11233455678899999999999999876
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=319.46 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=199.5
Q ss_pred ccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||+||+++... ++.+|+|.+..............+|+.++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 456789999999999999875 6689999987665444433455679999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.++|.. ...+++..++.++.|+++||+|||+.+ |+|+||||+|||+++++.++|+|||++.... ..
T Consensus 82 ~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~ 151 (260)
T PF00069_consen 82 GGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--EN 151 (260)
T ss_dssp TEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--ST
T ss_pred cccccccccc-----ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cc
Confidence 9999999982 235789999999999999999999999 9999999999999999999999999987541 11
Q ss_pred CCCccCCCCcCCccChhhhh-cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYR-LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~-~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
........++..|+|||++. ...++.++||||||+++|||++|+.||........ ......... .. .......
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~-~~---~~~~~~~- 225 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEKILK-RP---LPSSSQQ- 225 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHHHHH-TH---HHHHTTS-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhh-hhhhhhccc-cc---ccccccc-
Confidence 22334456899999999998 88899999999999999999999999875411111 111111110 00 0000000
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.......+.+++.+||+.+|++||++.++++
T Consensus 226 --~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 --SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011268899999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=319.67 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=188.3
Q ss_pred ccCcccceEEEEEEEcCCc---EEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLKDGT---VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~~---~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
+||+|+||.||++...++. .+++|.+.... .....+.|.+|+.+++.++||||+++++++.+....+|||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 5999999999999865433 45566543322 2234578999999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++++.... ...+++.....++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 156 (268)
T cd05086 81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156 (268)
T ss_pred cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence 999999764321 234566677889999999999999998 9999999999999999999999999986432222111
Q ss_pred CccCCCCcCCccChhhhhc-------CCCCCcchHHHHHHHHHHHHhC-CCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 678 LAELPAGTLGYLDPEYYRL-------HYLTTKSDVYSFGVLLLEILSG-RKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~-------~~~s~ksDV~S~GvvL~ElltG-~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
......++..|+|||++.. ..++.++||||||+++|||+++ ..||..... . +.....+.. ....+.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-~---~~~~~~~~~-~~~~~~~ 231 (268)
T cd05086 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-R---EVLNHVIKD-QQVKLFK 231 (268)
T ss_pred cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-H---HHHHHHHhh-cccccCC
Confidence 2233457899999999853 2457899999999999999975 556643211 1 111112222 2223333
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
+.+..+ ....+.+++..|| .+|++||++++|++.|
T Consensus 232 ~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 232 PQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred CccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 333222 2346778889999 6799999999998877
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=333.96 Aligned_cols=239 Identities=26% Similarity=0.342 Sum_probs=188.4
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHH-HHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELD-LLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.||+|+||+||+++.+ +++.||+|++..... ......++..|.. +++.++||||+++++++.+.+..+|||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 5999999999999976 589999998865322 1222345555655 567889999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... .+++.....++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 151 (323)
T cd05575 82 ELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--K 151 (323)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--C
Confidence 9999997543 4778888899999999999999999 9999999999999999999999999986532221 1
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
......||+.|+|||++....++.++||||||++||||++|+.||..... .+... .+.... ...+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~-~i~~~~--------~~~~~- 217 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT----AEMYD-NILNKP--------LRLKP- 217 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH----HHHHH-HHHcCC--------CCCCC-
Confidence 22334689999999999999999999999999999999999999864321 11111 111111 11111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSMDK 784 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~~e 784 (914)
.....+.+++.+||+.+|.+||++.+
T Consensus 218 -~~~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 218 -NISVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred -CCCHHHHHHHHHHhhcCHHhCCCCCC
Confidence 22457889999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=321.90 Aligned_cols=259 Identities=27% Similarity=0.470 Sum_probs=203.2
Q ss_pred ccccccCcccceEEEEEEEc-----CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec--CCeEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-----DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE--GRERLL 589 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~L 589 (914)
.+.+.||+|+||.||++++. .++.+|||++...... ...++|.+|++++++++||||+++++++.. ....++
T Consensus 7 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 7 KFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred hhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 35578999999999999864 3678999987654332 245789999999999999999999999887 567899
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++..
T Consensus 86 v~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 9999999999999976432 5889999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCC-CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccc----------cHHHHHHhh
Q 002512 670 GPADSSS-PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEG----------NIVEWAVPL 738 (914)
Q Consensus 670 ~~~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~----------~l~~~~~~~ 738 (914)
....... .......++..|++||.+....++.++||||||+++|||+||+.|+....... .........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence 6532221 11222345677999999998899999999999999999999998875432211 001111111
Q ss_pred hhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
+.. ....+.+...+.++.+|+.+||+.+|++||++.||+++|+.+
T Consensus 239 ~~~---------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 239 LKE---------GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHc---------CCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111 111222223346789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=329.85 Aligned_cols=259 Identities=19% Similarity=0.285 Sum_probs=194.5
Q ss_pred cccccCcc--cceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 518 FKEEVGKG--SFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 518 ~~~~LG~G--~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.++||+| +|++||+++.+ +++.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 78999999875 6899999988654333333456778999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++++||+.........
T Consensus 82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 99999999965322 24788899999999999999999999 9999999999999999999999998654322111
Q ss_pred C-----CCCccCCCCcCCccChhhhhc--CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccc
Q 002512 675 S-----SPLAELPAGTLGYLDPEYYRL--HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 675 ~-----~~~~~~~~Gt~~y~aPE~l~~--~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 747 (914)
. ........++..|+|||++.. ..++.++|||||||++|||++|+.||............. .+.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~-----~~~~~~~ 230 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL-----NGTVPCL 230 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHh-----cCCcccc
Confidence 0 011122346788999999976 458899999999999999999999986432211111100 0000000
Q ss_pred cc------------------------------------cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 748 LD------------------------------------PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 748 ~d------------------------------------~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
++ .....+........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00 00000111233457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=331.59 Aligned_cols=241 Identities=23% Similarity=0.303 Sum_probs=191.4
Q ss_pred ccccccCcccceEEEEEEEcC-CcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCC-ceeeeeceeecCCeEEEEEee
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHA-HLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~Hp-nIv~l~g~~~~~~~~~LV~Ey 593 (914)
.+.+.||+|+||.||+++.++ ++.||+|++..... .....+.+..|++++..++|+ +|+++++++.+.+..|+||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 456789999999999999764 78899998865322 223456788999999999764 688999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++|+|.+++.... .+++.....++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 83 VNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999997543 4778888999999999999999999 999999999999999999999999998643211
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
. .......||+.|+|||++.+..++.++|||||||+||||+||+.||....... +. ..+.... ..
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-~~----~~i~~~~--------~~ 219 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LF----QSIMEHN--------VS 219 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HH----HHHHcCC--------CC
Confidence 1 12233468999999999999999999999999999999999999986432211 11 1111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
. +.....++.+++.+||..+|.+||+.
T Consensus 220 ~--~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 Y--PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C--CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1 11233577899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=330.58 Aligned_cols=242 Identities=26% Similarity=0.362 Sum_probs=191.1
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.||+|+||.||+++.+ +++.||+|.+..... .....+.+..|..++..+ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 35999999999999986 588999998865321 122345677888888765 899999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
|+|.+++.... .+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 150 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-- 150 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--
Confidence 99999987542 4788888999999999999999999 9999999999999999999999999986432211
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 756 (914)
.......||+.|+|||++....++.++||||||+++|||++|+.||...... .+. ..+.... + ..+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~-~~~----~~~~~~~------~--~~~- 216 (316)
T cd05620 151 NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED-ELF----ESIRVDT------P--HYP- 216 (316)
T ss_pred CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHH----HHHHhCC------C--CCC-
Confidence 1223456899999999999999999999999999999999999998643221 111 1111110 0 011
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHH-HHH
Q 002512 757 DLDALKRIANVACKCVRMRGKERPSMD-KVT 786 (914)
Q Consensus 757 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~-ev~ 786 (914)
.....++.+++.+||+.||++||++. +++
T Consensus 217 -~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 -RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11235678999999999999999984 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=337.99 Aligned_cols=252 Identities=22% Similarity=0.350 Sum_probs=194.1
Q ss_pred hcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
.+.+.+.||+|+||.||+++.+ +++.+|+|.+..... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 44 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~E 123 (370)
T cd05621 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVME 123 (370)
T ss_pred HCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEc
Confidence 3456678999999999999976 478899998754221 22234568899999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|+++|+|.+++... .++......++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++.....
T Consensus 124 y~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 124 YMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred CCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999643 3677778889999999999999999 99999999999999999999999999976543
Q ss_pred CCCCCCccCCCCcCCccChhhhhcC----CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccc
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLH----YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~~----~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 748 (914)
... .......||+.|||||++... .++.++|||||||+||||++|+.||....... ..........
T Consensus 195 ~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~----~~~~i~~~~~----- 264 (370)
T cd05621 195 TGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG----TYSKIMDHKN----- 264 (370)
T ss_pred CCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH----HHHHHHhCCc-----
Confidence 221 122345699999999999754 37899999999999999999999996432211 1111111110
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhcCCC--CCCCHHHHHH
Q 002512 749 DPVLKLPSDLDALKRIANVACKCVRMRGK--ERPSMDKVTT 787 (914)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~--~RPs~~ev~~ 787 (914)
.+..+........+.+++..|+..++. .||++.|+++
T Consensus 265 --~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 265 --SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred --ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 112222233445677888899975554 3788887765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=340.38 Aligned_cols=249 Identities=21% Similarity=0.260 Sum_probs=189.1
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.||+|+||.||+++.. +++.||+|++..... .......+.+|++++++++||||+++++++.+.+..+|||||++
T Consensus 5 ~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~ 84 (382)
T cd05625 5 KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIP 84 (382)
T ss_pred EEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCC
Confidence 4567999999999999975 578999998764321 12334678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+|+|.+++.+.. .++......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 85 gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 85 GGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999997543 3677778889999999999999999 99999999999999999999999999753211000
Q ss_pred ---------------------------------------------CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHH
Q 002512 676 ---------------------------------------------SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGV 710 (914)
Q Consensus 676 ---------------------------------------------~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~Gv 710 (914)
........||+.|||||++....++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012246999999999999989999999999999
Q ss_pred HHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCC---HHHHH
Q 002512 711 LLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPS---MDKVT 786 (914)
Q Consensus 711 vL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~ev~ 786 (914)
+||||++|+.||......... ...... ...+..+.......++.+++.+++ .+|++|++ ++|++
T Consensus 237 il~elltG~~Pf~~~~~~~~~----~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~ 303 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQ----MKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK 303 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHH----HHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence 999999999999643221111 111110 011111222223345667777765 49999997 55544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=330.79 Aligned_cols=237 Identities=25% Similarity=0.358 Sum_probs=190.8
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.||+|+||.||+++++ +++.||+|++..... .......+.+|.+++..+ +||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 5999999999999976 478999998865421 223346678899999888 7999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 151 (318)
T cd05570 82 DLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-- 151 (318)
T ss_pred CHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--
Confidence 9999987543 4888999999999999999999999 99999999999999999999999999865322211
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+ ...+..... ..+
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-~~----~~~i~~~~~--------~~~-- 216 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-EL----FQSILEDEV--------RYP-- 216 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-HH----HHHHHcCCC--------CCC--
Confidence 122345899999999999999999999999999999999999998643211 11 111211111 111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
......+.+|+.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~ 241 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGC 241 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCC
Confidence 1233578899999999999999999
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.26 Aligned_cols=247 Identities=24% Similarity=0.412 Sum_probs=196.5
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeee--ccccccchHHHHHHHHHHHhccCCceeeeeceeecCCe--EEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIA--TSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRE--RLLVY 591 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~--~~LV~ 591 (914)
.|.++||+|+|-+||||.+. +|..||--.+.. ........++|..|+.+|+.|+|||||++++++.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 35677999999999999976 477777553322 22334455889999999999999999999999987655 77999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC-CCcEEEeecCCcccC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE-EHNARVADFGLSLLG 670 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kl~DFGla~~~ 670 (914)
|.|..|+|+.|+++.+. ++.+....|+.||++||.|||++. |||||||||-+||+|+. -|.+||+|+|||.+.
T Consensus 123 EL~TSGtLr~Y~kk~~~-----vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR-----VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred ecccCCcHHHHHHHhcc-----CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 99999999999987653 677788899999999999999987 89999999999999975 578999999999887
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
.... .....|||.|||||.+. ..|++..||||||+.|+||+|+.-||..-..... +++.+.+|....-+..
T Consensus 197 r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ----IYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 197 RKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ----IYKKVTSGIKPAALSK 267 (632)
T ss_pred hccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH----HHHHHHcCCCHHHhhc
Confidence 6543 33468999999999999 6779999999999999999999999864333222 2233333332222211
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.. ..++.+||.+|+.. .++|||+.|++.
T Consensus 268 V~--------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 268 VK--------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cC--------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 11 13678999999999 999999999875
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=322.49 Aligned_cols=252 Identities=28% Similarity=0.435 Sum_probs=197.6
Q ss_pred ccCcccceEEEEEEEcC-------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 521 EVGKGSFSCVYKGVLKD-------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
.||+|+||.||+++.++ ++.+++|.+.... ......+|.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998753 2578988764432 223456899999999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccc--hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC-----cEEEeecCC
Q 002512 594 MAHGSLHQHLHGKSKA--LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-----NARVADFGL 666 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~--~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~-----~~kl~DFGl 666 (914)
+++++|.++++..... ....+++..++.++.|++.||+|||+.+ ++|+||||+|||++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999753221 1234788999999999999999999998 99999999999999877 899999999
Q ss_pred cccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcc
Q 002512 667 SLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDIT 745 (914)
Q Consensus 667 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 745 (914)
++...............++..|+|||++....++.++||||||+++|||+| |+.||...... ... ..+..+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-~~~----~~~~~~~-- 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-EVL----QHVTAGG-- 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-HHH----HHHhcCC--
Confidence 875543322222223346789999999999999999999999999999998 99888532111 111 1111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
........+..+.+++.+||..+|.+||+++++++.|+
T Consensus 231 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 -------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred -------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11112234567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.99 Aligned_cols=241 Identities=23% Similarity=0.310 Sum_probs=192.2
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEee
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
.+.+.||+|+||.||+++.+ +++.||+|.+..... .....+.+..|..++..+ +|++|+++++++.+.+..+|||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 35678999999999999976 478999998865432 122345677888888887 689999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 83 VNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred CCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999987543 4788889999999999999999999 999999999999999999999999998753322
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.. ......||+.|+|||++....++.++|||||||+||||+||+.||...... .+. ..+.... ..
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~----~~i~~~~--------~~ 219 (323)
T cd05616 155 GV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELF----QSIMEHN--------VA 219 (323)
T ss_pred CC--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHH----HHHHhCC--------CC
Confidence 21 223456899999999999999999999999999999999999998643221 111 1121211 11
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
.+ .....++.+++.+||+.+|++|++.
T Consensus 220 ~p--~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 YP--KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC--CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 11 1234577899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=329.25 Aligned_cols=241 Identities=25% Similarity=0.374 Sum_probs=190.3
Q ss_pred cccCcccceEEEEEEEcC-CcEEEEEEeeeccc-cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 520 EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.||+|+||.||+++.++ ++.||+|++..... .....+.+..|..++..+ +||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 359999999999999764 78999998865321 122345677788888865 999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 99999997542 4788888999999999999999999 99999999999999999999999999864322111
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 756 (914)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+.. .+.... +.. +
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-~~~~----~i~~~~------~~~--~- 216 (316)
T cd05619 152 -KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-ELFQ----SIRMDN------PCY--P- 216 (316)
T ss_pred -ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-HHHH----HHHhCC------CCC--C-
Confidence 122346899999999999989999999999999999999999998643211 1111 111111 100 1
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHH-HH
Q 002512 757 DLDALKRIANVACKCVRMRGKERPSMD-KV 785 (914)
Q Consensus 757 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~-ev 785 (914)
.....++.+++.+||+.+|++||++. ++
T Consensus 217 -~~~~~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 217 -RWLTREAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred -ccCCHHHHHHHHHHhccCHhhcCCChHHH
Confidence 11235678999999999999999996 44
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=320.66 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=201.8
Q ss_pred HhcccccccCcccceEEEEEEEcCC----cEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEE
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLKDG----TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLL 589 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 589 (914)
....+.+.||+|+||.||+|.+.+. ..|++|....... ....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3445678899999999999986542 4688887754332 2344689999999999999999999999876 45789
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 84 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~ 156 (270)
T cd05056 84 VMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY 156 (270)
T ss_pred EEEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeee
Confidence 999999999999997542 24789999999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccccc
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 748 (914)
....... ......++..|+|||.+....++.++||||||+++|||++ |+.||....... ... .+..+...
T Consensus 157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-~~~----~~~~~~~~--- 227 (270)
T cd05056 157 LEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-VIG----RIENGERL--- 227 (270)
T ss_pred cccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHH----HHHcCCcC---
Confidence 5443221 1222335578999999988889999999999999999996 999986443221 111 11111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
+.+...+..+.+++.+|+..+|.+|||+.++++.|+.+..
T Consensus 228 ------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 228 ------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1112334578899999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.31 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=192.1
Q ss_pred cccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC-----eEEEEEee
Q 002512 520 EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR-----ERLLVYEF 593 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~LV~Ey 593 (914)
+.+|.|+||.||+|++.. ++.||||+......- =-+|+++|++++|||||+|+-+|.... ..-|||||
T Consensus 30 ~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVley 103 (364)
T KOG0658|consen 30 RLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEY 103 (364)
T ss_pred EEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHh
Confidence 569999999999999764 789999998654321 136999999999999999998885432 23489999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC-CcEEEeecCCcccCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE-HNARVADFGLSLLGPA 672 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kl~DFGla~~~~~ 672 (914)
||. ||+++++.... .+..++...+.-+..||.+||.|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+.+..
T Consensus 104 mP~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 104 MPE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred chH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 986 99999985321 2345677777788999999999999999 9999999999999976 8999999999998766
Q ss_pred CCCCCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHh-------hhhcCCc
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVP-------LIKSGDI 744 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~-------~~~~~~~ 744 (914)
...+. ...-|..|.|||.+.+. .|+.+.||||.|||+.||+-|++.|........+++.+.- .+.....
T Consensus 179 ~epni---SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~ 255 (364)
T KOG0658|consen 179 GEPNI---SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNP 255 (364)
T ss_pred CCCce---eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCc
Confidence 54432 22457899999999764 7999999999999999999999998775555555544321 1111111
Q ss_pred --ccccccccCCC-----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 --TAILDPVLKLP-----SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 --~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+...+.+... .......+..+|+.++|+.+|.+|.++.|++.
T Consensus 256 ~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 256 NYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred ccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 11111111111 12234467889999999999999999988764
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=340.67 Aligned_cols=251 Identities=21% Similarity=0.272 Sum_probs=191.4
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||+++.+ +++.||+|++..... .......+.+|+++|++++||||+++++.+.+.+..+|||||+
T Consensus 4 ~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~ 83 (376)
T cd05598 4 VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83 (376)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCC
Confidence 45678999999999999975 588999998754321 1223467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.+++.+.. .++......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++..+....
T Consensus 84 ~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 84 PGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999997643 3677777889999999999999999 9999999999999999999999999975321000
Q ss_pred C-----------------------------------------CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHH
Q 002512 675 S-----------------------------------------SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLL 713 (914)
Q Consensus 675 ~-----------------------------------------~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ 713 (914)
. ........||+.|||||++....++.++|||||||+||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0 00011246999999999999999999999999999999
Q ss_pred HHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCC---CHHHHHH
Q 002512 714 EILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERP---SMDKVTT 787 (914)
Q Consensus 714 ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP---s~~ev~~ 787 (914)
||++|+.||........ ... +.... ..+..+.......++.+++.+|+ .+|.+|+ ++.|++.
T Consensus 236 ell~G~~Pf~~~~~~~~----~~~-i~~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 236 EMLVGQPPFLADTPAET----QLK-VINWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred ehhhCCCCCCCCCHHHH----HHH-HhccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999965322111 111 11100 01111111123345667777765 5999999 7777664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=341.18 Aligned_cols=257 Identities=23% Similarity=0.320 Sum_probs=193.6
Q ss_pred cccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||.||++.+.. ++.||||... ...+.+|+++|++|+|||||++++++......+|||||+
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~ 242 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY 242 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc
Confidence 3455679999999999999864 7889999532 135678999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
. ++|.+++.... ..++|..++.|+.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 243 ~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 243 R-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred C-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 5 79999886542 25899999999999999999999999 9999999999999999999999999998654433
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCccccccc---ccHHHHHHhhhhcCCcc--ccc-
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE---GNIVEWAVPLIKSGDIT--AIL- 748 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~---~~l~~~~~~~~~~~~~~--~~~- 748 (914)
.........||+.|||||++.+..++.++|||||||+||||++|..++...... ......+...+...... +..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 222233456999999999999999999999999999999999988765322111 11111111111111100 000
Q ss_pred ------------------ccccCCCCC---HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 749 ------------------DPVLKLPSD---LDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 749 ------------------d~~l~~~~~---~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.+....+.. ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000000000 0112367889999999999999999999863
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=319.70 Aligned_cols=255 Identities=25% Similarity=0.441 Sum_probs=202.6
Q ss_pred HHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEE
Q 002512 512 ERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 512 ~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
......+.++||+|+||.||++.+.++..+++|.+... ....+.|.+|++++++++|+||+++++++.+ ...+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 34455677889999999999999887888999976532 2234679999999999999999999999887 7789999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 80 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 80 EFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EeCCCCcHHHHHHhCCc---cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 99999999999976432 35788889999999999999999998 9999999999999999999999999987654
Q ss_pred CCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 672 ~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
.... .......++..|+|||++....++.++||||||+++|||+| |+.||...... .+. ..+..+..
T Consensus 154 ~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~-~~~----~~~~~~~~------ 221 (260)
T cd05073 154 DNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-EVI----RALERGYR------ 221 (260)
T ss_pred CCCc-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH-HHH----HHHhCCCC------
Confidence 3221 11222346678999999998889999999999999999999 88888542211 111 11222111
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
.+.....+.++.+++.+|++.+|++||++.++.+.|+.
T Consensus 222 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11112334578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=322.72 Aligned_cols=247 Identities=22% Similarity=0.343 Sum_probs=198.1
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||.||++... +++.|++|++..... ...+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 344567999999999999864 588999998754332 23477999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++.+. .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 100 ~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred CCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999998642 3678889999999999999999999 9999999999999999999999999987543322
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. ......+++.|+|||.+....++.++||||||+++|||++|+.||........+. ...... . + ..
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~----~~~~~~-~-----~--~~ 236 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY----LIATNG-T-----P--EL 236 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH----HHhcCC-C-----C--CC
Confidence 1 1223458899999999998888999999999999999999999986432211111 111111 0 0 11
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+.+......+.+++.+||..+|++||++.+++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 112234467889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.40 Aligned_cols=257 Identities=19% Similarity=0.262 Sum_probs=198.0
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec--CCeEEEEEeeCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE--GRERLLVYEFMAH 596 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~Ey~~~ 596 (914)
+.|++|.||.||+|+++ +++.||+|+++...+...-.-.-++||.+|.+++|||||.+-.+... -+..|||||||+.
T Consensus 82 nrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh 161 (419)
T KOG0663|consen 82 NRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH 161 (419)
T ss_pred hhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh
Confidence 46999999999999976 58999999987665444333456899999999999999999887653 4579999999986
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
+|..+|+... +++...+...+..|+++||+|||.+. |+|||||++|+|+.+.|.+||+|||||+.+....
T Consensus 162 -DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~-- 231 (419)
T KOG0663|consen 162 -DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL-- 231 (419)
T ss_pred -hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCCc--
Confidence 9999998654 46888888999999999999999999 9999999999999999999999999999875542
Q ss_pred CCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC--C-cccccc-c-
Q 002512 677 PLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG--D-ITAILD-P- 750 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~--~-~~~~~d-~- 750 (914)
...+..+-|.-|.|||.+.+. .|+...|+||+|||+.|||++++.|....+-+.+...+.. +--. . +..+.+ +
T Consensus 232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l-lGtPte~iwpg~~~lp~ 310 (419)
T KOG0663|consen 232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL-LGTPSEAIWPGYSELPA 310 (419)
T ss_pred ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH-hCCCccccCCCccccch
Confidence 223445678999999999765 6899999999999999999999888766555444333221 1000 0 000000 0
Q ss_pred --ccCC---CCC--------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 751 --VLKL---PSD--------LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 --~l~~---~~~--------~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.... +.+ ....+.-++|+...|..||.+|.|+.|.++
T Consensus 311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0000 000 012356788999999999999999988664
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=335.83 Aligned_cols=260 Identities=24% Similarity=0.337 Sum_probs=195.1
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC-----eEEEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR-----ERLLVY 591 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~LV~ 591 (914)
+.+.||+|+||.||++... +++.||+|++..........+++.+|+++++.++||||+++++++...+ ..++||
T Consensus 4 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 83 (372)
T cd07853 4 PDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVT 83 (372)
T ss_pred ccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEe
Confidence 3567999999999999975 6899999988654333334567899999999999999999999998776 789999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+. ++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 84 ELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred eccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9996 5888888643 24788889999999999999999999 9999999999999999999999999997654
Q ss_pred CCCCCCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcc-----
Q 002512 672 ADSSSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT----- 745 (914)
Q Consensus 672 ~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~----- 745 (914)
..... ......+|+.|+|||++.+. .++.++|||||||++|||++|+.||........+ .............
T Consensus 155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 155 PDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL-DLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHHcCCCCHHHHHHh
Confidence 33222 22334578999999999764 5789999999999999999999998643221111 1010000000000
Q ss_pred ------cccccccCC-------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 746 ------AILDPVLKL-------PSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 746 ------~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.+....... .......+++.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 0111224578899999999999999999988753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=316.02 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=197.6
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeecccc---ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR---QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
..+.||+|+||.||++... +++.+|+|.+...... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 6 ~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 85 (263)
T cd06625 6 RGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEY 85 (263)
T ss_pred ccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEE
Confidence 4567999999999999865 5899999987644321 22346789999999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++++|.+++.... .+++....+++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 86 ~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 86 MPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred CCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999987543 4778888999999999999999999 999999999999999999999999998765432
Q ss_pred CCCCC-ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 674 SSSPL-AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 674 ~~~~~-~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
..... .....++..|+|||++.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~--------- 224 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA----AIFKIATQPT--------- 224 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH----HHHHHhccCC---------
Confidence 21111 123457889999999999889999999999999999999999985431111 1111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
....+......+.+++.+||..+|++|||+.++++.
T Consensus 225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 225 NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 011112334578899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.08 Aligned_cols=246 Identities=29% Similarity=0.457 Sum_probs=196.0
Q ss_pred cccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceee-cCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCE-EGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~-~~~~~~LV~Ey~ 594 (914)
..+.+.||+|+||.||++..+ +..+++|..... ...+.|.+|+.++++++|+||+++++++. +.+..++||||+
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 8 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred CeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 446678999999999999875 788999976432 23467999999999999999999999764 456789999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.++++.... ..+++..+++++.|++.+|+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 83 AKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999976432 34788999999999999999999999 9999999999999999999999999987543221
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.....+..|+|||++....++.++||||||+++|||++ |+.||... .+.+ ..+.+..+...
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~----~~~~-~~~~~~~~~~~-------- 218 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKD-VVPRVEKGYKM-------- 218 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----CHHH-HHHHHhcCCCC--------
Confidence 22235678999999998889999999999999999998 88887532 1111 11222221111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
......+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 219 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 219 -DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1111234578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=318.57 Aligned_cols=251 Identities=21% Similarity=0.305 Sum_probs=195.8
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||.||+|+.. +++.||+|++.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 445678999999999999974 68889999875432 223456889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.++++... .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 89 GGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 9999999987542 4788889999999999999999998 9999999999999999999999999997653221
Q ss_pred CCCCccCCCCcCCccChhhhh---cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 675 SSPLAELPAGTLGYLDPEYYR---LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~---~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
. ......|+..|+|||.+. ...++.++||||||+++|||++|+.|+.......... .+... ....+.
T Consensus 161 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-----~~~~~---~~~~~~ 230 (267)
T cd06646 161 A--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-----LMSKS---NFQPPK 230 (267)
T ss_pred c--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-----eeecC---CCCCCC
Confidence 1 122345889999999984 3457889999999999999999999985332111100 00000 001111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.. ........+.+++.+||..+|++||+++++++.
T Consensus 231 ~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 231 LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 11 111234678899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=333.06 Aligned_cols=243 Identities=27% Similarity=0.316 Sum_probs=190.0
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHH-HHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELD-LLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.||+|+||.||+++.+ +++.+|+|++..... ......++..|.. +++.++||||+++++++...+..+|||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35999999999999975 589999998864321 1223345666665 46778999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 150 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-- 150 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--
Confidence 99999887543 4788888999999999999999999 9999999999999999999999999986532211
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 756 (914)
.......||+.|||||++.+..++.++|||||||+||||++|+.||...... +.... +.... +..+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~----~~~~~-~~~~~--------~~~~- 216 (325)
T cd05604 151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA----EMYDN-ILHKP--------LVLR- 216 (325)
T ss_pred CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH----HHHHH-HHcCC--------ccCC-
Confidence 1223446999999999999999999999999999999999999998643211 11111 11111 1111
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 757 DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 757 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
......+.+++.+|++.+|.+||++.+.++
T Consensus 217 -~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 217 -PGASLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred -CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 123356788999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.71 Aligned_cols=249 Identities=27% Similarity=0.487 Sum_probs=198.7
Q ss_pred cccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
..+.+.||+|+||.||++.+.+++.+|+|++.... ....+|.+|++++++++||||+++++++......++||||++
T Consensus 6 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 6 LTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA---MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred eEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC---CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 34667899999999999998778899999875332 234679999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++.... ..+++..++.++.|++.+|+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 83 HGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 999999997543 24788889999999999999999999 99999999999999999999999999875433221
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. ......++..|+|||++....++.++||||||+++|||++ |+.||...... .+. ..+..+. ....+.
T Consensus 156 ~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-~~~----~~~~~~~--~~~~~~--- 224 (256)
T cd05112 156 T-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-EVV----ETINAGF--RLYKPR--- 224 (256)
T ss_pred c-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-HHH----HHHhCCC--CCCCCC---
Confidence 1 1112235678999999998889999999999999999998 88887543211 111 1111110 111111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
.....+.+|+.+||+.+|++||++.|+++.|
T Consensus 225 ----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 225 ----LASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1235789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.67 Aligned_cols=243 Identities=22% Similarity=0.347 Sum_probs=192.6
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.||+|+||.||+++.+ +++.+|+|++..... .....+.+.+|+.++.++ +||||+++++++.+.+..+|||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 5999999999999976 578999998865432 223346688999999998 6999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++...... .
T Consensus 82 ~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 82 DLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 9999886542 4888999999999999999999999 9999999999999999999999999987432211 1
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccc--cHHHHHHhhhhcCCcccccccccCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEG--NIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~--~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......||+.|+|||++.+..++.++||||||++||||++|+.||....... ...+.....+.... ...+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~p 223 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------IRIP 223 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------CCCC
Confidence 2233469999999999999999999999999999999999999996432211 12222222222211 1111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMD 783 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 783 (914)
. .....+.+++.+||+.||++||++.
T Consensus 224 ~--~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 R--FLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred C--CCCHHHHHHHHHHhccCHHHcCCCC
Confidence 1 2235678999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=319.80 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=193.3
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
..+.||+|+||+||++... +++.+|+|.+...... ......+.+|++++++++|+||+++++++.+++..++||||++
T Consensus 4 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05632 4 QYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMN 83 (285)
T ss_pred EEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEecc
Confidence 3567999999999999975 5889999987543221 2223557889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++..... ..+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~L~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 84 GGDLKFHIYNMGN---PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred CccHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999998865322 25899999999999999999999999 9999999999999999999999999987643321
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........ .+.......... ..
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~~~--------~~-- 223 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLETE--------EV-- 223 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhccc--------cc--
Confidence 12234689999999999988999999999999999999999999864322111 111111111110 00
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMD 783 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 783 (914)
........+.+|+..||+.+|++||++.
T Consensus 224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 224 YSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred cCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 1112335678999999999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.55 Aligned_cols=242 Identities=24% Similarity=0.296 Sum_probs=187.9
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHH-HHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELD-LLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.||+|+||.||+++.+ +++.+|+|.+..... ......++..|.. +++.++||||+++++++.+.+..++||||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 5999999999999976 477899998764321 1122344555544 567889999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... .+.......++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~ 151 (325)
T cd05602 82 ELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--G 151 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--C
Confidence 9999997543 3566777789999999999999999 9999999999999999999999999987532221 1
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
......||+.|||||++.+..++.++|||||||++|||++|+.||...... +.... +.... ... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~-i~~~~--------~~~--~ 216 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----EMYDN-ILNKP--------LQL--K 216 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH----HHHHH-HHhCC--------cCC--C
Confidence 223446999999999999999999999999999999999999998643221 11111 11111 111 1
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
......+.+++.+||+.+|.+||++.+.+.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 123456789999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=343.27 Aligned_cols=258 Identities=21% Similarity=0.265 Sum_probs=188.4
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC--------Ce
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--------RE 586 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--------~~ 586 (914)
+.+.+.||+|+||.||+|... .++.||||++.... ....+|+.+|++++|||||++++++... ..
T Consensus 68 y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred EEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 456778999999999999975 58899999875321 2345799999999999999999886432 24
Q ss_pred EEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC-cEEEeecC
Q 002512 587 RLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-NARVADFG 665 (914)
Q Consensus 587 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kl~DFG 665 (914)
.++||||+++ +|.+++..... ....+++.....++.||++||+|||+.+ |+||||||+||||+.++ .+||+|||
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 6799999974 78777753211 1235888889999999999999999999 99999999999998664 79999999
Q ss_pred CcccCCCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhc---
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKS--- 741 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~--- 741 (914)
+++....... .....||+.|||||++.+ ..++.++|||||||+||||++|++||........+..... .+..
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~-~~~~p~~ 292 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ-VLGTPTE 292 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH-HhCCCCH
Confidence 9986543221 223468999999999865 4689999999999999999999999865433222222111 0000
Q ss_pred -------CCcccc-----cccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 742 -------GDITAI-----LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 742 -------~~~~~~-----~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.....+ ....+....+...+.++.+|+.+||+.+|.+|||+.|++..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 000000 00000000111234578899999999999999999998743
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=320.17 Aligned_cols=260 Identities=23% Similarity=0.297 Sum_probs=192.6
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc---cCCceeeeeceeec-----CCeE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL---NHAHLLNLLGYCEE-----GRER 587 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~~-----~~~~ 587 (914)
.+.+.||+|+||.||+++.+ +++.||+|.+............+.+|+.+++++ +||||+++++++.. ....
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~ 82 (288)
T cd07863 3 EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKV 82 (288)
T ss_pred eEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceE
Confidence 35678999999999999976 588999998765433333334567788877766 69999999998864 3457
Q ss_pred EEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCc
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla 667 (914)
++||||++ ++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 83 ~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 83 TLVFEHVD-QDLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred EEEEcccc-cCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 89999997 489998875432 34788999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC---Cc
Q 002512 668 LLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG---DI 744 (914)
Q Consensus 668 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~---~~ 744 (914)
+...... ......||..|+|||++....++.++|||||||++|||++|++||........+.... ..+... ..
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~-~~~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF-DLIGLPPEDDW 231 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHH-HHhCCCChhhC
Confidence 7654322 1223458899999999998899999999999999999999999986433222221111 111000 00
Q ss_pred c-------cccccccCC---CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 T-------AILDPVLKL---PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 ~-------~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
. ....+.... ....+..+.+.+++.+||+.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 000000000 000123456789999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=327.13 Aligned_cols=253 Identities=28% Similarity=0.468 Sum_probs=196.3
Q ss_pred ccccCcccceEEEEEEEc-CCc----EEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGT----VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
.+.||+|+||.||++.+. +++ .+|+|.+..... .....+|.+|+.++++++||||+++++++... ..++++||
T Consensus 12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~ 89 (303)
T cd05110 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQL 89 (303)
T ss_pred ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehh
Confidence 457999999999999864 344 468887643322 22335789999999999999999999998764 46799999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 90 ~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 90 MPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCc
Confidence 99999999997543 24788889999999999999999998 999999999999999999999999999865433
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
..........++..|+|||++....++.++||||||+++|||++ |+.||..... .... ..+..+..
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~-~~~~----~~~~~~~~-------- 229 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT-REIP----DLLEKGER-------- 229 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH-HHHH----HHHHCCCC--------
Confidence 32222223346789999999998899999999999999999998 8888854211 1111 12222111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
.+........+.+++..||..+|++||+++++++.|+++..
T Consensus 230 -~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 230 -LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111223568899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=352.07 Aligned_cols=255 Identities=22% Similarity=0.328 Sum_probs=195.8
Q ss_pred hcccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec--CCeEEEEE
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE--GRERLLVY 591 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~ 591 (914)
.+.+.+.||+|+||.||+++... ++.+|+|.+............|..|+.+|.+|+|||||+++++|.+ ....||||
T Consensus 14 ~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVM 93 (1021)
T PTZ00266 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILM 93 (1021)
T ss_pred CEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEE
Confidence 45567889999999999999764 6788888776544344445779999999999999999999998854 45789999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCC----CCeeccCCCccceEEcC------------
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC----PPVIHRDIKSSNILIDE------------ 655 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~----~~iiHrDIKp~NILl~~------------ 655 (914)
||+++|+|.++|..... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.
T Consensus 94 EY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~ 172 (1021)
T PTZ00266 94 EFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172 (1021)
T ss_pred eCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccc
Confidence 99999999999975321 12358899999999999999999998542 34999999999999964
Q ss_pred -----CCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhc--CCCCCcchHHHHHHHHHHHHhCCCCccccccc
Q 002512 656 -----EHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL--HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE 728 (914)
Q Consensus 656 -----~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~ 728 (914)
...+||+|||++....... ......||+.|+|||++.. ..++.++||||||||||||+||+.||.....
T Consensus 173 ~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~- 248 (1021)
T PTZ00266 173 NNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANN- 248 (1021)
T ss_pred cccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCc-
Confidence 2348999999997654322 2233469999999999854 4588999999999999999999999864322
Q ss_pred ccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 729 GNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 729 ~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+.. +...+.... .+.. .....++.+|+..||+.+|.+||++.+++.
T Consensus 249 --~~q-li~~lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 249 --FSQ-LISELKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred --HHH-HHHHHhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 111 111121111 0111 112357889999999999999999999884
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.87 Aligned_cols=239 Identities=23% Similarity=0.409 Sum_probs=185.6
Q ss_pred cccCcccceEEEEEEEcC-------------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCe
Q 002512 520 EEVGKGSFSCVYKGVLKD-------------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRE 586 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~ 586 (914)
+.||+|+||.||+|++.+ ...|++|.+.... ......|.+|+.++++++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 359999999999998532 2257888754332 2334678999999999999999999999999999
Q ss_pred EEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCc-------E
Q 002512 587 RLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHN-------A 659 (914)
Q Consensus 587 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~-------~ 659 (914)
.+|||||+++++|..+++... ..+++..+++++.||++||+|||+++ |+||||||+|||++.++. +
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCcee
Confidence 999999999999999987542 24788889999999999999999999 999999999999987664 8
Q ss_pred EEeecCCcccCCCCCCCCCccCCCCcCCccChhhhh-cCCCCCcchHHHHHHHHHHHH-hCCCCcccccccccHHHHHHh
Q 002512 660 RVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR-LHYLTTKSDVYSFGVLLLEIL-SGRKAIDMQFEEGNIVEWAVP 737 (914)
Q Consensus 660 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~ksDV~S~GvvL~Ell-tG~~p~~~~~~~~~l~~~~~~ 737 (914)
|++|||++...... ....++..|+|||++. ...++.++||||||++||||+ +|+.|+..... .+ ...
T Consensus 152 ~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~-~~~ 220 (262)
T cd05077 152 KLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL----AE-KER 220 (262)
T ss_pred EeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch----hH-HHH
Confidence 99999998654321 2235788999999987 567899999999999999998 57777643211 11 001
Q ss_pred hhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 738 LIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 738 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
.. .... . ... ....++.+|+.+||+.+|++||++.+|++.|
T Consensus 221 ~~-~~~~-~-----~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 221 FY-EGQC-M-----LVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HH-hcCc-c-----CCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 11 1110 0 011 1235788999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=312.27 Aligned_cols=246 Identities=27% Similarity=0.409 Sum_probs=198.8
Q ss_pred ccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||++..++ ++.+++|.+..... .++|.+|++++++++||||+++++++.+....+++|||++
T Consensus 6 ~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 81 (256)
T cd06612 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCG 81 (256)
T ss_pred hhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCC
Confidence 345679999999999999875 78999998754322 5789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++.... ..+++.....++.|+++||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 82 AGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999996533 35789999999999999999999999 99999999999999999999999999876543321
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......++..|+|||++.+..++.++||||||+++|||++|+.||.......... .+.. ...+ ...
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~~~~-----~~~~--~~~ 220 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----MIPN-----KPPP--TLS 220 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----hhcc-----CCCC--CCC
Confidence 1223457899999999999999999999999999999999999986432211110 0000 0001 111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+......+.+++.+||+.+|++|||+.||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12233457889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=319.46 Aligned_cols=263 Identities=24% Similarity=0.279 Sum_probs=197.0
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||+|+.+ +++.||+|++..........+.+.+|+.++++++||||+++++++.+++..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 34578999999999999976 58899999886544334445678999999999999999999999999999999999997
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
++|.+++..... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 83 -~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 83 -MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred -CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 689998865432 235888999999999999999999999 99999999999999999999999999875433211
Q ss_pred CCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhc-----------CC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKS-----------GD 743 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~-----------~~ 743 (914)
......+++.|+|||++.+. .++.++||||||+++|||+||+.||........+.......... .+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD 234 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence 12233578899999998654 57899999999999999999999986433222111111000000 00
Q ss_pred cccccccccC---CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 744 ITAILDPVLK---LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 744 ~~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....+.... .........++.+++.+||..||++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 0000113456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=315.22 Aligned_cols=237 Identities=27% Similarity=0.460 Sum_probs=187.1
Q ss_pred cccCcccceEEEEEEEcCCc-----------EEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEE
Q 002512 520 EEVGKGSFSCVYKGVLKDGT-----------VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 588 (914)
+.||+|+||.||+|.+.+.. .+++|.+..... ....|.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 36999999999999987533 467776543221 15789999999999999999999999988 7789
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC-------cEEE
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-------NARV 661 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~-------~~kl 661 (914)
+||||+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEe
Confidence 99999999999999976432 5788889999999999999999998 99999999999999887 7999
Q ss_pred eecCCcccCCCCCCCCCccCCCCcCCccChhhhhcC--CCCCcchHHHHHHHHHHHHhC-CCCcccccccccHHHHHHhh
Q 002512 662 ADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH--YLTTKSDVYSFGVLLLEILSG-RKAIDMQFEEGNIVEWAVPL 738 (914)
Q Consensus 662 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~s~ksDV~S~GvvL~ElltG-~~p~~~~~~~~~l~~~~~~~ 738 (914)
+|||++..... .....++..|+|||++... .++.++||||||+++|||++| ..|+...... .... .
T Consensus 150 ~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-~~~~----~ 218 (259)
T cd05037 150 SDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-EKER----F 218 (259)
T ss_pred CCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-hHHH----H
Confidence 99999876433 1223467789999999876 789999999999999999995 6666433211 1111 1
Q ss_pred hhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
..... ....+. ...+.+++.+||..+|.+||++.++++.|
T Consensus 219 ~~~~~-------~~~~~~----~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 219 YQDQH-------RLPMPD----CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HhcCC-------CCCCCC----chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11110 001111 16788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=330.21 Aligned_cols=239 Identities=26% Similarity=0.339 Sum_probs=187.1
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHH-HHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELD-LLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~-~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.||+|+||.||+++.. +++.||+|++..... ......++.+|.. +++.++||||+++++++.+.+..+|||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 35999999999999976 588999998764321 1222345666654 57888999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++.... .++......++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 150 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-- 150 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--
Confidence 99999886532 4677778889999999999999999 9999999999999999999999999987532211
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 756 (914)
.......||+.|+|||++....++.++|||||||++|||++|+.||..... .... ..+... .+..+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~-~~i~~~--------~~~~~- 216 (321)
T cd05603 151 ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----SQMY-DNILHK--------PLQLP- 216 (321)
T ss_pred CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH----HHHH-HHHhcC--------CCCCC-
Confidence 122334689999999999988999999999999999999999999864321 1111 111111 11111
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 002512 757 DLDALKRIANVACKCVRMRGKERPSMD 783 (914)
Q Consensus 757 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 783 (914)
......+.+++.+||+.+|.+||+..
T Consensus 217 -~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 -GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12345788999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=319.58 Aligned_cols=258 Identities=28% Similarity=0.385 Sum_probs=199.1
Q ss_pred cccccCcccceEEEEEEEc----CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC------eE
Q 002512 518 FKEEVGKGSFSCVYKGVLK----DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR------ER 587 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~ 587 (914)
+.+.||+|+||.||+|.++ .++.||||++..........+++.+|++++++++||||+++++++...+ ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4567999999999999864 3688999988654444445678999999999999999999999886542 34
Q ss_pred EEEEeeCCCCCHHHhhhcCcc-chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCC
Q 002512 588 LLVYEFMAHGSLHQHLHGKSK-ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~-~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGl 666 (914)
++++||+++|+|.+++..... .....+++...++++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcccc
Confidence 789999999999998753221 11224788889999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcc
Q 002512 667 SLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDIT 745 (914)
Q Consensus 667 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~ 745 (914)
++...............+++.|++||.+....++.++||||||+++|||++ |+.||..... ..+.. .+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-~~~~~----~~~~~~~- 233 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-SEIYN----YLIKGNR- 233 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-HHHHH----HHHcCCc-
Confidence 986543322222223345678999999999999999999999999999999 7888753221 11111 1111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
+ ......+..+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 234 ------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 ------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred ------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 11123346889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=319.86 Aligned_cols=250 Identities=24% Similarity=0.317 Sum_probs=195.9
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
..+.||+|+||.||++... +++.+|+|++...... ......+.+|+.++++++|+||+++++.+.+.+..++||||++
T Consensus 4 ~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 83 (285)
T cd05630 4 QYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83 (285)
T ss_pred eeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecC
Confidence 3467999999999999976 5889999987543322 2223557889999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.++|+|||++........
T Consensus 84 g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 84 GGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred CCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 9999999864322 35788899999999999999999998 99999999999999999999999999876433221
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
.....|+..|+|||++....++.++||||||+++|||++|+.||.......... ........ ... .
T Consensus 158 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~-~~~~~~~~-----~~~-----~ 223 (285)
T cd05630 158 ---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE-EVERLVKE-----VQE-----E 223 (285)
T ss_pred ---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH-HHHhhhhh-----hhh-----h
Confidence 123468999999999999999999999999999999999999997532211111 01111110 000 0
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPS-----MDKVTT 787 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs-----~~ev~~ 787 (914)
........+.+|+.+||+.||++||| ++|+++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 224 YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11123356789999999999999999 667665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=327.22 Aligned_cols=242 Identities=23% Similarity=0.323 Sum_probs=192.4
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhcc-CCceeeeeceeecCCeEEEEEee
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
++.+.||+|+||.||+++.+ +++.||+|++..... .....+.+..|..++..+. |++|+++++++.+.+..+|||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45678999999999999976 588999998865322 2233466888999999885 57888999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++|+|.+++.... .+++...+.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 83 VNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999987543 4788899999999999999999999 999999999999999999999999998753322
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.. ......||+.|+|||++....++.++||||||++||||++|+.||...... .+. ..+..... .
T Consensus 155 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~----~~i~~~~~--------~ 219 (323)
T cd05615 155 GV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-ELF----QSIMEHNV--------S 219 (323)
T ss_pred Cc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-HHH----HHHHhCCC--------C
Confidence 21 223346899999999999989999999999999999999999998643221 111 11111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMD 783 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 783 (914)
.+ .....++.+++.+||+.+|.+|++..
T Consensus 220 ~p--~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 220 YP--KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CC--ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11 12235678999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=319.17 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=199.7
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||+||++... +++.+|+|++.... .....+.|.+|+++++.++||||+++++++...+..+|||||+
T Consensus 7 ~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (284)
T cd06620 7 LETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFM 85 (284)
T ss_pred HHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecC
Confidence 335578999999999999975 58889999875432 2334578999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
++++|.+++.... .+++.....++.+++.+|.|||+ .+ |+||||||+||++++++.++|+|||++......
T Consensus 86 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 86 DCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 9999999987542 47888999999999999999997 46 999999999999999999999999998654222
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccc-------cHHHHHHhhhhcCCccc
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEG-------NIVEWAVPLIKSGDITA 746 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~-------~l~~~~~~~~~~~~~~~ 746 (914)
......|+..|+|||++....++.++||||||+++|||+||+.||....... .+.+.....+.. .
T Consensus 158 ----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--- 229 (284)
T cd06620 158 ----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-P--- 229 (284)
T ss_pred ----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-c---
Confidence 1223468999999999988889999999999999999999999997533211 111111111111 0
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 747 ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
.......+.+..+.+++.+||+.+|++|||+.|+++..
T Consensus 230 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 230 -----PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred -----CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 00011112446788999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=309.88 Aligned_cols=261 Identities=25% Similarity=0.312 Sum_probs=200.0
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCc-eeeeeceeecCC------eEEEEE
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAH-LLNLLGYCEEGR------ERLLVY 591 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~g~~~~~~------~~~LV~ 591 (914)
++||+|.||+||+|+.+ +|+.||+|++....+.+.......+|+.+|++|+|+| ||+|++++...+ ..+|||
T Consensus 17 eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvf 96 (323)
T KOG0594|consen 17 EKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVF 96 (323)
T ss_pred HHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEE
Confidence 46999999999999965 6899999999876554333456789999999999999 999999998877 788999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+. -+|.+|+....... ..++-..+..+..||++||+|||+++ |+||||||.||||++++.+||+|||+|+...
T Consensus 97 e~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ 171 (323)
T KOG0594|consen 97 EFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAFS 171 (323)
T ss_pred Eeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHhc
Confidence 9996 59999998655321 34566778899999999999999999 9999999999999999999999999998654
Q ss_pred CCCCCCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC---Ccc--
Q 002512 672 ADSSSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG---DIT-- 745 (914)
Q Consensus 672 ~~~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~---~~~-- 745 (914)
.... ..+...+|.-|.|||++.+. .|+...||||+|||+.||++++..|....+.+.+...+.. +... .+.
T Consensus 172 ip~~--~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~-lGtP~e~~Wp~v 248 (323)
T KOG0594|consen 172 IPMR--TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRL-LGTPNEKDWPGV 248 (323)
T ss_pred CCcc--cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHH-cCCCCccCCCCc
Confidence 3322 23445689999999999876 7999999999999999999999888766554433332221 1110 000
Q ss_pred -cccccccC---CC--CC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 746 -AILDPVLK---LP--SD-----LDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 746 -~~~d~~l~---~~--~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.+.+-... .. .. +.......+++.+||+.+|.+|.|++..++.
T Consensus 249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 01111000 00 00 0111467899999999999999999887754
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=334.59 Aligned_cols=260 Identities=22% Similarity=0.297 Sum_probs=196.6
Q ss_pred HHhcccccccCcccceEEEEEEEc---CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEE
Q 002512 513 RATGGFKEEVGKGSFSCVYKGVLK---DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLL 589 (914)
Q Consensus 513 ~~t~~~~~~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 589 (914)
...+.+.+.||+|+||.||++... .++.||+|.+... ..+.+|+++|++++|||||++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 344667788999999999999754 3567898876432 345789999999999999999999999999999
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||+. ++|.+++... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 164 v~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred EehhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 999995 6899988433 35889999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccH--HHHHHhhhhcCCc---
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNI--VEWAVPLIKSGDI--- 744 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l--~~~~~~~~~~~~~--- 744 (914)
..............||+.|+|||++....++.++|||||||+||||++|+.||......... .......+.....
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 54433333333456999999999999999999999999999999999999998643222110 1111111100000
Q ss_pred --------------ccccccccCCCCC---HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 745 --------------TAILDPVLKLPSD---LDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 745 --------------~~~~d~~l~~~~~---~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.....+....+.. .....++.+++.+||..+|++|||+.|++..
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000000 0123467889999999999999999998754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=329.18 Aligned_cols=258 Identities=24% Similarity=0.277 Sum_probs=192.6
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC------eEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR------ERL 588 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~ 588 (914)
+.+.+.||+|+||.||++... .++.||+|++...........++.+|+.+++.++||||+++++++...+ ..+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence 445678999999999999975 5889999988654433444577889999999999999999999986543 579
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
+||||+++ +|.+.++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 103 lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 103 LVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred EEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 99999975 67776642 3677778889999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHH--------------
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEW-------------- 734 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~-------------- 734 (914)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........+...
T Consensus 172 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 172 TACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 543221 223346899999999999999999999999999999999999999643221111000
Q ss_pred ----HHhhhhcC-Cc-----ccccccccCCC----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 735 ----AVPLIKSG-DI-----TAILDPVLKLP----SDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 735 ----~~~~~~~~-~~-----~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
........ .. .+.... ...+ .......++.+|+.+||..||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPD-WIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccc-cccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 00 000000 0000 001123568899999999999999999998753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=333.30 Aligned_cols=253 Identities=22% Similarity=0.336 Sum_probs=193.9
Q ss_pred HhcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEE
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
..+.+.+.||+|+||.||+++.+ +++.+|+|.+..... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 34556778999999999999986 478899998754221 1223356889999999999999999999999999999999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+++|+|.+++... .++......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 123 Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 123 EYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred cCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 999999999998643 3667777889999999999999999 9999999999999999999999999997654
Q ss_pred CCCCCCCccCCCCcCCccChhhhhcC----CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccc
Q 002512 672 ADSSSPLAELPAGTLGYLDPEYYRLH----YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 672 ~~~~~~~~~~~~Gt~~y~aPE~l~~~----~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 747 (914)
..... ......||+.|||||++... .++.++|||||||+||||++|+.||..... ............
T Consensus 194 ~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~---- 264 (371)
T cd05622 194 KEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMNHKN---- 264 (371)
T ss_pred cCCcc-cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCC----
Confidence 33211 22345699999999999754 378999999999999999999999964322 111111111111
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhhhcCCCC---CCCHHHHHHH
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKE---RPSMDKVTTA 788 (914)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~---RPs~~ev~~~ 788 (914)
.+..+........+.+++..|+. +|.. ||+++|+++.
T Consensus 265 ---~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 265 ---SLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRH 304 (371)
T ss_pred ---cccCCCcCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcC
Confidence 11122222345677889999998 4444 6777777654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.24 Aligned_cols=260 Identities=25% Similarity=0.351 Sum_probs=200.8
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec-----CCeEEEEEee
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE-----GRERLLVYEF 593 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-----~~~~~LV~Ey 593 (914)
+.||+|+||.|..+..+ +++.|||||+...-......++-.+|+++|+.++|+||+.+++.+.. -+..|+|+|+
T Consensus 28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el 107 (359)
T KOG0660|consen 28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL 107 (359)
T ss_pred ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence 56999999999999976 58999999998666666667889999999999999999999998865 3578999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
| .-+|.+.|+... .++......+..||++||.|+|+.+ |+||||||+|+|++.+..+||+|||+|+.....
T Consensus 108 M-etDL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 108 M-ETDLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred H-hhHHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence 9 569999998653 3777788889999999999999999 999999999999999999999999999987654
Q ss_pred CCCCCccCCCCcCCccChhhhh-cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHH----------HHHhhhhcC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYR-LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE----------WAVPLIKSG 742 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~-~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~----------~~~~~~~~~ 742 (914)
......+..+-|.-|.|||.+. ...|+.+.||||.||||.|||+|++.|.....-..+.. .....+.+.
T Consensus 179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~ 258 (359)
T KOG0660|consen 179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE 258 (359)
T ss_pred CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence 3334445667899999999985 45899999999999999999999988865432211110 011111111
Q ss_pred CcccccccccCCCC-C-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 743 DITAILDPVLKLPS-D-----LDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 743 ~~~~~~d~~l~~~~-~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.....+......+. + +.......+|+.+||..||.+|+|++|.++.
T Consensus 259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111111111110 0 1233567899999999999999999987653
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=322.84 Aligned_cols=197 Identities=26% Similarity=0.357 Sum_probs=159.3
Q ss_pred cccCcccceEEEEEEEc---CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec--CCeEEEEEeeC
Q 002512 520 EEVGKGSFSCVYKGVLK---DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE--GRERLLVYEFM 594 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~Ey~ 594 (914)
.+||+|+||.||+++.+ +++.+|+|++.... ....+.+|++++++++||||+++++++.. ....++||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred cccccCCCeEEEEEEEccCCCCceEEEEEECCCC----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 46999999999999965 46789999874322 23567899999999999999999998854 45678999998
Q ss_pred CCCCHHHhhhcCccc----hhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE----cCCCcEEEeecCC
Q 002512 595 AHGSLHQHLHGKSKA----LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI----DEEHNARVADFGL 666 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~----~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl----~~~~~~kl~DFGl 666 (914)
. ++|.+++...... ....+++.....++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 6 5888887532211 1224788888999999999999999999 9999999999999 4567899999999
Q ss_pred cccCCCCCCC-CCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 002512 667 SLLGPADSSS-PLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDM 724 (914)
Q Consensus 667 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~ 724 (914)
++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~ 218 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence 9765432211 12234568999999999976 4689999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.11 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=199.4
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec-CCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE-GRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||++..+ +++.+|+|++..........+.+.+|++++++++|||++++++.+.. ....++||||+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (257)
T cd08223 3 CFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFC 82 (257)
T ss_pred eEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEeccc
Confidence 46778999999999999976 47889999886544444455678999999999999999999998764 44678999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++.... ...+++.+++.++.|++.+|+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 83 EGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999997532 235789999999999999999999999 9999999999999999999999999987653322
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. ......+++.|+|||++....++.++||||||+++|||++|+.||.... ....... +..+...
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~----~~~~~~~-~~~~~~~--------- 220 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD----MNSLVYR-IIEGKLP--------- 220 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHHHHH-HHhcCCC---------
Confidence 1 2233458899999999999999999999999999999999999986322 1111111 1122111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+.+......+.+++.+||+.+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111234467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.50 Aligned_cols=261 Identities=22% Similarity=0.303 Sum_probs=197.9
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||+++.+ +++.||+|++..........+.|.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~ 83 (286)
T cd07847 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83 (286)
T ss_pred eeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccC
Confidence 35567999999999999986 58999999886554333344678999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|..++.... .+++..++.++.|++.+|+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 84 ~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 84 HTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 998888775432 4789999999999999999999998 99999999999999999999999999976544321
Q ss_pred CCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHh---h-------hhcCCc
Q 002512 676 SPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVP---L-------IKSGDI 744 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~---~-------~~~~~~ 744 (914)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+.+...... . ......
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 156 --DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred --cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1223357889999999876 46789999999999999999999998643322211111000 0 000000
Q ss_pred -ccccccccCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 -TAILDPVLKLPSD-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 -~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....+....... ......+.+++.+||+.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000000000 112467889999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.27 Aligned_cols=249 Identities=25% Similarity=0.389 Sum_probs=197.2
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccc-------cchHHHHHHHHHHHhccCCceeeeeceeecCCeEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQ-------KNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 588 (914)
.+...||+|+||.||+|... +++.+|+|.+....... +..+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 3 ~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (267)
T cd06628 3 IKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLN 82 (267)
T ss_pred cccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccE
Confidence 35677999999999999875 57899999875443211 12356889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
+||||+++++|.+++.... .+++.....++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++
T Consensus 83 lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 83 IFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred EEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999997543 4778888899999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCC----CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCc
Q 002512 669 LGPADSSS----PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDI 744 (914)
Q Consensus 669 ~~~~~~~~----~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 744 (914)
........ .......|+..|+|||.+....++.++||||||+++|||++|+.||........+ .. ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~-~~~~-- 227 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI----FK-IGEN-- 227 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH----HH-Hhcc--
Confidence 66432111 1112235889999999999888999999999999999999999998643221111 00 1111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+ ..+......+.+++.+||+.+|.+||++.|+++
T Consensus 228 ---~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 228 ---ASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---CCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 001 111233467889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=321.21 Aligned_cols=261 Identities=24% Similarity=0.317 Sum_probs=194.7
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.++||+|+||.||+++.+ +++.||+|++..... ......+.+|+.++++++||||+++++++..++..++||||+
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 86 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL 86 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCC
Confidence 344577999999999999976 578899998764432 223356889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++ +|.+++.... ..+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 87 ~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 87 DK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 75 8988886543 24678888899999999999999999 9999999999999999999999999987543222
Q ss_pred CCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH----------hhhhcC-
Q 002512 675 SSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV----------PLIKSG- 742 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~----------~~~~~~- 742 (914)
. ......+|+.|+|||++.+ ..++.++||||||+++|||+||+.||......+.+..... +.+...
T Consensus 159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 1 1223457899999999865 4688999999999999999999999864432221111100 000000
Q ss_pred CcccccccccC----CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 743 DITAILDPVLK----LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 743 ~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.......+... .........++.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000000 0000123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=319.45 Aligned_cols=261 Identities=26% Similarity=0.353 Sum_probs=197.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||++.++ +++.||+|++..........+.+.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 83 (286)
T cd07846 4 ENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83 (286)
T ss_pred eEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCC
Confidence 45678999999999999986 48899999876544433345678999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++.... .+++..++.++.|++++|+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 84 ~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07846 84 HTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155 (286)
T ss_pred ccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence 999988775432 3789999999999999999999998 99999999999999999999999999876543321
Q ss_pred CCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHH----------HhhhhcCCc
Q 002512 676 SPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA----------VPLIKSGDI 744 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~----------~~~~~~~~~ 744 (914)
......++..|+|||++.. ..++.++||||||+++|||++|++||........+.... ........+
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07846 156 --VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233 (286)
T ss_pred --ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchH
Confidence 2223457899999999875 457889999999999999999998885332111100000 000000000
Q ss_pred -ccccccccCCCC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 -TAILDPVLKLPS-----DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 -~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....+...... .......+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000 1123467899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=320.35 Aligned_cols=258 Identities=26% Similarity=0.338 Sum_probs=195.8
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||++... ++..+|+|.+.... ......++.+|++++.+++||||+++++++.+++..+|||||++
T Consensus 4 ~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 4 EKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred eEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 34677999999999999976 47778888765332 22234668899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
+++|.++++... .+++.....++.|+++||.|||+ .+ |+||||||+|||+++++.+||+|||++......
T Consensus 83 ~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 83 GGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 999999997542 47888889999999999999997 46 999999999999999999999999998654322
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcc---------
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT--------- 745 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~--------- 745 (914)
......++..|+|||.+.+..++.++||||||+++|||++|+.||..... .................
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCC
Confidence 12234688999999999888899999999999999999999999853321 11111110000000000
Q ss_pred -----------ccccc-----ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 746 -----------AILDP-----VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 746 -----------~~~d~-----~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
+..+. ....+. .....++.+++.+||..+|++||++.+|+...
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000 000000 11345688999999999999999999987653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=314.18 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=190.3
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
..||+|+||.||+|++. ++..|++|.+.... ....+.|.+|+.++++++|+||+++++++..++..++||||+++++
T Consensus 14 ~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 91 (268)
T cd06624 14 VVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGS 91 (268)
T ss_pred EEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence 35999999999999965 57789999775433 2234679999999999999999999999999999999999999999
Q ss_pred HHHhhhcCccchhccc--chhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC-CCcEEEeecCCcccCCCCCC
Q 002512 599 LHQHLHGKSKALKEQL--DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE-EHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l--~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kl~DFGla~~~~~~~~ 675 (914)
|.++++.... .+ ++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++........
T Consensus 92 L~~~l~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~ 164 (268)
T cd06624 92 LSALLRSKWG----PLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP 164 (268)
T ss_pred HHHHHHHhcc----cCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCC
Confidence 9999975321 23 67778889999999999999998 999999999999976 67899999999875432221
Q ss_pred CCCccCCCCcCCccChhhhhcC--CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLH--YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~--~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
......+++.|+|||++... .++.++||||||+++|||++|+.||....... ...+..... . ..
T Consensus 165 --~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~-~~~~~~~~~------~-----~~ 230 (268)
T cd06624 165 --CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-AAMFKVGMF------K-----IH 230 (268)
T ss_pred --ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh-hhHhhhhhh------c-----cC
Confidence 12233588999999998654 37899999999999999999999985422111 111100000 0 00
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
...+.....++.+++.+||+.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 231 PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 0111233467889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=318.23 Aligned_cols=238 Identities=25% Similarity=0.432 Sum_probs=184.0
Q ss_pred ccCcccceEEEEEEEcC-------------------------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCcee
Q 002512 521 EVGKGSFSCVYKGVLKD-------------------------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLL 575 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv 575 (914)
.||+|+||.||+|.+.. ...|++|++.... .....+|.+|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 59999999999998521 1347888764322 22346789999999999999999
Q ss_pred eeeceeecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC
Q 002512 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE 655 (914)
Q Consensus 576 ~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~ 655 (914)
++++++.+....+|||||+++|+|.+++.... ..+++..+++++.||++||+|||+++ |+||||||+|||+++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~ 152 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLAR 152 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEec
Confidence 99999999999999999999999999987532 25788889999999999999999998 999999999999976
Q ss_pred CC-------cEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHH-hCCCCccccc
Q 002512 656 EH-------NARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEIL-SGRKAIDMQF 726 (914)
Q Consensus 656 ~~-------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~Ell-tG~~p~~~~~ 726 (914)
++ .+||+|||++...... ....++..|+|||.+.. ..++.++||||||+++|||+ +|+.||....
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 43 3899999987543221 12246788999999865 56899999999999999995 6888875432
Q ss_pred ccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 727 EEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 727 ~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
.. .... .+.. ....+. .....+.+++.+||+.+|++||++.+|++.|
T Consensus 227 ~~-~~~~----~~~~---------~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 227 PS-EKER----FYEK---------KHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred hH-HHHH----HHHh---------ccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11 1111 1111 001111 1124688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=310.11 Aligned_cols=250 Identities=22% Similarity=0.322 Sum_probs=202.9
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||.|+||.||.++.. +++.+++|++..........++|.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (256)
T cd08221 3 IPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82 (256)
T ss_pred eEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecC
Confidence 45678999999999999865 58899999876554444556789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++.... ...+++..+..++.|++++|+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 83 GGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred CCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 999999997542 235788899999999999999999999 99999999999999999999999999876544332
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......+++.|+|||.+.+..++.++||||||+++|||++|+.||..... .+.... +..+.....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~~~~~~-~~~~~~~~~-------- 221 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP----LNLVVK-IVQGNYTPV-------- 221 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH----HHHHHH-HHcCCCCCC--------
Confidence 22334589999999999888889999999999999999999999864321 111111 122221111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
......++.+++.+||+.+|++||++.++++.
T Consensus 222 -~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 222 -VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 12334678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=309.89 Aligned_cols=244 Identities=26% Similarity=0.353 Sum_probs=203.4
Q ss_pred ccccCcccceEEEEEEEcC-CcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 519 KEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
.+.||+|.-|+||++++++ +..+|+|++.+... ..+...+...|-+||+.++||-++.||..|+.++..+||||||+|
T Consensus 82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG 161 (459)
T KOG0610|consen 82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG 161 (459)
T ss_pred HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence 4579999999999999885 58999999866542 234456778899999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC----
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA---- 672 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~---- 672 (914)
|+|+.+++++.. +.++......++.+++-||+|||-.+ ||.|||||+||||.++|++-|+||.|+.....
T Consensus 162 GdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 162 GDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred ccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999999986643 56888888999999999999999999 99999999999999999999999998743210
Q ss_pred ----C------------------------C-C---------------------CCCccCCCCcCCccChhhhhcCCCCCc
Q 002512 673 ----D------------------------S-S---------------------SPLAELPAGTLGYLDPEYYRLHYLTTK 702 (914)
Q Consensus 673 ----~------------------------~-~---------------------~~~~~~~~Gt~~y~aPE~l~~~~~s~k 702 (914)
. . . .......+||-.|+|||++++...+.+
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 0 0 001122359999999999999999999
Q ss_pred chHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 002512 703 SDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPS 781 (914)
Q Consensus 703 sDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 781 (914)
.|.|.|||+|||||.|+.||.....+..+. .++-..+..+..++....+.+||.+.|.+||++|..
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~-------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg 381 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLR-------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLG 381 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHH-------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhc
Confidence 999999999999999999997665544333 344445566666677788999999999999999988
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.48 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=197.2
Q ss_pred ccccccCcccceEEEEEEEcCCcEEEEEEeeecccc----ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 517 GFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDR----QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
...+.||+|+||.||+|...+++.+|+|++...... ......+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 345679999999999999888999999987543211 2223568899999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|+++++|.+++.+.. .+++.....++.|++.+|+|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 83 ~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 83 FVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999997542 4678888899999999999999999 99999999999999999999999999875422
Q ss_pred CC----CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccc
Q 002512 673 DS----SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748 (914)
Q Consensus 673 ~~----~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 748 (914)
.. .........++..|+|||++....++.++||||||+++|||++|+.||.......... .+... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~~--~~~- 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-----YIGAH--RGL- 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-----Hhhhc--cCC-
Confidence 11 1111223458999999999998889999999999999999999999986432111110 01110 000
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+. .+.....++.+++.+||+.+|++||++.|++.
T Consensus 227 ~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPR----LPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC----CCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 011 11123467889999999999999999998874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.06 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=193.3
Q ss_pred cccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.++||+|+||.||++.... +..+++|.+.... ....+.|.+|+++++.++||||+++++++...+..++||||+++
T Consensus 9 i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 9 IIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 34679999999999999864 6778888764332 23457799999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++.+.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-- 157 (282)
T cd06643 87 GAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 157 (282)
T ss_pred CcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--
Confidence 99999886532 25889999999999999999999999 9999999999999999999999999986543221
Q ss_pred CCccCCCCcCCccChhhhh-----cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 677 PLAELPAGTLGYLDPEYYR-----LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~-----~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
.......++..|+|||++. ...++.++|||||||++|||++|+.||........ ....... .. +.
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----~~~~~~~-~~-----~~ 227 (282)
T cd06643 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV----LLKIAKS-EP-----PT 227 (282)
T ss_pred cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH----HHHHhhc-CC-----CC
Confidence 1122345899999999984 44578899999999999999999999864321111 1111111 10 01
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+ ..+.....++.+++.+||+.+|.+||++.++++
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 228 L--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred C--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1 111123457889999999999999999988753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=317.73 Aligned_cols=239 Identities=25% Similarity=0.457 Sum_probs=186.2
Q ss_pred cccCcccceEEEEEEEcC--------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEE
Q 002512 520 EEVGKGSFSCVYKGVLKD--------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
+.||+|+||.||+|..+. ...+++|.+... .....++|.+|+.++++++||||+++++++...+..++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999998642 234777765332 2233467899999999999999999999999989999999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCc--------EEEee
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHN--------ARVAD 663 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~--------~kl~D 663 (914)
||+++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 79 e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 79 EYVKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred ecCCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecc
Confidence 99999999999986532 5788889999999999999999999 999999999999987765 69999
Q ss_pred cCCcccCCCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCC-CCcccccccccHHHHHHhhhhc
Q 002512 664 FGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGR-KAIDMQFEEGNIVEWAVPLIKS 741 (914)
Q Consensus 664 FGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~-~p~~~~~~~~~l~~~~~~~~~~ 741 (914)
||++...... ....++..|+|||++.. ..++.++||||||+++|||++|. .|+... +..... .....
T Consensus 152 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~-~~~~~~----~~~~~ 220 (258)
T cd05078 152 PGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL-DSQKKL----QFYED 220 (258)
T ss_pred cccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc-cHHHHH----HHHHc
Confidence 9988654321 22357889999999986 45789999999999999999995 444321 111111 11111
Q ss_pred CCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 742 GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
....+. ....++.+++.+||+.+|++|||++++++.|
T Consensus 221 ---------~~~~~~--~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 221 ---------RHQLPA--PKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ---------cccCCC--CCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 011111 1225688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=316.62 Aligned_cols=261 Identities=19% Similarity=0.263 Sum_probs=195.3
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||+++.+ +++.+|+|++............+.+|++++++++||||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 35577999999999999976 58899999886544333344678899999999999999999999999999999999997
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
++|.+++.... ..+++...+.++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 -~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 83 -QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred -CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 58888876532 24789999999999999999999999 99999999999999999999999999875433221
Q ss_pred CCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC------ccccc
Q 002512 676 SPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD------ITAIL 748 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~------~~~~~ 748 (914)
......++..|+|||++.+. .++.++||||||+++|||+||+.|+....+................ +....
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 12233578899999998764 4789999999999999999999886432221111111110000000 00000
Q ss_pred cc----ccC-----CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 749 DP----VLK-----LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 749 d~----~l~-----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+. ... .........++.+++.+||+.+|.+|||++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 00 000 0001123467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=312.94 Aligned_cols=248 Identities=20% Similarity=0.311 Sum_probs=194.1
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||+++
T Consensus 13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 90 (267)
T cd06645 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGG 90 (267)
T ss_pred HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCC
Confidence 4567999999999999875 58889999875432 22345688999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++.... .+++...+.++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++.......
T Consensus 91 ~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 91 GSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 99999987543 4788889999999999999999999 9999999999999999999999999986543221
Q ss_pred CCccCCCCcCCccChhhhh---cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 677 PLAELPAGTLGYLDPEYYR---LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~---~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||........+.. ...... ..+...
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-----~~~~~~---~~~~~~ 232 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-----MTKSNF---QPPKLK 232 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-----hhccCC---CCCccc
Confidence 1123346899999999984 45688999999999999999999999854322111111 111111 011111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
........+.+++.+||+.+|++||++++|++
T Consensus 233 --~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 233 --DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 01122356889999999999999999998874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.53 Aligned_cols=246 Identities=24% Similarity=0.364 Sum_probs=191.6
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecC------CeEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEG------RERLL 589 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~------~~~~L 589 (914)
+.+.||+|+||.||+|... +++.||+|++.... ....++.+|+.++.++ +||||+++++++... ...++
T Consensus 10 ~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 86 (272)
T cd06637 10 LVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWL 86 (272)
T ss_pred HHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEE
Confidence 3456999999999999976 47889999875432 2346789999999999 799999999998753 46789
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||+++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 87 v~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 87 VMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred EEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 999999999999997532 235788889999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhh-----cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCc
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYR-----LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDI 744 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 744 (914)
..... .......|+..|+|||++. ...++.++||||||+++|||++|+.||.......... .......
T Consensus 161 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~~~~~~~ 233 (272)
T cd06637 161 LDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----LIPRNPA 233 (272)
T ss_pred ccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----HHhcCCC
Confidence 53322 1223356899999999986 3457889999999999999999999985332111110 0111110
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
... ........+.+|+.+||..+|.+|||+.++++
T Consensus 234 ~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 PRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 011 11123357889999999999999999999874
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=328.53 Aligned_cols=257 Identities=21% Similarity=0.252 Sum_probs=192.4
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC------CeEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG------RERL 588 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~ 588 (914)
+.+.+.||+|+||.||++... .++.||||++..........+++.+|+.+++.++||||+++++++... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 445678999999999999965 588999998865444444457788999999999999999999987543 3579
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
+||||+++ +|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 106 lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 106 IVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred EEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 99999975 78777742 3677788899999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH------------
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV------------ 736 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~------------ 736 (914)
...... ......+|+.|+|||++.+..++.++|||||||+||||++|+.||........+.....
T Consensus 175 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 175 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred ccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 643321 22334689999999999999999999999999999999999999964322111111000
Q ss_pred ------hhhhcC-Cc-----ccccccccCCC----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 737 ------PLIKSG-DI-----TAILDPVLKLP----SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 737 ------~~~~~~-~~-----~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
...... .. ..... ....+ ........+.+++.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFP-DVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCc-cccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000 00 00000 00000 01112356789999999999999999998865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=328.01 Aligned_cols=259 Identities=21% Similarity=0.236 Sum_probs=193.0
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC------CeEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG------RERL 588 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~ 588 (914)
+.+.+.||+|+||.||++... .++.||||++..........+.+.+|+.+++.++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 345678999999999999865 588999998865444444457788999999999999999999988643 3579
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
+||||+++ +|.+++.. .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 99 lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 99 LVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred EEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 99999965 67777642 3677788899999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH------------
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV------------ 736 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~------------ 736 (914)
...... ......||+.|+|||++.+..++.++||||||++||||++|+.||........+.....
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred cCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 643321 22334689999999999998999999999999999999999999864321111110000
Q ss_pred ------hhhhc-CCccccc------ccccCC--CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 737 ------PLIKS-GDITAIL------DPVLKL--PSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 737 ------~~~~~-~~~~~~~------d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
..... .....+. +..... ........++.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000 0000000 000000 0011223578899999999999999999998853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=332.53 Aligned_cols=247 Identities=21% Similarity=0.305 Sum_probs=190.0
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.||+|+||.||+++.+ +++.||+|++..... .......+.+|+.++.+++||||+++++.+.+.+..+|||||++
T Consensus 5 ~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~ 84 (360)
T cd05627 5 SLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLP 84 (360)
T ss_pred EEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCC
Confidence 4567999999999999976 588999998864321 22334678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+|+|.+++.... .++......++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 85 gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 85 GGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999997543 4788888899999999999999999 99999999999999999999999999865422110
Q ss_pred C---------------------------------CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCc
Q 002512 676 S---------------------------------PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722 (914)
Q Consensus 676 ~---------------------------------~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~ 722 (914)
. .......||+.|||||++....++.++|||||||+||||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0111346999999999999999999999999999999999999998
Q ss_pred ccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 002512 723 DMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDK 784 (914)
Q Consensus 723 ~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 784 (914)
....... .... +.... ..+..+.......++.+++.+++ .+|.+|++...
T Consensus 237 ~~~~~~~----~~~~-i~~~~------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 286 (360)
T cd05627 237 CSETPQE----TYRK-VMNWK------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNG 286 (360)
T ss_pred CCCCHHH----HHHH-HHcCC------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCC
Confidence 6432211 1111 11100 01111111122346677787766 49999997533
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=317.65 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=197.6
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 345678999999999999964 689999998754332 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++.+. .+++..++.++.|++.+|.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred CCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999998643 4678889999999999999999998 9999999999999999999999999987644332
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. ......+++.|+|||.+....++.++||||||+++|||++|+.||........+. .....+ .+ ..
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~----~~~~~~------~~--~~ 235 (297)
T cd06656 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIATNG------TP--EL 235 (297)
T ss_pred c--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee----eeccCC------CC--CC
Confidence 1 1223458899999999999889999999999999999999999986432211110 000000 00 01
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+......+.+++.+||+.+|++||+++++++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111233456789999999999999999998876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=327.83 Aligned_cols=189 Identities=24% Similarity=0.300 Sum_probs=161.5
Q ss_pred hcccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
.+.+.+.||+|+||.||+++.+. ++.||+|.... ..+..|+.++++++||||+++++++.+....++||||
T Consensus 67 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 67 GYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred CcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 45667789999999999999764 67889886321 2345799999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+. ++|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 139 ~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 139 YS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred cC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 95 69999886543 35889999999999999999999999 999999999999999999999999998753322
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCc
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~ 722 (914)
. ......||+.|+|||++....++.++|||||||+||||+++..++
T Consensus 211 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 122345899999999999999999999999999999999976665
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=322.23 Aligned_cols=254 Identities=22% Similarity=0.272 Sum_probs=191.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeecc-ccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||+++.+ +++.||+|++.... ......+.|.+|+.++.+++||||+++++++.+.+..+|||||+
T Consensus 4 ~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (331)
T cd05597 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYY 83 (331)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecC
Confidence 45678999999999999976 58899999886422 12223466899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.+++.+.. ..++......++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 84 VGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred CCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999997532 24778888899999999999999999 9999999999999999999999999986544322
Q ss_pred CCCCccCCCCcCCccChhhhhc-----CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 675 SSPLAELPAGTLGYLDPEYYRL-----HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
.. ......||+.|||||++.. ..++.++|||||||+||||++|+.||..... .+.............+.+
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~~~~~ 231 (331)
T cd05597 157 TV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKEHFQFPP 231 (331)
T ss_pred Cc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH----HHHHHHHHcCCCcccCCC
Confidence 11 1223458999999999973 4578899999999999999999999864321 111111111111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhc--CCCCCCCHHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRM--RGKERPSMDKVTTA 788 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~--~p~~RPs~~ev~~~ 788 (914)
........+.+++.+|+.. ++..||+++++++.
T Consensus 232 ------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 232 ------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0112345667788887754 33347788777654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=300.52 Aligned_cols=248 Identities=24% Similarity=0.339 Sum_probs=200.5
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.++||+|.|+.||+.... .|+.+|+|.+..........+++.+|++|-+.|+|||||+|.+...+....|||+|+|.|
T Consensus 15 l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G 94 (355)
T KOG0033|consen 15 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 94 (355)
T ss_pred HHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccc
Confidence 4578999999999998754 588899997765555555778899999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC---CCcEEEeecCCcccCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE---EHNARVADFGLSLLGPAD 673 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kl~DFGla~~~~~~ 673 (914)
++|..-|-.+ ..++....-....||+++|.|.|.++ |||||+||.|+||.. .--+||+|||++..+..
T Consensus 95 ~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~- 165 (355)
T KOG0033|consen 95 GELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND- 165 (355)
T ss_pred hHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeCC-
Confidence 9998776533 24566677788999999999999999 999999999999943 33489999999988762
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
........|||+|||||+++..+|+..+|||+.|||||-||.|.+||....... ....+..+.+.- .
T Consensus 166 --g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-----lye~I~~g~yd~------~ 232 (355)
T KOG0033|consen 166 --GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-----LYEQIKAGAYDY------P 232 (355)
T ss_pred --ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-----HHHHHhccccCC------C
Confidence 223445679999999999999999999999999999999999999997532221 222344443221 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+.-....++..+|+.+||..||.+|.|+.|.+.
T Consensus 233 ~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 233 SPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred CcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 1112234457789999999999999999998764
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.24 Aligned_cols=253 Identities=23% Similarity=0.394 Sum_probs=198.3
Q ss_pred cccccCcccceEEEEEEEcC--CcEEEEEEeeecc--------ccccchHHHHHHHHHHHh-ccCCceeeeeceeecCCe
Q 002512 518 FKEEVGKGSFSCVYKGVLKD--GTVVAVKKAIATS--------DRQKNSKEFHTELDLLSR-LNHAHLLNLLGYCEEGRE 586 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~f~~E~~~l~~-l~HpnIv~l~g~~~~~~~ 586 (914)
+.+.||+|+||.||++.++. ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++.+.+.
T Consensus 4 ~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 83 (269)
T cd08528 4 VLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDR 83 (269)
T ss_pred hhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCe
Confidence 45679999999999999875 6889999875432 122234568889998875 699999999999999999
Q ss_pred EEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceEEcCCCcEEEeecC
Q 002512 587 RLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 587 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NILl~~~~~~kl~DFG 665 (914)
.++||||+++++|.+++..... ....+++..+++++.|++.+|.|||+ .+ |+|+||||+|||+++++.+||+|||
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 84 LYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred EEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEeccc
Confidence 9999999999999998854211 12357888899999999999999996 56 9999999999999999999999999
Q ss_pred CcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcc
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 745 (914)
++....... ......|+..|++||.+....++.++||||||+++|||++|+.||.... ..... ..+......
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~----~~~~~-~~~~~~~~~ 231 (269)
T cd08528 160 LAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----MLSLA-TKIVEAVYE 231 (269)
T ss_pred ceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC----HHHHH-HHHhhccCC
Confidence 997654332 2233458899999999998889999999999999999999999985321 11111 111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
.. ........+.+++.+||+.+|++||++.|+.++|+
T Consensus 232 ~~--------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 PL--------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cC--------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 01122357889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.83 Aligned_cols=246 Identities=25% Similarity=0.364 Sum_probs=193.4
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.+.||+|+||.||++... +++.||+|++.... .....++|.+|++++++++||||+++++++...+..+|||||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 5 YQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred heeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 4577999999999999864 68899999875432 223346799999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|..+. .+++.....++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 84 ~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 84 GSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9997653 3567778899999999999999999 999999999999999999999999998754322
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHH--HHHHhhhhcCCcccccccccCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIV--EWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~--~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
......||..|+|||++....++.++||||||+++|||++|+.||.......... ......+.... .+.+
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~-- 220 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL-- 220 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC--
Confidence 1233468999999999998889999999999999999999999986432221110 00111111110 0111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.......++.+++.+||+.+|++||+++|+++.
T Consensus 221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 111233568899999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=311.73 Aligned_cols=253 Identities=21% Similarity=0.361 Sum_probs=196.0
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeecccc--------ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR--------QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 588 (914)
..+.||+|+||.||+|... +++.+|+|++...... ....+.|.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 3567999999999999865 5889999987532111 111356889999999999999999999999999999
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
+||||+++++|.+++++.. .+++..+..++.||+.+|.|||+.+ ++||||||+||++++++.+||+|||+++
T Consensus 85 lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred EEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999997652 4788888999999999999999998 9999999999999999999999999987
Q ss_pred cCCCCCCCCCccCCCCcCCccChhhhhcCC--CCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccc
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRLHY--LTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITA 746 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 746 (914)
...............++..|+|||.+.... ++.++||||||+++|||++|+.||........ ..... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~-~~~~~~ 231 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA----MFKLG-NKRSAP 231 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH----HHHhh-ccccCC
Confidence 654332222233345889999999987654 78999999999999999999999853211111 11111 111111
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 747 ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+++. .....+..+.+++.+||..+|++||++++|++
T Consensus 232 ~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 232 PIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 11111 11233567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=312.32 Aligned_cols=245 Identities=28% Similarity=0.488 Sum_probs=195.1
Q ss_pred cccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.+.||+|+||.||++.. .++.||+|+..... ..+.|.+|+.++++++||||+++++++... ..++||||++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 44677899999999999975 57889999874322 236799999999999999999999998765 4799999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 82 KGNLVNFLRTRGR---ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 9999999976432 35788889999999999999999998 9999999999999999999999999987543211
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
.....+..|+|||++....++.++||||||+++|||++ |+.||...... + ....+..+. ..
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~----~-~~~~~~~~~---------~~ 216 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK----E-VKECVEKGY---------RM 216 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH----H-HHHHHhCCC---------CC
Confidence 11234578999999998899999999999999999998 88887543211 1 111222211 11
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
+.....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1112334678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.70 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=200.4
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||++... +++.+|+|++..........+++.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 45678999999999999865 58899999886543333445689999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++..... ..+++..+++++.|++.+|.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 83 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 83 GGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999999975322 24688888999999999999999998 99999999999999999999999999876543221
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......|++.|+|||++....++.++||||||+++|||++|+.||.... ..+.....+ .+... +
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~----~~~~~~~~~-~~~~~---------~ 220 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN----MKNLVLKII-RGSYP---------P 220 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC----HHHHHHHHh-cCCCC---------C
Confidence 1223357889999999998889999999999999999999999985321 112111111 11111 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+......+.+++.+||+.+|++||++.+|++
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11233457899999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=314.33 Aligned_cols=244 Identities=25% Similarity=0.371 Sum_probs=195.8
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.+.||+|+||.||+|.+. +++.||+|.+.... .....+.|.+|++++++++||||+++++++...+..++||||++++
T Consensus 9 ~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06642 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred HHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence 456999999999999875 47789999765332 2234567999999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++... .+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 88 ~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06642 88 SALDLLKPG------PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred cHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch--
Confidence 999998642 4788888999999999999999998 99999999999999999999999999876543221
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
......++..|+|||++....++.++||||||+++|||++|+.|+........ . ..+.... .+. ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~----~~~~~~~-----~~~----~~ 222 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-L----FLIPKNS-----PPT----LE 222 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-H----hhhhcCC-----CCC----CC
Confidence 12234578999999999998899999999999999999999999753322111 0 0111111 111 11
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
......+.+++.+||+.+|++||+|.+++..
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1334578899999999999999999999874
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=319.25 Aligned_cols=197 Identities=26% Similarity=0.357 Sum_probs=158.9
Q ss_pred cccCcccceEEEEEEEcC---CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec--CCeEEEEEeeC
Q 002512 520 EEVGKGSFSCVYKGVLKD---GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE--GRERLLVYEFM 594 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~Ey~ 594 (914)
.+||+|+||.||+++.++ +..||+|++.... ....+.+|++++++++||||+++++++.. ....++||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 469999999999999753 5789999774322 23568899999999999999999998853 55789999998
Q ss_pred CCCCHHHhhhcCcc----chhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE----cCCCcEEEeecCC
Q 002512 595 AHGSLHQHLHGKSK----ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI----DEEHNARVADFGL 666 (914)
Q Consensus 595 ~~gsL~~~l~~~~~----~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl----~~~~~~kl~DFGl 666 (914)
+ ++|.+++..... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 7 488888753211 11234788889999999999999999999 9999999999999 5667899999999
Q ss_pred cccCCCCCCC-CCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 002512 667 SLLGPADSSS-PLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDM 724 (914)
Q Consensus 667 a~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~ 724 (914)
++........ .......||+.|+|||++.+ ..++.++||||||++||||+||+.||..
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 9865433211 12233468999999999976 4578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=295.98 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=203.0
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeecccccc--c----hHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEE
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQK--N----SKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~--~----~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV 590 (914)
++.||.|..+.|.+..++ .++..|+|++........ . .++-.+|+.||+++ .||||+.+.++++.+...++|
T Consensus 22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV 101 (411)
T KOG0599|consen 22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV 101 (411)
T ss_pred HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence 456999999999988765 588899998865433221 1 23456799999999 799999999999999999999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
+|.|+.|.|.|||... ..++.+...+|+.|+.+|++|||... ||||||||+|||+|++.++||+|||++..+
T Consensus 102 Fdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 102 FDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred hhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeecc
Confidence 9999999999999764 35888899999999999999999999 999999999999999999999999999887
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhc------CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCc
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRL------HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDI 744 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~------~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 744 (914)
.+... ....+|||+|+|||.++. ..|+...|+|++|||||.||.|.+||..... ..+...+.+|..
T Consensus 174 ~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-----mlMLR~ImeGky 245 (411)
T KOG0599|consen 174 EPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-----MLMLRMIMEGKY 245 (411)
T ss_pred CCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-----HHHHHHHHhccc
Confidence 66542 344579999999999853 3578899999999999999999999864311 123445555544
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.- ..|.-.+......+|+.+||+.||++|.|.+|.+..
T Consensus 246 qF------~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 246 QF------RSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 31 223333566788999999999999999999998754
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=321.72 Aligned_cols=250 Identities=24% Similarity=0.326 Sum_probs=207.9
Q ss_pred hcccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccc-cchHHHHHHHHHHHhcc-CCceeeeeceeecCCeEEEEE
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQ-KNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~ 591 (914)
.+.+.++||+|.||.||+++.+. |+.+|+|.+.+..... ...+.+.+|+.+|+++. |||||.+++.|++.+..+|||
T Consensus 36 ~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvm 115 (382)
T KOG0032|consen 36 KYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVM 115 (382)
T ss_pred cEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEE
Confidence 35566789999999999999875 9999999886654322 23468999999999998 999999999999999999999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC----CcEEEeecCCc
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE----HNARVADFGLS 667 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~----~~~kl~DFGla 667 (914)
|++.||.|.+.|... .++......++.|++.++.|||+.+ |+||||||+|+|+... +.+|++|||++
T Consensus 116 EL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 116 ELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred EecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 999999999999765 2788888999999999999999999 9999999999999533 47999999999
Q ss_pred ccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccc
Q 002512 668 LLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 668 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 747 (914)
..... .......+||+.|+|||++....|+.++||||+|+++|.|++|..||....+..... .+..+++
T Consensus 187 ~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~~~~~--- 255 (382)
T KOG0032|consen 187 KFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AILRGDF--- 255 (382)
T ss_pred eEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHHcCCC---
Confidence 88766 234556789999999999999999999999999999999999999997654433322 2223322
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
....+.-....+.+.+++..++..||..|+|+.++++
T Consensus 256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1112222344677889999999999999999999887
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.94 Aligned_cols=248 Identities=22% Similarity=0.327 Sum_probs=194.0
Q ss_pred ccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.++||+|+||.||+++... ++.+++|.+.... ....++|.+|+.++++++||||+++++++..+...++||||++
T Consensus 15 ~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 15 EIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 345679999999999999764 7889999875432 3345779999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|..++.+.. ..+++..++.++.|++.+|+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 93 ~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 93 GGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 999998886532 24788999999999999999999998 9999999999999999999999999986532221
Q ss_pred CCCccCCCCcCCccChhhhh-----cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 676 SPLAELPAGTLGYLDPEYYR-----LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~-----~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
.......+++.|+|||++. ...++.++||||||+++|||++|+.||...... +...... ... .+
T Consensus 165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~-~~~-----~~ 233 (292)
T cd06644 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIA-KSE-----PP 233 (292)
T ss_pred -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----HHHHHHh-cCC-----Cc
Confidence 1122345788999999984 345688999999999999999999998543211 1111111 111 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.. ..+.....++.+++.+||+.+|++||++.++++
T Consensus 234 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11 111233457889999999999999999998864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=315.92 Aligned_cols=246 Identities=22% Similarity=0.348 Sum_probs=197.7
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||.|+||.||++... +++.|++|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 22 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 22 TRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred EEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 34567999999999999864 68999999875432 2334678999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++... .+++..++.++.|++.+|+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 100 ~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 100 GGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998642 4789999999999999999999999 99999999999999999999999999876543322
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......++..|+|||.+....++.++||||||+++|||++|+.||.......... .... .... .+ .
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~----~~~~-~~~~-----~~--~ 236 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIAT-NGTP-----EL--Q 236 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHh-cCCc-----cc--C
Confidence 1223458899999999998889999999999999999999999986532221111 1111 1100 01 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+......+.+++.+||..+|++||++.+++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11223456889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.20 Aligned_cols=246 Identities=27% Similarity=0.382 Sum_probs=197.4
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeecccc---ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR---QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.||+|+||.||+|..+ +++.|++|.+...... ++..+.|.+|+.++++++||||+++++++.+.+..++||||
T Consensus 4 ~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 83 (258)
T cd06632 4 KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLEL 83 (258)
T ss_pred ccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEe
Confidence 4567999999999999986 7899999987654321 23456799999999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++++|.+++.... .+++..+..++.|++++|+|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 84 VPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred cCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999997542 4788888999999999999999999 999999999999999999999999998764332
Q ss_pred CCCCCccCCCCcCCccChhhhhcCC-CCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHY-LTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~-~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
. ......++..|++||.+.... ++.++|+||||+++|||++|+.||....... .............+
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~----- 223 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----AVFKIGRSKELPPI----- 223 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH----HHHHHHhcccCCCc-----
Confidence 2 123345889999999997766 8999999999999999999999986432111 11111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+......+.+++.+||+.+|.+||++.+++.
T Consensus 224 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 224 ----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1123457789999999999999999999874
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=321.02 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=191.5
Q ss_pred ccccccCcccceEEEEEEEcC-CcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.++||+|+||.||+++++. ++.+|+|.+..... .......|.+|+.++..++|+||+++++++.+.+..+|||||+
T Consensus 4 ~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~ 83 (332)
T cd05623 4 EILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYY 83 (332)
T ss_pred eEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEecc
Confidence 456789999999999999764 77899998754221 2223356889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.+++++.. ..+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 84 VGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred CCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999997532 24788888899999999999999999 9999999999999999999999999986543322
Q ss_pred CCCCccCCCCcCCccChhhhh-----cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 675 SSPLAELPAGTLGYLDPEYYR-----LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
. .......||+.|||||++. ...++.++|||||||+||||++|+.||.... ..+............
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~---- 227 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKERF---- 227 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC----HHHHHHHHhCCCccc----
Confidence 1 1223346999999999986 3467899999999999999999999986432 111111111111100
Q ss_pred cccCCCC-CHHHHHHHHHHHHHhhhcCCC--CCCCHHHHHHH
Q 002512 750 PVLKLPS-DLDALKRIANVACKCVRMRGK--ERPSMDKVTTA 788 (914)
Q Consensus 750 ~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~--~RPs~~ev~~~ 788 (914)
..+. ......++.+++.+|+..++. .||+++|+++.
T Consensus 228 ---~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ---QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ---cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 1111 112345677888888765443 46788777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=308.80 Aligned_cols=248 Identities=23% Similarity=0.341 Sum_probs=190.3
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeecccc---ccchHHHHHHHHHHHhccCCceeeeeceeec--CCeEEEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR---QKNSKEFHTELDLLSRLNHAHLLNLLGYCEE--GRERLLVY 591 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~ 591 (914)
..+.||+|+||.||++... .++.|++|++...... .+..+.+.+|+.++++++||||+++++++.+ ....+++|
T Consensus 6 ~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~ 85 (266)
T cd06651 6 RGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFM 85 (266)
T ss_pred ccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEE
Confidence 3567999999999999975 4889999987543221 2234568899999999999999999998865 35778999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+++++|.+++.... .+++...+.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 86 EYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred eCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999997543 3778888899999999999999998 9999999999999999999999999987643
Q ss_pred CCCC-CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 672 ADSS-SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 672 ~~~~-~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
.... ........++..|+|||++.+..++.++||||||+++|||++|+.||...... ........... .+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~----~~~~~~~~~~~-----~~ 228 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM----AAIFKIATQPT-----NP 228 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH----HHHHHHhcCCC-----CC
Confidence 2211 11122345889999999999888999999999999999999999998643211 11111111110 11
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+ +......+..++ +||..+|++||+++||++
T Consensus 229 ~~----~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 229 QL----PSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CC----chhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11 112234555666 788899999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.92 Aligned_cols=255 Identities=24% Similarity=0.378 Sum_probs=201.7
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||.|+||+||++... ++..+++|++....... ..+.+.+|+++++.++|+||+++++.+...+..++||||++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 4 ELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred eeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 45678999999999999965 57889999875433222 55789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.++++.... ...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 83 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 83 GGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred CCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999975422 235788889999999999999999999 99999999999999999999999999876554332
Q ss_pred CC--CccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 676 SP--LAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 676 ~~--~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
.. ......|+..|+|||++... .++.++||||||+++|||++|+.||........+.. .... . .+.+
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~----~~~~-~-----~~~~ 227 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML----TLQN-D-----PPSL 227 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHH----HhcC-C-----CCCc
Confidence 21 22334588999999999877 789999999999999999999999864432221111 1111 0 1111
Q ss_pred CCCC-CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 753 KLPS-DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 753 ~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.... ....+..+.+++.+||..+|++||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111 1234567889999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=308.01 Aligned_cols=249 Identities=20% Similarity=0.276 Sum_probs=199.7
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||++... +++.+|+|.+..... ....+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 81 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCD 81 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCC
Confidence 35678999999999999976 588999998754332 3345778999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++..... ..++....+.++.|++.||.|||+.+ |+|+||||+|||+++++.++|+|||++........
T Consensus 82 ~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 82 GGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred CCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 9999999865322 34678888999999999999999999 99999999999999999999999999876543221
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......|++.|+|||++....++.++||||||+++|||++|+.||..... .... ..+..+....+
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~-~~~~~~~~~~~-------- 220 (255)
T cd08219 156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW----KNLI-LKVCQGSYKPL-------- 220 (255)
T ss_pred --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH----HHHH-HHHhcCCCCCC--------
Confidence 22234588999999999988899999999999999999999999864321 1111 11222221111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
+......+.+++.+||+.+|++||++.|++..
T Consensus 221 -~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 -PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11233568899999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=318.83 Aligned_cols=241 Identities=27% Similarity=0.385 Sum_probs=196.4
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
..||.|+||.||-++.. +.+.||||++.-... .....++++.|++.|.+|+|||+|.+-|+|..+...+||||||- |
T Consensus 32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-G 110 (948)
T KOG0577|consen 32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-G 110 (948)
T ss_pred HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-c
Confidence 35999999999999965 688999999865442 22335789999999999999999999999999999999999995 6
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
|-.|+|.-. ++++....+..|..+.+.||+|||+.+ .||||||+.||||++.+.+||+|||.+.+..+
T Consensus 111 SAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----- 178 (948)
T KOG0577|consen 111 SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP----- 178 (948)
T ss_pred cHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc-----
Confidence 777777533 346788888999999999999999999 99999999999999999999999999877544
Q ss_pred CccCCCCcCCccChhhhh---cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 678 LAELPAGTLGYLDPEYYR---LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~---~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
....+|||.|||||++. .+.|+-|+|||||||+..||.-.++|+..... . .+...+...+ .|.+.
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----M-SALYHIAQNe-----sPtLq- 246 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----M-SALYHIAQNE-----SPTLQ- 246 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----H-HHHHHHHhcC-----CCCCC-
Confidence 23457999999999984 56899999999999999999999998642211 1 1222232221 12222
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+....+.+++..||+.-|.+|||.++++.
T Consensus 247 --s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 247 --SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred --CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 3467788999999999999999999988754
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.13 Aligned_cols=250 Identities=31% Similarity=0.502 Sum_probs=198.9
Q ss_pred cccccCcccceEEEEEEEcC-----CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 518 FKEEVGKGSFSCVYKGVLKD-----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
+.+.||.|+||.||+++..+ +..||+|++..... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 45789999999999999764 37899998754332 2245789999999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|+++++|.+++..... ..+++..+..++.|++.+|+|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 82 YMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred ccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999976432 12889999999999999999999999 99999999999999999999999999976554
Q ss_pred CCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
....... ...+++.|+|||.+....++.++||||||+++|||++ |+.||... ....+.+ .+..+...
T Consensus 156 ~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~-~~~~~~~----~~~~~~~~------ 223 (258)
T smart00219 156 DDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM-SNEEVLE----YLKKGYRL------ 223 (258)
T ss_pred ccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CHHHHHH----HHhcCCCC------
Confidence 4222111 2337789999999988889999999999999999999 77776532 1111111 12221111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
+.....+.++.+++.+|+..+|++|||+.++++.|
T Consensus 224 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 ---PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ---CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11112446788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.75 Aligned_cols=255 Identities=27% Similarity=0.428 Sum_probs=198.0
Q ss_pred cccccCcccceEEEEEEEc------CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
..+.||+|+||.||+++.+ +.+.+++|.+.... .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 9 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 87 (275)
T cd05046 9 EITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMIL 87 (275)
T ss_pred eeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEE
Confidence 3456999999999999964 24678888764322 1223467999999999999999999999999999999999
Q ss_pred eeCCCCCHHHhhhcCccch----hcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCc
Q 002512 592 EFMAHGSLHQHLHGKSKAL----KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~----~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla 667 (914)
||+++++|.++++...... ...+++..++.++.|++.+|+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~ 164 (275)
T cd05046 88 EYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLS 164 (275)
T ss_pred EecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEcccccc
Confidence 9999999999997543211 125899999999999999999999999 999999999999999999999999998
Q ss_pred ccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCccc
Q 002512 668 LLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITA 746 (914)
Q Consensus 668 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 746 (914)
......... ......++..|+|||.+....++.++||||||+++|||++ |..||..... ..+. .....+...
T Consensus 165 ~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~-~~~~----~~~~~~~~~- 237 (275)
T cd05046 165 KDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-EEVL----NRLQAGKLE- 237 (275)
T ss_pred cccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch-HHHH----HHHHcCCcC-
Confidence 654322211 1222346788999999988888999999999999999999 7778753221 1111 112222211
Q ss_pred ccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 747 ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 747 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
.+.....+..+.+++.+||+.+|++||++.|++..|.
T Consensus 238 -------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 -------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111223457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=309.15 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=198.7
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.+.||+|+||.||++.++ +++.+++|++..... ....+++.+|++++++++||||+++++++...+..+||+||+++
T Consensus 5 ~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 5 YLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred HHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 4567999999999999986 588999998765433 23457799999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
++|.+++.... ..++......++.|++++|+|||+ .+ ++|+||||+||++++++.+||+|||++........
T Consensus 84 ~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 84 GSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred CcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999997642 357888888999999999999999 88 99999999999999999999999999865432211
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCccccccc-ccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE-GNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ....+...... .... ...
T Consensus 157 ----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~-------~~~ 224 (265)
T cd06605 157 ----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIV-NEPP-------PRL 224 (265)
T ss_pred ----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHh-cCCC-------CCC
Confidence 1146888999999999999999999999999999999999998643211 12222221111 1110 011
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+. .....++.+++.+||..+|++|||+.+++.
T Consensus 225 ~~-~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 225 PS-GKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred Ch-hhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11 114467889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=346.07 Aligned_cols=268 Identities=27% Similarity=0.423 Sum_probs=213.8
Q ss_pred HHHHHhcccccccCcccceEEEEEEEcC--------CcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeece
Q 002512 510 ELERATGGFKEEVGKGSFSCVYKGVLKD--------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGY 580 (914)
Q Consensus 510 el~~~t~~~~~~LG~G~fG~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~ 580 (914)
|+.+....+.+.||+|.||.|++|.... ...||||++...... .+.+.|..|+++|..+ +||||+.++|+
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3333333456689999999999998541 457999988766554 5678999999999999 79999999999
Q ss_pred eecCCeEEEEEeeCCCCCHHHhhhcCc---------cchhc--ccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 002512 581 CEEGRERLLVYEFMAHGSLHQHLHGKS---------KALKE--QLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSS 649 (914)
Q Consensus 581 ~~~~~~~~LV~Ey~~~gsL~~~l~~~~---------~~~~~--~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~ 649 (914)
|......++|+||++.|+|.+||+..+ ....+ .++....+.++.|||.||+||++.. +|||||.++
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999998776 11122 3888899999999999999999999 999999999
Q ss_pred ceEEcCCCcEEEeecCCcccCCCCCCCCCccCC-CCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccc
Q 002512 650 NILIDEEHNARVADFGLSLLGPADSSSPLAELP-AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFE 727 (914)
Q Consensus 650 NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~-~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~ 727 (914)
|||+.++..+||+|||+++.............. .-...|||||.+....|+.|||||||||+||||+| |..|+..-..
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999875554433212111 13567999999999999999999999999999999 5566643111
Q ss_pred cccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 728 EGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 728 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
..++ ...+++| .+...+..+..++++||..||+.+|++||++.++++.|+..+.
T Consensus 528 ~~~l----~~~l~~G---------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 528 TEEL----LEFLKEG---------NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHH----HHHHhcC---------CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 2222 2234444 3334445567899999999999999999999999999998654
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=327.74 Aligned_cols=239 Identities=24% Similarity=0.316 Sum_probs=185.7
Q ss_pred cCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhc---cCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 522 VGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRL---NHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
||+|+||+||+++.+ +++.||+|++..... .......+..|..++.++ +||||+++++++.+.+..+|||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999976 589999998754321 122334566777777766 699999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
|+|.+++.... .+++.....++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-- 150 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-- 150 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--
Confidence 99999987543 4788889999999999999999999 9999999999999999999999999986533222
Q ss_pred CCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
.......||+.|||||++... .++.++|||||||+||||++|+.||...... + ....+..+.. ..+
T Consensus 151 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~----~-~~~~i~~~~~--------~~~ 217 (330)
T cd05586 151 KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ----Q-MYRNIAFGKV--------RFP 217 (330)
T ss_pred CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH----H-HHHHHHcCCC--------CCC
Confidence 122345699999999999754 4789999999999999999999998643211 1 1112222211 111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDK 784 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 784 (914)
. .....++.+++.+||+.+|++||++.+
T Consensus 218 ~-~~~~~~~~~li~~~L~~~P~~R~~~~~ 245 (330)
T cd05586 218 K-NVLSDEGRQFVKGLLNRNPQHRLGAHR 245 (330)
T ss_pred C-ccCCHHHHHHHHHHcCCCHHHCCCCCC
Confidence 1 112356789999999999999996543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=320.84 Aligned_cols=252 Identities=21% Similarity=0.284 Sum_probs=191.3
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeecc-ccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||+++.+ +++.||+|.+.... ........|.+|+.++..++|+||+++++++.+.+..||||||+
T Consensus 4 ~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~ 83 (331)
T cd05624 4 EIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYY 83 (331)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCC
Confidence 45678999999999999976 57889999875422 12223456889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.++++... ..+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 84 VGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred CCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999997532 24778888899999999999999999 9999999999999999999999999997654332
Q ss_pred CCCCccCCCCcCCccChhhhhc-----CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 675 SSPLAELPAGTLGYLDPEYYRL-----HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
.. ......||+.|||||++.. ..++.++||||||++||||++|+.||..... .+..........
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~------ 225 (331)
T cd05624 157 TV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHEE------ 225 (331)
T ss_pred ce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH----HHHHHHHHcCCC------
Confidence 21 1223469999999999875 4678999999999999999999999864321 111111111110
Q ss_pred cccCCCCC-HHHHHHHHHHHHHhhhcCCCC--CCCHHHHHH
Q 002512 750 PVLKLPSD-LDALKRIANVACKCVRMRGKE--RPSMDKVTT 787 (914)
Q Consensus 750 ~~l~~~~~-~~~~~~l~~l~~~Cl~~~p~~--RPs~~ev~~ 787 (914)
....+.. ....+++.+++.+|+..++++ |++++++++
T Consensus 226 -~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 226 -RFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -cccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0111111 123457788899988865543 456666654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=315.50 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=194.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.++||+|+||.||+++.+ +++.||+|.+..... ......+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 9 ~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 9 IKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred EEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 45677999999999999976 578999998754432 2233568899999999999999999999999999999999997
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
++|.+++.... ..+++.....++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||++........
T Consensus 88 -~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 88 -KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred -cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 59999887543 24778888999999999999999999 99999999999999999999999999875432221
Q ss_pred CCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhc---CCcccccc--
Q 002512 676 SPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKS---GDITAILD-- 749 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~---~~~~~~~d-- 749 (914)
......+++.|+|||.+.+. .++.++||||||+++|||+||+.||........ .......+.. .....+.+
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ-LHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCChhhchhhhccc
Confidence 12233578999999998654 578899999999999999999999864322211 1111110000 00000000
Q ss_pred -------cccCCC----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 750 -------PVLKLP----SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 750 -------~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+..... ........+.+|+.+||+.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 01123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=306.30 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=200.3
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
...+.||+|+||.||++... +++.+++|.+..........+.+.+|+.++++++|+||+++++++.+.+..++|+||++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 34578999999999999975 68899999886554433456789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++.... .+++..+..|+.|+++||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 83 GGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999997542 3678888999999999999999999 99999999999999999999999999877544332
Q ss_pred CCC--ccCCCCcCCccChhhhhcCC---CCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 676 SPL--AELPAGTLGYLDPEYYRLHY---LTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 676 ~~~--~~~~~Gt~~y~aPE~l~~~~---~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
... .....++..|+|||++.... .+.++||||||+++|||++|+.||.......... .. +..+ .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~---~~-~~~~-------~ 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM---FH-VGAG-------H 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH---HH-HhcC-------C
Confidence 211 11245789999999998766 8899999999999999999999986432111111 10 1111 1
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
....+........+.+++.+||+.+|++||++.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111222223457789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=319.13 Aligned_cols=249 Identities=23% Similarity=0.359 Sum_probs=203.2
Q ss_pred cccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.++||+||.+.||++...+.+.+|+|++.......+...-|.+|+..|.+| .|.+||+|++|-..+..+||||||= .
T Consensus 365 ilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d 443 (677)
T KOG0596|consen 365 ILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-D 443 (677)
T ss_pred HHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-c
Confidence 4567999999999999988889999998877666667788899999999999 6999999999999999999999986 4
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
-+|...|++.... ...| .+..+..|++.++.++|.++ |||-||||.|+|+-+ |.+||+|||+|.....+...
T Consensus 444 ~DL~kiL~k~~~~---~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 444 IDLNKILKKKKSI---DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred ccHHHHHHhccCC---CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccccc
Confidence 6999999876431 2334 56778999999999999999 999999999998854 58999999999999888888
Q ss_pred CCccCCCCcCCccChhhhhcC-----------CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcc
Q 002512 677 PLAELPAGTLGYLDPEYYRLH-----------YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~-----------~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 745 (914)
......+||+.||+||.+... +.+++|||||||||||+|+.|+.||... .... ..+.
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~------~n~~------aKl~ 583 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI------INQI------AKLH 583 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH------HHHH------HHHH
Confidence 778888999999999998532 3668999999999999999999998632 1111 1223
Q ss_pred cccccccCCCCCH-HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 746 AILDPVLKLPSDL-DALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 746 ~~~d~~l~~~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+.||.-..+++. ....++.++|..||..||++||+..|+++
T Consensus 584 aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 584 AITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred hhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 4445533222211 11223889999999999999999999874
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=306.78 Aligned_cols=251 Identities=22% Similarity=0.337 Sum_probs=199.3
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||.||++... +++.+++|.+..... ...+.+.+|++++++++||||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 345678999999999999975 478899998764432 24578999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++.... ..++......++.|++.+|+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 83 GGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999987542 24788889999999999999999999 9999999999999999999999999987644321
Q ss_pred CCCCccCCCCcCCccChhhhhcC---CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLH---YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~---~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
. ......++..|+|||.+... .++.++||||||+++|||+||+.||........... ...... ..+.
T Consensus 156 ~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-----~~~~~~---~~~~ 225 (262)
T cd06613 156 A--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-----ISKSNF---PPPK 225 (262)
T ss_pred h--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-----HHhccC---CCcc
Confidence 1 12234578899999999776 889999999999999999999999864322111111 111100 0111
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+ ........++.+++.+||..+|.+||++.+|+.
T Consensus 226 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 226 L--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred c--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1 112234567899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=311.84 Aligned_cols=247 Identities=23% Similarity=0.327 Sum_probs=195.4
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.+.||.|+||.||++..+ +++.+|+|...... ....+.|.+|++++++++||||+++++++.+....++||||+++
T Consensus 9 i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (280)
T cd06611 9 IIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG 86 (280)
T ss_pred HHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence 4567999999999999975 58899999875432 23446799999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++.... ..+++.....++.|++.+|.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 87 ~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 87 GALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 99999987542 25888899999999999999999999 99999999999999999999999999865433221
Q ss_pred CCccCCCCcCCccChhhhh-----cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 677 PLAELPAGTLGYLDPEYYR-----LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~-----~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
......+++.|+|||.+. ...++.++||||||+++|||++|+.||....... .... +..... +.
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~----~~~~-~~~~~~-----~~ 227 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR----VLLK-ILKSEP-----PT 227 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH----HHHH-HhcCCC-----CC
Confidence 122345889999999985 3457789999999999999999999986432111 1111 111111 11
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+ ..+.....++.+++.+||+.+|.+||++.++++
T Consensus 228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 228 L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 1 111123457889999999999999999998865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=311.17 Aligned_cols=250 Identities=25% Similarity=0.375 Sum_probs=196.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||++..+ +++.||+|.+.... .......|.+|++++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMD 82 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecC
Confidence 35678999999999999976 68999999875432 22234679999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhcc-CCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY-ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~-~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
+++|.++++.... ...+++..+..++.|++.+|.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 83 AGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred CCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 9999999875321 23588999999999999999999974 6 999999999999999999999999998654322
Q ss_pred CCCCccCCCCcCCccChhhhhcC------CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccc
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLH------YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~------~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 748 (914)
......++..|+|||++... .++.++||||||+++|||++|+.||...... ...... ..+..+...
T Consensus 157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~-~~~~~~~~~--- 228 (286)
T cd06622 157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-NIFAQL-SAIVDGDPP--- 228 (286)
T ss_pred ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-hHHHHH-HHHhhcCCC---
Confidence 22234588899999998554 3588999999999999999999998643211 111111 111111111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+.....++.+++.+||+.+|++||++++++.
T Consensus 229 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 229 ------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred ------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111234567889999999999999999998875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=305.12 Aligned_cols=248 Identities=23% Similarity=0.345 Sum_probs=198.7
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||++... +++.+|+|++..........+.|.+|++++++++||||+++++.+...+..++||||++
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08220 3 EKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAP 82 (256)
T ss_pred eEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCC
Confidence 45678999999999999875 58889999886554344456789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC-CcEEEeecCCcccCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE-HNARVADFGLSLLGPADS 674 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kl~DFGla~~~~~~~ 674 (914)
+++|.+++..... ..+++..+++++.|++++|+|||+++ |+|+||||+||+++++ ..+||+|||++.......
T Consensus 83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 83 GGTLAEYIQKRCN---SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999976432 34788899999999999999999999 9999999999999855 468999999997654332
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. .....++..|+|||.+....++.++||||||+++|||++|+.||...... ..... +.......+
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~----~~~~~-~~~~~~~~~------- 221 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP----ALVLK-IMSGTFAPI------- 221 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH----HHHHH-HHhcCCCCC-------
Confidence 1 12245889999999999888999999999999999999999998543211 11111 111111111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.......+.+++.+||+.+|++|||+.|++.
T Consensus 222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred --CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=316.28 Aligned_cols=254 Identities=21% Similarity=0.274 Sum_probs=199.4
Q ss_pred ccccccCcccceEEEEEEEcC-CcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||++...+ ++.+|+|.+...... ....+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (316)
T cd05574 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYC 83 (316)
T ss_pred EEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEec
Confidence 345679999999999999764 899999988654322 134567899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++.... ...+++.....++.|++++|+|||+.+ ++|+||||+|||++.++.++|+|||++.......
T Consensus 84 ~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 84 PGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred CCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 9999999987542 235788889999999999999999999 9999999999999999999999999986543221
Q ss_pred CC---------------------------CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccc
Q 002512 675 SS---------------------------PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFE 727 (914)
Q Consensus 675 ~~---------------------------~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~ 727 (914)
.. .......||..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 011123588999999999988899999999999999999999999864332
Q ss_pred cccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 728 EGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 728 ~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
...+.. .. +.....+........+.+++.+||..+|++||++...++.+
T Consensus 238 ~~~~~~----~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l 286 (316)
T cd05574 238 DETFSN----IL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286 (316)
T ss_pred HHHHHH----Hh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence 221111 11 11111222222457899999999999999999955444333
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=305.64 Aligned_cols=248 Identities=23% Similarity=0.299 Sum_probs=191.6
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccc---cccchHHHHHHHHHHHhccCCceeeeeceeecC--CeEEEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD---RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RERLLVY 591 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~ 591 (914)
+.+.||+|+||.||++... +++.||+|++..... .....+.|.+|+.++++++||||+++++++.+. ...++||
T Consensus 6 ~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~ 85 (265)
T cd06652 6 LGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFM 85 (265)
T ss_pred EeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEE
Confidence 4577999999999999975 488999998753321 122346788999999999999999999998764 4678999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+++++|.+++.... .+++...++++.|++.+|+|||+.+ |+|+||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 86 EHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 9999999999987542 3677788899999999999999999 9999999999999999999999999987543
Q ss_pred CCCCC-CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 672 ADSSS-PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 672 ~~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
..... .......++..|+|||++....++.++||||||+++|||++|+.||....... . ........
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---~-~~~~~~~~-------- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---A-IFKIATQP-------- 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---H-HHHHhcCC--------
Confidence 22111 11223358899999999988889999999999999999999999986331111 1 11111110
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....+......+.+++.+|+. +|++||+++||++
T Consensus 226 -~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 -TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred -CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0111122344567788999985 9999999998874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=311.27 Aligned_cols=261 Identities=22% Similarity=0.284 Sum_probs=199.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||+|+.. +++.|++|++..........+.|.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 45678999999999999975 6899999988665433444578999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++.... ..+++..++.++.||+++|+|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 82 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 82 PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 999999987543 35888999999999999999999999 99999999999999999999999999976544322
Q ss_pred CCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC------------
Q 002512 676 SPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG------------ 742 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~------------ 742 (914)
.......++..|+|||.+... .++.++||||||+++|||+||.++|....... ........+...
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE-QLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH-HHHHHHHHcCCCChHHHhhccCcc
Confidence 122334689999999998654 46899999999999999999977775332211 111111111000
Q ss_pred CcccccccccC---C-CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 743 DITAILDPVLK---L-PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 743 ~~~~~~d~~l~---~-~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+...+..+... . ....+....+.+++.+||+.+|++||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00000000000 0 000123478899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=310.85 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=191.0
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceee-----cCCeEEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCE-----EGRERLLV 590 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~-----~~~~~~LV 590 (914)
+.+.||+|+||.||++..+ +++.+|+|+..... ....++.+|+.+++++ +||||+++++++. .++..++|
T Consensus 22 ~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 22 IIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 4567999999999999875 47889999764322 2235788999999999 7999999999884 34578999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
|||+++++|.++++.... ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 99 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 99 LELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 999999999998864321 1235788888999999999999999998 999999999999999999999999998765
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhc-----CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcc
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRL-----HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 745 (914)
..... ......|++.|+|||++.. ..++.++||||||+++|||++|+.|+........+. . ....
T Consensus 175 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~----~-~~~~--- 244 (286)
T cd06638 175 TSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF----K-IPRN--- 244 (286)
T ss_pred ccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh----h-cccc---
Confidence 43221 2233468999999999853 457889999999999999999999986432211111 0 0000
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
..+....+ ......+.+++.+||+.+|++|||+.|+++.
T Consensus 245 --~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 245 --PPPTLHQP--ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred --CCCcccCC--CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00111111 1123468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=312.58 Aligned_cols=260 Identities=22% Similarity=0.288 Sum_probs=196.6
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeecccc---ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR---QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
.+.+.||+|+||.||+|..+ +++.||+|++...... ......+..|++++++++|+||+++++++.+.+..++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 34567999999999999975 5899999988654432 2233567889999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|+ +++|.+++.... ..+++..++.++.||++||+|||+++ |+|+||||+|||++.++.+||+|||+++....
T Consensus 83 ~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 83 FM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred cc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 99 999999997643 25889999999999999999999999 99999999999999999999999999976543
Q ss_pred CCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC---------
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG--------- 742 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~--------- 742 (914)
... ......+++.|+|||.+.. ..++.++||||||+++|||++|.++|........+... ...+...
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI-FEALGTPTEENWPGVT 231 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH-HHHcCCCchhhhhhcc
Confidence 321 1222346788999999864 46789999999999999999997776543222111111 1000000
Q ss_pred CcccccccccCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 743 DITAILDPVLKLPSD-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 743 ~~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
............+.+ ......+.+++.+||+.+|++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000111 123467889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.33 Aligned_cols=244 Identities=23% Similarity=0.360 Sum_probs=196.9
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.+.||+|+||.||+|..+ +++.||+|.+.... .....+.|.+|+.++++++||||+++++++.+....++||||++++
T Consensus 9 ~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06640 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG 87 (277)
T ss_pred hhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence 456999999999999976 48899999775432 2334578999999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++... .+++.....++.|++.+|+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 88 ~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06640 88 SALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred cHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--
Confidence 999998642 3677888899999999999999998 99999999999999999999999999876543221
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
......++..|+|||++....++.++||||||+++|||+||+.||....... .. ..+... ......
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~----~~~~~~---------~~~~~~ 222 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-VL----FLIPKN---------NPPTLT 222 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-Hh----hhhhcC---------CCCCCc
Confidence 1223457889999999998889999999999999999999999986432111 00 011111 011122
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
......+.+++.+||+.+|++||++.+++..
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 223 GEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 3456778999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=313.62 Aligned_cols=243 Identities=21% Similarity=0.329 Sum_probs=194.9
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
.||+|+||.||++... +++.||+|++..... ...+.+.+|+.++..++||||+++++++..++..++||||+++++|
T Consensus 28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 5999999999999875 689999998754332 3346789999999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCc
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 679 (914)
.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ ..
T Consensus 106 ~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 174 (297)
T cd06659 106 TDIVSQT------RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KR 174 (297)
T ss_pred HHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cc
Confidence 9987542 4788889999999999999999999 99999999999999999999999999875443221 12
Q ss_pred cCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHH
Q 002512 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLD 759 (914)
Q Consensus 680 ~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 759 (914)
....|+..|+|||++....++.++||||||+++|||++|+.||........+ ..+.... .+... ....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~-----~~~~~--~~~~ 242 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-----KRLRDSP-----PPKLK--NAHK 242 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-----HHHhccC-----CCCcc--ccCC
Confidence 2345889999999999888999999999999999999999998643211111 1111111 00001 1112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 760 ALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 760 ~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
....+.+++.+||+.+|++||+++++++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 33567899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=311.78 Aligned_cols=263 Identities=24% Similarity=0.280 Sum_probs=199.0
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||.||++..+ +++.|++|++..........+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 345678999999999999976 4789999987654444444578999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
+++.|..++... ..+++.....++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 83 ERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred CCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 987776665432 24788889999999999999999999 9999999999999999999999999987755443
Q ss_pred CCCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH----------hhh-hcC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV----------PLI-KSG 742 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~----------~~~-~~~ 742 (914)
.. ......++..|+|||++... .++.++||||||++||||++|+.||........+..... ... ...
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 21 12234578899999999888 889999999999999999999998864322111111000 000 000
Q ss_pred Ccc--ccccccc----CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 743 DIT--AILDPVL----KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 743 ~~~--~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
... ...+... ....+.....++.+++.+||..+|++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000000 00011122577899999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=321.59 Aligned_cols=256 Identities=22% Similarity=0.287 Sum_probs=189.8
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC------CeEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG------RERLL 589 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~L 589 (914)
.+.+.||+|+||.||++... +++.||||++..........+.+.+|++++++++||||+++++++... ...++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~ 97 (343)
T cd07878 18 QNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYL 97 (343)
T ss_pred hhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEE
Confidence 34567999999999999965 578999998865433333446788999999999999999999988543 35689
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
++|++ +++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 98 ~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 98 VTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred EeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcccee
Confidence 99988 78998887532 4788889999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH----------hh
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV----------PL 738 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~----------~~ 738 (914)
.... .....||+.|+|||++.+ ..++.++||||||++||||++|+.||........+..... ..
T Consensus 168 ~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07878 168 ADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKK 242 (343)
T ss_pred cCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 5332 223468999999999976 5788999999999999999999999864322111111100 00
Q ss_pred hhcCCcccccccccCCCCC------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 739 IKSGDITAILDPVLKLPSD------LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~------~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+........+......+.. ......+.+|+.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 243 ISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred cchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000000 011235779999999999999999999885
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=313.84 Aligned_cols=255 Identities=22% Similarity=0.285 Sum_probs=197.8
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||++... .++.|++|.+..... .....+.+.+|++++++++||||+++++.+.+.+..++||||+
T Consensus 4 ~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 83 (305)
T cd05609 4 ETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83 (305)
T ss_pred eEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecC
Confidence 34577999999999999976 478999998754432 1233467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 84 EGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999997543 4788888999999999999999998 9999999999999999999999999986421110
Q ss_pred C-------------CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhc
Q 002512 675 S-------------SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKS 741 (914)
Q Consensus 675 ~-------------~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~ 741 (914)
. ........++..|+|||++....++.++||||||+++|||++|+.||...... + .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~----~-~~~~~~~ 230 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE----E-LFGQVIS 230 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----H-HHHHHHh
Confidence 0 00111235788999999998888999999999999999999999998632211 1 1111111
Q ss_pred CCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 742 GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
+... .+.. ....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 231 ~~~~---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 231 DDIE---WPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred cccC---CCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1111 1110 01234568899999999999999998777666653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=307.18 Aligned_cols=251 Identities=25% Similarity=0.359 Sum_probs=199.8
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec--CCeEEEEEee
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE--GRERLLVYEF 593 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~Ey 593 (914)
.+.+.||+|+||.||++... +++.+|+|.+..........+++.+|++++++++||||+++++++.. ....+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 34577999999999999865 57899999876544444455779999999999999999999998754 4567999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhh-----ccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH-----GYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH-----~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
+++++|.+++..... ....+++...+.++.||+.||+||| +.+ |+|+||||+||++++++.+||+|||++.
T Consensus 83 ~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 83 CEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred ccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccccc
Confidence 999999999975321 2346889999999999999999999 666 9999999999999999999999999998
Q ss_pred cCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccc
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~ 748 (914)
....... ......++..|+|||.+....++.++||||||+++|+|++|+.||.... ... ....+..+....
T Consensus 159 ~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~----~~~~~~~~~~~~-- 229 (265)
T cd08217 159 ILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN-QLQ----LASKIKEGKFRR-- 229 (265)
T ss_pred cccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC-HHH----HHHHHhcCCCCC--
Confidence 7654332 1223468999999999998889999999999999999999999986432 111 112222221111
Q ss_pred ccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 749 d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+......+.+++.+|++.+|++||++.+|++
T Consensus 230 -------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 230 -------IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred -------CccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11234467889999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=316.94 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=196.0
Q ss_pred cccCcc--cceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 520 EEVGKG--SFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 520 ~~LG~G--~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
++||+| +|++||++++. +++.||+|.+..........+.|.+|+.+++.++||||++++++|...+..++||||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 357777 99999999975 689999998765443344457889999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 999999876432 24788888899999999999999998 999999999999999999999999865332211110
Q ss_pred -----CCccCCCCcCCccChhhhhcC--CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHh------------
Q 002512 677 -----PLAELPAGTLGYLDPEYYRLH--YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVP------------ 737 (914)
Q Consensus 677 -----~~~~~~~Gt~~y~aPE~l~~~--~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~------------ 737 (914)
.......++..|||||++.+. .++.++||||||+++|||++|+.||........+......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccc
Confidence 001112356779999999764 4789999999999999999999998643222111111000
Q ss_pred --------------------hhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 738 --------------------LIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 738 --------------------~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.+.......+.+..+..+........+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000000001111222223334556789999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=308.12 Aligned_cols=245 Identities=28% Similarity=0.388 Sum_probs=197.9
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.+.||.|+||.||+++.. +++.||+|.+.... .......|.+|++++++++||||+++++++.++...++|+||+++
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 5 LLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 4567999999999999976 58899999875432 233456789999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.++++.. .+++.....++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 84 ~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 153 (274)
T cd06609 84 GSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS- 153 (274)
T ss_pred CcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence 9999999753 5788999999999999999999999 99999999999999999999999999977654321
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 756 (914)
......++..|+|||++....++.++||||||+++|||+||+.||....... . ...+....... +..
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-~----~~~~~~~~~~~-----~~~-- 220 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-V----LFLIPKNNPPS-----LEG-- 220 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-H----HHHhhhcCCCC-----Ccc--
Confidence 1223458889999999998889999999999999999999999986432111 1 11111111111 110
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 757 DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 757 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
......+.+++.+||..+|++||+++++++
T Consensus 221 -~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 221 -NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred -cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 013456889999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=310.28 Aligned_cols=260 Identities=24% Similarity=0.328 Sum_probs=192.6
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||+++.+ +++.||+|.+..... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 8 ~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 8 KKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 34577999999999999976 588999998765432 2223567889999999999999999999999999999999998
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+ +|.+++.... ..+++.....++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 87 ~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 87 T-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred C-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 5 9999987543 25788888999999999999999999 99999999999999999999999999865332111
Q ss_pred CCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC---Cccc-----
Q 002512 676 SPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG---DITA----- 746 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~---~~~~----- 746 (914)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||................+... ....
T Consensus 159 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07844 159 --TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236 (291)
T ss_pred --cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcc
Confidence 1122346889999999875 4578999999999999999999999864321111111111110000 0000
Q ss_pred -ccccccCC---------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 747 -ILDPVLKL---------PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 747 -~~d~~l~~---------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
........ .........+.+++.+||+.+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000000 001111256789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=306.31 Aligned_cols=257 Identities=23% Similarity=0.279 Sum_probs=196.7
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC--CeEEEEEeeC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RERLLVYEFM 594 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey~ 594 (914)
+.+.||.|++|.||++.++ +++.+|+|.+..... .....+|.+|++++++++||||+++++++.+. ...+|||||+
T Consensus 5 ~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 5 ELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 4567999999999999985 478899998764332 23457799999999999999999999998654 3689999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++..... ....++......++.|++++|.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 84 ~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 84 EGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred CCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99999998764321 1235788889999999999999999999 9999999999999999999999999986543221
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCccccccc-ccHHHHHHhhhhcCCcccccccccC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE-GNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~-~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.....++..|+|||.+....++.++||||||+++|||++|+.||...... ....+. ...+.......+.+.
T Consensus 160 ----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~--- 231 (287)
T cd06621 160 ----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIEL-LSYIVNMPNPELKDE--- 231 (287)
T ss_pred ----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHH-HHHHhcCCchhhccC---
Confidence 12234788999999999889999999999999999999999998754221 111111 111111111111110
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..........+.+++.+||+.+|.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1111224567899999999999999999998876
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.16 Aligned_cols=260 Identities=19% Similarity=0.228 Sum_probs=194.9
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC--CeEEEEEeeC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RERLLVYEFM 594 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey~ 594 (914)
+.+.||+|+||.||+|..+ +++.+++|++............+.+|+.++.+++||||+++++++... +..+|||||+
T Consensus 9 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~ 88 (293)
T cd07843 9 KLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV 88 (293)
T ss_pred hhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhc
Confidence 4567999999999999986 588999998865544433445678999999999999999999998877 8899999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
+ ++|.+++..... .+++...+.++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||++.......
T Consensus 89 ~-~~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 89 E-HDLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred C-cCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 7 599999875432 5889999999999999999999999 9999999999999999999999999987654332
Q ss_pred CCCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHH----------Hhhh----
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA----------VPLI---- 739 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~----------~~~~---- 739 (914)
. ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||........+.... ++.+
T Consensus 161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 161 K--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred c--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 1 12234578899999998754 46899999999999999999999986432211111100 0000
Q ss_pred --hcCCcccccccccCCCCCHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 740 --KSGDITAILDPVLKLPSDLD-ALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 740 --~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
............+....... ....+.+++.+||+.+|++|||+.|++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000000000000001111 2456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=311.24 Aligned_cols=261 Identities=25% Similarity=0.359 Sum_probs=197.0
Q ss_pred CCHHHHHHHhcc--cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeecee
Q 002512 506 FTYEELERATGG--FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYC 581 (914)
Q Consensus 506 ~~~~el~~~t~~--~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~ 581 (914)
++..++.+++.+ +.+.||+|+||.||++..+ +++.+|+|.+.... ....++.+|+.++.++ +||||+++++++
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~ 88 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence 344444444444 3567999999999999975 58899999874322 2235688899999999 899999999998
Q ss_pred ecC-----CeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC
Q 002512 582 EEG-----RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE 656 (914)
Q Consensus 582 ~~~-----~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~ 656 (914)
... ...++||||+++++|.++++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++++
T Consensus 89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~ 164 (291)
T cd06639 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTE 164 (291)
T ss_pred EeccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCC
Confidence 754 358999999999999999864321 1235788999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcC-----CCCCcchHHHHHHHHHHHHhCCCCcccccccccH
Q 002512 657 HNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH-----YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNI 731 (914)
Q Consensus 657 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l 731 (914)
+.+||+|||++......... .....|+..|+|||.+... .++.++||||||+++|||++|+.||........+
T Consensus 165 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~ 242 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242 (291)
T ss_pred CCEEEeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH
Confidence 99999999998765432211 1234588999999998643 3689999999999999999999998643221111
Q ss_pred HHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 732 VEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 732 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.. +.......+ . ........+.+++.+||+.+|++||++.|+++
T Consensus 243 ~~-----~~~~~~~~~-----~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 FK-----IPRNPPPTL-----L--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HH-----HhcCCCCCC-----C--cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 111111111 1 11223457899999999999999999999875
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=310.87 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=194.8
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
..+.||.|+||.||+++.+ +++.||||++............|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~- 82 (284)
T cd07860 4 KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH- 82 (284)
T ss_pred eeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-
Confidence 3567999999999999976 58899999886544444444679999999999999999999999999999999999996
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++..... ..+++.....++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 83 ~~l~~~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 83 QDLKKFMDASPL---SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 689999875432 35788999999999999999999998 99999999999999999999999999875433221
Q ss_pred CCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC-------------
Q 002512 677 PLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG------------- 742 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~------------- 742 (914)
......++..|+|||++.+. .++.++||||||+++|||+||+.||....+...+..... .....
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR-TLGTPDEVVWPGVTSLPD 233 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-HhCCCChhhhhhhhHHHH
Confidence 12233478899999988664 468899999999999999999999864322221111110 00000
Q ss_pred ---CcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 743 ---DITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 743 ---~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.........+.. .......++.+++.+||+.||++||++++++.
T Consensus 234 ~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 234 YKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000000000000 00112346778999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=303.77 Aligned_cols=250 Identities=27% Similarity=0.354 Sum_probs=202.1
Q ss_pred ccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|++|.||+++.++ ++.|++|++...... ...++|.+|+.++.+++||||+++++++...+..++||||++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMD 82 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecC
Confidence 345789999999999999874 899999987654332 345789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
+++|.+++... ..++...++.++.|++++|+|||+ .+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 83 GGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 99999999754 357888999999999999999999 98 9999999999999999999999999987654333
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
.. .....++..|+|||.+....++.++||||||+++|||+||+.||..... ....+... .+......
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~-~~~~~~~~--------- 221 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQ-AICDGPPP--------- 221 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHH-HHhcCCCC---------
Confidence 22 1234578999999999999999999999999999999999999865432 11111111 11111111
Q ss_pred CCCHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 755 PSDLD-ALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 755 ~~~~~-~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
..+.. .+..+.+++.+||..+|++||++.++++.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11111 44678999999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=309.25 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=190.2
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHH-HHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDL-LSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~-l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||+++.+ +++.||+|++....... ...++..|+.+ ++.++||||+++++++......++||||+
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred eEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 35577999999999999976 58999999876543222 23456667665 55569999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhcc-CCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY-ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~-~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+ ++|.+++..... ....+++...+.++.||+.||+|||++ + ++||||||+|||+++++.+||+|||++......
T Consensus 83 ~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 83 D-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred c-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 6 689888865322 124689999999999999999999987 7 999999999999999999999999998765322
Q ss_pred CCCCCccCCCCcCCccChhhhhc----CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRL----HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~----~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
. ......++..|+|||.+.. ..++.++||||||+++|||++|+.||...... . +...... .+....+
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~-~~~~~~~-~~~~~~~-- 228 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--F-QQLKQVV-EEPSPQL-- 228 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--H-HHHHHHH-hcCCCCC--
Confidence 1 1222458899999998864 45688999999999999999999998532211 1 1111111 1111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+ ....+.++.+++.+||..+|++||++.++++
T Consensus 229 -----~-~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 -----P-AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -----C-ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 1123457889999999999999999998875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-34 Score=309.28 Aligned_cols=261 Identities=25% Similarity=0.295 Sum_probs=196.4
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.+.||.|++|.||++..+ +++.||+|++..........+.|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~- 81 (283)
T cd07835 3 KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD- 81 (283)
T ss_pred hheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-
Confidence 4567999999999999975 68999999886554333444678999999999999999999999999999999999995
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++..... ..+++..++.++.|++++|+|||+.+ ++||||+|+|||+++++.+||+|||+++.......
T Consensus 82 ~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 82 LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 699999875432 35889999999999999999999998 99999999999999999999999999875433221
Q ss_pred CCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC--------Ccccc
Q 002512 677 PLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG--------DITAI 747 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~--------~~~~~ 747 (914)
......++..|+|||++... .++.++||||||+++|||++|+.||........+........... .+.+.
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhh
Confidence 11223468899999988654 578999999999999999999999864322221111111000000 00000
Q ss_pred cccccCC------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 748 LDPVLKL------PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 748 ~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
....... .........+.+++.+||+.+|++||+++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000000 001122357889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=304.32 Aligned_cols=249 Identities=22% Similarity=0.372 Sum_probs=198.8
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||++..+ ++..+|+|.+..........+.+.+|++++++++||||+++++.+.+....++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 35678999999999999976 47889999876543333445678899999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC-cEEEeecCCcccCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-NARVADFGLSLLGPADS 674 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kl~DFGla~~~~~~~ 674 (914)
+++|.+++..... ..+++..++.++.|++++|+|||+.+ |+|+||||+||++++++ .+||+|||.+.......
T Consensus 83 ~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 83 GGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999975432 24789999999999999999999999 99999999999999885 46999999987654322
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. ......|++.|+|||++....++.++||||||+++|||++|+.||.... ..+...... ......+
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~-~~~~~~~------- 222 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN----LHQLVLKIC-QGYFAPI------- 222 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHh-cccCCCC-------
Confidence 1 1223458899999999998889999999999999999999999985322 112221111 1111111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.......+.+++.+||..+|++|||+.|++.
T Consensus 223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred --CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1123357889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=310.85 Aligned_cols=260 Identities=18% Similarity=0.210 Sum_probs=183.9
Q ss_pred HhcccccccCcccceEEEEEEEcCC----cEEEEEEeeeccccccc---------hHHHHHHHHHHHhccCCceeeeece
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLKDG----TVVAVKKAIATSDRQKN---------SKEFHTELDLLSRLNHAHLLNLLGY 580 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~~~----~~vavK~~~~~~~~~~~---------~~~f~~E~~~l~~l~HpnIv~l~g~ 580 (914)
..+.+.+.||+|+||.||+|...+. ..+|+|+.......... ......+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 3456678899999999999997653 45566643222111000 0112334455666789999999997
Q ss_pred eecCC----eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC
Q 002512 581 CEEGR----ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE 656 (914)
Q Consensus 581 ~~~~~----~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~ 656 (914)
+.... ..++++|++. .++.+.+.... ..++.....|+.|+++||+|||+.+ |+||||||+|||++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 75543 4578888774 46766665322 2456778899999999999999998 9999999999999999
Q ss_pred CcEEEeecCCcccCCCCCCC-----CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccH
Q 002512 657 HNARVADFGLSLLGPADSSS-----PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNI 731 (914)
Q Consensus 657 ~~~kl~DFGla~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l 731 (914)
+.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||+||||++|+.||........+
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999765332211 1122346999999999999999999999999999999999999999754333322
Q ss_pred HHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 732 VEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 732 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
.......+ +..+....+..+ ....++.+++..|++.+|++||+++++.+.|
T Consensus 243 ~~~~~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDF----IKRLHEGKIKIK---NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHH----HHHhhhhhhccC---CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 22111100 011111111111 2246788999999999999999999999876
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=303.49 Aligned_cols=251 Identities=25% Similarity=0.437 Sum_probs=196.6
Q ss_pred ccccCcccceEEEEEEE-cCCcEEEEEEeeecccc----ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 519 KEEVGKGSFSCVYKGVL-KDGTVVAVKKAIATSDR----QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
.+.||+|+||.||++.. .+++.+|+|++...... ....+.|.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~ 84 (268)
T cd06630 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84 (268)
T ss_pred cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence 46799999999999986 46889999987543311 12346799999999999999999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC-cEEEeecCCcccCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-NARVADFGLSLLGPA 672 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kl~DFGla~~~~~ 672 (914)
+++++|.+++.+.. .+++...+.++.|++.||.|||+++ ++|+||||+||+++.++ .+||+|||++.....
T Consensus 85 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 85 MAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred cCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999997542 4788889999999999999999999 99999999999998775 599999999876543
Q ss_pred CCCC--CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 673 DSSS--PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 673 ~~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
.... .......++..|+|||.+....++.++||||||+++|||++|+.||........ ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~-------- 227 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFKIASAT-------- 227 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHHHhccC--------
Confidence 3211 112234588999999999888899999999999999999999999864322111 11111110000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....+.....++.+++.+||..+|++||++.+++.
T Consensus 228 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 -TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011122234467889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=311.39 Aligned_cols=244 Identities=22% Similarity=0.327 Sum_probs=194.4
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
..||+|+||.||++... +++.||||++.... ....+.|.+|+.++++++||||+++++.+...+..++||||+++++
T Consensus 28 ~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 45999999999999875 58899999874432 2334678999999999999999999999999999999999999999
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
|.+++... .+++.....++.||+.||+|||+++ |+||||||+||++++++.+||+|||++........ .
T Consensus 106 L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 174 (292)
T cd06658 106 LTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--K 174 (292)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--c
Confidence 99988532 4788889999999999999999999 99999999999999999999999999875433221 1
Q ss_pred ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
.....|+..|+|||.+....++.++||||||+++|||++|+.||........ . ..+.. ...+.... ..
T Consensus 175 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~----~-~~~~~-----~~~~~~~~--~~ 242 (292)
T cd06658 175 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA----M-RRIRD-----NLPPRVKD--SH 242 (292)
T ss_pred CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----H-HHHHh-----cCCCcccc--cc
Confidence 2234588999999999888899999999999999999999999864321111 1 11111 11111111 11
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.....+..++.+||..+|.+|||++|+++.
T Consensus 243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 243 KVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 233467889999999999999999998863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.00 Aligned_cols=253 Identities=27% Similarity=0.390 Sum_probs=191.6
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhcc-CCceeeeeceeecCCeEEEEEeeCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
.++||+|+||.||++... +++.+|+|++...... .....+.+|+.++.++. ||||+++++++......+++|||+.
T Consensus 9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~- 86 (288)
T cd06616 9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD- 86 (288)
T ss_pred HHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-
Confidence 356999999999999975 5899999987644322 34467899999999996 9999999999999999999999986
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhcc-CCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY-ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~-~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
++|.++...........+++....+++.|++.||+|||+. + |+||||||+|||++.++.+||+|||+++.......
T Consensus 87 ~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 163 (288)
T cd06616 87 ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA 163 (288)
T ss_pred CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCc
Confidence 4665543211111123588889999999999999999975 7 99999999999999999999999999875433221
Q ss_pred CCCccCCCCcCCccChhhhhcC---CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 676 SPLAELPAGTLGYLDPEYYRLH---YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~---~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
.....|+..|+|||++... .++.++||||||+++|||++|+.||.... ...+....... +. .+.+
T Consensus 164 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~-~~-----~~~~ 231 (288)
T cd06616 164 ---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVK-GD-----PPIL 231 (288)
T ss_pred ---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcC-CC-----CCcC
Confidence 1223588999999999776 68999999999999999999999986432 11111111111 11 1111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
........+.++.+|+.+||+.+|++|||+++|+..
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 112222355688999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=298.57 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=202.6
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC--CeEEEEEeeC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RERLLVYEFM 594 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey~ 594 (914)
..+.||+|++|.||+|..+ +++.|++|++..........+.+.+|+.++++++||||+++++.+.+. +..++||||+
T Consensus 4 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 83 (260)
T cd06606 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83 (260)
T ss_pred eeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEec
Confidence 3467999999999999987 688999998866544344568899999999999999999999999988 8999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++.... .+++..++.++.|++++|+|||+.+ ++|+||+|+||++++++.+||+|||.+.......
T Consensus 84 ~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 84 SGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999997543 5889999999999999999999998 9999999999999999999999999987765443
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
.........++..|+|||.+.....+.++||||||+++|||++|+.||.... .................
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~-------- 224 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---NPMAALYKIGSSGEPPE-------- 224 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHhccccCCCcC--------
Confidence 2111233468899999999998889999999999999999999999986433 11111111111011111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+......+.+++.+|+..+|++||++.+++.
T Consensus 225 -~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 225 -IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11122568899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=312.01 Aligned_cols=267 Identities=20% Similarity=0.265 Sum_probs=195.1
Q ss_pred ccccccCcccceEEEEEEEcC---CcEEEEEEeeecc-ccccchHHHHHHHHHHHhccCCceeeeeceeecC--CeEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD---GTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RERLLV 590 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV 590 (914)
.+.++||+|+||.||+|+.+. ++.||+|.+.... ......+.+.+|+.++++++||||+++++++.+. +..+||
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 356779999999999999754 7899999886533 1223346788999999999999999999999988 789999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC----CCcEEEeecCC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE----EHNARVADFGL 666 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~----~~~~kl~DFGl 666 (914)
|||+++ +|.+++..........++......++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~ 158 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGL 158 (316)
T ss_pred EeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence 999975 7777775433222235788889999999999999999999 999999999999999 89999999999
Q ss_pred cccCCCCCC-CCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCccccccccc--------HHHHHH
Q 002512 667 SLLGPADSS-SPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGN--------IVEWAV 736 (914)
Q Consensus 667 a~~~~~~~~-~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~--------l~~~~~ 736 (914)
+........ ........++..|+|||.+.+ ..++.++||||||++||||++|+.||........ ....+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 976543322 112233457899999998876 4578999999999999999999999864332210 000000
Q ss_pred hhhh------------cCCcccccccccCCCCC---H--------HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 737 PLIK------------SGDITAILDPVLKLPSD---L--------DALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 737 ~~~~------------~~~~~~~~d~~l~~~~~---~--------~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+. ..+.....+.......+ . ....++.+++.+||+.+|++|||+.|+++
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000 00000000000000000 0 22346889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=303.81 Aligned_cols=247 Identities=23% Similarity=0.305 Sum_probs=199.0
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccc-cchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQ-KNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||.|+||.||++..+ +++.+|+|.+....... ...+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 45678999999999999976 58899999886543222 34578999999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++... ..++......++.|++++|.|||+.+ |+|+||||+||++++++.++|+|||++.......
T Consensus 83 ~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 83 LGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 999999999754 24788889999999999999999999 9999999999999999999999999987654432
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
......|+..|+|||.+....++.++||||||+++|+|++|+.||...... ........... . ..
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~--------~--~~ 219 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET--------A--DV 219 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc--------c--cc
Confidence 122345889999999999888999999999999999999999998754321 11111111111 0 01
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCH--HHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSM--DKVT 786 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~--~ev~ 786 (914)
..+......+.+++.+||+.+|.+||++ +|++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112234688899999999999999999 5543
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=330.21 Aligned_cols=254 Identities=17% Similarity=0.239 Sum_probs=185.1
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccC------CceeeeeceeecC-CeE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH------AHLLNLLGYCEEG-RER 587 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~H------pnIv~l~g~~~~~-~~~ 587 (914)
+.+.++||+|+||+||++++. .++.||||++.... ....++..|++++.+++| ++|+++++++... ...
T Consensus 131 y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred EEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 455678999999999999975 47889999875322 223456778888877755 4589999988765 467
Q ss_pred EEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceEEcCCC---------
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNILIDEEH--------- 657 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NILl~~~~--------- 657 (914)
+||||++ +++|.+++.+.. .+++..+..|+.||+.||+|||+ .+ ||||||||+||||+.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred EEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccccc
Confidence 8999988 789999887543 47888999999999999999997 48 99999999999998765
Q ss_pred -------cEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCccccccccc
Q 002512 658 -------NARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGN 730 (914)
Q Consensus 658 -------~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~ 730 (914)
.+||+|||++..... ......||+.|||||++.+..++.++|||||||+||||++|+.||........
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~ 353 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEH 353 (467)
T ss_pred ccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 499999998754221 22345799999999999999999999999999999999999999964322111
Q ss_pred HHHHHHhh--------------------hhc-CCcccccccc-----cC--CCCCHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002512 731 IVEWAVPL--------------------IKS-GDITAILDPV-----LK--LPSDLDALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 731 l~~~~~~~--------------------~~~-~~~~~~~d~~-----l~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
+. .+... +.. +.+....++. .. ..........+.+|+.+||+.||++|||+
T Consensus 354 ~~-~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 354 LH-LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HH-HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 11 00000 000 0000000000 00 00001113467899999999999999999
Q ss_pred HHHHH
Q 002512 783 DKVTT 787 (914)
Q Consensus 783 ~ev~~ 787 (914)
+|+++
T Consensus 433 ~e~L~ 437 (467)
T PTZ00284 433 RQMTT 437 (467)
T ss_pred HHHhc
Confidence 99885
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=307.79 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=190.3
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeec------CCeEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEE------GRERLL 589 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~------~~~~~L 589 (914)
+.+.||+|+||.||+++.. +++.+|+|...... ....++..|+.++.++ +||||+++++++.. .+..++
T Consensus 20 ~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~i 96 (282)
T cd06636 20 LVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWL 96 (282)
T ss_pred hheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEE
Confidence 4567999999999999975 57889999764332 2336788999999999 79999999999853 457899
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||+|||++..
T Consensus 97 v~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 97 VMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred EEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 9999999999999975332 24677788899999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhh-----cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCc
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYR-----LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDI 744 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 744 (914)
...... ......|+..|+|||.+. ...++.++||||||+++|||++|+.||.......... . +...
T Consensus 171 ~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~----~-~~~~-- 241 (282)
T cd06636 171 LDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF----L-IPRN-- 241 (282)
T ss_pred hhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh----h-HhhC--
Confidence 432211 123346889999999986 3467889999999999999999999986432111111 0 0000
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+. ......+..+.+++.+||+.+|.+||++.|+++
T Consensus 242 ---~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 242 ---PPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ---CCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000 111134467899999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=309.61 Aligned_cols=263 Identities=23% Similarity=0.270 Sum_probs=193.8
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCe-----EEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRE-----RLLV 590 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~-----~~LV 590 (914)
+.+.||+|+||.||++... +++.||+|+.............+.+|+.+++++ +||||+++++++...+. .|+|
T Consensus 5 ~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv 84 (295)
T cd07837 5 KLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLV 84 (295)
T ss_pred EeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEE
Confidence 4567999999999999976 588999998765443333446789999999999 56999999999987665 8999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC-CCcEEEeecCCccc
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE-EHNARVADFGLSLL 669 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kl~DFGla~~ 669 (914)
|||+++ +|.+++..........+++...+.++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 85 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~ 160 (295)
T cd07837 85 FEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160 (295)
T ss_pred eeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeeccccee
Confidence 999985 8999987543322346889999999999999999999999 999999999999998 88999999999875
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCc----
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDI---- 744 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~---- 744 (914)
...... ......+++.|+|||++.. ..++.++||||||+++|||++|+.||........+.... ..+.....
T Consensus 161 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (295)
T cd07837 161 FSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF-KLLGTPTEQVWP 237 (295)
T ss_pred cCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-HHhCCCChhhCc
Confidence 433211 1122346889999998865 457899999999999999999999986432211111111 00000000
Q ss_pred --ccccc----cccCC----CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 --TAILD----PVLKL----PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 --~~~~d----~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
....+ +.... ...+....++.+++.+||+.+|.+||++.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 238 GVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred chhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 00000 000123467889999999999999999998874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=314.49 Aligned_cols=244 Identities=26% Similarity=0.380 Sum_probs=195.2
Q ss_pred ccCcccceEEEEEEEcCC-cEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 521 EVGKGSFSCVYKGVLKDG-TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
.||+|.||+||.|++.+. ..+|||.+..... +..+-+++|+.+.++|+|+|||+++|.+.++..+-|.||-+|||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 499999999999998764 5689997754433 3346789999999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhccc--chhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEc-CCCcEEEeecCCcccCCCCCCC
Q 002512 600 HQHLHGKSKALKEQL--DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID-EEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l--~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~-~~~~~kl~DFGla~~~~~~~~~ 676 (914)
.++|+..=. ++ .....-.+..||++||.|||++. |||||||-+|+|++ -.|.+||+|||-++.+.. .+
T Consensus 660 SsLLrskWG----PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--in 730 (1226)
T KOG4279|consen 660 SSLLRSKWG----PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--IN 730 (1226)
T ss_pred HHHHHhccC----CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CC
Confidence 999975422 23 34455667899999999999999 99999999999996 578899999999876533 33
Q ss_pred CCccCCCCcCCccChhhhhcC--CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLH--YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~--~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
+.+.+..||..|||||++..+ .|..++|||||||++.||.||++||....+.. ...++-|-.. ...
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq------AAMFkVGmyK------vHP 798 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ------AAMFKVGMYK------VHP 798 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh------Hhhhhhccee------cCC
Confidence 455667799999999999755 58899999999999999999999996432221 1122222111 122
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+.+.+...+...++.+|+..+|.+||++.+++.
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 334566788999999999999999999998864
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=307.18 Aligned_cols=236 Identities=24% Similarity=0.330 Sum_probs=192.3
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||++... +++.+|+|++..... ..+..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 4 ~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (290)
T cd05580 4 EFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYV 83 (290)
T ss_pred EEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecC
Confidence 45678999999999999976 589999998754322 2234567899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++.... .++...+..++.|+++||.|||+.+ |+|+||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 84 PGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred CCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999997642 4788889999999999999999999 999999999999999999999999998765433
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
.....+++.|+|||.+.....+.++||||||+++|||++|+.||...... .....+..+.. ..
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~--------~~ 217 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-----QIYEKILEGKV--------RF 217 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCc--------cC
Confidence 22335889999999998888899999999999999999999998643211 11111111111 11
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCC
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERP 780 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RP 780 (914)
+ ......+.+++.+||..+|.+||
T Consensus 218 ~--~~~~~~l~~li~~~l~~~p~~R~ 241 (290)
T cd05580 218 P--SFFSPDAKDLIRNLLQVDLTKRL 241 (290)
T ss_pred C--ccCCHHHHHHHHHHccCCHHHcc
Confidence 1 12245788999999999999998
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=304.51 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=197.5
Q ss_pred cCcccceEEEEEEEcC-CcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
||+|+||.||+++..+ ++.+++|.+..... .....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999874 89999998754332 223456799999999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC----
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS---- 675 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~---- 675 (914)
.+++.... .+++..++.++.|++++|+|||+.+ ++|+||+|+|||+++++.+||+|||++........
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 99997543 4788899999999999999999999 99999999999999999999999999876433321
Q ss_pred --CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 676 --SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 676 --~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
........++..|++||.+.....+.++||||||+++|||++|+.||...... +.. ..+..+.. .
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~-~~~~~~~~--------~ 219 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----EIF-QNILNGKI--------E 219 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHH-HHHhcCCc--------C
Confidence 11223345788999999998888899999999999999999999998643211 111 11111111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
.+........+.+++.+||+.+|++|||+.++.+.|+
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 1111112467889999999999999999977776664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=300.30 Aligned_cols=245 Identities=22% Similarity=0.354 Sum_probs=203.5
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.++||+|+||.|||+.++ .|+.+|||++... ...+++..|+.+|++.+.|+||++||.+.....+++|||||--|
T Consensus 38 ~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAG 113 (502)
T KOG0574|consen 38 VGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAG 113 (502)
T ss_pred HHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCC
Confidence 467999999999999976 5999999987543 34688999999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+..+.++-+. ++|+...+-.++...++||+|||... -||||||+.||||+-++.+||+|||.+-.+.... .
T Consensus 114 SiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM--A 184 (502)
T KOG0574|consen 114 SISDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM--A 184 (502)
T ss_pred cHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH--H
Confidence 9999997654 46888899999999999999999998 8999999999999999999999999986554322 1
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
..+...||+.|||||+++.-.|..++||||||++..||..|++|+.+...-..+. -+.. .|......+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF----------MIPT--~PPPTF~KP 252 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF----------MIPT--KPPPTFKKP 252 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE----------eccC--CCCCCCCCh
Confidence 2345679999999999999999999999999999999999999986432211000 0001 122223334
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.+...++-+++..||..+|++|-|+.++.+.
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 5677889999999999999999998887653
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.73 Aligned_cols=248 Identities=23% Similarity=0.328 Sum_probs=197.5
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||.||++... +++.|++|.+.... ....+.|.+|+.++++++||||+++++++...+..++||||+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 345678999999999999864 57889999874332 233467899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......
T Consensus 99 ~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~ 169 (293)
T cd06647 99 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (293)
T ss_pred CCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence 999999999643 3678888999999999999999999 9999999999999999999999999986544332
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
. ......+++.|++||.+....++.++||||||+++|||++|+.||........+.. .... .....
T Consensus 170 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~----~~~~--------~~~~~ 235 (293)
T cd06647 170 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATN--------GTPEL 235 (293)
T ss_pred c--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee----hhcC--------CCCCC
Confidence 2 12233588899999999888899999999999999999999999864322111100 0000 01111
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.........+.+++.+||..+|++||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122334578899999999999999999998854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=306.51 Aligned_cols=260 Identities=24% Similarity=0.312 Sum_probs=191.2
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||++... +++.||+|++..... ......+.+|+.++++++|+||+++++++.+++..++||||+.
T Consensus 8 ~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 8 LNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred EEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 34577999999999999875 588999998754432 2333578899999999999999999999999999999999996
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
++|.+++.... ..+++.....++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 87 -~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 87 -TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred -CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 78877775432 24677778889999999999999999 99999999999999999999999999875432211
Q ss_pred CCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC---------Ccc
Q 002512 676 SPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG---------DIT 745 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~---------~~~ 745 (914)
......+++.|+|||++.+. .++.++||||||++||||++|+.||................+... ...
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (291)
T cd07870 159 --TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP 236 (291)
T ss_pred --CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc
Confidence 12233578999999998754 578899999999999999999999864322111111110000000 000
Q ss_pred cccccccCC--C-------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 746 AILDPVLKL--P-------SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 746 ~~~d~~l~~--~-------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
...+..... + ........+.+++.+|+..+|++|||+.|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 237 NYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred cccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000 0 00112356789999999999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=304.67 Aligned_cols=244 Identities=20% Similarity=0.263 Sum_probs=186.2
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHh---ccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSR---LNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~---l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.||+|+||.||++... +++.+|+|.+...... ......+.+|..++.. .+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999975 5889999987654322 1222334555544444 379999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 999999987542 4889999999999999999999999 9999999999999999999999999986543221
Q ss_pred CCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
.....|+..|+|||.+.. ..++.++||||||+++|||++|+.||........ ......... ...
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~----------~~~ 216 (279)
T cd05633 152 ---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLT----------VNV 216 (279)
T ss_pred ---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhc----------CCc
Confidence 123458999999999864 5688999999999999999999999964322211 111111000 001
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERP-----SMDKVTTA 788 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~~ 788 (914)
..+.....++.+++.+||+.+|++|| +++|+++.
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 11122346788999999999999999 57777553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=301.93 Aligned_cols=239 Identities=23% Similarity=0.277 Sum_probs=191.9
Q ss_pred cCcccceEEEEEEEcC-CcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
||.|+||.||+++... ++.+++|++...... ....+.|.+|++++++++||||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999864 889999987654322 23346799999999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCc
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 679 (914)
.+++.+.. .+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~ 149 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KT 149 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cc
Confidence 99997643 3788888999999999999999998 9999999999999999999999999987654332 12
Q ss_pred cCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHH
Q 002512 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLD 759 (914)
Q Consensus 680 ~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 759 (914)
....++..|++||.+....++.++|+||||+++|||++|+.||.....+ ..+......... .....+..
T Consensus 150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~---------~~~~~~~~ 218 (262)
T cd05572 150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED--PMEIYNDILKGN---------GKLEFPNY 218 (262)
T ss_pred ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC--HHHHHHHHhccC---------CCCCCCcc
Confidence 2335789999999998888999999999999999999999998654321 111111111100 01111112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCH
Q 002512 760 ALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 760 ~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
...++.+++.+||+.+|++||++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCC
Confidence 25688999999999999999993
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=305.60 Aligned_cols=244 Identities=20% Similarity=0.307 Sum_probs=203.1
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.+.||+|.|+.|-++++- .|+.||||++.+..........+.+|++.|+.++|||||+||.+......+|||+|+=.+|
T Consensus 23 ekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~G 102 (864)
T KOG4717|consen 23 EKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGG 102 (864)
T ss_pred hhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCc
Confidence 356999999999999854 6999999998776655555567899999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccce-EEcCCCcEEEeecCCcccCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI-LIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NI-Ll~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
+|++||-+.. +.+......+++.||+.|+.|.|..+ +|||||||+|+ ++.+-|-+||.|||++..+.+...
T Consensus 103 Dl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k- 174 (864)
T KOG4717|consen 103 DLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK- 174 (864)
T ss_pred hHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcch-
Confidence 9999997653 35777888899999999999999999 99999999996 556778899999999977665442
Q ss_pred CCccCCCCcCCccChhhhhcCCCC-CcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLT-TKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s-~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
.+..+|+..|-|||++.+..|. ++.||||||||||.|++|+.||+...+.+.+. .++|-.+..
T Consensus 175 --L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT-------------mImDCKYtv- 238 (864)
T KOG4717|consen 175 --LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT-------------MIMDCKYTV- 238 (864)
T ss_pred --hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh-------------hhhcccccC-
Confidence 3446899999999999887654 68999999999999999999997544333222 334433333
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+.....+..+||..||..||++|.+.+||+.
T Consensus 239 -PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 239 -PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred -chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 3355678899999999999999999999864
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=332.05 Aligned_cols=268 Identities=19% Similarity=0.221 Sum_probs=185.1
Q ss_pred HhcccccccCcccceEEEEEEEcC--CcEEEEEE--------------eee-ccccccchHHHHHHHHHHHhccCCceee
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLKD--GTVVAVKK--------------AIA-TSDRQKNSKEFHTELDLLSRLNHAHLLN 576 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~~--~~~vavK~--------------~~~-~~~~~~~~~~f~~E~~~l~~l~HpnIv~ 576 (914)
..+.+.++||+|+||+||++.++. +...++|. +.. ..........|.+|+++|++++|||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 446677889999999999987642 22222220 100 0111123356889999999999999999
Q ss_pred eeceeecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC
Q 002512 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE 656 (914)
Q Consensus 577 l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~ 656 (914)
+++++.+.+..|+|+|++. ++|.+++..................|+.||+.||+|||+++ ||||||||+||||+.+
T Consensus 228 l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~ 303 (501)
T PHA03210 228 IEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCD 303 (501)
T ss_pred EeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence 9999999999999999985 68888876543221222334566789999999999999999 9999999999999999
Q ss_pred CcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH
Q 002512 657 HNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV 736 (914)
Q Consensus 657 ~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~ 736 (914)
+.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||+||||++|+.++......... ....
T Consensus 304 ~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~-~~~~ 381 (501)
T PHA03210 304 GKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG-KQLL 381 (501)
T ss_pred CCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH-HHHH
Confidence 99999999999765433221 222346999999999999999999999999999999999998543221111110 0111
Q ss_pred hhhhcCC--ccccccc-----------cc-----CCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 737 PLIKSGD--ITAILDP-----------VL-----KLPS---DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 737 ~~~~~~~--~~~~~d~-----------~l-----~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+..-. ..++.+. .+ ..+. .......+.+++.+||+.||.+|||+.|++.
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1110000 0000000 00 0000 0011245677899999999999999999975
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=307.39 Aligned_cols=260 Identities=22% Similarity=0.284 Sum_probs=193.3
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||+++.+ +++.||+|++..........+.|.+|++++++++||||+++++++.+.+..++||||++
T Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (294)
T PLN00009 5 EKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD 84 (294)
T ss_pred EEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc
Confidence 35677999999999999976 68899999876544333444678999999999999999999999999999999999996
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC-CCcEEEeecCCcccCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE-EHNARVADFGLSLLGPADS 674 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kl~DFGla~~~~~~~ 674 (914)
++|.+++..... ..+++.....++.||+.||+|||+++ |+||||||+||++++ +..+||+|||++.......
T Consensus 85 -~~l~~~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 85 -LDLKKHMDSSPD---FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred -ccHHHHHHhCCC---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 588888864332 23567777889999999999999998 999999999999985 5679999999997543321
Q ss_pred CCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccc------
Q 002512 675 SSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI------ 747 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~------ 747 (914)
. ......+++.|+|||++.+ ..++.++||||||+++|||+||+.||......+.+.... ..+... ....
T Consensus 158 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~ 233 (294)
T PLN00009 158 R--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIF-RILGTP-NEETWPGVTS 233 (294)
T ss_pred c--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhCCC-Chhhcccccc
Confidence 1 1223457889999999876 457899999999999999999999986432222221111 000000 0000
Q ss_pred -cc-----cccCCC----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 748 -LD-----PVLKLP----SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 748 -~d-----~~l~~~----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+ +..... .......++.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 000000 01123356789999999999999999999885
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=296.37 Aligned_cols=246 Identities=25% Similarity=0.412 Sum_probs=199.5
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
..+.||+|+||.||++..+ +++.+++|++..... ...+.+.+|++++++++||||+++++++...+..++++||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 4 ILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred eeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 4567999999999999986 688999998865433 3457899999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++.... ..+++..+..++.|++.+|+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 82 GSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999987642 35889999999999999999999988 99999999999999999999999999876554332
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 756 (914)
.....++..|++||++....++.++||||||+++|||++|+.||......... .. ......... +.
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~-~~~~~~~~~-------~~ 219 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL----FK-IATNGPPGL-------RN 219 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH----HH-HHhcCCCCc-------Cc
Confidence 23346889999999999888999999999999999999999998643211111 11 111111111 11
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 757 DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 757 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.......+.+++.+||+.+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112457889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.21 Aligned_cols=245 Identities=25% Similarity=0.382 Sum_probs=197.5
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.+.||+|+||.||++.++ +++.+++|++..... ..+.+.+|++++++++|+||+++++++...+..++||||++++
T Consensus 24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 100 (286)
T cd06614 24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGG 100 (286)
T ss_pred hHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCC
Confidence 456999999999999987 688999998754332 3477999999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.+++.... ..+++..++.++.|++.+|+|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 101 ~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 171 (286)
T cd06614 101 SLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS-- 171 (286)
T ss_pred cHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh--
Confidence 9999998653 25889999999999999999999998 99999999999999999999999998865433221
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
......++..|++||++....++.++||||||+++|||++|+.|+.......... . +....... .+..
T Consensus 172 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~----~-~~~~~~~~-------~~~~ 239 (286)
T cd06614 172 KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF----L-ITTKGIPP-------LKNP 239 (286)
T ss_pred hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH----H-HHhcCCCC-------Ccch
Confidence 1123357889999999988889999999999999999999999985322111111 1 11111111 1111
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
......+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 123467889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=305.87 Aligned_cols=260 Identities=25% Similarity=0.327 Sum_probs=196.6
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC--CeEEEEEeeC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RERLLVYEFM 594 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey~ 594 (914)
+.+.||+|+||.||+++.. +++.+|+|++............+.+|++++++++|||++++++++.+. +..++||||+
T Consensus 3 ~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07840 3 KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYM 82 (287)
T ss_pred eeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccc
Confidence 4577999999999999976 488999999876543344456789999999999999999999999988 8999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||+|||+++++.+||+|||++.......
T Consensus 83 ~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 83 DH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 75 8999887542 25888999999999999999999998 9999999999999999999999999997654432
Q ss_pred CCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC---Ccccc---
Q 002512 675 SSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG---DITAI--- 747 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~---~~~~~--- 747 (914)
. .......++..|+|||.+.+ ..++.++||||||+++|||+||+.||........ ........... ....+
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccc
Confidence 1 11223356889999998764 4578999999999999999999999864332211 11111111000 00000
Q ss_pred -----cccccCCCC------CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 748 -----LDPVLKLPS------DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 748 -----~d~~l~~~~------~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+....+. .......+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000 0012467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=308.87 Aligned_cols=245 Identities=27% Similarity=0.338 Sum_probs=193.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||+++.. +++.||+|++..... .....+++.+|++++++++||||+++++++.+.+..+|||||+
T Consensus 18 ~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 97 (307)
T cd06607 18 TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC 97 (307)
T ss_pred hhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhh
Confidence 34567999999999999975 589999998754332 2233467899999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
+ |+|.+++.... ..+++..+..++.|++.+|.|||+.+ |+||||+|+||++++++.+||+|||++......
T Consensus 98 ~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 98 L-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred C-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 7 68878775432 25788999999999999999999999 999999999999999999999999998764322
Q ss_pred CCCCccCCCCcCCccChhhhh---cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 675 SSPLAELPAGTLGYLDPEYYR---LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~---~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
....++..|+|||++. ...++.++||||||+++|||+||+.||...... .... .+.......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~----~~~~-~~~~~~~~~----- 233 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALY-HIAQNDSPT----- 233 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH----HHHH-HHhcCCCCC-----
Confidence 2235788999999874 456889999999999999999999998532111 1111 111111100
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.........+.+++.+||+.+|++||++.+++..
T Consensus 234 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 234 ---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0112345678999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=303.14 Aligned_cols=243 Identities=23% Similarity=0.291 Sum_probs=191.1
Q ss_pred cCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 522 VGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
||+|+||+||++..+ +++.+|+|.+...... ......|.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999865 5889999987643321 22345678999999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCc
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 679 (914)
.+++..... ..+++..++.++.|++.+|.|||+.+ ++||||||+|||+++++.+||+|||++....... ..
T Consensus 81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 151 (277)
T cd05577 81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KI 151 (277)
T ss_pred HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---cc
Confidence 999975432 35788899999999999999999999 9999999999999999999999999987654321 12
Q ss_pred cCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHH
Q 002512 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLD 759 (914)
Q Consensus 680 ~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 759 (914)
....++..|+|||++....++.++||||||+++|||++|+.||........... ....... . ....+..
T Consensus 152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~--------~--~~~~~~~ 220 (277)
T cd05577 152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE-LKRRTLE--------M--AVEYPDK 220 (277)
T ss_pred ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH-HHhcccc--------c--cccCCcc
Confidence 234578899999999888899999999999999999999999864332111111 1000000 0 0011112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHH
Q 002512 760 ALKRIANVACKCVRMRGKERPSMDK 784 (914)
Q Consensus 760 ~~~~l~~l~~~Cl~~~p~~RPs~~e 784 (914)
....+.+++.+||+.+|.+||+.+|
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCc
Confidence 3457889999999999999996555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=303.13 Aligned_cols=245 Identities=24% Similarity=0.361 Sum_probs=196.6
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.++||+|+||.||++..+ +++.+|+|...... .....+.|.+|+.++++++||||+++++++.+++..++||||+++
T Consensus 8 ~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 86 (277)
T cd06641 8 KLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGG 86 (277)
T ss_pred hheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCC
Confidence 4567999999999999865 58899999764332 223446799999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++... .+++.....++.|++.+|.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 87 ~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 87 GSALDLLEPG------PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999998642 4788889999999999999999999 99999999999999999999999999876533211
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 756 (914)
......++..|+|||++....++.++||||||+++|||++|+.|+...... . ....+...... ..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~----~~~~~~~~~~~---------~~ 221 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-K----VLFLIPKNNPP---------TL 221 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-H----HHHHHhcCCCC---------CC
Confidence 122345788999999999888899999999999999999999998532211 1 11111111110 01
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 757 DLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 757 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.......+.+++.+||+.+|.+||++.+++..
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11234578899999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=308.31 Aligned_cols=246 Identities=24% Similarity=0.350 Sum_probs=193.8
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
.+.||+|+||.||+++.. +++.+|+|++..... ......+|.+|++++++++|||++++++++.+.+..+|||||++
T Consensus 30 ~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 108 (317)
T cd06635 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL- 108 (317)
T ss_pred hheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-
Confidence 456999999999999975 588999998754322 22334678999999999999999999999999999999999997
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
|+|.+++.... ..+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 109 g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 109 GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 58888775432 35889999999999999999999999 999999999999999999999999998654321
Q ss_pred CCccCCCCcCCccChhhhh---cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 677 PLAELPAGTLGYLDPEYYR---LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~---~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
....+++.|+|||++. ...++.++||||||+++|||++|+.||........+. .+..... .
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-----~~~~~~~--------~ 242 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQNES--------P 242 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH-----HHHhccC--------C
Confidence 2235888999999984 4568899999999999999999999985432111111 1111111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
..........+.+++.+||+.+|.+||++.++++.+..
T Consensus 243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 11112334578899999999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=315.62 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=197.3
Q ss_pred ccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
++...||.|+||.||++..++...+|.-+.+... ...+.++|+-|++||+..+||+||+|++.|..++.++|+.|||.|
T Consensus 35 eIiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 35 EIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 3455799999999999998876655544443332 345678999999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
|-.+..+-.-. ..|+..++.-++.|+++||.|||++. |||||||+.|||++-+|.++|+|||.+...... .
T Consensus 114 GAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~ 184 (1187)
T KOG0579|consen 114 GAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R 184 (1187)
T ss_pred chHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence 99998876543 36888899999999999999999999 999999999999999999999999998543221 1
Q ss_pred CCccCCCCcCCccChhhh-----hcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 677 PLAELPAGTLGYLDPEYY-----RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l-----~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
.......|||.|||||++ +..+|+.++|||||||+|.||..+.+|.... +....+....++. .|.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel----npMRVllKiaKSe------PPT 254 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL----NPMRVLLKIAKSE------PPT 254 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc----chHHHHHHHhhcC------CCc
Confidence 223456799999999987 4568999999999999999999999886432 2222222221111 122
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+. .+......+.+++.+||..+|..||++.++++
T Consensus 255 Ll--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 LL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 22 23355678899999999999999999998864
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=300.47 Aligned_cols=249 Identities=24% Similarity=0.381 Sum_probs=202.2
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.++||+|+||.||+++.+ +++.+++|++...........++.+|++++++++||||+++++++.+....++||||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 34678999999999999865 57899999886544444455788999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++.+... ....+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 83 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-- 156 (256)
T cd08530 83 FGDLSKAISKRKK-KRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-- 156 (256)
T ss_pred CCCHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC--
Confidence 9999999876321 2245788899999999999999999999 999999999999999999999999999776543
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
......++..|++||.+....++.++|+||||+++|||++|+.||...... .+ ...+..+....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-~~----~~~~~~~~~~~--------- 220 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-DL----RYKVQRGKYPP--------- 220 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH----HHHHhcCCCCC---------
Confidence 122245789999999999988999999999999999999999998643211 11 11111211111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.......++.+++.+|++.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=303.57 Aligned_cols=243 Identities=22% Similarity=0.335 Sum_probs=194.5
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
+.||+|+||.||++..+ +++.+++|++.... ....+.+.+|+.++++++||||+++++++...+..++|+||+++++
T Consensus 25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~ 102 (285)
T cd06648 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGA 102 (285)
T ss_pred eEeccCCCeEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCC
Confidence 47999999999999965 68899999875432 2234668999999999999999999999999999999999999999
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
|.+++... .+++..+..++.|++.+|+|||+.+ |+||||||+||+++.++.++|+|||++........ .
T Consensus 103 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 103 LTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred HHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 99998752 4788888999999999999999999 99999999999999999999999998865433221 1
Q ss_pred ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
.....|++.|+|||.+....++.++||||||+++|||++|+.||..... ..... .+.... .+... ...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~~-~~~~~~-----~~~~~--~~~ 239 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAMK-RIRDNL-----PPKLK--NLH 239 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHHH-HHHhcC-----CCCCc--ccc
Confidence 2234588999999999988899999999999999999999999853211 11111 111111 11111 111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....+.+++.+||+.+|++||++.++++
T Consensus 240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 240 KVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 23457899999999999999999998874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=301.02 Aligned_cols=250 Identities=26% Similarity=0.400 Sum_probs=193.8
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCC------eEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGR------ERL 588 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~------~~~ 588 (914)
.+.+.||+|+||.||++..+ +++.+++|.+..... ..++|.+|+.+++++ +||||+++++++.+.. ..+
T Consensus 9 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 9 ELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred eheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 34577999999999999986 578899998754322 346799999999999 7999999999997644 489
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
+||||+++++|.++++.... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 86 lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccce
Confidence 99999999999999865321 1235788899999999999999999999 9999999999999999999999999986
Q ss_pred cCCCCCCCCCccCCCCcCCccChhhhhc-----CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRL-----HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD 743 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~ 743 (914)
...... .......++..|+|||++.. ..++.++||||||++||||++|+.||........+. . +....
T Consensus 162 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~-~~~~~ 234 (275)
T cd06608 162 QLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF----K-IPRNP 234 (275)
T ss_pred ecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH----H-hhccC
Confidence 543322 12233458899999999853 346789999999999999999999986432211111 1 11111
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
. + ...........+.+++.+||..||++|||+.++++
T Consensus 235 ~-----~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 235 P-----P--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred C-----C--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1 1 11122234567889999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=313.38 Aligned_cols=258 Identities=22% Similarity=0.259 Sum_probs=192.7
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC------CeEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG------RERL 588 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~ 588 (914)
+...+.||+|+||.||++... +++.||+|++..........+++.+|+.++++++||||+++++++... ...+
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 344577999999999999975 689999998754433333446788999999999999999999988643 3579
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
|||||+. ++|.+++... ++......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 98 lv~e~~~-~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 98 LVMELMD-ANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred EEEeccC-CCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccce
Confidence 9999996 5888887532 677788889999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHH-------------
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA------------- 735 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~------------- 735 (914)
...... ......++..|+|||++.+..++.++||||||+++|||++|+.||.............
T Consensus 167 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 167 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 654322 1223457899999999999999999999999999999999999986432111110000
Q ss_pred -----HhhhhcCC------ccccccccc----CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 736 -----VPLIKSGD------ITAILDPVL----KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 736 -----~~~~~~~~------~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
........ +..+..... ...........+.+++.+||+.||++|||+.|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000 000110000 00001133567889999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=305.86 Aligned_cols=260 Identities=22% Similarity=0.272 Sum_probs=192.6
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC--CeEEEEEee
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RERLLVYEF 593 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV~Ey 593 (914)
.+.+.||+|+||.||++..+ +++.||+|++............+.+|+.++++++|+||+++++++.+. +..++||||
T Consensus 10 ~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~ 89 (309)
T cd07845 10 EKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEY 89 (309)
T ss_pred eEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEec
Confidence 34567999999999999976 589999998865443333334677899999999999999999998765 568999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+. ++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 90 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 90 CE-QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred CC-CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 97 48998887542 35889999999999999999999999 999999999999999999999999999765433
Q ss_pred CCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC--Cc------
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG--DI------ 744 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~--~~------ 744 (914)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........+.. ........ ..
T Consensus 162 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07845 162 AK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL-IIQLLGTPNESIWPGFSD 238 (309)
T ss_pred cC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHhcCCCChhhchhhhc
Confidence 21 1222345788999999865 5678999999999999999999999864322211111 11100000 00
Q ss_pred ----c--cccccccCC-C-CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 ----T--AILDPVLKL-P-SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 ----~--~~~d~~l~~-~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
. .+....... . ........+.+++.+||+.||++|||+++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0 000000000 0 00012456788999999999999999998875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.95 Aligned_cols=269 Identities=25% Similarity=0.360 Sum_probs=207.3
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC------eEEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR------ERLLV 590 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~LV 590 (914)
..+.||+|+||.||+|+.+ .|+.||||.+.... .....+...+|+++|++|+|||||++++.-++.. ...+|
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 3567999999999999965 69999999887655 3445678899999999999999999999866543 67899
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEc--CCCc--EEEeecCC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID--EEHN--ARVADFGL 666 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~--~~~~--~kl~DFGl 666 (914)
||||++|||+..|++..+ ..-|+....+.+..++..||.|||+++ |+||||||.||++- ++++ -||+|||.
T Consensus 96 mEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 999999999999987543 346899999999999999999999999 99999999999883 3344 69999999
Q ss_pred cccCCCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC--C
Q 002512 667 SLLGPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG--D 743 (914)
Q Consensus 667 a~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~--~ 743 (914)
|+.+..+. ......||..|++||.+.. ++|+...|.|||||++||.+||..||.......+..+.++..+... .
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99877654 4556689999999999985 8999999999999999999999999965433333222222222111 1
Q ss_pred ccccccccc--------CCCC----CHHHHHHHHHHHHHhhhcCCCCCC--CHHHHHHHHHHHHHH
Q 002512 744 ITAILDPVL--------KLPS----DLDALKRIANVACKCVRMRGKERP--SMDKVTTALERALAQ 795 (914)
Q Consensus 744 ~~~~~d~~l--------~~~~----~~~~~~~l~~l~~~Cl~~~p~~RP--s~~ev~~~L~~~l~~ 795 (914)
+....++.. .+|. .......+-+.+..+|..+|++|- ...+....+..+++.
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 111111111 1122 123446677888888999999998 777777777766654
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=306.63 Aligned_cols=262 Identities=20% Similarity=0.233 Sum_probs=192.7
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
+.+|.|+++.||++.. +++.||||++..........+.+.+|++++++++||||+++++++.+.+..+++|||+++++|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3455566666666555 589999999865533444567899999999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC----
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS---- 675 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~---- 675 (914)
.++++.... ..+++.....++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.+........
T Consensus 87 ~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 87 EDLLKTHFP---EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred HHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999975432 24778888899999999999999999 99999999999999999999999998864432211
Q ss_pred -CCCccCCCCcCCccChhhhhcC--CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhh----hcC------
Q 002512 676 -SPLAELPAGTLGYLDPEYYRLH--YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLI----KSG------ 742 (914)
Q Consensus 676 -~~~~~~~~Gt~~y~aPE~l~~~--~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~----~~~------ 742 (914)
........++..|+|||++... .++.++||||||+++|||++|+.||........+.+...... ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 1112233477899999999763 578999999999999999999999864322222211110000 000
Q ss_pred -Cccc----ccccc----cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 743 -DITA----ILDPV----LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 743 -~~~~----~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.... ..++. ...........++.+++.+||+.+|++|||++++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 0111122334678899999999999999999998864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=300.83 Aligned_cols=245 Identities=26% Similarity=0.385 Sum_probs=194.8
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhcc---CCceeeeeceeecCCeEEEEEee
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN---HAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.||+|+||.||+|.+. +++.+|+|.+.... .....+++.+|+.++++++ ||||+++++++.+....++||||
T Consensus 5 ~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06917 5 RLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEY 83 (277)
T ss_pred hhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEec
Confidence 3467999999999999974 68899999875432 2334567899999999997 99999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++++|.++++.. .+++...+.++.|++.+|.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 84 ~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 84 AEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred CCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 9999999998643 4788899999999999999999999 999999999999999999999999998765443
Q ss_pred CCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
.. ......|+..|+|||++.. ..++.++||||||+++|||++|+.||...... ... ..+... ..+.+
T Consensus 155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~-~~~~~~-----~~~~~ 222 (277)
T cd06917 155 SS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF----RAM-MLIPKS-----KPPRL 222 (277)
T ss_pred cc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh----hhh-hccccC-----CCCCC
Confidence 32 1223458899999999875 45789999999999999999999998643211 110 011110 01111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.. .....++.+++.+||+.+|++||++.+++.
T Consensus 223 ~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 223 ED---NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred Cc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 11 113457889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.10 Aligned_cols=261 Identities=23% Similarity=0.305 Sum_probs=194.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC----------
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR---------- 585 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~---------- 585 (914)
.+.+.||+|+||.||+|..+ +++.||+|++............+.+|++++++++||||+++++++.+.+
T Consensus 10 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 89 (302)
T cd07864 10 DIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKG 89 (302)
T ss_pred heeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCC
Confidence 35678999999999999986 4889999988655443444467889999999999999999999987655
Q ss_pred eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecC
Q 002512 586 ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 586 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFG 665 (914)
..+|||||+++ +|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 90 ~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 90 AFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred cEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999986 7878776542 25889999999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC-
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD- 743 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~- 743 (914)
++......... ......++..|+|||.+.. ..++.++||||||+++|||++|+.||........+. .+........
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (302)
T cd07864 162 LARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE-LISRLCGSPCP 239 (302)
T ss_pred ccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCh
Confidence 99765443321 1122346788999998865 457899999999999999999999986432211111 1111110000
Q ss_pred --cccc--------cccccCC-----CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 744 --ITAI--------LDPVLKL-----PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 744 --~~~~--------~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
...+ .++.... ......+..+.+++.+||+.+|.+||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0000 0000000 000012467899999999999999999998874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=301.09 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=195.5
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.++||.|+||.||+|+.+ +++.||||++..... ....+.+.+|++++++++||||+++++++.+.+..+|||||+++
T Consensus 4 ~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 4 QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred EeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 4578999999999999986 588999998865432 23346788999999999999999999999999999999999985
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
+|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 -~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 83 -DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred -cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 89998875432 235899999999999999999999999 99999999999999999999999999875433211
Q ss_pred CCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC---------Cccc
Q 002512 677 PLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG---------DITA 746 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~---------~~~~ 746 (914)
......++..|++||.+... .++.++||||||+++|||++|+.||........+.... ...... ....
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF-RIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-HHhCCCChhhHHHHhcCch
Confidence 11223578899999998654 57899999999999999999999986543222111111 000000 0000
Q ss_pred ccccccCCC------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 747 ILDPVLKLP------SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 747 ~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
......... ........+.+++.+|++.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000000 00122457789999999999999999998874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=302.62 Aligned_cols=255 Identities=22% Similarity=0.274 Sum_probs=197.3
Q ss_pred ccccccCcccceEEEEEEEc----CCcEEEEEEeeeccc--cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK----DGTVVAVKKAIATSD--RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLL 589 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~L 589 (914)
.+.+.||+|+||.||+++.. +++.+|||.+..... .....+.+.+|++++.++ +||||+++++.+......+|
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 35678999999999999853 578899998764321 223346788999999999 69999999999999999999
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||+++++|.+++.... .+++.....++.|++++|+|||+.+ ++||||||+|||++.++.++|+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 83 ILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999987532 4788888999999999999999998 99999999999999999999999999876
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhhcCC--CCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccc
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRLHY--LTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~--~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 747 (914)
....... ......|+..|+|||.+.... .+.++||||||+++|||++|..||..........+...... ..
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~----- 227 (288)
T cd05583 155 FLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL-KS----- 227 (288)
T ss_pred ccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH-cc-----
Confidence 5433211 122345889999999987654 78899999999999999999999853322211111111111 10
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
.. +.+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 228 ---~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ---KP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ---CC--CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 00 1111233567899999999999999999988877653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=298.81 Aligned_cols=246 Identities=22% Similarity=0.245 Sum_probs=189.3
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHH-HhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLL-SRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l-~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.||+|+||.||++... +++.||+|.+...... ......+..|..++ ...+||||+++++++.+.+..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 45999999999999975 5889999987543211 12223455565554 445899999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||+|+|||+++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 99999997543 4778888999999999999999998 99999999999999999999999999865432
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 756 (914)
.....++..|+|||.+.+..++.++||||||+++|||++|..||....... . ...+..+.... ....
T Consensus 150 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~----~~~~~~~~~~~------~~~~ 216 (260)
T cd05611 150 --NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-V----FDNILSRRINW------PEEV 216 (260)
T ss_pred --cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-H----HHHHHhcccCC------CCcc
Confidence 223357889999999988888999999999999999999999986432211 1 11111111100 0001
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 757 DLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 757 ~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
.......+.+++.+||+.+|++||++.++.+.|.
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 1123467889999999999999998877766553
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=305.00 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=191.3
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC--------e
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR--------E 586 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--------~ 586 (914)
+.+.++||+|+||.||+++.+ +++.||||++............+.+|++++++++||||+++++++.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 345677999999999999976 5889999988654433333456778999999999999999999987654 4
Q ss_pred EEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCC
Q 002512 587 RLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666 (914)
Q Consensus 587 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGl 666 (914)
.++||||+. ++|.+++.... ..+++...+.++.||+.||+|||+++ |+|+||||+|||+++++.+||+|||+
T Consensus 94 ~~lv~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred EEEEEcCCC-cCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 599999996 48888886542 24789999999999999999999998 99999999999999999999999999
Q ss_pred cccCCCCCCC--CCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhh---
Q 002512 667 SLLGPADSSS--PLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIK--- 740 (914)
Q Consensus 667 a~~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~--- 740 (914)
+......... .......++..|+|||.+... .++.++||||||+++|||++|+.||....... ..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH-QLTLISQLCGSIT 244 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 9765432211 112234578899999998664 46889999999999999999999886432211 1111111000
Q ss_pred -----cCCcccccccccCCCCC-----------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 741 -----SGDITAILDPVLKLPSD-----------LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 741 -----~~~~~~~~d~~l~~~~~-----------~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
........+. +..+.. ......+.+|+.+||..+|.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKK-MELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhh-ccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000000000 000000 001245678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=300.34 Aligned_cols=260 Identities=23% Similarity=0.286 Sum_probs=195.1
Q ss_pred cccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhc---cCCceeeeeceeecCCe-----EE
Q 002512 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL---NHAHLLNLLGYCEEGRE-----RL 588 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~~~~~-----~~ 588 (914)
+.+.||+|+||.||+++.+. ++.+|+|++............+.+|+.++.++ +||||+++++++.+.+. .+
T Consensus 3 ~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~ 82 (287)
T cd07838 3 ELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT 82 (287)
T ss_pred EEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeE
Confidence 45679999999999999874 89999998865443333345677888887766 59999999999988776 89
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
++|||++ ++|.+++..... ..+++..++.++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||++.
T Consensus 83 l~~e~~~-~~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 83 LVFEHVD-QDLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred EEehhcc-cCHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 9999997 489998875432 25889999999999999999999999 9999999999999999999999999987
Q ss_pred cCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcc---
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT--- 745 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~--- 745 (914)
....... .....++..|+|||++....++.++||||||+++|||++|+.||........+..............
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPR 232 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCC
Confidence 6543321 1223478899999999998999999999999999999999988865332222221111100000000
Q ss_pred ------cccccccCCC---CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 746 ------AILDPVLKLP---SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 746 ------~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.......... ...+....+.+++.+||+.+|++||++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 01133467789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-33 Score=301.02 Aligned_cols=257 Identities=23% Similarity=0.235 Sum_probs=191.2
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhcc-CCceeeeeceeecC--CeEEEEEe
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEG--RERLLVYE 592 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~--~~~~LV~E 592 (914)
.+.++||+|+||.||+++.+ +++.+|+|++....... ....+.+|+.++.++. ||||+++++++.+. +..++|||
T Consensus 2 ~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred ceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 35678999999999999975 58899999876543222 2234567999999995 99999999999987 88999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++ +.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 997 58888886532 35899999999999999999999999 999999999999999 9999999999976543
Q ss_pred CCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhh-----------h
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLI-----------K 740 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~-----------~ 740 (914)
... .....++..|+|||++.. ..++.++|||||||++|||++|+.||......+ ......... .
T Consensus 152 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 152 KPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHHHHHcCCCCHHHHHhhc
Confidence 221 122357889999998754 567899999999999999999999986432211 111111111 0
Q ss_pred cCCcccccccccCC----CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 741 SGDITAILDPVLKL----PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 741 ~~~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.........+.... ......+..+.+++.+||+.+|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000000 001133578999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=294.65 Aligned_cols=247 Identities=25% Similarity=0.407 Sum_probs=200.3
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||+++.. +++.+++|.+......+...+.+.+|++++++++|||++++++++.+.+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 34678999999999999876 57899999887655433456789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++... ..+++..+..++.|++.+|.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 83 NGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999754 25789999999999999999999999 99999999999999999999999999976544332
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
. .....++..|+|||.+....++.++||||||+++|||++|+.||...... ... .... ..... .
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~---~~~-~~~~-~~~~~---------~ 218 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM---AAL-FRIV-QDDHP---------P 218 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH---HHH-HHHh-ccCCC---------C
Confidence 1 22345889999999998888899999999999999999999998643211 111 1111 11111 1
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+......+.+++.+||..+|++||++.+++.
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 11123457889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=310.16 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=193.2
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecC--CeEEEEEee
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEG--RERLLVYEF 593 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~--~~~~LV~Ey 593 (914)
+.+.||+|+||.||+|... +++.+|+|++............+.+|+.+++++ +||||+++++++... ...+|||||
T Consensus 11 ~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~ 90 (337)
T cd07852 11 ILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY 90 (337)
T ss_pred HhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecc
Confidence 4567999999999999976 588999998864333333446688999999999 999999999998653 468999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 91 ~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 91 ME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred cc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 97 5999988653 4678888899999999999999998 999999999999999999999999999765433
Q ss_pred CCC---CCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH----------hhh
Q 002512 674 SSS---PLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV----------PLI 739 (914)
Q Consensus 674 ~~~---~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~----------~~~ 739 (914)
... .......|+..|+|||++.. ..++.++||||||+++|||+||+.||........+..... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 221 12223458899999998854 5678999999999999999999999864322211111000 000
Q ss_pred hcCCcccccc----cccC--CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 740 KSGDITAILD----PVLK--LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 740 ~~~~~~~~~d----~~l~--~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.......+++ .... .........++.+++.+||+.+|++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000110 0000 00001134678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=312.00 Aligned_cols=246 Identities=25% Similarity=0.380 Sum_probs=201.8
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|.|+.|.++++. .+..||||.+.+........+.+.+|+++|..|+|||||+|+.+.+....+||||||+.
T Consensus 59 ~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~ 138 (596)
T KOG0586|consen 59 VIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYAS 138 (596)
T ss_pred eeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEecc
Confidence 34567999999999999976 58999999887776666666779999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+|.|++||...+. +.......+..|+.++++|+|++. |+|||||++||||+.+.++||+|||++..+...
T Consensus 139 ~ge~~~yl~~~gr-----~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-- 208 (596)
T KOG0586|consen 139 GGELFDYLVKHGR-----MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYG-- 208 (596)
T ss_pred CchhHHHHHhccc-----chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeeccc--
Confidence 9999999987764 333566778899999999999999 999999999999999999999999999876533
Q ss_pred CCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
.......|++.|.|||++.+. +..+++|+||+|++||-|+.|..||+...-.. ++. .++-..++.
T Consensus 209 -~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~---------Lr~----rvl~gk~rI 274 (596)
T KOG0586|consen 209 -LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE---------LRP----RVLRGKYRI 274 (596)
T ss_pred -ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc---------ccc----hheeeeecc
Confidence 345567899999999999876 45689999999999999999999997542110 111 122222333
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
+... ..+..++++++|..+|.+|++++++.+.
T Consensus 275 p~~m--s~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 275 PFYM--SCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ccee--echhHHHHHHhhccCccccCCHHHhhhh
Confidence 3322 2356688999999999999999988653
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=293.25 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=202.9
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.+.+.||+|+||.||++... +++.+++|++..........+++.+|++++++++|||++++++.+...+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 34567999999999999976 58899999886654444556789999999999999999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++..... ....+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 83 GGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred CCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 9999999976431 1246899999999999999999999998 9999999999999999999999999987654432
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
.......|++.|+|||.+....++.++||||||+++|||++|+.||.... ..+.... ........+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~-~~~~~~~~~-------- 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----LLELALK-ILKGQYPPI-------- 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc----HHHHHHH-HhcCCCCCC--------
Confidence 12233468899999999998889999999999999999999999985432 1111111 111111111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+......+.+++.+||..+|++||++.|+++
T Consensus 224 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 224 -PSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=295.25 Aligned_cols=249 Identities=22% Similarity=0.285 Sum_probs=192.7
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeecc---ccccchHHHHHHHHHHHhccCCceeeeeceeecC--CeEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS---DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RERLLV 590 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~LV 590 (914)
.+.+.||+|+||.||++... +++.+|+|.+.... ........|.+|++++++++||||+++++++.+. ...++|
T Consensus 5 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v 84 (264)
T cd06653 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIF 84 (264)
T ss_pred eeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEE
Confidence 35678999999999999975 58899999874322 1223346789999999999999999999998764 467899
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
|||+++++|.+++.... .+++...++++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++..
T Consensus 85 ~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 85 VEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 99999999999997542 3678888899999999999999999 999999999999999999999999999764
Q ss_pred CCCCC-CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 671 PADSS-SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 671 ~~~~~-~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
..... ........++..|+|||++....++.++||||||+++|||++|+.||....... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~------- 225 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA----AIFKIATQP------- 225 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH----HHHHHHcCC-------
Confidence 32111 111123458899999999998888999999999999999999999986431111 111111111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....+....+.+.+++.+||+ +|..||+..+++.
T Consensus 226 --~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 --TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0011122344678899999999 5799999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=296.24 Aligned_cols=243 Identities=21% Similarity=0.275 Sum_probs=185.8
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccccc-cchHHHHHHHHH---HHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQ-KNSKEFHTELDL---LSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~f~~E~~~---l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
.||+|+||.||++... +++.||+|.+....... .....+..|..+ ++..+||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999875 48899999876543221 112234455444 444579999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 99999988643 25899999999999999999999998 9999999999999999999999999987543221
Q ss_pred CCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~ 754 (914)
.....|+..|+|||++... .++.++||||||+++|||++|+.||........ .. ........ +. ..
T Consensus 152 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~-~~~~~~~~------~~--~~ 218 (278)
T cd05606 152 ---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HE-IDRMTLTM------AV--EL 218 (278)
T ss_pred ---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HH-HHHHhhcc------CC--CC
Confidence 1234689999999999754 688999999999999999999999864322111 10 11111100 00 11
Q ss_pred CCCHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHH
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERP-----SMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~~p~~RP-----s~~ev~~ 787 (914)
+ .....++.+++.+|+..+|.+|| ++.++++
T Consensus 219 ~--~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 219 P--DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred C--CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 1 12245788999999999999999 8888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=330.12 Aligned_cols=246 Identities=24% Similarity=0.342 Sum_probs=183.7
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec----------------
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE---------------- 583 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~---------------- 583 (914)
.||+||||.|||++.+ ||+.+||||+.... ..+....+.+|+++|++|+|||||+++..+.+
T Consensus 486 lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~ 564 (1351)
T KOG1035|consen 486 LLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE 564 (1351)
T ss_pred HhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence 5999999999999976 89999999998766 45556788999999999999999998432200
Q ss_pred --------------------------------------------------------------------------------
Q 002512 584 -------------------------------------------------------------------------------- 583 (914)
Q Consensus 584 -------------------------------------------------------------------------------- 583 (914)
T Consensus 565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~ 644 (1351)
T KOG1035|consen 565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD 644 (1351)
T ss_pred hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence
Q ss_pred ---------------C--------CeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCC
Q 002512 584 ---------------G--------RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640 (914)
Q Consensus 584 ---------------~--------~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~ 640 (914)
+ ...||-||||+.-+|+++++++.... .-...+++..+|++||+|+|+++
T Consensus 645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLaYIH~~g--- 717 (1351)
T KOG1035|consen 645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLAYIHDQG--- 717 (1351)
T ss_pred chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHHHHHhCc---
Confidence 0 12478899999988888887654311 23445789999999999999999
Q ss_pred eeccCCCccceEEcCCCcEEEeecCCcccCC----------------CCCCCCCccCCCCcCCccChhhhhcC---CCCC
Q 002512 641 VIHRDIKSSNILIDEEHNARVADFGLSLLGP----------------ADSSSPLAELPAGTLGYLDPEYYRLH---YLTT 701 (914)
Q Consensus 641 iiHrDIKp~NILl~~~~~~kl~DFGla~~~~----------------~~~~~~~~~~~~Gt~~y~aPE~l~~~---~~s~ 701 (914)
||||||||.||+||++..+||+|||++.... ........+..+||.-|+|||++... .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999997621 00111123455799999999999654 4999
Q ss_pred cchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 002512 702 KSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPS 781 (914)
Q Consensus 702 ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 781 (914)
|+|+|||||||+||+. ||....+... ...-++.+.+..- +.+ .. +....=++++.++++.||.+|||
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMERa~----iL~~LR~g~iP~~--~~f---~~-~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMERAS----ILTNLRKGSIPEP--ADF---FD-PEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHHHH----HHHhcccCCCCCC--ccc---cc-ccchHHHHHHHHHhcCCCccCCC
Confidence 9999999999999996 5654333221 1122333333221 111 11 22233468999999999999999
Q ss_pred HHHHHH
Q 002512 782 MDKVTT 787 (914)
Q Consensus 782 ~~ev~~ 787 (914)
+.|++.
T Consensus 865 A~eLL~ 870 (1351)
T KOG1035|consen 865 ATELLN 870 (1351)
T ss_pred HHHHhh
Confidence 998863
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=294.26 Aligned_cols=263 Identities=24% Similarity=0.319 Sum_probs=213.3
Q ss_pred cccccccCcccceEEEEEEEcC------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec-CCeEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE-GRERL 588 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~ 588 (914)
..++..+-+|.||.||.|.+.+ .+.|.+|.+.. ...+-....|+.|..++..+.|||+..+.+++.+ .+.++
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~ 364 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPF 364 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcce
Confidence 3445568999999999997643 44566665432 2234445779999999999999999999998855 46789
Q ss_pred EEEeeCCCCCHHHhhhcCc---cchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecC
Q 002512 589 LVYEFMAHGSLHQHLHGKS---KALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~---~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFG 665 (914)
.+|.++.-|+|..||...+ ....+.++-.+.+.++.|++.||+|||.++ |||.||.++|++||+..++||+|=.
T Consensus 365 V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsa 441 (563)
T KOG1024|consen 365 VLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSA 441 (563)
T ss_pred EEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccch
Confidence 9999999999999997321 223456777888999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh-CCCCcccccccccHHHHHHhhhhcCCc
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDI 744 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt-G~~p~~~~~~~~~l~~~~~~~~~~~~~ 744 (914)
+++.+-+.+.+......-.+..||+||.+....|+.++|||||||+||||+| |+.|+..... ..+..++++|
T Consensus 442 LSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-----fEm~~ylkdG-- 514 (563)
T KOG1024|consen 442 LSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-----FEMEHYLKDG-- 514 (563)
T ss_pred hccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-----HHHHHHHhcc--
Confidence 9998877777766666667889999999999999999999999999999999 6777643211 1233344443
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 002512 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~~ 796 (914)
.+...+.+++.++..+|.-||...|++||++++++.-|.+.-.++
T Consensus 515 -------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 515 -------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred -------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 344556678889999999999999999999999999998876654
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=297.90 Aligned_cols=259 Identities=23% Similarity=0.296 Sum_probs=198.2
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.+.||+|++|.||++..+ +++.+++|++............+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 3467999999999999975 688999998765544334457788999999999999999999999999999999999975
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
+|.+++.... ..+++..++.++.|++++|.|||+.+ |+|+||||+||++++++.+||+|||.+........
T Consensus 83 -~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 83 -DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred -CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 8988887542 35889999999999999999999999 99999999999999999999999999876654331
Q ss_pred CCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC---Ccccccc---
Q 002512 677 PLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG---DITAILD--- 749 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~---~~~~~~d--- 749 (914)
......++..|+|||.+... .++.++||||||+++|||+||+.||........+.. ....+... ....+.+
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK-IFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHcCCCchHhcccchhhhh
Confidence 12223578899999999876 789999999999999999999998854322111111 10000000 0000000
Q ss_pred ------cccC----CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 750 ------PVLK----LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 750 ------~~l~----~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+... .........++.+++.+||+.+|.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0000 0011234578999999999999999999999874
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=299.52 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=189.4
Q ss_pred ccccccCcccceEEEEEEE----cCCcEEEEEEeeeccc--cccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVL----KDGTVVAVKKAIATSD--RQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLL 589 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~L 589 (914)
.+.+.||+|+||.||+++. .+++.||+|.+..... .....+.+.+|++++.++ +|+||+++++++..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 3457799999999999986 3688999998754321 122346788999999999 69999999999999999999
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||+++++|.+++.... .+++.....++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 83 ILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999997542 4777888889999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhhcC--CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccc
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRLH--YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 747 (914)
....... ......|+..|+|||.+... .++.++||||||+++|||++|+.||....................
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~----- 228 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE----- 228 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-----
Confidence 5433211 12234588999999998753 467899999999999999999999864322222222211111110
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhhhcCCCCCC
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERP 780 (914)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 780 (914)
.+.+......+.+++.+||+.+|++||
T Consensus 229 ------~~~~~~~~~~~~~ll~~~l~~~p~~R~ 255 (290)
T cd05613 229 ------PPYPQEMSALAKDIIQRLLMKDPKKRL 255 (290)
T ss_pred ------CCCCccCCHHHHHHHHHHhcCCHHHhc
Confidence 011122345788999999999999998
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=300.11 Aligned_cols=243 Identities=21% Similarity=0.334 Sum_probs=193.2
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
.+||+|+||.||++..+ +++.||+|++.... ......|.+|+.++++++||||+++++++...+..++||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 46999999999999875 68899999874322 2334679999999999999999999999999999999999999999
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
|.+++... .+++.....++.|++.+|+|||+.+ |+|+||||+||++++++.++|+|||++........ .
T Consensus 104 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~ 172 (292)
T cd06657 104 LTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R 172 (292)
T ss_pred HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--c
Confidence 99987542 3688888999999999999999999 99999999999999999999999999865443221 1
Q ss_pred ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
.....+++.|++||++....++.++||||||+++|||++|+.||....... .. ..+... . .+.+.. ..
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-~~----~~~~~~-~----~~~~~~--~~ 240 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-AM----KMIRDN-L----PPKLKN--LH 240 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HH----HHHHhh-C----CcccCC--cc
Confidence 223458899999999988888999999999999999999999985321111 11 111110 1 111110 11
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....+.+++.+||+.+|.+||++.+++.
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 22346788999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.96 Aligned_cols=262 Identities=23% Similarity=0.316 Sum_probs=191.4
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC--------eE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR--------ER 587 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~--------~~ 587 (914)
.+.+.||+|+||.||+++.+ +++.+|+|++............+.+|++++++++||||+++++++.+.. ..
T Consensus 11 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 90 (311)
T cd07866 11 EILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSV 90 (311)
T ss_pred EEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceE
Confidence 45677999999999999976 5889999988665443333456789999999999999999999875433 46
Q ss_pred EEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCc
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla 667 (914)
++||||+.. +|.+.+.... ..+++..+..++.|+++||+|||+.+ |+|+||||+|||+++++.+||+|||++
T Consensus 91 ~lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 91 YMVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred EEEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence 999999975 7877776532 25889999999999999999999999 999999999999999999999999999
Q ss_pred ccCCCCCCCC---------CccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHh
Q 002512 668 LLGPADSSSP---------LAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVP 737 (914)
Q Consensus 668 ~~~~~~~~~~---------~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~ 737 (914)
+......... ......+++.|+|||.+.+ ..++.++||||||+++|||++|++||........+.. ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~-~~~ 241 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL-IFK 241 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHH
Confidence 7643322111 1122357888999998865 4578999999999999999999999864322211111 110
Q ss_pred hhhc---------CCcccccc--cccCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 738 LIKS---------GDITAILD--PVLKLPSD-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 738 ~~~~---------~~~~~~~d--~~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.... ..+....+ .....+.. ......+.+++.+||+.+|++|||+.|++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 00000000 00001111 112257889999999999999999998874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=312.95 Aligned_cols=198 Identities=26% Similarity=0.339 Sum_probs=167.7
Q ss_pred hcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhcc-CC-----ceeeeeceeecCCeE
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HA-----HLLNLLGYCEEGRER 587 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-Hp-----nIv~l~g~~~~~~~~ 587 (914)
++.+.+.||+|.||.|.++... .++.||||+++... ....+-..|+.+|..|+ |. |+|++++||...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 5667889999999999999965 59999999885432 23355667999999996 43 899999999999999
Q ss_pred EEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC--CcEEEeecC
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE--HNARVADFG 665 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~--~~~kl~DFG 665 (914)
+||+|.+. -+|+++|+.+.. ..++...+..|+.||+.+|.+||+.+ |||+||||+||||.+- ..+||+|||
T Consensus 264 ciVfELL~-~NLYellK~n~f---~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 264 CIVFELLS-TNLYELLKNNKF---RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeehhhh-hhHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecc
Confidence 99999995 599999987654 35889999999999999999999999 9999999999999654 369999999
Q ss_pred CcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccc
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFE 727 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~ 727 (914)
.|......-. ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.|....+
T Consensus 337 SSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 337 SSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 9976544322 23457899999999999999999999999999999999877765433
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=308.64 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=195.0
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec----CCeEEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE----GRERLLVY 591 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~LV~ 591 (914)
.+.+.||+|+||.||++..+ +++.||+|++............+.+|+.++++++||||+++++++.. ....++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~ 87 (334)
T cd07855 8 KPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVM 87 (334)
T ss_pred eeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEE
Confidence 34567999999999999976 58999999886544434455778899999999999999999998763 34689999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
||+. ++|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 88 e~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 88 DLME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred ehhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 9996 69999986542 4788999999999999999999999 9999999999999999999999999987643
Q ss_pred CCCCC--CCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH----------hh
Q 002512 672 ADSSS--PLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV----------PL 738 (914)
Q Consensus 672 ~~~~~--~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~----------~~ 738 (914)
..... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||........+..... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32211 11223468899999999865 4688999999999999999999999864321111100000 00
Q ss_pred hhcCCccccccccc-CCCC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 739 IKSGDITAILDPVL-KLPS-----DLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 739 ~~~~~~~~~~d~~l-~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.....+.+..+... ..+. ....+.++.+++.+||+.+|++||++.+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00000101000000 0000 01235678999999999999999999987753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=301.35 Aligned_cols=249 Identities=24% Similarity=0.374 Sum_probs=190.3
Q ss_pred ccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.+.||+|+||.||++..++ ++.||||++..... .....++..|+.++.++ .||||+++++++.+....++||||+
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 96 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM 96 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc
Confidence 356789999999999999875 88999998764432 22345677788877777 4999999999999999999999998
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+ ++|.+++.... ..+++..+..++.|+++||+|||+ .+ |+||||+|+|||+++++.+||+|||++......
T Consensus 97 ~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 97 S-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred C-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 5 47777765422 258889999999999999999997 46 999999999999999999999999998765332
Q ss_pred CCCCCccCCCCcCCccChhhhhcCC----CCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccc
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHY----LTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~----~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d 749 (914)
.. .....++..|+|||++.... ++.++||||||+++|||++|+.||...... .+....... .....
T Consensus 169 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~-~~~~~--- 238 (296)
T cd06618 169 KA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQ-EEPPS--- 238 (296)
T ss_pred Cc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhc-CCCCC---
Confidence 21 12234788999999997554 788999999999999999999998542111 111111111 11111
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.+.......++.+++.+||+.+|++||++.+++..
T Consensus 239 ----~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 239 ----LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11111234578999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=305.88 Aligned_cols=254 Identities=22% Similarity=0.320 Sum_probs=187.3
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC------eEEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR------ERLLV 590 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~LV 590 (914)
..+.||+|+||.||+|+.. +++.||+|++............+.+|+.++++++||||+++++++.... ..++|
T Consensus 19 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv 98 (342)
T cd07879 19 SLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98 (342)
T ss_pred EEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEE
Confidence 3457999999999999965 5899999988654333334467889999999999999999999987543 46899
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
+||+.. +|.+++. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 99 ~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 99 MPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred eccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 999964 7776653 14778888999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH----------hhh
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV----------PLI 739 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~----------~~~ 739 (914)
... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||........+..... +..
T Consensus 168 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 168 DAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 321 122357889999999876 4688999999999999999999999864321111111000 000
Q ss_pred hcCCcccccccccCCCC-C-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 740 KSGDITAILDPVLKLPS-D-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 740 ~~~~~~~~~d~~l~~~~-~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
...............+. . ......+.+++.+||+.+|++||++++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000000000000000 0 012356789999999999999999999974
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=297.10 Aligned_cols=247 Identities=24% Similarity=0.334 Sum_probs=197.5
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhcc-CCceeeeeceeecCCeEEEEEee
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
.+.+.||+|+||.||+++.+ +++.||+|....... .....+.+.+|++++++++ ||||+++++++.+.+..++||||
T Consensus 4 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd05581 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEY 83 (280)
T ss_pred eEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcC
Confidence 45678999999999999976 689999998754321 2233467889999999998 99999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++++|.+++.+.. .+++..++.|+.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 84 APNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred CCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999997643 5899999999999999999999999 999999999999999999999999998765433
Q ss_pred CCC------------------CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHH
Q 002512 674 SSS------------------PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA 735 (914)
Q Consensus 674 ~~~------------------~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~ 735 (914)
... .......++..|+|||.+....++.++||||||++++||++|+.||........ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~ 231 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT----F 231 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH----H
Confidence 211 112233578999999999988899999999999999999999999864421111 1
Q ss_pred HhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCH----HHHH
Q 002512 736 VPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSM----DKVT 786 (914)
Q Consensus 736 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~----~ev~ 786 (914)
.... .. ....+......+.+++.+||+.+|.+||++ ++++
T Consensus 232 ~~~~-~~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll 275 (280)
T cd05581 232 QKIL-KL----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275 (280)
T ss_pred HHHH-hc----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHh
Confidence 1111 10 011111224678899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=297.74 Aligned_cols=259 Identities=21% Similarity=0.293 Sum_probs=193.4
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhcc-CCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.||+|+||.||+|+.. +++.|++|++...... .....+.+|+..+.+++ ||||+++++++.+.+..++||||+
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 3 VIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 5678999999999999986 4788999987554322 22234567999999998 999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+|+|.+++.... ...+++..++.++.|++.+|.|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999987653 135799999999999999999999999 99999999999999999999999999876543221
Q ss_pred CCCccCCCCcCCccChhhhh-cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHH------------HHHhhhhcC
Q 002512 676 SPLAELPAGTLGYLDPEYYR-LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE------------WAVPLIKSG 742 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~-~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~------------~~~~~~~~~ 742 (914)
.....++..|+|||++. ...++.++||||||+++|||++|+.||........+.. |........
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 12235788999999885 44578999999999999999999988854322111110 000000000
Q ss_pred CcccccccccCCC---CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 743 DITAILDPVLKLP---SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 743 ~~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....+....... ........+.+++.+||+.+|++||+++|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000000 00011367889999999999999999999874
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=306.10 Aligned_cols=260 Identities=21% Similarity=0.280 Sum_probs=193.8
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC-----CeEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG-----RERLLV 590 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~LV 590 (914)
...+.||+|+||.||+++.. +++.||||++............+.+|+.+++.++||||+++++++... ...+||
T Consensus 8 ~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv 87 (337)
T cd07858 8 VPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIV 87 (337)
T ss_pred eEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEE
Confidence 34567999999999999965 589999998765433334456788999999999999999999988654 347999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
|||+. ++|.+++.... .+++.....++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 88 ~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 88 YELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EeCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 99996 78999887542 4788889999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhh----------
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLI---------- 739 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~---------- 739 (914)
.... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||....... ........+
T Consensus 159 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 159 SEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVH-QLKLITELLGSPSEEDLGF 235 (337)
T ss_pred CCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCChHHhhh
Confidence 4322 12223457889999999865 468899999999999999999999986432111 011000000
Q ss_pred -hcCCcccccccccCC------CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 740 -KSGDITAILDPVLKL------PSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 740 -~~~~~~~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
............... ........++.+++.+||+.+|++|||++|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000000000 0011234678899999999999999999998865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=301.51 Aligned_cols=244 Identities=24% Similarity=0.341 Sum_probs=190.8
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeecc-ccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
.+.||+|+||.||+|+.. +++.+++|++.... ......++|.+|++++++++|+|++++++++...+..++||||+.
T Consensus 20 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~- 98 (308)
T cd06634 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL- 98 (308)
T ss_pred HHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-
Confidence 356999999999999975 57889999875432 222334678899999999999999999999999999999999996
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
|+|.+++.... ..+++..+..++.|++.+|.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 99 ~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--- 168 (308)
T cd06634 99 GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (308)
T ss_pred CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc---
Confidence 68888775432 24788889999999999999999998 999999999999999999999999998764322
Q ss_pred CCccCCCCcCCccChhhhh---cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 677 PLAELPAGTLGYLDPEYYR---LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~---~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
....++..|+|||++. ...++.++||||||+++|||++|+.|+......... . .+.......
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~-~~~~~~~~~------- 233 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL----Y-HIAQNESPA------- 233 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH----H-HHhhcCCCC-------
Confidence 2235788999999985 346788999999999999999999997532111111 1 111111110
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
.........+.+++.+||+.+|++||++.+++...
T Consensus 234 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred -cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 01113345788999999999999999999988653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=295.88 Aligned_cols=259 Identities=23% Similarity=0.307 Sum_probs=197.1
Q ss_pred cccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.+.||+|+||.||+++..+ ++.+++|++..........+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 34679999999999999764 8999999887654334445778999999999999999999999999999999999998
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++.... ..+++..++.++.|++++|+|||+.+ |+||||+|+||++++++.+||+|||+++.......
T Consensus 82 ~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 82 MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 59999997642 25889999999999999999999999 99999999999999999999999999876543321
Q ss_pred CCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhc---------CC---
Q 002512 677 PLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKS---------GD--- 743 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~---------~~--- 743 (914)
......++..|+|||.+... .++.++||||||+++|||++|+.||........+.. ....... ..
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFK-IFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH-HHHHhCCCcHHHHHhhccccc
Confidence 11223457789999999776 889999999999999999999988854322111110 0000000 00
Q ss_pred cccccccccCCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 744 ITAILDPVLKLPS---DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 744 ~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
............. .......+.+++.+||..+|++||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000 0112457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=306.09 Aligned_cols=261 Identities=22% Similarity=0.318 Sum_probs=191.5
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC-----CeEEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG-----RERLL 589 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~L 589 (914)
+.+.+.||+|+||.||+|+.. +++.||+|++.... ......++.+|+.++++++||||+++++++... ...++
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 85 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYI 85 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEE
Confidence 345678999999999999865 58899999875322 223446788999999999999999999987654 35799
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||++ ++|.+++... .+++.....++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 86 v~e~~~-~~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 86 VQELME-TDLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred Eehhcc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999997 4888887642 4788889999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCC-CCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC---Cc
Q 002512 670 GPADSSS-PLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG---DI 744 (914)
Q Consensus 670 ~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~---~~ 744 (914)
....... .......||..|+|||.+.. ..++.++||||||+++|||++|+.||........+ ......+... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~-~~~~~~~~~~~~~~~ 234 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL-NLILGVLGTPSQEDL 234 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHcCCCCHHHH
Confidence 5432211 11223458899999998754 56889999999999999999999998543211111 1111101000 00
Q ss_pred ccccc-----------cccCCC---CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 745 TAILD-----------PVLKLP---SDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 745 ~~~~d-----------~~l~~~---~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
..+.+ .....+ .......++.+++.+||+.+|++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 000000 001224578899999999999999999998864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=303.47 Aligned_cols=259 Identities=22% Similarity=0.269 Sum_probs=191.7
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeecccccc------------chHHHHHHHHHHHhccCCceeeeeceeecCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQK------------NSKEFHTELDLLSRLNHAHLLNLLGYCEEGR 585 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~------------~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~ 585 (914)
.+.||+|+||.||++..+ +++.||+|++........ ....+.+|++++++++||||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 456999999999999976 589999998755432210 0125789999999999999999999999999
Q ss_pred eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecC
Q 002512 586 ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 586 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFG 665 (914)
..++||||++ ++|.+++.... .+++.....++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcc
Confidence 9999999997 69999986532 4788889999999999999999999 9999999999999999999999999
Q ss_pred CcccCCCCCC------------CCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHH
Q 002512 666 LSLLGPADSS------------SPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIV 732 (914)
Q Consensus 666 la~~~~~~~~------------~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~ 732 (914)
++........ ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~- 243 (335)
T PTZ00024 165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL- 243 (335)
T ss_pred ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-
Confidence 9876541110 0111223468899999998764 4689999999999999999999998644322211
Q ss_pred HHHHhhhhcCCccccc--------ccccC-CCC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 733 EWAVPLIKSGDITAIL--------DPVLK-LPS-----DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 733 ~~~~~~~~~~~~~~~~--------d~~l~-~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
................ .+... .+. ......++.+++.+||+.+|++||+++|++.
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 1111111110000000 00000 000 0122457889999999999999999999875
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=290.89 Aligned_cols=234 Identities=21% Similarity=0.254 Sum_probs=181.0
Q ss_pred cCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 522 VGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
||+|+||.||++..+ +++.+|+|........ . .|+.....+ +||||+++++++...+..++||||+++++|
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-----~--~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L 96 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-----A--IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDL 96 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhcc-----h--hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcH
Confidence 699999999999975 5788888876432211 1 122222223 799999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC-cEEEeecCCcccCCCCCCCCC
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-NARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~ 678 (914)
.+++.... .+++.....++.|+++||.|||+.+ |+||||||+||+++.++ .++|+|||++......
T Consensus 97 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~----- 163 (267)
T PHA03390 97 FDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP----- 163 (267)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----
Confidence 99997543 5889999999999999999999999 99999999999999998 9999999998754322
Q ss_pred ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
....++..|+|||++....++.++||||||+++|||++|+.||.....+........... . ... +...
T Consensus 164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~--------~~~--~~~~ 231 (267)
T PHA03390 164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q--------KKL--PFIK 231 (267)
T ss_pred -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c--------ccC--Cccc
Confidence 123588999999999988899999999999999999999999974332211111111111 0 000 1111
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCC-HHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERPS-MDKVTT 787 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RPs-~~ev~~ 787 (914)
.....+.+++.+||+.+|.+||+ ++|+++
T Consensus 232 ~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 232 NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 34467889999999999999995 677763
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-32 Score=298.44 Aligned_cols=242 Identities=26% Similarity=0.360 Sum_probs=189.6
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
.++||+|+||.||+|+.. +++.|++|++..... .....+++.+|++++++++|||++++++++.+.+..++||||+.
T Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 104 (313)
T cd06633 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL- 104 (313)
T ss_pred ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence 356999999999999975 588999998754332 22234578899999999999999999999999999999999996
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++.... ..+++..++.++.|++.+|+|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 105 ~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---- 173 (313)
T cd06633 105 GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---- 173 (313)
T ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence 68888876432 35889999999999999999999999 99999999999999999999999999854321
Q ss_pred CCccCCCCcCCccChhhhh---cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 677 PLAELPAGTLGYLDPEYYR---LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~---~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.....|+..|+|||++. ...++.++||||||+++|||++|..|+....... ...... ....... .
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~----~~~~~~-~~~~~~~-----~ 241 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYHIA-QNDSPTL-----Q 241 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHH-hcCCCCC-----C
Confidence 22346889999999984 4568889999999999999999999985432111 111111 1111111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.......+.+++.+||+.+|.+||++.+++.
T Consensus 242 ---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 ---SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122346889999999999999999998874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-33 Score=278.80 Aligned_cols=247 Identities=23% Similarity=0.387 Sum_probs=191.8
Q ss_pred ccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 519 KEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
...||.|..|.|++.+.+. |..+|||.+...... ++.++++..++++.+- +.|.||+.+|||..+...++.||.|.
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs- 174 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS- 174 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-
Confidence 4569999999999999774 889999998776554 3457788888887766 48999999999999999999999984
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
--++++|+.. ..++++...-++...+.+||.||.+++ .|||||+||+|||+|+.|++||+|||++-.+-....
T Consensus 175 ~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 175 TCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred HHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc-
Confidence 3455555433 235777777889999999999999876 399999999999999999999999999976554432
Q ss_pred CCccCCCCcCCccChhhhhc---CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 677 PLAELPAGTLGYLDPEYYRL---HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~---~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
.+...|-+.|||||.+.- ..|..++|||||||+|+||.||..||.....+-+. +...+. +....+
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~---ltkvln--~ePP~L----- 315 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV---LTKVLN--EEPPLL----- 315 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH---HHHHHh--cCCCCC-----
Confidence 234468899999999953 47889999999999999999999998754332111 111221 111222
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+........+.+++..||+.|+.+||.+.++++
T Consensus 316 -~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 316 -PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -CcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 222224567889999999999999999988764
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=302.25 Aligned_cols=262 Identities=25% Similarity=0.316 Sum_probs=198.7
Q ss_pred ccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC-----eEEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR-----ERLLV 590 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~LV 590 (914)
.+.+.||.|+||.||+++..+ ++.+|+|++..........+.|.+|+.++++++||||+++++++...+ ..|+|
T Consensus 3 ~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv 82 (330)
T cd07834 3 ELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82 (330)
T ss_pred eeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEE
Confidence 456789999999999999764 899999988655433444578999999999999999999999998775 78999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
|||++ ++|.+++.... .+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.++|+|||++...
T Consensus 83 ~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 83 TELME-TDLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred ecchh-hhHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99998 58999987543 5889999999999999999999999 999999999999999999999999999765
Q ss_pred CCCCCC-CCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhh--------
Q 002512 671 PADSSS-PLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIK-------- 740 (914)
Q Consensus 671 ~~~~~~-~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~-------- 740 (914)
...... .......++..|+|||++... .++.++||||||+++|||++|+.||........+ ........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~-~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL-NLIVEVLGTPSEEDLK 232 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH-HHHHHhcCCCChhHhh
Confidence 443210 112234578899999999887 8899999999999999999999998643321111 10000000
Q ss_pred ---cCCcccccccccC-CC-----CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 741 ---SGDITAILDPVLK-LP-----SDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 741 ---~~~~~~~~d~~l~-~~-----~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.......+..... .+ ........+.+++.+||+.+|.+||++++++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000000 00 001234678899999999999999999998864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=299.23 Aligned_cols=255 Identities=24% Similarity=0.304 Sum_probs=189.8
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec-CCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE-GRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~LV~Ey~~ 595 (914)
+.+.||.|+||.||++..+ +++.||+|++..........+.+.+|++++++++||||+++++++.. .+..++||||+
T Consensus 14 ~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~- 92 (328)
T cd07856 14 DLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL- 92 (328)
T ss_pred EEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-
Confidence 4567999999999999866 68999999876544333445778899999999999999999999865 56789999998
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
+++|.++++.. .+++.....++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++......
T Consensus 93 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-- 161 (328)
T cd07856 93 GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQ-- 161 (328)
T ss_pred ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCC--
Confidence 56999888643 3667777889999999999999999 999999999999999999999999998754321
Q ss_pred CCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHH----------HHhhhhcCCc
Q 002512 676 SPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEW----------AVPLIKSGDI 744 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~----------~~~~~~~~~~ 744 (914)
.....++..|+|||.+.+ ..++.++||||||+++|||+||+.||........+... +...+.....
T Consensus 162 ---~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd07856 162 ---MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT 238 (328)
T ss_pred ---cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence 122356889999999866 56899999999999999999999998643221111000 0000000000
Q ss_pred cccccc-ccCCCCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 745 TAILDP-VLKLPSD-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 ~~~~d~-~l~~~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+++.. ....+.+ ......+.+++.+||+.+|++||++.+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 0000111 112367889999999999999999988754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=286.11 Aligned_cols=238 Identities=27% Similarity=0.335 Sum_probs=192.6
Q ss_pred cCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 522 VGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
||+|+||.||++..+ +++.+++|.+...... ......+..|++++++++||||+++++.++.++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 799999999999976 4889999987654322 22456899999999999999999999999999999999999999999
Q ss_pred HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCc
Q 002512 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679 (914)
Q Consensus 600 ~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~ 679 (914)
.+++.... .+++.....++.|++++|.|||+.+ ++|+||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~ 150 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRT 150 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Ccc
Confidence 99997543 4788889999999999999999988 9999999999999999999999999987654332 122
Q ss_pred cCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHH
Q 002512 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLD 759 (914)
Q Consensus 680 ~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~ 759 (914)
....++..|++||.+.....+.++|+||||+++|||++|+.||..... ..... .+... .+. .+..
T Consensus 151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~~----~~~~~--------~~~--~~~~ 215 (250)
T cd05123 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIYE----KILKD--------PLR--FPEF 215 (250)
T ss_pred cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHHH----HHhcC--------CCC--CCCC
Confidence 334588899999999988889999999999999999999999864322 11111 11111 111 1112
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCHHH
Q 002512 760 ALKRIANVACKCVRMRGKERPSMDK 784 (914)
Q Consensus 760 ~~~~l~~l~~~Cl~~~p~~RPs~~e 784 (914)
....+.+++.+||..+|++||++.+
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 2467889999999999999999965
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=289.10 Aligned_cols=250 Identities=23% Similarity=0.311 Sum_probs=192.1
Q ss_pred ccccccCcccceEEEEEEEcC-CcEEEEEEeeec---cccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIAT---SDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
.+.++||+|+||.||+++... +..+++|.+... ........++..|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 456789999999999998753 344555544322 1222334567789999999999999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
|+++++|.+++..... ....+++...+.++.|+++||.|||+.+ ++|+||||+||++++ +.+||+|||++.....
T Consensus 83 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~ 157 (260)
T cd08222 83 YCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG 157 (260)
T ss_pred eCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCC
Confidence 9999999999875321 1246899999999999999999999999 999999999999975 5699999999876543
Q ss_pred CCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
... ......|+..|+|||.+....++.++||||||+++|+|++|..||... ........ +..+...
T Consensus 158 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~----~~~~~~~~-~~~~~~~------- 223 (260)
T cd08222 158 SCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ----NFLSVVLR-IVEGPTP------- 223 (260)
T ss_pred Ccc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHHH-HHcCCCC-------
Confidence 221 222345789999999998888899999999999999999999998532 11111111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+.....++.+++.+||+.+|++||++.|+++
T Consensus 224 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 224 --SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred --CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 112234467889999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=298.06 Aligned_cols=261 Identities=22% Similarity=0.264 Sum_probs=189.6
Q ss_pred ccccccCcccceEEEEEEEcC---CcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecC----CeEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD---GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEG----RERL 588 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~----~~~~ 588 (914)
.+.+.||+|+||.||+++... +..||+|++..........+.+.+|+.++.++ +||||+++++++... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 356789999999999999763 67899998754333333456788999999999 599999999875432 4578
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
+++||+. ++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 8999986 69999986532 4788899999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCC--CCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhh-------
Q 002512 669 LGPADSSS--PLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPL------- 738 (914)
Q Consensus 669 ~~~~~~~~--~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~------- 738 (914)
........ .......||..|+|||++.. ..++.++||||||+++|||++|+.||....... ........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 232 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD-QLNQILQVLGTPDEE 232 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH-HHHHHHHHhCCCCHH
Confidence 65432211 11223468999999998865 468899999999999999999999986432111 11100000
Q ss_pred ----hhcCCccccc---c--cccCCC-CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 739 ----IKSGDITAIL---D--PVLKLP-SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 739 ----~~~~~~~~~~---d--~~l~~~-~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+......... . +....+ ........+.+++.+||+.+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 0 000000 00112357889999999999999999998863
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-33 Score=294.76 Aligned_cols=254 Identities=26% Similarity=0.413 Sum_probs=197.4
Q ss_pred cccccCcccceEEEEEEE-cCCcEEEEEEeeecccccc-----chHHHHHHHHHHHhccCCceeeeeceee-cCCeEEEE
Q 002512 518 FKEEVGKGSFSCVYKGVL-KDGTVVAVKKAIATSDRQK-----NSKEFHTELDLLSRLNHAHLLNLLGYCE-EGRERLLV 590 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~-----~~~~f~~E~~~l~~l~HpnIv~l~g~~~-~~~~~~LV 590 (914)
+.+.||+|||+.|||+.+ ...+.||||+-.....-.. ..+...+|.+|.+.|+||.||++++||. +.+.++-|
T Consensus 467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence 345699999999999994 4688899996543322111 1234678999999999999999999996 45577899
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEc---CCCcEEEeecCCc
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID---EEHNARVADFGLS 667 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~---~~~~~kl~DFGla 667 (914)
+||++|.+|+-||+... .++.+....|+.||+.||.||.+.. |||||-||||.||||. .-|.+||.||||+
T Consensus 547 LEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred eeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 99999999999998764 4788889999999999999999986 8899999999999995 3567999999999
Q ss_pred ccCCCCCCC-----CCccCCCCcCCccChhhhhcC----CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhh
Q 002512 668 LLGPADSSS-----PLAELPAGTLGYLDPEYYRLH----YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPL 738 (914)
Q Consensus 668 ~~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~----~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~ 738 (914)
+++..+... ..+....||..|++||.+.-+ +++.|.||||.|||+|..|.|++||.......++.+.- ..
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN-TI 699 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN-TI 699 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh-ch
Confidence 998776544 234455799999999998543 67889999999999999999999997654443333211 11
Q ss_pred hhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002512 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVT 786 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~ 786 (914)
++. ....+|..+....+...+|.+||...-++|....+++
T Consensus 700 lkA--------tEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 700 LKA--------TEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hcc--------eeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 111 1223344444556778999999999999998766654
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-33 Score=332.47 Aligned_cols=247 Identities=25% Similarity=0.347 Sum_probs=195.6
Q ss_pred ccccCcccceEEEEEEE-cCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVL-KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
...||.|.||.||-+.. .+|+..|+|-+.......+..+...+|+.++..|+|||+|+++|+-.+.+..+|-||||++|
T Consensus 1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence 34699999999999985 45888999977665555666788899999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC--
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS-- 675 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~-- 675 (914)
+|.+.+...+. .++.....+..|++.||+|||+++ ||||||||.||||+.++.+|++|||.|........
T Consensus 1320 sLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1320 SLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred cHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence 99999976543 445555667889999999999999 99999999999999999999999999976554321
Q ss_pred CCCccCCCCcCCccChhhhhcC---CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhh-hhcCCcccccccc
Q 002512 676 SPLAELPAGTLGYLDPEYYRLH---YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPL-IKSGDITAILDPV 751 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~---~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~-~~~~~~~~~~d~~ 751 (914)
........||+.|||||++.+. ....+.||||+|||++||+||++||.....+ |+..+ +..|....+
T Consensus 1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-----~aIMy~V~~gh~Pq~---- 1462 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-----WAIMYHVAAGHKPQI---- 1462 (1509)
T ss_pred CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-----hHHHhHHhccCCCCC----
Confidence 1112334699999999999643 3567899999999999999999999754332 32222 222322222
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+.....+=.+++.+||+.||+.|.++.|+++
T Consensus 1463 -----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1463 -----PERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred -----chhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1224456678999999999999977765543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=299.60 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=190.1
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC------eEEE
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR------ERLL 589 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~L 589 (914)
.+.+.||+|+||.||++... +++.||||++..........+.+.+|++++++++||||+++++++.... ..++
T Consensus 18 ~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~l 97 (343)
T cd07880 18 RDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYL 97 (343)
T ss_pred EEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEE
Confidence 34567999999999999865 6899999987543333333467889999999999999999999987654 4589
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
||||+ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||++..
T Consensus 98 v~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~ 167 (343)
T cd07880 98 VMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 167 (343)
T ss_pred EEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccc
Confidence 99999 77999888642 4788889999999999999999999 99999999999999999999999999876
Q ss_pred CCCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHH----------Hhh
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA----------VPL 738 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~----------~~~ 738 (914)
.... .....+++.|+|||.+.. ..++.++||||||+++|||++|+.||........+.... ...
T Consensus 168 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 168 TDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred cccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 4322 122357889999999876 458899999999999999999999986432211111100 000
Q ss_pred hhcCCcccccccccCCC------CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 739 IKSGDITAILDPVLKLP------SDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 739 ~~~~~~~~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+................ ........+.+++.+|++.+|++|||+.+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000000000 00122346889999999999999999999874
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=275.79 Aligned_cols=262 Identities=22% Similarity=0.374 Sum_probs=201.8
Q ss_pred CHHHHHHHhcccccccCcccceEEEEEE-EcCCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecC
Q 002512 507 TYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEG 584 (914)
Q Consensus 507 ~~~el~~~t~~~~~~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~ 584 (914)
+++|+.+.| .+.||+|+|+.|--.+ +..+..+|||++.+.. .....+..+|++++.+. .|+||+.|+++|+++
T Consensus 74 ~F~d~YkLt---~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT---SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH---HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 356777666 4679999999999877 5689999999875442 23347788999999999 699999999999999
Q ss_pred CeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCc---EEE
Q 002512 585 RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHN---ARV 661 (914)
Q Consensus 585 ~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~---~kl 661 (914)
..+|||||-|.||.|..+|+++. .++..+.-++..+|+.||.|||.++ |.||||||+|||-.+... +||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKi 220 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKI 220 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceee
Confidence 99999999999999999998753 4788888899999999999999999 999999999999976554 799
Q ss_pred eecCCcccCCCC-----CCCCCccCCCCcCCccChhhhh-----cCCCCCcchHHHHHHHHHHHHhCCCCccccccc---
Q 002512 662 ADFGLSLLGPAD-----SSSPLAELPAGTLGYLDPEYYR-----LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE--- 728 (914)
Q Consensus 662 ~DFGla~~~~~~-----~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~--- 728 (914)
+||.|..-.... ...+....++|+..|||||+.. ...|+.++|.||||||||-||+|.+||...-.+
T Consensus 221 CDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 221 CDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred eccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 999987432211 1122234567999999999873 347899999999999999999999999753322
Q ss_pred ---ccH----HHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 729 ---GNI----VEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 729 ---~~l----~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
++. .+.....+++|... +.|.. -.....+..+++...+..++.+|.++.+++.
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYe-FPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYE-FPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCc-CChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111 11222344444332 11111 1134567778889999999999998887765
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-33 Score=282.64 Aligned_cols=265 Identities=24% Similarity=0.325 Sum_probs=199.2
Q ss_pred ccCCHHHHHHHhcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeecee
Q 002512 504 QMFTYEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYC 581 (914)
Q Consensus 504 ~~~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~ 581 (914)
..|+-++|+.. ..||.|+||+|+|-.++ .|+..|||++..... .++.++|+.|.+...+- +.||||+++|.+
T Consensus 59 ~~F~~~~Lqdl-----g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 59 HTFTSDNLQDL-----GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred cccccchHHHH-----HHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 34555566542 35999999999999876 599999999876654 44557899999887776 789999999999
Q ss_pred ecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEE
Q 002512 582 EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARV 661 (914)
Q Consensus 582 ~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl 661 (914)
..+...+|.||.|. -||+.+...-....+..+++...-.|..-.++||.||.+.- .||||||||+||||+..|.+||
T Consensus 133 F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKL 209 (361)
T KOG1006|consen 133 FSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKL 209 (361)
T ss_pred hcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEee
Confidence 99999999999995 57766543222222345777777788889999999998764 3999999999999999999999
Q ss_pred eecCCcccCCCCCCCCCccCCCCcCCccChhhhhc--CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhh
Q 002512 662 ADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL--HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLI 739 (914)
Q Consensus 662 ~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~--~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~ 739 (914)
+|||++-.+..+- ..+...|-..|||||.+.. ..|..+|||||||++|||+.||+.|+..-. +..+.+.. +
T Consensus 210 CDFGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~---svfeql~~-V 282 (361)
T KOG1006|consen 210 CDFGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD---SVFEQLCQ-V 282 (361)
T ss_pred ecccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH---HHHHHHHH-H
Confidence 9999986543321 2334568899999999953 358899999999999999999999975321 12222222 2
Q ss_pred hcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 740 KSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
..++...+.. .....+....+..++..|+..|-.+||.+.++.+.
T Consensus 283 v~gdpp~l~~----~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 283 VIGDPPILLF----DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred HcCCCCeecC----cccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 2232222111 11123456788999999999999999999988754
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=296.11 Aligned_cols=260 Identities=20% Similarity=0.252 Sum_probs=188.1
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC----------
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG---------- 584 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~---------- 584 (914)
+.+.+.||.|+||.||++... +++.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 345677999999999999975 588999998754432 3446789999999999999999999876543
Q ss_pred ----CeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEc-CCCcE
Q 002512 585 ----RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID-EEHNA 659 (914)
Q Consensus 585 ----~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~-~~~~~ 659 (914)
...++||||++ ++|.+++... .+++.....++.||++||.|||+.+ |+||||||+|||++ ++..+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999997 5999888642 4788888999999999999999999 99999999999997 45678
Q ss_pred EEeecCCcccCCCCCCC-CCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHh
Q 002512 660 RVADFGLSLLGPADSSS-PLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVP 737 (914)
Q Consensus 660 kl~DFGla~~~~~~~~~-~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~ 737 (914)
||+|||++......... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||...............
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998765332111 11122357889999998754 56788999999999999999999999643222111111000
Q ss_pred h--hhc---CC----c-ccccccccCCCC-----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 738 L--IKS---GD----I-TAILDPVLKLPS-----DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 738 ~--~~~---~~----~-~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
. ... .. + ............ ......++.+++.+||+.+|++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0 000 00 0 000000000000 0123357889999999999999999998874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=298.18 Aligned_cols=265 Identities=22% Similarity=0.271 Sum_probs=192.1
Q ss_pred HHHHHHhcc--cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC-
Q 002512 509 EELERATGG--FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG- 584 (914)
Q Consensus 509 ~el~~~t~~--~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~- 584 (914)
.++...+.+ +.+.||+|+||.||++... +++.||+|++..........+.+.+|+.++.+++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 334434433 3457999999999999864 688999998865433333346788999999999999999999988643
Q ss_pred -----CeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcE
Q 002512 585 -----RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA 659 (914)
Q Consensus 585 -----~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 659 (914)
...++++|++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~ 159 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCEL 159 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCE
Confidence 3467888887 78998887642 4788889999999999999999999 9999999999999999999
Q ss_pred EEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH--
Q 002512 660 RVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV-- 736 (914)
Q Consensus 660 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~-- 736 (914)
||+|||+++..... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||........+.....
T Consensus 160 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (345)
T cd07877 160 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234 (345)
T ss_pred EEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999998754321 123457889999999876 5688999999999999999999999854322111111000
Q ss_pred --------hhhhcCCcccc---cccccCCCC---CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 737 --------PLIKSGDITAI---LDPVLKLPS---DLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 737 --------~~~~~~~~~~~---~d~~l~~~~---~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
..+........ ++....... ......++.+++.+|++.+|.+||++.+++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000000000 000000000 00123568899999999999999999888754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=278.46 Aligned_cols=203 Identities=26% Similarity=0.345 Sum_probs=169.4
Q ss_pred cccccCcccceEEEEEEEcC-----CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeec-CCeEEEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLKD-----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE-GRERLLVY 591 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~LV~ 591 (914)
...+||+|.||.|||+.-++ .+.+|+|++....+.........+|+.+++.|+||||+.|..+|.. +...+|++
T Consensus 28 ~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~f 107 (438)
T KOG0666|consen 28 GIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLF 107 (438)
T ss_pred ccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEe
Confidence 45679999999999996432 3478999987665444445678899999999999999999999987 77889999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC----CcEEEeecCCc
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE----HNARVADFGLS 667 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~----~~~kl~DFGla 667 (914)
||.+. +|.+.|+-.+......++-.....|+.||+.|+.|||++- |+||||||+|||+..+ |.+||+|||++
T Consensus 108 dYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGla 183 (438)
T KOG0666|consen 108 DYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLA 183 (438)
T ss_pred hhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHH
Confidence 99987 8999887655544567888889999999999999999999 9999999999999877 89999999999
Q ss_pred ccCCCCCCCC-CccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCccc
Q 002512 668 LLGPADSSSP-LAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDM 724 (914)
Q Consensus 668 ~~~~~~~~~~-~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~ 724 (914)
+++...-..- .....+-|+-|.|||.+.+. .||.+.|||+.|||+.||||-++.|..
T Consensus 184 R~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 184 RLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred HHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 9875432221 22334578999999999875 689999999999999999999877753
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=299.84 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=190.5
Q ss_pred cccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCe------EEEE
Q 002512 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRE------RLLV 590 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~------~~LV 590 (914)
+.+.||+|+||.||+++.. +++.||+|++..........+.+.+|+.++++++||||+++++++...+. .++|
T Consensus 19 ~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv 98 (343)
T cd07851 19 NLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98 (343)
T ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEE
Confidence 4567999999999999986 57899999875433333344668889999999999999999998876655 8999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 99 ~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 99 THLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred EecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccc
Confidence 9998 6799999864 24788899999999999999999999 999999999999999999999999998765
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH----------hhh
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV----------PLI 739 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~----------~~~ 739 (914)
... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||........+..... ..+
T Consensus 169 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred ccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 332 223357889999999865 3678999999999999999999999864322111111000 000
Q ss_pred hcCCcccccccccCC-CCC-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 740 KSGDITAILDPVLKL-PSD-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 740 ~~~~~~~~~d~~l~~-~~~-----~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
........+...... ... .....++.+++.+||+.+|++|||+.||+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000000 000 012467889999999999999999998864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=281.16 Aligned_cols=222 Identities=18% Similarity=0.199 Sum_probs=176.7
Q ss_pred ccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCHHHhh
Q 002512 525 GSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL 603 (914)
Q Consensus 525 G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l 603 (914)
|.||.||+++.+ +++.+|+|++.... .+.+|...+....||||+++++++.+.+..+|||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999975 58899999875432 3445556666678999999999999999999999999999999998
Q ss_pred hcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCccCCC
Q 002512 604 HGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA 683 (914)
Q Consensus 604 ~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 683 (914)
.... .+++.....++.|+++||+|||+.+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 77 ~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~ 143 (237)
T cd05576 77 SKFL-----NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEA 143 (237)
T ss_pred HHhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCC
Confidence 7542 4788999999999999999999999 9999999999999999999999999876543321 1234
Q ss_pred CcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHH
Q 002512 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKR 763 (914)
Q Consensus 684 Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 763 (914)
++..|+|||++....++.++||||||+++|||++|+.|+...... .... ..+..+ ......
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~----------~~~~-------~~~~~~--~~~~~~ 204 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG----------INTH-------TTLNIP--EWVSEE 204 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh----------cccc-------cccCCc--ccCCHH
Confidence 567899999998888899999999999999999999876422110 0000 000111 123457
Q ss_pred HHHHHHHhhhcCCCCCCCHHHH
Q 002512 764 IANVACKCVRMRGKERPSMDKV 785 (914)
Q Consensus 764 l~~l~~~Cl~~~p~~RPs~~ev 785 (914)
+.+++.+|++.||++||++.+.
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~~ 226 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGVA 226 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCcc
Confidence 8899999999999999997543
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=274.47 Aligned_cols=243 Identities=21% Similarity=0.307 Sum_probs=195.4
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeec----CCeEEEEEee
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEE----GRERLLVYEF 593 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~----~~~~~LV~Ey 593 (914)
++||-|-.|.|.....+ .++.+|+|++... ...++|+++.-+. .|||||.++++|++ ...+++|||+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 56999999999999876 5888999977432 4567899887777 69999999999865 3466899999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC---CCcEEEeecCCcccC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE---EHNARVADFGLSLLG 670 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kl~DFGla~~~ 670 (914)
|+||.|...|++++. ..++..+.-.|..||..|+.|||+.+ |.||||||+|+|... |-.+||+|||+|+..
T Consensus 141 meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t 214 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET 214 (400)
T ss_pred ccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccccccc
Confidence 999999999987654 46889999999999999999999999 999999999999964 556899999999864
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
.. ......+.-|+.|.|||++...+|+...|+||+||++|-||+|.+||+...... +.--+...+..+.
T Consensus 215 ~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-ispgMk~rI~~gq------- 283 (400)
T KOG0604|consen 215 QE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKRRIRTGQ------- 283 (400)
T ss_pred CC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-CChhHHhHhhccC-------
Confidence 43 234456778999999999999999999999999999999999999997654321 1111222233332
Q ss_pred ccCCCCC--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 751 VLKLPSD--LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~l~~~~~--~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
..+|.+ ...++...++++..|+.+|++|.|++++++
T Consensus 284 -y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 284 -YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 222222 356678889999999999999999998864
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=288.41 Aligned_cols=243 Identities=23% Similarity=0.295 Sum_probs=195.5
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
..||+||||.||-.+.+ .|+.+|.|++.+... ..+.....++|-.+|.+++.+-||.|-..|+..+.++||+..|.||
T Consensus 191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG 270 (591)
T KOG0986|consen 191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG 270 (591)
T ss_pred EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence 46999999999998866 489999998754432 2233455788999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|.-+|...+. ..++....+.++.+|+-||++||... ||.|||||+|||||+.|+++|+|+|||..++....
T Consensus 271 DLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~-- 342 (591)
T KOG0986|consen 271 DLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP-- 342 (591)
T ss_pred ceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCc--
Confidence 99999976653 35888889999999999999999999 99999999999999999999999999987765543
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCC
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~ 757 (914)
....+||.+|||||+++...|+...|.|||||+||||+.|+.||....+...- +.+...+.+. .. ..+
T Consensus 343 -~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~-eEvdrr~~~~--------~~--ey~ 410 (591)
T KOG0986|consen 343 -IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR-EEVDRRTLED--------PE--EYS 410 (591)
T ss_pred -cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH-HHHHHHHhcc--------hh--hcc
Confidence 23347999999999999999999999999999999999999999654332111 0111111111 11 112
Q ss_pred HHHHHHHHHHHHHhhhcCCCCCCCH
Q 002512 758 LDALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 758 ~~~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
....++..+|....|..||.+|.--
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccC
Confidence 3445677888999999999999643
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=317.68 Aligned_cols=144 Identities=27% Similarity=0.405 Sum_probs=126.8
Q ss_pred ccccccCcccceEEEEEEEc-CCcEEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.++||+|+||.||++.+. +++.||||++..... .......+.+|+.++..++||||+++++++...+..+|||||+
T Consensus 7 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~ 86 (669)
T cd05610 7 VIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYL 86 (669)
T ss_pred EEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCC
Confidence 45678999999999999976 588999998864322 2223467889999999999999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
++++|.++++... .+++...+.|+.||+.||+|||+.+ ||||||||+||||+.++.+||+|||+++
T Consensus 87 ~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 87 IGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999997543 4677888999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=273.53 Aligned_cols=246 Identities=24% Similarity=0.315 Sum_probs=196.2
Q ss_pred cCCHHHHHHHhcccccccCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceee
Q 002512 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCE 582 (914)
Q Consensus 505 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~ 582 (914)
..+.++.+ |.+.||+|.||+|.+.+-+ .++.+|+|++++..-. ..+...-+.|-++|+..+||-+..|-..|+
T Consensus 164 kvTm~dFd-----fLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 164 KVTMEDFD-----FLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred eeccchhh-----HHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 34555543 5678999999999999976 5899999987654322 223345667999999999999999999999
Q ss_pred cCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEe
Q 002512 583 EGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVA 662 (914)
Q Consensus 583 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~ 662 (914)
..+.++.||||..||.|.-+|.+.. .++......+..+|+.||.|||+++ ||.||||.+|+|||++|++||+
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKit 310 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKIT 310 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEee
Confidence 9999999999999999999997643 4677777778999999999999999 9999999999999999999999
Q ss_pred ecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC
Q 002512 663 DFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG 742 (914)
Q Consensus 663 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~ 742 (914)
||||.+..-... ..+...+|||.|+|||++....|..+.|.|.+|||||||++|+.||.....+ .+.+ ++...
T Consensus 311 DFGLCKE~I~~g--~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-kLFe----LIl~e 383 (516)
T KOG0690|consen 311 DFGLCKEEIKYG--DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-KLFE----LILME 383 (516)
T ss_pred ecccchhccccc--ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-HHHH----HHHhh
Confidence 999997643322 2455678999999999999999999999999999999999999999754322 2222 12111
Q ss_pred CcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCC
Q 002512 743 DITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERP 780 (914)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 780 (914)
+ ++.| .....+...|+...|..||.+|.
T Consensus 384 d--------~kFP--r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 D--------LKFP--RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred h--------ccCC--ccCCHHHHHHHHHHhhcChHhhc
Confidence 1 1222 12234667888999999999995
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=272.70 Aligned_cols=239 Identities=26% Similarity=0.370 Sum_probs=192.4
Q ss_pred cceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCHHHhhh
Q 002512 526 SFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLH 604 (914)
Q Consensus 526 ~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~ 604 (914)
+||.||+++..+ ++.+++|++........ .+.|.+|++.+++++|+||+++++++......+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999874 89999998765433221 5789999999999999999999999999999999999999999999987
Q ss_pred cCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCccCCCC
Q 002512 605 GKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAG 684 (914)
Q Consensus 605 ~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~G 684 (914)
... .+++..++.++.+++++|.|||+.+ |+|+||+|+||++++++.++|+|||++....... ......+
T Consensus 80 ~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~ 148 (244)
T smart00220 80 KRG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVG 148 (244)
T ss_pred hcc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccC
Confidence 543 2788889999999999999999998 9999999999999999999999999997755432 2233457
Q ss_pred cCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHH
Q 002512 685 TLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRI 764 (914)
Q Consensus 685 t~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l 764 (914)
+..|++||.+....++.++||||||+++|||++|..||..........+ .+....... .........++
T Consensus 149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~----~~~~~~~~~-------~~~~~~~~~~~ 217 (244)
T smart00220 149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK----KIGKPKPPF-------PPPEWKISPEA 217 (244)
T ss_pred CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH----HHhccCCCC-------ccccccCCHHH
Confidence 8899999999988889999999999999999999999864322222211 111111110 00000034678
Q ss_pred HHHHHHhhhcCCCCCCCHHHHHH
Q 002512 765 ANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 765 ~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 89999999999999999999985
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=311.69 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=196.6
Q ss_pred cccccCcccceEEEEEEEcC-CcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.||+|+||.|.+++++. ++.+|+|++.+-... .....-|..|-.+|..-+.+-|+.|+..|.+++++|||||||+
T Consensus 79 ilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~p 158 (1317)
T KOG0612|consen 79 ILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMP 158 (1317)
T ss_pred HHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEeccc
Confidence 45789999999999999874 788999987653221 2334568999999999899999999999999999999999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
||+|..+|.+.. .++......++..|+-||.-||+.+ +|||||||+|||||..|++||+|||-+-.+..+..
T Consensus 159 GGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~ 230 (1317)
T KOG0612|consen 159 GGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGT 230 (1317)
T ss_pred CchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCc
Confidence 999999997654 3666667788999999999999999 99999999999999999999999998876665543
Q ss_pred CCCccCCCCcCCccChhhhhc-----CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 676 SPLAELPAGTLGYLDPEYYRL-----HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~-----~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
......+|||-|++||+++. +.|...+|.||+||++||||.|..||+.. .+++--...+.- ..
T Consensus 231 -V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad----slveTY~KIm~h-------k~ 298 (1317)
T KOG0612|consen 231 -VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD----SLVETYGKIMNH-------KE 298 (1317)
T ss_pred -EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH----HHHHHHHHHhch-------hh
Confidence 34456789999999999952 57899999999999999999999999743 233211111111 12
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPS---MDKVTT 787 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs---~~ev~~ 787 (914)
.+.+|...+.+++..+||.+.+. +|+.|.. ++++..
T Consensus 299 ~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 299 SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 33445445566778888887665 5666766 666543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=286.19 Aligned_cols=244 Identities=24% Similarity=0.347 Sum_probs=195.1
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
+.||+|.||+||-|+++ .|+.||||++.+..-..+....+++|+.||++++||.||.|.-.|+..+..|+|||-+ +|+
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~GD 648 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HGD 648 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cch
Confidence 45999999999999975 6999999998776655556688999999999999999999999999999999999999 556
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC---CcEEEeecCCcccCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE---HNARVADFGLSLLGPADSS 675 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~---~~~kl~DFGla~~~~~~~~ 675 (914)
..+.|-... +..|+......+..||+.||.|||.++ |+|.||||+||||... -++||+|||+|++.....
T Consensus 649 MLEMILSsE---kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 649 MLEMILSSE---KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred HHHHHHHhh---cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 666664322 235777777788999999999999999 9999999999999643 469999999999876543
Q ss_pred CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCC
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~ 755 (914)
.....+||+.|+|||+++.+.|...-|+||.|||+|--|+|..||... +++-+ .+++..+. ....
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd---EdInd----QIQNAaFM------yPp~ 786 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED---EDIND----QIQNAAFM------YPPN 786 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc---cchhH----Hhhccccc------cCCC
Confidence 445678999999999999999999999999999999999999998643 22221 12221111 1111
Q ss_pred CCHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVT 786 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~ 786 (914)
+-.+.....++||...|+..-.+|-|.++-+
T Consensus 787 PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 787 PWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred chhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 2234556778899999999888888876554
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=296.03 Aligned_cols=249 Identities=25% Similarity=0.370 Sum_probs=201.8
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeec-----CCeEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEE-----GRERL 588 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~-----~~~~~ 588 (914)
..|.+.||+|.+|.||+++.. +++.+|||++....+. .++...|.++|+.+ +|||++.++|++.. ++.++
T Consensus 21 ~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLW 97 (953)
T KOG0587|consen 21 FEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLW 97 (953)
T ss_pred cEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEE
Confidence 346788999999999999954 6888999977655433 26788899999988 79999999999854 56899
Q ss_pred EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
||||||.+||.-|+++... ...+.|..+.-|+..++.||.+||... +||||||-.||||+.++.+||.|||++.
T Consensus 98 LVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 98 LVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred EEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeee
Confidence 9999999999999998654 457899999999999999999999999 9999999999999999999999999997
Q ss_pred cCCCCCCCCCccCCCCcCCccChhhhhc-----CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRL-----HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD 743 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~~-----~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~ 743 (914)
.+.... ....+..||+.|||||++.. ..|+.++|+||||++..||--|.+|+.+.....-+ +.
T Consensus 172 QldsT~--grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-------F~--- 239 (953)
T KOG0587|consen 172 QLDSTV--GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------FL--- 239 (953)
T ss_pred eeeccc--ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-------cc---
Confidence 654332 23445679999999999853 34778999999999999999999998644322111 11
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+ ...|...+..+....+++.+++..||..|.++||++.++++
T Consensus 240 I--pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 240 I--PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred C--CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 1 11233333445567789999999999999999999998864
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=291.74 Aligned_cols=236 Identities=25% Similarity=0.348 Sum_probs=190.8
Q ss_pred cccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEee
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.|...+|.|+|+.|-.+.+. .++..+||++.... .+-.+|+.++.+. +||||+++.+.+.+..+.|+|||+
T Consensus 324 y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~ 397 (612)
T KOG0603|consen 324 YEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL 397 (612)
T ss_pred hccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence 446667999999999998865 58889999875441 2334677777766 899999999999999999999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE-cCCCcEEEeecCCcccCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI-DEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl-~~~~~~kl~DFGla~~~~~ 672 (914)
+.++-|.+.+..... .. ..+..|+.+|+.++.|||+++ ||||||||+|||+ ++.++++|+|||.++....
T Consensus 398 l~g~ell~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 398 LDGGELLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred ccccHHHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 999999888865432 22 566779999999999999999 9999999999999 6899999999999988766
Q ss_pred CCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccccc
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l 752 (914)
+ ...+.-|..|.|||++....+++++|+||||++|||||+|+.||.......+ ....+..+.
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e----i~~~i~~~~--------- 530 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE----IHTRIQMPK--------- 530 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH----HHHhhcCCc---------
Confidence 5 2334568899999999999999999999999999999999999865433211 112222221
Q ss_pred CCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....++...+|+.+||+.||.+||+|.++..
T Consensus 531 ---~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 531 ---FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred ---cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 12345567889999999999999999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=276.49 Aligned_cols=242 Identities=24% Similarity=0.297 Sum_probs=194.5
Q ss_pred HhcccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccc-cchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEE
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQ-KNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV 590 (914)
..-+|...||+|+||.|.++..+. .+.+|||++.+..-.+ ...+--+.|-++|... +-|-++.|+.+|+..+.+|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 345788999999999999998764 6789999876543222 2234456788888877 567899999999999999999
Q ss_pred EeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
|||+.||+|--+|++-++ +.....+.++.+||-||-|||+++ ||.||||.+|||||.++++||+|||+++..
T Consensus 429 MEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999987654 666777889999999999999999 999999999999999999999999999764
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
-.+. ..+.+..||+.|+|||++...+|....|.|||||+|||||.|.+||+...+++ +. ..+.+.+
T Consensus 501 i~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-lF----~aI~ehn------- 566 (683)
T KOG0696|consen 501 IFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LF----QAIMEHN------- 566 (683)
T ss_pred ccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-HH----HHHHHcc-------
Confidence 3332 24556789999999999999999999999999999999999999998654443 22 1222221
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCC
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERP 780 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 780 (914)
. ..+...+.+...|....|...|.+|.
T Consensus 567 -v--syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 -V--SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -C--cCcccccHHHHHHHHHHhhcCCcccc
Confidence 1 22334455677888888999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=291.38 Aligned_cols=262 Identities=18% Similarity=0.244 Sum_probs=176.5
Q ss_pred ccccccCcccceEEEEEEE-----------------cCCcEEEEEEeeeccccc------------cchHHHHHHHHHHH
Q 002512 517 GFKEEVGKGSFSCVYKGVL-----------------KDGTVVAVKKAIATSDRQ------------KNSKEFHTELDLLS 567 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~f~~E~~~l~ 567 (914)
.+.++||+|+||.||+|.+ .+++.||||++....... ...+.+..|+.++.
T Consensus 148 ~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~ 227 (507)
T PLN03224 148 QLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCA 227 (507)
T ss_pred eEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHH
Confidence 3457799999999999964 235689999975432210 01123445778888
Q ss_pred hccCCce-----eeeeceeec--------CCeEEEEEeeCCCCCHHHhhhcCccc-------------------hhcccc
Q 002512 568 RLNHAHL-----LNLLGYCEE--------GRERLLVYEFMAHGSLHQHLHGKSKA-------------------LKEQLD 615 (914)
Q Consensus 568 ~l~HpnI-----v~l~g~~~~--------~~~~~LV~Ey~~~gsL~~~l~~~~~~-------------------~~~~l~ 615 (914)
+++|.++ +++++||.. ....+|||||+++++|.++|+..... ....++
T Consensus 228 ~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~ 307 (507)
T PLN03224 228 KIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRD 307 (507)
T ss_pred HhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCC
Confidence 8876654 778888753 34689999999999999999753210 112356
Q ss_pred hhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhh
Q 002512 616 WVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695 (914)
Q Consensus 616 ~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~ 695 (914)
|..+..++.|++++|.|||+.+ |+||||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.
T Consensus 308 ~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~l~ 383 (507)
T PLN03224 308 INVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEELV 383 (507)
T ss_pred HHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhhhc
Confidence 7788899999999999999998 999999999999999999999999999764432211 111223578999999985
Q ss_pred cCC----------------------CCCcchHHHHHHHHHHHHhCCC-Cccccccc-ccHHH--HHHhhhhcCCcccccc
Q 002512 696 LHY----------------------LTTKSDVYSFGVLLLEILSGRK-AIDMQFEE-GNIVE--WAVPLIKSGDITAILD 749 (914)
Q Consensus 696 ~~~----------------------~s~ksDV~S~GvvL~ElltG~~-p~~~~~~~-~~l~~--~~~~~~~~~~~~~~~d 749 (914)
... ...+.||||+||+||||+++.. |+...... .++.. .....+. ....
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-----~~~~ 458 (507)
T PLN03224 384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-----MYKG 458 (507)
T ss_pred CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-----hhcc
Confidence 432 1235799999999999999985 55321100 00000 0000000 0000
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCC---CCCCCHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRG---KERPSMDKVTT 787 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p---~~RPs~~ev~~ 787 (914)
.....+..........+|+.++|..+| .+|+|++|+++
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 111111112234577889999999766 68999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-31 Score=261.78 Aligned_cols=260 Identities=22% Similarity=0.347 Sum_probs=193.0
Q ss_pred ccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC--------CeEEEEE
Q 002512 521 EVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--------RERLLVY 591 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--------~~~~LV~ 591 (914)
+||+|.||.||+++.++ ++.||+|+.....+....-..-++|+++|..|+|+|++.++..|... ..+||||
T Consensus 24 kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf 103 (376)
T KOG0669|consen 24 KIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVF 103 (376)
T ss_pred hcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeH
Confidence 59999999999999764 78899998766555444456678999999999999999999988542 2479999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
++++. +|.-+|.... ..++...+.++..++..||.|+|... |+|||+||+|+||+.++.+||+|||+++.+.
T Consensus 104 ~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~fs 175 (376)
T KOG0669|consen 104 DFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAFS 175 (376)
T ss_pred HHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccccee
Confidence 99986 8888886542 35888889999999999999999999 9999999999999999999999999997654
Q ss_pred CCCC--CCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHH--H--------HHhh
Q 002512 672 ADSS--SPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE--W--------AVPL 738 (914)
Q Consensus 672 ~~~~--~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~--~--------~~~~ 738 (914)
.... ....+..+-|..|.+||.+.+. .++++.|||.-||||.||+|+.+.+..+.+...+.. . ++|-
T Consensus 176 ~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~ 255 (376)
T KOG0669|consen 176 TSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPN 255 (376)
T ss_pred cccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCC
Confidence 4322 2223444568999999998764 689999999999999999999988875544332211 0 1110
Q ss_pred hhcCCccccc--ccccCCCC--CHHHH------HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 739 IKSGDITAIL--DPVLKLPS--DLDAL------KRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 739 ~~~~~~~~~~--d~~l~~~~--~~~~~------~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
...-.+.+-+ +|...... -.+.+ .+..+|+..++..||.+||+..+++..
T Consensus 256 ~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 256 VDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0000000000 00000000 01111 266789999999999999999988754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=295.53 Aligned_cols=256 Identities=19% Similarity=0.237 Sum_probs=163.5
Q ss_pred cccccccCcccceEEEEEEEcC-----CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeece------eecC
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD-----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY------CEEG 584 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~------~~~~ 584 (914)
+.+.+.||+|+||.||+|++.+ +..||+|++..... .+.+..| .+.+..+.+++.++.. ..+.
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhcccccccC
Confidence 3456789999999999999764 68999998643221 1222222 1222223333333222 2456
Q ss_pred CeEEEEEeeCCCCCHHHhhhcCccch---------------hcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCcc
Q 002512 585 RERLLVYEFMAHGSLHQHLHGKSKAL---------------KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSS 649 (914)
Q Consensus 585 ~~~~LV~Ey~~~gsL~~~l~~~~~~~---------------~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~ 649 (914)
...+|||||+++++|.++++...... ........+..|+.||+.||+|||+++ |+||||||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~ 284 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQ 284 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHH
Confidence 68899999999999999987542100 001122335578999999999999998 999999999
Q ss_pred ceEEcC-CCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcC----------------------CCCCcchHH
Q 002512 650 NILIDE-EHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH----------------------YLTTKSDVY 706 (914)
Q Consensus 650 NILl~~-~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~----------------------~~s~ksDV~ 706 (914)
||||++ ++.+||+|||+++........ ......+|+.|||||.+... .++.++|||
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred HEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 999986 578999999999765433222 22345689999999976422 234567999
Q ss_pred HHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC-----cccccccccCCC------CCHHHHHHHHHHHHHhhhcC
Q 002512 707 SFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD-----ITAILDPVLKLP------SDLDALKRIANVACKCVRMR 775 (914)
Q Consensus 707 S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~-----~~~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~~ 775 (914)
||||+||||+++..+.+.. +.... ..+.... +....++..... ..........+|+.+||+.|
T Consensus 364 SlGviL~el~~~~~~~~~~-----~~~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDSN-----LIQFN-RQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHHHHHHhCcCCCchH-----HHHHH-HHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 9999999999977654321 11110 1111000 000111110000 00001123458999999999
Q ss_pred CCCCCCHHHHHH
Q 002512 776 GKERPSMDKVTT 787 (914)
Q Consensus 776 p~~RPs~~ev~~ 787 (914)
|++|||++|+++
T Consensus 438 P~kR~ta~e~L~ 449 (566)
T PLN03225 438 GRQRISAKAALA 449 (566)
T ss_pred cccCCCHHHHhC
Confidence 999999998875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=292.33 Aligned_cols=242 Identities=26% Similarity=0.393 Sum_probs=185.6
Q ss_pred cccCcccce-EEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 520 EEVGKGSFS-CVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 520 ~~LG~G~fG-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
+.+|.|..| .||+|..+ ++.||||++.... ..-..+|+..|+.- +|||||++++.-.+....||..|.|. -
T Consensus 515 eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~ 587 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE-GREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-C 587 (903)
T ss_pred HHcccCCCCcEEEEEeeC-CceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-h
Confidence 448999987 57999996 8999999885432 23457899999988 79999999999889999999999995 5
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC---C--CcEEEeecCCcccCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE---E--HNARVADFGLSLLGPA 672 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~---~--~~~kl~DFGla~~~~~ 672 (914)
+|++++...... .....-...+.+..|+++||+|||+.+ ||||||||.||||+. + ..++|+|||+++.+..
T Consensus 588 sL~dlie~~~~d-~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 SLQDLIESSGLD-VEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hHHHHHhccccc-hhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 999999874111 111111344678899999999999999 999999999999975 3 4689999999998766
Q ss_pred CCCC-CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhC-CCCcccccccc-cHHHHHHhhhhcCCcccccc
Q 002512 673 DSSS-PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG-RKAIDMQFEEG-NIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 673 ~~~~-~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG-~~p~~~~~~~~-~l~~~~~~~~~~~~~~~~~d 749 (914)
+... .......||-+|+|||++....-+.+.||||||||+|+.++| ++||....+.+ ++. .+..
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl--------~~~~----- 730 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL--------TGNY----- 730 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh--------cCcc-----
Confidence 5433 234456799999999999998888899999999999999997 78986543221 111 1110
Q ss_pred cccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 750 ~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
....+.+..+. +..+||.+|+.++|..||++.+|+.
T Consensus 731 ~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 731 TLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 01111122222 6789999999999999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.2e-29 Score=272.99 Aligned_cols=212 Identities=25% Similarity=0.326 Sum_probs=170.4
Q ss_pred CHHHHHHHhcc---cc--cccCcccceEEEEEEEcC-CcEEEEEEeeecc-ccccchHHHHHHHHHHHhccCCceeeeec
Q 002512 507 TYEELERATGG---FK--EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLG 579 (914)
Q Consensus 507 ~~~el~~~t~~---~~--~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g 579 (914)
.|-.|+++.-. |. +.||-|+||+|.++...| ...+|.|.+.+.. ...........|-+||..-+.+-||+|+.
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 44556555432 33 349999999999998554 5678888775543 12223455778999999999999999999
Q ss_pred eeecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcE
Q 002512 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA 659 (914)
Q Consensus 580 ~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~ 659 (914)
.|.+.+.+|+||||++||++-.+|.+.+. +.+.....++.++..|+++.|..+ +|||||||+|||||.+|++
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrmgI-----FeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHI 768 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRMGI-----FEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHI 768 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHhcc-----CHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCce
Confidence 99999999999999999999999987653 666666778889999999999999 9999999999999999999
Q ss_pred EEeecCCcccCC--------CCCCC--------------------------------CCccCCCCcCCccChhhhhcCCC
Q 002512 660 RVADFGLSLLGP--------ADSSS--------------------------------PLAELPAGTLGYLDPEYYRLHYL 699 (914)
Q Consensus 660 kl~DFGla~~~~--------~~~~~--------------------------------~~~~~~~Gt~~y~aPE~l~~~~~ 699 (914)
||.||||+.-+. ....+ ......+||+.|+|||++....+
T Consensus 769 KLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~ 848 (1034)
T KOG0608|consen 769 KLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY 848 (1034)
T ss_pred eeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc
Confidence 999999974221 00000 00123459999999999999999
Q ss_pred CCcchHHHHHHHHHHHHhCCCCccccc
Q 002512 700 TTKSDVYSFGVLLLEILSGRKAIDMQF 726 (914)
Q Consensus 700 s~ksDV~S~GvvL~ElltG~~p~~~~~ 726 (914)
+.-+|.||.|||||||+.|+.||....
T Consensus 849 ~q~cdwws~gvil~em~~g~~pf~~~t 875 (1034)
T KOG0608|consen 849 TQLCDWWSVGVILYEMLVGQPPFLADT 875 (1034)
T ss_pred cccchhhHhhHHHHHHhhCCCCccCCC
Confidence 999999999999999999999997543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=233.32 Aligned_cols=257 Identities=21% Similarity=0.273 Sum_probs=190.6
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
|+||+|.||+|||++.. ..+.||+|+++...+.+.......+|+-+|+.++|+|||++++....++..-||+||+. .+
T Consensus 8 ekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qd 86 (292)
T KOG0662|consen 8 EKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QD 86 (292)
T ss_pred HhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HH
Confidence 57999999999999965 48899999998877666666788999999999999999999999999999999999995 58
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCC
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~ 678 (914)
|.+|+..-. ..++......++.|+++||.|.|+++ +.|||+||.|.||+.|+++|++|||+++.+...-. .
T Consensus 87 lkkyfdsln----g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr--c 157 (292)
T KOG0662|consen 87 LKKYFDSLN----GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR--C 157 (292)
T ss_pred HHHHHHhcC----CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE--e
Confidence 888886543 25777788899999999999999999 99999999999999999999999999986543221 1
Q ss_pred ccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCC-cccccccccHHHHHHhhh--hcCCc---ccccccc
Q 002512 679 AELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKA-IDMQFEEGNIVEWAVPLI--KSGDI---TAILDPV 751 (914)
Q Consensus 679 ~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p-~~~~~~~~~l~~~~~~~~--~~~~~---~~~~d~~ 751 (914)
.....-|.-|.+|+++-+. .|+...|+||-|||+.||..-..| |......+.+...++..- .+... ..+.|-.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 2223468899999998764 588999999999999999985544 544433333433322111 11111 1112211
Q ss_pred cCC--CCC-------HHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002512 752 LKL--PSD-------LDALKRIANVACKCVRMRGKERPSMDKVT 786 (914)
Q Consensus 752 l~~--~~~-------~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~ 786 (914)
.-. +.. +.....=.+++...+.-+|..|.++++.+
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal 281 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL 281 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence 100 000 01112234677777888888888887654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=264.67 Aligned_cols=268 Identities=16% Similarity=0.244 Sum_probs=201.6
Q ss_pred cCCHHHHHHHhcccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhcc-C-C----ceeee
Q 002512 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-H-A----HLLNL 577 (914)
Q Consensus 505 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-H-p----nIv~l 577 (914)
++...|.....+.+.+.+|+|.||.|-+..+.. +..||||+++... +..+.-+-|+++|.+|. + | -+|.+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 344455555666667789999999999998654 6899999875432 33456778999999993 2 3 38899
Q ss_pred eceeecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC--
Q 002512 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE-- 655 (914)
Q Consensus 578 ~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~-- 655 (914)
.++|+..++.+||+|.+ |-|++++|..+.- .+++...+..|+.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y---~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNY---IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSE 229 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCc---cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccc
Confidence 99999999999999988 6699999987643 46888899999999999999999999 999999999999931
Q ss_pred ------------------CCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 002512 656 ------------------EHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717 (914)
Q Consensus 656 ------------------~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt 717 (914)
+..+||+|||-|+...... ...+-|..|.|||++.+-.++.++||||+||||+||.|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 3358999999997754332 34567899999999999999999999999999999999
Q ss_pred CCCCcccccccccHHH--HH--------------HhhhhcCCc-----------ccccccccC----CCCCHHHHHHHHH
Q 002512 718 GRKAIDMQFEEGNIVE--WA--------------VPLIKSGDI-----------TAILDPVLK----LPSDLDALKRIAN 766 (914)
Q Consensus 718 G~~p~~~~~~~~~l~~--~~--------------~~~~~~~~~-----------~~~~d~~l~----~~~~~~~~~~l~~ 766 (914)
|...|+...+.+.+.. .+ .+++..+.+ ..+.++... .....++..+|.+
T Consensus 305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfD 384 (415)
T KOG0671|consen 305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFD 384 (415)
T ss_pred cceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHH
Confidence 9998875443332211 00 011111111 111111100 1122345568999
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 002512 767 VACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 767 l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
|+..+|..||.+|+|+.|++.
T Consensus 385 Ll~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 385 LLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHccCccccccHHHHhc
Confidence 999999999999999998874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=239.44 Aligned_cols=197 Identities=28% Similarity=0.396 Sum_probs=161.7
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
+.||+|++|.|-+-++. +|+..|+|++...... +..++.++|+.+..+- ..|.+|.++|...++...++.||.|. -
T Consensus 52 ~elGrGayG~vekmrh~~sg~imAvKri~~tvn~-q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-t 129 (282)
T KOG0984|consen 52 EELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNS-QEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-T 129 (282)
T ss_pred hhhcCCccchhhheeeccCCeEEEEeeehhhcCh-HHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-h
Confidence 46999999999888864 6999999998765543 3446788899988776 79999999999988899999999995 4
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
||..+-.+-- .....+++...-+|+..+.+||.|||++-+ +||||+||+||||+.+|++||+|||++-.+..+-
T Consensus 130 Sldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--- 203 (282)
T KOG0984|consen 130 SLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--- 203 (282)
T ss_pred hHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeehhhh---
Confidence 7776654321 123457888888999999999999999753 9999999999999999999999999997654432
Q ss_pred CccCCCCcCCccChhhhhc----CCCCCcchHHHHHHHHHHHHhCCCCccc
Q 002512 678 LAELPAGTLGYLDPEYYRL----HYLTTKSDVYSFGVLLLEILSGRKAIDM 724 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~----~~~s~ksDV~S~GvvL~ElltG~~p~~~ 724 (914)
..+...|-..|||||.+.. ..|+.||||||||+++.||.+++.|++.
T Consensus 204 Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 204 AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 1223457889999999853 3689999999999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=272.22 Aligned_cols=248 Identities=21% Similarity=0.260 Sum_probs=195.4
Q ss_pred cCCHHHHHHHhcccccccCcccceEEEEEEEcCCc-EEEEEEeeeccc-cccchHHHHHHHHHHHhccCCceeeeeceee
Q 002512 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGT-VVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCE 582 (914)
Q Consensus 505 ~~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~~~~-~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~ 582 (914)
...+++|++. ..||-|+||.|=+...+..+ .+|+|.+.+..- ..+..+....|-.+|.+.+.|.||+||-.|.
T Consensus 416 ~v~l~dl~~i-----aTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr 490 (732)
T KOG0614|consen 416 QVKLSDLKRI-----ATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR 490 (732)
T ss_pred ccchhhhhhh-----hhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence 3455666532 34999999999999887544 377776544321 1233467889999999999999999999999
Q ss_pred cCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEe
Q 002512 583 EGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVA 662 (914)
Q Consensus 583 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~ 662 (914)
+..+.||.||-|-||.|...|+.++. ++......++.-+++|++|||+++ ||.|||||+|+|||.+|-+||.
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLV 562 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLV 562 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEe
Confidence 99999999999999999999987653 666666778899999999999999 9999999999999999999999
Q ss_pred ecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcC
Q 002512 663 DFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG 742 (914)
Q Consensus 663 DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~ 742 (914)
|||+|+.+.... .+.+.+||+.|.|||++..+..+.+.|.|||||++||||+|++||.....-..+ ..+..|
T Consensus 563 DFGFAKki~~g~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY-----n~ILkG 634 (732)
T KOG0614|consen 563 DFGFAKKIGSGR---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY-----NLILKG 634 (732)
T ss_pred ehhhHHHhccCC---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH-----HHHHhh
Confidence 999998765543 345568999999999999999999999999999999999999999754322111 111111
Q ss_pred CcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCC
Q 002512 743 DITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPS 781 (914)
Q Consensus 743 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs 781 (914)
+ | ....+........+|+.+..+.+|.+|.-
T Consensus 635 -i----d---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 635 -I----D---KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -h----h---hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 0 0 11112234456678899999999999976
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=242.20 Aligned_cols=211 Identities=34% Similarity=0.547 Sum_probs=182.4
Q ss_pred cCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCHH
Q 002512 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLH 600 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~ 600 (914)
||+|.+|.||++...+ ++.+++|+........ ..+.+.+|++.+++++|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999865 8899999876543221 3467999999999999999999999999999999999999999999
Q ss_pred HhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC-CCcEEEeecCCcccCCCCCCCCCc
Q 002512 601 QHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE-EHNARVADFGLSLLGPADSSSPLA 679 (914)
Q Consensus 601 ~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kl~DFGla~~~~~~~~~~~~ 679 (914)
+++.... ..+++..+..++.+++++|+|||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~ 150 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LL 150 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hh
Confidence 9997542 24788899999999999999999998 999999999999999 89999999999876544321 12
Q ss_pred cCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCH
Q 002512 680 ELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758 (914)
Q Consensus 680 ~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~ 758 (914)
....+...|++||.+... ..+.++|+|+||+++++|
T Consensus 151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------- 187 (215)
T cd00180 151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------- 187 (215)
T ss_pred hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence 234578899999999887 888999999999999999
Q ss_pred HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 759 DALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 759 ~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 467789999999999999999998864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-29 Score=253.16 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=190.6
Q ss_pred cccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCC-----eEEEEEee
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR-----ERLLVYEF 593 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~-----~~~LV~Ey 593 (914)
+.||-|.||.||..++. +|+.||.||+......-...+++.+|+++|..++|.|++..++...-.. +.|+|.|.
T Consensus 59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL 138 (449)
T KOG0664|consen 59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL 138 (449)
T ss_pred CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence 45999999999999864 7999999998766555555678999999999999999999988765432 46788898
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
|. .+|.+.|-.. +.++-..+.-+..||++||.|||+.+ |.||||||.|.|++.|-.+||+|||+++.-..+
T Consensus 139 mQ-SDLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d 209 (449)
T KOG0664|consen 139 MQ-SDLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR 209 (449)
T ss_pred HH-hhhhheeccC-----CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence 85 4787777543 45777777789999999999999999 999999999999999999999999999986665
Q ss_pred CCCCCccCCCCcCCccChhhhhcC-CCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH-----------hhhhc
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV-----------PLIKS 741 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~-~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~-----------~~~~~ 741 (914)
....+ +..+-|..|.|||.+.+. .|+.+.||||.|||+.|||.++..|.....-..+ +... ..--+
T Consensus 210 ~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL-~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 210 DRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQL-QMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHH-HHHHHHhCCCcHHHHHHHhh
Confidence 54433 334568899999999865 7999999999999999999988777543222111 1111 11111
Q ss_pred CCcccccccc---------cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 002512 742 GDITAILDPV---------LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTAL 789 (914)
Q Consensus 742 ~~~~~~~d~~---------l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L 789 (914)
|....++... .........-.+-..+...++..||+.|.+.++.+..+
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 1111111111 11111112223455777888999999999888776544
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=246.27 Aligned_cols=243 Identities=23% Similarity=0.361 Sum_probs=191.5
Q ss_pred cccccCcccceEEEEEEEcC-CcEEEEEEeeecc-ccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeC
Q 002512 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATS-DRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+...||+|+|++|.+++++. .+.+|+|++++.. ..++.++-.+.|-.+..+. +||.+|-|+.+|..+..+++|.||+
T Consensus 254 ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv 333 (593)
T KOG0695|consen 254 LLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYV 333 (593)
T ss_pred eeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEe
Confidence 35679999999999999764 7788999775543 2233444566777777777 8999999999999999999999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCC
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~ 674 (914)
++|+|.-++++.++ ++......+..+|.-||.|||+.+ ||.||||..|+|||..+.+||.|+|+.+..-...
T Consensus 334 ~ggdlmfhmqrqrk-----lpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~g 405 (593)
T KOG0695|consen 334 NGGDLMFHMQRQRK-----LPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG 405 (593)
T ss_pred cCcceeeehhhhhc-----CcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCC
Confidence 99999888876543 677777788899999999999999 9999999999999999999999999997643332
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCccccc---ccccHHHHHHhhhhcCCcccccccc
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQF---EEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~---~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
..+.+..||+.|+|||.+++..|....|.|+|||+|+||+.|+.||+.-. .+.+.-++....+.+ ..
T Consensus 406 --d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile--------kq 475 (593)
T KOG0695|consen 406 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE--------KQ 475 (593)
T ss_pred --cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh--------hc
Confidence 23456789999999999999999999999999999999999999997422 222333333333332 33
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCC
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERP 780 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 780 (914)
++.|... .-....++..-|+.||++|.
T Consensus 476 iriprsl--svkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 IRIPRSL--SVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred cccccee--ehhhHHHHHHhhcCCcHHhc
Confidence 3333322 22445677888999999984
|
|
| >COG5184 ATS1 Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=251.11 Aligned_cols=240 Identities=20% Similarity=0.285 Sum_probs=200.7
Q ss_pred cceeeeeeCCCCceEEEEeeCCceeEEecCCCCCcccCCCC------------------------CC----------CEE
Q 002512 40 MSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGTPA------------------------HF----------PFI 85 (914)
Q Consensus 40 ~~~~a~~~g~~~~~~c~~~~~~~~~v~cwg~n~~~~~~~p~------------------------~~----------~~~ 85 (914)
+..+-++.|+. |+-+|..|+.+ |.||.|..|+++.-. .+ .++
T Consensus 104 ~~i~~~acGg~--hsl~ld~Dg~l--yswG~N~~G~Lgr~~~~~~~~~~~~~~~~~~~~~~~tP~~v~~~s~~~s~~~vv 179 (476)
T COG5184 104 ASIIKIACGGN--HSLGLDHDGNL--YSWGDNDDGALGRDIHKDICDQNNDIIDFDDYELESTPFKVPGGSSAKSHLRVV 179 (476)
T ss_pred eeeEEeecCCc--eEEeecCCCCE--EEeccCcccccccccccccccccccccccchhhcccCCceeeccccccCChheE
Confidence 45667888876 89999999987 999999888766432 11 388
Q ss_pred EEecCCCeeEEEEeCCCceeecCCCCCCCCC--------------CCccccCCCeEEEEEeCCceeeeeecCCCCccCCC
Q 002512 86 GLTAGDGFVCGLLLDSNQPYCWGSSGYIQMG--------------VPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNY 151 (914)
Q Consensus 86 ~i~~G~~~~cal~~~~~~~~cWG~n~~gqlg--------------~p~~~~~~~~~~~i~~G~~h~cal~~~~~~~~~~~ 151 (914)
+|+||+.++++| ..+|.+|.||.+.-+.++ .|..++ ...+++|++|..|..+| +.+
T Consensus 180 ~l~cg~e~svil-~~~G~V~~~gt~r~~e~~~g~~~~s~k~~~~~~p~~v~-~~~i~qla~G~dh~i~l--------t~~ 249 (476)
T COG5184 180 KLACGWEISVIL-TADGRVYSWGTFRCGELGQGSYKNSQKTSIQFTPLKVP-KKAIVQLAAGADHLIAL--------TNE 249 (476)
T ss_pred EeecCCceEEEE-ccCCcEEEecCccccccccccccccccceeeeeeeecC-chheeeeccCCceEEEE--------ecC
Confidence 999999999999 888899999987666554 233333 24689999999999997 479
Q ss_pred ceEEEcccCCCCCCcCCC-----------------cEEEEeecCCceeEeeecCCeEEEecCCCCCceeec---------
Q 002512 152 SYVDCWGYNMTKNYVFDG-----------------QIESISAGSEFNCGLFSQNRTVFCWGDESSSRVISL--------- 205 (914)
Q Consensus 152 g~v~cWG~n~~gql~~~~-----------------~~~~ia~G~~~~cal~~~~g~v~cWG~n~~g~~~~~--------- 205 (914)
|+||.||.|..||||... .+..|++|.+|+.|| +++|.+|+||.|.+||+...
T Consensus 250 G~vy~~Gs~qkgqlG~~~~e~~~~~~lv~~~f~i~~i~~vacG~~h~~al-~~~G~i~a~G~n~fgqlg~~~~~~~~a~~ 328 (476)
T COG5184 250 GKVYGWGSNQKGQLGRPTSERLKLVVLVGDPFAIRNIKYVACGKDHSLAL-DEDGEIYAWGVNIFGQLGAGSDGEIGALT 328 (476)
T ss_pred CcEEEecCCcccccCCchhhhcccccccCChhhhhhhhhcccCcceEEEE-cCCCeEEEeccchhcccccCcccccceee
Confidence 999999999999996443 146699999999999 89999999999999999443
Q ss_pred -------CCCCccEEEEEecCcceeEEEeCCCccEEEeecCCCCcccccc--ccccccccCCCCCCCeeEeecCCcEEEe
Q 002512 206 -------IPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSV--AYSRQGNVDLPPSDPMLSIVGGKFHACG 276 (914)
Q Consensus 206 -------~~~~~~~~~i~aG~~h~c~l~~~~~g~v~cWG~n~~~~~g~~~--~~~~~~~~~~~~~~~~~sia~g~~htcg 276 (914)
...+..+.+|++|..|+.+|+ .+|.||.||++..+|+|..+ +.....+..++....+.++++|..|+.+
T Consensus 329 tk~~~~~~~~~~~i~~is~ge~H~l~L~--~~G~l~a~Gr~~~~qlg~~~~~~~~~~~~~~ls~~~~~~~v~~gt~~~~~ 406 (476)
T COG5184 329 TKPNYKQLLSGVTICSISAGESHSLILR--KDGTLYAFGRGDRGQLGIQEEITIDVSTPTKLSVAIKLEQVACGTHHNIA 406 (476)
T ss_pred ccccccccCCCceEEEEecCcceEEEEe--cCceEEEecCCccccccCcccceeecCCccccccccceEEEEecCcccee
Confidence 112234789999999999998 78999999999999999988 7777777777767789999999999999
Q ss_pred eeecCCceEEeeeccCCCCCC
Q 002512 277 IKSYDRGVICWGFIIKPSTPV 297 (914)
Q Consensus 277 ~~~~~g~v~CWG~n~~gq~~i 297 (914)
. +.+|.|+|||++.+||+..
T Consensus 407 ~-t~~gsvy~wG~ge~gnlG~ 426 (476)
T COG5184 407 R-TDDGSVYSWGWGEHGNLGN 426 (476)
T ss_pred e-ccCCceEEecCchhhhccC
Confidence 9 7899999999999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-26 Score=237.38 Aligned_cols=198 Identities=31% Similarity=0.470 Sum_probs=169.5
Q ss_pred cccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.+.||+|++|.||++...+ ++.+++|........ ...+.+.+|++.+.+++|+|++++++++......++++||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~ 81 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEG 81 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCC
Confidence 45679999999999999875 889999987654322 2457899999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
++|.+++..... .+++.....++.+++++|.|||+.+ ++|+||+|+||+++.++.++|+|||++.........
T Consensus 82 ~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 82 GDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999976432 1788889999999999999999998 999999999999999999999999998776543211
Q ss_pred CCccCCCCcCCccChhhh-hcCCCCCcchHHHHHHHHHHHHhCCCCccc
Q 002512 677 PLAELPAGTLGYLDPEYY-RLHYLTTKSDVYSFGVLLLEILSGRKAIDM 724 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l-~~~~~s~ksDV~S~GvvL~ElltG~~p~~~ 724 (914)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12234577899999999 667788899999999999999999999954
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >COG5184 ATS1 Alpha-tubulin suppressor and related RCC1 domain-containing proteins [Cell division and chromosome partitioning / Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-25 Score=243.42 Aligned_cols=251 Identities=20% Similarity=0.277 Sum_probs=194.5
Q ss_pred EEecCCCCCcccCCCC-----------------CCCEEEEecCCCeeEEEEeCCCceeecCCCCCCCCC-----------
Q 002512 65 VTCYGSNSAIIYGTPA-----------------HFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMG----------- 116 (914)
Q Consensus 65 v~cwg~n~~~~~~~p~-----------------~~~~~~i~~G~~~~cal~~~~~~~~cWG~n~~gqlg----------- 116 (914)
|++||+|..+++|... ...++.+|||+.|+.+| ..||.+|.||.|..|+||
T Consensus 70 v~~~Gsn~~~eLGlg~de~~~~~P~~~~~~~~d~~~i~~~acGg~hsl~l-d~Dg~lyswG~N~~G~Lgr~~~~~~~~~~ 148 (476)
T COG5184 70 VYSWGSNGMNELGLGNDETKVDRPQLNPFGRIDKASIIKIACGGNHSLGL-DHDGNLYSWGDNDDGALGRDIHKDICDQN 148 (476)
T ss_pred eEEEecCcceeeccCCchhcccCceecCcccccceeeEEeecCCceEEee-cCCCCEEEeccCccccccccccccccccc
Confidence 5999999888887631 13678899999999999 899999999999999998
Q ss_pred -------------CCccccC------CCeEEEEEeCCceeeeeecCCCCccCCCceEEEcccCCCCCCcCC---------
Q 002512 117 -------------VPQPIIK------GAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFD--------- 168 (914)
Q Consensus 117 -------------~p~~~~~------~~~~~~i~~G~~h~cal~~~~~~~~~~~g~v~cWG~n~~gql~~~--------- 168 (914)
+|..+.. -..|++++||+.++++| +++|.||.||.+..+.++.+
T Consensus 149 ~~~~~~~~~~~~~tP~~v~~~s~~~s~~~vv~l~cg~e~svil--------~~~G~V~~~gt~r~~e~~~g~~~~s~k~~ 220 (476)
T COG5184 149 NDIIDFDDYELESTPFKVPGGSSAKSHLRVVKLACGWEISVIL--------TADGRVYSWGTFRCGELGQGSYKNSQKTS 220 (476)
T ss_pred ccccccchhhcccCCceeeccccccCChheEEeecCCceEEEE--------ccCCcEEEecCccccccccccccccccce
Confidence 2444444 23699999999999997 57999999998776665433
Q ss_pred ----------CcEEEEeecCCceeEeeecCCeEEEecCCCCCceee----------cCCC---CccEEEEEecCcceeEE
Q 002512 169 ----------GQIESISAGSEFNCGLFSQNRTVFCWGDESSSRVIS----------LIPK---EMKFQKVAAGGYHVCGI 225 (914)
Q Consensus 169 ----------~~~~~ia~G~~~~cal~~~~g~v~cWG~n~~g~~~~----------~~~~---~~~~~~i~aG~~h~c~l 225 (914)
..+.++|+|.+|..+| +.+|+||.||+|..|||.. .++. ...+..|++|.+|+.||
T Consensus 221 ~~~~p~~v~~~~i~qla~G~dh~i~l-t~~G~vy~~Gs~qkgqlG~~~~e~~~~~~lv~~~f~i~~i~~vacG~~h~~al 299 (476)
T COG5184 221 IQFTPLKVPKKAIVQLAAGADHLIAL-TNEGKVYGWGSNQKGQLGRPTSERLKLVVLVGDPFAIRNIKYVACGKDHSLAL 299 (476)
T ss_pred eeeeeeecCchheeeeccCCceEEEE-ecCCcEEEecCCcccccCCchhhhcccccccCChhhhhhhhhcccCcceEEEE
Confidence 1369999999999999 8999999999999999911 1111 12356699999999999
Q ss_pred EeCCCccEEEeecCCCCccccc------cccccccccCCCCCCCeeEeecCCcEEEeeeecCCceEEeeeccCCCCCCCC
Q 002512 226 LEGLDSRTRCWGRSLDLEEEVS------VAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPT 299 (914)
Q Consensus 226 ~~~~~g~v~cWG~n~~~~~g~~------~~~~~~~~~~~~~~~~~~sia~g~~htcg~~~~~g~v~CWG~n~~gq~~ip~ 299 (914)
. .+|.||+||.|-.+|++.+ +....+....+..+-.+.+|++|..|...+ ..+|.++.||.+..+|+.++.
T Consensus 300 ~--~~G~i~a~G~n~fgqlg~~~~~~~~a~~tk~~~~~~~~~~~i~~is~ge~H~l~L-~~~G~l~a~Gr~~~~qlg~~~ 376 (476)
T COG5184 300 D--EDGEIYAWGVNIFGQLGAGSDGEIGALTTKPNYKQLLSGVTICSISAGESHSLIL-RKDGTLYAFGRGDRGQLGIQE 376 (476)
T ss_pred c--CCCeEEEeccchhcccccCcccccceeeccccccccCCCceEEEEecCcceEEEE-ecCceEEEecCCccccccCcc
Confidence 7 7999999999999999887 333344444555555689999999999999 558999999999999987766
Q ss_pred C--------------ccEEEEEecCccceeeeccCCCcccccCCC
Q 002512 300 G--------------IKVYEIAAGNYFTCGVLAEKSMLPVCWGTG 330 (914)
Q Consensus 300 g--------------~~~~~v~~g~~~~Ca~l~e~~~~~~~Wg~~ 330 (914)
. ..+..++.+..|+-+.+ +++.+ ++||.+
T Consensus 377 ~~~~~~~~~~~ls~~~~~~~v~~gt~~~~~~t-~~gsv-y~wG~g 419 (476)
T COG5184 377 EITIDVSTPTKLSVAIKLEQVACGTHHNIART-DDGSV-YSWGWG 419 (476)
T ss_pred cceeecCCccccccccceEEEEecCccceeec-cCCce-EEecCc
Confidence 2 12444555544444544 45554 677743
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=228.18 Aligned_cols=251 Identities=18% Similarity=0.334 Sum_probs=188.3
Q ss_pred cccccCcccceEEEEEE-EcCCcEEEEEEeeeccccccchHHHHHHHHHHHhcc-CCceeeeeceeecC--CeEEEEEee
Q 002512 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEG--RERLLVYEF 593 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~--~~~~LV~Ey 593 (914)
+..++|+|-++.||.|. ..+++.++||.+.... .+.+.+|++||..|. ||||++|++...+. ..+.||+||
T Consensus 42 ivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~ 116 (338)
T KOG0668|consen 42 IVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEY 116 (338)
T ss_pred HHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhh
Confidence 34579999999999998 4568889999875432 367899999999996 99999999998765 467899999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC-CcEEEeecCCcccCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE-HNARVADFGLSLLGPA 672 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kl~DFGla~~~~~ 672 (914)
+.+-+...+.. .++...+.....+++.||.|.|+.+ |.|||+||.|++||.. -.++|+|+|||.++.+
T Consensus 117 v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 117 VNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 99988766553 4666677788999999999999999 9999999999999864 4699999999988766
Q ss_pred CCCCCCccCCCCcCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCccccccc-ccHHHHHH--------hhhhc-
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE-GNIVEWAV--------PLIKS- 741 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~-~~l~~~~~--------~~~~~- 741 (914)
.... +..+.+..|--||.+.. +.|...-|+|||||+|.+|+..+.||....++ +.++..+. ..+..
T Consensus 186 ~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY 262 (338)
T KOG0668|consen 186 GKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY 262 (338)
T ss_pred Ccee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence 5432 33456778899999854 56788999999999999999999998654333 33443322 11111
Q ss_pred -----CCcccccccccCC-------CCCH-HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 742 -----GDITAILDPVLKL-------PSDL-DALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 742 -----~~~~~~~d~~l~~-------~~~~-~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.....++....+. +.+. -...+..+++...|..|-.+|||++|.+.
T Consensus 263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111111111110 1111 12257789999999999999999998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-26 Score=252.63 Aligned_cols=193 Identities=24% Similarity=0.388 Sum_probs=160.4
Q ss_pred ccccCcccceEEEEEEEcC-CcEEEEEEeeeccc------cccchHHHHHHHHHHHhcc---CCceeeeeceeecCCeEE
Q 002512 519 KEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSD------RQKNSKEFHTELDLLSRLN---HAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~------~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~ 588 (914)
.+.||.|+||.|+++.++. ...|+||.+.+..- +++..-..-.|+.||..|+ |+||++++++|+++++.|
T Consensus 566 lq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yy 645 (772)
T KOG1152|consen 566 LQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYY 645 (772)
T ss_pred eeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeE
Confidence 4569999999999999875 56788887654321 1112223557999999997 999999999999999999
Q ss_pred EEEeeCC-CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCc
Q 002512 589 LVYEFMA-HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667 (914)
Q Consensus 589 LV~Ey~~-~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla 667 (914)
|+||-.. +-+|.++|..+. .+++.+..-|..||+.|+++||+++ |||||||-+|+.++.+|-+||+|||.+
T Consensus 646 l~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 646 LETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred EEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccch
Confidence 9999753 669999998654 4788888899999999999999999 999999999999999999999999988
Q ss_pred ccCCCCCCCCCccCCCCcCCccChhhhhcCCC-CCcchHHHHHHHHHHHHhCCCCcc
Q 002512 668 LLGPADSSSPLAELPAGTLGYLDPEYYRLHYL-TTKSDVYSFGVLLLEILSGRKAID 723 (914)
Q Consensus 668 ~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~-s~ksDV~S~GvvL~ElltG~~p~~ 723 (914)
....... .....||..|.|||++.+.+| ...-|||++||+||.++..+.||+
T Consensus 718 a~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 6543322 234579999999999998754 556899999999999999988875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=224.99 Aligned_cols=251 Identities=19% Similarity=0.286 Sum_probs=182.3
Q ss_pred cccccccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeece-eecCCeEEEEEe
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGY-CEEGRERLLVYE 592 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~-~~~~~~~~LV~E 592 (914)
+++.+.||+|-||.+-++.++. .+.+++|-+.... ....+|.+|..---.| .|.||+.-++. |+..+..+.++|
T Consensus 26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhHHHHhcccceeeEEeeeccCCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 3456779999999999999874 6778888765543 2357899998765556 68999998864 677788889999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE-c-CCCcEEEeecCCcccC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI-D-EEHNARVADFGLSLLG 670 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl-~-~~~~~kl~DFGla~~~ 670 (914)
|+|.|+|.+-+...+ +-+....+++.|++.||.|||+++ +||||||.+|||| + +...+||+|||+.+..
T Consensus 103 ~aP~gdL~snv~~~G------igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG------IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred cCccchhhhhcCccc------ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 999999999886543 555667789999999999999999 9999999999999 3 3447999999998653
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhcC-----CCCCcchHHHHHHHHHHHHhCCCCccccc-ccccHHHHHHhhhhcCCc
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLH-----YLTTKSDVYSFGVLLLEILSGRKAIDMQF-EEGNIVEWAVPLIKSGDI 744 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~-----~~s~ksDV~S~GvvL~ElltG~~p~~~~~-~~~~l~~~~~~~~~~~~~ 744 (914)
... .....-+..|.+||..... ...+.+|||.|||++|..|||+.||+... ....+.+|.. +..+..
T Consensus 174 g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~--w~~rk~ 246 (378)
T KOG1345|consen 174 GTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQ--WLKRKN 246 (378)
T ss_pred Cce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHH--HhcccC
Confidence 221 1112245679999987543 34567999999999999999999997532 2334444433 222222
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHH
Q 002512 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~ 791 (914)
..+.+..- ...+.+.++..+-+..++++|=-..++.++...
T Consensus 247 ~~~P~~F~------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~ 287 (378)
T KOG1345|consen 247 PALPKKFN------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC 287 (378)
T ss_pred ccCchhhc------ccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence 22222111 122456677788889999998666666655543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=232.44 Aligned_cols=249 Identities=24% Similarity=0.317 Sum_probs=184.6
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecC------CeEEEEEee
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG------RERLLVYEF 593 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~LV~Ey 593 (914)
.++.|.- .|-.+.+. .+++||+|++..........++..+|..++..++|+||++++.+|.-. ...|+||||
T Consensus 24 p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~ 102 (369)
T KOG0665|consen 24 PIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMEL 102 (369)
T ss_pred ccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHh
Confidence 3677766 45545432 489999999876655555567888999999999999999999998643 366999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
|. .+|.+.++- .++-.....|..|+..|++|||+.+ |+||||||+||++..+..+||.|||+++....+
T Consensus 103 m~-~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 103 MD-ANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD 171 (369)
T ss_pred hh-hHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCcc
Confidence 95 699888872 3555667789999999999999999 999999999999999999999999999765444
Q ss_pred CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHH-----------------
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV----------------- 736 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~----------------- 736 (914)
-..+....|..|.|||++.+..+.+.+||||.||++-||++|+..|.... .+-+|..
T Consensus 172 ---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d---~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 172 ---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD---HIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch---HHHHHHHHHHHhcCCCHHHHHHhh
Confidence 23445568899999999988889999999999999999999998775321 1112211
Q ss_pred ----hhhhcC------Cccc-ccccccCC--CCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 737 ----PLIKSG------DITA-ILDPVLKL--PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 737 ----~~~~~~------~~~~-~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
.+.... ...+ +.|..... ..+........+++.+||..+|++|.+.++++.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 011100 0111 11111110 111123346778999999999999999988764
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-26 Score=255.66 Aligned_cols=246 Identities=23% Similarity=0.343 Sum_probs=193.1
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
...+|.|.||.|||++.+ .++..|+|.+..... ....-..+|+-+++..+|||||.++|.+...+..++.|||+-+|
T Consensus 20 lqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycggg 97 (829)
T KOG0576|consen 20 LQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGG 97 (829)
T ss_pred eeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCC
Confidence 356999999999999976 588999998765443 23456788999999999999999999999999999999999999
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+|++.-+... +++..++-..+.+.++||+|||+++ -+|||||-.|||+++.+.+|++|||.+-.+...- .
T Consensus 98 slQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati--~ 167 (829)
T KOG0576|consen 98 SLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI--A 167 (829)
T ss_pred cccceeeecc-----cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh--h
Confidence 9999887655 4777777888999999999999999 8999999999999999999999999985543322 2
Q ss_pred CccCCCCcCCccChhhhh---cCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccc-cccC
Q 002512 678 LAELPAGTLGYLDPEYYR---LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD-PVLK 753 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~---~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d-~~l~ 753 (914)
......||+.|||||+.. .+.|..++|||++|+...||---.+|.........+. +... ..++ +.++
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~-----LmTk----S~~qpp~lk 238 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF-----LMTK----SGFQPPTLK 238 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH-----Hhhc----cCCCCCccc
Confidence 234457999999999873 4578999999999999999988887754322221111 1111 1111 1121
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
......+.+.++++.++..+|++||+.+.++.
T Consensus 239 --Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 239 --DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred --CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 12234567889999999999999999987653
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=244.07 Aligned_cols=213 Identities=24% Similarity=0.259 Sum_probs=175.9
Q ss_pred ccccCCHHHHHHHhcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccC------Cce
Q 002512 502 RAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH------AHL 574 (914)
Q Consensus 502 ~~~~~~~~el~~~t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~H------pnI 574 (914)
....+.+.|+....+.+.-..|+|-|++|.+|... -|+.||||++.....+ .+.=+.|+++|.+|+. -|.
T Consensus 420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHH
Confidence 34456778898888888888999999999999975 4889999988654322 2445789999999952 489
Q ss_pred eeeeceeecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEc
Q 002512 575 LNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID 654 (914)
Q Consensus 575 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~ 654 (914)
++|+-.|.+.++++||||-+ ..+|.+.|++.+.. .-|....+..++.|+.-||..|...+ |+|.||||.|||++
T Consensus 497 lrl~r~F~hknHLClVFE~L-slNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVN 570 (752)
T ss_pred HHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEec
Confidence 99999999999999999987 46999999876653 34667778889999999999999999 99999999999998
Q ss_pred CCC-cEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccc
Q 002512 655 EEH-NARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFE 727 (914)
Q Consensus 655 ~~~-~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~ 727 (914)
+.. .+||||||.|.........+ ..-+..|.|||++.+.+|+...|+||.||+||||.||+..|.....
T Consensus 571 E~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TN 640 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTN 640 (752)
T ss_pred cCcceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCc
Confidence 765 57999999986654433221 1235679999999999999999999999999999999988875443
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-25 Score=278.29 Aligned_cols=196 Identities=19% Similarity=0.218 Sum_probs=140.1
Q ss_pred hccC-Cceeeeecee-------ecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCC
Q 002512 568 RLNH-AHLLNLLGYC-------EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639 (914)
Q Consensus 568 ~l~H-pnIv~l~g~~-------~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~ 639 (914)
.++| +||++++++| .+.+.++++|||+ +++|+++|+... ..+++..++.|+.||++||+|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~g-- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQG-- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 4566 6888999988 3334667889988 569999997532 35889999999999999999999999
Q ss_pred CeeccCCCccceEEcC-------------------CCcEEEeecCCcccCCCCCC--------------CCCccCCCCcC
Q 002512 640 PVIHRDIKSSNILIDE-------------------EHNARVADFGLSLLGPADSS--------------SPLAELPAGTL 686 (914)
Q Consensus 640 ~iiHrDIKp~NILl~~-------------------~~~~kl~DFGla~~~~~~~~--------------~~~~~~~~Gt~ 686 (914)
|+||||||+||||+. ++.+||+|||+++....... ........||+
T Consensus 101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 999999999999954 44566667776653211000 00011235889
Q ss_pred CccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHH
Q 002512 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIAN 766 (914)
Q Consensus 687 ~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~ 766 (914)
.|||||++.+..++.++|||||||+||||++|..|+.... .... .+.. ..+++.. .........
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~----~~~~----~~~~~~~-----~~~~~~~~~ 243 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMS----SLRH----RVLPPQI-----LLNWPKEAS 243 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHH----HHHH----hhcChhh-----hhcCHHHHH
Confidence 9999999999999999999999999999999988754211 0110 0110 0111110 112234568
Q ss_pred HHHHhhhcCCCCCCCHHHHHH
Q 002512 767 VACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 767 l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
++.+||+.+|.+||+|.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 889999999999999999864
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.5e-24 Score=229.93 Aligned_cols=150 Identities=21% Similarity=0.307 Sum_probs=120.3
Q ss_pred chhhhhhccccCCHHHHHH-HhcccccccCcccceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhcc--
Q 002512 495 FDDLKIRRAQMFTYEELER-ATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-- 570 (914)
Q Consensus 495 ~~~~~~~~~~~~~~~el~~-~t~~~~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-- 570 (914)
.+++...........|... ..+...++||-|.|++||++.+. +.+.||+|+.+.. +...+..+.||++|++++
T Consensus 58 ~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~ 134 (590)
T KOG1290|consen 58 PEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREG 134 (590)
T ss_pred hhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhc
Confidence 3444444555556666665 77778889999999999999965 5778999977432 233466789999999993
Q ss_pred ---C---Cceeeeeceeec----CCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCC
Q 002512 571 ---H---AHLLNLLGYCEE----GRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640 (914)
Q Consensus 571 ---H---pnIv~l~g~~~~----~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~ 640 (914)
| .+||+|+++|.. +.+.+||+|++ |-+|..+|....- +-++...+.+|+.||+.||.|||.+. .
T Consensus 135 Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Y---rGlpl~~VK~I~~qvL~GLdYLH~ec--g 208 (590)
T KOG1290|consen 135 DPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNY---RGLPLSCVKEICRQVLTGLDYLHREC--G 208 (590)
T ss_pred CCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCC---CCCcHHHHHHHHHHHHHHHHHHHHhc--C
Confidence 3 369999999965 45889999999 7799999976543 45888899999999999999999876 3
Q ss_pred eeccCCCccceEE
Q 002512 641 VIHRDIKSSNILI 653 (914)
Q Consensus 641 iiHrDIKp~NILl 653 (914)
|||-||||+||||
T Consensus 209 IIHTDlKPENvLl 221 (590)
T KOG1290|consen 209 IIHTDLKPENVLL 221 (590)
T ss_pred ccccCCCcceeee
Confidence 9999999999999
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=215.53 Aligned_cols=169 Identities=21% Similarity=0.201 Sum_probs=127.9
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
|||.++++... ..+++..++.|+.||++||+|||+++ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence 78999997542 25899999999999999999999876 999999999999999 99987654322
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 756 (914)
..||+.|||||++.+..++.++||||||+++|||+||+.||................... . ++.. .+.
T Consensus 64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~-----~-~~~~-~~~ 131 (176)
T smart00750 64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA-----D-DPRD-RSN 131 (176)
T ss_pred -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc-----C-Cccc-ccc
Confidence 258899999999999999999999999999999999999986433222222111111110 0 0000 011
Q ss_pred CHHHHH--HHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 757 DLDALK--RIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 757 ~~~~~~--~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
...... ++.+++.+||..+|++||++.|+++.+.....
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 112222 68999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4e-24 Score=229.43 Aligned_cols=255 Identities=25% Similarity=0.347 Sum_probs=187.0
Q ss_pred cccccCcccceEEEEEEEcC----CcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEe
Q 002512 518 FKEEVGKGSFSCVYKGVLKD----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
..++||.|.|++||++++.. .+.||+|.+..... ..+..+|+++|..+ -+.||+++.+++..++...+|+|
T Consensus 40 ~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp 115 (418)
T KOG1167|consen 40 VVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLP 115 (418)
T ss_pred hhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEec
Confidence 35679999999999998643 67899998866543 25689999999999 68999999999999999999999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC-CCcEEEeecCCcccCC
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE-EHNARVADFGLSLLGP 671 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kl~DFGla~~~~ 671 (914)
|++.-+..+++.. ++...+...+..++.||+|+|.++ ||||||||+|+|.+. -+.-.|.||||+....
T Consensus 116 ~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 116 YFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred ccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHH
Confidence 9999999888864 556677788999999999999999 999999999999975 4567899999986110
Q ss_pred CCC------C------------------------------------CCCccCCCCcCCccChhhhh-cCCCCCcchHHHH
Q 002512 672 ADS------S------------------------------------SPLAELPAGTLGYLDPEYYR-LHYLTTKSDVYSF 708 (914)
Q Consensus 672 ~~~------~------------------------------------~~~~~~~~Gt~~y~aPE~l~-~~~~s~ksDV~S~ 708 (914)
... . ........||++|.|||++. ....+.+.||||-
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0 00011234999999999985 4567899999999
Q ss_pred HHHHHHHHhCCCCccccccc-ccHHHHHH--------h-hhhcCC--------ccccc-----------ccccCCCC---
Q 002512 709 GVLLLEILSGRKAIDMQFEE-GNIVEWAV--------P-LIKSGD--------ITAIL-----------DPVLKLPS--- 756 (914)
Q Consensus 709 GvvL~ElltG~~p~~~~~~~-~~l~~~~~--------~-~~~~~~--------~~~~~-----------d~~l~~~~--- 756 (914)
|||++-+++++.||.....+ +.+.+.+. + ....+. +..+. ........
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 99999999999999654333 22222211 0 000011 00000 00001000
Q ss_pred -----CHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 757 -----DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 757 -----~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
....+..+++++.+|+..+|.+|.|+++.++
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 0112236889999999999999999998764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-24 Score=218.24 Aligned_cols=249 Identities=21% Similarity=0.341 Sum_probs=190.9
Q ss_pred ccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCC
Q 002512 517 GFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+|..+|.....|..|+|+++ |..+++|++....-.....++|..|.-.|+.+.||||+.+++.|.....+.+|..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 35557999999999999998 44566676654444444557899999999999999999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEe--ecCCcccCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVA--DFGLSLLGPADS 674 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~--DFGla~~~~~~~ 674 (914)
|+|+..||+... -.++-.+.++++++||+|++|||+.. |-|.---|.+..+++|++.+++|+ |--++..
T Consensus 272 gslynvlhe~t~---vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq----- 342 (448)
T KOG0195|consen 272 GSLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ----- 342 (448)
T ss_pred hHHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence 999999997654 34677888999999999999999987 334444688899999999998874 3222211
Q ss_pred CCCCccCCCCcCCccChhhhhcCCCC---CcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccc
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLT---TKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y~aPE~l~~~~~s---~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~ 751 (914)
.....-.+.||+||.++..+.. .++|+|||.++||||.|.+.||..-..-+--. .+.-+.
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm-------------kialeg 405 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM-------------KIALEG 405 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh-------------hhhhcc
Confidence 0111235899999999876533 57999999999999999999996432211100 111122
Q ss_pred cCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHH
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 752 l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~ 792 (914)
++...++.....+.+|+.-|+..||.+||.++.|+-.||+.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 33333445567889999999999999999999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-22 Score=223.14 Aligned_cols=263 Identities=21% Similarity=0.222 Sum_probs=195.7
Q ss_pred hcccccccCcccceEEEEEEEcCC--cEEEEEEeeeccccccchHHHHHHHHHHHhccC----Cceeeeecee-ecCCeE
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKDG--TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH----AHLLNLLGYC-EEGRER 587 (914)
Q Consensus 515 t~~~~~~LG~G~fG~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~H----pnIv~l~g~~-~~~~~~ 587 (914)
.+.+.++||+|+||.||++...+. ..+|+|.......... ..+..|+.++..+.. +++..+++.. ......
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 345677899999999999997653 4788886654332221 268889999999973 5899999999 578889
Q ss_pred EEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC-----CcEEEe
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE-----HNARVA 662 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~-----~~~kl~ 662 (914)
||||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.+ ++||||||+|+++... ..++|.
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEE
Confidence 9999987 889999876543 346899999999999999999999999 9999999999999754 469999
Q ss_pred ecCCcc--cCCCCCCC----C-C-ccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHH
Q 002512 663 DFGLSL--LGPADSSS----P-L-AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEW 734 (914)
Q Consensus 663 DFGla~--~~~~~~~~----~-~-~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~ 734 (914)
|||+++ .+...... . . .....||.+|+++..+.+...+.+.|+||++.++.||+.|..||...........
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~- 248 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK- 248 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH-
Confidence 999998 32222211 1 1 1234599999999999999999999999999999999999999964332221111
Q ss_pred HHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 002512 735 AVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~~ 796 (914)
+..... ...... .....+.++.+++..+-..+..++|....+...|+......
T Consensus 249 ~~~~~~----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 249 FEKDPR----KLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHHhh----hhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 111000 011111 11122345666667777799999999999999988877654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-22 Score=207.49 Aligned_cols=270 Identities=20% Similarity=0.220 Sum_probs=207.7
Q ss_pred ccccccCcccceEEEEEE-EcCCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeC
Q 002512 517 GFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.++||+|+||.++.|+ +-++++||||.-...+ +...+..|.+..+.| ..++|+..+.|..++.+-.||||.+
T Consensus 31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred eeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 356789999999999998 5579999999654433 335688899999998 5689999999999999999999988
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC-----CcEEEeecCCccc
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE-----HNARVADFGLSLL 669 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~-----~~~kl~DFGla~~ 669 (914)
|-||.|++.-.++ .++.+.++.||.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||+|+.
T Consensus 107 -GPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred -CcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 7899998865443 5899999999999999999999999 9999999999999643 3589999999987
Q ss_pred CCCCCCC-----CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCc
Q 002512 670 GPADSSS-----PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDI 744 (914)
Q Consensus 670 ~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 744 (914)
+.+.... ...+...||.+||+-....++..+.+.|+-|||-++++.|-|..||.......+-. .+-+.++.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~----kYeKIGe~ 254 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE----KYEKIGET 254 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH----HHHHhccc
Confidence 6544322 12344569999999999999999999999999999999999999998643322111 11111211
Q ss_pred ccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHHcCCCCCCCC
Q 002512 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQP 805 (914)
Q Consensus 745 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~~~~~~~~~~~ 805 (914)
....... ......++++..-+.-.-+.+-.+-|..+-+...+..++...........+
T Consensus 255 Kr~T~i~---~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yD 312 (449)
T KOG1165|consen 255 KRSTPIE---VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYD 312 (449)
T ss_pred cccCCHH---HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCccccccc
Confidence 1110000 001124467788888888899999999999999998888876554443333
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7e-23 Score=203.81 Aligned_cols=264 Identities=19% Similarity=0.199 Sum_probs=201.0
Q ss_pred HhcccccccCcccceEEEEEE-EcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccC-CceeeeeceeecCCeEEEEE
Q 002512 514 ATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH-AHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 514 ~t~~~~~~LG~G~fG~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~LV~ 591 (914)
..+.+.++||.|+||.+|+|. ..+|+.||||.-..... ...+..|.++...|+| ..|+.+..|..+.++-.|||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 345667889999999999998 46799999997543322 2457889999999976 68999999999999999999
Q ss_pred eeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC---CCcEEEeecCCcc
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE---EHNARVADFGLSL 668 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kl~DFGla~ 668 (914)
|.+ |.||.+++.-.. ..++.++.+.++-|++.-++|+|.++ +|||||||+|+|..- ...+.++|||||+
T Consensus 91 dLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchh
Confidence 988 889999886443 35888899999999999999999999 999999999999964 4568999999998
Q ss_pred cCCCCCCC-----CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCC
Q 002512 669 LGPADSSS-----PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD 743 (914)
Q Consensus 669 ~~~~~~~~-----~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~ 743 (914)
.+.+.... .......||.+|.+-..+.+...+.+.|+-|+|.+|.++.-|..||+......... -...+.+..
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q--KyEkI~EkK 240 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ--KYEKISEKK 240 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH--HHHHHHHhh
Confidence 76443221 12334569999999999988888999999999999999999999998643221111 111122211
Q ss_pred cccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 002512 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 744 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~~ 796 (914)
....+... ....+.++...+.-|-...-++.|...-+.+.+.-++..+
T Consensus 241 ~s~~ie~L-----C~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 241 MSTPIEVL-----CKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred cCCCHHHH-----hCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 11111110 1123467888899999999999999988887776655544
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=224.97 Aligned_cols=163 Identities=19% Similarity=0.170 Sum_probs=124.4
Q ss_pred cccccccCcccceEEEEEEEc--CCcEEEEEEeeeccc---cccchHHHHHHHHHHHhccCCceee-eeceeecCCeEEE
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK--DGTVVAVKKAIATSD---RQKNSKEFHTELDLLSRLNHAHLLN-LLGYCEEGRERLL 589 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~f~~E~~~l~~l~HpnIv~-l~g~~~~~~~~~L 589 (914)
+.+.+.||+|+||+||+|.++ +++.+|||++..... .....+.|.+|+++|++++|+|+++ ++++ ...+|
T Consensus 20 Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~L 95 (365)
T PRK09188 20 FVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGL 95 (365)
T ss_pred ceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEE
Confidence 345678999999999999875 477889998643211 1223466999999999999999985 4432 35799
Q ss_pred EEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCC-CccceEEcCCCcEEEeecCCcc
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDI-KSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDI-Kp~NILl~~~~~~kl~DFGla~ 668 (914)
||||+++++|... ... . ...++.|++++|+|||+.+ |+|||| ||+|||++.++.+||+|||+++
T Consensus 96 VmE~~~G~~L~~~-~~~--------~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~ 160 (365)
T PRK09188 96 VRGWTEGVPLHLA-RPH--------G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLAS 160 (365)
T ss_pred EEEccCCCCHHHh-Ccc--------c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccce
Confidence 9999999999632 110 0 1356789999999999999 999999 9999999999999999999998
Q ss_pred cCCCCCCCCC------ccCCCCcCCccChhhhhcC
Q 002512 669 LGPADSSSPL------AELPAGTLGYLDPEYYRLH 697 (914)
Q Consensus 669 ~~~~~~~~~~------~~~~~Gt~~y~aPE~l~~~ 697 (914)
.......... .....+++.|+|||++...
T Consensus 161 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 161 VFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 7654331111 1345688999999999643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.6e-21 Score=208.11 Aligned_cols=262 Identities=27% Similarity=0.408 Sum_probs=196.9
Q ss_pred cccccCcccceEEEEEEEcCCcEEEEEEeeecccccc-chHHHHHHHHHHHhccCC-ceeeeeceeecCCeEEEEEeeCC
Q 002512 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQK-NSKEFHTELDLLSRLNHA-HLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~f~~E~~~l~~l~Hp-nIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.||.|+|+.||++... ..+++|.+........ ....|.+|+.++..+.|+ +|+++++++......++++||+.
T Consensus 4 ~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 81 (384)
T COG0515 4 ILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD 81 (384)
T ss_pred eEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence 4567999999999999987 7889998766554332 467899999999999988 79999999977777899999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC-cEEEeecCCcccCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-NARVADFGLSLLGPADS 674 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kl~DFGla~~~~~~~ 674 (914)
+++|.+++...... ..+.......+..|++.+|.|+|+.+ ++||||||+|||++... .+++.|||+++......
T Consensus 82 ~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 82 GGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999777654311 24677788899999999999999999 99999999999999988 79999999997554433
Q ss_pred CCC----CccCCCCcCCccChhhhhc---CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccc
Q 002512 675 SSP----LAELPAGTLGYLDPEYYRL---HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 675 ~~~----~~~~~~Gt~~y~aPE~l~~---~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~ 747 (914)
... ......||..|++||.+.. ...+...|+||+|++++++++|..|+...... .........+........
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTPSL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCccc
Confidence 221 2355679999999999987 68889999999999999999999996543321 001111111111111100
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
...............+.+++..++..+|..|.++.+....
T Consensus 236 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 -ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0000000002223577889999999999999998887765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-21 Score=229.82 Aligned_cols=254 Identities=19% Similarity=0.242 Sum_probs=185.6
Q ss_pred ccccCcccceEEEEEEEc-CCcEEEEEEee----eccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAI----ATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~-~~~~vavK~~~----~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
...+|.|.+|.|+..... ..+..+.|... ...........+..|+-+-..|+|||++..+..+.+....+-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 456999999988877643 34444444332 1111111122266788888889999999999888887777777999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~ 673 (914)
+++ +|..++.... .+....+..+..|+..|+.|||+.+ |.|||||++|++++.++.+||+|||.+......
T Consensus 403 ~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred ccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 999 9999997652 3666777889999999999999999 999999999999999999999999999766544
Q ss_pred CCC--CCccCCCCcCCccChhhhhcCCCCC-cchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCccccccc
Q 002512 674 SSS--PLAELPAGTLGYLDPEYYRLHYLTT-KSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 674 ~~~--~~~~~~~Gt~~y~aPE~l~~~~~s~-ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~ 750 (914)
... .......|+..|+|||.+....|.+ ..||||.|+++..|++|+.||......++... .........+...
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----~~~~~~~~~~~~~ 549 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----TNNYSDQRNIFEG 549 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----hhccccccccccC
Confidence 433 4455667999999999998887665 58999999999999999999975443322110 0000000000000
Q ss_pred ccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
........+.+...++.++|+.+|.+|.|+++|++
T Consensus 550 --~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 550 --PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred --hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00111234567788999999999999999999874
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-20 Score=190.71 Aligned_cols=139 Identities=19% Similarity=0.195 Sum_probs=107.4
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccc-------hHHH-----------------HHHHHHHHhccCCcee
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKN-------SKEF-----------------HTELDLLSRLNHAHLL 575 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~-------~~~f-----------------~~E~~~l~~l~HpnIv 575 (914)
..||+|+||.||+|...+|+.||||++......... ...| .+|++++.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 569999999999999888999999998654321111 1222 3499999999888764
Q ss_pred eeeceeecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHh-hccCCCCeeccCCCccceEEc
Q 002512 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL-HGYACPPVIHRDIKSSNILID 654 (914)
Q Consensus 576 ~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yL-H~~~~~~iiHrDIKp~NILl~ 654 (914)
....+... ..+|||||+++++|...+... ..++.....+++.|++.+|.|| |+.+ |+||||||+|||++
T Consensus 83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~ 152 (190)
T cd05147 83 CPEPILLK--SHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH 152 (190)
T ss_pred CCcEEEec--CCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence 43333222 238999999998776553222 2477888899999999999999 6888 99999999999998
Q ss_pred CCCcEEEeecCCccc
Q 002512 655 EEHNARVADFGLSLL 669 (914)
Q Consensus 655 ~~~~~kl~DFGla~~ 669 (914)
++.++|+|||+|..
T Consensus 153 -~~~v~LiDFG~a~~ 166 (190)
T cd05147 153 -DGKLYIIDVSQSVE 166 (190)
T ss_pred -CCcEEEEEcccccc
Confidence 47899999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.1e-20 Score=211.16 Aligned_cols=219 Identities=25% Similarity=0.397 Sum_probs=165.9
Q ss_pred HHhccCCceeeeeceeecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccC
Q 002512 566 LSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRD 645 (914)
Q Consensus 566 l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrD 645 (914)
|+.+.|.|+.+++|.+.++...++|.+|+..|+|+|.+.... ..++|.....+..+|+.||+|||+.. -..|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~----~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED----IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc----cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeee
Confidence 356899999999999999999999999999999999998643 36899999999999999999999866 139999
Q ss_pred CCccceEEcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcC-------CCCCcchHHHHHHHHHHHHhC
Q 002512 646 IKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH-------YLTTKSDVYSFGVLLLEILSG 718 (914)
Q Consensus 646 IKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~-------~~s~ksDV~S~GvvL~ElltG 718 (914)
++++|+++|..+.+||+|||+..+..............-..-|.|||.++.. ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998776431111111112234679999999763 146789999999999999999
Q ss_pred CCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHH
Q 002512 719 RKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 719 ~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~ 794 (914)
+.||+.........+.+.+ ++. .....+.|.+... .+..+++..++.+||..+|.+||++++|...++....
T Consensus 155 ~~~~~~~~~~~~~~eii~~-~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILR-VKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHH-HHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999864433332222222 222 1112222222211 1344478999999999999999999999988876554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.4e-20 Score=190.04 Aligned_cols=177 Identities=12% Similarity=0.083 Sum_probs=134.6
Q ss_pred HHHHHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeecccccc-chHH------HHHHHHHHHhccCCceeeeecee
Q 002512 509 EELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQK-NSKE------FHTELDLLSRLNHAHLLNLLGYC 581 (914)
Q Consensus 509 ~el~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~------f~~E~~~l~~l~HpnIv~l~g~~ 581 (914)
+++.+..+...+.||.|+||.||+... +++.+|+|.+.......+ .... |.+|++.+.+++||+|+.+.+++
T Consensus 26 ~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~ 104 (232)
T PRK10359 26 DDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFY 104 (232)
T ss_pred HHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEee
Confidence 455566667778899999999999655 577899998865432221 1122 68999999999999999999987
Q ss_pred ecC--------CeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE
Q 002512 582 EEG--------RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 653 (914)
Q Consensus 582 ~~~--------~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl 653 (914)
... ...+|||||++|.+|.++.. ++. ....+++.+|..||+.+ ++||||||+|||+
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili 168 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIV 168 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEE
Confidence 643 35789999999999988742 111 24568999999999999 9999999999999
Q ss_pred cCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHh
Q 002512 654 DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717 (914)
Q Consensus 654 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~Ellt 717 (914)
++++ ++|+|||.......+... ..++....+..++|+|+||+++.-+..
T Consensus 169 ~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 169 SKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred eCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 9988 999999987654322111 113444556689999999999876653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=183.69 Aligned_cols=141 Identities=20% Similarity=0.169 Sum_probs=109.8
Q ss_pred ccccCcccceEEEEEEEcCCcEEEEEEeeeccccccc------------------------hHHHHHHHHHHHhccCCce
Q 002512 519 KEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKN------------------------SKEFHTELDLLSRLNHAHL 574 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~f~~E~~~l~~l~HpnI 574 (914)
...||+|+||.||+|.+.+|+.||||++......... ...+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3569999999999999888999999988754321110 1224579999999999987
Q ss_pred eeeeceeecCCeEEEEEeeCCCCCHHHh-hhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceE
Q 002512 575 LNLLGYCEEGRERLLVYEFMAHGSLHQH-LHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNIL 652 (914)
Q Consensus 575 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~-l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NIL 652 (914)
.....+... ..+|||||++++++... +.. ..++.....+++.|++.+|.|||+ .+ |+||||||+|||
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIl 150 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNIL 150 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEE
Confidence 544443332 24899999998865443 332 235667788999999999999999 88 999999999999
Q ss_pred EcCCCcEEEeecCCcccCC
Q 002512 653 IDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 653 l~~~~~~kl~DFGla~~~~ 671 (914)
++ ++.++|+|||++....
T Consensus 151 l~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 151 YH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred EE-CCCEEEEEcccceecC
Confidence 99 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.2e-19 Score=179.33 Aligned_cols=184 Identities=18% Similarity=0.140 Sum_probs=137.9
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeecccc--ccchHHHHHHHHHHHhcc-CCceeeeeceeecCCeEEEEEeeCCC
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDR--QKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
..|++|+||+||.+.. ++.+++.+.+.....- ......|.+|+++|++|. |++|++++++ +..+++|||++|
T Consensus 8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G 82 (218)
T PRK12274 8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG 82 (218)
T ss_pred eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence 4699999999997765 5777776665433211 111235889999999995 5889999886 346999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCC-CccceEEcCCCcEEEeecCCcccCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDI-KSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDI-Kp~NILl~~~~~~kl~DFGla~~~~~~~~ 675 (914)
.+|.+.+... ...+..|++++|+|+|+++ |+|||| ||+|||+++++.++|+|||++........
T Consensus 83 ~~L~~~~~~~------------~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 83 AAMYQRPPRG------------DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ccHHhhhhhh------------hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9997643210 1346789999999999999 999999 79999999999999999999986443321
Q ss_pred C----C-------CccCCCCcCCccChhhhhcC-CCC-CcchHHHHHHHHHHHHhCCCCcc
Q 002512 676 S----P-------LAELPAGTLGYLDPEYYRLH-YLT-TKSDVYSFGVLLLEILSGRKAID 723 (914)
Q Consensus 676 ~----~-------~~~~~~Gt~~y~aPE~l~~~-~~s-~ksDV~S~GvvL~ElltG~~p~~ 723 (914)
. . .......++.|++|+....- ..+ .+.+.++-|.-+|.++|++.+..
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0 0 01122378899999976543 223 57799999999999999998754
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.4e-18 Score=208.84 Aligned_cols=254 Identities=21% Similarity=0.226 Sum_probs=182.5
Q ss_pred HHHHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhcc---CCceeeeeceeecCCe
Q 002512 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN---HAHLLNLLGYCEEGRE 586 (914)
Q Consensus 510 el~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~ 586 (914)
++...+..+.+.||+|+||+||+|...+++.||+|+-.... ..+|.-=.+++.||+ -+-|..+...+.-.+.
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~-----~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN-----PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC-----ceeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 44444455677899999999999998889999999765443 345665666777776 2344555555666778
Q ss_pred EEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEc-------CCCcE
Q 002512 587 RLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID-------EEHNA 659 (914)
Q Consensus 587 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~-------~~~~~ 659 (914)
-+||+||.+.|||.+++... +.++|...+.|+.|+++.+++||..+ |||+||||+|+||. ++.-+
T Consensus 769 S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred ceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 89999999999999999843 45899999999999999999999999 99999999999993 24458
Q ss_pred EEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhh
Q 002512 660 RVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLI 739 (914)
Q Consensus 660 kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~ 739 (914)
+|+|||.+..+..-.....-....+|-.+--+|...++.++.+.|.|.|.-+++-||.|+..- .
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q----------------~ 904 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME----------------V 904 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH----------------h
Confidence 999999986433222222233345788899999999999999999999999999999997321 1
Q ss_pred hcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHHHHHHHH
Q 002512 740 KSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 740 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~~~l~~~ 796 (914)
..+... .++..++.-...+ ...+|....|..+-..=|...++...|+..+.+.
T Consensus 905 ~~g~~~-~~~~~~~Ry~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~ 957 (974)
T KOG1166|consen 905 KNGSSW-MVKTNFPRYWKRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEH 957 (974)
T ss_pred cCCcce-eccccchhhhhHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHH
Confidence 122111 1111111111112 2334555556655555577888888887776653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-19 Score=204.62 Aligned_cols=226 Identities=21% Similarity=0.288 Sum_probs=179.9
Q ss_pred cCcccceEEEEEE----EcCCcEEEEEEeeeccccccchHHHHHHHHHHHhcc-CCceeeeeceeecCCeEEEEEeeCCC
Q 002512 522 VGKGSFSCVYKGV----LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 522 LG~G~fG~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+|+|.||.|++.. .+.+..+|.|.+.+.............|..++..++ ||.+|++...++.+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 7999999999764 334778888877665544333346677889999996 99999999999999999999999999
Q ss_pred CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~ 676 (914)
|+|...+.... .+...........++-+++++|+.+ |+|||+|++||+++.+|.+|+.|||+++..-....
T Consensus 82 g~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 82 GDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred chhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 99999887654 3455555667788999999999999 99999999999999999999999999986543321
Q ss_pred CCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCC
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756 (914)
Q Consensus 677 ~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~ 756 (914)
..||..|||||++. .....+|-||||++++||+||..||.. +......+ ...+.
T Consensus 153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~-----------~~~~~ 206 (612)
T KOG0603|consen 153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILK-----------AELEM 206 (612)
T ss_pred -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhh-----------hccCC
Confidence 17899999999999 456899999999999999999999864 11111111 12334
Q ss_pred CHHHHHHHHHHHHHhhhcCCCCCCCH
Q 002512 757 DLDALKRIANVACKCVRMRGKERPSM 782 (914)
Q Consensus 757 ~~~~~~~l~~l~~~Cl~~~p~~RPs~ 782 (914)
+.+.......++..++..+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 45666777888889999999998755
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=8e-18 Score=173.93 Aligned_cols=133 Identities=18% Similarity=0.206 Sum_probs=102.9
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhc-----cCCceeeeeceeecCC---eEE-EE
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-----NHAHLLNLLGYCEEGR---ERL-LV 590 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-----~HpnIv~l~g~~~~~~---~~~-LV 590 (914)
+.||+|+|+.||. +.+....+||++.... ....+++.+|+++++++ +||||++++|+++++. ..+ +|
T Consensus 8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred ceecCCCceEEEE--CCCCcCeEEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 4699999999996 4443444788875432 22346799999999999 5799999999998874 333 78
Q ss_pred Eee--CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHH-HHhhccCCCCeeccCCCccceEEcC----CCcEEEee
Q 002512 591 YEF--MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI-EYLHGYACPPVIHRDIKSSNILIDE----EHNARVAD 663 (914)
Q Consensus 591 ~Ey--~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL-~yLH~~~~~~iiHrDIKp~NILl~~----~~~~kl~D 663 (914)
+|| ++++||.+++.+.. ++.. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 84 ~e~~G~~~~tL~~~l~~~~------~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQCR------YEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred ecCCCCcchhHHHHHHccc------ccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 999 66899999996531 3333 35577888777 9999999 999999999999974 34799999
Q ss_pred cCCc
Q 002512 664 FGLS 667 (914)
Q Consensus 664 FGla 667 (914)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5433
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.9e-18 Score=180.04 Aligned_cols=232 Identities=22% Similarity=0.358 Sum_probs=149.9
Q ss_pred ccccCcccceEEEEEEEcC-CcEEEEEEeeeccc-cccchHHHHHHHHHHHhccC----------Cceeeeecee-----
Q 002512 519 KEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNH----------AHLLNLLGYC----- 581 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~H----------pnIv~l~g~~----- 581 (914)
.+.||.|+|+.||.+++.+ ++.+|+|....... .....+++.+|.-....+.+ -.++.-++..
T Consensus 17 ~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~ 96 (288)
T PF14531_consen 17 GRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGK 96 (288)
T ss_dssp EEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS
T ss_pred ccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCC
Confidence 4569999999999999875 89999998766543 23345777777766655432 1122112211
Q ss_pred ----ecC---C-----eEEEEEeeCCCCCHHHhhhc---CccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCC
Q 002512 582 ----EEG---R-----ERLLVYEFMAHGSLHQHLHG---KSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDI 646 (914)
Q Consensus 582 ----~~~---~-----~~~LV~Ey~~~gsL~~~l~~---~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDI 646 (914)
... . ..+++|+-+ -+||.+++.. .... ...+....++.+..|+++.+++||+.+ ++|+||
T Consensus 97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi 171 (288)
T PF14531_consen 97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDI 171 (288)
T ss_dssp -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-
T ss_pred CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcc---eEeccc
Confidence 111 1 236778877 4688887642 2111 234566778889999999999999999 999999
Q ss_pred CccceEEcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcC--------CCCCcchHHHHHHHHHHHHhC
Q 002512 647 KSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH--------YLTTKSDVYSFGVLLLEILSG 718 (914)
Q Consensus 647 Kp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~--------~~s~ksDV~S~GvvL~ElltG 718 (914)
||+|+|++++|.++|+||+.......... ....+..|.+||..... .++.+.|.|+||+++|.|+++
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 99999999999999999987654332111 12345789999987442 578899999999999999999
Q ss_pred CCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCC
Q 002512 719 RKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKER 779 (914)
Q Consensus 719 ~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~R 779 (914)
+.||......... ++ ... .+. +.++.+..|+..+|+.+|.+|
T Consensus 247 ~lPf~~~~~~~~~-~~----------------~f~-~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADP-EW----------------DFS-RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTS-GG----------------GGT-TSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccc-cc----------------cch-hcC-CcCHHHHHHHHHHccCCcccC
Confidence 9998754222100 00 011 122 667889999999999999987
|
|
| >KOG1427 consensus Uncharacterized conserved protein, contains RCC1 domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.6e-17 Score=165.76 Aligned_cols=229 Identities=15% Similarity=0.199 Sum_probs=169.7
Q ss_pred eeeCCCCceEEEEeeCCceeEEecCCCCCcccCCCCC--------C------CEEEEecCCCeeEEEEeCCCceeecCCC
Q 002512 45 ISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGTPAH--------F------PFIGLTAGDGFVCGLLLDSNQPYCWGSS 110 (914)
Q Consensus 45 ~~~g~~~~~~c~~~~~~~~~v~cwg~n~~~~~~~p~~--------~------~~~~i~~G~~~~cal~~~~~~~~cWG~n 110 (914)
++.|...+|+.+|.-++.. |.||+|..||+|...- + ..++.|+|..||.+| +++|+++..|.|
T Consensus 61 VasG~~aaH~vli~megk~--~~wGRNekGQLGhgD~k~~e~Ptvi~gL~~~~iv~AA~GrnHTl~l-tdtG~v~afGeN 137 (443)
T KOG1427|consen 61 VASGCAAAHCVLIDMEGKC--YTWGRNEKGQLGHGDMKQRERPTVISGLSKHKIVKAAAGRNHTLVL-TDTGQVLAFGEN 137 (443)
T ss_pred EecccchhhEEEEecccce--eecccCccCccCccchhhccCCchhhhhhhhhHHHHhhccCcEEEE-ecCCcEEEeccc
Confidence 4444444466666667776 9999999999997521 1 456689999999999 999999999999
Q ss_pred CCCCCC----------CCccccCCCeEEEEEeCCceeeeeecCCCCccCCCceEEEcccCCCCCCcCCC-----------
Q 002512 111 GYIQMG----------VPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDG----------- 169 (914)
Q Consensus 111 ~~gqlg----------~p~~~~~~~~~~~i~~G~~h~cal~~~~~~~~~~~g~v~cWG~n~~gql~~~~----------- 169 (914)
-+|||| .|..-..+..++.|+||..++.-|. ..+.+...|--.|||||.++
T Consensus 138 K~GQlGlgn~~~~v~s~~~~~~~~~~v~~v~cga~ftv~l~--------~~~si~t~glp~ygqlgh~td~~~~~~~~~~ 209 (443)
T KOG1427|consen 138 KYGQLGLGNAKNEVESTPLPCVVSDEVTNVACGADFTVWLS--------STESILTAGLPQYGQLGHGTDNEFNMKDSSV 209 (443)
T ss_pred ccccccccccccccccCCCccccCccceeeccccceEEEee--------cccceeecCCccccccccCcchhhccccccc
Confidence 999999 2222234456899999999999984 47799999999999996554
Q ss_pred -------------------cEEEEeecCCceeEeeecCCeEEEecCCCCCceeecCC--------------CCccEEEEE
Q 002512 170 -------------------QIESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLIP--------------KEMKFQKVA 216 (914)
Q Consensus 170 -------------------~~~~ia~G~~~~cal~~~~g~v~cWG~n~~g~~~~~~~--------------~~~~~~~i~ 216 (914)
+++.+|+|.+||.|+ +.++.||.||.+.+|+|....+ .+..-.++.
T Consensus 210 ~~~~e~~pr~~~i~~~dgvqiv~~acg~nhtvav-d~nkrVysWGFGGyGRLGHaEqKDEmvpRlik~Fd~~~rg~~~~~ 288 (443)
T KOG1427|consen 210 RLAYEAQPRPKAIASLDGVQIVKVACGTNHTVAV-DKNKRVYSWGFGGYGRLGHAEQKDEMVPRLIKVFDRNNRGPPNAI 288 (443)
T ss_pred eeeeecCCCccccccccceeeEEEeccCcceeee-cCCccEEEeccccccccccccchhhHHHHHHHHhcCCCCCCccee
Confidence 258899999999999 8999999999999999922211 122234688
Q ss_pred ecCcceeEEEeCCCccEEEeecCCCCccccccccccccccCCCCCCCeeEeecCCcEEEeeeecCCceEEeeeccCC
Q 002512 217 AGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKP 293 (914)
Q Consensus 217 aG~~h~c~l~~~~~g~v~cWG~n~~~~~g~~~~~~~~~~~~~~~~~~~~sia~g~~htcg~~~~~g~v~CWG~n~~g 293 (914)
+|...+..+. .-|.++-||.+.+- +.+---+.|+....+-+..-+..+..| |.+ ..|.....||....+
T Consensus 289 ~g~t~Sl~v~--e~G~Lf~~g~~k~~----ge~~mypkP~~dlsgwnl~~~~~~~~h-~~v-~ad~s~i~wg~~~~g 357 (443)
T KOG1427|consen 289 LGYTGSLNVA--EGGQLFMWGKIKNN----GEDWMYPKPMMDLSGWNLRWMDSGSMH-HFV-GADSSCISWGHAQYG 357 (443)
T ss_pred eecccceeec--ccceeEEeeccccC----cccccCCCchhhcCCccCCCcCcccee-eee-ccccccccccccccc
Confidence 8888888886 56999999998442 223334566555555555666666554 445 336777789876554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.2e-18 Score=204.71 Aligned_cols=248 Identities=21% Similarity=0.298 Sum_probs=177.0
Q ss_pred cccccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHH--hccCCceeeeeceeecCCeEEEEEee
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLS--RLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~--~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
..+.+.||++.|=+|.++++++|. |+||++.+.... -..+.|.++++-++ .++|||.+++.-.-..+...|||-+|
T Consensus 25 ~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~-~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 25 CHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPT-ISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred eeeecccCchhhhhhhhccCCCce-EEEEEEeccCCC-CCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 345678999999999999998887 889988665432 23455655544444 45899999999888888888999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc--CC
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL--GP 671 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~--~~ 671 (914)
+.+ +|+|.|..+. -+...+..-|+.|++.||.-.|..+ |.|+|||.+||||+.-+-+.|+||---+- ++
T Consensus 103 vkh-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred Hhh-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCC
Confidence 965 9999997653 3555566669999999999999999 99999999999999999999999975432 22
Q ss_pred CCCCCCC---ccCCCCcCCccChhhhhcC-----------CCCCcchHHHHHHHHHHHHhC-CCCcccccccccHHHHHH
Q 002512 672 ADSSSPL---AELPAGTLGYLDPEYYRLH-----------YLTTKSDVYSFGVLLLEILSG-RKAIDMQFEEGNIVEWAV 736 (914)
Q Consensus 672 ~~~~~~~---~~~~~Gt~~y~aPE~l~~~-----------~~s~ksDV~S~GvvL~ElltG-~~p~~~~~~~~~l~~~~~ 736 (914)
.+..... -.+...-..|+|||.+... ..+++-||||+||++.||++- +++|... .+..
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS----QL~a--- 246 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS----QLLA--- 246 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH----HHHh---
Confidence 2221111 1112233579999988531 267889999999999999985 6666421 1111
Q ss_pred hhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 737 PLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 737 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.+.+. .......++.-.+ ..+.+++..|++.||++|.++++.++.
T Consensus 247 --Yr~~~-~~~~e~~Le~Ied----~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 --YRSGN-ADDPEQLLEKIED----VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred --HhccC-ccCHHHHHHhCcC----ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11221 0000111111111 257789999999999999999999876
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=9.1e-17 Score=167.50 Aligned_cols=136 Identities=20% Similarity=0.332 Sum_probs=113.5
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeecccccc------chHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQK------NSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.||+|++|.||+|.. ++..+++|+......... ....+.+|++++..++|++|+....++.+.+..+|||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4699999999999988 577899997654322111 124588999999999999988877777777888999999
Q ss_pred CCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
+++++|.+++.... + .+..++.+++.+|.+||+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986421 1 67889999999999999999 99999999999999 78899999998754
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=164.60 Aligned_cols=138 Identities=18% Similarity=0.182 Sum_probs=107.7
Q ss_pred cccccccCcccceEEEEEEEcCCcEEEEEEeeeccccc--------------------cchHHHHHHHHHHHhccCC--c
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQ--------------------KNSKEFHTELDLLSRLNHA--H 573 (914)
Q Consensus 516 ~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~f~~E~~~l~~l~Hp--n 573 (914)
+.+.+.||+|+||.||++..++++.||||++....... .....+..|..++.++.|+ .
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 44567899999999999998889999999865432110 0112367899999999887 4
Q ss_pred eeeeeceeecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE
Q 002512 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 653 (914)
Q Consensus 574 Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl 653 (914)
++..++. ...++||||+++++|.+.... .....++.+++.++.++|+.+ |+||||||+|||+
T Consensus 97 v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill 158 (198)
T cd05144 97 VPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV 158 (198)
T ss_pred CCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence 5555543 345899999999999765431 123568889999999999998 9999999999999
Q ss_pred cCCCcEEEeecCCcccCC
Q 002512 654 DEEHNARVADFGLSLLGP 671 (914)
Q Consensus 654 ~~~~~~kl~DFGla~~~~ 671 (914)
++++.++|+|||++....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999985543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.3e-16 Score=169.30 Aligned_cols=198 Identities=20% Similarity=0.225 Sum_probs=137.3
Q ss_pred cCCceeeeeceeec---------------------------CCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHH
Q 002512 570 NHAHLLNLLGYCEE---------------------------GRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI 622 (914)
Q Consensus 570 ~HpnIv~l~g~~~~---------------------------~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i 622 (914)
+|||||+++++|.+ ....||||.-++. +|++||..+. .+.....-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence 69999999888754 2246899988754 9999997653 345556678
Q ss_pred HHHHHHHHHHhhccCCCCeeccCCCccceEE--cCCC--cEEEeecCCcccCCCCC----CCCCccCCCCcCCccChhhh
Q 002512 623 AVQAARGIEYLHGYACPPVIHRDIKSSNILI--DEEH--NARVADFGLSLLGPADS----SSPLAELPAGTLGYLDPEYY 694 (914)
Q Consensus 623 ~~qia~gL~yLH~~~~~~iiHrDIKp~NILl--~~~~--~~kl~DFGla~~~~~~~----~~~~~~~~~Gt~~y~aPE~l 694 (914)
+.|+++|+.|||.++ |.|||+|++|||| |+|. .+.|+|||.+--..... .....-...|.-.-||||+.
T Consensus 347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 899999999999999 9999999999999 4444 47899999874321100 00011112477889999998
Q ss_pred hcCC------CCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHH
Q 002512 695 RLHY------LTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVA 768 (914)
Q Consensus 695 ~~~~------~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~ 768 (914)
...+ --.|+|.|+.|.+.||+++...||+...+. .+.. . ..++..+..+ +...+..+.+++
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~--r-~Yqe~qLPal---------p~~vpp~~rqlV 490 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDT--R-TYQESQLPAL---------PSRVPPVARQLV 490 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eech--h-hhhhhhCCCC---------cccCChHHHHHH
Confidence 6542 236899999999999999999999752211 0000 0 0111111111 123345678899
Q ss_pred HHhhhcCCCCCCCHHHHHHHHH
Q 002512 769 CKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 769 ~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
...|+.||.+||+..-....|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999776665553
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.6e-16 Score=164.09 Aligned_cols=131 Identities=23% Similarity=0.374 Sum_probs=106.7
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEeeeccccc------cchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCC
Q 002512 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQ------KNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
||+|+||.||+|.+ ++..+++|+........ ....++.+|++++..++|+++.....++.+.+..+|||||++
T Consensus 2 ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 2 IAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 89999999999996 47889999865432111 123567899999999998876555555556667799999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
+++|.+++..... .++.+++.+|.+||+.+ ++|+|+||.|||++ ++.++|.|||++..
T Consensus 81 g~~l~~~~~~~~~------------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 81 GKPLKDVIEEGND------------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CccHHHHHhhcHH------------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998754210 67899999999999999 99999999999999 78999999999855
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-17 Score=184.04 Aligned_cols=175 Identities=26% Similarity=0.381 Sum_probs=130.5
Q ss_pred eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecC
Q 002512 586 ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 586 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFG 665 (914)
++|+.|+++.-.+|.++|.++.. ....++...+.++.|++.+++| ++ .+|||+||.||+...+.++||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 57899999999999999986544 3456888899999999999999 66 9999999999999999999999999
Q ss_pred CcccCCCCC----CCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhc
Q 002512 666 LSLLGPADS----SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKS 741 (914)
Q Consensus 666 la~~~~~~~----~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~ 741 (914)
+........ .....+...||..||+||++.+..|+.|+||||||++|+||++ +|...++. ..+...+..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er----~~t~~d~r~ 474 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFER----IATLTDIRD 474 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHH----HHhhhhhhc
Confidence 987654443 1223455679999999999999999999999999999999998 22211111 111122333
Q ss_pred CCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 002512 742 GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDK 784 (914)
Q Consensus 742 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~e 784 (914)
+.+. |......+ .=+.|+.+++.+.|.+||++.+
T Consensus 475 g~ip----~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 475 GIIP----PEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred CCCC----hHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 3222 11111111 2247889999999999994433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-16 Score=187.68 Aligned_cols=133 Identities=21% Similarity=0.331 Sum_probs=108.6
Q ss_pred ccccCcccceEEEEEEEcCCcEEEEEEeeecccc------ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEe
Q 002512 519 KEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDR------QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
.+.||+|+||.||++.+.+. .+++|+....... ....+++.+|++++.+++|++++....++.+.+..+||||
T Consensus 338 ~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 338 DHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred cceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 46799999999999988644 3444443222111 1123568899999999999999988888877778899999
Q ss_pred eCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
|+++++|.+++. ....++.+++++|.|||+.+ |+||||||+|||+ +++.++|+|||+++.
T Consensus 417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 999999999885 23568899999999999999 9999999999999 677899999999865
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-16 Score=166.05 Aligned_cols=141 Identities=18% Similarity=0.182 Sum_probs=107.3
Q ss_pred ccccccCcccceEEEEEE--EcCCcEEEEEEeeecccccc----------------------chHHHHHHHHHHHhccC-
Q 002512 517 GFKEEVGKGSFSCVYKGV--LKDGTVVAVKKAIATSDRQK----------------------NSKEFHTELDLLSRLNH- 571 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~--~~~~~~vavK~~~~~~~~~~----------------------~~~~f~~E~~~l~~l~H- 571 (914)
.+.+.||+|+||.||+|. ..+|+.||+|++........ ....+..|+.++.++.+
T Consensus 31 ~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~ 110 (237)
T smart00090 31 AIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEA 110 (237)
T ss_pred HhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 356789999999999998 56799999998865421100 01235689999999975
Q ss_pred -CceeeeeceeecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccc
Q 002512 572 -AHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSN 650 (914)
Q Consensus 572 -pnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~N 650 (914)
..+++++++ ...+|||||+++.+|...+.... .+.......++.|++.+|+|||+.+ .|+||||||+|
T Consensus 111 ~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 111 GVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred CCCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 334555543 23489999999988877653221 2344456789999999999999887 39999999999
Q ss_pred eEEcCCCcEEEeecCCccc
Q 002512 651 ILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 651 ILl~~~~~~kl~DFGla~~ 669 (914)
||++ ++.++|+|||++..
T Consensus 180 Ili~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred EEEE-CCCEEEEEChhhhc
Confidence 9999 88999999999864
|
|
| >KOG1427 consensus Uncharacterized conserved protein, contains RCC1 domain [Function unknown] | Back alignment and domain information |
|---|
Probab=99.65 E-value=6e-16 Score=157.74 Aligned_cols=196 Identities=17% Similarity=0.193 Sum_probs=144.8
Q ss_pred CEEEEecCCCeeEEEEeCCCceeecCCCCCCCCC--------CCccccCCC--eEEEEEeCCceeeeeecCCCCccCCCc
Q 002512 83 PFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMG--------VPQPIIKGA--QYVEISAGDYHLCGLRKPLTGKWRNYS 152 (914)
Q Consensus 83 ~~~~i~~G~~~~cal~~~~~~~~cWG~n~~gqlg--------~p~~~~~~~--~~~~i~~G~~h~cal~~~~~~~~~~~g 152 (914)
.|++--+-..|+.+| .-++..|.||+|..|||| .|+.+.... .+++-++|..||.+| +++|
T Consensus 59 R~VasG~~aaH~vli-~megk~~~wGRNekGQLGhgD~k~~e~Ptvi~gL~~~~iv~AA~GrnHTl~l--------tdtG 129 (443)
T KOG1427|consen 59 RFVASGCAAAHCVLI-DMEGKCYTWGRNEKGQLGHGDMKQRERPTVISGLSKHKIVKAAAGRNHTLVL--------TDTG 129 (443)
T ss_pred EEEecccchhhEEEE-ecccceeecccCccCccCccchhhccCCchhhhhhhhhHHHHhhccCcEEEE--------ecCC
Confidence 444444556788888 778899999999999999 555544332 577889999999997 6899
Q ss_pred eEEEcccCCCCCCcCCC----------------cEEEEeecCCceeEeeecCCeEEEecCCCCCcee-------------
Q 002512 153 YVDCWGYNMTKNYVFDG----------------QIESISAGSEFNCGLFSQNRTVFCWGDESSSRVI------------- 203 (914)
Q Consensus 153 ~v~cWG~n~~gql~~~~----------------~~~~ia~G~~~~cal~~~~g~v~cWG~n~~g~~~------------- 203 (914)
+|+.+|+|.+||||.+. .+..|++|.+||.-| ...+.+...|--.||||.
T Consensus 130 ~v~afGeNK~GQlGlgn~~~~v~s~~~~~~~~~~v~~v~cga~ftv~l-~~~~si~t~glp~ygqlgh~td~~~~~~~~~ 208 (443)
T KOG1427|consen 130 QVLAFGENKYGQLGLGNAKNEVESTPLPCVVSDEVTNVACGADFTVWL-SSTESILTAGLPQYGQLGHGTDNEFNMKDSS 208 (443)
T ss_pred cEEEecccccccccccccccccccCCCccccCccceeeccccceEEEe-ecccceeecCCccccccccCcchhhcccccc
Confidence 99999999999997666 379999999999999 899999999999999991
Q ss_pred -------------ecCCCCccEEEEEecCcceeEEEeCCCccEEEeecCCCCccccccc--cccccccCCCC--CCCeeE
Q 002512 204 -------------SLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVA--YSRQGNVDLPP--SDPMLS 266 (914)
Q Consensus 204 -------------~~~~~~~~~~~i~aG~~h~c~l~~~~~g~v~cWG~n~~~~~g~~~~--~~~~~~~~~~~--~~~~~s 266 (914)
.....+..++.+++|.+||.|+. ++++||-||..+.|.+|...- +-.+..+++=. ...-.+
T Consensus 209 ~~~~~e~~pr~~~i~~~dgvqiv~~acg~nhtvavd--~nkrVysWGFGGyGRLGHaEqKDEmvpRlik~Fd~~~rg~~~ 286 (443)
T KOG1427|consen 209 VRLAYEAQPRPKAIASLDGVQIVKVACGTNHTVAVD--KNKRVYSWGFGGYGRLGHAEQKDEMVPRLIKVFDRNNRGPPN 286 (443)
T ss_pred ceeeeecCCCccccccccceeeEEEeccCcceeeec--CCccEEEeccccccccccccchhhHHHHHHHHhcCCCCCCcc
Confidence 01223456788999999999996 789999999999999886422 11111111100 111123
Q ss_pred eecCCcEEEeeeecCCceEEeeecc
Q 002512 267 IVGGKFHACGIKSYDRGVICWGFII 291 (914)
Q Consensus 267 ia~g~~htcg~~~~~g~v~CWG~n~ 291 (914)
+-+|...++.+ ...|.++-||.+.
T Consensus 287 ~~~g~t~Sl~v-~e~G~Lf~~g~~k 310 (443)
T KOG1427|consen 287 AILGYTGSLNV-AEGGQLFMWGKIK 310 (443)
T ss_pred eeeecccceee-cccceeEEeeccc
Confidence 34444445555 4468888888764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.9e-15 Score=152.05 Aligned_cols=137 Identities=23% Similarity=0.260 Sum_probs=98.6
Q ss_pred ccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHH----------------------HHHHHHHHhccCC--ce
Q 002512 519 KEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEF----------------------HTELDLLSRLNHA--HL 574 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f----------------------~~E~~~l~~l~Hp--nI 574 (914)
.+.||+|+||.||++...+++.||||++............+ ..|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 45799999999999998889999999876432211111111 3566667666443 34
Q ss_pred eeeeceeecCCeEEEEEeeCCCCCHHHh-hhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceE
Q 002512 575 LNLLGYCEEGRERLLVYEFMAHGSLHQH-LHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNIL 652 (914)
Q Consensus 575 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~-l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NIL 652 (914)
++.+++ ...+|||||++++++... +.... .. .....++.+++.++.++|. .+ |+||||||+|||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 555443 245899999999654321 21110 01 4467889999999999999 88 999999999999
Q ss_pred EcCCCcEEEeecCCcccC
Q 002512 653 IDEEHNARVADFGLSLLG 670 (914)
Q Consensus 653 l~~~~~~kl~DFGla~~~ 670 (914)
++ ++.++|+|||.+...
T Consensus 148 i~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 148 VD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred EE-CCcEEEEECcccccc
Confidence 99 889999999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-14 Score=141.44 Aligned_cols=133 Identities=20% Similarity=0.199 Sum_probs=111.9
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccC--CceeeeeceeecCCeEEEEEeeCCCC
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH--AHLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| +++++++.+....+..+++|||++++
T Consensus 4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred eecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 569999999999999864 7899997643322 4679999999999976 59999999998888999999999988
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
++..+ +......++.+++++|++||....+.++|+||||+|||+++++.+++.|||++..
T Consensus 79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 3345567889999999999987545599999999999999989999999998754
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.1e-15 Score=176.46 Aligned_cols=202 Identities=23% Similarity=0.318 Sum_probs=136.1
Q ss_pred cccCcccceEEEEEEEcC-CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
+.|-.|++|.||..+++. .+.+|+| +.+... +.+- ++.....|-+| |+
T Consensus 89 klisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv---------------------gD 137 (1205)
T KOG0606|consen 89 KLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV---------------------GD 137 (1205)
T ss_pred EeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee---------------------ch
Confidence 458999999999999875 5567773 322111 1110 22222233222 55
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCC---
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS--- 675 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~--- 675 (914)
-...++..+. ++ .+++.+++|||+.+ |+|||+||+|.||+.-+.+|+.|||+++..-....
T Consensus 138 c~tllk~~g~-----lP--------vdmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 138 CATLLKNIGP-----LP--------VDMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred hhhhcccCCC-----Cc--------chhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 5555554322 22 23478899999999 99999999999999999999999999875321110
Q ss_pred ----------CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcc
Q 002512 676 ----------SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745 (914)
Q Consensus 676 ----------~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 745 (914)
.-..+...||+.|+|||++..+.|....|.|++|+|+||.+-|+.||.....++ +...+.. . ++
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee-lfg~vis---d-~i- 275 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-LFGQVIS---D-DI- 275 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH-HHhhhhh---h-hc-
Confidence 011234479999999999999999999999999999999999999997654432 2221111 1 11
Q ss_pred cccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCC
Q 002512 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERP 780 (914)
Q Consensus 746 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RP 780 (914)
...+ .+.....+...++.+.|+.+|.+|-
T Consensus 276 ~wpE------~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 276 EWPE------EDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred cccc------cCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1111 1222335778889999999999995
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=6.2e-14 Score=148.75 Aligned_cols=136 Identities=18% Similarity=0.137 Sum_probs=105.1
Q ss_pred cccC-cccceEEEEEEEcCCcEEEEEEeeeccc-----------cccchHHHHHHHHHHHhccCCce--eeeeceeecCC
Q 002512 520 EEVG-KGSFSCVYKGVLKDGTVVAVKKAIATSD-----------RQKNSKEFHTELDLLSRLNHAHL--LNLLGYCEEGR 585 (914)
Q Consensus 520 ~~LG-~G~fG~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~f~~E~~~l~~l~HpnI--v~l~g~~~~~~ 585 (914)
..|| .||.|+||+.... +..++||....... .......+.+|++++.+|+|++| ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 3587 8999999999875 77889987743210 01223568899999999998874 77777654432
Q ss_pred ----eEEEEEeeCCC-CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEE
Q 002512 586 ----ERLLVYEFMAH-GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNAR 660 (914)
Q Consensus 586 ----~~~LV~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~k 660 (914)
..+|||||+++ .+|.+++... .++. ....+|+.+|.+||+.+ |+||||||.|||++.++.++
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~----~~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA------PLSE----EQWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC------CCCH----HHHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 23599999997 6999988643 2332 23568999999999999 99999999999999988999
Q ss_pred EeecCCccc
Q 002512 661 VADFGLSLL 669 (914)
Q Consensus 661 l~DFGla~~ 669 (914)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999998754
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-15 Score=181.29 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=183.1
Q ss_pred cccccCcccceEEEEEEEcC--CcEEEEEEeeeccccccchHHHHHHHHHHHhcc-CCceeeeeceeecCCeEEEEEeeC
Q 002512 518 FKEEVGKGSFSCVYKGVLKD--GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 518 ~~~~LG~G~fG~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.||+|.|+.|-...... ...+|+|.+..........+....|..+-..+. |+|++.+++...+.+..++++||.
T Consensus 24 ~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s 103 (601)
T KOG0590|consen 24 LSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYS 103 (601)
T ss_pred ccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcc
Confidence 34559999999998887643 445666655443322222344455888888886 999999999999999999999999
Q ss_pred CCCCHHHhh-hcCccchhcccchhhHHHHHHHHHHHHHHhh-ccCCCCeeccCCCccceEEcCCC-cEEEeecCCcccCC
Q 002512 595 AHGSLHQHL-HGKSKALKEQLDWVRRVTIAVQAARGIEYLH-GYACPPVIHRDIKSSNILIDEEH-NARVADFGLSLLGP 671 (914)
Q Consensus 595 ~~gsL~~~l-~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH-~~~~~~iiHrDIKp~NILl~~~~-~~kl~DFGla~~~~ 671 (914)
.++++.+.+ +.... ..+....-.+..|+..+|.|+| ..+ +.||||||+|.+++..+ ..|++|||+|..+.
T Consensus 104 ~g~~~f~~i~~~~~~----~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 104 DGGSLFSKISHPDST----GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cccccccccccCCcc----CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 999999988 43321 2334445567889999999999 888 99999999999999999 99999999998776
Q ss_pred C-CCCCCCccCCCC-cCCccChhhhhc-CCCCCcchHHHHHHHHHHHHhCCCCccccccccc-HHHHHHhhhhcCCcccc
Q 002512 672 A-DSSSPLAELPAG-TLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGN-IVEWAVPLIKSGDITAI 747 (914)
Q Consensus 672 ~-~~~~~~~~~~~G-t~~y~aPE~l~~-~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~-l~~~~~~~~~~~~~~~~ 747 (914)
. ...........| ++.|+|||.+.. .+..+..|+||.|+++.-+++|..|++....... +..|... ..
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~-----~~--- 248 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN-----KG--- 248 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc-----cc---
Confidence 6 444444455568 999999999987 4667889999999999999999999875433321 1111110 00
Q ss_pred cccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVT 786 (914)
Q Consensus 748 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~ 786 (914)
...............++...++..+|..|.+.+++.
T Consensus 249 ---~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 ---RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ---ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 000011112223556777888889999999987764
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=8.2e-13 Score=152.12 Aligned_cols=140 Identities=21% Similarity=0.215 Sum_probs=100.3
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEeeecccccc--------------------------------------chHHHHHH
Q 002512 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQK--------------------------------------NSKEFHTE 562 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~f~~E 562 (914)
.||.|++|.||+|++++|+.||||+........- ..-+|.+|
T Consensus 124 plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~E 203 (437)
T TIGR01982 124 PLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRRE 203 (437)
T ss_pred ceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHH
Confidence 4999999999999999999999998754321000 00136667
Q ss_pred HHHHHhcc-----CCceeeeecee-ecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHH-HHHHhhc
Q 002512 563 LDLLSRLN-----HAHLLNLLGYC-EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAAR-GIEYLHG 635 (914)
Q Consensus 563 ~~~l~~l~-----HpnIv~l~g~~-~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~-gL~yLH~ 635 (914)
++.+.+++ +++| .+-..+ ......+|||||++|++|.+++..... .+ .+.+++.++++ .+..+|.
T Consensus 204 a~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 204 AANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHHh
Confidence 77777663 3332 222222 234457999999999999887653211 11 23456666666 4788999
Q ss_pred cCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 636 ~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
.+ ++|+|+||.||+++++++++|.|||++..+.
T Consensus 276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 88 9999999999999999999999999986543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1428 consensus Inhibitor of type V adenylyl cyclases/Neuronal presynaptic protein Highwire/PAM/RPM-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1e-11 Score=145.80 Aligned_cols=208 Identities=18% Similarity=0.258 Sum_probs=155.2
Q ss_pred CCEEEEecCCCeeEEEEeCCCceeecCCCCCCCCCCCcc-ccCCC-eEEEEEeCCceeeeeecCCCCccCCCceEEEccc
Q 002512 82 FPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQP-IIKGA-QYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGY 159 (914)
Q Consensus 82 ~~~~~i~~G~~~~cal~~~~~~~~cWG~n~~gqlg~p~~-~~~~~-~~~~i~~G~~h~cal~~~~~~~~~~~g~v~cWG~ 159 (914)
.++++|+.|-+..-++ .+.+.-|..--++.-+.|.-.+ ++.+. .++.+ +|..|+.+. +..||.++-.|.
T Consensus 525 ~~IVq~SVG~D~~~~~-~~A~~G~I~~v~D~k~~~~~Rr~~P~n~rKIv~v-~~s~~VY~~-------vSenGkifM~G~ 595 (3738)
T KOG1428|consen 525 EPIVQISVGIDTIMFR-SGAGHGWIASVDDKKRNGRLRRLVPSNRRKIVHV-CASGHVYGY-------VSENGKIFMGGL 595 (3738)
T ss_pred CceEEEEeccchhhee-eccCcceEEeccCcccccchhhcCCCCcceeEEE-eeeeEEEEE-------EccCCeEEeecc
Confidence 4799999998877777 4444434333323223332222 22222 23333 677788886 568999999984
Q ss_pred -----CCCCCCcCCC---cEEEEeecCCceeEeeecCCeEEEecCCCCCce-----------------------------
Q 002512 160 -----NMTKNYVFDG---QIESISAGSEFNCGLFSQNRTVFCWGDESSSRV----------------------------- 202 (914)
Q Consensus 160 -----n~~gql~~~~---~~~~ia~G~~~~cal~~~~g~v~cWG~n~~g~~----------------------------- 202 (914)
|.+.|+..+. -+.++|.|..|+||+ +.+|.||.||-|.-+|.
T Consensus 596 ~tm~~n~SSqmln~L~~~~isslAlGKsH~~av-~rNG~l~T~GlNN~~QCGRVEs~sTt~s~~~s~~~e~~iCP~G~Ht 674 (3738)
T KOG1428|consen 596 HTMRVNVSSQMLNGLDNVMISSLALGKSHGVAV-TRNGHLFTWGLNNMNQCGRVESTSTTSSPRHSGRQEYQICPIGEHT 674 (3738)
T ss_pred eeEEecchHHHhhccccceeehhhccccceeEE-EeCCeEEEEecCCcccccccccccccCCcccccceeecccCCccce
Confidence 5666764333 268999999999999 89999999999877766
Q ss_pred --------------------------------------------------------------------------------
Q 002512 203 -------------------------------------------------------------------------------- 202 (914)
Q Consensus 203 -------------------------------------------------------------------------------- 202 (914)
T Consensus 675 W~~dt~~VCa~CG~Cs~~GvaC~~~~RP~G~mC~CG~GES~C~~CG~Cr~C~e~tE~~QPG~aqHvQ~~staa~QR~~~H 754 (3738)
T KOG1428|consen 675 WLTDTPSVCAQCGLCSARGVACGRVPRPKGTMCHCGVGESTCLRCGLCRPCGEVTEPAQPGRAQHVQFSSTAAPQRSTLH 754 (3738)
T ss_pred eecCCcchhhhcccccccccccccCCCCCCcccccCCCcccceeccccccccCcCCcCCCCHHHhheecccccccccccC
Confidence
Q ss_pred ee-----cCCCCccEEEEEecCcceeEEEeCCCccEEEeecCCCCccccccccccccc--cCCCCCCCeeEeecCCcEEE
Q 002512 203 IS-----LIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGN--VDLPPSDPMLSIVGGKFHAC 275 (914)
Q Consensus 203 ~~-----~~~~~~~~~~i~aG~~h~c~l~~~~~g~v~cWG~n~~~~~g~~~~~~~~~~--~~~~~~~~~~sia~g~~htc 275 (914)
|. +.+...++.+|++|..||-.|. .|++|+.+|.|-+||+|.|++..+.+| +.+|+++..+++++|.+||.
T Consensus 755 Ps~V~~sq~~Hdvkv~sVSCG~~HtVlL~--sd~~VfTFG~~~HGQLG~GDt~Sk~~Pq~V~~~~~t~~vQVaAGSNHT~ 832 (3738)
T KOG1428|consen 755 PSRVILSQGPHDVKVSSVSCGNFHTVLLA--SDRRVFTFGSNCHGQLGVGDTLSKNTPQQVILPSDTVIVQVAAGSNHTI 832 (3738)
T ss_pred chheeeccCCcceeEEEEeccCceEEEEe--cCCcEEEecCCcccccCcCccccCCCcceEEcCCCCceEEEecCCCceE
Confidence 00 0123346789999999999997 799999999999999999988766665 56688889999999999998
Q ss_pred eeeecCCceEEeeeccCCCCCCCCCcc
Q 002512 276 GIKSYDRGVICWGFIIKPSTPVPTGIK 302 (914)
Q Consensus 276 g~~~~~g~v~CWG~n~~gq~~ip~g~~ 302 (914)
-. ..||.|+-+|....||+..|.+-.
T Consensus 833 l~-~~DGsVFTFGaF~KGQL~RP~~e~ 858 (3738)
T KOG1428|consen 833 LR-ANDGSVFTFGAFGKGQLARPAGEK 858 (3738)
T ss_pred EE-ecCCcEEEeccccCccccCccccc
Confidence 77 789999999999999988877643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=8e-13 Score=149.96 Aligned_cols=256 Identities=19% Similarity=0.198 Sum_probs=180.9
Q ss_pred HHHHHHhcccccccCc--ccceEEEEEEE---cCCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceee
Q 002512 509 EELERATGGFKEEVGK--GSFSCVYKGVL---KDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCE 582 (914)
Q Consensus 509 ~el~~~t~~~~~~LG~--G~fG~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~ 582 (914)
.+.....-++.+.+|. |.+|.||.+.. .+...+|+|+.............=.+|+....++ .|+|.++.+..++
T Consensus 109 ~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e 188 (524)
T KOG0601|consen 109 DSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE 188 (524)
T ss_pred cchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc
Confidence 3444444556677999 99999999987 3588899998654443223223345677777777 5999999999999
Q ss_pred cCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHH----HHHHhhccCCCCeeccCCCccceEEcCC-C
Q 002512 583 EGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAAR----GIEYLHGYACPPVIHRDIKSSNILIDEE-H 657 (914)
Q Consensus 583 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~----gL~yLH~~~~~~iiHrDIKp~NILl~~~-~ 657 (914)
..+..|+-+|++. .+|.++.+..... ++....+.+..+..+ ||.++|+.. ++|-|+||.||++..+ .
T Consensus 189 ~~~~lfiqtE~~~-~sl~~~~~~~~~~----~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~ 260 (524)
T KOG0601|consen 189 GSGILFIQTELCG-ESLQSYCHTPCNF----LPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWT 260 (524)
T ss_pred cCCcceeeecccc-chhHHhhhccccc----CCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccc
Confidence 9999999999884 7999999876553 333444455555666 999999999 9999999999999999 7
Q ss_pred cEEEeecCCcccCCCCCCCC---CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHH
Q 002512 658 NARVADFGLSLLGPADSSSP---LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEW 734 (914)
Q Consensus 658 ~~kl~DFGla~~~~~~~~~~---~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~ 734 (914)
..++.|||+...+....... ......|...|++||.++.. ++.++|||+||.+.+|..++-......... .|
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----~W 335 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNS----SW 335 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCC----Cc
Confidence 89999999987765543221 11223578899999998864 478999999999999999987664322111 11
Q ss_pred HHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 735 AVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 735 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
. .+..+. +.+. .......++...+.++++.+|..|++.+.+..
T Consensus 336 ~--~~r~~~---ip~e-----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 336 S--QLRQGY---IPLE-----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred c--cccccc---Cchh-----hhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 1 011100 1111 11112234455888999999999998877653
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.5e-12 Score=136.08 Aligned_cols=207 Identities=22% Similarity=0.330 Sum_probs=139.9
Q ss_pred HHHHHhccCCceeeeeceeecCC-----eEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccC
Q 002512 563 LDLLSRLNHAHLLNLLGYCEEGR-----ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637 (914)
Q Consensus 563 ~~~l~~l~HpnIv~l~g~~~~~~-----~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~ 637 (914)
..-|-++.|-|||+++.|..+.. ...++.|||+-|+|.++|++... ....+......+++.||..||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 34455668999999999986644 35789999999999999986543 2345666667889999999999999986
Q ss_pred CCCeeccCCCccceEEcCCCcEEEeecCCcccCCCC--CCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHH
Q 002512 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD--SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEI 715 (914)
Q Consensus 638 ~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~--~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~El 715 (914)
|||+|+++..+-|++..++-+||.----....+.- ..........+-++|.+||+=.....+-++|||+||...+||
T Consensus 197 -PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 -PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred -CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 88999999999999999998887421111110000 000111223467899999998888888999999999999999
Q ss_pred HhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 002512 716 LSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 716 ltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~ 788 (914)
.-+..-.... +..-.++ ..+...+ +..... .=..++..|++..|..||+|++++..
T Consensus 276 ailEiq~tns-eS~~~~e--------e~ia~~i---~~len~-----lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNS-ESKVEVE--------ENIANVI---IGLENG-----LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCC-cceeehh--------hhhhhhe---eeccCc-----cccCcCcccccCCCCCCcchhhhhcC
Confidence 8877431111 1000011 0111100 000000 01245678999999999999987543
|
|
| >KOG0783 consensus Uncharacterized conserved protein, contains ankyrin and BTB/POZ domains [Function unknown] | Back alignment and domain information |
|---|
Probab=99.30 E-value=9.1e-12 Score=141.88 Aligned_cols=214 Identities=18% Similarity=0.238 Sum_probs=152.6
Q ss_pred eCCCceeecCCCCCCCCC--------CCcccc----CCCeEEEEEeCCceeeeeecCCCCccCCCceEEEcccCCCCCCc
Q 002512 99 LDSNQPYCWGSSGYIQMG--------VPQPII----KGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYV 166 (914)
Q Consensus 99 ~~~~~~~cWG~n~~gqlg--------~p~~~~----~~~~~~~i~~G~~h~cal~~~~~~~~~~~g~v~cWG~n~~gql~ 166 (914)
.+-..||.||.|-+-.|| .|..|. .+.-+.+|..|.+|+..| +..|.||..|-+.-|.||
T Consensus 139 d~pndvy~wG~N~N~tLGign~~~~~~Pe~Vdlf~~Sg~~~~qV~l~kfHSvfl--------~~kgqvY~cGhG~GGRlG 210 (1267)
T KOG0783|consen 139 DLPNDVYGWGTNVNNTLGIGNGKEPSSPERVDLFKTSGQLFSQVQLSKFHSVFL--------TEKGQVYVCGHGAGGRLG 210 (1267)
T ss_pred CCccceeEecccccccccccCCCCCCChHHhHHHHhccHHHHHHHHhhceeeEe--------cCCCcEEEeccCCCCccC
Confidence 455789999999999998 565543 334467899999999997 468999999999999886
Q ss_pred CCC----------------cEEEEeecCCceeEeeecCCeEEEecCCCCCceeecC----------------CCCccEEE
Q 002512 167 FDG----------------QIESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLI----------------PKEMKFQK 214 (914)
Q Consensus 167 ~~~----------------~~~~ia~G~~~~cal~~~~g~v~cWG~n~~g~~~~~~----------------~~~~~~~~ 214 (914)
.|. .+.+||+-..|+.+| +.+|.||.||-|.++||.... .+-..+..
T Consensus 211 ~gdeq~~~iPkrV~gL~gh~~~qisvs~~HslvL-T~~g~Vys~GlN~~hqLG~~~~~~~~~~p~qI~a~r~kg~~~iIg 289 (1267)
T KOG0783|consen 211 FGDEQYNFIPKRVPGLIGHKVIQISVSHTHSLVL-TKFGSVYSWGLNGSHQLGLSNDELKKDDPIQITARRIKGFKQIIG 289 (1267)
T ss_pred cCcccccccccccccccccceEEEEeecceeEEE-eecceEEEeecCcccccCCcCchhhcCchhhhhhHhhcchhhhhh
Confidence 554 379999999999999 899999999999999992211 11224567
Q ss_pred EEecCcceeEEEeCCCccEEEeecCCCCccccccccccc-cccC-CCCCCCeeEeecCCcEEEeeeecCCceEEeeeccC
Q 002512 215 VAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQ-GNVD-LPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIK 292 (914)
Q Consensus 215 i~aG~~h~c~l~~~~~g~v~cWG~n~~~~~g~~~~~~~~-~~~~-~~~~~~~~sia~g~~htcg~~~~~g~v~CWG~n~~ 292 (914)
|+||..|+.|. ++-.||.||.| +||+|..++.... +|-. .+....+..+++...-|+-+ +..+.++|.-+ +
T Consensus 290 vaAg~~hsVaw---t~~~VY~wGlN-~GQlGi~~n~~~Vt~Pr~l~~~~~~v~~v~a~~~ATVc~-~~~~~i~~~ad--y 362 (1267)
T KOG0783|consen 290 VAAGKSHSVAW---TDTDVYSWGLN-NGQLGISDNISVVTTPRRLAGLLSPVIHVVATTRATVCL-LQNNSIIAFAD--Y 362 (1267)
T ss_pred hhcccceeeee---ecceEEEeccc-CceecCCCCCceeecchhhcccccceEEEEecCccEEEE-ecCCcEEEEec--c
Confidence 89999999999 58999999998 6888876553222 2212 22344666666766666666 45888888753 3
Q ss_pred CCCCCCCCccE---EEEEecC-------------ccce-eeeccCCCcccccCC
Q 002512 293 PSTPVPTGIKV---YEIAAGN-------------YFTC-GVLAEKSMLPVCWGT 329 (914)
Q Consensus 293 gq~~ip~g~~~---~~v~~g~-------------~~~C-a~l~e~~~~~~~Wg~ 329 (914)
.|...|....+ ..|+-|. ...| +++.|.+.+ +||..
T Consensus 363 ~~~k~~~n~~~lks~~V~gg~l~~~~~~~~k~~a~~~kll~lte~g~V-y~w~s 415 (1267)
T KOG0783|consen 363 NQVKLPFNVDFLKSLKVTGGPLSLTRFNVRKLLASENKLLVLTELGEV-YEWDS 415 (1267)
T ss_pred cceecCcchhccceeEEecCccchhhhhhhhcchhhhheeeeccCCeE-EEEec
Confidence 35444443222 3333221 1235 677788887 88863
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.6e-11 Score=137.46 Aligned_cols=139 Identities=19% Similarity=0.126 Sum_probs=89.4
Q ss_pred ccCcccceEEEEEEEcC-CcEEEEEEeeeccccc--------------------------------cch------HHHHH
Q 002512 521 EVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQ--------------------------------KNS------KEFHT 561 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~-~~~vavK~~~~~~~~~--------------------------------~~~------~~f~~ 561 (914)
.||+|++|.||+|++++ |+.||||++....... +.. -+|.+
T Consensus 126 PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~~ 205 (537)
T PRK04750 126 PLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLMR 205 (537)
T ss_pred hhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHHH
Confidence 49999999999999987 9999999886432100 000 12455
Q ss_pred HHHHHHhcc----CCceeeeeceeec-CCeEEEEEeeCCCCCHHHh--hhcCccchhcccchhhHHHHHHHHHHHHHHhh
Q 002512 562 ELDLLSRLN----HAHLLNLLGYCEE-GRERLLVYEFMAHGSLHQH--LHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634 (914)
Q Consensus 562 E~~~l~~l~----HpnIv~l~g~~~~-~~~~~LV~Ey~~~gsL~~~--l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH 634 (914)
|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.++ +...+. ....+.......+..| ++
T Consensus 206 Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~~~la~~~v~~~~~Q-------if 277 (537)
T PRK04750 206 EAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DMKLLAERGVEVFFTQ-------VF 277 (537)
T ss_pred HHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CHHHHHHHHHHHHHHH-------HH
Confidence 555555552 3333333333322 3467899999999999874 322211 1112222222223333 34
Q ss_pred ccCCCCeeccCCCccceEEcCCC----cEEEeecCCcccC
Q 002512 635 GYACPPVIHRDIKSSNILIDEEH----NARVADFGLSLLG 670 (914)
Q Consensus 635 ~~~~~~iiHrDIKp~NILl~~~~----~~kl~DFGla~~~ 670 (914)
..+ ++|+|+||.||+++.++ ++++.|||++..+
T Consensus 278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 567 99999999999999888 9999999998554
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=3e-11 Score=121.08 Aligned_cols=129 Identities=15% Similarity=0.112 Sum_probs=96.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCce-eeeeceeecCCeEEEEEeeCCCCC
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHL-LNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnI-v~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
+.|+.|.++.||+.+.. ++.+++|....... ....+.+|++++..+.+.++ ++++.+.. ...++||||+++.+
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 45899999999999875 77899997643321 12457889999999965554 45555433 34589999999988
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccC--CCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA--CPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~--~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
+.+.. . ....+..+++++|+.||+.. ...++|+|++|.||+++ ++.++|.||+.+.
T Consensus 78 l~~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 78 LLTED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred ccccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 76430 0 11235678999999999987 23369999999999999 6689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0783 consensus Uncharacterized conserved protein, contains ankyrin and BTB/POZ domains [Function unknown] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-10 Score=133.49 Aligned_cols=216 Identities=16% Similarity=0.200 Sum_probs=147.4
Q ss_pred CCceeEEecCCCCCcccCCCCC----------------CCEEEEecCCCeeEEEEeCCCceeecCCCCCCCCC-------
Q 002512 60 DRSHLVTCYGSNSAIIYGTPAH----------------FPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMG------- 116 (914)
Q Consensus 60 ~~~~~v~cwg~n~~~~~~~p~~----------------~~~~~i~~G~~~~cal~~~~~~~~cWG~n~~gqlg------- 116 (914)
|.-.+|+.||.|...-+|.+.+ .-+.+|+.|..|+..+ +.-|.||.=|.+.-|+||
T Consensus 139 d~pndvy~wG~N~N~tLGign~~~~~~Pe~Vdlf~~Sg~~~~qV~l~kfHSvfl-~~kgqvY~cGhG~GGRlG~gdeq~~ 217 (1267)
T KOG0783|consen 139 DLPNDVYGWGTNVNNTLGIGNGKEPSSPERVDLFKTSGQLFSQVQLSKFHSVFL-TEKGQVYVCGHGAGGRLGFGDEQYN 217 (1267)
T ss_pred CCccceeEecccccccccccCCCCCCChHHhHHHHhccHHHHHHHHhhceeeEe-cCCCcEEEeccCCCCccCcCccccc
Confidence 3334579999997766665421 1356699999999999 688889999999999999
Q ss_pred -CCcccc--CCCeEEEEEeCCceeeeeecCCCCccCCCceEEEcccCCCCCCcCCC--------------------cEEE
Q 002512 117 -VPQPII--KGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDG--------------------QIES 173 (914)
Q Consensus 117 -~p~~~~--~~~~~~~i~~G~~h~cal~~~~~~~~~~~g~v~cWG~n~~gql~~~~--------------------~~~~ 173 (914)
.|..|. .+.++.+|++-..|+.+| +.+|.|+.||-|..+|||... ++..
T Consensus 218 ~iPkrV~gL~gh~~~qisvs~~HslvL--------T~~g~Vys~GlN~~hqLG~~~~~~~~~~p~qI~a~r~kg~~~iIg 289 (1267)
T KOG0783|consen 218 FIPKRVPGLIGHKVIQISVSHTHSLVL--------TKFGSVYSWGLNGSHQLGLSNDELKKDDPIQITARRIKGFKQIIG 289 (1267)
T ss_pred ccccccccccccceEEEEeecceeEEE--------eecceEEEeecCcccccCCcCchhhcCchhhhhhHhhcchhhhhh
Confidence 674444 466899999999999998 579999999999999996544 2578
Q ss_pred EeecCCceeEeeecCCeEEEecCCCCCcee------------ecCCCCccEEEEEecCcceeEEEeCCCccEEEeecCCC
Q 002512 174 ISAGSEFNCGLFSQNRTVFCWGDESSSRVI------------SLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLD 241 (914)
Q Consensus 174 ia~G~~~~cal~~~~g~v~cWG~n~~g~~~------------~~~~~~~~~~~i~aG~~h~c~l~~~~~g~v~cWG~n~~ 241 (914)
|+||..|+.|. .+..||.||-|. ||+. ...+....+..+.|-.+-|..++ ..+.++|.-+...
T Consensus 290 vaAg~~hsVaw--t~~~VY~wGlN~-GQlGi~~n~~~Vt~Pr~l~~~~~~v~~v~a~~~ATVc~~--~~~~i~~~ady~~ 364 (1267)
T KOG0783|consen 290 VAAGKSHSVAW--TDTDVYSWGLNN-GQLGISDNISVVTTPRRLAGLLSPVIHVVATTRATVCLL--QNNSIIAFADYNQ 364 (1267)
T ss_pred hhcccceeeee--ecceEEEecccC-ceecCCCCCceeecchhhcccccceEEEEecCccEEEEe--cCCcEEEEecccc
Confidence 99999999999 667899999874 7871 11223345666666655554444 5799999886533
Q ss_pred CccccccccccccccCCCCCC------CeeEeecCCcEEEeeeecCCceEEeeeccC
Q 002512 242 LEEEVSVAYSRQGNVDLPPSD------PMLSIVGGKFHACGIKSYDRGVICWGFIIK 292 (914)
Q Consensus 242 ~~~g~~~~~~~~~~~~~~~~~------~~~sia~g~~htcg~~~~~g~v~CWG~n~~ 292 (914)
.-.-.... ...-+.|.++. .+....+-..--+++ +..|.|+||-.++.
T Consensus 365 ~k~~~n~~--~lks~~V~gg~l~~~~~~~~k~~a~~~kll~l-te~g~Vy~w~s~ns 418 (1267)
T KOG0783|consen 365 VKLPFNVD--FLKSLKVTGGPLSLTRFNVRKLLASENKLLVL-TELGEVYEWDSKNS 418 (1267)
T ss_pred eecCcchh--ccceeEEecCccchhhhhhhhcchhhhheeee-ccCCeEEEEecCCC
Confidence 22211111 00111121111 122223333444555 77899999986654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.6e-10 Score=114.23 Aligned_cols=137 Identities=18% Similarity=0.190 Sum_probs=97.3
Q ss_pred cccCcccceEEEEEEEcC-------CcEEEEEEeeecccc----------c----------cchHHHH----HHHHHHHh
Q 002512 520 EEVGKGSFSCVYKGVLKD-------GTVVAVKKAIATSDR----------Q----------KNSKEFH----TELDLLSR 568 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~-------~~~vavK~~~~~~~~----------~----------~~~~~f~----~E~~~l~~ 568 (914)
..||.|--+.||.|...+ +..+|||..+..... + ...+.+. +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998653 478999965432110 0 0012233 79999999
Q ss_pred ccC--CceeeeeceeecCCeEEEEEeeCCCCCHHH-hhhcCccchhcccchhhHHHHHHHHHHHHHHh-hccCCCCeecc
Q 002512 569 LNH--AHLLNLLGYCEEGRERLLVYEFMAHGSLHQ-HLHGKSKALKEQLDWVRRVTIAVQAARGIEYL-HGYACPPVIHR 644 (914)
Q Consensus 569 l~H--pnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~-~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yL-H~~~~~~iiHr 644 (914)
+.. -++++++++ ...+|||||+.+..+.. .|+.. .++......+..+++.+|.+| |..+ |||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 953 577777765 45689999997654422 22211 133334556788999999999 8888 9999
Q ss_pred CCCccceEEcCCCcEEEeecCCcccC
Q 002512 645 DIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 645 DIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
||++.|||+++ +.++|+|||.+...
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeC
Confidence 99999999974 67999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.2e-10 Score=117.10 Aligned_cols=143 Identities=20% Similarity=0.274 Sum_probs=108.0
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccC--CceeeeeceeecCC---eEEEEEeeC
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH--AHLLNLLGYCEEGR---ERLLVYEFM 594 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~~---~~~LV~Ey~ 594 (914)
+.|+.|.++.||++...+|+.+++|........ ....++.+|+++++.+++ .++++++.+..+.. ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 458999999999999877788999976443221 234678999999999965 45677887776643 568999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccC-------------------------------------
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA------------------------------------- 637 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~------------------------------------- 637 (914)
++.+|.+.+.. ..++...+..++.++++.|.+||+..
T Consensus 83 ~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (223)
T cd05154 83 DGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA 156 (223)
T ss_pred CCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence 99988776531 12455566677778888888887421
Q ss_pred ----------------CCCeeccCCCccceEEcC--CCcEEEeecCCccc
Q 002512 638 ----------------CPPVIHRDIKSSNILIDE--EHNARVADFGLSLL 669 (914)
Q Consensus 638 ----------------~~~iiHrDIKp~NILl~~--~~~~kl~DFGla~~ 669 (914)
...++|+|++|.|||++. ++.+.|.||+.+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245899999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=7.9e-10 Score=108.60 Aligned_cols=132 Identities=22% Similarity=0.329 Sum_probs=99.7
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEeeeccccccc------hHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeC
Q 002512 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKN------SKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~------~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.|.+|+-+.+|.+.+. |.++++|.-....-.... .++-.+|++++.+++--.|.--+=|..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775 445667754433322222 244678999999997655544444555666778999999
Q ss_pred CCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
+|-.|.++|... +..++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 999999898754 1345667777788899999 99999999999997765 99999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.7e-11 Score=133.99 Aligned_cols=242 Identities=21% Similarity=0.225 Sum_probs=170.8
Q ss_pred ccccCcccceEEEEEEEc--CCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCC
Q 002512 519 KEEVGKGSFSCVYKGVLK--DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
...||.|.|+.||+...+ ++..+++|.+............-..|+.+...+ .|.++++.+..+...+..|+=-||++
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~ 349 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCE 349 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhc
Confidence 345999999999987744 578899997765543332222234677777777 69999998888888888889999999
Q ss_pred CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCC-CcEEEeecCCcccCCCCC
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE-HNARVADFGLSLLGPADS 674 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~-~~~kl~DFGla~~~~~~~ 674 (914)
++++...+. ....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +.-++.|||+...+....
T Consensus 350 ~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~ 421 (524)
T KOG0601|consen 350 GGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS 421 (524)
T ss_pred CcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceec
Confidence 999887762 2345677778899999999999999998 9999999999999886 778999999885421111
Q ss_pred CCCCccCCCCcCCc-cChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccC
Q 002512 675 SSPLAELPAGTLGY-LDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 675 ~~~~~~~~~Gt~~y-~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~ 753 (914)
......+..| .+|+.+....+-.+.|+||||..+.|.+++..--.. ...| ..+..+....
T Consensus 422 ----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~------~~~~--~~i~~~~~p~------- 482 (524)
T KOG0601|consen 422 ----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES------GVQS--LTIRSGDTPN------- 482 (524)
T ss_pred ----ccccccccccccchhhccccccccccccccccccccccccCcccCcc------cccc--eeeecccccC-------
Confidence 1111233344 366666777888999999999999999998743211 1111 0111221111
Q ss_pred CCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHH
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~~L~ 790 (914)
.+ ....++..+...++..++..||.+.++....+
T Consensus 483 ~~---~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 483 LP---GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred CC---chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11 11245666777788899999999888765544
|
|
| >KOG1428 consensus Inhibitor of type V adenylyl cyclases/Neuronal presynaptic protein Highwire/PAM/RPM-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=5.2e-09 Score=123.84 Aligned_cols=156 Identities=19% Similarity=0.230 Sum_probs=121.2
Q ss_pred CCCCCCCEEEEecCCCeeEEEEeCCCceeecCC-----CCCCCCCCCccccCCCeEEEEEeCCceeeeeecCCCCccCCC
Q 002512 77 GTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGS-----SGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNY 151 (914)
Q Consensus 77 ~~p~~~~~~~i~~G~~~~cal~~~~~~~~cWG~-----n~~gqlg~p~~~~~~~~~~~i~~G~~h~cal~~~~~~~~~~~ 151 (914)
..|.+..-+.=.+|..|+-++...+|.+|-.|. |...|+ ..-..+.-+++++.|..|.||+ +.+
T Consensus 563 ~~P~n~rKIv~v~~s~~VY~~vSenGkifM~G~~tm~~n~SSqm---ln~L~~~~isslAlGKsH~~av--------~rN 631 (3738)
T KOG1428|consen 563 LVPSNRRKIVHVCASGHVYGYVSENGKIFMGGLHTMRVNVSSQM---LNGLDNVMISSLALGKSHGVAV--------TRN 631 (3738)
T ss_pred cCCCCcceeEEEeeeeEEEEEEccCCeEEeecceeEEecchHHH---hhccccceeehhhccccceeEE--------EeC
Confidence 356665444445677899999899999988774 222332 1122344588999999999997 469
Q ss_pred ceEEEcccCCCCCCc----------------------------------------------------------------C
Q 002512 152 SYVDCWGYNMTKNYV----------------------------------------------------------------F 167 (914)
Q Consensus 152 g~v~cWG~n~~gql~----------------------------------------------------------------~ 167 (914)
|.||.||-|+.+|.| .
T Consensus 632 G~l~T~GlNN~~QCGRVEs~sTt~s~~~s~~~e~~iCP~G~HtW~~dt~~VCa~CG~Cs~~GvaC~~~~RP~G~mC~CG~ 711 (3738)
T KOG1428|consen 632 GHLFTWGLNNMNQCGRVESTSTTSSPRHSGRQEYQICPIGEHTWLTDTPSVCAQCGLCSARGVACGRVPRPKGTMCHCGV 711 (3738)
T ss_pred CeEEEEecCCcccccccccccccCCcccccceeecccCCccceeecCCcchhhhcccccccccccccCCCCCCcccccCC
Confidence 999999999988861 0
Q ss_pred CC------------------------------------------------------cEEEEeecCCceeEeeecCCeEEE
Q 002512 168 DG------------------------------------------------------QIESISAGSEFNCGLFSQNRTVFC 193 (914)
Q Consensus 168 ~~------------------------------------------------------~~~~ia~G~~~~cal~~~~g~v~c 193 (914)
|. .+++|++|..||.-| .+|++|+.
T Consensus 712 GES~C~~CG~Cr~C~e~tE~~QPG~aqHvQ~~staa~QR~~~HPs~V~~sq~~Hdvkv~sVSCG~~HtVlL-~sd~~VfT 790 (3738)
T KOG1428|consen 712 GESTCLRCGLCRPCGEVTEPAQPGRAQHVQFSSTAAPQRSTLHPSRVILSQGPHDVKVSSVSCGNFHTVLL-ASDRRVFT 790 (3738)
T ss_pred CcccceeccccccccCcCCcCCCCHHHhheecccccccccccCchheeeccCCcceeEEEEeccCceEEEE-ecCCcEEE
Confidence 00 038999999999998 89999999
Q ss_pred ecCCCCCce------------eecCCCCccEEEEEecCcceeEEEeCCCccEEEeecCCCCcccc
Q 002512 194 WGDESSSRV------------ISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEV 246 (914)
Q Consensus 194 WG~n~~g~~------------~~~~~~~~~~~~i~aG~~h~c~l~~~~~g~v~cWG~n~~~~~g~ 246 (914)
+|.|.+||| .+..+.++..++|+||.+||..+. .||.|+.+|.=+.||++-
T Consensus 791 FG~~~HGQLG~GDt~Sk~~Pq~V~~~~~t~~vQVaAGSNHT~l~~--~DGsVFTFGaF~KGQL~R 853 (3738)
T KOG1428|consen 791 FGSNCHGQLGVGDTLSKNTPQQVILPSDTVIVQVAAGSNHTILRA--NDGSVFTFGAFGKGQLAR 853 (3738)
T ss_pred ecCCcccccCcCccccCCCcceEEcCCCCceEEEecCCCceEEEe--cCCcEEEeccccCccccC
Confidence 999999999 233455667899999999999887 799999999999999763
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.1e-09 Score=102.92 Aligned_cols=143 Identities=20% Similarity=0.274 Sum_probs=103.5
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeecc------ccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEee
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATS------DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.|-+|+-+.|+++.+. |+...||.-.... +.+-...+-.+|+++|.+++--.|.--.=++.+...-.|+|||
T Consensus 13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~ 91 (229)
T KOG3087|consen 13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF 91 (229)
T ss_pred eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence 46889999999999986 7777777543322 1222345678999999998654444444455555666799999
Q ss_pred CCC-CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC---cEEEeecCCccc
Q 002512 594 MAH-GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH---NARVADFGLSLL 669 (914)
Q Consensus 594 ~~~-gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~---~~kl~DFGla~~ 669 (914)
+++ -++.+++...... ...-.....++.+|-+.+.-||..+ |||+||..+||+|..++ .+.++|||++..
T Consensus 92 ~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 92 IDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred ccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 976 5888888654321 1222223577888899999999999 99999999999996544 358999999855
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.5e-08 Score=111.07 Aligned_cols=171 Identities=15% Similarity=0.229 Sum_probs=129.5
Q ss_pred ceEEEEEEEc-CCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceee----cCCeEEEEEeeCCC-CCHH
Q 002512 527 FSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCE----EGRERLLVYEFMAH-GSLH 600 (914)
Q Consensus 527 fG~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~----~~~~~~LV~Ey~~~-gsL~ 600 (914)
-.+.||+... ||..+++|++..... .....-..-+++++++.|+|||+|..++. .+...+|||+|.|+ ++|.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3578999865 799999998843322 22223445688999999999999999886 34467899999996 7898
Q ss_pred HhhhcCccch----------hcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccC
Q 002512 601 QHLHGKSKAL----------KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 601 ~~l~~~~~~~----------~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~ 670 (914)
++.....+.. ...++....+.++.|+..||.++|+.+ +.-+-|.+.+||++.+.+++|+..|+..+.
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeee
Confidence 8664332211 223567788999999999999999999 888999999999999999999998887665
Q ss_pred CCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCC
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKA 721 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p 721 (914)
..+.. |.+.. -.+-|.=-||.+++.|.||...
T Consensus 444 ~~d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 54431 11111 1467999999999999999643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.5e-09 Score=118.87 Aligned_cols=166 Identities=18% Similarity=0.191 Sum_probs=123.1
Q ss_pred EcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCCHHHhhhcCccchhccc
Q 002512 535 LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQL 614 (914)
Q Consensus 535 ~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l 614 (914)
..++.+|.|........ .......+-++.|+.|+||||+++++.++.+...|||+|-+. -|..+|.+..
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------- 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------- 102 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-------
Confidence 34688888887755443 223557788899999999999999999999999999999875 5667776433
Q ss_pred chhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhh
Q 002512 615 DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694 (914)
Q Consensus 615 ~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l 694 (914)
-....-.+.||+.||.|||+.+. ++|++|.-+-|++++.|..||++|-++........ ......--..|..|+.+
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEI 177 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhc
Confidence 22233467899999999986553 99999999999999999999999988754322211 11111223356777765
Q ss_pred hcCCCCCcchHHHHHHHHHHHHhC
Q 002512 695 RLHYLTTKSDVYSFGVLLLEILSG 718 (914)
Q Consensus 695 ~~~~~s~ksDV~S~GvvL~ElltG 718 (914)
.... ...|.|-||++++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 5332 356999999999999999
|
|
| >PF13540 RCC1_2: Regulator of chromosome condensation (RCC1) repeat; PDB: 3QI0_D 1JTD_B 3QHY_B | Back alignment and domain information |
|---|
Probab=98.89 E-value=1.7e-09 Score=74.66 Aligned_cols=30 Identities=30% Similarity=0.864 Sum_probs=25.5
Q ss_pred EEEEeecCCceeEeeecCCeEEEecCCCCCc
Q 002512 171 IESISAGSEFNCGLFSQNRTVFCWGDESSSR 201 (914)
Q Consensus 171 ~~~ia~G~~~~cal~~~~g~v~cWG~n~~g~ 201 (914)
+++||+|.+|+||| ++||+|||||+|.+||
T Consensus 1 V~~ia~G~~ht~al-~~~g~v~~wG~n~~GQ 30 (30)
T PF13540_consen 1 VVQIACGGYHTCAL-TSDGEVYCWGDNNYGQ 30 (30)
T ss_dssp EEEEEEESSEEEEE-E-TTEEEEEE--TTST
T ss_pred CEEEEecCCEEEEE-EcCCCEEEEcCCcCCC
Confidence 57999999999999 8999999999999997
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1e-09 Score=130.74 Aligned_cols=242 Identities=18% Similarity=0.204 Sum_probs=158.5
Q ss_pred ccCcccceEEEEEEEc-CCcEEEEEEeeecccc-ccchHHHHHHHHHHHhccCCceeeeeceeecCCeEEEEEeeCCCCC
Q 002512 521 EVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR-QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
.+-+|.|+.++.+.-. .+...++|.......- ....+....+-.++-..+||-+++...-+.-....+|+++|+.+++
T Consensus 811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~ 890 (1205)
T KOG0606|consen 811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD 890 (1205)
T ss_pred cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence 5778899988876532 2333333322111110 1112333334333333456777776666666778899999999999
Q ss_pred HHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC-C-----
Q 002512 599 LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP-A----- 672 (914)
Q Consensus 599 L~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~-~----- 672 (914)
|...|+......... .......+..+++|||... ++|||+||.|+|+..++..+++|||...... .
T Consensus 891 ~~Skl~~~~~~saep-----aRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 891 LPSKLHNSGCLSAEP-----ARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred chhhhhcCCCccccc-----ccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999998765322111 2234556788899999988 9999999999999999999999998332110 0
Q ss_pred ---------------CCC--------CCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCcccccccc
Q 002512 673 ---------------DSS--------SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEG 729 (914)
Q Consensus 673 ---------------~~~--------~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~ 729 (914)
... ........||+.|.+||.+.+......+|.|++|++++|.++|..||.......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 000 001223459999999999999999999999999999999999999987543322
Q ss_pred cHHHHHHhhhhcCCcccccccccCCCC-CHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 002512 730 NIVEWAVPLIKSGDITAILDPVLKLPS-DLDALKRIANVACKCVRMRGKERPSMD 783 (914)
Q Consensus 730 ~l~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~~p~~RPs~~ 783 (914)
.+ ..++......+. +.+...+..+++...+..+|.+|-.|.
T Consensus 1043 ~f-------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1043 IF-------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hh-------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 11 111111111111 123345667788888899999987765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.4e-08 Score=104.63 Aligned_cols=135 Identities=16% Similarity=0.127 Sum_probs=97.0
Q ss_pred eEEEEEEEcCCcEEEEEEeeeccccc---------cchHHHHHHHHHHHhccCC--ceeeeeceeec-----CCeEEEEE
Q 002512 528 SCVYKGVLKDGTVVAVKKAIATSDRQ---------KNSKEFHTELDLLSRLNHA--HLLNLLGYCEE-----GRERLLVY 591 (914)
Q Consensus 528 G~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~f~~E~~~l~~l~Hp--nIv~l~g~~~~-----~~~~~LV~ 591 (914)
..|++..+ +|+.+.||+........ .....+.+|...+.+|... .++.++++.+. ....+|||
T Consensus 36 rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 36 RRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred ceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 34667666 57889999764332110 0112488999999999543 34455666643 23568999
Q ss_pred eeCCCC-CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC-------CCcEEEee
Q 002512 592 EFMAHG-SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE-------EHNARVAD 663 (914)
Q Consensus 592 Ey~~~g-sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~-------~~~~kl~D 663 (914)
|++++- +|.+++..... ...+...+..++.+++..+.-||..+ |+|+|++++|||++. +..+.|+|
T Consensus 115 e~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~LID 188 (268)
T PRK15123 115 EDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLSVID 188 (268)
T ss_pred eeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEEEEE
Confidence 999986 89999853211 12344566789999999999999999 999999999999975 46799999
Q ss_pred cCCccc
Q 002512 664 FGLSLL 669 (914)
Q Consensus 664 FGla~~ 669 (914)
|+.+..
T Consensus 189 l~r~~~ 194 (268)
T PRK15123 189 LHRAQI 194 (268)
T ss_pred CCcccc
Confidence 998743
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=4.1e-08 Score=99.62 Aligned_cols=126 Identities=25% Similarity=0.283 Sum_probs=81.9
Q ss_pred EEEEEEEcCCcEEEEEEeeeccc-------------c-----------ccchHHHHHHHHHHHhccCC--ceeeeeceee
Q 002512 529 CVYKGVLKDGTVVAVKKAIATSD-------------R-----------QKNSKEFHTELDLLSRLNHA--HLLNLLGYCE 582 (914)
Q Consensus 529 ~Vy~~~~~~~~~vavK~~~~~~~-------------~-----------~~~~~~f~~E~~~l~~l~Hp--nIv~l~g~~~ 582 (914)
.||.|...++..+|||....... . ........+|.+.|.++..- ++++++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999998999999996643211 0 00012356899999999765 677777553
Q ss_pred cCCeEEEEEeeCC--CCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHH-hhccCCCCeeccCCCccceEEcCCCcE
Q 002512 583 EGRERLLVYEFMA--HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY-LHGYACPPVIHRDIKSSNILIDEEHNA 659 (914)
Q Consensus 583 ~~~~~~LV~Ey~~--~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~y-LH~~~~~~iiHrDIKp~NILl~~~~~~ 659 (914)
..+|||||++ +..|..+.. .. ++......+..++++.+.. +|..+ |+|+||.+.|||++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-~~------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-VD------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-CG------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHHh-cc------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 3479999998 545544332 11 1123345677788886655 57888 9999999999999988 99
Q ss_pred EEeecCCccc
Q 002512 660 RVADFGLSLL 669 (914)
Q Consensus 660 kl~DFGla~~ 669 (914)
.|+|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13540 RCC1_2: Regulator of chromosome condensation (RCC1) repeat; PDB: 3QI0_D 1JTD_B 3QHY_B | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.4e-08 Score=70.10 Aligned_cols=30 Identities=33% Similarity=0.806 Sum_probs=24.8
Q ss_pred EEEEEecCcceeEEEeCCCccEEEeecCCCCc
Q 002512 212 FQKVAAGGYHVCGILEGLDSRTRCWGRSLDLE 243 (914)
Q Consensus 212 ~~~i~aG~~h~c~l~~~~~g~v~cWG~n~~~~ 243 (914)
+++|++|.+|+|+|+ .||+|||||.|..||
T Consensus 1 V~~ia~G~~ht~al~--~~g~v~~wG~n~~GQ 30 (30)
T PF13540_consen 1 VVQIACGGYHTCALT--SDGEVYCWGDNNYGQ 30 (30)
T ss_dssp EEEEEEESSEEEEEE---TTEEEEEE--TTST
T ss_pred CEEEEecCCEEEEEE--cCCCEEEEcCCcCCC
Confidence 579999999999998 789999999997765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.7e-07 Score=99.32 Aligned_cols=262 Identities=15% Similarity=0.138 Sum_probs=156.4
Q ss_pred ccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeece------eecC-CeEEEE
Q 002512 519 KEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGY------CEEG-RERLLV 590 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~------~~~~-~~~~LV 590 (914)
...||+|+.+.+|-.- +-..-+.|+....... .-.+.+..|.+. .||-+-.-+.+ .-+. ...-+.
T Consensus 16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa-----~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPA-----AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CccccCCccceeeecc--hhhchhheeecCCCch-----HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 4569999999999532 1112234554433211 112233344444 56644331211 1122 225567
Q ss_pred EeeCCCC-CHHHhhhc-CccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 591 YEFMAHG-SLHQHLHG-KSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 591 ~Ey~~~g-sL~~~l~~-~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
|..+++. -...++.- .....-....|...++.+..+|.+.+-||+.+ .+-+|+.++|+|+.++..+.|.|-.--.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7777664 22233321 11112235789999999999999999999999 8999999999999999999998843221
Q ss_pred cCCCCCCCCCccCCCCcCCccChhhhh-----cCCCCCcchHHHHHHHHHHHHhC-CCCccccc---ccccHHHHHHhhh
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYR-----LHYLTTKSDVYSFGVLLLEILSG-RKAIDMQF---EEGNIVEWAVPLI 739 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~y~aPE~l~-----~~~~s~ksDV~S~GvvL~ElltG-~~p~~~~~---~~~~l~~~~~~~~ 739 (914)
+. .........+|...|.+||.-. +..-+..+|-|.||+++++||.| ++||.... ...+..+ ..+
T Consensus 166 i~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~I 239 (637)
T COG4248 166 IN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDI 239 (637)
T ss_pred ec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhh
Confidence 11 1222344567999999999865 33456789999999999999997 89986422 1111111 011
Q ss_pred hcCCccccccc------ccCCCCCHHHHHHHHHHHHHhhhc--CCCCCCCHHHHHHHHHHHHHHH
Q 002512 740 KSGDITAILDP------VLKLPSDLDALKRIANVACKCVRM--RGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 740 ~~~~~~~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~--~p~~RPs~~ev~~~L~~~l~~~ 796 (914)
..+.+..-.|. .....+-.-.+..+..+..+|+.. .+.-|||.+-.+..|..+..++
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 12221111111 111111112235666777888865 3678999999888886655544
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.1e-07 Score=93.79 Aligned_cols=124 Identities=23% Similarity=0.252 Sum_probs=91.8
Q ss_pred CcEEEEEEeeecccc-----ccchHHHHHHHHHHHhccC--CceeeeeceeecCC----eEEEEEeeCCC-CCHHHhhhc
Q 002512 538 GTVVAVKKAIATSDR-----QKNSKEFHTELDLLSRLNH--AHLLNLLGYCEEGR----ERLLVYEFMAH-GSLHQHLHG 605 (914)
Q Consensus 538 ~~~vavK~~~~~~~~-----~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~~----~~~LV~Ey~~~-gsL~~~l~~ 605 (914)
++.+.+|........ ......+.+|...+.+|.. -.+++.+++.+... ..+||+|++++ -+|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 556666654322111 1233568889999888853 34666777766533 45899999998 489999875
Q ss_pred CccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCC---cEEEeecCCccc
Q 002512 606 KSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH---NARVADFGLSLL 669 (914)
Q Consensus 606 ~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~---~~kl~DFGla~~ 669 (914)
... .+......++.++++.+.-||+.+ |+|+|+++.|||++.+. .+.|+||+.++.
T Consensus 112 ~~~-----~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 112 WEQ-----LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hcc-----cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 321 344456788999999999999999 99999999999999887 899999997755
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.8e-06 Score=86.93 Aligned_cols=139 Identities=18% Similarity=0.119 Sum_probs=103.7
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEeeec-cc--c-ccchHHHHHHHHHHHhccC--CceeeeeceeecC-----CeEEEE
Q 002512 522 VGKGSFSCVYKGVLKDGTVVAVKKAIAT-SD--R-QKNSKEFHTELDLLSRLNH--AHLLNLLGYCEEG-----RERLLV 590 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~~~~~vavK~~~~~-~~--~-~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~-----~~~~LV 590 (914)
-|+||-+.|+.-.+. |+.+.+|+.... .. . ......|.+|+..|.+|.. -.+++.+ ++... -.-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 677999999998775 557999976411 11 1 2345789999999999953 3366666 44321 135899
Q ss_pred EeeCCC-CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCc--EEEeecCCc
Q 002512 591 YEFMAH-GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHN--ARVADFGLS 667 (914)
Q Consensus 591 ~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~--~kl~DFGla 667 (914)
+|-+++ -||.+++.+... .+.+...+..+..++++.|.-||+.+ +.|+|+-+.|||++.++. ++++||--+
T Consensus 104 Te~L~g~~~L~~~l~~~~~---~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAV---SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEeCCCCccHHHHHhcCCc---CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 998764 689888865422 23566677889999999999999999 999999999999986666 999999765
Q ss_pred c
Q 002512 668 L 668 (914)
Q Consensus 668 ~ 668 (914)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 4
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=8.1e-07 Score=92.71 Aligned_cols=134 Identities=20% Similarity=0.224 Sum_probs=94.1
Q ss_pred ccccccCcccceEEEEEEEcCCcEEEEEEeeecccc--------------------ccchHHHHHHHHHHHhccCC--ce
Q 002512 517 GFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDR--------------------QKNSKEFHTELDLLSRLNHA--HL 574 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~f~~E~~~l~~l~Hp--nI 574 (914)
.+.++||-|--+.||.|...+|.++|||.-+..... ........+|.++|.+|.-. .|
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 456789999999999999999999999943221110 00112356899999999654 78
Q ss_pred eeeeceeecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEc
Q 002512 575 LNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID 654 (914)
Q Consensus 575 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~ 654 (914)
++.+++ +...+||||+++-.|...-- +....-.|+..|++-+.-+-..+ |||+|+.+=|||++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r~----------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLRL----------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCcccc----ccceeeeehcccceeecccC----------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 877765 45579999999866654321 11112233444444444444667 99999999999999
Q ss_pred CCCcEEEeecCCc
Q 002512 655 EEHNARVADFGLS 667 (914)
Q Consensus 655 ~~~~~kl~DFGla 667 (914)
+|+.++|+||--+
T Consensus 237 ~dg~~~vIDwPQ~ 249 (304)
T COG0478 237 EDGDIVVIDWPQA 249 (304)
T ss_pred cCCCEEEEeCccc
Confidence 9999999999544
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.41 E-value=8.3e-07 Score=103.22 Aligned_cols=142 Identities=22% Similarity=0.277 Sum_probs=92.3
Q ss_pred cc-cccCcccceEEEEEEEcCCcEEEEEEeeeccccc--------------------------------------cchHH
Q 002512 518 FK-EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQ--------------------------------------KNSKE 558 (914)
Q Consensus 518 ~~-~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------------------~~~~~ 558 (914)
|. +.|+.++-|.||+|++++|+.||||+.+...... ..+-+
T Consensus 128 F~~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElD 207 (517)
T COG0661 128 FEPEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELD 207 (517)
T ss_pred cCCCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhC
Confidence 44 3499999999999999999999999776542100 00112
Q ss_pred HHHHHHHHHhcc-----CCceeeeeceeecCCeEEEEEeeCCCCCHHHhh--hcCccchhcccchhhHHHHHHHHHHH-H
Q 002512 559 FHTELDLLSRLN-----HAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARG-I 630 (914)
Q Consensus 559 f~~E~~~l~~l~-----HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~l--~~~~~~~~~~l~~~~~l~i~~qia~g-L 630 (914)
|.+|..-+.+++ .|+|.--.=|.+-....+|+|||++|-.+.+.. +..+ ++- ..|+..++++ +
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g------~d~---k~ia~~~~~~f~ 278 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG------IDR---KELAELLVRAFL 278 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC------CCH---HHHHHHHHHHHH
Confidence 456666666662 233222222233355779999999998888874 3322 221 2223222222 2
Q ss_pred HHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCC
Q 002512 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 631 ~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~ 671 (914)
..+-..+ ++|.|.+|.||+++.++++.+.|||+...+.
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 2233356 9999999999999999999999999975543
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.5e-07 Score=108.82 Aligned_cols=153 Identities=24% Similarity=0.327 Sum_probs=102.7
Q ss_pred HHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCC-------CCccCCCCcCCccChhhhhc
Q 002512 624 VQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS-------PLAELPAGTLGYLDPEYYRL 696 (914)
Q Consensus 624 ~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~-------~~~~~~~Gt~~y~aPE~l~~ 696 (914)
.++++||.|+|... .+||++|.|++|.++.++..||+.|+.+......... .......-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 45669999999765 4999999999999999999999999987543321111 11112235678999999999
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCC
Q 002512 697 HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRG 776 (914)
Q Consensus 697 ~~~s~ksDV~S~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p 776 (914)
...+.++|+||||+++|-+..+.++.-...... ..+... ...+..-..-...+.+.++.+=+.+.+..++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~--~~~~~~--------~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGL--LSYSFS--------RNLLNAGAFGYSNNLPSELRESLKKLLNGDS 253 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCc--chhhhh--------hcccccccccccccCcHHHHHHHHHHhcCCc
Confidence 888999999999999999995555532211111 110000 0001111111123445677778888999999
Q ss_pred CCCCCHHHHHHH
Q 002512 777 KERPSMDKVTTA 788 (914)
Q Consensus 777 ~~RPs~~ev~~~ 788 (914)
.-||++.++...
T Consensus 254 ~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 254 AVRPTLDLLLSI 265 (700)
T ss_pred ccCcchhhhhcc
Confidence 999988777543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.4e-05 Score=84.30 Aligned_cols=139 Identities=14% Similarity=0.163 Sum_probs=85.4
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCC--ceeeeeceeecCCeEEEEEeeCCCC
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA--HLLNLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hp--nIv~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
+.||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+++.+++..+.+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 35999999999983 24567778654321 235578899999999643 3577888888877888999999986
Q ss_pred C-HHHh---------------------hhcCccchhcccchhhHH-HHH----------HHHHH-HHHHhhcc-CCCCee
Q 002512 598 S-LHQH---------------------LHGKSKALKEQLDWVRRV-TIA----------VQAAR-GIEYLHGY-ACPPVI 642 (914)
Q Consensus 598 s-L~~~---------------------l~~~~~~~~~~l~~~~~l-~i~----------~qia~-gL~yLH~~-~~~~ii 642 (914)
+ +.+. ||.-... ........ ++- ..+.+ ...+|... ..+.++
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~---~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD---TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC---CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 4 2211 1211000 00000000 000 00111 12222221 234578
Q ss_pred ccCCCccceEEcCCCcEEEeecCCccc
Q 002512 643 HRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 643 HrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
|+|+.|.||++++++ +.|.||+.+..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999888 99999997743
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=5.5e-06 Score=96.07 Aligned_cols=141 Identities=19% Similarity=0.253 Sum_probs=90.3
Q ss_pred ccc-ccCcccceEEEEEEEcCCcEEEEEEeeeccccc-----------------------------------cchHHHHH
Q 002512 518 FKE-EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQ-----------------------------------KNSKEFHT 561 (914)
Q Consensus 518 ~~~-~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------------------~~~~~f~~ 561 (914)
|.+ .|+.-+.|.||+|++++|+.||||+.+...... ..+-+|.+
T Consensus 164 f~~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~ 243 (538)
T KOG1235|consen 164 FDEEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTK 243 (538)
T ss_pred cCcchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHH
Confidence 443 499999999999999999999999876542211 00112555
Q ss_pred HHHHHHhc----cCCc------eeeeeceeecCCeEEEEEeeCCCCCHHHh--hhcCccchhcccchhhHHHHHHHHHHH
Q 002512 562 ELDLLSRL----NHAH------LLNLLGYCEEGRERLLVYEFMAHGSLHQH--LHGKSKALKEQLDWVRRVTIAVQAARG 629 (914)
Q Consensus 562 E~~~l~~l----~Hpn------Iv~l~g~~~~~~~~~LV~Ey~~~gsL~~~--l~~~~~~~~~~l~~~~~l~i~~qia~g 629 (914)
|++-..++ .|-+ |++++-.+ ...+.|+||||+|.-+.|. |.+.+ ++.. .|+..+.++
T Consensus 244 EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g------i~~~---~i~~~l~~~ 312 (538)
T KOG1235|consen 244 EAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG------ISPH---DILNKLVEA 312 (538)
T ss_pred HHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC------CCHH---HHHHHHHHH
Confidence 65544443 3555 44444332 3478999999999877654 44332 3322 233333332
Q ss_pred H-HHhhccCCCCeeccCCCccceEEcC----CCcEEEeecCCcccCCC
Q 002512 630 I-EYLHGYACPPVIHRDIKSSNILIDE----EHNARVADFGLSLLGPA 672 (914)
Q Consensus 630 L-~yLH~~~~~~iiHrDIKp~NILl~~----~~~~kl~DFGla~~~~~ 672 (914)
. +-|-..+ ++|.|-+|.|||++. +..+.+-|||+......
T Consensus 313 ~~~qIf~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 313 YLEQIFKTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHhcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 1 1122344 999999999999984 67799999999865543
|
|
| >PF00415 RCC1: Regulator of chromosome condensation (RCC1) repeat; InterPro: IPR000408 The regulator of chromosome condensation (RCC1) [] is a eukaryotic protein which binds to chromatin and interacts with ran, a nuclear GTP-binding protein IPR002041 from INTERPRO, to promote the loss of bound GDP and the uptake of fresh GTP, thus acting as a guanine-nucleotide dissociation stimulator (GDS) | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.1e-06 Score=69.17 Aligned_cols=40 Identities=35% Similarity=0.735 Sum_probs=33.4
Q ss_pred CCceeecCCCCCCCCC---------CCcccc--CCCeEEEEEeCCceeeee
Q 002512 101 SNQPYCWGSSGYIQMG---------VPQPII--KGAQYVEISAGDYHLCGL 140 (914)
Q Consensus 101 ~~~~~cWG~n~~gqlg---------~p~~~~--~~~~~~~i~~G~~h~cal 140 (914)
||.+|+||.|.+|||| .|+++. ....+++|+||..|+++|
T Consensus 1 dG~vy~wG~n~~GqLG~~~~~~~~~~P~~v~~~~~~~i~~va~G~~ht~~l 51 (51)
T PF00415_consen 1 DGRVYSWGSNDYGQLGSGGDNKNVSVPTKVPFLSGVRIVQVACGSDHTLAL 51 (51)
T ss_dssp TSEEEEEEEETTSTTSSSSSSSEEEEEEEEGGGTTSEEEEEEEESSEEEEE
T ss_pred CCcEEEEECCCCCCCCCCCCCCceeEEEEECCCCCCCEEEEEeCcceEEEC
Confidence 6889999999999999 455443 445699999999999985
|
The interaction of RCC1 with ran probably plays an important role in the regulation of gene expression. RCC1, known as PRP20 or SRM1 in yeast, pim1 in fission yeast and BJ1 in Drosophila, is a protein that contains seven tandem repeats of a domain of about 50 to 60 amino acids. As shown in the following schematic representation, the repeats make up the major part of the length of the protein. Outside the repeat region, there is just a small N-terminal domain of about 40 to 50 residues and, in the Drosophila protein only, a C-terminal domain of about 130 residues. +----+-------+-------+-------+-------+-------+-------+-------+-------------+ |N-t.|Rpt. 1 |Rpt. 2 |Rpt. 3 |Rpt. 4 |Rpt. 5 |Rpt. 6 |Rpt. 7 | C-terminal | +----+-------+-------+-------+-------+-------+-------+-------+-------------+ The RCC1-type of repeat is also found in the X-linked retinitis pigmentosa GTPase regulator []. The RCC repeats form a beta-propeller structure.; PDB: 3MVD_L 3OF7_A 1I2M_D 1A12_B 3KCI_A 4DNV_B 4DNU_A 4D9S_B 4DNW_A. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.12 E-value=2.6e-05 Score=83.21 Aligned_cols=140 Identities=20% Similarity=0.147 Sum_probs=85.4
Q ss_pred cCcccc-eEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhc-cCCceeeeeceeecCCeEEEEEeeCCCCCH
Q 002512 522 VGKGSF-SCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 522 LG~G~f-G~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL 599 (914)
|-.|.. ..||+.... +..+.+|...... ..++.+|+++++.+ .+--+++++++....+..+|||||++|.+|
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 444444 789998765 4678888653321 24577899999888 345577888888777778999999999877
Q ss_pred HHhh-------------------hcCccchhcccc--hhhHHHHHH--------------------HHHHHHHHhh----
Q 002512 600 HQHL-------------------HGKSKALKEQLD--WVRRVTIAV--------------------QAARGIEYLH---- 634 (914)
Q Consensus 600 ~~~l-------------------~~~~~~~~~~l~--~~~~l~i~~--------------------qia~gL~yLH---- 634 (914)
.+.. |.... ....+. +..++.... .+.+.+..|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 158 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPV-ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRP 158 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCc-ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCC
Confidence 6432 11100 000000 000000000 0111122221
Q ss_pred ccCCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 635 ~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
....+.++|+|+.|.|||++++....|+||+.+.
T Consensus 159 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 159 AEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 1123569999999999999998778999998763
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=1.1e-06 Score=100.49 Aligned_cols=181 Identities=18% Similarity=0.164 Sum_probs=132.8
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCc-eeeeeceeecCCeEEEEEeeCCCC-
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAH-LLNLLGYCEEGRERLLVYEFMAHG- 597 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~LV~Ey~~~g- 597 (914)
+.+++++++++||.+-.-.+....+.+... ....-++++|.+++||| .++.++-++.++..+++++|+..+
T Consensus 248 h~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 248 HNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 458899999999887543444444433211 45567899999999999 778788888888899999999877
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCC
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~ 677 (914)
+-..... ..+..+...+...+...-+++|+|||+.. -+||| |||..+ ...|..||+....+....
T Consensus 321 s~~~~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 321 SSALEMT----VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred cccccCC----hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence 2222111 11223444445566777888999999875 58999 887766 578999999886655443
Q ss_pred CccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHHHHhCCCCc
Q 002512 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722 (914)
Q Consensus 678 ~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~ElltG~~p~ 722 (914)
..+...+|+.++|||......+..+-|+|++++--.+|--|-+|-
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234456999999999999999999999999998777777776654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.02 E-value=3.7e-05 Score=79.05 Aligned_cols=140 Identities=16% Similarity=0.146 Sum_probs=84.2
Q ss_pred HHHHhcccccccCcccceEEEEEEEcCCcEEEEEEeeecccccc-chH------HHHHHHHHHHhccCCc---eeeeece
Q 002512 511 LERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQK-NSK------EFHTELDLLSRLNHAH---LLNLLGY 580 (914)
Q Consensus 511 l~~~t~~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~------~f~~E~~~l~~l~Hpn---Iv~l~g~ 580 (914)
+........+.+-......|.+-.. +++.+++|.........+ ... ...+++..+.+++... ...++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3333333444555555555655554 478888886644322111 011 1234444455553322 2222222
Q ss_pred ee-----cCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEcC
Q 002512 581 CE-----EGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE 655 (914)
Q Consensus 581 ~~-----~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~ 655 (914)
.+ .....+|||||++|-.|.++.. ++. .++..+++.|.-||+.+ ++|+|++|.|+++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC
Confidence 22 2235579999999988876542 111 24566778899999999 999999999999986
Q ss_pred CCcEEEeecCCcc
Q 002512 656 EHNARVADFGLSL 668 (914)
Q Consensus 656 ~~~~kl~DFGla~ 668 (914)
++ +++.||+..+
T Consensus 171 ~~-i~iID~~~k~ 182 (229)
T PF06176_consen 171 NG-IRIIDTQGKR 182 (229)
T ss_pred Cc-EEEEECcccc
Confidence 55 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.9e-05 Score=80.48 Aligned_cols=101 Identities=26% Similarity=0.317 Sum_probs=82.3
Q ss_pred HHHHHHHHhccC-CceeeeeceeecCCeEEEEEeeCCCCCHHHh---hhcCccchhcccchhhHHHHHHHHHHHHHHhhc
Q 002512 560 HTELDLLSRLNH-AHLLNLLGYCEEGRERLLVYEFMAHGSLHQH---LHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635 (914)
Q Consensus 560 ~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~---l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~ 635 (914)
..|.-+|+.+++ +++++++|+|- .++|.||...+++... +.+- -..+|..|.+||.++++.+++|++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~-----~~~~w~~R~~iA~~lL~~l~~l~~ 77 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF-----LQSPWEQRAKIALQLLELLEELDH 77 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc-----cccCHHHHHHHHHHHHHHHHHHhc
Confidence 358888888976 69999999993 4789999998766532 1111 135899999999999999999998
Q ss_pred cCCCCeeccCCCccceEEcCCCcEEEeecCCccc
Q 002512 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 636 ~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~ 669 (914)
.....+.-.|++++|+-+++++++|+.|...+..
T Consensus 78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 6655688899999999999999999999987644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.97 E-value=7.5e-05 Score=78.45 Aligned_cols=143 Identities=17% Similarity=0.187 Sum_probs=83.4
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCC--ceeeeeceeec---CCeEEEEEeeC
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA--HLLNLLGYCEE---GRERLLVYEFM 594 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hp--nIv~l~g~~~~---~~~~~LV~Ey~ 594 (914)
+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.|... .+++++.+... ....+++|||+
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 458899999999999876 68999975432 2346788899999988433 46677764433 33578999999
Q ss_pred CCCCHHH----------------hh---hcCccchhcccchhh---------HHH------------HHHHHHH-HHHHh
Q 002512 595 AHGSLHQ----------------HL---HGKSKALKEQLDWVR---------RVT------------IAVQAAR-GIEYL 633 (914)
Q Consensus 595 ~~gsL~~----------------~l---~~~~~~~~~~l~~~~---------~l~------------i~~qia~-gL~yL 633 (914)
++.++.+ .| |.... ....+.+.. ... ....+.+ .++.+
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPP-PFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHT-TCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccc-cccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 9988877 11 11100 000000000 000 0112222 33333
Q ss_pred hc----cCCCCeeccCCCccceEEc-CCCcEEEeecCCcc
Q 002512 634 HG----YACPPVIHRDIKSSNILID-EEHNARVADFGLSL 668 (914)
Q Consensus 634 H~----~~~~~iiHrDIKp~NILl~-~~~~~kl~DFGla~ 668 (914)
++ .....++|+|+.|.|||++ +++.+.|.||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 32 2345599999999999999 66666899998763
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF00415 RCC1: Regulator of chromosome condensation (RCC1) repeat; InterPro: IPR000408 The regulator of chromosome condensation (RCC1) [] is a eukaryotic protein which binds to chromatin and interacts with ran, a nuclear GTP-binding protein IPR002041 from INTERPRO, to promote the loss of bound GDP and the uptake of fresh GTP, thus acting as a guanine-nucleotide dissociation stimulator (GDS) | Back alignment and domain information |
|---|
Probab=97.92 E-value=5e-06 Score=65.40 Aligned_cols=48 Identities=13% Similarity=0.117 Sum_probs=39.0
Q ss_pred CccEEEeecCCCCccc-cccccccccccCC--CCCCCeeEeecCCcEEEee
Q 002512 230 DSRTRCWGRSLDLEEE-VSVAYSRQGNVDL--PPSDPMLSIVGGKFHACGI 277 (914)
Q Consensus 230 ~g~v~cWG~n~~~~~g-~~~~~~~~~~~~~--~~~~~~~sia~g~~htcg~ 277 (914)
||+||+||.|.++|+| .+.......|..+ +....+++|++|..|+++|
T Consensus 1 dG~vy~wG~n~~GqLG~~~~~~~~~~P~~v~~~~~~~i~~va~G~~ht~~l 51 (51)
T PF00415_consen 1 DGRVYSWGSNDYGQLGSGGDNKNVSVPTKVPFLSGVRIVQVACGSDHTLAL 51 (51)
T ss_dssp TSEEEEEEEETTSTTSSSSSSSEEEEEEEEGGGTTSEEEEEEEESSEEEEE
T ss_pred CCcEEEEECCCCCCCCCCCCCCceeEEEEECCCCCCCEEEEEeCcceEEEC
Confidence 6999999999999999 6666666666544 4445699999999999986
|
The interaction of RCC1 with ran probably plays an important role in the regulation of gene expression. RCC1, known as PRP20 or SRM1 in yeast, pim1 in fission yeast and BJ1 in Drosophila, is a protein that contains seven tandem repeats of a domain of about 50 to 60 amino acids. As shown in the following schematic representation, the repeats make up the major part of the length of the protein. Outside the repeat region, there is just a small N-terminal domain of about 40 to 50 residues and, in the Drosophila protein only, a C-terminal domain of about 130 residues. +----+-------+-------+-------+-------+-------+-------+-------+-------------+ |N-t.|Rpt. 1 |Rpt. 2 |Rpt. 3 |Rpt. 4 |Rpt. 5 |Rpt. 6 |Rpt. 7 | C-terminal | +----+-------+-------+-------+-------+-------+-------+-------+-------------+ The RCC1-type of repeat is also found in the X-linked retinitis pigmentosa GTPase regulator []. The RCC repeats form a beta-propeller structure.; PDB: 3MVD_L 3OF7_A 1I2M_D 1A12_B 3KCI_A 4DNV_B 4DNU_A 4D9S_B 4DNW_A. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=7.8e-05 Score=93.47 Aligned_cols=150 Identities=16% Similarity=0.332 Sum_probs=92.0
Q ss_pred cccCcccceEEEEEEEcCC---cEEEEEEeeeccccccchHHHHHHHHHHHhcc-CCce--eeeeceeecC---CeEEEE
Q 002512 520 EEVGKGSFSCVYKGVLKDG---TVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHL--LNLLGYCEEG---RERLLV 590 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnI--v~l~g~~~~~---~~~~LV 590 (914)
+.|+.|.+..+|+....++ ..+++|+..... .......+.+|+++|+.|. |++| ++++.+|.+. ...|+|
T Consensus 44 ~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 44 SQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4589999999999887654 367777653322 1122357889999999995 6664 8888888764 367899
Q ss_pred EeeCCCCCHHH-----------------------hhhcCccc------hhcc-------c-chhhHHHH---------HH
Q 002512 591 YEFMAHGSLHQ-----------------------HLHGKSKA------LKEQ-------L-DWVRRVTI---------AV 624 (914)
Q Consensus 591 ~Ey~~~gsL~~-----------------------~l~~~~~~------~~~~-------l-~~~~~l~i---------~~ 624 (914)
|||+++..+.+ .||.-... ...+ + .|.....- .-
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999865321 12221110 0000 1 11111000 11
Q ss_pred HHHHHHHHhhccC--------CCCeeccCCCccceEEcC-CCc-EEEeecCCcccC
Q 002512 625 QAARGIEYLHGYA--------CPPVIHRDIKSSNILIDE-EHN-ARVADFGLSLLG 670 (914)
Q Consensus 625 qia~gL~yLH~~~--------~~~iiHrDIKp~NILl~~-~~~-~kl~DFGla~~~ 670 (914)
.+.+.+++|..+- .+.+||+|+++.|||++. +.. .-|.||.++...
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G 258 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG 258 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence 2334456664322 135999999999999985 333 578999988654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00016 Score=75.10 Aligned_cols=135 Identities=20% Similarity=0.261 Sum_probs=89.9
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEeeeccccccch-------HH---------------HHHHHHHHHhcc--CCceee
Q 002512 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNS-------KE---------------FHTELDLLSRLN--HAHLLN 576 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------~~---------------f~~E~~~l~~l~--HpnIv~ 576 (914)
.|..|--+.||+|.-.++..+|||+.......-+.. .+ -.+|..-|.++. +-.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 488888999999998889999999875442211110 11 235777777773 445555
Q ss_pred eeceeecCCeEEEEEeeCCCCCH-HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc-cCCCCeeccCCCccceEEc
Q 002512 577 LLGYCEEGRERLLVYEFMAHGSL-HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNILID 654 (914)
Q Consensus 577 l~g~~~~~~~~~LV~Ey~~~gsL-~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NILl~ 654 (914)
-+++. .-.|||||+...-+ .-.|..- .+.......+..++++.+.-|-. .+ +||+||..=|||+.
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~LkDv------~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~ 201 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLKDV------PLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH 201 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcccC------CcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE
Confidence 55554 33799999965311 0111111 12222345567777777777776 66 99999999999999
Q ss_pred CCCcEEEeecCCccc
Q 002512 655 EEHNARVADFGLSLL 669 (914)
Q Consensus 655 ~~~~~kl~DFGla~~ 669 (914)
++.+.|+||+-|..
T Consensus 202 -~~~p~iID~~QaV~ 215 (268)
T COG1718 202 -DGEPYIIDVSQAVT 215 (268)
T ss_pred -CCeEEEEECccccc
Confidence 88999999998754
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00022 Score=73.10 Aligned_cols=129 Identities=18% Similarity=0.258 Sum_probs=93.5
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeecc--------------ccccchHHHHHHHHHHHhcc------CCceeeeec
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATS--------------DRQKNSKEFHTELDLLSRLN------HAHLLNLLG 579 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~~f~~E~~~l~~l~------HpnIv~l~g 579 (914)
..||+|+.-.|| .+.++....||+..... ......+++.+|+.-...+. +.+|.+++|
T Consensus 7 ~~i~~G~~R~cy--~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 7 DLIAQGGERDCY--QHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred cccccCCCceEE--ECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 359999999999 56667778889876544 01122466777887777776 789999999
Q ss_pred eeecCCeEEEEEeeCCC------CCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE
Q 002512 580 YCEEGRERLLVYEFMAH------GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 653 (914)
Q Consensus 580 ~~~~~~~~~LV~Ey~~~------gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl 653 (914)
+.+.+...-+|+|.+.+ -||.+++.... ++. . +...+-+-.+||-+.+ |+.+||+|.||++
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~------~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEGG------LTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcCC------ccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEE
Confidence 99999999999998764 36888885432 333 2 2233334456777777 9999999999999
Q ss_pred cCC---C-cEEEee
Q 002512 654 DEE---H-NARVAD 663 (914)
Q Consensus 654 ~~~---~-~~kl~D 663 (914)
..+ . .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 533 2 588888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00022 Score=75.64 Aligned_cols=73 Identities=22% Similarity=0.277 Sum_probs=46.5
Q ss_pred cccCcccce-EEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCC---ceeeeeceeecCC---eEEEEEe
Q 002512 520 EEVGKGSFS-CVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA---HLLNLLGYCEEGR---ERLLVYE 592 (914)
Q Consensus 520 ~~LG~G~fG-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hp---nIv~l~g~~~~~~---~~~LV~E 592 (914)
+.|+.|+.. .||+. +..+++|.... ......+.+|.++|..|... .++++++.....+ ..++|||
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~----~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~ 74 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA----AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYR 74 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc----cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEE
Confidence 347777776 48875 23466675322 11235788999999888532 4555555544322 4589999
Q ss_pred eCCCCCHH
Q 002512 593 FMAHGSLH 600 (914)
Q Consensus 593 y~~~gsL~ 600 (914)
+++|.++.
T Consensus 75 ~i~G~~l~ 82 (235)
T cd05155 75 WLEGETAT 82 (235)
T ss_pred eecCCCCC
Confidence 99997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00028 Score=69.52 Aligned_cols=127 Identities=19% Similarity=0.280 Sum_probs=86.0
Q ss_pred ccccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCcee-eeeceeecCCeEEEEEeeCCCC
Q 002512 519 KEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLL-NLLGYCEEGRERLLVYEFMAHG 597 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv-~l~g~~~~~~~~~LV~Ey~~~g 597 (914)
.+.|++|.++.||++.+. |..+|+|+...+. ....+..|+++|..+.-.++- +++.|..+ ++.|||+.|-
T Consensus 27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhcccccEEEEeecc-CceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 456999999999999997 5689999765443 236799999999999765543 44544333 4559999998
Q ss_pred CHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCC-ccceEEcCCCcEEEeecCCccc
Q 002512 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIK-SSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 598 sL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIK-p~NILl~~~~~~kl~DFGla~~ 669 (914)
.|.+.-.... - +-...+++.---|-..+ |-|..|. |..++|-.+..+.|+||.-|+.
T Consensus 98 ~L~~~~~~~~--------r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGGD--------R----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhccc--------H----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8877654321 1 11233444433344556 8888886 4444444555899999987753
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.0007 Score=76.81 Aligned_cols=77 Identities=19% Similarity=0.249 Sum_probs=56.1
Q ss_pred cccCcccceEEEEEEEcCC-cEEEEEEeeecc----cc-ccchHHHHHHHHHHHhcc---CCceeeeeceeecCCeEEEE
Q 002512 520 EEVGKGSFSCVYKGVLKDG-TVVAVKKAIATS----DR-QKNSKEFHTELDLLSRLN---HAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~-~~vavK~~~~~~----~~-~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~LV 590 (914)
+.||.|.+..||+....+| +.++||...... .. .-..+++..|.+.|..+. -.++++++.+.. +..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEEE
Confidence 4699999999999999877 589999754221 11 124467888999888872 246788887743 457899
Q ss_pred EeeCCCCC
Q 002512 591 YEFMAHGS 598 (914)
Q Consensus 591 ~Ey~~~gs 598 (914)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998744
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00091 Score=70.80 Aligned_cols=74 Identities=19% Similarity=0.174 Sum_probs=47.7
Q ss_pred cccCcccceEEEEEEEcC--CcEEEEEEeeeccccccchHHHHHHHHHHHhccC-CceeeeeceeecCCeEEEEEeeCCC
Q 002512 520 EEVGKGSFSCVYKGVLKD--GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH-AHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.|..|-...+|+....+ ++.+++|....... . ..+..+|+.++..+.. .-.++++..+. ..+||||++|
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~--~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G 76 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE--L-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPG 76 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc--c-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCC
Confidence 347778888999988764 67788886532211 1 1233578989998843 33455554433 2489999998
Q ss_pred CCHH
Q 002512 597 GSLH 600 (914)
Q Consensus 597 gsL~ 600 (914)
-+|.
T Consensus 77 ~~l~ 80 (235)
T cd05157 77 RTLE 80 (235)
T ss_pred CcCC
Confidence 7763
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.001 Score=73.19 Aligned_cols=75 Identities=15% Similarity=0.111 Sum_probs=55.4
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccC---CceeeeeceeecC---CeEEEEEee
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH---AHLLNLLGYCEEG---RERLLVYEF 593 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~H---pnIv~l~g~~~~~---~~~~LV~Ey 593 (914)
+.||.|..+.||+....+++ +.+|.. +. ......|..|.+.|+.|.- -.++++++++... +..+||||+
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~-~~~k~~-~~---~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGN-PMPLMA-RS---FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eecCCccceeEEEEEcCCCC-EEEEEe-cc---cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 45999999999998766554 555653 21 1122578999999999943 4688899887653 568999999
Q ss_pred CCCCCH
Q 002512 594 MAHGSL 599 (914)
Q Consensus 594 ~~~gsL 599 (914)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.001 Score=67.74 Aligned_cols=127 Identities=26% Similarity=0.376 Sum_probs=90.0
Q ss_pred HhcccccccCcccc-eEEEEEEEcCCcEEEEEEeee---ccc---------cc-------cchHHHHHHHHHHHhcc---
Q 002512 514 ATGGFKEEVGKGSF-SCVYKGVLKDGTVVAVKKAIA---TSD---------RQ-------KNSKEFHTELDLLSRLN--- 570 (914)
Q Consensus 514 ~t~~~~~~LG~G~f-G~Vy~~~~~~~~~vavK~~~~---~~~---------~~-------~~~~~f~~E~~~l~~l~--- 570 (914)
....|.+.||.|.. |.|||+++. |+.+|+|.... ... .. ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 45567888999999 999999986 78999998221 000 00 11235889999999984
Q ss_pred CCce--eeeeceeecC------------------CeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHH
Q 002512 571 HAHL--LNLLGYCEEG------------------RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630 (914)
Q Consensus 571 HpnI--v~l~g~~~~~------------------~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL 630 (914)
+.++ |+.+||..-. ....||.||++... .+ ..+-+.+|.+-|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~----~~~~~~~~~~dl 177 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PL----QIRDIPQMLRDL 177 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------cc----chhHHHHHHHHH
Confidence 3456 9999987322 12357888876533 01 122345777889
Q ss_pred HHhhccCCCCeeccCCCccceEEcCCCcEEEeecCCc
Q 002512 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667 (914)
Q Consensus 631 ~yLH~~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla 667 (914)
..+|..+ |+-+|+|+.|.. .-||+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 9999999 999999999975 3489999864
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0015 Score=70.16 Aligned_cols=139 Identities=12% Similarity=0.129 Sum_probs=77.8
Q ss_pred cCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCCc-eeeeeceeecCCeEEEEEeeCCCCCHH
Q 002512 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAH-LLNLLGYCEEGRERLLVYEFMAHGSLH 600 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~LV~Ey~~~gsL~ 600 (914)
+..|-...+|+... +++.+++|....... ...-++.+|.++++.+.... .++++.... .++||||++|..+.
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~--~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCK--ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccc--cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 55677788998874 467788886432211 11024578999999885432 344454432 36899999987654
Q ss_pred Hh-----------------hhcCccchhcccchhhHH-HHH---------HHHHHHHHHhhcc-----CCCCeeccCCCc
Q 002512 601 QH-----------------LHGKSKALKEQLDWVRRV-TIA---------VQAARGIEYLHGY-----ACPPVIHRDIKS 648 (914)
Q Consensus 601 ~~-----------------l~~~~~~~~~~l~~~~~l-~i~---------~qia~gL~yLH~~-----~~~~iiHrDIKp 648 (914)
.. ||.... ...+++...++ ... ..+.+-+..+-.. ..+.++|+|+.|
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~-~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPR-FGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCC-CCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 21 222211 11111211111 110 1111112222211 124589999999
Q ss_pred cceEEcCCCcEEEeecCCccc
Q 002512 649 SNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 649 ~NILl~~~~~~kl~DFGla~~ 669 (914)
.|||+++++ ++|.||..+..
T Consensus 156 ~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCC-CEEEeccccCc
Confidence 999999877 78999987643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG0941 consensus E3 ubiquitin protein ligase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.23 E-value=2.7e-05 Score=91.45 Aligned_cols=116 Identities=20% Similarity=0.322 Sum_probs=94.9
Q ss_pred CEEEEecCCCeeEEEEeCCCceeecCCCCCCCCCC--------Ccc--ccCCCeEEEEEeCCceeeeeecCCCCccCCCc
Q 002512 83 PFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGV--------PQP--IIKGAQYVEISAGDYHLCGLRKPLTGKWRNYS 152 (914)
Q Consensus 83 ~~~~i~~G~~~~cal~~~~~~~~cWG~n~~gqlg~--------p~~--~~~~~~~~~i~~G~~h~cal~~~~~~~~~~~g 152 (914)
...+++||..|+.|+ ..+|+++.||.|.+||+|. |.. -..++...+|++|..|+|++..- +--.+..|
T Consensus 15 ~~lq~~cGn~hclal-~~~g~~~~wg~~~~g~~~~~~~~~~~~p~~~~sl~g~p~a~v~~g~~hs~~lS~~-~~~lt~e~ 92 (850)
T KOG0941|consen 15 HILQVGCGNNHCLAL-SCAGELFVWGMNNNGQLGRALYFPDAKPEPVESLKGVPLAQVSAGEAHSFALSSH-TVLLTDEG 92 (850)
T ss_pred hhhhhccccHHHHhh-hccCCeeeccCCccchhhhhccCCCCCCccchhhcCCcHHHHhcCCCcchhhhhc-hhhcchhc
Confidence 567899999999999 8899999999999999992 333 33556677999999999998431 11124689
Q ss_pred eEEEcccCCCCCCcCCC----------------cEEEEeecCCceeEeeecCCeEEEecCCCCC
Q 002512 153 YVDCWGYNMTKNYVFDG----------------QIESISAGSEFNCGLFSQNRTVFCWGDESSS 200 (914)
Q Consensus 153 ~v~cWG~n~~gql~~~~----------------~~~~ia~G~~~~cal~~~~g~v~cWG~n~~g 200 (914)
.+.-.|....||++.+. .++.|++|..|+-++...-|.++..|-+..|
T Consensus 93 ~~fs~Ga~~~~q~~h~~~~~~~~~~~v~e~i~~~~t~ia~~~~ht~a~v~~l~qsf~~~~~~sG 156 (850)
T KOG0941|consen 93 KVFSFGAGSTGQLGHSLTENEVLPLLVLELIGSRVTRIACVRGHTLAIVPRLGQSFSFGKGASG 156 (850)
T ss_pred cccccCCcccccccccccccccccHHHHHHHhhhhHHHHHHHHHHHhhhhhhcceeecccCCCC
Confidence 99999999999997622 3789999999999998888899999988887
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.00093 Score=82.13 Aligned_cols=196 Identities=20% Similarity=0.224 Sum_probs=134.0
Q ss_pred HHHHHHHHHhccCCceeeeeceeecCCeEE----EEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhh
Q 002512 559 FHTELDLLSRLNHAHLLNLLGYCEEGRERL----LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634 (914)
Q Consensus 559 f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~----LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH 634 (914)
-..|...+.++.|+|++.++.|..+....- +..||+..-++...+..-. .++....+.+..++.+||.|+|
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~-----~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG-----SIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc-----ccCHHHHHHHHHHHhhhHHHHH
Confidence 445777888889999999999987655433 4457888888888776543 3667777788999999999999
Q ss_pred ccCCCCeeccCCCcc---ceEEcCCCcEEEe--ecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCC--cchHHH
Q 002512 635 GYACPPVIHRDIKSS---NILIDEEHNARVA--DFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTT--KSDVYS 707 (914)
Q Consensus 635 ~~~~~~iiHrDIKp~---NILl~~~~~~kl~--DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~--ksDV~S 707 (914)
+.. ..|.-+..+ +-..+..+...++ ||+.++.+...... ....-+..|.+||......+.. ..|+|.
T Consensus 304 ~~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~ 377 (1351)
T KOG1035|consen 304 SLS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWC 377 (1351)
T ss_pred Hhc---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHH
Confidence 986 666655555 5555667777777 99888765443221 1122345678888887665444 479999
Q ss_pred HHHHHHHHHhCCCCcccccccccHHHHHHhhhhcCCcccccccccCCCCCHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 002512 708 FGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 708 ~GvvL~ElltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~~p~~RPs~~ev~~ 787 (914)
+|..+..+..+..+-.... .+ ..+++. . ....+......|+..++++|++..+++.
T Consensus 378 lgll~~~~~~~~~i~~~~~----~~------------~~~l~~----~----~~~~~~d~~~~~~~~~~~~Rl~~~~ll~ 433 (1351)
T KOG1035|consen 378 LGLLLLQLSQGEDISEKSA----VP------------VSLLDV----L----STSELLDALPKCLDEDSEERLSALELLT 433 (1351)
T ss_pred HHHHHhhhhhcCccccccc----ch------------hhhhcc----c----cchhhhhhhhhhcchhhhhccchhhhhh
Confidence 9999999999875421110 00 001110 0 0014566778899999999999999887
Q ss_pred HH
Q 002512 788 AL 789 (914)
Q Consensus 788 ~L 789 (914)
..
T Consensus 434 ~~ 435 (1351)
T KOG1035|consen 434 HP 435 (1351)
T ss_pred ch
Confidence 65
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.05 E-value=0.0038 Score=68.86 Aligned_cols=141 Identities=21% Similarity=0.226 Sum_probs=81.7
Q ss_pred ccCcccceEEEEEEEcC-------CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCc-eeeeeceeecCCeEEEEEe
Q 002512 521 EVGKGSFSCVYKGVLKD-------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAH-LLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~LV~E 592 (914)
.|..|-...+|+....+ ++.+++|...... ....+..+|.+++..+.... .+++++++.. .+|||
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e 77 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEE 77 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhh
Confidence 35566667899988665 4788888753321 12245678888888884322 3455655542 36899
Q ss_pred eCCCCCHHHh-----------------hhcCccch-h-----cccchhhHHH--------------------------HH
Q 002512 593 FMAHGSLHQH-----------------LHGKSKAL-K-----EQLDWVRRVT--------------------------IA 623 (914)
Q Consensus 593 y~~~gsL~~~-----------------l~~~~~~~-~-----~~l~~~~~l~--------------------------i~ 623 (914)
|++|.++... ||...... . ...-|....+ +.
T Consensus 78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (302)
T cd05156 78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL 157 (302)
T ss_pred eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence 9998776431 12211110 0 0000111000 11
Q ss_pred HHHHHHHHHhhc------cCCCCeeccCCCccceEEcCC----CcEEEeecCCcc
Q 002512 624 VQAARGIEYLHG------YACPPVIHRDIKSSNILIDEE----HNARVADFGLSL 668 (914)
Q Consensus 624 ~qia~gL~yLH~------~~~~~iiHrDIKp~NILl~~~----~~~kl~DFGla~ 668 (914)
..+..-+.+|-. .....++|+|+.+.|||++++ +.++|+||..+.
T Consensus 158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 222223334432 133569999999999999985 789999998764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0051 Score=66.91 Aligned_cols=31 Identities=26% Similarity=0.502 Sum_probs=25.9
Q ss_pred CCeeccCCCccceEEcCCCc-EEEeecCCccc
Q 002512 639 PPVIHRDIKSSNILIDEEHN-ARVADFGLSLL 669 (914)
Q Consensus 639 ~~iiHrDIKp~NILl~~~~~-~kl~DFGla~~ 669 (914)
+.++|+|++|.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45999999999999997555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0052 Score=67.53 Aligned_cols=142 Identities=20% Similarity=0.214 Sum_probs=84.3
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCC--ceeeeecee------ecCCeEEEEEe
Q 002512 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA--HLLNLLGYC------EEGRERLLVYE 592 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hp--nIv~l~g~~------~~~~~~~LV~E 592 (914)
.|..|....+|+.... +..+++|+... ....+...|++++..|.+. .+++++... ...+..++|||
T Consensus 21 ~i~~G~~n~~y~v~~~-~~~~vLr~~~~-----~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 21 GISAGIENTNYFVTTD-SGRYVLTLFEK-----VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred cccCccccceEEEEeC-CCcEEEEEcCC-----CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4777877899998765 44688886542 1235677788888888533 355555421 22345689999
Q ss_pred eCCCCCHHH--------------hhhcCccc------hhcccchhhHH----------HHHHHHHHHHHHhhcc----CC
Q 002512 593 FMAHGSLHQ--------------HLHGKSKA------LKEQLDWVRRV----------TIAVQAARGIEYLHGY----AC 638 (914)
Q Consensus 593 y~~~gsL~~--------------~l~~~~~~------~~~~l~~~~~l----------~i~~qia~gL~yLH~~----~~ 638 (914)
|++|..+.. .||..... ......|.... .....+.+.+.++... ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876532 11211000 00111222211 1112233445555431 12
Q ss_pred CCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 639 PPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 639 ~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
..++|+|+.|.|||++++..+.|.||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 349999999999999998778899998763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0087 Score=65.69 Aligned_cols=147 Identities=21% Similarity=0.330 Sum_probs=82.7
Q ss_pred cccce-EEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccC--CceeeeeceeecCC--eEEEEEeeCCCCC
Q 002512 524 KGSFS-CVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH--AHLLNLLGYCEEGR--ERLLVYEFMAHGS 598 (914)
Q Consensus 524 ~G~fG-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~H--pnIv~l~g~~~~~~--~~~LV~Ey~~~gs 598 (914)
+||+. .+|..... ++.+++. ...............+|.++|+.+.- --+.+.+++|.++. .+|.||||++|..
T Consensus 34 ~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~ 111 (321)
T COG3173 34 SGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEV 111 (321)
T ss_pred cCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEeccee
Confidence 34443 44444433 6777777 32212222334556778888888743 34666778887776 6799999999844
Q ss_pred HHHhhhcCccc---------------------------------hhcccchhhHHHHH--------HHHHHHHHHhhcc-
Q 002512 599 LHQHLHGKSKA---------------------------------LKEQLDWVRRVTIA--------VQAARGIEYLHGY- 636 (914)
Q Consensus 599 L~~~l~~~~~~---------------------------------~~~~l~~~~~l~i~--------~qia~gL~yLH~~- 636 (914)
+.+.+...... .++...|....+.+ -....-..+|+.+
T Consensus 112 ~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~ 191 (321)
T COG3173 112 VWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANR 191 (321)
T ss_pred ccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcC
Confidence 33322211000 00001111111100 0111223344432
Q ss_pred ----CCCCeeccCCCccceEEcCCCcEEEeecCCcccCCC
Q 002512 637 ----ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 637 ----~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~ 672 (914)
+.+.++|+|+++.||+++.+.-+=|.||+++.+..+
T Consensus 192 p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 192 PPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 235799999999999999988899999999876543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.016 Score=64.05 Aligned_cols=142 Identities=18% Similarity=0.187 Sum_probs=80.9
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCC--ceeeeecee------ecCCeEEEEEe
Q 002512 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA--HLLNLLGYC------EEGRERLLVYE 592 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hp--nIv~l~g~~------~~~~~~~LV~E 592 (914)
.++.|-...+|+....++ .+++|+.... ...++...|++++..|... .+++++... ...+..+++||
T Consensus 29 ~~~~G~~n~~y~v~t~~~-~~vLK~~~~~----~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 29 GIAEGVENSNYLLTTDVG-RYILTLYEKR----VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccCCccccceEEEEeCCC-cEEEEEecCC----CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 467777789998876544 5777865321 1124556677777777422 245555432 22346789999
Q ss_pred eCCCCCHHH--------------hhhcCccch----hc---ccchhhHH------------HHHHHHHHHHHHhhc----
Q 002512 593 FMAHGSLHQ--------------HLHGKSKAL----KE---QLDWVRRV------------TIAVQAARGIEYLHG---- 635 (914)
Q Consensus 593 y~~~gsL~~--------------~l~~~~~~~----~~---~l~~~~~l------------~i~~qia~gL~yLH~---- 635 (914)
|++|..+.. .||...... .. .-.|.... .....+.+.+++|..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999855421 122111100 00 01121110 011223345555542
Q ss_pred cCCCCeeccCCCccceEEcCCCcEEEeecCCc
Q 002512 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLS 667 (914)
Q Consensus 636 ~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla 667 (914)
...+.++|+|+++.||++++++...|.||+.+
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 12345999999999999999877789999876
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.009 Score=65.10 Aligned_cols=139 Identities=23% Similarity=0.341 Sum_probs=73.7
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhcc---CCceeeeeceeecCCeEEEEEeeCCC
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN---HAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
+.|+-|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+++.+++....+..+|||||++.
T Consensus 23 ~~v~GG~i~~a~~~~-~~~~~~FvK~~~~-----~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 23 EPVSGGDINEAYRLD-TDGGSYFVKVNSE-----SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEE--SSSSEEEEEE-TTS-EEEEEEEEG-----GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred EecCCCChhheEEEE-CCCccEEEEecCh-----hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 358889999999877 5688899997541 12356889999999883 34688999998888888999999987
Q ss_pred CCH--------HH---hhhc-Cccc------------hhcc----cchhh-----HHHHHH--------------HHHHH
Q 002512 597 GSL--------HQ---HLHG-KSKA------------LKEQ----LDWVR-----RVTIAV--------------QAARG 629 (914)
Q Consensus 597 gsL--------~~---~l~~-~~~~------------~~~~----l~~~~-----~l~i~~--------------qia~g 629 (914)
+.. -. .||+ .... ..+. -+|.. |+.-.. ++.+.
T Consensus 97 ~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~ 176 (288)
T PF03881_consen 97 GSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVER 176 (288)
T ss_dssp ----CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHH
Confidence 611 11 2343 1100 0011 12221 111111 12222
Q ss_pred H-HHhhcc-CCCCeeccCCCccceEEcCCCcEEEeec
Q 002512 630 I-EYLHGY-ACPPVIHRDIKSSNILIDEEHNARVADF 664 (914)
Q Consensus 630 L-~yLH~~-~~~~iiHrDIKp~NILl~~~~~~kl~DF 664 (914)
| ..|+.. -.|.++|+||.+.|++.+.++.+.|.|=
T Consensus 177 ~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DP 213 (288)
T PF03881_consen 177 LPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDP 213 (288)
T ss_dssp HHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S-
T ss_pred HHHHhcCCCCCceeeEcCccccceeecCCCCceeecc
Confidence 2 223322 2577999999999999999998999883
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.00024 Score=88.54 Aligned_cols=161 Identities=14% Similarity=0.018 Sum_probs=113.4
Q ss_pred HHHHHHHHHhccCCceeeeeceeec--CCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhc-
Q 002512 559 FHTELDLLSRLNHAHLLNLLGYCEE--GRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG- 635 (914)
Q Consensus 559 f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~- 635 (914)
...|...++...|+++.....-... ..+.+.+++|+..|.+.+.|-+..... ..+........-.+......-+|+
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~-~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEES-PDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccC-CcchhchHHHHHHHHHhccchhhhc
Confidence 4455566666789988876554432 345689999999999999886543211 122222222222232444444443
Q ss_pred -cCCCCeeccCCCccceEEcCCCcEEEeecCCcccCCCCCCCCCccCCCCcCCccChhhhhcCCCCCcchHHHHHHHHHH
Q 002512 636 -YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLE 714 (914)
Q Consensus 636 -~~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~Gt~~y~aPE~l~~~~~s~ksDV~S~GvvL~E 714 (914)
......+|+++|+.|.+|..+..+|+.++|+.++..+... ......+++.|+.|++...-.++.++|+|..++.+|+
T Consensus 1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s--f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS--FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred ccCCccchhhhhhhhccceecCCcccccccccccccCchHh--hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 2335589999999999999999999999999985443322 3344568889999999999899999999999999999
Q ss_pred HHhCCCCc
Q 002512 715 ILSGRKAI 722 (914)
Q Consensus 715 lltG~~p~ 722 (914)
+--|..+|
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 98877664
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.027 Score=63.91 Aligned_cols=81 Identities=19% Similarity=0.224 Sum_probs=53.6
Q ss_pred cccCcccceEEEEEEEcCCcEEEEEEeeeccc-----cccchHHHHHHHHHHHhcc---CCceeeeeceeecCCeEEEEE
Q 002512 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSD-----RQKNSKEFHTELDLLSRLN---HAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 520 ~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~f~~E~~~l~~l~---HpnIv~l~g~~~~~~~~~LV~ 591 (914)
+.||-|....||+.... ++.++||+-..... -.-...+-..|++.|..+. ..++++++.++.+ ..+++|
T Consensus 38 ~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 46899999999998864 56799997652111 0112334445577776663 3588899988884 467899
Q ss_pred eeCCC--CCHHHhh
Q 002512 592 EFMAH--GSLHQHL 603 (914)
Q Consensus 592 Ey~~~--gsL~~~l 603 (914)
||+++ -.|.+.|
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99977 3455433
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.029 Score=62.38 Aligned_cols=142 Identities=14% Similarity=0.159 Sum_probs=76.0
Q ss_pred ccCcccceEEEEEEEcCCcEEEEEEeeeccccccchHHHHHHHHHHHhccCC--ceeeeece------eecCCeEEEEEe
Q 002512 521 EVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA--HLLNLLGY------CEEGRERLLVYE 592 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hp--nIv~l~g~------~~~~~~~~LV~E 592 (914)
.|..|....+|+....++ .+++|+.. . . ..+....|+.++..|... .+++.+.. ....+..+++||
T Consensus 29 ~l~~G~~n~~y~v~t~~g-~~vLK~~~-~-~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 29 GIAEGIENSNFFLTTTQG-EYVLTLFE-R-L---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred hhccccccceEEEEeCCC-cEEEEEec-c-C---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 467777789999886655 67888653 1 1 123344455666655321 23444421 223456789999
Q ss_pred eCCCCCHH-----------Hh---hhcCccc------hhcccchh-hHHH------------HH-HHHHHHHHHhhcc--
Q 002512 593 FMAHGSLH-----------QH---LHGKSKA------LKEQLDWV-RRVT------------IA-VQAARGIEYLHGY-- 636 (914)
Q Consensus 593 y~~~gsL~-----------~~---l~~~~~~------~~~~l~~~-~~l~------------i~-~qia~gL~yLH~~-- 636 (914)
|++|..+. +. ||..... ....+.|. .... .. ..+...++.+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 99987542 11 1211100 00011121 1111 11 1111222333211
Q ss_pred --CCCCeeccCCCccceEEcCCCcEEEeecCCcc
Q 002512 637 --ACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 637 --~~~~iiHrDIKp~NILl~~~~~~kl~DFGla~ 668 (914)
-...++|+|++|.|||++++...-|.||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 22359999999999999977666899998763
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.027 Score=62.77 Aligned_cols=81 Identities=20% Similarity=0.256 Sum_probs=52.7
Q ss_pred ccCcccceEEEEEEEcCC-cEEEEEEeeecc-----ccccchHHHHHHHHHHHhcc--CC-ceeeeeceeecCCeEEEEE
Q 002512 521 EVGKGSFSCVYKGVLKDG-TVVAVKKAIATS-----DRQKNSKEFHTELDLLSRLN--HA-HLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 521 ~LG~G~fG~Vy~~~~~~~-~~vavK~~~~~~-----~~~~~~~~f~~E~~~l~~l~--Hp-nIv~l~g~~~~~~~~~LV~ 591 (914)
+||-|....||++...++ +.|+||...... ...-..++-..|.+.|.... -| .+++++.| +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999998754 689999654221 11233455667888887663 24 45555544 444567999
Q ss_pred eeCCC-CCHHHhh
Q 002512 592 EFMAH-GSLHQHL 603 (914)
Q Consensus 592 Ey~~~-gsL~~~l 603 (914)
|+++. ..|++.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 99965 3454444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.0035 Score=67.37 Aligned_cols=132 Identities=18% Similarity=0.172 Sum_probs=90.3
Q ss_pred ccccccCcccceEEEEEEEcCCcEEEEEEeeecccc------------------ccc--hHHHHHHHHHHHhccC--Cce
Q 002512 517 GFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDR------------------QKN--SKEFHTELDLLSRLNH--AHL 574 (914)
Q Consensus 517 ~~~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~--~~~f~~E~~~l~~l~H--pnI 574 (914)
.+.+.||-|--+.||.+-..+|++.++|.-+..... ... .-...+|...|+.|.. --|
T Consensus 95 svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfpV 174 (465)
T KOG2268|consen 95 SVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFPV 174 (465)
T ss_pred hhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCCC
Confidence 356789999999999999999999999943221100 000 0123468888888843 346
Q ss_pred eeeeceeecCCeEEEEEeeCCCCCHHHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEEc
Q 002512 575 LNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID 654 (914)
Q Consensus 575 v~l~g~~~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~ 654 (914)
++.+++. ..++|||++.+-.|.+.-+-..+ -.+...+..-+.-|-..+ +||+|..-=||+++
T Consensus 175 PkpiD~~----RH~Vvmelv~g~Pl~~v~~v~d~-----------~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 175 PKPIDHN----RHCVVMELVDGYPLRQVRHVEDP-----------PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCccccc----ceeeHHHhhcccceeeeeecCCh-----------HHHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 6666654 45789999998887665432211 122333333445566677 99999999999999
Q ss_pred CCCcEEEeecCC
Q 002512 655 EEHNARVADFGL 666 (914)
Q Consensus 655 ~~~~~kl~DFGl 666 (914)
++..++++||--
T Consensus 237 dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 237 DDDKIVVIDFPQ 248 (465)
T ss_pred cCCCEEEeechH
Confidence 999999999964
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.055 Score=60.83 Aligned_cols=140 Identities=20% Similarity=0.199 Sum_probs=78.4
Q ss_pred cCcccceEEEEEEEcC-----CcEEEEEEeeeccccccchHHHHHHHHHHHhccCCc-eeeeeceeecCCeEEEEEeeCC
Q 002512 522 VGKGSFSCVYKGVLKD-----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAH-LLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 522 LG~G~fG~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
|-.|-...+|+....+ ++.+++|...... ... -+-.+|..++..+..-+ -+++++++..+ .|+||++
T Consensus 44 l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 44 LKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELF-FDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred cCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Cee-echHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 5457778899987542 3578888654322 222 22367999999885433 34556665443 5899998
Q ss_pred CCCHHHh-----------------hhcCccchhc-ccchhhHHHHHHH-----------------HHHHHHH----hhc-
Q 002512 596 HGSLHQH-----------------LHGKSKALKE-QLDWVRRVTIAVQ-----------------AARGIEY----LHG- 635 (914)
Q Consensus 596 ~gsL~~~-----------------l~~~~~~~~~-~l~~~~~l~i~~q-----------------ia~gL~y----LH~- 635 (914)
+.+|... ||........ ...|....++..+ +..-+.. +..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 2222111111 1112222122111 1111212 222
Q ss_pred cCCCCeeccCCCccceEEcC-CCcEEEeecCCcc
Q 002512 636 YACPPVIHRDIKSSNILIDE-EHNARVADFGLSL 668 (914)
Q Consensus 636 ~~~~~iiHrDIKp~NILl~~-~~~~kl~DFGla~ 668 (914)
.....++|+|+++.|||+++ +..++|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 22335899999999999986 4679999998764
|
|
| >KOG0941 consensus E3 ubiquitin protein ligase [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.00039 Score=81.99 Aligned_cols=122 Identities=15% Similarity=0.137 Sum_probs=91.7
Q ss_pred EEEEeecCCceeEeeecCCeEEEecCCCCCceeec----------C--CCCccEEEEEecCcceeEEEe-----CCCccE
Q 002512 171 IESISAGSEFNCGLFSQNRTVFCWGDESSSRVISL----------I--PKEMKFQKVAAGGYHVCGILE-----GLDSRT 233 (914)
Q Consensus 171 ~~~ia~G~~~~cal~~~~g~v~cWG~n~~g~~~~~----------~--~~~~~~~~i~aG~~h~c~l~~-----~~~g~v 233 (914)
+.++++|..|..|+ ...|+++.||.|.+||+... + ..+..-++|++|.+|+|++.. +.+|.+
T Consensus 16 ~lq~~cGn~hclal-~~~g~~~~wg~~~~g~~~~~~~~~~~~p~~~~sl~g~p~a~v~~g~~hs~~lS~~~~~lt~e~~~ 94 (850)
T KOG0941|consen 16 ILQVGCGNNHCLAL-SCAGELFVWGMNNNGQLGRALYFPDAKPEPVESLKGVPLAQVSAGEAHSFALSSHTVLLTDEGKV 94 (850)
T ss_pred hhhhccccHHHHhh-hccCCeeeccCCccchhhhhccCCCCCCccchhhcCCcHHHHhcCCCcchhhhhchhhcchhccc
Confidence 56899999999999 89999999999999998221 1 123455789999999999861 127899
Q ss_pred EEeecCCCCccccccccccccccCCC--CCCCeeEeecCCcEEEeeeecCCceEEeeeccCC
Q 002512 234 RCWGRSLDLEEEVSVAYSRQGNVDLP--PSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKP 293 (914)
Q Consensus 234 ~cWG~n~~~~~g~~~~~~~~~~~~~~--~~~~~~sia~g~~htcg~~~~~g~v~CWG~n~~g 293 (914)
.-.|....+|.|...+....-|..+. -+..+..|++|..|+.+....-+.++-.|.+..|
T Consensus 95 fs~Ga~~~~q~~h~~~~~~~~~~~v~e~i~~~~t~ia~~~~ht~a~v~~l~qsf~~~~~~sG 156 (850)
T KOG0941|consen 95 FSFGAGSTGQLGHSLTENEVLPLLVLELIGSRVTRIACVRGHTLAIVPRLGQSFSFGKGASG 156 (850)
T ss_pred cccCCcccccccccccccccccHHHHHHHhhhhHHHHHHHHHHHhhhhhhcceeecccCCCC
Confidence 99999988888874333322222221 2346888999999999986666888888888776
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.089 Score=57.87 Aligned_cols=140 Identities=21% Similarity=0.241 Sum_probs=89.3
Q ss_pred ccccCcccceEEEEEEEcCCcEEEEEEeeeccccccch-------------------HH-----HHHHHHHHHhccCCce
Q 002512 519 KEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNS-------------------KE-----FHTELDLLSRLNHAHL 574 (914)
Q Consensus 519 ~~~LG~G~fG~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------------------~~-----f~~E~~~l~~l~HpnI 574 (914)
.-.|..|--+.||.+.-.+|..+|||+..-....-+.. +. ...|++-|.+|+...|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred ccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34588999999999999999999999764332111110 11 2357778888865554
Q ss_pred eeeeceeecCCeEEEEEeeCCCCCH-HHhhhcCccchhcccchhhHHHHHHHHHHHHHHhhccCCCCeeccCCCccceEE
Q 002512 575 LNLLGYCEEGRERLLVYEFMAHGSL-HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 653 (914)
Q Consensus 575 v~l~g~~~~~~~~~LV~Ey~~~gsL-~~~l~~~~~~~~~~l~~~~~l~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl 653 (914)
+----... ...+|||+|+-.-.. .-.|+. -.++......+-.+++.-|.-|-... .+||.||.-=|+|+
T Consensus 229 P~PePIlL--k~hVLVM~FlGrdgw~aPkLKd------~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFLGRDGWAAPKLKD------ASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCceee--ecceEeeeeccCCCCcCccccc------ccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 32221111 134799999853211 111211 13444455566677777777777665 39999999999999
Q ss_pred cCCCcEEEeecCCccc
Q 002512 654 DEEHNARVADFGLSLL 669 (914)
Q Consensus 654 ~~~~~~kl~DFGla~~ 669 (914)
.+ +.+.|+|-+-+..
T Consensus 299 hd-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVE 313 (520)
T ss_pred EC-CEEEEEEcccccc
Confidence 54 5799999887644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 914 | ||||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-52 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-52 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-46 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-44 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-34 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 9e-29 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-27 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-27 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-26 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-25 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-24 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-24 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-24 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-24 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-24 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-24 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-24 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 9e-24 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-23 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-21 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-21 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-21 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-21 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-20 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-20 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-20 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-20 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-20 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-20 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-20 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-20 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-20 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-20 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-20 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-20 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-20 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-20 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-20 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-20 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-20 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-20 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-20 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-20 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-20 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-19 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-19 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 7e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 7e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-19 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 9e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 9e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-18 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-17 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-17 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-17 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 7e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 9e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-16 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-16 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-16 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-16 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-16 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-16 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 7e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-16 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-16 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 9e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 9e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-15 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-15 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 5e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-15 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-15 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 8e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-15 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-14 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-14 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-14 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-14 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 7e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 9e-14 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-13 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-13 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-13 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-13 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-13 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-13 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-13 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-13 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-13 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-13 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 4e-13 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-13 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-13 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-13 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 5e-13 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-13 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-13 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-13 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-13 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-13 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-13 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-13 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-13 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 7e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 8e-13 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-13 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-13 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 8e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 9e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 9e-13 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-13 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-12 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-12 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-12 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-12 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 4e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-12 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-11 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-11 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-11 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-11 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-11 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-11 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 7e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 8e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-10 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 2e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-10 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-10 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-10 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-10 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 7e-10 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 8e-10 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 8e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-10 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 8e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 9e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 1e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-09 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-09 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-09 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-09 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 7e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 9e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-08 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-08 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-08 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-08 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-08 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-08 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 5e-08 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-08 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-08 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 8e-08 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-08 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-08 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-07 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-07 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-07 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-07 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 2e-07 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-07 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 3e-07 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-07 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-07 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-07 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 4e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 6e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 8e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-06 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-06 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-06 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-06 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-06 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-06 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-06 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 5e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 6e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 7e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 7e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 8e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 8e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 8e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-05 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 4e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 4e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-05 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 4e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-05 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 4e-05 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 5e-05 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 5e-05 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-05 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 6e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-05 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-05 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-04 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-04 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 5e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 6e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 8e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-04 |
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 402 bits (1035), Expect = e-133
Identities = 125/320 (39%), Positives = 180/320 (56%), Gaps = 12/320 (3%)
Query: 481 GSPYQKDNGKIRPDFDDLKIRR--AQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLK 536
GS Y K I + + +LE AT F + +G G F VYKGVL+
Sbjct: 2 GSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61
Query: 537 DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596
DG VA+K+ S Q +EF TE++ LS H HL++L+G+C+E E +L+Y++M +
Sbjct: 62 DGAKVALKRRTPES-SQGI-EEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMEN 119
Query: 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE 656
G+L +HL+G + W +R+ I + AARG+ YLH +IHRD+KS NIL+DE
Sbjct: 120 GNLKRHLYGSDLP-TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDEN 175
Query: 657 HNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEIL 716
++ DFG+S G + L+ + GTLGY+DPEY+ LT KSDVYSFGV+L E+L
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 717 SGRKAIDMQF--EEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRM 774
R AI E N+ EWAV +G + I+DP L ++L++ + A KC+ +
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295
Query: 775 RGKERPSMDKVTTALERALA 794
++RPSM V LE AL
Sbjct: 296 SSEDRPSMGDVLWKLEYALR 315
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-121
Identities = 106/295 (35%), Positives = 174/295 (58%), Gaps = 9/295 (3%)
Query: 502 RAQMFTYEELERATGGFKEE--VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEF 559
+ + F+ EL+ A+ F + +G+G F VYKG L DGT+VAVK+ Q +F
Sbjct: 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQF 74
Query: 560 HTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR 619
TE++++S H +LL L G+C ERLLVY +MA+GS+ L + ++ + LDW +R
Sbjct: 75 QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKR 133
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679
IA+ +ARG+ YLH + P +IHRD+K++NIL+DEE A V DFGL+ L + +
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD-YKDTHVT 192
Query: 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQF----EEGNIVEWA 735
GT+G++ PEY + K+DV+ +GV+LLE+++G++A D+ ++ +++W
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 736 VPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
L+K + A++D L+ + ++++ VA C + ERP M +V LE
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 362 bits (931), Expect = e-118
Identities = 100/300 (33%), Positives = 156/300 (52%), Gaps = 19/300 (6%)
Query: 502 RAQMFTYEELERATGGFKEE--------VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQ 553
R F++ EL+ T F E +G+G F VYKG + + T VAVKK A D
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 554 KN--SKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALK 611
++F E+ ++++ H +L+ LLG+ +G + LVY +M +GSL L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--T 127
Query: 612 EQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671
L W R IA AA GI +LH IHRDIKS+NIL+DE A+++DFGL+
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASE 184
Query: 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNI 731
+ + + GT Y+ PE R +T KSD+YSFGV+LLEI++G A+D E +
Sbjct: 185 KFAQTVMTSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243
Query: 732 VEWAVPLIKS-GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
++ + I +D + +D +++ + +VA +C+ + +RP + KV L+
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 4e-73
Identities = 78/311 (25%), Positives = 117/311 (37%), Gaps = 36/311 (11%)
Query: 506 FTYEELERATGGFK--EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTEL 563
E L + + E +G F CV+K L VAVK + K S + E+
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIF---PIQDKQSWQNEYEV 69
Query: 564 DLLSRLNHAHLLNLLGYCEEGR----ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR 619
L + H ++L +G + G + L+ F GSL L + W
Sbjct: 70 YSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK------ANVVSWNEL 123
Query: 620 VTIAVQAARGIEYLH-------GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672
IA ARG+ YLH P + HRDIKS N+L+ A +ADFGL+L A
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 673 DSSSPLAELPAGTLGYLDPEYYR-----LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFE 727
S+ GT Y+ PE + D+Y+ G++L E+ S A D +
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD 243
Query: 728 EGNIV-EWAVPLIKS-GDITAI-----LDPVL-KLPSDLDALKRIANVACKCVRMRGKER 779
E + E + S D+ + PVL + + +C + R
Sbjct: 244 EYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 780 PSMDKVTTALE 790
S V +
Sbjct: 304 LSAGCVGERIT 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-65
Identities = 87/329 (26%), Positives = 153/329 (46%), Gaps = 30/329 (9%)
Query: 472 SKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVY 531
++ + + D DD+ I + +L KE++G GSF V+
Sbjct: 6 HHHPMSDYDIPTTENLYFQGAMDGDDMDIP------WCDLN-----IKEKIGAGSFGTVH 54
Query: 532 KGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591
+ G+ VAVK + + EF E+ ++ RL H +++ +G + +V
Sbjct: 55 RAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113
Query: 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 651
E+++ GSL++ LH +EQLD RR+++A A+G+ YLH PP++HR++KS N+
Sbjct: 114 EYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNL 170
Query: 652 LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVL 711
L+D+++ +V DFGLS L + S + AGT ++ PE R KSDVYSFGV+
Sbjct: 171 LVDKKYTVKVCDFGLSRLKASTFLSSKSA--AGTPEWMAPEVLRDEPSNEKSDVYSFGVI 228
Query: 712 LLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKC 771
L E+ + + + N + + ++P +L+ ++A + C
Sbjct: 229 LWELATLQ----QPWGNLNPAQVVAAVGFKC-----KRL--EIPRNLN--PQVAAIIEGC 275
Query: 772 VRMRGKERPSMDKVTTALERALAQLMGSP 800
+RPS + L + + P
Sbjct: 276 WTNEPWKRPSFATIMDLLRPLIKSAVPPP 304
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 5e-63
Identities = 75/294 (25%), Positives = 132/294 (44%), Gaps = 32/294 (10%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLS 567
Y+E+E +E VG+G+F V K + VA+K+ + S+R K F EL LS
Sbjct: 7 YKEIE-----VEEVVGRGAFGVVCKAKWR-AKDVAIKQIESESER----KAFIVELRQLS 56
Query: 568 RLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAA 627
R+NH +++ L G C LV E+ GSL+ LHG ++ +Q +
Sbjct: 57 RVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCS 112
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHN-ARVADFGLSLLGPADSSSPLAELPAGTL 686
+G+ YLH +IHRD+K N+L+ ++ DFG + ++ G+
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTN-----NKGSA 167
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITA 746
++ PE + + K DV+S+G++L E+++ RK F+E + +
Sbjct: 168 AWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTR- 222
Query: 747 ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSP 800
L +L K I ++ +C +RPSM+++ + + G+
Sbjct: 223 -----PPLIKNLP--KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-58
Identities = 68/335 (20%), Positives = 124/335 (37%), Gaps = 50/335 (14%)
Query: 471 ASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCV 530
+ + + + + + + I +E+LE E +GKG F V
Sbjct: 1 GPEMNLSLLSARSFPRKASQTSIFLQEWDIP------FEQLE-----IGELIGKGRFGQV 49
Query: 531 YKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590
Y G G V A++ D + K F E+ + H +++ +G C ++
Sbjct: 50 YHGRWH-GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII 107
Query: 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSN 650
+L+ + K LD + IA + +G+ YLH ++H+D+KS N
Sbjct: 108 TSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKN 160
Query: 651 ILIDEEHNARVADFGLS---LLGPADSSSPLAELPAGTLGYLDPEYYR----------LH 697
+ D + DFGL + A + G L +L PE R L
Sbjct: 161 VFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLP 219
Query: 698 YLTTKSDVYSFGVLLLEILSGRKAI-DMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756
+ + SDV++ G + E+ + E + W + +G + S
Sbjct: 220 F-SKHSDVFALGTIWYELHAREWPFKTQPAEA---IIWQM---GTG--------MKPNLS 264
Query: 757 DLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
+ K I+++ C +ERP+ K+ LE+
Sbjct: 265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 7e-58
Identities = 58/289 (20%), Positives = 121/289 (41%), Gaps = 35/289 (12%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLS 567
+++L F ++ + ++KG + G + VK + S++F+ E L
Sbjct: 9 FKQLN-----FLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLR 62
Query: 568 RLNHAHLLNLLGYCEEGRERLL--VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQ 625
+H ++L +LG C+ + +M +GSL+ LH + +D + V A+
Sbjct: 63 IFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQSQAVKFALD 119
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGT 685
ARG+ +LH P + + S +++IDE+ AR++ + +
Sbjct: 120 MARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYA 171
Query: 686 LGYLDPEYYR---LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG 742
++ PE + +D++SF VLL E+++ + F + + +E + + G
Sbjct: 172 PAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE----VPFADLSNMEIGMKVALEG 227
Query: 743 DITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
L P +P + ++ + C+ +RP D + LE+
Sbjct: 228 -----LRP--TIPPGIS--PHVSKLMKICMNEDPAKRPKFDMIVPILEK 267
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 7e-58
Identities = 82/319 (25%), Positives = 153/319 (47%), Gaps = 35/319 (10%)
Query: 481 GSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTV 540
+ + R DD +I ++ + +G GSF VYKG G V
Sbjct: 2 KKGHHHHHHGSRDAADDWEIPD------GQIT-----VGQRIGSGSFGTVYKGKWH-GDV 49
Query: 541 VAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLH 600
AVK T+ + + F E+ +L + H ++L +GY + +V ++ SL+
Sbjct: 50 -AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLY 107
Query: 601 QHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNAR 660
HLH + + + + + IA Q ARG++YLH +IHRD+KS+NI + E++ +
Sbjct: 108 HHLHAS----ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVK 160
Query: 661 VADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR----LHYLTTKSDVYSFGVLLLEIL 716
+ DFGL+ S S E +G++ ++ PE R Y + +SDVY+FG++L E++
Sbjct: 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELM 219
Query: 717 SGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRG 776
+G+ + + N + + ++ G + + K+ S+ KR+ + +C++ +
Sbjct: 220 TGQ----LPYSNINNRDQIIEMVGRGS---LSPDLSKVRSNCP--KRMKRLMAECLKKKR 270
Query: 777 KERPSMDKVTTALERALAQ 795
ERPS ++ +E +
Sbjct: 271 DERPSFPRILAEIEELARE 289
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 7e-58
Identities = 84/293 (28%), Positives = 124/293 (42%), Gaps = 39/293 (13%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVK--KAIATSDRQKNSKEFHTELDL 565
+ EL +E +G G F VY+ G VAVK + D + + E L
Sbjct: 6 FAELT-----LEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKL 59
Query: 566 LSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQ 625
+ L H +++ L G C + LV EF G L++ L GK ++ V AVQ
Sbjct: 60 FAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQ 113
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEE--------HNARVADFGLSLLGPADSSSP 677
ARG+ YLH A P+IHRD+KSSNILI ++ ++ DFGL+ +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS 173
Query: 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVP 737
AG ++ PE R + SDV+S+GVLL E+L+G + F + + A
Sbjct: 174 ----AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE----VPFRGIDGLAVAYG 225
Query: 738 LIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
+ + L LP + A + C RPS + L
Sbjct: 226 VAMNK---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 7e-58
Identities = 84/303 (27%), Positives = 127/303 (41%), Gaps = 53/303 (17%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNS-----KEFHT 561
E+E +++++GKG F V+KG L D +VVA+K I + +EF
Sbjct: 18 DNEIE-----YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQR 72
Query: 562 ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVT 621
E+ ++S LNH +++ L G +V EF+ G L+ L K + W ++
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLR 126
Query: 622 IAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-----NARVADFGLSLLGPADSSS 676
+ + A GIEY+ PP++HRD++S NI + A+VADFGLS S
Sbjct: 127 LMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSG 185
Query: 677 PLAELPAGTLGYLDPEYYRL---HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
G ++ PE Y T K+D YSF ++L IL+G F+E
Sbjct: 186 -----LLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGP----FDE----- 230
Query: 734 WAVPLIKSGDITAILDPV-----LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788
G I I +P D R+ NV C K+RP +
Sbjct: 231 -----YSYGKIKFINMIREEGLRPTIPEDCP--PRLRNVIELCWSGDPKKRPHFSYIVKE 283
Query: 789 LER 791
L
Sbjct: 284 LSE 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-57
Identities = 74/347 (21%), Positives = 127/347 (36%), Gaps = 61/347 (17%)
Query: 506 FTYEELERATGGFK--EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTEL 563
E K E +G+G + VYKG L D VAVK + ++RQ F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKV-FSFANRQ----NFINEK 56
Query: 564 D--LLSRLNHAHLLNLLGYCEEG-----RERLLVYEFMAHGSLHQHLHGKSKALKEQLDW 616
+ + + H ++ + E E LLV E+ +GSL ++L DW
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDW 110
Query: 617 VRRVTIAVQAARGIEYLH------GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670
V +A RG+ YLH + P + HRD+ S N+L+ + ++DFGLS+
Sbjct: 111 VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL 170
Query: 671 PADSSSPLAELP------AGTLGYLDPEYYR-------LHYLTTKSDVYSFGVLLLEILS 717
+ E GT+ Y+ PE + D+Y+ G++ EI
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 718 GRKAIDMQFEEGNIVEWAVP----LIKSGDITAILDPVLK----------LPSDLDALKR 763
+ F ++ E+ + + + V + + A++
Sbjct: 231 RCTDL---FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRS 287
Query: 764 IANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTE 810
+ C + R + E +A+LM + + PT
Sbjct: 288 LKETIEDCWDQDAEARLTAQXA----EERMAELMMIWERNKSVSPTA 330
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 4e-54
Identities = 72/304 (23%), Positives = 120/304 (39%), Gaps = 38/304 (12%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
E +GKG F K ++ G V+ +K+ I + + + F E+ ++ L H ++L
Sbjct: 14 HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQ--RTFLKEVKVMRCLEHPNVLK 71
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
+G + + + E++ G+L + Q W +RV+ A A G+ YLH
Sbjct: 72 FIGVLYKDKRLNFITEYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLH-- 125
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP------------AG 684
+IHRD+ S N L+ E N VADFGL+ L + + P G
Sbjct: 126 -SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 685 TLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDI 744
++ PE K DV+SFG++L EI+ A L ++ D
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA------------DPDYLPRTMDF 232
Query: 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQ 804
+ L + + +C + ++RPS K+ LE L
Sbjct: 233 GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLE----TLRMHLAGHL 288
Query: 805 PILP 808
P+ P
Sbjct: 289 PLGP 292
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 5e-51
Identities = 62/301 (20%), Positives = 121/301 (40%), Gaps = 40/301 (13%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+++GKG + V+ G + G VAVK ++ S TE+ + H ++L
Sbjct: 41 MVKQIGKGRYGEVWMGKWR-GEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGF 96
Query: 578 LGYCEEGRER----LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
+ +G L+ ++ +GSL+ +L + LD + +A + G+ +L
Sbjct: 97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKSTT------LDAKSMLKLAYSSVSGLCHL 150
Query: 634 HGYAC-----PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP----AG 684
H P + HRD+KS NIL+ + +AD GL++ S + ++P G
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVK--FISDTNEVDIPPNTRVG 208
Query: 685 TLGYLDPE-------YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQ------FEEGNI 731
T Y+ PE +D+YSFG++L E+ + + + +
Sbjct: 209 TKRYMPPEVLDESLNRNHFQS-YIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 732 VEWAVPLIKSGDITAILDPVL-KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
+ + ++ L P S + L+++ + +C R + +V L
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 791 R 791
+
Sbjct: 328 K 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 3e-50
Identities = 68/306 (22%), Positives = 119/306 (38%), Gaps = 50/306 (16%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
E VGKG + V++G + G VAVK S R + S TEL L H ++L
Sbjct: 12 LLECVGKGRYGEVWRGSWQ-GENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGF 67
Query: 578 LGYCEEGR----ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
+ R + L+ + GSL+ +L LD V + I + A G+ +L
Sbjct: 68 IASDMTSRHSSTQLWLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHL 121
Query: 634 HGYAC-----PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP----AG 684
H P + HRD+KS NIL+ + +AD GL+++ S+ ++ G
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM--HSQSTNQLDVGNNPRVG 179
Query: 685 TLGYLDPE------YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPL 738
T Y+ PE + D+++FG++L E+ + G + ++ P
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS------NGIVEDYKPPF 233
Query: 739 IKSGDITAILDPVLK----------LPSDL---DALKRIANVACKCVRMRGKERPSMDKV 785
+ + K +P+ L +A + +C R + ++
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 786 TTALER 791
L +
Sbjct: 294 KKTLTK 299
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 3e-49
Identities = 71/304 (23%), Positives = 129/304 (42%), Gaps = 46/304 (15%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+E +GKG F V++G + G VAVK S R++ S E+ L H ++L
Sbjct: 46 LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 101
Query: 578 LGYCEEGR----ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
+ + + LV ++ HGSL +L+ + + + +A+ A G+ +L
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHL 155
Query: 634 HGYAC-----PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP----AG 684
H P + HRD+KS NIL+ + +AD GL++ DS++ ++ G
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--HDSATDTIDIAPNHRVG 213
Query: 685 TLGYLDPE-------YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIV-EWAV 736
T Y+ PE ++D+Y+ G++ EI R +I E+ + V
Sbjct: 214 TKRYMAPEVLDDSINMKHFES-FKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLV 271
Query: 737 PLIKSGDITAILDPV------LKLPS---DLDALKRIANVACKCVRMRGKERPSMDKVTT 787
P S + + V +P+ +AL+ +A + +C G R + ++
Sbjct: 272 PSDPS--VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
Query: 788 ALER 791
L +
Sbjct: 330 TLSQ 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 2e-39
Identities = 58/208 (27%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
F E+G+GSF VYKG+ + VA + + + F E ++L L H +++
Sbjct: 30 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89
Query: 577 LLGYCE---EGRERLLVY-EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
E +G++ +++ E M G+L +L + K +K ++ +R Q +G+++
Sbjct: 90 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLK-RFKVMKIKV--LRSWC--RQILKGLQF 144
Query: 633 LHGYACPPVIHRDIKSSNILIDEEH-NARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
LH PP+IHRD+K NI I + ++ D GL+ + A+ GT ++ P
Sbjct: 145 LHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPEFMAP 199
Query: 692 EYYRLHYLTTKSDVYSFGVLLLEILSGR 719
E Y Y DVY+FG+ +LE+ +
Sbjct: 200 EMYEEKY-DESVDVYAFGMCMLEMATSE 226
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-38
Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 37/307 (12%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKD-----GTVVAVK--KAIATSDRQKNSKEFHTE 562
+ ++G+G F V G +VAVK KA A ++ + E
Sbjct: 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP---QHRSGWKQE 83
Query: 563 LDLLSRLNHAHLLNLLGYCEEGRER--LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRV 620
+D+L L H H++ G CE+ LV E++ GSL +L S L + L +
Sbjct: 84 IDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF---- 139
Query: 621 TIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS----SS 676
A Q G+ YLH IHRD+ + N+L+D + ++ DFGL+ P
Sbjct: 140 --AQQICEGMAYLHAQHY---IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVR 194
Query: 677 PLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNI 731
+ P A PE + + SDV+SFGV L E+L+ + + +
Sbjct: 195 EDGDSPVFWYA-------PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLEL 247
Query: 732 VEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
+ A + +T +L+ +LP + ++ C RP+ + + L+
Sbjct: 248 IGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKT 307
Query: 792 ALAQLMG 798
+ G
Sbjct: 308 VHEKYQG 314
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-38
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 27/218 (12%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTV-VAVK--KAIATSDRQKNSKEFHTELDLL 566
L E++G+G+F V+ G L+ VAVK + D + +F E +L
Sbjct: 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA---KFLQEARIL 166
Query: 567 SRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQA 626
+ +H +++ L+G C + + +V E + G L + +L + + A
Sbjct: 167 KQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTE----GARLRVKTLLQMVGDA 222
Query: 627 ARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD---SSSPLAELP- 682
A G+EYL C IHRD+ + N L+ E++ +++DFG+S +S L ++P
Sbjct: 223 AAGMEYLESKCC---IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 683 ---AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
A PE +++SDV+SFG+LL E S
Sbjct: 280 KWTA-------PEALNYGRYSSESDVWSFGILLWETFS 310
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-37
Identities = 67/300 (22%), Positives = 118/300 (39%), Gaps = 35/300 (11%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLK-----DGTVVAVK--KAIATSDRQKNSKEFHTE 562
E+ ++G+G F V G VAVK K + + + E
Sbjct: 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG---GNHIADLKKE 73
Query: 563 LDLLSRLNHAHLLNLLGYC-EEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRV 620
+++L L H +++ G C E+G + L+ EF+ GSL ++L K +++ +++
Sbjct: 74 IEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQL 129
Query: 621 TIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS----SS 676
AVQ +G++YL +HRD+ + N+L++ EH ++ DFGL+ D
Sbjct: 130 KYAVQICKGMDYLGSRQY---VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVK 186
Query: 677 PLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNI 731
+ P A PE SDV+SFGV L E+L+ +
Sbjct: 187 DDRDSPVFWYA-------PECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKM 239
Query: 732 VEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
+ + + L +LP + + + KC + R S + E
Sbjct: 240 IGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-37
Identities = 76/260 (29%), Positives = 117/260 (45%), Gaps = 52/260 (20%)
Query: 483 PYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDG---T 539
+ +GK PD Y L+ F++ +G+G+F V K +K
Sbjct: 4 HHHHHHGKNNPDPTI----------YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRM 53
Query: 540 VVAVK--KAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAH 596
A+K K A+ D + +F EL++L +L +H +++NLLG CE L E+ H
Sbjct: 54 DAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 110
Query: 597 GSLHQHL-----------HGKSKALKEQLDWVRRVTIAVQAARGIEYL--HGYACPPVIH 643
G+L L + + L + + A ARG++YL + IH
Sbjct: 111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF-----IH 165
Query: 644 RDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP----AGTLGYLDPE--YYRLH 697
RD+ + NIL+ E + A++ADFGLS + LP A E Y ++
Sbjct: 166 RDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA-------IESLNYSVY 218
Query: 698 YLTTKSDVYSFGVLLLEILS 717
TT SDV+S+GVLL EI+S
Sbjct: 219 --TTNSDVWSYGVLLWEIVS 236
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 4e-37
Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 33/228 (14%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG------TVVAVK--KAIATSDRQKNSKEFHT 561
E+ R E+G+GSF VY+GV K T VA+K A+ + EF
Sbjct: 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS---MRERIEFLN 77
Query: 562 ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL-----HGKSKALKEQLDW 616
E ++ N H++ LLG +G+ L++ E M G L +L + +
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 617 VRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPAD-- 673
+ + +A + A G+ YL+ +HRD+ + N ++ E+ ++ DFG++ + D
Sbjct: 138 SKMIQMAGEIADGMAYLNANKF---VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 674 SSSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
LP + PE + TT SDV+SFGV+L EI +
Sbjct: 195 RKGGKGLLPVRWMS-------PESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-37
Identities = 63/228 (27%), Positives = 92/228 (40%), Gaps = 32/228 (14%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG----TVVAVK--KAIATSDRQKNSKEFHTEL 563
+ +GKG F V + LK VAVK KA + +EF E
Sbjct: 19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI--EEFLREA 76
Query: 564 DLLSRLNHAHLLNLLGYCEEGRER------LLVYEFMAHGSLHQHL-HGKSKALKEQLDW 616
+ +H H+ L+G R + +++ FM HG LH L + L
Sbjct: 77 ACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPL 136
Query: 617 VRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPAD-- 673
V V A G+EYL IHRD+ + N ++ E+ VADFGLS + D
Sbjct: 137 QTLVRFMVDIACGMEYLSSRNF---IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY 193
Query: 674 SSSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
++LP A E + T SDV++FGV + EI++
Sbjct: 194 RQGCASKLPVKWLA-------LESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-37
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 34/223 (15%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLS 567
++ + F +E+G G F V+ G + VA+K + A S ++F E +++
Sbjct: 4 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-----EEDFIEEAEVMM 58
Query: 568 RLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALK-EQLDWVRRVTIAVQA 626
+L+H L+ L G C E LV EFM HG L +L + E L + + +
Sbjct: 59 KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL-----LGMCLDV 113
Query: 627 ARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS--SSPLAELP 682
G+ YL IHRD+ + N L+ E +V+DFG++ D SS + P
Sbjct: 114 CEGMAYLEEACV-----IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFP 168
Query: 683 ----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
+ PE + ++KSDV+SFGVL+ E+ S G+
Sbjct: 169 VKWAS-------PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 7e-37
Identities = 62/227 (27%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG----TVVAVK--KAIATSDRQKNSKEFHTEL 563
++R + +G+G F V +G LK VAVK K +S R+ +EF +E
Sbjct: 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREI--EEFLSEA 87
Query: 564 DLLSRLNHAHLLNLLGYCEEGR-----ERLLVYEFMAHGSLHQHL-HGKSKALKEQLDWV 617
+ +H +++ LLG C E + +++ FM +G LH +L + + + + +
Sbjct: 88 ACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQ 147
Query: 618 RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPAD--S 674
+ V A G+EYL +HRD+ + N ++ ++ VADFGLS + D
Sbjct: 148 TLLKFMVDIALGMEYLSNRNF---LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR 204
Query: 675 SSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+A++P A E T+KSDV++FGV + EI +
Sbjct: 205 QGRIAKMPVKWIA-------IESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 34/223 (15%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLS 567
EL+R +E+G G F V G K VAVK K + S+ EF E +
Sbjct: 4 ELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-----DEFFQEAQTMM 58
Query: 568 RLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALK-EQLDWVRRVTIAVQA 626
+L+H L+ G C + +V E++++G L +L K L+ QL + +
Sbjct: 59 KLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDV 113
Query: 627 ARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS--SSPLAELP 682
G+ +L H + IHRD+ + N L+D + +V+DFG++ D SS + P
Sbjct: 114 CEGMAFLESHQF-----IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP 168
Query: 683 ----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
A PE + ++KSDV++FG+L+ E+ S G+
Sbjct: 169 VKWSA-------PEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 70/219 (31%), Positives = 110/219 (50%), Gaps = 31/219 (14%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTV-VAVK--KAIATSDRQKNSKEFHTELDLL 566
E+ER K ++G G + VY+GV K ++ VAVK K +EF E ++
Sbjct: 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-----VEEFLKEAAVM 63
Query: 567 SRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQA 626
+ H +L+ LLG C ++ EFM +G+L +L + ++++ V + +A Q
Sbjct: 64 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQI 120
Query: 627 ARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD--SSSPLAELP 682
+ +EYL + IHRD+ + N L+ E H +VADFGLS L D ++ A+ P
Sbjct: 121 SSAMEYLEKKNF-----IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 175
Query: 683 ----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
A PE + + KSDV++FGVLL EI +
Sbjct: 176 IKWTA-------PESLAYNKFSIKSDVWAFGVLLWEIAT 207
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 68/247 (27%), Positives = 103/247 (41%), Gaps = 44/247 (17%)
Query: 488 NGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDG----TVVAV 543
+ + + D+ I ER +GKG F VY G D A+
Sbjct: 4 DSALLAEVKDVLIPH---------ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAI 54
Query: 544 K--KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLL-VYEFMAHGSLH 600
K I + + F E L+ LNH ++L L+G + +M HG L
Sbjct: 55 KSLSRITE---MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLL 111
Query: 601 QHLHGKSKALK-EQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA 659
Q + + + L ++ +Q ARG+EYL +HRD+ + N ++DE
Sbjct: 112 QFIRSPQRNPTVKDL-----ISFGLQVARGMEYLAEQKF---VHRDLAARNCMLDESFTV 163
Query: 660 RVADFGLS-LLGPAD----SSSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGV 710
+VADFGL+ + + A LP A E + + TTKSDV+SFGV
Sbjct: 164 KVADFGLARDILDREYYSVQQHRHARLPVKWTA-------LESLQTYRFTTKSDVWSFGV 216
Query: 711 LLLEILS 717
LL E+L+
Sbjct: 217 LLWELLT 223
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 66/225 (29%), Positives = 103/225 (45%), Gaps = 35/225 (15%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG----TVVAVK--KAIATSDRQKNSKEFHTEL 563
F E +G+G F CVY G L D AVK I +F TE
Sbjct: 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD---IGEVSQFLTEG 77
Query: 564 DLLSRLNHAHLLNLLGYCEEGRE-RLLVYEFMAHGSLHQHLHGKSKALK-EQLDWVRRVT 621
++ +H ++L+LLG C L+V +M HG L + ++ + L +
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IG 132
Query: 622 IAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPAD----SSS 676
+Q A+G++YL +HRD+ + N ++DE+ +VADFGL+ + + +
Sbjct: 133 FGLQVAKGMKYLASKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189
Query: 677 PLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
A+LP A E + TTKSDV+SFGVLL E+++
Sbjct: 190 TGAKLPVKWMA-------LESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 31/223 (13%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVL-----KDGTVVAVKKAIATSDRQKNSKEFHTELD 564
+ E F +++GKG+F V G VVAVKK +++ ++F E++
Sbjct: 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 94
Query: 565 LLSRLNHAHLLNLLGYCEEGRER--LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI 622
+L L H +++ G C R L+ E++ +GSL +L KE++D ++ +
Sbjct: 95 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQY 150
Query: 623 AVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS----SSPL 678
Q +G+EYL IHRD+ + NIL++ E+ ++ DFGL+ + P D
Sbjct: 151 TSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 679 AELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
E P A PE + SDV+SFGV+L E+ +
Sbjct: 208 GESPIFWYA-------PESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLS 567
E++ F +E+G G F V G + VA+K K + S EF E ++
Sbjct: 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-----EDEFIEEAKVMM 74
Query: 568 RLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAA 627
L+H L+ L G C + R ++ E+MA+G L +L + ++ + + + +
Sbjct: 75 NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVC 130
Query: 628 RGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD--SSSPLAELP- 682
+EYL + +HRD+ + N L++++ +V+DFGLS D +SS ++ P
Sbjct: 131 EAMEYLESKQF-----LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPV 185
Query: 683 ---AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
PE ++KSD+++FGVL+ EI S
Sbjct: 186 RWSP-------PEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 64/223 (28%), Positives = 106/223 (47%), Gaps = 31/223 (13%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLK-----DGTVVAVKKAIATSDRQKNSKEFHTELD 564
+ E F +++GKG+F V G VVAVKK +++ ++F E++
Sbjct: 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHL--RDFEREIE 63
Query: 565 LLSRLNHAHLLNLLGYCEEGRER--LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI 622
+L L H +++ G C R L+ E++ +GSL +L KE++D ++ +
Sbjct: 64 ILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQY 119
Query: 623 AVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS----SSPL 678
Q +G+EYL IHRD+ + NIL++ E+ ++ DFGL+ + P D
Sbjct: 120 TSQICKGMEYLGTKRY---IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 679 AELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
E P A PE + SDV+SFGV+L E+ +
Sbjct: 177 GESPIFWYA-------PESLTESKFSVASDVWSFGVVLYELFT 212
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-36
Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 34/221 (15%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLS 567
L + +GKG F V G + G VAVK K AT+ + F E +++
Sbjct: 17 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA------QAFLAEASVMT 69
Query: 568 RLNHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQA 626
+L H++L+ LLG E + L +V E+MA GSL +L + + L + ++
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDV 126
Query: 627 ARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP-- 682
+EYL + + +HRD+ + N+L+ E++ A+V+DFGL+ A S+ +LP
Sbjct: 127 CEAMEYLEGNNF-----VHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKLPVK 179
Query: 683 --AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
A PE R +TKSDV+SFG+LL EI S GR
Sbjct: 180 WTA-------PEALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 3e-36
Identities = 73/289 (25%), Positives = 129/289 (44%), Gaps = 36/289 (12%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTV-VAVKKAIATSDRQKNSKEFHTELDLLSR 568
E+ER K ++G G + VY+GV K ++ VAVK + + EF E ++
Sbjct: 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKE 272
Query: 569 LNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQA 626
+ H +L+ LLG C ++ EFM +G+L +L + + L + +A Q
Sbjct: 273 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL-----LYMATQI 327
Query: 627 ARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAG 684
+ +EYL IHR++ + N L+ E H +VADFGLS + G ++ A+ P
Sbjct: 328 SSAMEYLEKKNF---IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP-- 382
Query: 685 TLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKA--IDMQFEEGNIVEWAVPLIKSG 742
+ + PE + + KSDV++FGVLL EI + + + + L++
Sbjct: 383 -IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKD 435
Query: 743 DITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
++ +++ + C + +RPS ++ A E
Sbjct: 436 Y---------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 475
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 66/328 (20%), Positives = 135/328 (41%), Gaps = 32/328 (9%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEF-HTELDLLSRLNHAHLLNL 577
+++G+GSF +DG +K+ I S +E E+ +L+ + H +++
Sbjct: 30 QKIGEGSFGKAILVKSTEDGRQYVIKE-INISRMSSKEREESRREVAVLANMKHPNIVQY 88
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHG-KSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
EE +V ++ G L + ++ K +E VQ ++++H
Sbjct: 89 RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD----WFVQICLALKHVHD- 143
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
++HRDIKS NI + ++ ++ DFG++ + +S+ LA GT YL PE
Sbjct: 144 --RKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPEICEN 199
Query: 697 HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756
KSD+++ G +L E+ + + A FE G++ V I SG +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHA----FEAGSMKN-LVLKIISGSFP-------PVSL 247
Query: 757 DL-DALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTEVVLGS 815
L+ + + + + ++RPS++ + LE+ ++ E L +
Sbjct: 248 HYSYDLRSLVS---QLFKRNPRDRPSVNSI---LEKGFIAKRIEKFLSPQLIAEEFCLKT 301
Query: 816 NRMHKKSSQRSSNRSTSETDVAEAEDQR 843
+ ++ + ++ Q+
Sbjct: 302 FSKFGSQPIPAKRPASGQNSISVMPAQK 329
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 6e-36
Identities = 70/217 (32%), Positives = 109/217 (50%), Gaps = 33/217 (15%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLS 567
L + +GKG F V G + G VAVK K AT+ + F E +++
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA------QAFLAEASVMT 241
Query: 568 RLNHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQA 626
+L H++L+ LLG E + L +V E+MA GSL +L + + L + ++
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDV 298
Query: 627 ARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP-- 682
+EYL + + +HRD+ + N+L+ E++ A+V+DFGL+ A S+ +LP
Sbjct: 299 CEAMEYLEGNNF-----VHRDLAARNVLVSEDNVAKVSDFGLT--KEASSTQDTGKLPVK 351
Query: 683 --AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
A PE R +TKSDV+SFG+LL EI S
Sbjct: 352 WTA-------PEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-36
Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 39/233 (16%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG------TVVAVKKAIATSDRQKNSKEFHTEL 563
++R K E+G+G+F V+ + +VAVK S+ + +F E
Sbjct: 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ--DFQREA 94
Query: 564 DLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL----------HGKSKALKEQ 613
+LL+ L H H++ G C EGR L+V+E+M HG L++ L G
Sbjct: 95 ELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 614 LDWVRRVTIAVQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLG 670
L + + +A Q A G+ YL + +HRD+ + N L+ + ++ DFG+S +
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHF-----VHRDLATRNCLVGQGLVVKIGDFGMSRDIY 209
Query: 671 PAD--SSSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
D LP PE TT+SDV+SFGV+L EI +
Sbjct: 210 STDYYRVGGRTMLPIRWMP-------PESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 9e-36
Identities = 65/236 (27%), Positives = 109/236 (46%), Gaps = 43/236 (18%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG------TVVAVK--KAIATSDRQKNSKEFHT 561
E+ + F EE+G+ F VYKG L VA+K K A ++ EF
Sbjct: 5 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE---EFRH 61
Query: 562 ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKS-----------KAL 610
E L +RL H +++ LLG + + +++ + +HG LH+ L +S + +
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 611 KEQLDWVRRVTIAVQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS- 667
K L+ V + Q A G+EYL H +H+D+ + N+L+ ++ N +++D GL
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFR 176
Query: 668 LLGPAD--SSSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ AD + LP A PE + SD++S+GV+L E+ S
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMA-------PEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 63/245 (25%), Positives = 105/245 (42%), Gaps = 62/245 (25%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG------TVVAVKKAIATSDRQKNSKEFHTEL 563
++R K E+G+G+F V+ + +VAVK + + +F E
Sbjct: 11 HIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK--DFQREA 68
Query: 564 DLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL-----------HGKSKALKE 612
+LL+ L H H++ G C +G ++V+E+M HG L++ L G+ + K
Sbjct: 69 ELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 613 QLDWVRRVTIAVQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670
+L + + IA Q A G+ YL + +HRD+ + N L+ ++ DFG+S
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHF-----VHRDLATRNCLVGANLLVKIGDFGMSRD- 182
Query: 671 PADSSSPLAELPAGTLGYLDPEYYR----------------LHY--LTTKSDVYSFGVLL 712
+YYR + Y TT+SDV+SFGV+L
Sbjct: 183 -----------------VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 225
Query: 713 LEILS 717
EI +
Sbjct: 226 WEIFT 230
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-35
Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 518 FKEEVGKGSFSCVYKGVLKDG-----TVVAVK--KAIATSDRQKNSKEFHTELDLLSRLN 570
+ +G G+F VYKG+ VA+K + + K +KE E +++ ++
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVD 75
Query: 571 HAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
+ H+ LLG C L+ + M G L ++ K+ + + VQ A+G+
Sbjct: 76 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGM 130
Query: 631 EYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADS--SSPLAELP--- 682
YL +HRD+ + N+L+ + ++ DFGL+ LLG + + ++P
Sbjct: 131 NYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 683 -AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
A E T +SDV+S+GV + E+++ G K
Sbjct: 186 MA-------LESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-35
Identities = 73/328 (22%), Positives = 132/328 (40%), Gaps = 39/328 (11%)
Query: 502 RAQMFTYE---ELERATGGFKEEVGKGSFSCVYKGVLK-----DGTVVAVK--KAIATSD 551
AQ++ + E + ++GKG+F V G +VAVK +
Sbjct: 8 HAQLYACQDPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ 67
Query: 552 RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRER--LLVYEFMAHGSLHQHLHGKSKA 609
+ ++F E+ +L L+ ++ G + LV E++ G L L
Sbjct: 68 Q----RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH--- 120
Query: 610 LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669
+ +LD R + + Q +G+EYL C +HRD+ + NIL++ E + ++ADFGL+ L
Sbjct: 121 -RARLDASRLLLYSSQICKGMEYLGSRRC---VHRDLAARNILVESEAHVKIADFGLAKL 176
Query: 670 GPADS----SSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
P D + P A PE + + +SDV+SFGV+L E+ + K
Sbjct: 177 LPLDKDYYVVREPGQSPIFWYA-------PESLSDNIFSRQSDVWSFGVVLYELFTYCDK 229
Query: 721 AIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERP 780
+ E ++ + + +L+ +LP+ + + C ++RP
Sbjct: 230 SCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP 289
Query: 781 SMDKVTTALERALAQLMGSPCSEQPILP 808
S + L+ + G P
Sbjct: 290 SFSALGPQLDMLWSGSRGCETHAFTAHP 317
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 3e-35
Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 37/272 (13%)
Query: 465 CQCSGKASKSQKTNGAGSPYQKDNGKIRPDFDDL--KIRRAQMFTYEELERATGGFKEEV 522
C ++ K G+ + Y + + D L ++ +A F E +
Sbjct: 38 CSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVI 97
Query: 523 GKGSFSCVYKGVLKDG----TVVAVK--KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
G+G F CVY G L D AVK I +F TE ++ +H ++L+
Sbjct: 98 GRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD---IGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 577 LLGYCEEGRE-RLLVYEFMAHGSLHQHLHGKSKALK-EQLDWVRRVTIAVQAARGIEYLH 634
LLG C L+V +M HG L + ++ + L + +Q A+G+++L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL-----IGFGLQVAKGMKFLA 209
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAE----LP----AGT 685
+HRD+ + N ++DE+ +VADFGL+ + + S + LP A
Sbjct: 210 SKKF---VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA-- 264
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
E + TTKSDV+SFGVLL E+++
Sbjct: 265 -----LESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 62/230 (26%), Positives = 110/230 (47%), Gaps = 40/230 (17%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG----TVVAVK--KAIATSDRQKNSKEFHTEL 563
E+E + ++ +G G V G L+ VA+K KA T + ++F +E
Sbjct: 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE---RQRRDFLSEA 101
Query: 564 DLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIA 623
++ + +H +++ L G GR ++V E+M +GSL L Q ++ V +
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTH----DGQFTIMQLVGML 157
Query: 624 VQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS----SSP 677
G+ YL GY +HRD+ + N+L+D +V+DFGLS + D ++
Sbjct: 158 RGVGAGMRYLSDLGY-----VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT 212
Query: 678 LAELP----AGTLGYLDPE--YYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
++P A PE +R + ++ SDV+SFGV++ E+L+ G +
Sbjct: 213 GGKIPIRWTA-------PEAIAFR-TF-SSASDVWSFGVVMWEVLAYGER 253
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 66/313 (21%), Positives = 114/313 (36%), Gaps = 50/313 (15%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
F +++G+G FS V L DG A+K+ + + + E E D+ NH ++L
Sbjct: 33 FIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE--EAQREADMHRLFNHPNILR 90
Query: 577 LLGYCEE----GRERLLVYEFMAHGSLHQHL---HGKSKALKEQLDWVRRVTIAVQAARG 629
L+ YC E L+ F G+L + K L E + + RG
Sbjct: 91 LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL----WLLLGICRG 146
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPA---- 683
+E +H HRD+K +NIL+ +E + D G + S L
Sbjct: 147 LEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 684 -GTLGYLDPE---YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLI 739
T+ Y PE + ++DV+S G +L ++ G ++ +V L
Sbjct: 204 RCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP----YDMVFQKGDSVALA 259
Query: 740 KSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGS 799
++ P + S L L + + + +RP + L+
Sbjct: 260 VQNQLSIPQSP--RHSSALWQL--LN----SMMTVDPHQRPHIP-----------LLLSQ 300
Query: 800 PCSEQPILPTEVV 812
+ QP P +
Sbjct: 301 LEALQPPAPGQHT 313
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-34
Identities = 74/290 (25%), Positives = 129/290 (44%), Gaps = 40/290 (13%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
E+ R + + ++G+G F V+ G T VA+K + + + F E ++ +L
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKL 236
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAA 627
H L+ L E +V E+M+ GSL L QL V +A Q A
Sbjct: 237 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIA 290
Query: 628 RGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPA 683
G+ Y+ Y +HRD++++NIL+ E +VADFGL+ + ++ A+ P
Sbjct: 291 SGMAYVERMNY-----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP- 344
Query: 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKA--IDMQFEEGNIVEWAVPLIKS 741
+ + PE T KSDV+SFG+LL E+ + + M E + ++
Sbjct: 345 --IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVER 396
Query: 742 GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
G ++P + + + ++ C+C R +ERP+ + + LE
Sbjct: 397 GY---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 437
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 62/218 (28%), Positives = 108/218 (49%), Gaps = 36/218 (16%)
Query: 519 KEEVGKGSFSCVYKGVLKDG---TVVAVK--KAIATSDRQKNSKEFHTELDLLSRLNHAH 573
E+G G+F V +GV + VA+K K + +++E E ++ +L++ +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPY 71
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
++ L+G C+ +LV E G LH+ L GK +E++ + Q + G++YL
Sbjct: 72 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYL 126
Query: 634 --HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADS---SSPLAELP----A 683
+ +HRD+ + N+L+ H A+++DFGLS LG DS + + P A
Sbjct: 127 EEKNF-----VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181
Query: 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
PE +++SDV+S+GV + E LS G+K
Sbjct: 182 -------PECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 57/228 (25%), Positives = 98/228 (42%), Gaps = 37/228 (16%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG-----TVVAVK--KAIATSDRQKNSKEFHTE 562
+ + +G G F V+KGV V +K + + ++ +
Sbjct: 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR---QSFQAVTDH 65
Query: 563 LDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI 622
+ + L+HAH++ LLG C LV +++ GSL H+ + L +
Sbjct: 66 MLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQH----RGALGPQLLLNW 120
Query: 623 AVQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS---SSP 677
VQ A+G+ YL HG +HR++ + N+L+ +VADFG++ L P D
Sbjct: 121 GVQIAKGMYYLEEHGM-----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS 175
Query: 678 LAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
A+ P A E T +SDV+S+GV + E+++ G +
Sbjct: 176 EAKTPIKWMA-------LESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-34
Identities = 57/237 (24%), Positives = 111/237 (46%), Gaps = 53/237 (22%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTV-----VAVK--KAIATSDRQKNSKEFHTE 562
E+ + ++ +G G F VYKG+LK + VA+K KA +++Q+ +F E
Sbjct: 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-GYTEKQR--VDFLGE 96
Query: 563 LDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI 622
++ + +H +++ L G + + +++ E+M +G+L + L K + ++ V +
Sbjct: 97 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK----DGEFSVLQLVGM 152
Query: 623 AVQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAE 680
A G++YL Y +HRD+ + NIL++ +V+DFGLS + D
Sbjct: 153 LRGIAAGMKYLANMNY-----VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP------ 201
Query: 681 LPAGTLGYLDPEYYR--------------LHY--LTTKSDVYSFGVLLLEILS-GRK 720
+ Y + Y T+ SDV+SFG+++ E+++ G +
Sbjct: 202 ---------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLS 567
E+ R T E +G G F V+ G T VAVK K + S F E +L+
Sbjct: 9 EVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-----PDAFLAEANLMK 63
Query: 568 RLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAA 627
+L H L+ L + ++ E+M +GSL L S +L + + +A Q A
Sbjct: 64 QLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIA 119
Query: 628 RGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELP- 682
G+ ++ Y IHRD++++NIL+ + + ++ADFGL+ + ++ A+ P
Sbjct: 120 EGMAFIEERNY-----IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174
Query: 683 ---AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
A PE T KSDV+SFG+LL EI++
Sbjct: 175 KWTA-------PEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-34
Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 36/228 (15%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLK----DGTVVAVK--KAIATSDRQKNSKEFHTEL 563
EL+ + VG G F V G LK VA+K K T K ++F E
Sbjct: 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTE---KQRRDFLGEA 97
Query: 564 DLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIA 623
++ + +H +++ L G + + ++V E+M +GSL L Q ++ V +
Sbjct: 98 SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH----DAQFTVIQLVGML 153
Query: 624 VQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAE- 680
A G++YL GY +HRD+ + NILI+ +V+DFGL + D +
Sbjct: 154 RGIASGMKYLSDMGY-----VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR 208
Query: 681 ---LP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
+P + PE T+ SDV+S+G++L E++S G +
Sbjct: 209 GGKIPIRWTS-------PEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 3e-34
Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 37/230 (16%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG------TVVAVK--KAIATSDRQKNSKEFHT 561
E+ R +G G+F VY+G + VAVK + S++ + +F
Sbjct: 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE--LDFLM 82
Query: 562 ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRR 619
E ++S+ NH +++ +G + R ++ E MA G L L + L +
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 620 VTIAVQAARGIEYL--HGYACPPVIHRDIKSSNILID---EEHNARVADFGLS-LLGPAD 673
+ +A A G +YL + + IHRDI + N L+ A++ DFG++ + A
Sbjct: 143 LHVARDIACGCQYLEENHF-----IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS 197
Query: 674 --SSSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
A LP PE + T+K+D +SFGVLL EI S
Sbjct: 198 YYRKGGCAMLPVKWMP-------PEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 66/242 (27%), Positives = 104/242 (42%), Gaps = 47/242 (19%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG------TVVAVK--KAIATSDRQKNSKEFHT 561
E R + +G+G F V K T VAVK K A+ + + +
Sbjct: 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELR---DLLS 75
Query: 562 ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL------------------ 603
E ++L ++NH H++ L G C + LL+ E+ +GSL L
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 604 -HGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVA 662
+ L ++ A Q ++G++YL A ++HRD+ + NIL+ E +++
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKIS 192
Query: 663 DFGLS-LLGPAD--SSSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEI 715
DFGLS + D +P A E H TT+SDV+SFGVLL EI
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMA-------IESLFDHIYTTQSDVWSFGVLLWEI 245
Query: 716 LS 717
++
Sbjct: 246 VT 247
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 57/229 (24%), Positives = 89/229 (38%), Gaps = 37/229 (16%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLK----DGTVVAVK--KAIATSDRQKNSKEFHTEL 563
+ E++G GSF V +G VAVK K S + +F E+
Sbjct: 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQ-PEAMDDFIREV 72
Query: 564 DLLSRLNHAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI 622
+ + L+H +L+ L G + +V E GSL L +
Sbjct: 73 NAMHSLDHRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLRKH----QGHFLLGTLSRY 126
Query: 623 AVQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADS---SS 676
AVQ A G+ YL + IHRD+ + N+L+ ++ DFGL L D
Sbjct: 127 AVQVAEGMGYLESKRF-----IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQ 181
Query: 677 PLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
++P A PE + + SD + FGV L E+ + G++
Sbjct: 182 EHRKVPFAWCA-------PESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-34
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 31/218 (14%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
E+ R + ++++G G F V+ T VAVK S + F E +++ L
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKTL 240
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAA 627
H L+ L + ++ EFMA GSL L SK +L + + Q A
Sbjct: 241 QHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL-----IDFSAQIA 294
Query: 628 RGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELP- 682
G+ ++ Y IHRD++++NIL+ ++ADFGL+ + ++ A+ P
Sbjct: 295 EGMAFIEQRNY-----IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI 349
Query: 683 ---AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
A PE T KSDV+SFG+LL+EI++
Sbjct: 350 KWTA-------PEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-34
Identities = 71/268 (26%), Positives = 117/268 (43%), Gaps = 58/268 (21%)
Query: 484 YQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDG----- 538
YQ+ + P L+ R +E + ++G+G+F V++
Sbjct: 28 YQRMPLLLNPKLLSLEYPR------NNIE-----YVRDIGEGAFGRVFQARAPGLLPYEP 76
Query: 539 -TVVAVK--KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595
T+VAVK K A++D Q +F E L++ ++ +++ LLG C G+ L++E+MA
Sbjct: 77 FTMVAVKMLKEEASADMQA---DFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133
Query: 596 HGSLHQHLHGKSKALKEQLDWVRR-------------------VTIAVQAARGIEYLHGY 636
+G L++ L S L + IA Q A G+ YL
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPAD--SSSPLAELP----AGTLGYL 689
+HRD+ + N L+ E ++ADFGLS + AD + +P
Sbjct: 194 KF---VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMP------ 244
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILS 717
PE + TT+SDV+++GV+L EI S
Sbjct: 245 -PESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 78/320 (24%), Positives = 127/320 (39%), Gaps = 38/320 (11%)
Query: 471 ASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCV 530
+SQ G P + +RPD + + + ++G+G FS V
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMG-----YNTLANFRIEK--------KIGRGQFSEV 48
Query: 531 YKGV-LKDGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588
Y+ L DG VA+KK I K + E+DLL +LNH +++ E E
Sbjct: 49 YRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108
Query: 589 LVYEFMAHGSLHQHL--HGKSKA-LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRD 645
+V E G L + + K K + E+ W VQ +E++H V+HRD
Sbjct: 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWK----YFVQLCSALEHMHSRR---VMHRD 161
Query: 646 IKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDV 705
IK +N+ I ++ D GL S + A GT Y+ PE + KSD+
Sbjct: 162 IKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDI 219
Query: 706 YSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIA 765
+S G LL E+ + + ++ N+ I+ D + P +L
Sbjct: 220 WSLGCLLYEMAALQSP--FYGDKMNLYS-LCKKIEQCDYPPL--PSDHYSEEL------R 268
Query: 766 NVACKCVRMRGKERPSMDKV 785
+ C+ ++RP + V
Sbjct: 269 QLVNMCINPDPEKRPDVTYV 288
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-34
Identities = 74/290 (25%), Positives = 128/290 (44%), Gaps = 40/290 (13%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
E+ R + + ++G+G F V+ G T VA+K + + F E ++ +L
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKL 319
Query: 570 NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAA 627
H L+ L E +V E+M+ GSL L QL V +A Q A
Sbjct: 320 RHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIA 373
Query: 628 RGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPA 683
G+ Y+ Y +HRD++++NIL+ E +VADFGL+ + ++ A+ P
Sbjct: 374 SGMAYVERMNY-----VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP- 427
Query: 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKA--IDMQFEEGNIVEWAVPLIKS 741
+ + PE T KSDV+SFG+LL E+ + + M E + ++
Sbjct: 428 --IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVER 479
Query: 742 GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
G ++P + + + ++ C+C R +ERP+ + + LE
Sbjct: 480 GY---------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 520
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 8e-34
Identities = 55/245 (22%), Positives = 100/245 (40%), Gaps = 65/245 (26%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKD--------GTVVAVK--KAIATSDRQKNSKEF 559
++ F E +G+G+F+ ++KGV ++ T V +K + + F
Sbjct: 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS----ESF 59
Query: 560 HTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR 619
++S+L+H HL+ G C G E +LV EF+ GSL +L K ++ + +
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN----KNCINILWK 115
Query: 620 VTIAVQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNAR--------VADFGLSLL 669
+ +A Q A + +L + IH ++ + NIL+ E + + ++D G+S+
Sbjct: 116 LEVAKQLAAAMHFLEENTL-----IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT 170
Query: 670 GPADSSSPLAELPAGTLGYLDPEYYR----------LHY---LTTKSDVYSFGVLLLEIL 716
L + + + L +D +SFG L EI
Sbjct: 171 ------------------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212
Query: 717 S-GRK 720
S G K
Sbjct: 213 SGGDK 217
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 9e-34
Identities = 64/237 (27%), Positives = 108/237 (45%), Gaps = 42/237 (17%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKD--------GTVVAVK--KAIATSDRQKNSKEF 559
E R + +G+G+F V VAVK K AT +
Sbjct: 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS---DL 87
Query: 560 HTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL-----------HGKS 607
+E++++ + H +++NLLG C + ++ E+ + G+L ++L + +
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 608 KALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
+ +EQ+ + V+ Q ARG+EYL A IHRD+ + N+L+ E + ++ADFGL+
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 668 -LLGPADS--SSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ D + LP A PE T +SDV+SFGVL+ EI +
Sbjct: 205 RDINNIDYYKKTTNGRLPVKWMA-------PEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 518 FKEEVGKGSFSCVYKGVLKDG-----TVVAVK--KAIATSDRQKNSKEFHTELDLLSRLN 570
+ +G G+F VYKG+ VA+K + + K +KE E +++ ++
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS---PKANKEILDEAYVMASVD 75
Query: 571 HAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
+ H+ LLG C L+ + M G L ++ K+ + + VQ A+G+
Sbjct: 76 NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGM 130
Query: 631 EYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADS--SSPLAELP--- 682
YL +HRD+ + N+L+ + ++ DFGL+ LLG + + ++P
Sbjct: 131 NYLEDRRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185
Query: 683 -AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
A E T +SDV+S+GV + E+++ G K
Sbjct: 186 MA-------LESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-33
Identities = 61/228 (26%), Positives = 97/228 (42%), Gaps = 33/228 (14%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG------TVVAVK--KAIATSDRQKNSKEFHT 561
E+ R +G G+F VY+G + VAVK + S++ + +F
Sbjct: 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE--LDFLM 123
Query: 562 ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRR 619
E ++S+ NH +++ +G + R ++ E MA G L L + L +
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID---EEHNARVADFGLS-LLGPAD-- 673
+ +A A G +YL IHRDI + N L+ A++ DFG++ + A
Sbjct: 184 LHVARDIACGCQYLEENHF---IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY 240
Query: 674 SSSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
A LP PE + T+K+D +SFGVLL EI S
Sbjct: 241 RKGGCAMLPVKWMP-------PEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 32/214 (14%)
Query: 521 EVGKGSFSCVYKGVLKDG---TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
E+G G+F V KG + VAVK ++ E E +++ +L++ +++ +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL--HG 635
+G CE +LV E G L+++L + + + + Q + G++YL
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEESN 137
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS----SSPLAELP----AGTLG 687
+ +HRD+ + N+L+ +H A+++DFGLS AD + + P A
Sbjct: 138 F-----VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA---- 188
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
PE + ++KSDV+SFGVL+ E S G+K
Sbjct: 189 ---PECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 61/237 (25%), Positives = 98/237 (41%), Gaps = 57/237 (24%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG----TVVAVK--KAIATSDRQKNSKEFHTEL 563
+ R +G+G F VY+GV + VAVK K T N ++F +E
Sbjct: 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT---LDNKEKFMSEA 64
Query: 564 DLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIA 623
++ L+H H++ L+G EE ++ E +G L +L + K L + V +
Sbjct: 65 VIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYS 119
Query: 624 VQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAEL 681
+Q + + YL +HRDI NIL+ ++ DFGLS
Sbjct: 120 LQICKAMAYLESINC-----VHRDIAVRNILVASPECVKLGDFGLSRY------------ 162
Query: 682 PAGTLGYLDPEYYR---------------LHY--LTTKSDVYSFGVLLLEILS-GRK 720
D +YY+ +++ TT SDV+ F V + EILS G++
Sbjct: 163 ------IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 69/233 (29%), Positives = 106/233 (45%), Gaps = 38/233 (16%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKD------GTVVAVK--KAIATSDRQKNSKEFHT 561
E R F + +G G+F V + VAVK K+ A +D ++ +
Sbjct: 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKE---ALMS 98
Query: 562 ELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR- 619
EL ++S L H +++NLLG C G L++ E+ +G L L KS+ L+ +
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 620 --------VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671
+ + Q A+G+ +L A IHRD+ + N+L+ H A++ DFGL+
Sbjct: 159 STASTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 672 ADS---SSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
DS A LP A PE T +SDV+S+G+LL EI S
Sbjct: 216 NDSNYIVKGNARLPVKWMA-------PESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 69/263 (26%), Positives = 111/263 (42%), Gaps = 52/263 (19%)
Query: 483 PYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKD----- 537
P + ++ D + R + L+ + +G+G+F V +
Sbjct: 7 PLDEHCERLPYDASKWEFPR------DRLK-----LGKPLGRGAFGQVIEADAFGIDKTA 55
Query: 538 -GTVVAVK--KAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYC-EEGRERLLVYE 592
VAVK K AT + +EL +L + +H +++NLLG C + G +++ E
Sbjct: 56 TCRTVAVKMLKEGATH---SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 112
Query: 593 FMAHGSLHQHL-----------HGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPV 641
F G+L +L K+ L + + Q A+G+E+L A
Sbjct: 113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKC 169
Query: 642 IHRDIKSSNILIDEEHNARVADFGLS-LLGPAD--SSSPLAELP----AGTLGYLDPEYY 694
IHRD+ + NIL+ E++ ++ DFGL+ + A LP A PE
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA-------PETI 222
Query: 695 RLHYLTTKSDVYSFGVLLLEILS 717
T +SDV+SFGVLL EI S
Sbjct: 223 FDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 42/214 (19%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE-FHTELDLLSRLNH--AHLLN 576
+++G G S V++ + + + A+K + + + + + E+ L++L ++
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKY-VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L Y + +V E + L+ L K K++ + + +H +
Sbjct: 93 LYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDP--WERKS--YWKNMLEAVHTIHQH 146
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE---- 692
++H D+K +N LI + ++ DFG++ D++S + + GT+ Y+ PE
Sbjct: 147 G---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 202
Query: 693 -------YYRLHYLTTKSDVYSFGVLLLEILSGR 719
++ KSDV+S G +L + G+
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 64/237 (27%), Positives = 107/237 (45%), Gaps = 42/237 (17%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKD--------GTVVAVK--KAIATSDRQKNSKEF 559
E R + +G+G F V VAVK K AT +
Sbjct: 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS---DL 133
Query: 560 HTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL-----------HGKS 607
+E++++ + H +++NLLG C + ++ E+ + G+L ++L + +
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193
Query: 608 KALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
+ +EQ+ + V+ Q ARG+EYL A IHRD+ + N+L+ E + ++ADFGL+
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
Query: 668 -LLGPADS--SSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ D + LP A PE T +SDV+SFGVL+ EI +
Sbjct: 251 RDINNIDYYKKTTNGRLPVKWMA-------PEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 71/237 (29%), Positives = 113/237 (47%), Gaps = 42/237 (17%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKD--------GTVVAVK--KAIATSDRQKNSKEF 559
EL R + +G+G+F V T VAVK K+ AT K+ +
Sbjct: 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE---KDLSDL 121
Query: 560 HTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL-----------HGKS 607
+E++++ + H +++NLLG C + ++ E+ + G+L ++L + S
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 608 KALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
+EQL V+ A Q ARG+EYL A IHRD+ + N+L+ E++ ++ADFGL+
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
Query: 668 -LLGPADS--SSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ D + LP A PE T +SDV+SFGVLL EI +
Sbjct: 239 RDIHHIDYYKKTTNGRLPVKWMA-------PEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 35/226 (15%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG----TVVAVK--KAIATSDRQKNSKEFHTEL 563
E++R +G+G F V++G+ VA+K K + ++F E
Sbjct: 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSD---SVREKFLQEA 67
Query: 564 DLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIA 623
+ + +H H++ L+G E ++ E G L L + K LD + A
Sbjct: 68 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFL----QVRKYSLDLASLILYA 122
Query: 624 VQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLA 679
Q + + YL + +HRDI + N+L+ ++ DFGLS + +
Sbjct: 123 YQLSTALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 177
Query: 680 ELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
+LP A PE T+ SDV+ FGV + EIL G K
Sbjct: 178 KLPIKWMA-------PESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 54/236 (22%), Positives = 96/236 (40%), Gaps = 19/236 (8%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
+G GS+ K DG ++ K+ S + + +E++LL L H +++
Sbjct: 12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 579 G-YCEEGRERL-LVYEFMAHGSLHQHLHGKSKA---LKEQLDWVRRVTIAVQAARGIEYL 633
+ L +V E+ G L + +K L E+ + Q ++
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----RVMTQLTLALKEC 127
Query: 634 H--GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
H V+HRD+K +N+ +D + N ++ DFGL+ + + + A+ GT Y+ P
Sbjct: 128 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKTFVGTPYYMSP 185
Query: 692 EYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747
E KSD++S G LL E+ + F + E I+ G I
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKE-LAGKIREGKFRRI 236
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 7e-33
Identities = 54/204 (26%), Positives = 86/204 (42%), Gaps = 16/204 (7%)
Query: 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNL 577
+G GS+ V+K K DG + AVK++++ K+ E+ ++ H + L
Sbjct: 63 SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRL 122
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
EEG L E SL QH +L E W + +LH
Sbjct: 123 EQAWEEGGILYLQTEL-CGPSLQQHCEAWGASLPEAQVW----GYLRDTLLALAHLHSQG 177
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYYRL 696
++H D+K +NI + ++ DFGL LG A E+ G Y+ PE +
Sbjct: 178 ---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG----AGEVQEGDPRYMAPELLQG 230
Query: 697 HYLTTKSDVYSFGVLLLEILSGRK 720
Y T +DV+S G+ +LE+ +
Sbjct: 231 SY-GTAADVFSLGLTILEVACNME 253
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 42/214 (19%), Positives = 92/214 (42%), Gaps = 25/214 (11%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE-FHTELDLLSRLNH--AHLLN 576
+++G G S V++ + + + A+K + + + + + E+ L++L ++
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKY-VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L Y + +V E + L+ L K K++ + + +H +
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDP--WERKS--YWKNMLEAVHTIHQH 127
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE---- 692
++H D+K +N LI + ++ DFG++ D++S + + GT+ Y+ PE
Sbjct: 128 G---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 693 -------YYRLHYLTTKSDVYSFGVLLLEILSGR 719
++ KSDV+S G +L + G+
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 63/237 (26%), Positives = 97/237 (40%), Gaps = 42/237 (17%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKD------GTVVAVK--KAIATSDRQKNSKEFHT 561
E R F + +G G+F V + VAVK K A ++ +
Sbjct: 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE---ALMS 75
Query: 562 ELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR- 619
EL +LS L NH +++NLLG C G L++ E+ +G L L K +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 620 ------------VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
++ + Q A+G+ +L C IHRD+ + NIL+ ++ DFGL+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNC---IHRDLAARNILLTHGRITKICDFGLA 192
Query: 668 -LLGPAD--SSSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+ A LP A PE T +SDV+S+G+ L E+ S
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMA-------PESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-32
Identities = 64/278 (23%), Positives = 122/278 (43%), Gaps = 39/278 (14%)
Query: 459 RYRLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGF 518
L + + + ++ + + P D +++ +
Sbjct: 284 IDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKK---LFLKRDNLLIA 340
Query: 519 KEEVGKGSFSCVYKGVLKDG---TVVAVK--KAIATSDRQKNSKEFHTELDLLSRLNHAH 573
E+G G+F V +GV + VA+K K + +++E E ++ +L++ +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE---KADTEEMMREAQIMHQLDNPY 397
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
++ L+G C+ +LV E G LH+ L GK +E++ + Q + G++YL
Sbjct: 398 IVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYL 452
Query: 634 --HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADS---SSPLAELP----A 683
+ +HR++ + N+L+ H A+++DFGLS LG DS + + P A
Sbjct: 453 EEKNF-----VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 507
Query: 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRK 720
PE +++SDV+S+GV + E LS G+K
Sbjct: 508 -------PECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-32
Identities = 63/242 (26%), Positives = 99/242 (40%), Gaps = 47/242 (19%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG------TVVAVK--KAIATSDRQKNSKEFHT 561
E R F + +G G+F V VAVK K A S ++ +
Sbjct: 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE---ALMS 97
Query: 562 ELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR- 619
EL ++++L +H +++NLLG C L++E+ +G L +L K + E
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ 157
Query: 620 -----------------VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVA 662
+ A Q A+G+E+L +HRD+ + N+L+ ++
Sbjct: 158 KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKIC 214
Query: 663 DFGLS-LLGPAD--SSSPLAELP----AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEI 715
DFGL+ + A LP A PE T KSDV+S+G+LL EI
Sbjct: 215 DFGLARDIMSDSNYVVRGNARLPVKWMA-------PESLFEGIYTIKSDVWSYGILLWEI 267
Query: 716 LS 717
S
Sbjct: 268 FS 269
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-32
Identities = 41/214 (19%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE-FHTELDLLSRLNH--AHLLN 576
+++G G S V++ + + + A+K + + + + + E+ L++L ++
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKY-VNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L Y + +V E + L+ L K K++ + + +H +
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDP--WERKS--YWKNMLEAVHTIHQH 174
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE---- 692
++H D+K +N LI + ++ DFG++ D++S + + G + Y+ PE
Sbjct: 175 G---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 693 -------YYRLHYLTTKSDVYSFGVLLLEILSGR 719
++ KSDV+S G +L + G+
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 26/218 (11%)
Query: 510 ELERATGGFKEEVGKGSFSCVYKGVLKDG----TVVAVK--KAIATSDRQKNSKEFHTEL 563
E++R +G+G F V++G+ VA+K K + ++F E
Sbjct: 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD---SVREKFLQEA 442
Query: 564 DLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIA 623
+ + +H H++ L+G E ++ E G L L + K LD + A
Sbjct: 443 LTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVR----KFSLDLASLILYA 497
Query: 624 VQAARGIEYL--HGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLA 679
Q + + YL + +HRDI + N+L+ ++ DFGLS + +
Sbjct: 498 YQLSTALAYLESKRF-----VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG 552
Query: 680 ELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
+LP + ++ PE T+ SDV+ FGV + EIL
Sbjct: 553 KLP---IKWMAPESINFRRFTSASDVWMFGVCMWEILM 587
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 43/231 (18%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+G+G+F V K D A+KK I ++ + +E+ LL+ LNH +++
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKK-IRHTEEKL--STILSEVMLLASLNHQYVVR 66
Query: 577 LLG-YCEEGRERL------------LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIA 623
+ E + E+ +G+L+ +H ++ + W +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR----LF 122
Query: 624 VQAARGIEYLH--GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAEL 681
Q + Y+H G +IHRD+K NI IDE N ++ DFGL+ +
Sbjct: 123 RQILEALSYIHSQG-----IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 682 PA------------GTLGYLDPE--YYRLHYLTTKSDVYSFGVLLLEILSG 718
GT Y+ E HY K D+YS G++ E++
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHY-NEKIDMYSLGIIFFEMIYP 227
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 57/286 (19%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E +G G F V+K DG +K+ + + N+++ E+ L++L+H ++++
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKR-V-----KYNNEKAEREVKALAKLDHVNIVHYN 70
Query: 579 GYCEEGRERL----------------LVYEFMAHGSLHQHLHG-KSKALKEQLDWVRRVT 621
G + + EF G+L Q + + + L + L
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL----E 126
Query: 622 IAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAE 680
+ Q +G++Y+H +I+RD+K SNI + + ++ DFGL L +
Sbjct: 127 LFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSL----KNDGKRT 179
Query: 681 LPAGTLGYLDPE-YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLI 739
GTL Y+ PE Y + D+Y+ G++L E+L FE +
Sbjct: 180 RSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDT---AFETSKFFT----DL 231
Query: 740 KSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
+ G I+ I D K + K + + ++RP+ ++
Sbjct: 232 RDGIISDIFDKKEK------------TLLQKLLSKKPEDRPNTSEI 265
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 523 GKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHT--ELDLLSRLNHAHLLNLLG 579
GKG F VY K ++A+K + + +K E E+++ S L H ++L L G
Sbjct: 18 GKGKFGNVYLAREKQSKFILALK-VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
Y + L+ E+ G++++ L K EQ R T + A + Y H
Sbjct: 77 YFHDATRVYLILEYAPLGTVYRELQ-KLSKFDEQ----RTATYITELANALSYCHSKR-- 129
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYL 699
VIHRDIK N+L+ ++ADFG S+ P+ + L GTL YL PE
Sbjct: 130 -VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL----CGTLDYLPPEMIEGRMH 184
Query: 700 TTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
K D++S GVL E L G+ FE E
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPP----FEANTYQE 214
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 61/330 (18%), Positives = 122/330 (36%), Gaps = 66/330 (20%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLL 566
+E ++ +G+G F V++ K D A+K+ I +R+ ++ E+ L
Sbjct: 7 FEPIQC--------LGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKAL 57
Query: 567 SRLNHAHLLNLLGYCEEG---------RERLLVY---EFMAHGSLHQHLHGKSKALKEQL 614
++L H ++ E ++ +Y + +L + + E+
Sbjct: 58 AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEER 115
Query: 615 DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPA 672
+ + I +Q A +E+LH ++HRD+K SNI + +V DFGL +
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172
Query: 673 DSSSPLAELPA--------GTLGYLDPE-YYRLHYLTTKSDVYSFGVLLLEILSGRKAID 723
+ + L +PA GT Y+ PE + Y + K D++S G++L E+L
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELL------- 224
Query: 724 MQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMD 783
F + +++ + + + + + ERP
Sbjct: 225 YPFSTQMERVRTLTDVRNLKFPPLFT---QKYPCEYVMVQ------DMLSPSPMERPEAI 275
Query: 784 KVTTALERALAQLMGSPCSEQPILPTEVVL 813
++ + E P + VL
Sbjct: 276 -----------NIIENAVFEDLDFPGKTVL 294
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 58/215 (26%), Positives = 91/215 (42%), Gaps = 19/215 (8%)
Query: 523 GKGSFSCVYKGV-LKDGTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
GKGSF+ VY+ + G VA+K K + E+ + +L H +L L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMV--QRVQNEVKIHCQLKHPSILELY 77
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
Y E+ LV E +G ++++L + K E R Q G+ YLH +
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE--ARH--FMHQIITGMLYLHSHG- 132
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
++HRD+ SN+L+ N ++ADFGL+ GT Y+ PE
Sbjct: 133 --ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISPEIATRSA 188
Query: 699 LTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
+SDV+S G + +L GR F+ +
Sbjct: 189 HGLESDVWSLGCMFYTLLIGR----PPFDTDTVKN 219
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 2e-29
Identities = 38/218 (17%), Positives = 74/218 (33%), Gaps = 20/218 (9%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIAT-SDRQKNSKEFHTELDLLSRLN---HAH 573
+G+G+F+ VY+ D K+ + N EF+ L+ RL
Sbjct: 69 VHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHM 128
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
+ +LV E ++G+L ++ ++ + ++ A++ IE +
Sbjct: 129 FMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQV 188
Query: 634 HGYACPPVIHRDIKSSNILI-----------DEEHNARVADFGLSLLGPADSSSPLAELP 682
H +IH DIK N ++ D + D G S+ +
Sbjct: 189 HDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK 245
Query: 683 AGTLGYLDPE-YYRLHYLTTKSDVYSFGVLLLEILSGR 719
T G+ E + + D + + +L G
Sbjct: 246 CETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGT 282
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 20/214 (9%)
Query: 523 GKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHT--ELDLLSRLNHAHLLNLLG 579
GKG F VY K ++A+K + S +K E E+++ S L H ++L +
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALK-VLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
Y + + L+ EF G L++ L K EQ R T + A + Y H
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQ-KHGRFDEQ----RSATFMEELADALHYCHERK-- 134
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYL 699
VIHRDIK N+L+ + ++ADFG S+ P+ + GTL YL PE
Sbjct: 135 -VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM----CGTLDYLPPEMIEGKTH 189
Query: 700 TTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
K D++ GVL E L G F+ + E
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP----FDSPSHTE 219
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 7e-29
Identities = 62/332 (18%), Positives = 128/332 (38%), Gaps = 52/332 (15%)
Query: 519 KEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLN 576
+ + +G F+ VY+ + G A+K+ + +++ +KN + E+ + +L H +++
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGREYALKR-LLSNEEEKN-RAIIQEVCFMKKLSGHPNIVQ 90
Query: 577 LLGYCEEGRER-------LLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAA 627
G+E L+ + G L + L L D V + I Q
Sbjct: 91 FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC--DTVLK--IFYQTC 146
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS---LLGPADSSSPLAELPA- 683
R ++++H PP+IHRD+K N+L+ + ++ DFG + P S S
Sbjct: 147 RAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 684 ------GTLGYLDPE---YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEW 734
T Y PE Y + K D+++ G +L + + FE+G +
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDGAKL-- 259
Query: 735 AVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794
I++ +P ++ +++ +ER S+ +V + + L
Sbjct: 260 -----------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV---VHQ-LQ 304
Query: 795 QLMGSPCSEQPILPTEVVLGSNRMHKKSSQRS 826
++ + TE++ + + R
Sbjct: 305 EIAAARNVNPKSPITELLEQNGGYGSATLSRG 336
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 63/263 (23%), Positives = 106/263 (40%), Gaps = 27/263 (10%)
Query: 466 QCSGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYE---ELERATGGFKEEV 522
Q AS ++ + + Q+ + + L + + YE E+ T V
Sbjct: 9 QAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQ--PRV 66
Query: 523 GKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYC 581
G+GSF V++ + G AVKK R + EL + L+ ++ L G
Sbjct: 67 GRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYG-A 118
Query: 582 EEGRERLLVY-EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640
+ ++ E + GSL Q + + L E QA G+EYLH
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIK-QMGCLPEDR--ALYYL--GQALEGLEYLHTRR--- 170
Query: 641 VIHRDIKSSNILIDEE-HNARVADFGLSL-LGPADSSSPLAELPA--GTLGYLDPEYYRL 696
++H D+K+ N+L+ + A + DFG +L L P L GT ++ PE
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230
Query: 697 HYLTTKSDVYSFGVLLLEILSGR 719
K D++S ++L +L+G
Sbjct: 231 KPCDAKVDIWSSCCMMLHMLNGC 253
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-28
Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 23/211 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLN 576
K+ +G G+ + + D VAVK+ I + E+ LL + H +++
Sbjct: 28 PKDVLGHGAEGTIVYRGMFDNRDVAVKR-ILPECFSFADR----EVQLLRESDEHPNVIR 82
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
++ + + + E A +L +++ K A +T+ Q G+ +LH
Sbjct: 83 YFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL----EPITLLQQTTSGLAHLHSL 137
Query: 637 ACPPVIHRDIKSSNILIDEEHN-----ARVADFGLS-LLGPADSSSPLAELPAGTLGYLD 690
++HRD+K NILI + A ++DFGL L S GT G++
Sbjct: 138 N---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194
Query: 691 PEYYRLHY---LTTKSDVYSFGVLLLEILSG 718
PE T D++S G + ++S
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+ +G+G+ + V++G K G + A+K + E ++L +LNH +++
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 577 LLGYCEEGRERL--LVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEY 632
L EE R L+ EF GSL+ L + L E V G+ +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE--FLIVLR--DVVGGMNH 127
Query: 633 LHGYACPPVIHRDIKSSNILI----DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGY 688
L ++HR+IK NI+ D + ++ DFG + + L GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSL-YGTEEY 181
Query: 689 LDPEYYRLHYLTT--------KSDVYSFGVLLLEILSGR 719
L P+ Y L D++S GV +G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 19/205 (9%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
+GKG++ VY G L + +A+K+ I D + S+ H E+ L L H +++ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKE-IPERD-SRYSQPLHEEIALHKHLKHKNIVQYLG- 86
Query: 581 CEEGRERLLVY-EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
+ ++ E + GSL L K LK+ + T Q G++YLH
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYT--KQILEGLKYLHDNQ-- 142
Query: 640 PVIHRDIKSSNILIDEEH-NARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEYYRL 696
++HRDIK N+LI+ +++DFG S L G + GTL Y+ PE
Sbjct: 143 -IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF----TGTLQYMAPEIIDK 197
Query: 697 HYL--TTKSDVYSFGVLLLEILSGR 719
+D++S G ++E+ +G+
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGK 222
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+++G G S VY VA+K + + F E+ S+L+H ++++
Sbjct: 17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVS 75
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
++ EE LV E++ +L +++ L + Q GI++ H
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP-----LSVDTAINFTNQILDGIKHAHDM 130
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA--GTLGYLDPEYY 694
++HRDIK NILID ++ DFG++ A S + L + GT+ Y PE
Sbjct: 131 R---IVHRDIKPQNILIDSNKTLKIFDFGIAK---ALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGR 719
+ +D+YS G++L E+L G
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGE 209
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 52/219 (23%), Positives = 86/219 (39%), Gaps = 28/219 (12%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+ +G+G+ + V++G K G + A+K + E ++L +LNH +++
Sbjct: 13 LSDILGQGATANVFRGRHKKTGDLFAIKV-FNNISFLRPVDVQMREFEVLKKLNHKNIVK 71
Query: 577 LLGYCEEGRERL--LVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEY 632
L EE R L+ EF GSL+ L + L E V G+ +
Sbjct: 72 LFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESE--FLIVLR--DVVGGMNH 127
Query: 633 LHGYACPPVIHRDIKSSNILI----DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGY 688
L ++HR+IK NI+ D + ++ DFG + + L GT Y
Sbjct: 128 LRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSL-YGTEEY 181
Query: 689 LDPEYYRLHYLTT--------KSDVYSFGVLLLEILSGR 719
L P+ Y L D++S GV +G
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 43/218 (19%), Positives = 79/218 (36%), Gaps = 29/218 (13%)
Query: 523 GKGSFSCVYKGVLKDGTVVAVK---KAIATSDRQKNSKEFHT------------ELDLLS 567
+G F+ + KD A+K K++ R EL +++
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 568 RLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV--- 624
+ + + L G E ++YE+M + S+ + L + + +
Sbjct: 99 DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDE-YFFVLDKNYTCFIPIQVIKCII 157
Query: 625 -QAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA 683
Y+H + HRD+K SNIL+D+ +++DFG S +
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMV----DKKIKGSR 211
Query: 684 GTLGYLDPE--YYRLHYLTTKSDVYSFGVLLLEILSGR 719
GT ++ PE Y K D++S G+ L +
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 23/234 (9%), Positives = 51/234 (21%), Gaps = 41/234 (17%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNS-KEFHTELDLLSRLNHAHLL 575
E + G S V+ + A+K ++ ++ + H +RL
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125
Query: 576 NLLGYC--------------------------EEGRERLLVYEFMAHGSLHQ--HLHGKS 607
LL+ + L
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV 184
Query: 608 KALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
+ + + Q R L ++H N+ I + + D
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA- 240
Query: 668 LLGPADSSSPLAELPAGTLGYLDPEYYRLH--YLTTKSDVYSFGVLLLEILSGR 719
+ + Y E+ T + + G+ + +
Sbjct: 241 ----LWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 523 GKGSFSCVYKGV-LKDGTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
GKG F+ ++ V A K K++ Q+ ++ E+ + L H H++
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSLAHQHVVGFH 107
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
G+ E+ +V E SL LH + KAL E R Q G +YLH
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPE--ARY--YLRQIVLGCQYLHRNR- 161
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE--YYRL 696
VIHRD+K N+ ++E+ ++ DFGL+ D ++ GT Y+ PE +
Sbjct: 162 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKG 217
Query: 697 HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
H + + DV+S G ++ +L G+ FE + E
Sbjct: 218 H--SFEVDVWSIGCIMYTLLVGK----PPFETSCLKE 248
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 36/242 (14%), Positives = 72/242 (29%), Gaps = 52/242 (21%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVK----KAIATSDRQKNSKE---------------- 558
+G+ + + G V S+ K KE
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 559 ------FHTELDLLSRLNHAHLLNLLGYCEEG--RERLLVYEFMAH--GSLHQHLHGKSK 608
F DL+ ++ + + R +Y M + + L S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 609 ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668
+ L R+ + +Q R + LH Y ++H ++ +I++D+ + F +
Sbjct: 199 -THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 254
Query: 669 LGPADSSSPLAELPAGTLGYLDPEY-----------YRLHYLTTKSDVYSFGVLLLEILS 717
A S + G+ PE R +T D ++ G+++ I
Sbjct: 255 RDGARVVSS------VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 718 GR 719
Sbjct: 309 AD 310
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 24/217 (11%)
Query: 523 GKGSFSCVYKGV-LKDGTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
GKG F+ ++ V A K K++ Q+ ++ E+ + L H H++
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQR--EKMSMEISIHRSLAHQHVVGFH 81
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
G+ E+ +V E SL LH + KAL E R Q G +YLH
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLL-ELHKRRKALTEPE--ARY--YLRQIVLGCQYLHRNR- 135
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE--YYRL 696
VIHRD+K N+ ++E+ ++ DFGL+ D ++ GT Y+ PE +
Sbjct: 136 --VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKG 191
Query: 697 HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
H + + DV+S G ++ +L G+ FE + E
Sbjct: 192 H--SFEVDVWSIGCIMYTLLVGK----PPFETSCLKE 222
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 5e-26
Identities = 48/225 (21%), Positives = 85/225 (37%), Gaps = 38/225 (16%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNL 577
E++G G F V+K V DG + A+K++ + + E+ + L H+H++
Sbjct: 17 EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRY 76
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHL---HGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
E L+ E+ GSL + + KE + +Q RG+ Y+H
Sbjct: 77 FSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD----LLLQVGRGLRYIH 132
Query: 635 GYACPPVIHRDIKSSNILIDEE-------------------HNARVADFGLSLLGPADSS 675
+ ++H DIK SNI I ++ D G S
Sbjct: 133 SMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV----TRIS 185
Query: 676 SPLAELPAGTLGYLDPEYYRLHYL-TTKSDVYSFGVLLLEILSGR 719
SP E G +L E + +Y K+D+++ + ++
Sbjct: 186 SPQVE--EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 7e-26
Identities = 55/214 (25%), Positives = 87/214 (40%), Gaps = 23/214 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
KE +G G F V + + +D G VA+K+ KN + + E+ ++ +LNH ++++
Sbjct: 18 MKERLGTGGFGYVLRWIHQDTGEQVAIKQ-CRQELSPKNRERWCLEIQIMKKLNHPNVVS 76
Query: 577 LL------GYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAAR 628
LL E+ G L ++L LKE +R + +
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE--GPIRT--LLSDISS 132
Query: 629 GIEYLHGYACPPVIHRDIKSSNILIDEEHNAR---VADFGLSLLGPADSSSPLAELPAGT 685
+ YLH +IHRD+K NI++ + D G + L GT
Sbjct: 133 ALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGT 186
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
L YL PE T D +SFG L E ++G
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 44/214 (20%), Positives = 78/214 (36%), Gaps = 24/214 (11%)
Query: 520 EEVGKG--SFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+GKG V G V V++ + + EL + NH +++
Sbjct: 31 TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHL-HGKSKALKEQLDWVRRVTIAV---QAARGIEY 632
E +V FMA+GS + + E IA + ++Y
Sbjct: 91 YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-------IAYILQGVLKALDY 143
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPA---GTLG 687
+H +HR +K+S+ILI + ++ + ++ + + P L
Sbjct: 144 IHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 688 YLDPE--YYRLHYLTTKSDVYSFGVLLLEILSGR 719
+L PE L KSD+YS G+ E+ +G
Sbjct: 201 WLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 19/209 (9%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
E +G G S V+ L+D VAVK +A D + F E + LNH ++
Sbjct: 18 EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVA 76
Query: 577 LLGYCEE-GRERLLVY---EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+ E L Y E++ +L +H + + R + + A + + +
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNF 131
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA--GTLGYLD 690
H +IHRD+K +NI+I + +V DFG++ ADS + + + A GT YL
Sbjct: 132 SHQNG---IIHRDVKPANIMISATNAVKVMDFGIA-RAIADSGNSVTQTAAVIGTAQYLS 187
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
PE R + +SDVYS G +L E+L+G
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 19/227 (8%)
Query: 494 DFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDR 552
F K + + ++ E+ E+G G+ V+K K G V+A K
Sbjct: 19 AFLTQKQKVGE-LKDDDFEKI-----SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP 72
Query: 553 QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKE 612
+ EL +L N +++ G E + E M GSL Q L K+ + E
Sbjct: 73 AIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK-KAGRIPE 130
Query: 613 QLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672
+ +V+IAV +G+ YL ++HRD+K SNIL++ ++ DFG+S G
Sbjct: 131 --QILGKVSIAV--IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS--GQL 182
Query: 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
S +A GT Y+ PE + + + +SD++S G+ L+E+ GR
Sbjct: 183 IDS--MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 57/255 (22%), Positives = 108/255 (42%), Gaps = 21/255 (8%)
Query: 473 KSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFK------EEVGKGS 526
+ K +G D+D + + + +E G EE+G G+
Sbjct: 4 SHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGA 63
Query: 527 FSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR 585
F V++ V K G V K I T + E+ ++++L+H L+NL E+
Sbjct: 64 FGVVHRCVEKATGRVFVAK-FINTP-YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 121
Query: 586 ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRD 645
E +L+ EF++ G L + + + E + QA G++++H ++ ++H D
Sbjct: 122 EMVLILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQACEGLKHMHEHS---IVHLD 174
Query: 646 IKSSNILI--DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKS 703
IK NI+ + + ++ DFGL+ + + T + PE + +
Sbjct: 175 IKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVT-TATAEFAAPEIVDREPVGFYT 231
Query: 704 DVYSFGVLLLEILSG 718
D+++ GVL +LSG
Sbjct: 232 DMWAIGVLGYVLLSG 246
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 59/254 (23%), Positives = 109/254 (42%), Gaps = 30/254 (11%)
Query: 473 KSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFT--YEELERATGGFKEEVGKGSFSCV 530
++G + Y + + + P + + Y+ +++G G++ V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPG--MFITSKKGHLSEMYQ--------RVKKLGSGAYGEV 53
Query: 531 YKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588
K A+K I + ++ + E+ +L L+H +++ L + E+ R
Sbjct: 54 LLCRDKVTHVERAIKI-IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY 112
Query: 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKS 648
LV E G L + + K E I Q G+ YLH + ++HRD+K
Sbjct: 113 LVMECYKGGELFDEIIHRMK-FNEV----DAAVIIKQVLSGVTYLHKHN---IVHRDLKP 164
Query: 649 SNILI---DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDV 705
N+L+ +++ ++ DFGLS + ++ + E GT Y+ PE R Y K DV
Sbjct: 165 ENLLLESKEKDALIKIVDFGLSAV--FENQKKMKER-LGTAYYIAPEVLRKKY-DEKCDV 220
Query: 706 YSFGVLLLEILSGR 719
+S GV+L +L+G
Sbjct: 221 WSIGVILFILLAGY 234
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 53/275 (19%), Positives = 90/275 (32%), Gaps = 53/275 (19%)
Query: 54 FCGLKSDRSHLVTCYGSNSA--IIYGTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSG 111
LK + V +G+N + + AG+ L + WG +
Sbjct: 36 GLALKGGK---VLGWGANLNGQLTMPAATQSGVDAIAAGNYHSLAL--KDGEVIAWGGNE 90
Query: 112 YIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQ- 170
Q VP G I+AG + L+ GK V WG + DGQ
Sbjct: 91 DGQTTVPAEARSGV--DAIAAGAWASYALK---DGK------VIAWGDD------SDGQT 133
Query: 171 ---------IESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQKVAAGGYH 221
+ ++ G + +N V WGD + + VA G +H
Sbjct: 134 TVPAEAQSGVTALDGGVYTALAV--KNGGVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFH 191
Query: 222 VCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYD 281
+ +G + WG + +Q V + +I G++++ +K +
Sbjct: 192 SLALKDG---KVIAWGDN----------RYKQTTVPTEALSGVSAIASGEWYSLALK--N 236
Query: 282 RGVICWGFIIKPSTPVPTGIKVYEIAAGNYFTCGV 316
VI WG + V +G+ I AG +
Sbjct: 237 GKVIAWGSSRTAPSSVQSGVS--SIEAGPNAAYAL 269
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 51/262 (19%), Positives = 89/262 (33%), Gaps = 49/262 (18%)
Query: 105 YCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKN 164
WG + P + I+ G +H L+ GK V WG N+
Sbjct: 5 VAWGGNNDWGEA-TVPAEAQSGVDAIAGGYFHGLALK---GGK------VLGWGANL--- 51
Query: 165 YVFDGQ----------IESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQK 214
+GQ +++I+AG+ + L ++ V WG +
Sbjct: 52 ---NGQLTMPAATQSGVDAIAAGNYHSLAL--KDGEVIAWGGNEDGQTTVPAEARSGVDA 106
Query: 215 VAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHA 274
+AAG + + +G + WG Q V + ++ GG + A
Sbjct: 107 IAAGAWASYALKDG---KVIAWGDD----------SDGQTTVPAEAQSGVTALDGGVYTA 153
Query: 275 CGIKSYDRGVICWGFIIKPSTPVPTGI--KVYEIAAGNYFTCGVLAEKSMLPVCWGTGFP 332
+K + GVI WG T VP V ++A G + + L + + + WG
Sbjct: 154 LAVK--NGGVIAWGDNYFGQTTVPAEAQSGVDDVAGGIFHSL-ALKDGKV--IAWGDNRY 208
Query: 333 TSLPLAVSPGLCKMTPCAPGYY 354
+ L ++ A G +
Sbjct: 209 KQTTVPT-EALSGVSAIASGEW 229
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 4e-15
Identities = 38/197 (19%), Positives = 64/197 (32%), Gaps = 40/197 (20%)
Query: 43 IAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGTPAH-FPFIGLTAGDGFVCGLLLDS 101
AI+ G LK + V +G +S PA + G + L + +
Sbjct: 105 DAIAAGAWA--SYALKDGK---VIAWGDDSDGQTTVPAEAQSGVTALDGGVYTA-LAVKN 158
Query: 102 NQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNM 161
WG + + Q VP G +++ G +H L+ GK V WG N
Sbjct: 159 GGVIAWGDNYFGQTTVPAEAQSGV--DDVAGGIFHSLALK---DGK------VIAWGDNR 207
Query: 162 TKNYVFDGQ----------IESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMK 211
Q + +I++G ++ L +N V WG ++
Sbjct: 208 ------YKQTTVPTEALSGVSAIASGEWYSLAL--KNGKVIAWGSSRTAPSSVQSG---- 255
Query: 212 FQKVAAGGYHVCGILEG 228
+ AG + G
Sbjct: 256 VSSIEAGPNAAYALKGG 272
|
| >3qhy_B Beta-lactamase inhibitory protein II; enyzme-inhibitor complex, beta-propeller, protein:protein interaction; 2.06A {Streptomyces exfoliatus} PDB: 3qi0_A 1jtd_B Length = 282 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 30/154 (19%), Positives = 52/154 (33%), Gaps = 21/154 (13%)
Query: 190 TVFCWGDESSSRVISL-IPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSV 248
+V WG + ++ + +A G +H + G + WG +
Sbjct: 3 SVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLALKGG---KVLGWGAN--------- 50
Query: 249 AYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGI--KVYEI 306
+ S + +I G +H+ +K D VI WG T VP V I
Sbjct: 51 LNGQLTMPAATQSG-VDAIAAGNYHSLALK--DGEVIAWGGNEDGQTTVPAEARSGVDAI 107
Query: 307 AAGNYFTCGVLAEKSMLPVCWGTGFPTSLPLAVS 340
AAG + + L + + + WG +
Sbjct: 108 AAGAWASY-ALKDGKV--IAWGDDSDGQTTVPAE 138
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 50/205 (24%), Positives = 84/205 (40%), Gaps = 17/205 (8%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVK--KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
VG+G VY+ +VA+K +SD ++ E RL H++
Sbjct: 40 RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTR-MQREARTAGRLQEPHVVP 98
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
+ + E + + + L L + L R V I Q ++ H
Sbjct: 99 IHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP-----LAPPRAVAIVRQIGSALDAAHAA 153
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA--GTLGYLDPEYY 694
HRD+K NIL+ + A + DFG++ A + L +L GTL Y+ PE +
Sbjct: 154 G---ATHRDVKPENILVSADDFAYLVDFGIAS---ATTDEKLTQLGNTVGTLYYMAPERF 207
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGR 719
+ T ++D+Y+ +L E L+G
Sbjct: 208 SESHATYRADIYALTCVLYECLTGS 232
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 3e-24
Identities = 68/396 (17%), Positives = 131/396 (33%), Gaps = 62/396 (15%)
Query: 520 EEVGKGSFSCVYKGV--LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+ G +Y + +G V +K + + D + + E L+ + H ++ +
Sbjct: 86 GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM-AMAERQFLAEVVHPSIVQI 144
Query: 578 LGYCEEGRERL-----LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+ E +V E++ SL + K L + ++ + Y
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSY 197
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
LH +++ D+K NI++ EE ++ D G +S L GT G+ PE
Sbjct: 198 LHS---IGLVYNDLKPENIMLTEEQ-LKLIDLGAV--SRINSFGYL----YGTPGFQAPE 247
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752
R T +D+Y+ G L + G V+ DPVL
Sbjct: 248 IVR-TGPTVATDIYTVGRTLAALTLDL-----PTRNGRYVDGLPE----------DDPVL 291
Query: 753 KLPSDLDALKRIANVACKCVRMRGKERP-SMDKVTTALERALAQLMGSPCSEQPILPTEV 811
K L + + + ++R + ++++ L L +++
Sbjct: 292 KTYDSYGRL-----LR-RAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGL--- 342
Query: 812 VLGSNRMHKKSSQRSSNRSTSETDVAEAE-DQRFEFRAPSWITFPSVTSSQRRKSSVSDA 870
S+ S +RST D+ A D + + + + + V
Sbjct: 343 ----------STIFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALSVPLVDPT 392
Query: 871 DVDGKNLEARNMGNAGSIGDGLRSLEEEIGPASPQE 906
DV L+A + D LR+ A +
Sbjct: 393 DVAASVLQATVLSQPVQTLDSLRAARHGALDADGVD 428
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-24
Identities = 52/226 (23%), Positives = 83/226 (36%), Gaps = 34/226 (15%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLN 576
++ +G GS V G VAVK+ + E+ LL+ +H +++
Sbjct: 19 SEKILGYGSSGTVVFQGSFQGRPVAVKR-M---LIDFCDIALM-EIKLLTESDDHPNVIR 73
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
R + E +L + S + +++ Q A G+ +LH
Sbjct: 74 YYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 635 GYACPPVIHRDIKSSNILID-------------EEHNARVADFGLSLLGPADSSSPLAEL 681
+IHRD+K NIL+ E ++DFGL + SS L
Sbjct: 133 SLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189
Query: 682 --PAGTLGYLDPE-------YYRLHYLTTKSDVYSFGVLLLEILSG 718
P+GT G+ PE LT D++S G + ILS
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS--DRQKNSKEFHTELDLLSRLNHAHL 574
+ +GKGSF V K G AVK I+ ++ + + E+ LL +L+H ++
Sbjct: 30 GQRVLGKGSFGEVILCKDKITGQECAVKV-ISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 575 LNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
+ L + E+ LV E G L + + + E I Q GI Y+H
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR-FSEV----DAARIIRQVLSGITYMH 143
Query: 635 GYACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
++HRD+K N+L+ ++ N R+ DFGLS ++S + + GT Y+ P
Sbjct: 144 KNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDK-IGTAYYIAP 197
Query: 692 EYYRLHYLTTKSDVYSFGVLLLEILSGR 719
E Y K DV+S GV+L +LSG
Sbjct: 198 EVLHGTY-DEKCDVWSTGVILYILLSGC 224
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 53/248 (21%), Positives = 83/248 (33%), Gaps = 50/248 (20%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAH 573
K +G+GS+ V + + A+K K K+ + TE+ L+ +L+H +
Sbjct: 30 LKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV--------- 624
+ L E+ + LV E G L L+ + T
Sbjct: 90 IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149
Query: 625 -------------------QAAR-------GIEYLHGYACPPVIHRDIKSSNILIDEEHN 658
+ + YLH + HRDIK N L +
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKS 206
Query: 659 ARV--ADFGLSLLGPADSSSPLAEL--PAGTLGYLDPE---YYRLHYLTTKSDVYSFGVL 711
+ DFGLS ++ + AGT ++ PE Y K D +S GVL
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVL 265
Query: 712 LLEILSGR 719
L +L G
Sbjct: 266 LHLLLMGA 273
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELD-LLSRLNHAHLLNL 577
E+G+G++ V K G ++AVK+ AT + Q+ K +LD + ++ +
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQ-KRLLMDLDISMRTVDCPFTVTF 71
Query: 578 LGYCEEGRERLLVYEFMAHGSLH---QHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
G + + E M SL + + K + + E D + + IAV + +E+LH
Sbjct: 72 YGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPE--DILGK--IAVSIVKALEHLH 126
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP--------AGTL 686
VIHRD+K SN+LI+ ++ DFG+S L AG
Sbjct: 127 SKL--SVIHRDVKPSNVLINALGQVKMCDFGIS-----------GYLVDDVAKDIDAGCK 173
Query: 687 GYLDPE-----YYRLHYLTTKSDVYSFGVLLLEILSGR 719
Y+ PE + Y + KSD++S G+ ++E+ R
Sbjct: 174 PYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILR 210
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 61/266 (22%), Positives = 104/266 (39%), Gaps = 31/266 (11%)
Query: 466 QCSGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATG--------G 517
+ + + K + D F + + G
Sbjct: 37 NEAKEVWSNADLTERMPVKSKRTSALAVDIP----APPAPFDHRIVTAKQGAVNSFYTVS 92
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
E +G G F V+K G +A K I T K+ +E E+ ++++L+HA+L+
Sbjct: 93 KTEILGGGRFGQVHKCEETATGLKLAAK-IIKTR-GMKDKEEVKNEISVMNQLDHANLIQ 150
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV--QAARGIEYLH 634
L E + +LV E++ G L + +S L E TI Q GI ++H
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTE------LDTILFMKQICEGIRHMH 204
Query: 635 GYACPPVIHRDIKSSNILI--DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
++H D+K NIL + ++ DFGL+ L GT +L PE
Sbjct: 205 QMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREKLKVN-FGTPEFLAPE 258
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSG 718
+++ +D++S GV+ +LSG
Sbjct: 259 VVNYDFVSFPTDMWSVGVIAYMLLSG 284
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 32/241 (13%), Positives = 67/241 (27%), Gaps = 51/241 (21%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVK--------------------------KAIATSDR 552
+G+ + + G V + I +
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 553 QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--RERLLVYEFMAHGSLHQHLHGKSKAL 610
K F DL+ ++ + + R +Y +L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP-RMQSNLQTFGEVLLSHS 202
Query: 611 KEQ--LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668
L R+ + +Q R + LH Y ++H ++ +I++D+ + F +
Sbjct: 203 STHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV 259
Query: 669 LGPADSSSPLAELPAGTLGYLDPEY----------YRLHYLTTKSDVYSFGVLLLEILSG 718
A + SP G+ PE + +T D ++ G+ + I
Sbjct: 260 RDGASAVSP------IGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 719 R 719
Sbjct: 314 D 314
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-23
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVK-----------KAIATSDRQKNSKEFHTELDL 565
++G G++ V K + A+K + + +K +E + E+ L
Sbjct: 40 KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99
Query: 566 LSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQ 625
L L+H +++ L E+ + LV EF G L + + + K E I Q
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK-FDEC----DAANIMKQ 154
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAELP 682
GI YLH + ++HRDIK NIL+ + N ++ DFGLS L +
Sbjct: 155 ILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRDR- 208
Query: 683 AGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
GT Y+ PE + Y K DV+S GV++ +L G
Sbjct: 209 LGTAYYIAPEVLKKKY-NEKCDVWSCGVIMYILLCGY 244
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 8e-23
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 18/207 (8%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLL 575
+GKGSF V K + AVK I + + K++ E++LL +L+H +++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKV-INKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L E+ +V E G L + + + E I Q GI Y+H
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKR-FSEH----DAARIIKQVFSGITYMHK 139
Query: 636 YACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
+ ++HRD+K NIL+ +++ + ++ DFGLS ++ + + GT Y+ PE
Sbjct: 140 HN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDR-IGTAYYIAPE 193
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSGR 719
R Y K DV+S GV+L +LSG
Sbjct: 194 VLRGTY-DEKCDVWSAGVILYILLSGT 219
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 9e-23
Identities = 57/261 (21%), Positives = 106/261 (40%), Gaps = 23/261 (8%)
Query: 468 SGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFK------EE 521
+ + + G + ++D+ + + + +E EE
Sbjct: 105 DERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEE 164
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGY 580
+G G+F V++ + G A K + T + + + E+ +S L H L+NL
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAK-FVMTP-HESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 581 CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640
E+ E +++YEFM+ G L + + + + E V Q +G+ ++H
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHNKMSED----EAVEYMRQVCKGLCHMHENN--- 275
Query: 641 VIHRDIKSSNILI--DEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
+H D+K NI+ + ++ DFGL+ L P S GT + PE
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT----TGTAEFAAPEVAEGK 331
Query: 698 YLTTKSDVYSFGVLLLEILSG 718
+ +D++S GVL +LSG
Sbjct: 332 PVGYYTDMWSVGVLSYILLSG 352
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-23
Identities = 54/212 (25%), Positives = 100/212 (47%), Gaps = 37/212 (17%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++GKGSF V+KG+ + VVA+K I + + ++ E+ +LS+ + ++
Sbjct: 28 EKIGKGSFGEVFKGIDNRTQKVVAIKI-IDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV---QAARGIEYLHG 635
G + + ++ E++ GS L + L E IA + +G++YLH
Sbjct: 87 GSYLKDTKLWIIMEYLGGGSALDLL--EPGPLDET-------QIATILREILKGLDYLHS 137
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA---------GTL 686
IHRDIK++N+L+ E ++ADFG++ +L GT
Sbjct: 138 EK---KIHRDIKAANVLLSEHGEVKLADFGVA-----------GQLTDTQIKRNTFVGTP 183
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
++ PE + +K+D++S G+ +E+ G
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARG 215
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-22
Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELD-LLSRLNHAHLLNL 577
E+G+G++ V K V K G ++AVK+ +T D ++ K+ +LD ++ + +++
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ-KQLLMDLDVVMRSSDCPYIVQF 86
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
G + + E M+ S + L + + I + + + +L
Sbjct: 87 YGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL 145
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAEL--------PAGTLGYL 689
+IHRDIK SNIL+D N ++ DFG+S +L AG Y+
Sbjct: 146 --KIIHRDIKPSNILLDRSGNIKLCDFGIS-----------GQLVDSIAKTRDAGCRPYM 192
Query: 690 DPE-----YYRLHYLTTKSDVYSFGVLLLEILSGR 719
PE R Y +SDV+S G+ L E+ +GR
Sbjct: 193 APERIDPSASRQGY-DVRSDVWSLGITLYELATGR 226
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 40/152 (26%), Positives = 76/152 (50%), Gaps = 16/152 (10%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E+G G+F VYK + G + A K + + ++ +++ E+++L+ +H +++ LL
Sbjct: 25 GELGDGAFGKVYKAKNKETGALAAAK--VIETKSEEELEDYIVEIEILATCDHPYIVKLL 82
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV---QAARGIEYLHG 635
G + ++ EF G++ + + L E I V Q + +LH
Sbjct: 83 GAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-------IQVVCRQMLEALNFLHS 135
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
+IHRD+K+ N+L+ E + R+ADFG+S
Sbjct: 136 KR---IIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 26/212 (12%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHA-- 572
+G G F VY G+ + D VA+K I+ N E+ LL +++
Sbjct: 49 PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108
Query: 573 HLLNLLGYCEEGRERLLVYEFMA-HGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARG 629
++ LL + E +L+ E L + G L+E+L R Q
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEEL--ARS--FFWQVLEA 161
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEH-NARVADFGLSLLGPADSSSPLAELPAGTLGY 688
+ + H V+HRDIK NILID ++ DFG L + GT Y
Sbjct: 162 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVY-TDFDGTRVY 214
Query: 689 LDPEYYRLH-YLTTKSDVYSFGVLLLEILSGR 719
PE+ R H Y + V+S G+LL +++ G
Sbjct: 215 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 41/204 (20%), Positives = 89/204 (43%), Gaps = 16/204 (7%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
E++G+G F V++ V K + + + E+ +L+ H ++L+
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKV--KGTDQVLVKKEISILNIARHRNILH 65
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L E E ++++EF++ + + ++ + L E+ V+ Q +++LH +
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTSAFELNER----EIVSYVHQVCEALQFLHSH 121
Query: 637 ACPPVIHRDIKSSNILIDEEHNARV--ADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
+ H DI+ NI+ ++ + +FG + L Y PE +
Sbjct: 122 N---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQ--LKPGDNFRLL-FTAPEYYAPEVH 175
Query: 695 RLHYLTTKSDVYSFGVLLLEILSG 718
+ ++T +D++S G L+ +LSG
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 3e-22
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 29/209 (13%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
E+G GSF VY +++ VVA+KK + + + ++ E+ L +L H + +
Sbjct: 60 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV---QAARGIEYLH 634
G LV E+ GS L K L+E IA A +G+ YLH
Sbjct: 120 RGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE-------IAAVTHGALQGLAYLH 171
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPE- 692
+ +IHRD+K+ NIL+ E ++ DFG + ++ PA+S GT ++ PE
Sbjct: 172 SHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-------VGTPYWMAPEV 221
Query: 693 ---YYRLHYLTTKSDVYSFGVLLLEILSG 718
Y K DV+S G+ +E+
Sbjct: 222 ILAMDEGQY-DGKVDVWSLGITCIELAER 249
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 50/215 (23%), Positives = 90/215 (41%), Gaps = 34/215 (15%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELD-LLSRLNHAHLLNLL 578
E+G G+ V+K + V K + S ++ +K +LD +L + +++
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCF 90
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
G + + E M + + E + ++T+A+ + + YL
Sbjct: 91 GTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPE--RILGKMTVAI--VKALYYLKEKH- 144
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP--------AGTLGYLD 690
VIHRD+K SNIL+DE ++ DFG+S L AG Y+
Sbjct: 145 -GVIHRDVKPSNILLDERGQIKLCDFGIS-----------GRLVDDKAKDRSAGCAAYMA 192
Query: 691 PE------YYRLHYLTTKSDVYSFGVLLLEILSGR 719
PE + Y ++DV+S G+ L+E+ +G+
Sbjct: 193 PERIDPPDPTKPDY-DIRADVWSLGISLVELATGQ 226
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 5e-22
Identities = 53/208 (25%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E +G G+ + V VA+K+ I Q + E E+ +S+ +H ++++
Sbjct: 21 EVIGSGATAVVQAAYCAPKKEKVAIKR-INLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV---QAARGIEYLHG 635
E LV + ++ GS+ + + + + TIA + G+EYLH
Sbjct: 80 TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELP-AGTLGYLDPE 692
IHRD+K+ NIL+ E+ + ++ADFG+S L D + GT ++ PE
Sbjct: 140 NG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 693 -YYRLHYLTTKSDVYSFGVLLLEILSGR 719
++ K+D++SFG+ +E+ +G
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGA 224
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 59/212 (27%), Positives = 95/212 (44%), Gaps = 30/212 (14%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLL 575
+GKGSF V K + AVK I + + K++ E++LL +L+H +++
Sbjct: 26 IVCMLGKGSFGEVLKCKDRITQQEYAVKV-INKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 576 NLLGYCEEGRERLLVYEFMAHGSL------HQHLHGKSKALKEQLDWVRRVTIAVQAARG 629
L E+ +V E G L + A I Q G
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-----------RIIKQVFSG 133
Query: 630 IEYLHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAELPAGTL 686
I Y+H + ++HRD+K NIL+ +++ + ++ DFGLS ++ + + GT
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDR-IGTA 187
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
Y+ PE R Y K DV+S GV+L +LSG
Sbjct: 188 YYIAPEVLRGTY-DEKCDVWSAGVILYILLSG 218
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 54/212 (25%), Positives = 101/212 (47%), Gaps = 38/212 (17%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+GS+ VYK + + G +VA+K+ + + +E E+ ++ + + H++
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQIVAIKQV----PVESDLQEIIKEISIMQQCDSPHVVKYY 90
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV---QAARGIEYLHG 635
G + + +V E+ GS+ + ++K L E IA +G+EYLH
Sbjct: 91 GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-------IATILQSTLKGLEYLHF 143
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA---------GTL 686
IHRDIK+ NIL++ E +A++ADFG++ +L GT
Sbjct: 144 MR---KIHRDIKAGNILLNTEGHAKLADFGVA-----------GQLTDTMAKRNTVIGTP 189
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
++ PE + +D++S G+ +E+ G
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEG 221
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 59/212 (27%), Positives = 85/212 (40%), Gaps = 24/212 (11%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLN---- 570
+GKG F V+ G L D VA+K + +S E+ LL ++
Sbjct: 37 PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96
Query: 571 HAHLLNLLGYCEEGRERLLVYEFMAHGS-LHQHLHGKSKALKEQLDWVRRVTIAVQAARG 629
H ++ LL + E +LV E L ++ K L E R Q
Sbjct: 97 HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-LGEGP--SRC--FFGQVVAA 151
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNA-RVADFGLSLLGPADSSSPLAELPAGTLGY 688
I++ H V+HRDIK NILID ++ DFG L P GT Y
Sbjct: 152 IQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH---DEPY-TDFDGTRVY 204
Query: 689 LDPEYYRLH-YLTTKSDVYSFGVLLLEILSGR 719
PE+ H Y + V+S G+LL +++ G
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-21
Identities = 48/368 (13%), Positives = 102/368 (27%), Gaps = 92/368 (25%)
Query: 32 RLVNGLGSMSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYG-----------TP- 79
++ L ++++ G + + + G +G TP
Sbjct: 60 TQLSALDGHQIVSVTCGADH--TVAYSQSGMEVYSW-GWGD---FGRLGHGNSSDLFTPL 113
Query: 80 -----AHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMG--------VPQPI--IKG 124
+ GD + + WG + Q+G VPQ I +G
Sbjct: 114 PIKALHGIRIKQIACGDSHCLAVT-MEGEVQSWGRNQNGQLGLGDTEDSLVPQKIQAFEG 172
Query: 125 AQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNM--------TKNY-------VFDG 169
+ ++AG H + + G + WG+ + G
Sbjct: 173 IRIKMVAAGAEHTAAVTE--DGD------LYGWGWGRYGNLGLGDRTDRLVPERVTSTGG 224
Query: 170 Q-IESISAGSEFNCGLFSQNRTVFCWGDESS------SRVISLIPKE------MKFQKVA 216
+ + ++ G + S + ++ +G LIP + +++
Sbjct: 225 EKMSMVACGWRHTISV-SYSGALYTYGWSKYGQLGHGDLEDHLIPHKLEALSNSFISQIS 283
Query: 217 AGGYHVCGILEGLDSRTRCWGRS----LDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKF 272
G H + D + WG + + + + Q V P ++ + G
Sbjct: 284 GGWRHTMALTS--DGKLYGWGWNKFGQVGVGNNLDQCSPVQ--VRFPDDQKVVQVSCGWR 339
Query: 273 HACGIKSYDRGVICWGF----------IIKPSTPVPTGIKVYEIAAGNYFTCGVLAEKSM 322
H + V WG + + P + A+G + + S
Sbjct: 340 HTLAVTE-RNNVFAWGRGTNGQLGIGESVDRNFPKIIEALSVDGASGQHIESSNIDPSSG 398
Query: 323 LPVCWGTG 330
W +
Sbjct: 399 K--SWVSP 404
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-20
Identities = 65/367 (17%), Positives = 115/367 (31%), Gaps = 108/367 (29%)
Query: 38 GSMSSIAISYGENGPVFC-----------GLKSDRSHLVTCYGSNSAIIYGTPAHFPFIG 86
G+ S+A+ V G DR + I +
Sbjct: 24 GASHSVALL--SGDIVCSWGRGEDGQLGHGDAEDRPSPTQLSALDGHQI---------VS 72
Query: 87 LTAGDGFVCGLLLDSNQPYCWGSSGYIQMG--------VPQPI--IKGAQYVEISAGDYH 136
+T G + Y WG + ++G P PI + G + +I+ GD H
Sbjct: 73 VTCGADHTVAYSQSGMEVYSWGWGDFGRLGHGNSSDLFTPLPIKALHGIRIKQIACGDSH 132
Query: 137 LCGLRKPLTGKWRNYSYVDCWGYNM--------TKNYVF--------DGQIESISAGSEF 180
+ G+ V WG N T++ + +I+ ++AG+E
Sbjct: 133 CLAVTM--EGE------VQSWGRNQNGQLGLGDTEDSLVPQKIQAFEGIRIKMVAAGAEH 184
Query: 181 NCGLFSQNRTVFCWGDESS------SRVISLIPKE------MKFQKVAAGGYHVCGILEG 228
+ +++ ++ WG R L+P+ K VA G H +
Sbjct: 185 TAAV-TEDGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEKMSMVACGWRHTISVSY- 242
Query: 229 LDSRTRCWGRSLDLEEEVSVAYSRQGN-----------VDLPPSDPMLSIVGGKFHACGI 277
+G S Y + G+ ++ + + I GG H +
Sbjct: 243 -SGALYTYGWS---------KYGQLGHGDLEDHLIPHKLEALSNSFISQISGGWRHTMAL 292
Query: 278 KSYDRGVICWGF----------IIKPSTPV----PTGIKVYEIAAGNYFTCGVLAEKSML 323
S D + WG+ + +PV P KV +++ G T V ++
Sbjct: 293 TS-DGKLYGWGWNKFGQVGVGNNLDQCSPVQVRFPDDQKVVQVSCGWRHTLAVTERNNVF 351
Query: 324 PVCWGTG 330
WG G
Sbjct: 352 --AWGRG 356
|
| >4d9s_A UVB-resistance protein UVR8; UV resistance, UV-B photoreceptor, tryptophan chromophores, homodimer, COP1, chromatin-binding protein; 1.70A {Arabidopsis thaliana} PDB: 4dnw_A 4dnu_A 4dnv_A Length = 406 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-15
Identities = 41/268 (15%), Positives = 73/268 (27%), Gaps = 73/268 (27%)
Query: 115 MGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQ---- 170
M + + + ISAG H L V WG DGQ
Sbjct: 6 MAADEVTAPPRKVLIISAGASHSVALLS--GDI------VCSWGRGE------DGQLGHG 51
Query: 171 ------------------IESISAGSEFNCGLFSQNRTVFCWGDESS------SRVISLI 206
I S++ G++ V+ WG +
Sbjct: 52 DAEDRPSPTQLSALDGHQIVSVTCGADHTVAYSQSGMEVYSWGWGDFGRLGHGNSSDLFT 111
Query: 207 PKE------MKFQKVAAGGYHVCGILEGLDSRTRCWGRS----LDLEEEVSVAYSRQGNV 256
P ++ +++A G H + + + WGR+ L L + ++ +
Sbjct: 112 PLPIKALHGIRIKQIACGDSHCLAVTM--EGEVQSWGRNQNGQLGLGDTEDSLVPQK--I 167
Query: 257 DLPPSDPMLSIVGGKFHACGIKSYDRGVICWGF----------IIKPSTPVP----TGIK 302
+ + G H + D + WG+ P G K
Sbjct: 168 QAFEGIRIKMVAAGAEHTAAVTE-DGDLYGWGWGRYGNLGLGDRTDRLVPERVTSTGGEK 226
Query: 303 VYEIAAGNYFTCGVLAEKSMLPVCWGTG 330
+ +A G T V ++ +G
Sbjct: 227 MSMVACGWRHTISVSYSGALY--TYGWS 252
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 2e-21
Identities = 58/226 (25%), Positives = 95/226 (42%), Gaps = 46/226 (20%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK-------KAIATSDRQKNSKEFHTELDLLSRL 569
KE +G+G S V + + K AVK + + + Q+ + E+D+L ++
Sbjct: 21 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80
Query: 570 N-HAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDW-VRRVT------ 621
+ H +++ L E LV++ M G L D+ +VT
Sbjct: 81 SGHPNIIQLKDTYETNTFFFLVFDLMKKGEL--------------FDYLTEKVTLSEKET 126
Query: 622 --IAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679
I I LH ++HRD+K NIL+D++ N ++ DFG S D L
Sbjct: 127 RKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ--LDPGEKLR 181
Query: 680 ELPAGTLGYLDPE-------YYRLHYLTTKSDVYSFGVLLLEILSG 718
E+ GT YL PE Y + D++S GV++ +L+G
Sbjct: 182 EV-CGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAG 225
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 24/212 (11%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHA 572
EE+G G F+ V K K G A K + +++S R + +E E+++L + H
Sbjct: 9 MGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV--QAARGI 630
+++ L E + +L+ E ++ G L L K L E Q G+
Sbjct: 69 NIITLHDIFENKTDVVLILELVSGGELFDFLAEKES-LTE------DEATQFLKQILDGV 121
Query: 631 EYLHGYACPPVIHRDIKSSNILI----DEEHNARVADFGLSLLGPADSSSPLAELPAGTL 686
YLH + H D+K NI++ ++ DFG++ ++ + + GT
Sbjct: 122 HYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKNI-FGTP 175
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
++ PE L ++D++S GV+ +LSG
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 19/208 (9%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
FK ++G G+F V+ + G +K I Q ++ E+++L L+H +++
Sbjct: 26 FKRKLGSGAFGDVHLVEERSSGLERVIKT-INKDRSQVPMEQIEAEIEVLKSLDHPNIIK 84
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQ---HLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
+ E+ +V E G L + + KAL E + Q + Y
Sbjct: 85 IFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG----YVAELMKQMMNALAYF 140
Query: 634 HGYACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLD 690
H V+H+D+K NIL ++ DFGL+ L S AGT Y+
Sbjct: 141 HSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL--FKSDEHSTNA-AGTALYMA 194
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEILSG 718
PE ++ T K D++S GV++ +L+G
Sbjct: 195 PEVFKRDV-TFKCDIWSAGVVMYFLLTG 221
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 3e-21
Identities = 53/210 (25%), Positives = 90/210 (42%), Gaps = 20/210 (9%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHA 572
EE+G G F+ V K K G A K + S R +E E+ +L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+++ L E + +L+ E ++ G L L K L E+ + Q G+ Y
Sbjct: 76 NIITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSEE----EATSFIKQILDGVNY 130
Query: 633 LHGYACPPVIHRDIKSSNILI----DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGY 688
LH + H D+K NI++ + ++ DFGL+ + + GT +
Sbjct: 131 LHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNI-FGTPEF 184
Query: 689 LDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
+ PE L ++D++S GV+ +LSG
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 4e-21
Identities = 58/268 (21%), Positives = 109/268 (40%), Gaps = 47/268 (17%)
Query: 469 GKASKSQKTNGAG-SPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSF 527
+ NG +P N I+ D K + Y + +G GSF
Sbjct: 2 SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKV--------IGNGSF 53
Query: 528 SCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRER 587
V++ L + VA+KK + R KN EL ++ + H ++++L + ++
Sbjct: 54 GVVFQAKLVESDEVAIKK-VLQDKRFKN-----RELQIMRIVKHPNVVDLKAFFYSNGDK 107
Query: 588 L------LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPV 641
LV E++ ++++ +K K+ + + Q R + Y+H +
Sbjct: 108 KDEVFLNLVLEYVPE-TVYRASRHYAKL-KQTMPMLLIKLYMYQLLRSLAYIHSIG---I 162
Query: 642 IHRDIKSSNILIDEE-HNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYYR---- 695
HRDIK N+L+D ++ DFG + +L + + Y+ YYR
Sbjct: 163 CHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNV----------SYICSRYYRAPEL 212
Query: 696 ----LHYLTTKSDVYSFGVLLLEILSGR 719
+Y TT D++S G ++ E++ G+
Sbjct: 213 IFGATNY-TTNIDIWSTGCVMAELMQGQ 239
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 50/157 (31%), Positives = 78/157 (49%), Gaps = 19/157 (12%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNL 577
E VG G++ VYKG +K G + A+K T D +E E+++L + +H ++
Sbjct: 30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATY 86
Query: 578 LG-----YCEEGRERL-LVYEFMAHGSLHQHLHG-KSKALKEQLDWVRRVTIAVQAARGI 630
G ++L LV EF GS+ + K LKE +W+ I + RG+
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE--EWIA--YICREILRGL 142
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
+LH + VIHRDIK N+L+ E ++ DFG+S
Sbjct: 143 SHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-21
Identities = 60/253 (23%), Positives = 103/253 (40%), Gaps = 33/253 (13%)
Query: 486 KDNGKIRPDFDDLKIRRAQMFTYEELERATGGFK------EEVGKGSFSCVYKGVLKD-G 538
+N +I K+ T ++ + + +G G+ V +
Sbjct: 101 NNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTC 160
Query: 539 TVVAVK-----KAIATSDRQKNSKE-FHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592
VA++ K S R+ + TE+++L +LNH ++ + + + + +V E
Sbjct: 161 KKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLE 219
Query: 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNIL 652
M G L + G + LKE + Q ++YLH +IHRD+K N+L
Sbjct: 220 LMEGGELFDKVVGNKR-LKE--ATCKLYFY--QMLLAVQYLHENG---IIHRDLKPENVL 271
Query: 653 I---DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE----YYRLHYLTTKSDV 705
+ +E+ ++ DFG S + +S + L GT YL PE Y D
Sbjct: 272 LSSQEEDCLIKITDFGHSKI--LGETSLMRTL-CGTPTYLAPEVLVSVGTAGY-NRAVDC 327
Query: 706 YSFGVLLLEILSG 718
+S GV+L LSG
Sbjct: 328 WSLGVILFICLSG 340
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 47/222 (21%), Positives = 81/222 (36%), Gaps = 40/222 (18%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHT---------ELDLLSRLN 570
+ GS+ V GV +G VA+K+ T + E+ LL+ +
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 571 HAHLLNLL-----GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQ 625
H ++L L + LV E M L Q +H + + Q
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQ----HIQYFMYH 142
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGT 685
G+ LH V+HRD+ NIL+ + ++ + DF L A + A
Sbjct: 143 ILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNL-----AREDTADANKT--- 191
Query: 686 LGYLDPEYYR--------LHYLTTKSDVYSFGVLLLEILSGR 719
Y+ +YR + T D++S G ++ E+ + +
Sbjct: 192 -HYVTHRWYRAPELVMQFKGF-TKLVDMWSAGCVMAEMFNRK 231
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 53/212 (25%), Positives = 90/212 (42%), Gaps = 24/212 (11%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHA 572
EE+G G F+ V K K G A K + S R + +E E+ +L ++ H
Sbjct: 16 IGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV--QAARGI 630
+++ L E + +L+ E ++ G L L K L E + Q G+
Sbjct: 76 NVITLHDVYENRTDVVLILELVSGGELFDFLAQKES-LSE------EEATSFIKQILDGV 128
Query: 631 EYLHGYACPPVIHRDIKSSNILI----DEEHNARVADFGLSLLGPADSSSPLAELPAGTL 686
YLH + H D+K NI++ + ++ DFGL+ + + GT
Sbjct: 129 NYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNI-FGTP 182
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
++ PE L ++D++S GV+ +LSG
Sbjct: 183 EFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 8e-21
Identities = 54/209 (25%), Positives = 82/209 (39%), Gaps = 20/209 (9%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVK---KAIATSDRQKNSKEFHT---ELDLLSRLNHA 572
+G G+F V+ V + V VK K D + E+ +LSR+ HA
Sbjct: 30 SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGS-LHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
+++ +L E LV E G L + + L E L I Q +
Sbjct: 90 NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPL--ASY--IFRQLVSAVG 144
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
YL +IHRDIK NI+I E+ ++ DFG + L GT+ Y P
Sbjct: 145 YLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYCAP 198
Query: 692 E-YYRLHYLTTKSDVYSFGVLLLEILSGR 719
E Y + +++S GV L ++
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-21
Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 26/208 (12%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+GKGSF V D + A+K + + +N EL ++ L H L+N
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVF---KELQIMQGLEHPFLVN 79
Query: 577 LLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L Y + E + +V + + G L HL ++ KE+ ++ I + ++YL
Sbjct: 80 LW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFKEE---TVKLFIC-ELVMALDYLQN 133
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYY 694
+IHRD+K NIL+DE + + DF ++ +L + + AGT Y+ PE +
Sbjct: 134 QR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTM----AGTKPYMAPEMF 186
Query: 695 RLHYLT--TKS-DVYSFGVLLLEILSGR 719
+ + D +S GV E+L GR
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGR 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 9e-21
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 523 GKGSFSCVYKGV-LKDGTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
GKG+F+ V + G VA+K + + QK E+ ++ LNH +++ L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQK----LFREVRIMKILNHPNIVKL 79
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
E + L+ E+ + G + +L HG+ +KE R Q ++Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKE--KEARS--KFRQIVSAVQYCHQ 132
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
++HRD+K+ N+L+D + N ++ADFG S + G Y PE ++
Sbjct: 133 KR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGAPPYAAPELFQ 186
Query: 696 -LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
Y + DV+S GV+L ++SG + F+ N+ E
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGS----LPFDGQNLKE 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 38/212 (17%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+G+ VY + + G VA+++ +K E+ ++ + +++N L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE--LIINEILVMRENKNPNIVNYL 83
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV---QAARGIEYLHG 635
G E +V E++A GSL + + E IA + + +E+LH
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEG-------QIAAVCRECLQALEFLHS 134
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA---------GTL 686
VIHRDIKS NIL+ + + ++ DFG A++ GT
Sbjct: 135 NQ---VIHRDIKSDNILLGMDGSVKLTDFGFC-----------AQITPEQSKRSTMVGTP 180
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
++ PE K D++S G++ +E++ G
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 22/207 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLL 575
KE++G GS+S + + K AV K I +++ E E+++L R H +++
Sbjct: 26 VKEDIGVGSYSVCKRCIHKATNMEFAV-KII--DKSKRDPTE---EIEILLRYGQHPNII 79
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L ++G+ +V E M G L + + K E+ + + +EYLH
Sbjct: 80 TLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSER----EASAVLFTITKTVEYLHA 134
Query: 636 YACPPVIHRDIKSSNIL-IDEEHNA---RVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
V+HRD+K SNIL +DE N R+ DFG + A+ + L P T ++ P
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMT-PCYTANFVAP 189
Query: 692 EYYRLHYLTTKSDVYSFGVLLLEILSG 718
E D++S GVLL +L+G
Sbjct: 190 EVLERQGYDAACDIWSLGVLLYTMLTG 216
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 46/211 (21%), Positives = 77/211 (36%), Gaps = 30/211 (14%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+ +G+GS+ V V K A K I ++ F E++++ L+H +++
Sbjct: 13 LENTIGRGSWGEVKIAVQKGTRIRRAA-KKIPKY-FVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 577 LLGYCEEGRERLLVYEFMAHGSL------HQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
L E+ + LV E G L + A I +
Sbjct: 71 LYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA-----------RIMKDVLSAV 119
Query: 631 EYLHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAELPAGTLG 687
Y H V HRD+K N L + ++ DFGL+ + GT
Sbjct: 120 AYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTK-VGTPY 173
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
Y+ P+ Y + D +S GV++ +L G
Sbjct: 174 YVSPQVLEGLY-GPECDEWSAGVMMYVLLCG 203
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 36/214 (16%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
F E +G G+FS V+ + G + A+K I S E+ +L ++ H +++
Sbjct: 13 FMEVLGSGAFSEVFLVKQRLTGKLFALKC-IKKS-PAFRDSSLENEIAVLKKIKHENIVT 70
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDW-VRR--------VTIAVQAA 627
L E LV + ++ G L D + R + Q
Sbjct: 71 LEDIYESTTHYYLVMQLVSGGEL--------------FDRILERGVYTEKDASLVIQQVL 116
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAELPAG 684
++YLH ++HRD+K N+L +E + DFGLS + + + ++ G
Sbjct: 117 SAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTA-CG 169
Query: 685 TLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
T GY+ PE + D +S GV+ +L G
Sbjct: 170 TPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 2e-20
Identities = 66/278 (23%), Positives = 110/278 (39%), Gaps = 60/278 (21%)
Query: 468 SGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFT--YEELERATGGFKEEVGKG 525
K + G + Y + G P+ + A+ F Y+ K+ +G+G
Sbjct: 57 EAKKLNDAQPKGTENLYFQSMG---PEDELPDWAAAKEFYQKYD--------PKDVIGRG 105
Query: 526 SFSCVYKGVLKD-GTVVAVK------KAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNL 577
S V + V + G AVK + ++ ++ + E +L ++ H H++ L
Sbjct: 106 VSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDW-VRRVT--------IAVQAAR 628
+ E LV++ M G L D+ +V I
Sbjct: 166 IDSYESSSFMFLVFDLMRKGEL--------------FDYLTEKVALSEKETRSIMRSLLE 211
Query: 629 GIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLG 687
+ +LH ++HRD+K NIL+D+ R++DFG S L P L EL GT G
Sbjct: 212 AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GEKLREL-CGTPG 264
Query: 688 YLDPE-------YYRLHYLTTKSDVYSFGVLLLEILSG 718
YL PE Y + D+++ GV+L +L+G
Sbjct: 265 YLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAG 301
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 64/270 (23%), Positives = 109/270 (40%), Gaps = 47/270 (17%)
Query: 468 SGKASKSQKTNGAGSPYQKDNGKI--RPDFDDLKIRRAQMFTYEELERATGGFKEEVGKG 525
+ KD K+ R Q +Y + + +G G
Sbjct: 14 CKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV--------IGNG 65
Query: 526 SFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG 584
SF VY+ L D G +VA+KK + R KN EL ++ +L+H +++ L +
Sbjct: 66 SFGVVYQAKLCDSGELVAIKK-VLQDKRFKN-----RELQIMRKLDHCNIVRLRYFFYSS 119
Query: 585 RERL------LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
E+ LV +++ ++++ S+A K+ L + Q R + Y+H +
Sbjct: 120 GEKKDEVYLNLVLDYVPE-TVYRVARHYSRA-KQTLPVIYVKLYMYQLFRSLAYIHSFG- 176
Query: 639 PPVIHRDIKSSNILIDEE-HNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR-- 695
+ HRDIK N+L+D + ++ DFG + P Y+ YYR
Sbjct: 177 --ICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVS-------YICSRYYRAP 225
Query: 696 ------LHYLTTKSDVYSFGVLLLEILSGR 719
Y T+ DV+S G +L E+L G+
Sbjct: 226 ELIFGATDY-TSSIDVWSAGCVLAELLLGQ 254
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-20
Identities = 51/213 (23%), Positives = 91/213 (42%), Gaps = 23/213 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAH 573
E +GKG FS V + + ++ G AVK A TS ++++ E + L H H
Sbjct: 28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKAL-----KEQLDWVRRVTIAVQAAR 628
++ LL +V+EFM L + ++ A ++R++ A++
Sbjct: 88 IVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR--- 144
Query: 629 GIEYLHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAELPAGT 685
Y H +IHRD+K +L+ + ++ FG+++ +S GT
Sbjct: 145 ---YCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGR-VGT 196
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
++ PE + DV+ GV+L +LSG
Sbjct: 197 PHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHA 572
EE+G G F+ V K K G A K + +S R + ++ E+ +L + H
Sbjct: 15 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV-QAARGIE 631
+++ L E + +L+ E +A G L L K L E T + Q G+
Sbjct: 75 NVITLHEVYENKTDVILILELVAGGELFDFLAEKES-LTE-----EEATEFLKQILNGVY 128
Query: 632 YLHGYACPPVIHRDIKSSNILI----DEEHNARVADFGLSLLGPADSSSPLAELPAGTLG 687
YLH + H D+K NI++ + ++ DFGL+ D + + GT
Sbjct: 129 YLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNI-FGTPE 182
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
++ PE L ++D++S GV+ +LSG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 22/209 (10%)
Query: 516 GGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAH 573
+ +G+GSFS K V K AV K I+ K E+ L H +
Sbjct: 13 DLKDKPLGEGSFSICRKCVHKKSNQAFAV-KIISKRMEANTQK----EITALKLCEGHPN 67
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSK-ALKEQLDWVRRVTIAVQAARGIEY 632
++ L + LV E + G L + + K + E +R++ AV +
Sbjct: 68 IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS------H 121
Query: 633 LHGYACPPVIHRDIKSSNIL-IDEEHNA--RVADFGLSLLGPADSSSPLAELPAGTLGYL 689
+H V+HRD+K N+L DE N ++ DFG + L P D + PL P TL Y
Sbjct: 122 MHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKT-PCFTLHYA 176
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
PE + D++S GV+L +LSG
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTMLSG 205
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 3e-20
Identities = 54/193 (27%), Positives = 89/193 (46%), Gaps = 29/193 (15%)
Query: 481 GSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKD-GT 539
G + + + ++L + M YE L VG+GS+ V K KD G
Sbjct: 2 GHHHHHHSSGVDLGTENLYFQ--SMEKYENLGL--------VGEGSYGMVMKCRNKDTGR 51
Query: 540 VVAVKKAIATSDRQKNSKE-FHT----ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594
+VA+KK + + + E+ LL +L H +L+NLL C++ + LV+EF+
Sbjct: 52 IVAIKKF-----LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106
Query: 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID 654
H ++ L L Q+ V++ Q GI + H + +IHRDIK NIL+
Sbjct: 107 DH-TILDDLELFPNGLDYQV--VQKYLF--QIINGIGFCHSHN---IIHRDIKPENILVS 158
Query: 655 EEHNARVADFGLS 667
+ ++ DFG +
Sbjct: 159 QSGVVKLCDFGFA 171
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 6e-20
Identities = 47/209 (22%), Positives = 89/209 (42%), Gaps = 32/209 (15%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
++G+GS V G VAVK +++ E+ ++ H +++ +
Sbjct: 51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRE--LLFNEVVIMRDYQHFNVVEMY 108
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
G E ++ EF+ G+L + L E + + T+ + + YLH
Sbjct: 109 KSYLVGEELWVLMEFLQGGALTDIV--SQVRLNE--EQIA--TVCEAVLQALAYLHA--- 159
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPA---------GTLGYL 689
VIHRDIKS +IL+ + +++DFG A++ GT ++
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFC-----------AQISKDVPKRKSLVGTPYWM 208
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
PE T+ D++S G++++E++ G
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDG 237
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 8e-20
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 31/209 (14%)
Query: 523 GKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYC 581
G+G++ V V VAVK + + E+ + LNH +++ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 582 EEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAAR--------GIE 631
EG + L E+ + G L + + E A+ G+
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIG---MPEP------------DAQRFFHQLMAGVV 119
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
YLHG + HRDIK N+L+DE N +++DFGL+ + ++ L GTL Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 692 E-YYRLHYLTTKSDVYSFGVLLLEILSGR 719
E R + DV+S G++L +L+G
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 49/210 (23%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 519 KEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKE-FHTELDLLSRLNHA-HLL 575
+E+G+G F+ V + + K G A K + R ++ + E+ +L ++
Sbjct: 34 SKELGRGKFAVVRQCISKSTGQEYAA-KFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKAL---KEQLDWVRRVTIAVQAARGIEY 632
NL E E +L+ E+ A G + + + + + ++ Q G+ Y
Sbjct: 93 NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK------QILEGVYY 146
Query: 633 LHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGY 688
LH ++H D+K NIL+ + ++ DFG+S +G + L E+ GT Y
Sbjct: 147 LHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH---ACELREI-MGTPEY 199
Query: 689 LDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
L PE +TT +D+++ G++ +L+
Sbjct: 200 LAPEILNYDPITTATDMWNIGIIAYMLLTH 229
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-19
Identities = 52/202 (25%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHT--ELDLLSRLNHAHLLNLL 578
+G+G F V+ +K G + A KK + +K E +L++++ +++L
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKK-LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA 251
Query: 579 GYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
Y E + L LV M G + H++ + R + Q G+E+LH
Sbjct: 252 -YAFETKTDLCLVMTIMNGGDIRYHIYNVDED-NPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
+I+RD+K N+L+D++ N R++D GL++ A + AGT G++ PE
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY--AGTPGFMAPELLLGE 364
Query: 698 YLTTKSDVYSFGVLLLEILSGR 719
D ++ GV L E+++ R
Sbjct: 365 EYDFSVDYFALGVTLYEMIAAR 386
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 1e-19
Identities = 74/350 (21%), Positives = 133/350 (38%), Gaps = 68/350 (19%)
Query: 453 ISILYVRY----RLRNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTY 508
+ LY ++ C G K + Y K+ F +++ + T+
Sbjct: 3 LHFLYYCSEPTLDVKIAFCQG-FDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDS---TF 58
Query: 509 EELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLS 567
L+R + +G G+ V VA+KK Q ++K + EL L+
Sbjct: 59 TVLKRYQ--NLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 116
Query: 568 RLNHAHLLNLL------GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVT 621
+NH ++++LL EE ++ LV E M +L Q ++ +LD R
Sbjct: 117 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQ-------VIQMELDHERMSY 168
Query: 622 IAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAEL 681
+ Q GI++LH +IHRD+K SNI++ + ++ DFGL+ A +S +
Sbjct: 169 LLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTP- 222
Query: 682 PAGTLGYLDPEYYR-------LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEW 734
Y+ YYR + Y D++S G ++ E++ +
Sbjct: 223 ------YVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHK--------------- 260
Query: 735 AVPLIKSGD----ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERP 780
L D +++ L P + +K++ V R K
Sbjct: 261 --ILFPGRDYIDQWNKVIE-QLGTPCP-EFMKKLQPTVRNYVENRPKYAG 306
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 1e-19
Identities = 61/273 (22%), Positives = 104/273 (38%), Gaps = 61/273 (22%)
Query: 523 GKGSFSCVYKGV-LKDGTVVAVK-----KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
G+GS+ V + + + AVK K + + N K E+ LL RL H +++
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK---KEIQLLRRLRHKNVIQ 70
Query: 577 LLG--YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAAR------ 628
L+ Y EE ++ +V E+ G ++E LD V V A
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCG------------MQEMLDSVPEKRFPVCQAHGYFCQL 118
Query: 629 --GIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTL 686
G+EYLH ++H+DIK N+L+ +++ G++ ++ G+
Sbjct: 119 IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSP 175
Query: 687 GYLDPEYYRLH--YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIV---------EWA 735
+ PE + K D++S GV L I +G FE NI +A
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL----YPFEGDNIYKLFENIGKGSYA 231
Query: 736 VPLIKSGD----ITAILDPVLKLPSDLDALKRI 764
+P + +L+ + KR
Sbjct: 232 IPGDCGPPLSDLLKGMLEY--------EPAKRF 256
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 55/221 (24%), Positives = 91/221 (41%), Gaps = 39/221 (17%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK-----KAIATSDRQKNSKE-FHTELDLLSRLN 570
+ +G G+ V + VA+K K S R+ + TE+++L +LN
Sbjct: 14 MSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73
Query: 571 HAHLLNLLGYCEEGRERLLVYEFMAHGSL------HQHLHGKSKALKEQLDWVRRVTIAV 624
H ++ + + + + +V E M G L ++ L + L
Sbjct: 74 HPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKL-----------YFY 121
Query: 625 QAARGIEYLHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAEL 681
Q ++YLH +IHRD+K N+L+ +E+ ++ DFG S + +S + L
Sbjct: 122 QMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTL 176
Query: 682 PAGTLGYLDPE----YYRLHYLTTKSDVYSFGVLLLEILSG 718
GT YL PE Y D +S GV+L LSG
Sbjct: 177 -CGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSG 215
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 31/209 (14%)
Query: 523 GKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYC 581
G+G++ V V VAVK + + E+ + LNH +++ G+
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 582 EEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAAR--------GIE 631
EG + L E+ + G L + + E A+ G+
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIG---MPEP------------DAQRFFHQLMAGVV 119
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
YLHG + HRDIK N+L+DE N +++DFGL+ + ++ L GTL Y+ P
Sbjct: 120 YLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 692 E-YYRLHYLTTKSDVYSFGVLLLEILSGR 719
E R + DV+S G++L +L+G
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHA 572
KEE+GKG+FS V + V K G A K K ++ D QK E + +L H
Sbjct: 10 VKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK----LEREARICRKLQHP 65
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+++ L +E LV++ + G L + + + E Q I Y
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF-YSEA----DASHCIQQILESIAY 120
Query: 633 LHGYACPPVIHRDIKSSNIL-IDEEHNARV--ADFGLSLLGPADSSSPLAELPAGTLGYL 689
H ++HR++K N+L + A V ADFGL++ + S AGT GYL
Sbjct: 121 CHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGF-AGTPGYL 174
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
PE + + D+++ GV+L +L G
Sbjct: 175 SPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 3e-19
Identities = 36/179 (20%), Positives = 70/179 (39%), Gaps = 17/179 (9%)
Query: 549 TSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSK 608
++ + + + + L + + +L ++ +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 609 ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS- 667
+ I +Q A +E+LH ++HRD+K SNI + +V DFGL
Sbjct: 158 LEDREHGVCLH--IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVT 212
Query: 668 -LLGPADSSSPLAELPA--------GTLGYLDPE-YYRLHYLTTKSDVYSFGVLLLEIL 716
+ + + L +PA GT Y+ PE + +Y + K D++S G++L E+L
Sbjct: 213 AMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY-SHKVDIFSLGLILFELL 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 17/116 (14%), Positives = 39/116 (33%), Gaps = 10/116 (8%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLL 566
+E ++ +G+G F V++ K D A+K+ I +R+ ++ E+ L
Sbjct: 8 FEPIQC--------MGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKAL 58
Query: 567 SRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI 622
++L H ++ E E + + ++
Sbjct: 59 AKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRR 114
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 56/215 (26%), Positives = 89/215 (41%), Gaps = 35/215 (16%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKE-FHTELDLLSRLNHAHLL 575
KEE+GKG+FS V + V K G A K I T + E + +L H +++
Sbjct: 33 VKEELGKGAFSVVRRCVHKTTGLEFAA-KIINTKKLSARDFQKLEREARICRKLQHPNIV 91
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDW-VRRVT--------IAVQA 626
L +E LV++ + G L + V R Q
Sbjct: 92 RLHDSIQEESFHYLVFDLVTGGEL--------------FEDIVAREFYSEADASHCIQQI 137
Query: 627 ARGIEYLHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAELPA 683
I Y H ++HR++K N+L+ + ++ADFGL++ + S A
Sbjct: 138 LESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE--VNDSEAWHGF-A 191
Query: 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
GT GYL PE + + D+++ GV+L +L G
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 58/220 (26%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 523 GKGSFSCVYKGV-LKDGTVVAVK-----KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
G G+F V G G VAVK K + K +E L H H++
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQN----LKLFRHPHIIK 75
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
L + +V E+++ G L ++ HG+ ++E RR + Q ++Y H
Sbjct: 76 LYQVISTPTDFFMVMEYVSGGELFDYICKHGR---VEE--MEARR--LFQQILSAVDYCH 128
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE-Y 693
+ V+HRD+K N+L+D NA++ADFGLS + G+ Y PE
Sbjct: 129 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVI 182
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
Y + D++S GV+L +L G + F++ ++
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGT----LPFDDEHVPT 218
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 4e-19
Identities = 64/256 (25%), Positives = 102/256 (39%), Gaps = 56/256 (21%)
Query: 491 IRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKD---GTVVAVKK-- 545
+ + R +F YE +VG+G++ VYK KD A+K+
Sbjct: 7 FKVKLSSERERVEDLFEYE---------GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE 57
Query: 546 ---AIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL--LVYEFMAH---G 597
++ R E+ LL L H ++++L +R L++++ H
Sbjct: 58 GTGISMSACR---------EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWH 108
Query: 598 SLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH 657
+ H K+ QL ++ Q GI YLH V+HRD+K +NIL+ E
Sbjct: 109 IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEG 165
Query: 658 NAR----VADFGLSLLGPADSSSPLAELPAG-----TLGYLDPEYYRL-----HYLTTKS 703
R +AD G + L +SPL L T Y PE L HY T
Sbjct: 166 PERGRVKIADMGFARL----FNSPLKPLADLDPVVVTFWYRAPE---LLLGARHY-TKAI 217
Query: 704 DVYSFGVLLLEILSGR 719
D+++ G + E+L+
Sbjct: 218 DIWAIGCIFAELLTSE 233
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 5e-19
Identities = 47/171 (27%), Positives = 83/171 (48%), Gaps = 26/171 (15%)
Query: 502 RAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE-FH 560
+ M Y++LE+ VG+G++ VYK G +VA+K+ R E
Sbjct: 17 QGLMEKYQKLEK--------VGEGTYGVVYKAKDSQGRIVALKRI-----RLDAEDEGIP 63
Query: 561 T----ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDW 616
+ E+ LL L+H ++++L+ R LV+EFM L + L L++
Sbjct: 64 STAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQ-- 120
Query: 617 VRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
++ Q RG+ + H + ++HRD+K N+LI+ + ++ADFGL+
Sbjct: 121 IK--IYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 6e-19
Identities = 44/302 (14%), Positives = 82/302 (27%), Gaps = 74/302 (24%)
Query: 520 EEVGKGSFSCVYKGVLKD---GTVVAVK-----KAIATSDRQKNSKEFHTELDLLSRLNH 571
G ++ + D VA+ + Q E + LSR++
Sbjct: 37 IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQ----ETLSRTLRLSRIDK 90
Query: 572 AHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
+ +L L+V E++ GSL + V + A +
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-------SPSPVGAIRAMQSLAAAAD 143
Query: 632 YLH--GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYL 689
H G V S + + + + +A T+
Sbjct: 144 AAHRAG-----VALSIDHPSRVRVSIDGDVVLAYP-------------------ATMPDA 179
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIK--SGDITAI 747
+P+ D+ G L +L R E + P + +G
Sbjct: 180 NPQ----------DDIRGIGASLYALLVNRWP----LPEAGVRSGLAPAERDTAGQPIEP 225
Query: 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPIL 807
D +P + A VA + V+ G R + + L + Q + +
Sbjct: 226 ADIDRDIPFQISA------VAARSVQGDGGIRSA-----STLLNLMQQATAVADRTEVLG 274
Query: 808 PT 809
P
Sbjct: 275 PI 276
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 7e-19
Identities = 54/209 (25%), Positives = 88/209 (42%), Gaps = 28/209 (13%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHT--ELDLLSRLNHAHL 574
+G+G F VY D G + A+K K I + E E +LS ++
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRI-----KMKQGETLALNERIMLSLVSTGDC 251
Query: 575 --LNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
+ + Y ++L + + M G LH HL + E A + G+E
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFSEA----DMRFYAAEIILGLE 306
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
++H V++RD+K +NIL+DE + R++D GL+ GT GY+ P
Sbjct: 307 HMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAP 359
Query: 692 EYYRLHYLTTKS-DVYSFGVLLLEILSGR 719
E + S D +S G +L ++L G
Sbjct: 360 EVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-19
Identities = 51/215 (23%), Positives = 83/215 (38%), Gaps = 34/215 (15%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKE-FHTELDLLSRLNHAHLL 575
EE+GKG+FS V + V G A I T + E + L H +++
Sbjct: 15 LFEELGKGAFSVVRRCVKVLAGQEYAAMI-INTKKLSARDHQKLEREARICRLLKHPNIV 73
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDW-VRR--------VTIAVQA 626
L E L+++ + G L + V R Q
Sbjct: 74 RLHDSISEEGHHYLIFDLVTGGEL--------------FEDIVAREYYSEADASHCIQQI 119
Query: 627 ARGIEYLHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAELPA 683
+ + H V+HR++K N+L+ + ++ADFGL++ + + A
Sbjct: 120 LEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA-WFGF-A 174
Query: 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
GT GYL PE R D+++ GV+L +L G
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 209
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 8e-19
Identities = 62/277 (22%), Positives = 106/277 (38%), Gaps = 58/277 (20%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL-- 578
+G G+ V VA+KK Q ++K + EL L+ +NH +++ LL
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV 92
Query: 579 ----GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
EE ++ +V E M +L Q ++ +LD R + Q GI++LH
Sbjct: 93 FTPQKSLEEFQDVYIVMELM-DANLCQ-------VIQMELDHERMSYLLYQMLCGIKHLH 144
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
+IHRD+K SNI++ + ++ DFGL + T Y+ YY
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGL--------ARTAGTSFMMT-PYVVTRYY 192
Query: 695 R-------LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD---- 743
R + Y D++S G ++ E++ G L D
Sbjct: 193 RAPEVILGMGY-KENVDIWSVGCIMGEMIKGG-----------------VLFPGTDHIDQ 234
Query: 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERP 780
+++ L P + +K++ V R K
Sbjct: 235 WNKVIE-QLGTPCP-EFMKKLQPTVRTYVENRPKYAG 269
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 9e-19
Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 21/205 (10%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+GKG F V ++ G + A K K I + + E +L ++N +++
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL---NEKQILEKVNSRFVVS 248
Query: 577 LLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L Y E ++ L LV M G L H++ + R V A + G+E LH
Sbjct: 249 L-AYAYETKDALCLVLTLMNGGDLKFHIY---HMGQAGFPEARAVFYAAEICCGLEDLHR 304
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSL-LGPADSSSPLAELPAGTLGYLDPEYY 694
+++RD+K NIL+D+ + R++D GL++ + + GT+GY+ PE
Sbjct: 305 ER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGR----VGTVGYMAPEVV 357
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGR 719
+ T D ++ G LL E+++G+
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 1e-18
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 31/218 (14%)
Query: 519 KEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLN 576
++ +G+G+ + V + AVK I S+ F E+++L + H ++L
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKI-IEKQPGHIRSRVF-REVEMLYQCQGHRNVLE 75
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSK-ALKEQLDWVRRVTIAVQAARGIEYLH- 634
L+ + EE LV+E M GS+ H+H + E V+ V A+ +LH
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD------FLHN 129
Query: 635 -GYACPPVIHRDIKSSNIL-IDEEHNA--RVADFGLS-LLGPADSSSPLAEL----PAGT 685
G + HRD+K NIL + ++ DF L + SP++ P G+
Sbjct: 130 KG-----IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
Query: 686 LGYLDPEYYRLHYLTTKS-----DVYSFGVLLLEILSG 718
Y+ PE D++S GV+L +LSG
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 1e-18
Identities = 47/170 (27%), Positives = 80/170 (47%), Gaps = 31/170 (18%)
Query: 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHT-- 561
M YE++ + +G+GS+ V+K +D G +VA+KK S++
Sbjct: 2 MEKYEKIGK--------IGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIK 46
Query: 562 -----ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDW 616
E+ +L +L H +L+NLL R LV+E+ H ++ L + + E L
Sbjct: 47 KIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHL-- 103
Query: 617 VRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666
V+ +T Q + + + H + IHRD+K NILI + ++ DFG
Sbjct: 104 VKSITW--QTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGF 148
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 62/247 (25%), Positives = 101/247 (40%), Gaps = 49/247 (19%)
Query: 519 KEEVGKGSFSCVYKGV-LKDGTVVAVK----------------------KAIATSDRQKN 555
K+E+GKGS+ V D T A+K + Q
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 556 SKEFHT--ELDLLSRLNHAHLLNLLGYCEEGRERLL--VYEFMAHGSLHQHL-HGKSKAL 610
E+ +L +L+H +++ L+ ++ E L V+E + G + + L
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP---L 134
Query: 611 KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LL 669
E D R +GIEYLH +IHRDIK SN+L+ E+ + ++ADFG+S
Sbjct: 135 SE--DQARF--YFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 670 GPADSSSPLAELPAGTLGYLDPE---YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQF 726
+D+ L GT ++ PE R + DV++ GV L + G+ F
Sbjct: 188 KGSDA---LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ----CPF 240
Query: 727 EEGNIVE 733
+ I+
Sbjct: 241 MDERIMC 247
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 55/214 (25%), Positives = 86/214 (40%), Gaps = 31/214 (14%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+G+G+FS V +K G V A+K K + F E D+L + + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE--VSCFREERDVLVNGDRRWITQL 126
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVR----RVTIAVQAARGIEY 632
+ + L LV E+ G L L + + + R + +A I+
Sbjct: 127 H-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPA--EMARFYLAEIVMA------IDS 177
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
+H +HRDIK NIL+D + R+ADFG L AD + + + GT YL PE
Sbjct: 178 VHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPE 233
Query: 693 YYRLHYLTTKSDVY-------SFGVLLLEILSGR 719
+ + Y + GV E+ G+
Sbjct: 234 ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 3e-18
Identities = 65/274 (23%), Positives = 105/274 (38%), Gaps = 83/274 (30%)
Query: 518 FKEEVGKGSFSCVYKGVLKD------GTVVAVK--KAIATSDRQKNSKEFHTELDLLSRL 569
+ +G+G+F V + VAVK K AT + +EL +L +
Sbjct: 26 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR---ALMSELKILIHI 82
Query: 570 -NHAHLLNLLG--------------YCEEG---------RERLLVYEFMAH--------- 596
+H +++NLLG +C+ G R + Y+
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 142
Query: 597 GSLHQHLHGKSKAL------------------------------KEQLDWVRRVTIAVQA 626
G++ L + ++ K+ L + + Q
Sbjct: 143 GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQV 202
Query: 627 ARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS---SSPLAELPA 683
A+G+E+L A IHRD+ + NIL+ E++ ++ DFGL+ D A LP
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP- 258
Query: 684 GTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS 717
L ++ PE T +SDV+SFGVLL EI S
Sbjct: 259 --LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 523 GKGSFSCVYKGV-LKDGTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
G+GSF V K VA+K + + SD + E+ L L H H++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---REISYLKLLRHPHIIKL 74
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
+ ++V E+ A G L ++ + + E RR Q IEY H
Sbjct: 75 YDVITTPTDIVMVIEY-AGGELFDYIVEKKR---MTEDE--GRR--FFQQIICAIEYCHR 126
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE-YY 694
+ ++HRD+K N+L+D+ N ++ADFGLS + + + G+ Y PE
Sbjct: 127 HK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVIN 180
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
Y + DV+S G++L +L GR + F++ I
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGR----LPFDDEFIPN 215
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 5e-18
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 523 GKGSFSCVYKGV-LKDGTVVAVK-----KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
G G+F V G G VAVK K + K E+ L H H++
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK----IRREIQNLKLFRHPHIIK 80
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
L + +V E+++ G L ++ +G+ L E RR + Q G++Y H
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDE--KESRR--LFQQILSGVDYCH 133
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE-Y 693
+ V+HRD+K N+L+D NA++ADFGLS + G+ Y PE
Sbjct: 134 RHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVI 187
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
Y + D++S GV+L +L G + F++ ++
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGT----LPFDDDHVPT 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 65/253 (25%), Positives = 111/253 (43%), Gaps = 42/253 (16%)
Query: 482 SPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTV 540
+ + + + RP F ++ + +E ER VG G++ V K G
Sbjct: 2 AHHHHHHSQERPTFYRQELNKT---IWEVPERYQ--NLSPVGSGAYGSVCAAFDTKTGLR 56
Query: 541 VAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL------GYCEEGRERLLVYEFM 594
VAVKK ++K + EL LL + H +++ LL EE + LV M
Sbjct: 57 VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 116
Query: 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID 654
L+ + K + L + + Q RG++Y+H +IHRD+K SN+ ++
Sbjct: 117 -GADLNNIV--KCQKLTDD----HVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVN 166
Query: 655 EEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR--------LHYLTTKSDVY 706
E+ ++ DFGL A ++ E+ GY+ +YR +HY D++
Sbjct: 167 EDCELKILDFGL-----ARHTAD--EMT----GYVATRWYRAPEIMLNWMHY-NQTVDIW 214
Query: 707 SFGVLLLEILSGR 719
S G ++ E+L+GR
Sbjct: 215 SVGCIMAELLTGR 227
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 5e-18
Identities = 55/210 (26%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHT--ELDLLSRLN 570
F + +G+GSFS V A+K + I K +K + E D++SRL+
Sbjct: 34 FGKILGEGSFSTVVLARELATSREYAIKILEKRHII-----KENKVPYVTRERDVMSRLD 88
Query: 571 HAHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARG 629
H + L + + E+L + +G L +++ K + E R A +
Sbjct: 89 HPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFDET---CTRFYTA-EIVSA 142
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYL 689
+EYLHG +IHRD+K NIL++E+ + ++ DFG + + +S A GT Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
PE SD+++ G ++ ++++G
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 43/236 (18%)
Query: 502 RAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFH 560
R +M ++ G+G+F V G K G VA+KK + R +N +E
Sbjct: 19 RKEMDRFQVERM--------AGQGTFGTVQLGKEKSTGMSVAIKK-VIQDPRFRN-RELQ 68
Query: 561 TELDLLSRLNHAHLLNLLGYCEEGRER-------LLVYEFMAHGSLHQHLHGKSKALKEQ 613
+ L+ L+H +++ L Y ER +V E++ +LH+ + +
Sbjct: 69 -IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-QVA 125
Query: 614 LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE-HNARVADFGLS-LLGP 671
+ Q R I LH + V HRDIK N+L++E ++ DFG + L P
Sbjct: 126 PPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP 184
Query: 672 ADSSSPLAELPAGTLGYLDPEYYR--------LHYLTTKSDVYSFGVLLLEILSGR 719
++ + Y+ YYR HY TT D++S G + E++ G
Sbjct: 185 SEPNV----------AYICSRYYRAPELIFGNQHY-TTAVDIWSVGCIFAEMMLGE 229
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 5e-18
Identities = 47/170 (27%), Positives = 81/170 (47%), Gaps = 22/170 (12%)
Query: 502 RAQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFH 560
+++ YE+L+ +G+G F+ VYK +VA+KK I R + +
Sbjct: 6 KSRAKRYEKLDF--------LGEGQFATVYKARDKNTNQIVAIKK-IKLGHRSEAKDGIN 56
Query: 561 T----ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDW 616
E+ LL L+H +++ LL LV++FM L + S L
Sbjct: 57 RTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSH-- 113
Query: 617 VRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666
++ + +G+EYLH + ++HRD+K +N+L+DE ++ADFGL
Sbjct: 114 IK--AYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 61/265 (23%), Positives = 100/265 (37%), Gaps = 43/265 (16%)
Query: 463 RNCQCSGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEV 522
N +S + + D + D L +E + E+
Sbjct: 16 ENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDF------FE--------VESEL 61
Query: 523 GKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYC 581
G+G+ S VY+ K A+K + + + K TE+ +L RL+H +++ L
Sbjct: 62 GRGATSIVYRCKQKGTQKPYALK-VL---KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 582 EEGRERLLVYEFMAHGSLHQHLHGKSK-----ALKEQLDWVRRVTIAVQAARGIEYLHGY 636
E E LV E + G L + K A Q + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDA----------ADAVKQILEAVAYLHEN 167
Query: 637 ACPPVIHRDIKSSNIL-IDEEHNARV--ADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
++HRD+K N+L +A + ADFGLS + + + + GT GY PE
Sbjct: 168 G---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQVLMKTV-CGTPGYCAPEI 221
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSG 718
R + D++S G++ +L G
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCG 246
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-18
Identities = 42/307 (13%), Positives = 76/307 (24%), Gaps = 77/307 (25%)
Query: 87 LTAGDGFVCGLLLDSNQPYCWGSSGYIQMG---------VPQPIIKGAQYVEISAGDYHL 137
+ G+ Q+G P+ V+ISAG H
Sbjct: 29 IAFHLELPK-RRTVLGNVLVCGNGDVGQLGLGEDILERKRLSPVAGIPDAVDISAGGMHN 87
Query: 138 CGLRKPLTGKWRNYSYVDCWGYN--------MTKNYV--------FDGQIESISAGSEFN 181
L K +G + +G N +++ G+ ISAG +
Sbjct: 88 LVLTK--SGD------IYSFGCNDEGALGRDTSEDGSESKPDLIDLPGKALCISAGDSHS 139
Query: 182 CGLFSQNRTVFCWGD------------ESSSRVISLIPKEMKFQKVAAGGYHVCGILEGL 229
L VF WG + + R + + +A+G H+ +
Sbjct: 140 ACLLEDG-RVFAWGSFRDSHGNMGLTIDGNKRTPIDLMEGTVCCSIASGADHLVILTT-- 196
Query: 230 DSRTRCWGR-------------SLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACG 276
+ G R + + + P +I +
Sbjct: 197 AGKVFTVGCAEQGQLGRLSERSISGEGRRGKRDLLRPTQLIITRAKPFEAIWATNYCTFM 256
Query: 277 IKSYDRGVICWGF----------IIKPSTPVPT---GIKVYEIAAGNYFTCGVLAEKSML 323
+S + + G K P + IA G + T + +
Sbjct: 257 RESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRHIAGGQHHTVILTTDLKCS 316
Query: 324 PVCWGTG 330
G
Sbjct: 317 --VVGRP 321
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 53/366 (14%), Positives = 104/366 (28%), Gaps = 113/366 (30%)
Query: 38 GSMSSIAISYGENGPVFC-----------GLKSDRSHLVTCYGSNSAIIYGTPAHFPFIG 86
G M ++ ++ ++G ++ D S P G
Sbjct: 83 GGMHNLVLT--KSGDIYSFGCNDEGALGRDTSEDGSES-------------KPDLIDLPG 127
Query: 87 ----LTAGDGFVCGLLLDSNQPYCWGS--SGYIQMG--------VPQPIIKGAQYVEISA 132
++AGD LL + + + WGS + MG P +++G I++
Sbjct: 128 KALCISAGDSHSACLL-EDGRVFAWGSFRDSHGNMGLTIDGNKRTPIDLMEGTVCCSIAS 186
Query: 133 GDYHLCGLRKPLTGKWRNYSYVDCWGYN--------MTKNYVFDGQ-------------- 170
G HL L GK V G ++ +G+
Sbjct: 187 GADHLVILTT--AGK------VFTVGCAEQGQLGRLSERSISGEGRRGKRDLLRPTQLII 238
Query: 171 -----IESISAGSEFNCGLFSQNRTVFCWGD-----------ESSSRVISLIPKEMKFQK 214
E+I A + SQ + ++ G + + + +
Sbjct: 239 TRAKPFEAIWATNYCTFMRESQTQVIWATGLNNFKQLAHETKGKEFALTPIKTELKDIRH 298
Query: 215 VAAGGYHVCGILEGLDSRTRCWGRS----LDLEEEVSVAYSRQGNVDLPPSDPMLSIVGG 270
+A G +H + D + GR L L + V + ++ ++S+ G
Sbjct: 299 IAGGQHHTVILTT--DLKCSVVGRPEYGRLGLGDVKDVVEKPT--IVKKLTEKIVSVGCG 354
Query: 271 KFHACGIKSYDRGVICWGF----------IIKPSTPVP------TGIKVYEIAAGNYFTC 314
+ + + D + WG P+ G + + G
Sbjct: 355 EVCSYAVTI-DGKLYSWGSGVNNQLGVGDGDDELEPIVVVSKNTQGKHMLLASGGGQHAI 413
Query: 315 GVLAEK 320
L +
Sbjct: 414 -FLVKA 418
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 44/291 (15%), Positives = 66/291 (22%), Gaps = 93/291 (31%)
Query: 108 GSSGYIQMG------VPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNM 161
GS + + A+ I+ V G
Sbjct: 1 GSPRRKALTNNNNAGEAEQQPPKAKRARIAFHLELPKRRTVLGN--------VLVCGNGD 52
Query: 162 TKNYVFDGQ---------------------IESISAGSEFNCGLFSQNRTVFCWG----- 195
GQ ISAG N L ++ +G
Sbjct: 53 ------VGQLGLGEDILERKRLSPVAGIPDAVDISAGGMHNLVLTKSG-DIYSFGCNDEG 105
Query: 196 -------DESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRS------LDL 242
++ S LI K ++AG H +LE D R WG + L
Sbjct: 106 ALGRDTSEDGSESKPDLIDLPGKALCISAGDSHSACLLE--DGRVFAWGSFRDSHGNMGL 163
Query: 243 EEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWG-------------- 288
+ + +DL SI G H + + V G
Sbjct: 164 TIDGNKRTP----IDLMEGTVCCSIASGADHLVILTT-AGKVFTVGCAEQGQLGRLSERS 218
Query: 289 -------FIIKPSTPVP----TGIKVYEIAAGNYFTCGVLAEKSMLPVCWG 328
P I A NY T ++ ++ G
Sbjct: 219 ISGEGRRGKRDLLRPTQLIITRAKPFEAIWATNYCTFMRESQTQVI-WATG 268
|
| >3mvd_K Regulator of chromosome condensation; protein-DNA complex, nucleosome core particle (NCP), NCP-CHR factor complex; HET: DNA; 2.90A {Drosophila melanogaster} Length = 423 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 9e-07
Identities = 21/154 (13%), Positives = 44/154 (28%), Gaps = 26/154 (16%)
Query: 195 GDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRS----LDLEEEVSVAY 250
+ +++ P + K ++A G L L E++
Sbjct: 9 TNNNNAGEAEQQPPKAKRARIAFHLELPKRRTV--LGNVLVCGNGDVGQLGLGEDIL--- 63
Query: 251 SRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGF------------IIKPSTP-- 296
R+ + + I G H + + +G S P
Sbjct: 64 ERKRLSPVAGIPDAVDISAGGMHNLVLTK-SGDIYSFGCNDEGALGRDTSEDGSESKPDL 122
Query: 297 VPTGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTG 330
+ K I+AG+ + +L + + WG+
Sbjct: 123 IDLPGKALCISAGDSHSACLLEDGRVF--AWGSF 154
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 8e-18
Identities = 45/168 (26%), Positives = 75/168 (44%), Gaps = 26/168 (15%)
Query: 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKE-FHT-- 561
M Y LE+ +G+G++ VYK G A+KK R + E +
Sbjct: 1 MEKYHGLEK--------IGEGTYGVVYKAQNNYGETFALKKI-----RLEKEDEGIPSTT 47
Query: 562 --ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR 619
E+ +L L H++++ L + +LV+E + L + L L+ +
Sbjct: 48 IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVT--AK- 103
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
+ +Q GI Y H V+HRD+K N+LI+ E ++ADFGL+
Sbjct: 104 -SFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA 147
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 38/215 (17%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
VG G++ V + + G VA+KK + +K + EL LL + H +++ LL
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 579 ------GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+ LV FM L + + + + + Q +G++Y
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFM-QTDLQK-------IMGLKFSEEKIQYLVYQMLKGLKY 141
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
+H V+HRD+K N+ ++E+ ++ DFGL A + E+ GY+
Sbjct: 142 IHSAG---VVHRDLKPGNLAVNEDCELKILDFGL-----ARHADA--EMT----GYVVTR 187
Query: 693 YYR--------LHYLTTKSDVYSFGVLLLEILSGR 719
+YR +HY D++S G ++ E+L+G+
Sbjct: 188 WYRAPEVILSWMHY-NQTVDIWSVGCIMAEMLTGK 221
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 1e-17
Identities = 54/232 (23%), Positives = 102/232 (43%), Gaps = 44/232 (18%)
Query: 505 MFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKE-FHT- 561
M YE+LE+ +G+G++ V+K + +VA+K+ R + E +
Sbjct: 1 MQKYEKLEK--------IGEGTYGTVFKAKNRETHEIVALKRV-----RLDDDDEGVPSS 47
Query: 562 ---ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVR 618
E+ LL L H +++ L ++ LV+EF L ++ + L ++ V+
Sbjct: 48 ALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEI--VK 104
Query: 619 RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678
+ Q +G+ + H V+HRD+K N+LI+ ++A+FGL+ P+
Sbjct: 105 --SFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARA----FGIPV 155
Query: 679 AELPAG--TLGYLDPE------YYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722
A TL Y P+ Y +T D++S G + E+ + + +
Sbjct: 156 RCYSAEVVTLWYRPPDVLFGAKLY-----STSIDMWSAGCIFAELANAGRPL 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 58/214 (27%), Positives = 87/214 (40%), Gaps = 33/214 (15%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+G+G+F V LK+ V A+K K + + F E D+L + + L
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE--TACFREERDVLVNGDSKWITTL 139
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVR----RVTIAVQAARGIEY 632
Y + L LV ++ G L L L E + R + IA I+
Sbjct: 140 H-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPE--EMARFYLAEMVIA------IDS 190
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
+H +HRDIK NIL+D + R+ADFG L D + + + GT Y+ PE
Sbjct: 191 VHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISPE 246
Query: 693 ------YYRLHYLTTKS-DVYSFGVLLLEILSGR 719
+ Y D +S GV + E+L G
Sbjct: 247 ILQAMEGGKGRY--GPECDWWSLGVCMYEMLYGE 278
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-17
Identities = 43/312 (13%), Positives = 80/312 (25%), Gaps = 89/312 (28%)
Query: 85 IGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMG--------VPQPII----KGAQYVEISA 132
+ L G+ + + + Y G ++G P + + V +++
Sbjct: 56 VQLIGGEQTLF-AVTADGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNS 114
Query: 133 GDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQ---------------------- 170
G H L G+ V WG DG+
Sbjct: 115 GGKHCLALSS--EGE------VYSWGEAE------DGKLGHGNRSPCDRPRVIESLRGIE 160
Query: 171 IESISAGSEFNCGLFSQNRTVFCWGDESS------SRVISLIPKE------MKFQKVA-- 216
+ ++AG + + + ++ WG L PK + +A
Sbjct: 161 VVDVAAGGAHSACV-TAAGDLYTWGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVDIACG 219
Query: 217 AGGYHVCGILEGLDSRTRCWGRS----LDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKF 272
+G + + D WG L + +D ++ + G
Sbjct: 220 SGDAQTLCLTD--DDTVWSWGDGDYGKLGRGGSDGCKVPMK--IDSLTGLGVVKVECGSQ 275
Query: 273 HACGIKSYDRGVICWGF----------IIKPSTPVP----TGIKVYEIAAGNYFTCGVLA 318
+ + V WG P G KV IA G+
Sbjct: 276 FSVALTK-SGAVYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIATGSLHCVCCTE 334
Query: 319 EKSMLPVCWGTG 330
+ + WG
Sbjct: 335 DGEVY--TWGDN 344
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 5e-17
Identities = 51/302 (16%), Positives = 92/302 (30%), Gaps = 77/302 (25%)
Query: 89 AGDGFVCGLLLDSNQPYCWGSSGYIQMG--------VPQPI--IKGAQYVEISAGDYHLC 138
+ S Y WG + Q+G VP P + + V++ G+ L
Sbjct: 8 SSGRENL-YFQGSGTIYGWGHNHRGQLGGIEGAKVKVPTPCEALATLRPVQLIGGEQTLF 66
Query: 139 GLRKPLTGKWRNYSYVDCWGYN--------MTKNYVFDGQIE----------SISAGSEF 180
+ GK + GY T++ +E ++++G +
Sbjct: 67 AVTA--DGK------LYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNSGGKH 118
Query: 181 NCGLFSQNRTVFCWGDESS------SRVISLIPK------EMKFQKVAAGGYHVCGILEG 228
L S V+ WG+ +R P+ ++ VAAGG H +
Sbjct: 119 CLAL-SSEGEVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGAHSACVTA- 176
Query: 229 LDSRTRCWGRS----LDLEEEVSVAYSRQGNVDLPPSDPMLSIV--GGKFHACGIKSYDR 282
WG+ L + + V+ ++ I G + D
Sbjct: 177 -AGDLYTWGKGRYGRLGHSDSEDQLKPKL--VEALQGHRVVDIACGSGDAQTLCLTD-DD 232
Query: 283 GVICWGF----------IIKPSTPVP----TGIKVYEIAAGNYFTCGVLAEKSMLPVCWG 328
V WG P+ TG+ V ++ G+ F+ + ++ WG
Sbjct: 233 TVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALTKSGAVY--TWG 290
Query: 329 TG 330
G
Sbjct: 291 KG 292
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 8e-17
Identities = 55/346 (15%), Positives = 98/346 (28%), Gaps = 93/346 (26%)
Query: 38 GSMSSIAISYGENGPVFC-----------GLKSDRSHLVTCYGSNSAIIYGTPAHFPFIG 86
G + A++ +G ++ G S I +
Sbjct: 61 GEQTLFAVT--ADGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFI-------KKVA 111
Query: 87 LTAGDGFVCGLLLDSNQPYCWGSSGYIQMG--------VPQPI--IKGAQYVEISAGDYH 136
+ +G L + Y WG + ++G P+ I ++G + V+++AG H
Sbjct: 112 VNSGGKHCL-ALSSEGEVYSWGEAEDGKLGHGNRSPCDRPRVIESLRGIEVVDVAAGGAH 170
Query: 137 LCGLRKPLTGKWRNYSYVDCWGYNM--------TKNYVFDGQIE----------SISAGS 178
+ G + WG +++ + +E + +G
Sbjct: 171 SACVTA--AGD------LYTWGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVDIACGSGD 222
Query: 179 EFNCGLFSQNRTVFCWG----------DESSSRVISLIP--KEMKFQKVAAGGYHVCGIL 226
L + + TV+ WG +V I + KV G +
Sbjct: 223 AQTLCL-TDDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSVALT 281
Query: 227 EGLDSRTRCWGR----SLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDR 282
+ WG+ L + V RQ V +++I G H D
Sbjct: 282 K--SGAVYTWGKGDYHRLGHGSDDHVRRPRQ--VQGLQGKKVIAIATGSLHCVCCTE-DG 336
Query: 283 GVICWGF----------IIKPSTPVP----TGIKVYEIAAGNYFTC 314
V WG P G KV +A G+ T
Sbjct: 337 EVYTWGDNDEGQLGDGTTNAIQRPRLVAALQGKKVNRVACGSAHTL 382
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 31/255 (12%), Positives = 70/255 (27%), Gaps = 66/255 (25%)
Query: 126 QYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNM---------------TKNYVFDGQ 170
+ + + +G + WG+N T
Sbjct: 2 HHHHHHSSGRENLYFQG--SGT------IYGWGHNHRGQLGGIEGAKVKVPTPCEALATL 53
Query: 171 -IESISAGSEFNCGLFSQNRTVFCWGDESS--------------SRVISLIPKEMKFQKV 215
+ G + + + + ++ G + + + S+ +K V
Sbjct: 54 RPVQLIGGEQTLFAV-TADGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAV 112
Query: 216 AAGGYHVCGILEGLDSRTRCWGRS----LDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGK 271
+GG H + + WG + L R ++ ++ + G
Sbjct: 113 NSGGKHCLALSS--EGEVYSWGEAEDGKLGHGNRSPCDRPRV--IESLRGIEVVDVAAGG 168
Query: 272 FHACGIKSYDRGVICWGF----------IIKPSTPVP----TGIKVYEIA--AGNYFTCG 315
H+ + + + WG P G +V +IA +G+ T
Sbjct: 169 AHSACVTA-AGDLYTWGKGRYGRLGHSDSEDQLKPKLVEALQGHRVVDIACGSGDAQTLC 227
Query: 316 VLAEKSMLPVCWGTG 330
+ + ++ WG G
Sbjct: 228 LTDDDTVW--SWGDG 240
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 2e-09
Identities = 35/179 (19%), Positives = 58/179 (32%), Gaps = 52/179 (29%)
Query: 89 AGDGFVCGLLLDSNQPYCWGSSGYIQMG--------VPQPI--IKGAQYVEISAGDYHLC 138
+GD L D + + WG Y ++G VP I + G V++ G
Sbjct: 220 SGDAQTL-CLTDDDTVWSWGDGDYGKLGRGGSDGCKVPMKIDSLTGLGVVKVECGSQFSV 278
Query: 139 GLRKPLTGKWRNYSYVDCWGYNM-------TKNYVF---------DGQIESISAGSEFNC 182
L K +G V WG + ++V ++ +I+ GS
Sbjct: 279 ALTK--SGA------VYTWGKGDYHRLGHGSDDHVRRPRQVQGLQGKKVIAIATGSLHCV 330
Query: 183 GLFSQNRTVFCWGDESS--------------SRVISLIPKEMKFQKVAAGGYHVCGILE 227
+++ V+ WGD V +L + K +VA G H
Sbjct: 331 CC-TEDGEVYTWGDNDEGQLGDGTTNAIQRPRLVAAL--QGKKVNRVACGSAHTLAWST 386
|
| >3kci_A Probable E3 ubiquitin-protein ligase HERC2; WD40, RCC1, structural genomics consortium, SGC, coiled coil, metal-binding, phosphoprotein; 1.80A {Homo sapiens} Length = 389 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 1e-06
Identities = 20/141 (14%), Positives = 37/141 (26%), Gaps = 27/141 (19%)
Query: 210 MKFQKVAAGGYHVCGILEGLDSRTRCWGRS----LDLEEEVSVAYSRQGNVDLPPSDPML 265
M + G WG + L E V + + +
Sbjct: 1 MHHHHHHSSGRENLYFQG--SGTIYGWGHNHRGQLGGIEGAKVKVPTP--CEALATLRPV 56
Query: 266 SIVGGKFHACGIKSYDRGVICWGF----------IIKPSTPVP------TGIKVYEIAAG 309
++GG+ + + D + G+ STP IK + +G
Sbjct: 57 QLIGGEQTLFAVTA-DGKLYATGYGAGGRLGIGGTESVSTPTLLESIQHVFIKKVAVNSG 115
Query: 310 NYFTCGVLAEKSMLPVCWGTG 330
+ +E + WG
Sbjct: 116 GKHCLALSSEGEVY--SWGEA 134
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 40/176 (22%), Positives = 79/176 (44%), Gaps = 33/176 (18%)
Query: 503 AQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAI---------ATSDR 552
+ +++LE+ +G G+++ VYKG+ G VA+K+ + +T+ R
Sbjct: 2 SSSSQFKQLEK--------LGNGTYATVYKGLNKTTGVYVALKE-VKLDSEEGTPSTAIR 52
Query: 553 QKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHL-HGKSKALK 611
E+ L+ L H +++ L + LV+EFM + L +++
Sbjct: 53 ---------EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTP 102
Query: 612 EQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
L+ Q +G+ + H ++HRD+K N+LI++ ++ DFGL+
Sbjct: 103 RGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 56/221 (25%), Positives = 94/221 (42%), Gaps = 34/221 (15%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
K +G+G++ V G +VA+KK I D+ + E+ +L H +++
Sbjct: 15 LKSLLGEGAYGVVCSATHKPTGEIVAIKK-IEPFDKPLFALRTLREIKILKHFKHENIIT 73
Query: 577 LL-----GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
+ E E ++ E M LH+ + ++ L + Q R ++
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELM-QTDLHRVI--STQMLSDD----HIQYFIYQTLRAVK 126
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
LHG + VIHRD+K SN+LI+ + +V DFGL+ + D S+ P G +
Sbjct: 127 VLHG-SN--VIHRDLKPSNLLINSNCDLKVCDFGLARI--IDESAADNSEPTGQQSGM-V 180
Query: 692 EY-----YR--------LHYLTTKSDVYSFGVLLLEILSGR 719
E+ YR Y + DV+S G +L E+ R
Sbjct: 181 EFVATRWYRAPEVMLTSAKY-SRAMDVWSCGCILAELFLRR 220
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 37/215 (17%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
+ VG G++ V V + G VA+KK + +K + EL LL + H +++ LL
Sbjct: 31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 90
Query: 579 ------GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
++ + LV FM L + + K + L E R + Q +G+ Y
Sbjct: 91 DVFTPDETLDDFTDFYLVMPFM-GTDLGKLM--KHEKLGED----RIQFLVYQMLKGLRY 143
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
+H +IHRD+K N+ ++E+ ++ DFGL A + E+ GY+
Sbjct: 144 IHAAG---IIHRDLKPGNLAVNEDCELKILDFGL-----ARQADS--EMT----GYVVTR 189
Query: 693 YYR--------LHYLTTKSDVYSFGVLLLEILSGR 719
+YR + Y T D++S G ++ E+++G+
Sbjct: 190 WYRAPEVILNWMRY-TQTVDIWSVGCIMAEMITGK 223
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-17
Identities = 62/259 (23%), Positives = 103/259 (39%), Gaps = 41/259 (15%)
Query: 468 SGKASKSQKTNGAGSPYQKDNGKIRP-DFDDLKIRRAQMFTYEELERATGGFKEEVGKGS 526
SG S + K ++ +F+ LK+ +GKG+
Sbjct: 122 SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKL---------------------LGKGT 160
Query: 527 FSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYC 581
F V K G A+K + I D ++ TE +L H L L Y
Sbjct: 161 FGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL---TENRVLQNSRHPFLTALK-YS 216
Query: 582 EEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640
+ +RL V E+ G L HL + + E R + ++YLH
Sbjct: 217 FQTHDRLCFVMEYANGGELFFHLS-RERVFSED----RARFYGAEIVSALDYLHSEK--N 269
Query: 641 VIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLT 700
V++RD+K N+++D++ + ++ DFGL G D ++ + GT YL PE +
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKTFCGTPEYLAPEVLEDNDYG 327
Query: 701 TKSDVYSFGVLLLEILSGR 719
D + GV++ E++ GR
Sbjct: 328 RAVDWWGLGVVMYEMMCGR 346
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 47/212 (22%), Positives = 87/212 (41%), Gaps = 32/212 (15%)
Query: 519 KEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLN 576
K+ +G G V + + G A+K + S + + E+D + H++
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKL-LYDSPKARQ------EVDHHWQASGGPHIVC 86
Query: 577 LLGYCEEGRER----LLVYEFMAHGSLHQHLHGKSKAL---KEQLDWVRRVTIAVQAARG 629
+L E L++ E M G L + + +E + +R + A+Q
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ---- 142
Query: 630 IEYLHGYACPPVIHRDIKSSNIL-IDEEHNA--RVADFGLSLLGPADSSSPLAELPAGTL 686
+LH + + HRD+K N+L +E +A ++ DFG + + + L P T
Sbjct: 143 --FLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE---TTQNALQT-PCYTP 193
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
Y+ PE D++S GV++ +L G
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 50/173 (28%), Positives = 81/173 (46%), Gaps = 36/173 (20%)
Query: 505 MFTYEELERATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAI---------ATSDRQK 554
M TY +L++ +G+G+++ VYKG K +VA+K+ I T+ R
Sbjct: 1 METYIKLDK--------LGEGTYATVYKGKSKLTDNLVALKE-IRLEHEEGAPCTAIR-- 49
Query: 555 NSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQL 614
E+ LL L HA+++ L + LV+E++ L Q+L +
Sbjct: 50 -------EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHN 101
Query: 615 DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
V+ Q RG+ Y H V+HRD+K N+LI+E ++ADFGL+
Sbjct: 102 --VK--LFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 82.6 bits (205), Expect = 4e-17
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 28/209 (13%)
Query: 522 VGKGSFSCVY---KGVLKD-GTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAHL 574
+G+GSF V+ K D + A+K KA + +K E D+L +NH +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTK---MERDILVEVNHPFI 88
Query: 575 LNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI-AVQAARGIEY 632
+ L Y + +L L+ +F+ G L L K E+ V + A +++
Sbjct: 89 VKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFTEE-----DVKFYLAELALALDH 141
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
LH +I+RD+K NIL+DEE + ++ DFGLS A GT+ Y+ PE
Sbjct: 142 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK--AYSFCGTVEYMAPE 196
Query: 693 -YYRLHYLTTKS-DVYSFGVLLLEILSGR 719
R + T+S D +SFGVL+ E+L+G
Sbjct: 197 VVNRRGH--TQSADWWSFGVLMFEMLTGT 223
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 31/214 (14%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
+G+G++ V + VA+KK I+ + Q + E+ +L R H +++ +
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENIIGIN 91
Query: 579 -----GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
E+ ++ +V + M L++ L K++ L Q RG++Y+
Sbjct: 92 DIIRAPTIEQMKDVYIVQDLM-ETDLYKLL--KTQHLSND----HICYFLYQILRGLKYI 144
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
H V+HRD+K SN+L++ + ++ DFGL A + P + Y+ +
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGL-----ARVADPDHDHTGFLTEYVATRW 196
Query: 694 YR--------LHYLTTKSDVYSFGVLLLEILSGR 719
YR Y T D++S G +L E+LS R
Sbjct: 197 YRAPEIMLNSKGY-TKSIDIWSVGCILAEMLSNR 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 47/191 (24%), Positives = 79/191 (41%), Gaps = 37/191 (19%)
Query: 490 KIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIA 548
K + + YE+L + +G+G+F V+K K G VA+KK
Sbjct: 3 KQYDSVECPFCDE--VSKYEKLAK--------IGQGTFGEVFKARHRKTGQKVALKKV-- 50
Query: 549 TSDRQKNSKE-FHT----ELDLLSRLNHAHLLNLLGYCEEGRERL--------LVYEFMA 595
+N KE F E+ +L L H +++NL+ C LV++F
Sbjct: 51 ---LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE 107
Query: 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE 655
H L L ++ + G+ Y+H ++HRD+K++N+LI
Sbjct: 108 H-DLAGLLSNVLVKFTLSE--IK--RVMQMLLNGLYYIHRNK---ILHRDMKAANVLITR 159
Query: 656 EHNARVADFGL 666
+ ++ADFGL
Sbjct: 160 DGVLKLADFGL 170
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 8e-17
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 26/207 (12%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+GKG+F V K G A+K + I D ++ TE +L H L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV---TESRVLQNTRHPFLTA 69
Query: 577 LLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI-AVQAARGIEYLH 634
L Y + +RL V E+ G L HL + + E+ R + +EYLH
Sbjct: 70 LK-YAFQTHDRLCFVMEYANGGELFFHLS-RERVFTEE-----RARFYGAEIVSALEYLH 122
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPE 692
V++RDIK N+++D++ + ++ DFGL + + GT YL PE
Sbjct: 123 SRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF----CGTPEYLAPE 175
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSGR 719
+ D + GV++ E++ GR
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 9e-17
Identities = 65/289 (22%), Positives = 112/289 (38%), Gaps = 56/289 (19%)
Query: 519 KEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+ +G GS+ V + + VVA+KK + + + K E+ +L+RLNH H++ +
Sbjct: 58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 578 L-----GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
L E+ E +V E + L E ++ T+ G++Y
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIA-DSDFKKLFR-TPVYLTELH--IK--TLLYNLLVGVKY 171
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGL--SLLGPADSSSPLAELPAGTLGYLD 690
+H ++HRD+K +N L++++ + +V DFGL ++ P + +S L P L
Sbjct: 172 VHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 691 P------------EY-----YR--------LHYLTTKSDVYSFGVLLLEILSGRKAIDMQ 725
+ YR +Y T DV+S G + E+L+ K
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENY-TEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 726 FEEGNIVEWAVPL-------IKSGDITAILDPVLKLPSDLDALKRIANV 767
+ PL S D A D + D L I N+
Sbjct: 288 HADR------GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNI 330
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 50/264 (18%), Positives = 92/264 (34%), Gaps = 33/264 (12%)
Query: 468 SGKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSF 527
+ T P + F ++ + + +G G
Sbjct: 16 APAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGIN 75
Query: 528 SCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGR 585
V + K A+K + + + E++L R H++ ++ E
Sbjct: 76 GKVLQIFNKRTQEKFALKM-LQDCPKARR------EVELHWRASQCPHIVRIVDVYENLY 128
Query: 586 ER----LLVYEFMAHGSLHQHLHGKSKAL---KEQLDWVRRVTIAVQAARGIEYLHGYAC 638
L+V E + G L + + +E + ++ + A+Q YLH
Sbjct: 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ------YLHSIN- 181
Query: 639 PPVIHRDIKSSNIL-IDEEHNA--RVADFGLSLLGPADSSSPLAELPAGTLGYLDPE-YY 694
+ HRD+K N+L + NA ++ DFG + S + L P T Y+ PE
Sbjct: 182 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKE--TTSHNSLTT-PCYTPYYVAPEVLG 236
Query: 695 RLHYLTTKSDVYSFGVLLLEILSG 718
Y D++S GV++ +L G
Sbjct: 237 PEKY-DKSCDMWSLGVIMYILLCG 259
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 36/198 (18%), Positives = 78/198 (39%), Gaps = 34/198 (17%)
Query: 480 AGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDG 538
G+ + G + + Y + + +G+G++ VYK +
Sbjct: 9 MGTLEAQTQGPGSMSVSAAPSATS-IDRYRRITK--------LGEGTYGEVYKAIDTVTN 59
Query: 539 TVVAVKKAIATSDRQKNSKE-FHT----ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593
VA+K+ R ++ +E E+ LL L H +++ L L++E+
Sbjct: 60 ETVAIKRI-----RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEY 114
Query: 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILI 653
+ L +++ K+ + ++ ++ + Q G+ + H +HRD+K N+L+
Sbjct: 115 AEN-DLKKYMD-KNPDVSMRV--IK--SFLYQLINGVNFCHSRR---CLHRDLKPQNLLL 165
Query: 654 DEEHNAR-----VADFGL 666
+ + DFGL
Sbjct: 166 SVSDASETPVLKIGDFGL 183
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 60/289 (20%), Positives = 108/289 (37%), Gaps = 65/289 (22%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
+ +G G V+ V VA+KK I +D ++ K E+ ++ RL+H +++ +
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKK-IVLTD-PQSVKHALREIKIIRRLDHDNIVKVF 74
Query: 579 --------------GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAV 624
G E +V E+M L L + L E+
Sbjct: 75 EILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVL--EQGPLLEE----HARLFMY 127
Query: 625 QAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-NARVADFGLSLLGPADSSSPLAELPA 683
Q RG++Y+H V+HRD+K +N+ I+ E ++ DFGL A P
Sbjct: 128 QLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGL-----ARIMDPHYSHKG 179
Query: 684 GTLGYLDPEYYR--------LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA 735
L ++YR +Y T D+++ G + E+L+G+
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNY-TKAIDMWAAGCIFAEMLTGK---------------- 222
Query: 736 VPLIKSGD----ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERP 780
L + IL+ + + + D + + +V +R E
Sbjct: 223 -TLFAGAHELEQMQLILE-SIPVVHEED-RQELLSVIPVYIRNDMTEPH 268
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 36/174 (20%)
Query: 505 MFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAI----------ATSDRQ 553
M ++++E+ +G+G++ VYK G VVA+KK I +T+ R
Sbjct: 2 MENFQKVEK--------IGEGTYGVVYKARNKLTGEVVALKK-IRLDTETEGVPSTAIR- 51
Query: 554 KNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ 613
E+ LL LNH +++ LL + LV+EF+ L + + +
Sbjct: 52 --------EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPL 102
Query: 614 LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667
++ + Q +G+ + H + V+HRD+K N+LI+ E ++ADFGL+
Sbjct: 103 -PLIK--SYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-16
Identities = 47/239 (19%), Positives = 96/239 (40%), Gaps = 41/239 (17%)
Query: 494 DFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDR 552
D++ + Y+ + + +G+G +S V++ + + + V VK +
Sbjct: 24 DYESHVVEWGNQDDYQLVRK--------LGRGKYSEVFEAINITNNEKVVVKIL-----K 70
Query: 553 QKNSKEFHTELDLLSRL-NHAHLLNLLG--YCEEGRERLLVYEFMAHGSLHQHLHGKSKA 609
K+ E+ +L L +++ L R LV+E + + Q +
Sbjct: 71 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QT 126
Query: 610 LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA-RVADFGLSL 668
L + +R + + ++Y H ++HRD+K N++ID EH R+ D+GL
Sbjct: 127 LTDYD--IRFYM--YEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGL-- 177
Query: 669 LGPADSSSPLAELPA--GTLGYLDPE---YYRLHYLTTKSDVYSFGVLLLEILSGRKAI 722
A+ P E + + PE Y+ Y D++S G +L ++ ++
Sbjct: 178 ---AEFYHPGQEYNVRVASRYFKGPELLVDYQ-MY-DYSLDMWSLGCMLASMIFRKEPF 231
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 9e-16
Identities = 44/316 (13%), Positives = 83/316 (26%), Gaps = 91/316 (28%)
Query: 77 GTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGS--SGYIQMG----------VPQPI--I 122
+ L A D C L + + Y WG+ +G P +
Sbjct: 143 PLAEGHKVVQLAATDNMSC-ALFSNGEVYAWGTFRCNEGILGFYQDKIKIQKTPWKVPTF 201
Query: 123 KGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYN-----------------MTKNY 165
V+++ G H+ L + G V WG +
Sbjct: 202 SKYNIVQLAPGKDHILFLDE--EGM------VFAWGNGQQNQLGRKVMERFRLKTLDPRP 253
Query: 166 VFDGQIESISAGSEFNCGLFSQNRTVFCWG----------DESSSRVISLIPKE------ 209
++ I++G L +++ + WG ++ + PK
Sbjct: 254 FGLRHVKYIASGENHCFAL-TKDNKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLALPDN 312
Query: 210 MKFQKVAAGGYHVCGILEGLDSRTRCWGR----------SLDLEEEVSVAYSRQGNVDLP 259
+ + +AAG +H + + D GR E + + V LP
Sbjct: 313 VVIRSIAAGEHHSLILSQ--DGDLYSCGRLDMFEVGIPKDNLPEYTYKDVHGKARAVPLP 370
Query: 260 PSDPMLS----IVGGKFHACGIKSYDRGVICWGF-----------IIKPSTPVP------ 298
+ + G H+ + + WGF P
Sbjct: 371 TKLNNVPKFKSVAAGSHHSVAVAQ-NGIAYSWGFGETYAVGLGPFEDDTEVPTRIKNTAT 429
Query: 299 TGIKVYEIAAGNYFTC 314
+ + G F+
Sbjct: 430 QDHNIILVGCGGQFSV 445
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 41/286 (14%), Positives = 80/286 (27%), Gaps = 62/286 (21%)
Query: 89 AGDGFVCGLLLDSNQPYCWGSSGYIQMG---------------VPQPIIKGAQYVEISAG 133
+ L + +CWG+ ++G P A+ + + G
Sbjct: 17 EDYKHMY-LSVQPLDIFCWGTGSMCELGLGPLAKNKEVKRPRLNPFLPRDEAKIISFAVG 75
Query: 134 DYHLCGLRKPLTGKWRNYSYVDCWGYN--------MTKNYVFDGQIESISAGSEFNCGLF 185
H L + V WG N + +++ + + + L
Sbjct: 76 GMHTLALDE--ESN------VWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLN 127
Query: 186 SQNRTVFCWGDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRS------ 239
T + + + K ++AA C + + WG
Sbjct: 128 ELEST----PAKIPRESFPPLAEGHKVVQLAATDNMSCALFS--NGEVYAWGTFRCNEGI 181
Query: 240 LDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWG----------- 288
L ++ V ++ + GK H + + V WG
Sbjct: 182 LGFYQDKIKIQKTPWKVPTFSKYNIVQLAPGKDHILFLDE-EGMVFAWGNGQQNQLGRKV 240
Query: 289 ---FIIKPSTPVPTGIK-VYEIAAGNYFTCGVLAEKSMLPVCWGTG 330
F +K P P G++ V IA+G + + ++ WG
Sbjct: 241 MERFRLKTLDPRPFGLRHVKYIASGENHCFALTKDNKLV--SWGLN 284
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 36/227 (15%), Positives = 55/227 (24%), Gaps = 72/227 (31%)
Query: 170 QIESISAGSEFNCGLFSQNRTVFCWGDESS-----------------SRVISLIPKEMKF 212
I + + Q +FCWG S L E K
Sbjct: 11 HIINAQEDYKHMYLS-VQPLDIFCWGTGSMCELGLGPLAKNKEVKRPRLNPFLPRDEAKI 69
Query: 213 QKVAAGGYHVCGILEGLDSRTRCWGR-------------------------------SLD 241
A GG H + E +S WG L+
Sbjct: 70 ISFAVGGMHTLALDE--ESNVWSWGCNDVGALGRDTSNAKEQLKDMDADDSSDDEDGDLN 127
Query: 242 LEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGF------------ 289
E R+ L ++ + +C + S + V WG
Sbjct: 128 ELESTPAKIPRESFPPLAEGHKVVQLAATDNMSCALFS-NGEVYAWGTFRCNEGILGFYQ 186
Query: 290 --IIKPSTPV----PTGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTG 330
I TP + + ++A G + E + WG G
Sbjct: 187 DKIKIQKTPWKVPTFSKYNIVQLAPGKDHILFLDEEGMVF--AWGNG 231
|
| >3of7_A Regulator of chromosome condensation; beta-propeller, guanine nucleotide exchange factor (GEF), GS histones, nucleus, cell cycle; 1.90A {Saccharomyces cerevisiae} Length = 473 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 5e-07
Identities = 36/266 (13%), Positives = 69/266 (25%), Gaps = 90/266 (33%)
Query: 32 RLVNGLGSMSSIAISYG--------ENGPVFC---------GLKSDRSHLVTCYGSNSAI 74
V + + ++ G E G VF G K +
Sbjct: 196 WKVPTFSKYNIVQLAPGKDHILFLDEEGMVFAWGNGQQNQLGRKVMERFRLKTLDPRPFG 255
Query: 75 IYGTPAHFPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMG------------VPQPI- 121
+ + +G+ L N+ WG + + Q G P+ +
Sbjct: 256 LRH------VKYIASGENHCF-ALTKDNKLVSWGLNQFGQCGVSEDVEDGALVTKPKRLA 308
Query: 122 -IKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYN-------------MTKNYVF 167
I+AG++H L + G + G
Sbjct: 309 LPDNVVIRSIAAGEHHSLILSQ--DGD------LYSCGRLDMFEVGIPKDNLPEYTYKDV 360
Query: 168 DGQ---------------IESISAGSEFNCGLFSQNRTVFCWGDESS------------- 199
G+ +S++AGS + + +QN + WG +
Sbjct: 361 HGKARAVPLPTKLNNVPKFKSVAAGSHHSVAV-AQNGIAYSWGFGETYAVGLGPFEDDTE 419
Query: 200 --SRVISLIPKEMKFQKVAAGGYHVC 223
+R+ + ++ V GG
Sbjct: 420 VPTRIKNTATQDHNIILVGCGGQFSV 445
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 34/213 (15%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+G+G+F V K V A+K K ++ +S F E D+++ N ++ L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMI--KRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVR----RVTIAVQAARGIEY 632
Y + L +V E+M G L + + + E W R V +A ++
Sbjct: 135 F-YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPE--KWARFYTAEVVLA------LDA 183
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
+H IHRD+K N+L+D+ + ++ADFG + + + GT Y+ PE
Sbjct: 184 IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPE 239
Query: 693 -----YYRLHYLTTKS-DVYSFGVLLLEILSGR 719
+Y + D +S GV L E+L G
Sbjct: 240 VLKSQGGDGYY--GRECDWWSVGVFLYEMLVGD 270
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 46/211 (21%), Positives = 93/211 (44%), Gaps = 30/211 (14%)
Query: 522 VGKGSFSCVY---KGVLKD-GTVVAVK---KA--IATSDRQKNSKEFHTELDLLSRLNHA 572
+GKG + V+ K + G + A+K KA + + ++K E ++L + H
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK---AERNILEEVKHP 81
Query: 573 HLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI-AVQAARGI 630
+++L+ Y + +L L+ E+++ G L L + E + + +
Sbjct: 82 FIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFMED-----TACFYLAEISMAL 134
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGY 688
+LH +I+RD+K NI+++ + + ++ DFGL + + GT+ Y
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF----CGTIEY 187
Query: 689 LDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
+ PE D +S G L+ ++L+G
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 60/227 (26%), Positives = 108/227 (47%), Gaps = 36/227 (15%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLL 575
+++GKG++ V+K + + G VVAVKK +++ E+ +L+ L+ H +++
Sbjct: 13 LVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIV 72
Query: 576 NLLG--YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
NLL + R+ LV+++M LH + ++ L+ + + Q + I+YL
Sbjct: 73 NLLNVLRADNDRDVYLVFDYM-ETDLHAVI--RANILEPV----HKQYVVYQLIKVIKYL 125
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGL--SLLGPADSSSPLAELPAGTLGYLDP 691
H ++HRD+K SNIL++ E + +VADFGL S + ++ + D
Sbjct: 126 HS-GG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182
Query: 692 E-----------YYR--------LHYLTTKSDVYSFGVLLLEILSGR 719
+ +YR Y T D++S G +L EIL G+
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKY-TKGIDMWSLGCILGEILCGK 228
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 60/268 (22%), Positives = 89/268 (33%), Gaps = 55/268 (20%)
Query: 523 GKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKE-FHTELDLLSRLNHAHLLNLLGY 580
G G+F +VAVK I +R E E+ L H +++
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVK-YI---ERGAAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 581 CEEGRERLLVYEFMAHGSLHQHL--HGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
++ E+ + G L++ + G+ E D R Q G+ Y H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICNAGR---FSE--DEARF--FFQQLLSGVSYCHSMQ- 136
Query: 639 PPVIHRDIKSSNILIDEEH--NARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE-YYR 695
+ HRD+K N L+D ++ DFG S S + GT Y+ PE R
Sbjct: 137 --ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLR 191
Query: 696 LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEW---AVPLIKSGD--------- 743
Y +DV+S GV L +L G FE+ + I S
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGA----YPFEDPEEPRDYRKTIQRILSVKYSIPDDIRI 247
Query: 744 -------ITAILDPVLKLPSDLDALKRI 764
I+ I D RI
Sbjct: 248 SPECCHLISRIFVA--------DPATRI 267
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 2e-15
Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 29/209 (13%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSR-LNHAHLL 575
+GKGSF V+ K A+K + D + + E +LS H L
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTM---VEKRVLSLAWEHPFLT 81
Query: 576 NLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
++ + +E L V E++ G L H+ R A + G+++LH
Sbjct: 82 HMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLS----RATFYAAEIILGLQFLH 135
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPE 692
+++RD+K NIL+D++ + ++ADFG+ + ++ GT Y+ PE
Sbjct: 136 SKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF----CGTPDYIAPE 188
Query: 693 -YYRLHYLTTKS-DVYSFGVLLLEILSGR 719
Y S D +SFGVLL E+L G+
Sbjct: 189 ILLGQKY--NHSVDWWSFGVLLYEMLIGQ 215
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 34/215 (15%)
Query: 522 VGKGSFSCVY---KGVLKD-GTVVAV----KKAIATSDRQKNSKEFHT--ELDLLSRLNH 571
+G G++ V+ K D G + A+ K I + HT E +L +
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTE----HTRTERQVLEHIRQ 117
Query: 572 AHLLNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI-AVQAARG 629
+ L L Y + +L L+ +++ G L HL + + E V I +
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLS-QRERFTEH-----EVQIYVGEIVLA 171
Query: 630 IEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS---LLGPADSSSPLAELPAGTL 686
+E+LH +I+RDIK NIL+D + + DFGLS + + + GT+
Sbjct: 172 LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDF----CGTI 224
Query: 687 GYLDPEYYR-LHYLTTKS-DVYSFGVLLLEILSGR 719
Y+ P+ R K+ D +S GVL+ E+L+G
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 78.3 bits (193), Expect = 3e-15
Identities = 48/230 (20%), Positives = 87/230 (37%), Gaps = 36/230 (15%)
Query: 519 KEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
K +G+GS+ VY VA+KK + + K E+ +L+RL +++ L
Sbjct: 31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 578 L-----GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+ E +V E L + L E+ TI G +
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADS-DLKKLFK-TPIFLTEE----HIKTILYNLLLGENF 144
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
+H +IHRD+K +N L++++ + +V DFGL+ ++ + +
Sbjct: 145 IHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 693 YYRLHYLT--------------------TKS-DVYSFGVLLLEILSGRKA 721
LT TKS D++S G + E+L+ ++
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 48/250 (19%), Positives = 93/250 (37%), Gaps = 73/250 (29%)
Query: 520 EEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
+ +G GSF V + + G A+KK + R KN ELD++ L+H +++ L+
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKK-VLQDPRYKNR-----ELDIMKVLDHVNIIKLV 66
Query: 579 GYCEEGRERL--------------------------------------LVYEFMAHGSLH 600
Y + ++ E++ +LH
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125
Query: 601 QHLHGKSKALKEQL--DWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE-H 657
+ L ++ + + + Q R + ++H + HRDIK N+L++ + +
Sbjct: 126 KVLKSFIRS-GRSIPMNLIS--IYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDN 179
Query: 658 NARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR--------LHYLTTKSDVYSFG 709
++ DFG A P + Y+ +YR Y T D++S G
Sbjct: 180 TLKLCDFGS-----AKKLIPSEPS----VAYICSRFYRAPELMLGATEY-TPSIDLWSIG 229
Query: 710 VLLLEILSGR 719
+ E++ G+
Sbjct: 230 CVFGELILGK 239
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 43/180 (23%), Positives = 72/180 (40%), Gaps = 39/180 (21%)
Query: 505 MFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHT-- 561
YE + +G G++ VYK G VA+K R N
Sbjct: 8 TSRYEPVAE--------IGVGAYGTVYKARDPHSGHFVALKSV-----RVPNGGGGGGGL 54
Query: 562 ------ELDLLSRLN---HAHLLNLL----GYCEEGRERL-LVYEFMAHGSLHQHL-HGK 606
E+ LL RL H +++ L+ + ++ LV+E + L +L
Sbjct: 55 PISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAP 113
Query: 607 SKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666
L + ++ + Q RG+++LH ++HRD+K NIL+ ++ADFGL
Sbjct: 114 PPGLPAET--IK--DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL 166
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 5e-15
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK---KAIATSDRQKNSKEFHTELDLLSR-LNHAHLLN 576
+G+GS++ V LK + A+K K + D + + TE + + NH L+
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQ--TEKHVFEQASNHPFLVG 74
Query: 577 LLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI-AVQAARGIEYLH 634
L C + RL V E++ G L H+ + + L E+ + + + + YLH
Sbjct: 75 LH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEE-----HARFYSAEISLALNYLH 127
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPE 692
+I+RD+K N+L+D E + ++ D+G+ L P D++S GT Y+ PE
Sbjct: 128 ERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----CGTPNYIAPE 180
Query: 693 -YYRLHYLTTKS-DVYSFGVLLLEILSGR 719
Y S D ++ GVL+ E+++GR
Sbjct: 181 ILRGEDY--GFSVDWWALGVLMFEMMAGR 207
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 8e-15
Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 54/263 (20%)
Query: 469 GKASKSQKTNGAGSPYQKDNGKIRP-DFDDLKIRRAQMFTYEELERATGGFKEEVGKGSF 527
G S++ NG G + ++ +F+ +++ +GKGSF
Sbjct: 1 GPKESSKEGNGIGV---NSSNRLGIDNFEFIRV---------------------LGKGSF 36
Query: 528 SCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSR-LNHAHLLNLLGYC 581
V +K+ G + AVK I D + + TE +LS NH L L C
Sbjct: 37 GKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM---TEKRILSLARNHPFLTQLF-CC 92
Query: 582 EEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPP 640
+ +RL V EF+ G L H+ KS+ E R A + + +LH
Sbjct: 93 FQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFDEA----RARFYAAEIISALMFLHDKG--- 144
Query: 641 VIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPE-YYRLH 697
+I+RD+K N+L+D E + ++ADFG+ + +++ GT Y+ PE +
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATF----CGTPDYIAPEILQEML 200
Query: 698 YLTTKS-DVYSFGVLLLEILSGR 719
Y + D ++ GVLL E+L G
Sbjct: 201 Y--GPAVDWWAMGVLLYEMLCGH 221
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 63/264 (23%), Positives = 112/264 (42%), Gaps = 51/264 (19%)
Query: 468 SGKASKSQKTNGAGSPYQKDNGKIRP-DFDDLKIRRAQMFTYEELERATGGFKEEVGKGS 526
G + +K K + + DFD L++ +G+GS
Sbjct: 26 MGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRV---------------------IGRGS 64
Query: 527 FSCVYKGVLKD-GTVVAVK---KAIATSDRQKNSKEFHTELDLLSR-LNHAHLLNLLGYC 581
++ V LK + A++ K + D + + TE + + NH L+ L C
Sbjct: 65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQ--TEKHVFEQASNHPFLVGLH-SC 121
Query: 582 EEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI-AVQAARGIEYLHGYACP 639
+ RL V E++ G L H+ + + L E+ + + + + YLH
Sbjct: 122 FQTESRLFFVIEYVNGGDLMFHMQ-RQRKLPEE-----HARFYSAEISLALNYLHERG-- 173
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPE-YYRL 696
+I+RD+K N+L+D E + ++ D+G+ L P D++S GT Y+ PE
Sbjct: 174 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTF----CGTPNYIAPEILRGE 228
Query: 697 HYLTTKS-DVYSFGVLLLEILSGR 719
Y S D ++ GVL+ E+++GR
Sbjct: 229 DY--GFSVDWWALGVLMFEMMAGR 250
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 55/377 (14%), Positives = 101/377 (26%), Gaps = 127/377 (33%)
Query: 38 GSMSSIAISYGENGPVFC-----------GLKSDRSHLVTCYGSNSAIIYGTPAHFPFIG 86
G M ++ +S ++G V+ + S +V +
Sbjct: 67 GGMHTVCLS--KSGQVYSFGCNDEGALGRDTSVEGSEMVPGK---------VELQEKVVQ 115
Query: 87 LTAGDGFVCGLLLDSNQPYCWGS--SGYIQMG---------VPQPIIKGAQYVEISAGDY 135
++AGD L D + + WGS +G VP + V++++G+
Sbjct: 116 VSAGDSHTAALT-DDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGND 174
Query: 136 HLCGLRKPLTGKWRNYSYVDCWGYN--------------------------------MTK 163
HL L G + G ++
Sbjct: 175 HLVMLTA--DGD------LYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSR 226
Query: 164 NYVFDGQIESISAGSEFNCGLFSQNRTVFCWGD-----------ESSS---RVISLIPKE 209
+ + G+ F + S V+ +G ES + S
Sbjct: 227 GSRGHVRFQDAFCGAYFTFAI-SHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNST 285
Query: 210 MKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGN--VDLPPSDPML-- 265
+ + G +H + + + GR+ Y R G S P L
Sbjct: 286 KSWVGFSGGQHHTVCMDS--EGKAYSLGRA---------EYGRLGLGEGAEEKSIPTLIS 334
Query: 266 ------SIVGGKFHACGIKSYDRGVICWGF----------IIKPSTPVP------TGIKV 303
S+ G + D V WG +PV V
Sbjct: 335 RLPAVSSVACGASVGYAVTK-DGRVFAWGMGTNYQLGTGQDEDAWSPVEMMGKQLENRVV 393
Query: 304 YEIAAGNYFTCGVLAEK 320
+++G T ++ +K
Sbjct: 394 LSVSSGGQHTVLLVKDK 410
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 49/355 (13%), Positives = 81/355 (22%), Gaps = 111/355 (31%)
Query: 89 AGDGFVCGLLLDSNQPYCWGSSGYIQMG---------VPQPIIKGAQYVEISAGDYHLCG 139
+ G Q+G P + V+ AG H
Sbjct: 15 VKVSHRS-HSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVC 73
Query: 140 LRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQ----------------------IESISAG 177
L K +G+ V +G N +G + +SAG
Sbjct: 74 LSK--SGQ------VYSFGCN------DEGALGRDTSVEGSEMVPGKVELQEKVVQVSAG 119
Query: 178 SEFNCGLFSQNRTVFCWGD-------------ESSSRVISLIPKEMKFQKVAAGGYHVCG 224
L + + VF WG S V + ++ KVA+G H+
Sbjct: 120 DSHTAAL-TDDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVM 178
Query: 225 ILEGLDSRTRCWGRS------LDLEEEVSVAYSRQGNVDLPPS------------DPMLS 266
+ D G E + + L P
Sbjct: 179 LTA--DGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQD 236
Query: 267 IVGGKFHACGIKSYDRGVICWGF----------IIKPSTPVP------TGIKVYEIAAGN 310
G + I + V +G P + + G
Sbjct: 237 AFCGAYFTFAISH-EGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQ 295
Query: 311 YFTCGVLAEKSMLPVCWG-----------TGFPTSLPLAVSPGLCKMTPCAPGYY 354
+ T + +E G S+P + L ++ A G
Sbjct: 296 HHTVCMDSEGKAY--SLGRAEYGRLGLGEGAEEKSIPTLI-SRLPAVSSVACGAS 347
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 5e-11
Identities = 39/272 (14%), Positives = 66/272 (24%), Gaps = 92/272 (33%)
Query: 128 VEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQ----------------- 170
H +P V G GQ
Sbjct: 11 KSKKVKVSHRSHSTEPGL--------VLTLGQGD------VGQLGLGENVMERKKPALVS 56
Query: 171 ----IESISAGSEFNCGLFSQNRTVFCWG------------DESSSRVISLIPKEMKFQK 214
+ AG L V+ +G E S V + + K +
Sbjct: 57 IPEDVVQAEAGGMHTVCLSKSG-QVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQ 115
Query: 215 VAAGGYHVCGILEGLDSRTRCWGRSLD------LEEEVSVAYSRQGNVDLPPSDPMLSIV 268
V+AG H + + D R WG D L E + + V + P++ +
Sbjct: 116 VSAGDSHTAALTD--DGRVFLWGSFRDNNGVIGLLEPMKKSMVP---VQVQLDVPVVKVA 170
Query: 269 GGKFHACGIKSYDRGVICWGF------------------------------IIKPSTPVP 298
G H + + D + G ++ S
Sbjct: 171 SGNDHLVMLTA-DGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSR 229
Query: 299 TGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTG 330
++ + G YFT + E + +G
Sbjct: 230 GHVRFQDAFCGAYFTFAISHEGHVY--GFGLS 259
|
| >1a12_A RCC1, regulator of chromosome condensation 1; guanine nucleotide exchange factor, GEF, RAN, RAS-like nuclear GTP binding protein; 1.70A {Homo sapiens} SCOP: b.69.5.1 PDB: 1i2m_B Length = 413 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 22/142 (15%), Positives = 41/142 (28%), Gaps = 26/142 (18%)
Query: 207 PKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRS----LDLEEEVSVAYSRQGNVDLPPSD 262
P + + H E G+ L L E V + +
Sbjct: 5 PADAIPKSKKVKVSHRSHSTE--PGLVLTLGQGDVGQLGLGENVMERKKP---ALVSIPE 59
Query: 263 PMLSIVGGKFHACGIKSYDRGVICWGF----------IIKPSTPVPT----GIKVYEIAA 308
++ G H + V +G ++ S VP KV +++A
Sbjct: 60 DVVQAEAGGMHTVCLSK-SGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSA 118
Query: 309 GNYFTCGVLAEKSMLPVCWGTG 330
G+ T + + + WG+
Sbjct: 119 GDSHTAALTDDGRVF--LWGSF 138
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 33/211 (15%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK---KAIATSDRQKNSKEFHT--ELD-LLSRLNHAHL 574
+GKGSF V K AVK K +++ H E + LL + H L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEK----HIMSERNVLLKNVKHPFL 101
Query: 575 LNLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTI-AVQAARGIEY 632
+ L + + ++L V +++ G L HL + + E R A + A + Y
Sbjct: 102 VGLH-FSFQTADKLYFVLDYINGGELFYHLQ-RERCFLEP-----RARFYAAEIASALGY 154
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLD 690
LH +++RD+K NIL+D + + + DFGL + ++S GT YL
Sbjct: 155 LHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTF----CGTPEYLA 207
Query: 691 PE-YYRLHYLTTKS-DVYSFGVLLLEILSGR 719
PE ++ Y ++ D + G +L E+L G
Sbjct: 208 PEVLHKQPY--DRTVDWWCLGAVLYEMLYGL 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 2e-14
Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 25/207 (12%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+GKGSF V K + AVK K + D E +L+ L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM--VEKRVLALPGKPPFLTQ 406
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L C + +RL V E++ G L H+ + KE V A + A G+ +L
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEP----HAVFYAAEIAIGLFFLQSK 461
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPE-Y 693
+I+RD+K N+++D E + ++ADFG+ + ++ GT Y+ PE
Sbjct: 462 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF----CGTPDYIAPEII 514
Query: 694 YRLHYLTTKS-DVYSFGVLLLEILSGR 719
Y KS D ++FGVLL E+L+G+
Sbjct: 515 AYQPY--GKSVDWWAFGVLLYEMLAGQ 539
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 23/206 (11%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+GKGSF V K + AVK + D + + E +L+ L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTM---VEKRVLALPGKPPFLT 84
Query: 577 LLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L C + +RL V E++ G L H+ + KE V A + A G+ +L
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFKEP----HAVFYAAEIAIGLFFLQS 139
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLDPEY 693
+I+RD+K N+++D E + ++ADFG+ + ++ GT Y+ PE
Sbjct: 140 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTF----CGTPDYIAPEI 192
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGR 719
D ++FGVLL E+L+G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 8e-14
Identities = 42/177 (23%), Positives = 76/177 (42%), Gaps = 35/177 (19%)
Query: 505 MFTYEELERATGGFKEEVGKGSFSCVYKG--VLKDGTVVAVKKAIATSDRQKNSKE-FHT 561
YE + +G+G++ V+K + G VA+K+ R + +E
Sbjct: 10 DQQYECVAE--------IGEGAYGKVFKARDLKNGGRFVALKRV-----RVQTGEEGMPL 56
Query: 562 ----ELDLLSRLN---HAHLLNLL----GYCEEGRERL-LVYEFMAHGSLHQHLHGKSKA 609
E+ +L L H +++ L + +L LV+E + L +L K
Sbjct: 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPE 114
Query: 610 LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666
+ ++ + Q RG+++LH + V+HRD+K NIL+ ++ADFGL
Sbjct: 115 PGVPTETIK--DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 4e-13
Identities = 63/261 (24%), Positives = 107/261 (40%), Gaps = 36/261 (13%)
Query: 469 GKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQ-MFTYEELERATGGFKEEVGKGSF 527
G A+ ++K + ++ K + DF +Q ++ + + +G GSF
Sbjct: 1 GNAAAAKKGSEQ-ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFD-----RIKTLGTGSF 54
Query: 528 SCVYKGVLKD-GTVVAVK---KAIATSDRQKNSKEFHT--ELDLLSRLNHAHLLNLLGYC 581
V K+ G A+K K +Q HT E +L +N L+ L
Sbjct: 55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIE----HTLNEKRILQAVNFPFLVKLEFSF 110
Query: 582 EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPV 641
++ +V E++A G + HL + E R A Q EYLH +
Sbjct: 111 KDNSNLYMVMEYVAGGEMFSHLR-RIGRFSEP---HARFYAA-QIVLTFEYLHSLD---L 162
Query: 642 IHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE--YYRLHYL 699
I+RD+K N+LID++ +V DFG + + + GT L PE + +
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGY-- 215
Query: 700 TTKS-DVYSFGVLLLEILSGR 719
K+ D ++ GVL+ E+ +G
Sbjct: 216 -NKAVDWWALGVLIYEMAAGY 235
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 4e-13
Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 31/208 (14%)
Query: 522 VGKGSFSCVYKGVLKD-GTVVAVK---KAIATSDRQKNSKEFHT--ELDLLSRLNHAHLL 575
+G GSF V+ + G A+K K I +Q HT E +LS + H ++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVE----HTNDERLMLSIVTHPFII 69
Query: 576 NLLGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
+ + +++ ++ +++ G L L KS+ V + A + +EYLH
Sbjct: 70 RMW-GTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFPNP---VAKFYAA-EVCLALEYLH 123
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE-- 692
+I+RD+K NIL+D+ + ++ DFG + P + + GT Y+ PE
Sbjct: 124 SKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVV 175
Query: 693 YYRLHYLTTKS-DVYSFGVLLLEILSGR 719
+ + KS D +SFG+L+ E+L+G
Sbjct: 176 STKPY---NKSIDWWSFGILIYEMLAGY 200
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 49/235 (20%), Positives = 92/235 (39%), Gaps = 62/235 (26%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFH----TELDLLSRLNHAHL 574
++G G FS V+ + + T VA+K I + K + E+ LL R+N A
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMK--I-----VRGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 575 LNLLGYCEEGRE---RLLVYEFMAHGSLHQH------LHGKS-----KALKEQ---LDWV 617
G +LL + F G H + G++ K + + L +V
Sbjct: 78 TK---EDSMGANHILKLLDH-FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 133
Query: 618 RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA------RVADFGLSLLGP 671
++ I+ Q G++Y+H +IH DIK N+L++ + ++AD G +
Sbjct: 134 KQ--ISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD 189
Query: 672 ADSSSPLAELPAGTLGYLDPEYYR-------LHYLTTKSDVYSFGVLLLEILSGR 719
++ + YR + +D++S L+ E+++G
Sbjct: 190 EHYTN-----------SIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGD 232
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 41/213 (19%), Positives = 76/213 (35%), Gaps = 52/213 (24%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLL 575
+ +G G V + K A+K + + + E++L R H++
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKM-LQDCPKARR------EVELHWRASQCPHIV 74
Query: 576 NLLGYCEEGRER----LLVYEFMAHGSLHQHLHGKSKAL---KEQLDWVRRVTIAVQAAR 628
++ E L+V E + G L + + +E + ++ + A+Q
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ--- 131
Query: 629 GIEYLHGYACPPVIHRDIKSSNIL-IDEEHNA--RVADFGLSLLGPADSSSPLAELPAGT 685
YLH + HRD+K N+L + NA ++ DFG +
Sbjct: 132 ---YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA------------------ 167
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSG 718
E Y D++S GV++ +L G
Sbjct: 168 -----KETTGEKY-DKSCDMWSLGVIMYILLCG 194
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 29/168 (17%), Positives = 62/168 (36%), Gaps = 31/168 (18%)
Query: 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYC 581
+G+G F C+Y + V ++ TEL R + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQ--KWI 100
Query: 582 EEGRERLL----VYEFMAHGSLHQH-------LHGKSKALKEQLDWVRR-------VTIA 623
+ + L + H + G L++ + + + ++
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANAKRFSRKTVLQLS 158
Query: 624 VQAARGIEYLH--GYACPPVIHRDIKSSNILIDEEHNARV--ADFGLS 667
++ +EY+H Y +H DIK+SN+L++ ++ +V D+GL+
Sbjct: 159 LRILDILEYIHEHEY-----VHGDIKASNLLLNYKNPDQVYLVDYGLA 201
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 64/230 (27%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFH----TELDLLSRLNHA-- 572
+GKGSF V K + VA+K I KN K F E+ LL +N
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIK-II------KNKKAFLNQAQIEVRLLELMNKHDT 112
Query: 573 ----HLLNLLGY-------CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ---LDWVR 618
++++L + C LV+E + +L+ L + + L+ R
Sbjct: 113 EMKYYIVHLKRHFMFRNHLC-------LVFEML-SYNLYDLL----RNTNFRGVSLNLTR 160
Query: 619 RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA--RVADFGLSLLGPADSSS 676
+ A Q + +L +IH D+K NIL+ + ++ DFG SS
Sbjct: 161 K--FAQQMCTALLFLATPELS-IIHCDLKPENILLCNPKRSAIKIVDFG--------SSC 209
Query: 677 PLAELPAGTLGYLDPEYYR-------LHYLTTKSDVYSFGVLLLEILSGR 719
L + Y+ +YR + Y D++S G +L+E+ +G
Sbjct: 210 QLGQRIY---QYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE 255
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 36/161 (22%), Positives = 60/161 (37%), Gaps = 31/161 (19%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
+++G G+F + G L VA+K S + E+ + + +
Sbjct: 15 KKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF---YKQLGSGDGIPQVY 71
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR-------VTIAVQAARGIE 631
+ G+ +V E L G S L++ D R + IA+Q +E
Sbjct: 72 YFGPCGKYNAMVLE----------LLGPS--LEDLFDLCDRTFSLKTVLMIAIQLISRME 119
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNAR-----VADFGLS 667
Y+H I+RD+K N LI N + DF L+
Sbjct: 120 YVHSKNL---IYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 37/160 (23%), Positives = 63/160 (39%), Gaps = 31/160 (19%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA-HLLNL 577
++G GSF +Y G + G VA+K + + E + + + +
Sbjct: 15 RKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESK----IYKMMQGGVGIPTI 70
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR-------VTIAVQAARGI 630
EG ++V E L G S L++ ++ R + +A Q I
Sbjct: 71 RWCGAEGDYNVMVME----------LLGPS--LEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 631 EYLHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLS 667
EY+H IHRD+K N L+ + + + DFGL+
Sbjct: 119 EYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 155
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 66/230 (28%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFH----TELDLLSRLNHA-- 572
+ +GKGSF V K K VA+K + +N K FH E+ +L L
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK-MV------RNEKRFHRQAAEEIRILEHLRKQDK 155
Query: 573 ----HLLNLLGY-------CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ---LDWVR 618
+++++L C + +E + +L++ + K K Q L VR
Sbjct: 156 DNTMNVIHMLENFTFRNHIC-------MTFELL-SMNLYELI----KKNKFQGFSLPLVR 203
Query: 619 RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA--RVADFGLSLLGPADSSS 676
+ A + ++ LH +IH D+K NIL+ ++ + +V DFG S +
Sbjct: 204 K--FAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258
Query: 677 PLAELPAGTLGYLDPEYYR-------LHYLTTKSDVYSFGVLLLEILSGR 719
Y+ +YR Y D++S G +L E+L+G
Sbjct: 259 -----------YIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGY 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 39/161 (24%), Positives = 66/161 (40%), Gaps = 31/161 (19%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
+G+GSF +++G L + VA+K SD + E+ T + N+
Sbjct: 16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT---YKLLAGCTGIPNVY 72
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR-------VTIAVQAARGIE 631
+ +EG +LV + L G S L++ LD R A Q ++
Sbjct: 73 YFGQEGLHNVLVID----------LLGPS--LEDLLDLCGRKFSVKTVAMAAKQMLARVQ 120
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNAR-----VADFGLS 667
+H + +++RDIK N LI ++ V DFG+
Sbjct: 121 SIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 37/192 (19%), Positives = 67/192 (34%), Gaps = 53/192 (27%)
Query: 509 EELERATGG-FK--EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELD 564
+ L+ G + +++G G F +Y A + + Q+N F EL
Sbjct: 29 KVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARH--VVKVEYQENGPLFS-ELK 85
Query: 565 LLSRLN---------HAHLLNLLG-----YC-----EEGRERLLVYEFMAHGSLHQHLHG 605
R+ L+ LG + R +V E G
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME----------RLG 135
Query: 606 KSKALKEQLDWVRRVT------IAVQAARGIEYLH--GYACPPVIHRDIKSSNILIDEEH 657
L++ + ++ +EY+H Y +H DIK++N+L+ ++
Sbjct: 136 ID--LQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEY-----VHGDIKAANLLLGYKN 188
Query: 658 NARV--ADFGLS 667
+V AD+GLS
Sbjct: 189 PDQVYLADYGLS 200
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 62.7 bits (152), Expect = 3e-10
Identities = 36/160 (22%), Positives = 65/160 (40%), Gaps = 31/160 (19%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA-HLLNL 577
++G GSF +Y G ++ VA+K + + E + L + N+
Sbjct: 13 RKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESK----IYRILQGGTGIPNV 68
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR-------VTIAVQAARGI 630
+ EG +LV + L G S L++ ++ R + +A Q +
Sbjct: 69 RWFGVEGDYNVLVMD----------LLGPS--LEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 631 EYLHGYACPPVIHRDIKSSNILI---DEEHNARVADFGLS 667
E++H + +HRDIK N L+ + + DFGL+
Sbjct: 117 EFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLA 153
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 57.6 bits (138), Expect = 7e-09
Identities = 29/193 (15%), Positives = 55/193 (28%), Gaps = 54/193 (27%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKK------AIATSDRQKNSKEFHTELDLLSRL---- 569
E++G+G F V++ + T VA+K + QK +E E+ + L
Sbjct: 26 EKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLS 84
Query: 570 -----NHAHLLNLLG-YCEEGR-----------------------------ERLLVYEFM 594
+ L +C +G + +V EF
Sbjct: 85 GEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFE 144
Query: 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID 654
G + + K +I Q + HRD+ N+L+
Sbjct: 145 FGGIDLEQMRTK------LSSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGNVLLK 196
Query: 655 EEHNARVADFGLS 667
+ ++
Sbjct: 197 KTSLKKLHYTLNG 209
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 27/176 (15%), Positives = 59/176 (33%), Gaps = 47/176 (26%)
Query: 522 VGKGSFSCVYKGV---------LKDGTVVAVK-----KAIATSDRQKNSKEFHTELDLLS 567
+ + +Y+ ++K + +++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 568 RLNHAHLL---NLLGY-CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRR---- 619
+L LL +G+ + + R LV G+S L+ LD +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLP----------SLGRS--LQSALDVSPKHVLS 157
Query: 620 ----VTIAVQAARGIEYLH--GYACPPVIHRDIKSSNILIDEEHNARV--ADFGLS 667
+ +A + +E+LH Y +H ++ + NI +D E ++V A +G +
Sbjct: 158 ERSVLQVACRLLDALEFLHENEY-----VHGNVTAENIFVDPEDQSQVTLAGYGFA 208
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 49/260 (18%), Positives = 88/260 (33%), Gaps = 76/260 (29%)
Query: 522 VGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA-------- 572
+G G FS V+ ++ VA+K + S + ++ E+ LL + ++
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK--VVKSA-EHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 573 HLLNLLGYCE----EGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAAR 628
++ LL + G +V+E + H L + + KS L V++ I Q +
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVLGH-HLLKWII-KSNYQGLPLPCVKK--IIQQVLQ 157
Query: 629 GIEYLHGYACPPVIHRDIKSSNILI----------------------------------- 653
G++YLH +IH DIK NIL+
Sbjct: 158 GLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215
Query: 654 --------------DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYL 699
E+ ++AD G + + T Y E
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSLEVLIGSGY 270
Query: 700 TTKSDVYSFGVLLLEILSGR 719
T +D++S + E+ +G
Sbjct: 271 NTPADIWSTACMAFELATGD 290
|
| >1du3_A Death receptor 5; trail, DR5, complex; 2.20A {Homo sapiens} SCOP: g.24.1.1 g.24.1.1 g.24.1.1 PDB: 1d0g_R 2h9g_R 1za3_R 1d4v_A Length = 130 | Back alignment and structure |
|---|
Score = 46.6 bits (110), Expect = 3e-06
Identities = 14/54 (25%), Positives = 21/54 (38%), Gaps = 9/54 (16%)
Query: 349 CAPGYYEASQENAPCKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSS 402
C G + + + +C C GCP M + +CT SD C + S
Sbjct: 86 CEEGTF--------REEDSPEMCRKCRTGCPRGMVKVGDCTPWSDIECV-HKES 130
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 39/240 (16%), Positives = 85/240 (35%), Gaps = 66/240 (27%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFH----TELDLLSRLNHA-- 572
++G G+F V + + AVK + +N K++ E D+L ++ +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVK-VV------RNIKKYTRSAKIEADILKKIQNDDI 93
Query: 573 ---HLLNLLGY-------CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ---LDWVRR 619
+++ G C L++E + SL++ + ++ ++
Sbjct: 94 NNNNIVKYHGKFMYYDHMC-------LIFEPLGP-SLYEII----TRNNYNGFHIEDIKL 141
Query: 620 VTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLA 679
++ + + YL + + H D+K NIL+D+ + + +
Sbjct: 142 --YCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 680 ELPA------GTLGYLDPE--------YYR-------LHYLTTKSDVYSFGVLLLEILSG 718
+ G + YR L + SD++SFG +L E+ +G
Sbjct: 197 KSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTG 255
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 47/247 (19%), Positives = 83/247 (33%), Gaps = 84/247 (34%)
Query: 520 EEVGKGSFSCVYKGV--LKDGTVVAVKKAIATSDRQKNSKEFH----TELDLLSRLNHA- 572
+G+G+F V + + + + VA+K I +N ++ E+++L ++
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALK-II------RNVGKYREAARLEINVLKKIKEKD 77
Query: 573 -----HLLNLLGY-------CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ---LDWV 617
+ + + C + +E + + + L K Q L V
Sbjct: 78 KENKFLCVLMSDWFNFHGHMC-------IAFELL-GKNTFEFL----KENNFQPYPLPHV 125
Query: 618 RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA------------------ 659
R +A Q + +LH + H D+K NIL
Sbjct: 126 RH--MAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180
Query: 660 -RVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR-------LHYLTTKSDVYSFGVL 711
RVADFG S++ E + +YR L + DV+S G +
Sbjct: 181 IRVADFG--------SATFDHEHHT---TIVATRHYRPPEVILELGW-AQPCDVWSIGCI 228
Query: 712 LLEILSG 718
L E G
Sbjct: 229 LFEYYRG 235
|
| >4fhq_A Tumor necrosis factor receptor superfamily member; cysteine rich domain, TNF receptor, structural genomics, PSI protein structure initiative; 2.25A {Homo sapiens} PDB: 2aw2_B* Length = 134 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 1e-04
Identities = 9/57 (15%), Positives = 16/57 (28%), Gaps = 7/57 (12%)
Query: 348 PCAPGYYEASQENAPCKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCF 404
C+PG++ Q+ C + C + T D +C
Sbjct: 84 GCSPGHFCIVQDGDHCAA-----CRAYAT-SSPGQRVQKGGTESQDTLCT-GHHHHH 133
|
| >3me4_A Tumor necrosis factor receptor superfamily member; RANK, rankl, rankl-RANK complex, tnfsf11, tnfrsf11A, TNF SUP signaling protein; 2.01A {Mus musculus} PDB: 3me2_R 3qbq_B 3nzy_B Length = 216 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 4e-04
Identities = 10/58 (17%), Positives = 20/58 (34%), Gaps = 8/58 (13%)
Query: 348 PCAPGYYEASQENAPCKSPNAHVCITCSNGCPVEMYQTAECTLKSDRVCEYNCSSCFS 405
PC G++ + C +N + + + T +SD VC + +
Sbjct: 152 PCLLGFFSDV-------FSSTDKCKPWTNCTLLGKLEAHQGTTESDVVCS-SSMTLRR 201
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 42.6 bits (101), Expect = 4e-04
Identities = 50/247 (20%), Positives = 89/247 (36%), Gaps = 84/247 (34%)
Query: 520 EEVGKGSFSCVYKGV--LKDGTVVAVKKAIATSDRQKNSKEFH----TELDLLSRLNHA- 572
+ +G+G+F V + + G VAVK + KN + +E+ +L LN
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVK-IV------KNVDRYCEAARSEIQVLEHLNTTD 72
Query: 573 -----HLLNLLGY-------CEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ---LDWV 617
+ +L + C +V+E + S + + K LD +
Sbjct: 73 PNSTFRCVQMLEWFEHHGHIC-------IVFELL-GLSTYDFI----KENGFLPFRLDHI 120
Query: 618 RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNA------------------ 659
R+ +A Q + + +LH + H D+K NIL +
Sbjct: 121 RK--MAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 660 -RVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR-------LHYLTTKSDVYSFGVL 711
+V DFG S++ E + + +YR L + + DV+S G +
Sbjct: 176 IKVVDFG--------SATYDDEHHS---TLVSTRHYRAPEVILALGW-SQPCDVWSIGCI 223
Query: 712 LLEILSG 718
L+E G
Sbjct: 224 LIEYYLG 230
|
| >3u3p_A Tumor necrosis factor receptor superfamily member; trigger apoptosis, apoptosis; 2.09A {Homo sapiens} PDB: 3u3q_A 3u3s_A 3u3t_A 3u3v_A 3qo4_A Length = 313 | Back alignment and structure |
|---|
Score = 41.9 bits (97), Expect = 7e-04
Identities = 14/98 (14%), Positives = 25/98 (25%), Gaps = 16/98 (16%)
Query: 340 SPGLCKM-TPCAPGYYEASQEN-------APCK-------SPNAHVCITCSNGCPVEMYQ 384
S C T C G+ + C + C ++ +
Sbjct: 99 SNATCAPHTVCPVGWGVRKKGTETEDVRCKQCARGTFSDVPSSVMKCKAYTDCLSQNLVV 158
Query: 385 TAECTLKSDRVCEYNCSSCFSAECYKNCSSQFSDGLTT 422
T ++D VC S S+ ++ F
Sbjct: 159 IKPGTKETDNVCG-TLPSFSSSTSPSPGTAIFPRPEHM 195
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 914 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-68 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 8e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-57 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-56 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-55 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-54 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-54 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-51 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-50 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 7e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-48 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-46 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-42 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-42 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-38 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-37 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-37 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-37 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-36 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-36 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-35 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-34 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-34 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-33 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-30 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-28 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-17 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 3e-09 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 1e-05 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 6e-05 | |
| d1jtdb_ | 273 | b.69.5.2 (B:) beta-lactamase inhibitor protein-II, | 3e-04 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 2e-05 | |
| d1a12a_ | 401 | b.69.5.1 (A:) Regulator of chromosome condensation | 3e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (578), Expect = 3e-68
Identities = 75/282 (26%), Positives = 143/282 (50%), Gaps = 22/282 (7%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+ +G GSF VYKG VAVK T+ + + F E+ +L + H ++L
Sbjct: 12 VGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
+GY + +V ++ SL+ HLH + + + ++ + IA Q A+G++YLH
Sbjct: 70 MGYSTAPQ-LAIVTQWCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLH--- 121
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
+IHRD+KS+NI + E+ ++ DFGL+ + S S E +G++ ++ PE R+
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 698 ---YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754
+ +SDVY+FG++L E+++G+ + N + + ++ G ++ L K+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLP----YSNINNRDQIIFMVGRGYLSPDLS---KV 234
Query: 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796
S+ K + + +C++ + ERP ++ ++E L
Sbjct: 235 RSNCP--KAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (525), Expect = 1e-60
Identities = 68/306 (22%), Positives = 132/306 (43%), Gaps = 39/306 (12%)
Query: 506 FTYEELERATGGFKEEV-----------GKGSFSCVYKGVLK----DGTVVAVKKAIATS 550
FT+E+ A F +E+ G G F V G LK VA+K + +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSG 65
Query: 551 DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKAL 610
+K ++F +E ++ + +H ++++L G + +++ EFM +GSL L
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG-- 123
Query: 611 KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670
Q ++ V + A G++YL +HRD+ + NIL++ +V+DFGLS
Sbjct: 124 --QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178
Query: 671 PADSSSPL---AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFE 727
D+S P A + + PE + T+ SDV+S+G+++ E++S +
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 728 EGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787
+++ ++ +LP +D + + C + RP ++
Sbjct: 239 NQDVINA-------------IEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 788 ALERAL 793
L++ +
Sbjct: 286 TLDKMI 291
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-60
Identities = 71/299 (23%), Positives = 129/299 (43%), Gaps = 34/299 (11%)
Query: 492 RPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSD 551
+P ++D E L+ E +G G F V+ G T VAVK
Sbjct: 1 KPWWED-----EWEVPRETLK-----LVERLGAGQFGEVWMGYYNGHTKVAVKSL---KQ 47
Query: 552 RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALK 611
+ F E +L+ +L H L+ L + ++ E+M +GSL L S
Sbjct: 48 GSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSG--- 103
Query: 612 EQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671
+L + + +A Q A G+ ++ IHRD++++NIL+ + + ++ADFGL+ L
Sbjct: 104 IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160
Query: 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNI 731
D+ E + + PE T KSDV+SFG+LL EI++ + +
Sbjct: 161 -DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
Query: 732 VEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
++ ++ G ++ + + + + C + R ++RP+ D + + LE
Sbjct: 220 IQN----LERG---------YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 6e-59
Identities = 66/302 (21%), Positives = 123/302 (40%), Gaps = 34/302 (11%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+E +GKG F V++G + G VAVK S R++ S E+ L H ++L
Sbjct: 7 LQESIGKGRFGEVWRGKWR-GEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGF 62
Query: 578 LGYCEEGR----ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
+ + + LV ++ HGSL +L+ + + + +A+ A G+ +L
Sbjct: 63 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHL 116
Query: 634 HGYAC-----PPVIHRDIKSSNILIDEEHNARVADFGLSLL--GPADSSSPLAELPAGTL 686
H P + HRD+KS NIL+ + +AD GL++ D+ GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 687 GYLDPEYYRLHY------LTTKSDVYSFGVLLLEILSGR------KAIDMQFEEGNIVEW 734
Y+ PE ++D+Y+ G++ EI + + + + +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 735 AVPLIKSGDITAILDPVL-KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
+V ++ L P + +AL+ +A + +C G R + ++ L +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
Query: 794 AQ 795
Q
Sbjct: 297 QQ 298
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (508), Expect = 3e-58
Identities = 77/328 (23%), Positives = 133/328 (40%), Gaps = 53/328 (16%)
Query: 491 IRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLK------DGTVVAVK 544
+ P L+ R +E + ++G+G+F V++ T+VAVK
Sbjct: 1 LNPKLLSLEYPR------NNIE-----YVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVK 49
Query: 545 KAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLH 604
+ +F E L++ ++ +++ LLG C G+ L++E+MA+G L++ L
Sbjct: 50 M-LKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR 108
Query: 605 GKSK-------------------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRD 645
S L ++ IA Q A G+ YL +HRD
Sbjct: 109 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRD 165
Query: 646 IKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDV 705
+ + N L+ E ++ADFGLS + A + ++ PE + TT+SDV
Sbjct: 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225
Query: 706 YSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIA 765
+++GV+L EI S Q G E + ++ G+I L P + +
Sbjct: 226 WAYGVVLWEIFSYGL----QPYYGMAHEEVIYYVRDGNI-------LACPENCP--LELY 272
Query: 766 NVACKCVRMRGKERPSMDKVTTALERAL 793
N+ C +RPS + L+R
Sbjct: 273 NLMRLCWSKLPADRPSFCSIHRILQRMC 300
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 9e-58
Identities = 69/274 (25%), Positives = 119/274 (43%), Gaps = 24/274 (8%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
F +E+G G F V+ G + VA+K + + ++F E +++ +L+H L+ L
Sbjct: 9 FVQEIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQL 65
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
G C E LV+EFM HG L +L + + + + + G+ YL
Sbjct: 66 YGVCLEQAPICLVFEFMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLE--- 118
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
VIHRD+ + N L+ E +V+DFG++ D + + + PE +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK-FPVKWASPEVFSFS 177
Query: 698 YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757
++KSDV+SFGVL+ E+ S K +VE I +G +L
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTG---------FRLYKP 224
Query: 758 LDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
A + + C + R ++RP+ ++ L
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE 258
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 2e-57
Identities = 67/284 (23%), Positives = 126/284 (44%), Gaps = 26/284 (9%)
Query: 521 EVGKGSFSCVYKGVLK---DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
E+G G+F V +GV + VA+K + + +++E E ++ +L++ +++ L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
+G C+ +LV E G LH+ L GK +E++ + Q + G++YL
Sbjct: 75 IGVCQ-AEALMLVMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE--- 126
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYYRL 696
+HRD+ + N+L+ H A+++DFGLS LG DS L + PE
Sbjct: 127 EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186
Query: 697 HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756
+++SDV+S+GV + E LS + +++ E + I+ G ++ P
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKP---YKKMKGPE-VMAFIEQGKR-------MECPP 235
Query: 757 DLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSP 800
+ + + C + ++RP V + L
Sbjct: 236 ECP--PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-57
Identities = 65/298 (21%), Positives = 122/298 (40%), Gaps = 36/298 (12%)
Query: 518 FKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-N 570
F + +G G+F V + VAVK + S + +EL +LS L N
Sbjct: 27 FGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSELKVLSYLGN 85
Query: 571 HAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKAL-------------KEQLDWV 617
H +++NLLG C G L++ E+ +G L L K + + LD
Sbjct: 86 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 618 RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677
++ + Q A+G+ +L IHRD+ + NIL+ ++ DFGL+ DS+
Sbjct: 146 DLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVP 737
+ + ++ PE T +SDV+S+G+ L E+ S + +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY---- 258
Query: 738 LIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795
++ ++ S A + ++ C +RP+ ++ +E+ +++
Sbjct: 259 --------KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 7e-57
Identities = 76/336 (22%), Positives = 132/336 (39%), Gaps = 49/336 (14%)
Query: 486 KDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKD------GT 539
DN DF + + F E LE F + +G G+F V
Sbjct: 14 SDNEYFYVDFREYEYDLKWEFPRENLE-----FGKVLGSGAFGKVMNATAYGISKTGVSI 68
Query: 540 VVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGS 598
VAVK + + +EL ++++L +H +++NLLG C L++E+ +G
Sbjct: 69 QVAVKM-LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 127
Query: 599 LHQHLHGKSKALKEQ------------------LDWVRRVTIAVQAARGIEYLHGYACPP 640
L +L K + E L + + A Q A+G+E+L
Sbjct: 128 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKS 184
Query: 641 VIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLT 700
+HRD+ + N+L+ ++ DFGL+ +DS+ + + ++ PE T
Sbjct: 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244
Query: 701 TKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDA 760
KSDV+S+G+LL EI S + + + ++ K+ A
Sbjct: 245 IKSDVWSYGILLWEIFSLGVNP---YPGIPVDA---------NFYKLIQNGFKMDQPFYA 292
Query: 761 LKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796
+ I + C ++RPS +T+ L QL
Sbjct: 293 TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG---CQL 325
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 195 bits (496), Expect = 8e-57
Identities = 75/305 (24%), Positives = 135/305 (44%), Gaps = 35/305 (11%)
Query: 492 RPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATS 550
P++D ++ R ++ K ++G G + VY+GV K VAVK
Sbjct: 6 SPNYDKWEMER------TDIT-----MKHKLGGGQYGEVYEGVWKKYSLTVAVKT---LK 51
Query: 551 DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKAL 610
+ +EF E ++ + H +L+ LLG C ++ EFM +G+L +L +
Sbjct: 52 EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--- 108
Query: 611 KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670
++++ V + +A Q + +EYL IHRD+ + N L+ E H +VADFGLS L
Sbjct: 109 RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165
Query: 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGN 730
D+ + A + + PE + + KSDV++FGVLL EI + + +
Sbjct: 166 TGDTYTAHAGAK-FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 224
Query: 731 IVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
+ E +L+ ++ +++ + C + +RPS ++ A E
Sbjct: 225 VYE-------------LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFE 271
Query: 791 RALAQ 795
+
Sbjct: 272 TMFQE 276
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 9e-57
Identities = 73/275 (26%), Positives = 122/275 (44%), Gaps = 30/275 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+ +GKG F V G + G VAVK ++ F E ++++L H++L+ L
Sbjct: 11 LLQTIGKGEFGDVMLGDYR-GNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 65
Query: 578 LGYCEEGRERL-LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
LG E + L +V E+MA GSL +L + + L + ++ +EYL G
Sbjct: 66 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLEG- 121
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
+HRD+ + N+L+ E++ A+V+DFGL+ + + + + PE R
Sbjct: 122 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG-----KLPVKWTAPEALRE 174
Query: 697 HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756
+TKSDV+SFG+LL EI S + ++ VP ++ G + P
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR----VPYPRIPLKDVVPRVEKG-------YKMDAPD 223
Query: 757 DLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791
+ V C + RPS ++ LE
Sbjct: 224 GCP--PAVYEVMKNCWHLDAAMRPSFLQLREQLEH 256
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-56
Identities = 65/273 (23%), Positives = 116/273 (42%), Gaps = 24/273 (8%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
F +E+G G F V G + VA+K + + EF E ++ L+H L+ L
Sbjct: 8 FLKELGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
G C + R ++ E+MA+G L +L + + + + + +EYL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLE--- 117
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
+HRD+ + N L++++ +V+DFGLS D + + + PE
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEVLMYS 176
Query: 698 YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757
++KSD+++FGVL+ EI S K +F E I G L+L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQG---------LRLYRP 223
Query: 758 LDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
A +++ + C + ERP+ + + +
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 9e-56
Identities = 66/274 (24%), Positives = 109/274 (39%), Gaps = 29/274 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
F E+G+GSF VYKG+ + VA + + + F E ++L L H +++
Sbjct: 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 72
Query: 577 LLGYCEEGRER----LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
E + +LV E M G+L +L + + Q +G+++
Sbjct: 73 FYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQF 127
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHN-ARVADFGLSLLGPADSSSPLAELPAGTLGYLDP 691
LH PP+IHRD+K NI I ++ D GL+ L A + + GT ++ P
Sbjct: 128 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV----IGTPEFMAP 182
Query: 692 EYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751
E Y Y DVY+FG+ +LE+ + I + V
Sbjct: 183 EMYEEKY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR------------VTSGV 229
Query: 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
D A+ + + C+R ER S+ +
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 2e-55
Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 28/288 (9%)
Query: 518 FKEEVGKGSFSCVYKGVLKD----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAH 573
F E +G+G F CVY G L D AVK + +F TE ++ +H +
Sbjct: 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 574 LLNLLGYCEEGRER-LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+L+LLG C L+V +M HG L + ++ + +Q A+G
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKG--- 142
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS--LLGPADSSSPLAELPAGTLGYLD 690
+ A +HRD+ + N ++DE+ +VADFGL+ + S + ++
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750
E + TTKSDV+SFGVLL E+++ + + N + V L++
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP---YPDVNTFDITVYLLQ--------GR 251
Query: 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMG 798
L P + V KC + + RPS ++ + + + +G
Sbjct: 252 RLLQPEYCP--DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 9e-55
Identities = 70/273 (25%), Positives = 125/273 (45%), Gaps = 24/273 (8%)
Query: 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
+ ++G+G F V+ G T VA+K + + F E ++ +L H L+ L
Sbjct: 21 LEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQL 77
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
E +V E+M+ GSL L G++ + L + V +A Q A G+ Y+
Sbjct: 78 YAVVSEE-PIYIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE--- 130
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
+HRD++++NIL+ E +VADFGL+ L D+ + + + PE
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYG 189
Query: 698 YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSD 757
T KSDV+SFG+LL E+ + + G + + ++ G ++P
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRV----PYPGMVNREVLDQVERG---------YRMPCP 236
Query: 758 LDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
+ + + ++ C+C R +ERP+ + + LE
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 3e-54
Identities = 60/284 (21%), Positives = 128/284 (45%), Gaps = 29/284 (10%)
Query: 518 FKEE--VGKGSFSCVYKGVLKDGT-----VVAVKKAIATSDRQKNSKEFHTELDLLSRLN 570
+ +G G F VYKG+LK + VA+K + +K +F E ++ + +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 571 HAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
H +++ L G + + +++ E+M +G+L + L K + ++ V + A G+
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGM 123
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYL 689
+YL +HRD+ + NIL++ +V+DFGLS +L ++ + +
Sbjct: 124 KYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749
PE T+ SDV+SFG+++ E+++ + + +++ ++
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK-------------AIN 227
Query: 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
+LP+ +D I + +C + RP + + L++ +
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 3e-54
Identities = 54/207 (26%), Positives = 91/207 (43%), Gaps = 13/207 (6%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
E+G G+ V+K K G V+A K I + + EL +L N +++
Sbjct: 10 KISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
G E + E M GSL Q L + + +++ +G+ YL
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLR-- 121
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRL 696
++HRD+K SNIL++ ++ DFG+S +A GT Y+ PE +
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQG 177
Query: 697 HYLTTKSDVYSFGVLLLEILSGRKAID 723
+ + +SD++S G+ L+E+ GR I
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 1e-53
Identities = 61/273 (22%), Positives = 115/273 (42%), Gaps = 22/273 (8%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+G GS+ K K DG ++ K+ S + + +E++LL L H +++
Sbjct: 8 VLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR 67
Query: 577 LLGYCEEGRERLL--VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
+ L V E+ G L + +K ++ LD + + Q ++ H
Sbjct: 68 YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECH 126
Query: 635 --GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
V+HRD+K +N+ +D + N ++ DFGL+ + D+S A+ GT Y+ PE
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVGTPYYMSPE 184
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752
KSD++S G LL E+ + F + E A I+ G
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPP----FTAFSQKELAG-KIREGKF-------R 232
Query: 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
++P + + + + ++ RPS++++
Sbjct: 233 RIPYRYS--DELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-53
Identities = 60/274 (21%), Positives = 118/274 (43%), Gaps = 26/274 (9%)
Query: 521 EVGKGSFSCVYKGVLKD---GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
E+G G+F V KG + VAVK ++ E E +++ +L++ +++ +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
+G CE +LV E G L+++L + + + Q + G++YL
Sbjct: 74 IGICEAE-SWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVSMGMKYLE--- 124
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEYYRL 696
+HRD+ + N+L+ +H A+++DFGLS L ++ + + PE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 697 HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPS 756
+ ++KSDV+SFGVL+ E S + + + +++ G+ + P+
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLEKGER-------MGCPA 233
Query: 757 DLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
+ + ++ C + RP V L
Sbjct: 234 GCP--REMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-53
Identities = 77/302 (25%), Positives = 133/302 (44%), Gaps = 38/302 (12%)
Query: 508 YEELERATGGFKEEVGKGSFSCVYKGVLK-DGTVVAVK-KAIATSDRQKNSKEFHTELDL 565
+ +++ F++ +G+G+F V K +K DG + K + + + ++F EL++
Sbjct: 9 WNDIK-----FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEV 63
Query: 566 LSRL-NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGK-----------SKALKEQ 613
L +L +H +++NLLG CE L E+ HG+L L + +
Sbjct: 64 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123
Query: 614 LDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673
L + + A ARG++YL IHRD+ + NIL+ E + A++ADFGLS
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVE 733
+ + ++ E TT SDV+S+GVLL EI+S G
Sbjct: 181 VKKTMG---RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT----PYCGMTCA 233
Query: 734 WAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
+ G +L L+ + ++ +C R + ERPS ++ +L R L
Sbjct: 234 ELYEKLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284
Query: 794 AQ 795
+
Sbjct: 285 EE 286
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 4e-53
Identities = 70/270 (25%), Positives = 111/270 (41%), Gaps = 29/270 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLL 575
+GKG F VY K ++A+K A ++ + E+++ S L H ++L
Sbjct: 10 IGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNIL 69
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L GY + L+ E+ G++++ L SK D R T + A + Y H
Sbjct: 70 RLYGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHS 124
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
VIHRDIK N+L+ ++ADFG S+ P+ + L GTL YL PE
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL----CGTLDYLPPEMIE 177
Query: 696 LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755
K D++S GVL E L G+ FE E I P
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPP----FEANTYQET---------YKRISRVEFTFP 224
Query: 756 SDLDALKRIANVACKCVRMRGKERPSMDKV 785
+ + ++ + ++ +RP + +V
Sbjct: 225 DFVT--EGARDLISRLLKHNPSQRPMLREV 252
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-52
Identities = 62/270 (22%), Positives = 110/270 (40%), Gaps = 23/270 (8%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
+ +G+G++ V V + VAVK + + E+ + LNH +++
Sbjct: 9 LVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHENVVK 67
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
G+ EG + L E+ + G L + + Q G+ YLHG
Sbjct: 68 FYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHG- 121
Query: 637 ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR- 695
+ HRDIK N+L+DE N +++DFGL+ + ++ L GTL Y+ PE +
Sbjct: 122 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 696 LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755
+ DV+S G++L +L+G +++ + K L+P K+
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKEKKT--YLNPWKKID 233
Query: 756 SDLDALKRIANVACKCVRMRGKERPSMDKV 785
S AL K + R ++ +
Sbjct: 234 SAPLALLH------KILVENPSARITIPDI 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 8e-51
Identities = 72/328 (21%), Positives = 135/328 (41%), Gaps = 36/328 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAH 573
+ +G G+F VYKG+ +G V + K + + K +KE E +++ +++ H
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 72
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
+ LLG C +L + + M G L ++ K+ + + VQ A+G+ YL
Sbjct: 73 VCRLLGICLTSTVQL-ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYL 127
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
++HRD+ + N+L+ + ++ DFGL+ L A+ AE + ++ E
Sbjct: 128 E---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753
T +SDV+S+GV + E+++ ++ E I++IL+ +
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKP---YDGIPASE----------ISSILEKGER 231
Query: 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTEVVL 813
LP + + KC + RP ++ + V+
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYL----------VIQ 281
Query: 814 GSNRMHKKSSQRSSNRSTSETDVAEAED 841
G RMH S SN + D + +D
Sbjct: 282 GDERMHLPSPT-DSNFYRALMDEEDMDD 308
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 178 bits (452), Expect = 1e-50
Identities = 58/274 (21%), Positives = 107/274 (39%), Gaps = 38/274 (13%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLLNL 577
E+G GSF VY +++ VVA+KK + + + ++ E+ L +L H + +
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 578 LGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA 637
G LV E+ + K L V + A +G+ YLH
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLH--- 132
Query: 638 CPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLH 697
+IHRD+K+ NIL+ E ++ DFG + + +S GT ++ PE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAM 186
Query: 698 Y---LTTKSDVYSFGVLLLEILSGRKAIDMQFEEG---NIVEWAVPLIKSGDITAILDPV 751
K DV+S G+ +E+ + + +I + P ++SG +
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246
Query: 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
+ C++ ++RP+ + +
Sbjct: 247 VD----------------SCLQKIPQDRPTSEVL 264
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-50
Identities = 67/287 (23%), Positives = 123/287 (42%), Gaps = 28/287 (9%)
Query: 518 FKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH 571
E+G+GSF VY+GV K T VA+K + + + EF E ++ N
Sbjct: 24 MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMKEFNC 82
Query: 572 AHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQ-----LDWVRRVTIAVQA 626
H++ LLG +G+ L++ E M G L +L A+ + + +A +
Sbjct: 83 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142
Query: 627 ARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTL 686
A G+ YL+ +HRD+ + N ++ E+ ++ DFG++ +
Sbjct: 143 ADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 199
Query: 687 GYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITA 746
++ PE + TT SDV+SFGV+L EI + + Q +G E + + G +
Sbjct: 200 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE----QPYQGLSNEQVLRFVMEGGLLD 255
Query: 747 ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
D + + + C + K RPS ++ ++++ +
Sbjct: 256 KPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 9e-50
Identities = 63/289 (21%), Positives = 115/289 (39%), Gaps = 34/289 (11%)
Query: 508 YEELERATGG-----FKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHT 561
YE + R E+G G+F VYK K+ + A K + + ++ +++
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAK--VIDTKSEEELEDYMV 58
Query: 562 ELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVT 621
E+D+L+ +H +++ LL ++ EF A G++ + + L +
Sbjct: 59 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQV 114
Query: 622 IAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAEL 681
+ Q + YLH +IHRD+K+ NIL + + ++ADFG+S +
Sbjct: 115 VCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR--RDS 169
Query: 682 PAGTLGYLDPEYYRLH-----YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV 736
GT ++ PE K+DV+S G+ L+E+ E N + +
Sbjct: 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP----HHELNPMRVLL 225
Query: 737 PLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
+ KS P L PS + KC+ R + ++
Sbjct: 226 KIAKSE------PPTLAQPSRWS--SNFKDFLKKCLEKNVDARWTTSQL 266
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 2e-49
Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 37/297 (12%)
Query: 518 FKEEVGKGSFSCVYKGVLK--------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL 569
+ +G+G+F V T VAVK + + +K+ + +E++++ +
Sbjct: 17 LGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLISEMEMMKMI 75
Query: 570 -NHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLH-----------GKSKALKEQLDWV 617
H +++NLLG C + ++ E+ + G+L ++L S +EQL
Sbjct: 76 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 135
Query: 618 RRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSP 677
V+ A Q ARG+EYL IHRD+ + N+L+ E++ ++ADFGL+
Sbjct: 136 DLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192
Query: 678 LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVP 737
+ ++ PE T +SDV+SFGVLL EI + + G VE
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS----PYPGVPVEELFK 248
Query: 738 LIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794
L+K G + PS+ + + C +RP+ ++ L+R +A
Sbjct: 249 LLKEG-------HRMDKPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 3e-49
Identities = 67/281 (23%), Positives = 108/281 (38%), Gaps = 26/281 (9%)
Query: 518 FKEEVGKGSFSCVYKGVLK----DGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHA 572
E++G GSF V +G VAVK + + +F E++ + L+H
Sbjct: 12 LLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHR 71
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+L+ L G ++ V E GSL L + R AVQ A G+ Y
Sbjct: 72 NLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLL--GTLSR--YAVQVAEGMGY 126
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDP 691
L IHRD+ + N+L+ ++ DFGL L D + E + P
Sbjct: 127 LE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 692 EYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751
E + + SD + FGV L E+ + + + N + + I
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEP---WIGLNGSQI---------LHKIDKEG 231
Query: 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792
+LP D + I NV +C + ++RP+ + L A
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 7e-49
Identities = 58/267 (21%), Positives = 114/267 (42%), Gaps = 26/267 (9%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+G+ VY + + G VA+++ +Q + E+ ++ + +++N L
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
G E +V E++A GSL + + +D + + + + +E+LH
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
VIHRDIKS NIL+ + + ++ DFG GT ++ PE
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 699 LTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDL 758
K D++S G++ +E++ G + N + + +G P L+ P L
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPP----YLNENPLRALYLIATNG------TPELQNPEKL 242
Query: 759 DALKRIANVACKCVRMRGKERPSMDKV 785
+ +C+ M ++R S ++
Sbjct: 243 S--AIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-48
Identities = 61/282 (21%), Positives = 110/282 (39%), Gaps = 27/282 (9%)
Query: 518 FKEEVGKGSFSCVYKGVLKD----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAH 573
+G+G F V++G+ VA+K ++F E + + +H H
Sbjct: 11 LGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 574 LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
++ L+G E ++ E G L L + +L D + A Q + + YL
Sbjct: 70 IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSL----DLASLILYAYQLSTALAYL 124
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
+HRDI + N+L+ ++ DFGLS DS+ A + ++ PE
Sbjct: 125 E---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPES 180
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753
T+ SDV+ FGV + EIL + +++ I++G+ L
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IENGER-------LP 229
Query: 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795
+P + + ++ KC RP ++ L L +
Sbjct: 230 MPPNCP--PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 3e-47
Identities = 54/275 (19%), Positives = 105/275 (38%), Gaps = 25/275 (9%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLL 575
F + +G+GSFS V L A+K ++ E D++SRL+H +
Sbjct: 12 FGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFV 71
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L ++ + + +G L +++ D + +EYLH
Sbjct: 72 KLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-----FDETCTRFYTAEIVSALEYLH- 125
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
+IHRD+K NIL++E+ + ++ DFG + + +S A GT Y+ PE
Sbjct: 126 --GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 696 LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755
SD+++ G ++ ++++G F GN I+ P
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLPP----FRAGNEYLI---------FQKIIKLEYDFP 230
Query: 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTALE 790
+ ++ K + + +R +++
Sbjct: 231 EKFF--PKARDLVEKLLVLDATKRLGCEEMEGYGP 263
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 66/295 (22%), Positives = 110/295 (37%), Gaps = 35/295 (11%)
Query: 518 FKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH 571
+ +G+G+F V + VAVK + + +EL +L + H
Sbjct: 17 LGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM-LKEGATHSEHRALMSELKILIHIGH 75
Query: 572 AHLLNLLGYC--EEGRERLLVYEFMAHGSLHQHLHGKSK-----------ALKEQLDWVR 618
+ L + G +++ EF G+L +L K K+ L
Sbjct: 76 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 619 RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678
+ + Q A+G+E+L IHRD+ + NIL+ E++ ++ DFGL+ D
Sbjct: 136 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 679 AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPL 738
L ++ PE T +SDV+SFGVLL EI S + I E
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVKIDEEFCRR 249
Query: 739 IKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793
+K G ++ P + C +RP+ ++ L L
Sbjct: 250 LKEG-------TRMRAPDYTT--PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (420), Expect = 8e-46
Identities = 68/342 (19%), Positives = 127/342 (37%), Gaps = 34/342 (9%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
EE+G G+F V++ G A K + + + + + E+ +S L H L+N
Sbjct: 30 IHEELGTGAFGVVHRVTERATGNNFAAKFVM--TPHESDKETVRKEIQTMSVLRHPTLVN 87
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L E+ E +++YEFM+ G L + + + ++ V Q +G+ ++H
Sbjct: 88 LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 637 ACPPVIHRDIKSSNILIDEEHNARV--ADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
+H D+K NI+ + + + DFGL+ ++ GT + PE
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVA 197
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754
+ +D++S GVL +LSG F N E + +KS D +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSP----FGGENDDE-TLRNVKSCDWNMDDSAFSGI 252
Query: 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPTEV--- 811
D R K + R ++ + ALE +P + I +
Sbjct: 253 SEDGKDFIR------KLLLADPNTRMTIHQ---ALEHPWLTPGNAPGRDSQIPSSRYTKI 303
Query: 812 --VLGSNRMHKKSSQRSSNRSTSETDVAEAEDQRFEFRAPSW 851
+ + R ++ + + + Q + R W
Sbjct: 304 RDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAFW 345
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 166 bits (420), Expect = 1e-45
Identities = 54/271 (19%), Positives = 112/271 (41%), Gaps = 26/271 (9%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
EE+G G+F V++ V G V K + + E+ ++++L+H L+N
Sbjct: 33 ILEELGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQLHHPKLIN 90
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L E+ E +L+ EF++ G L + + ++ + QA G++++H
Sbjct: 91 LHDAFEDKYEMVLILEFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 637 ACPPVIHRDIKSSNILIDEEHNARV--ADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
++H DIK NI+ + + + V DFGL+ + + ++ T + PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIV 200
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754
+ +D+++ GVL +LSG F + +E + +K D D +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL----SPFAGEDDLE-TLQNVKRCDWEFDEDAFSSV 255
Query: 755 PSDLDALKRIANVACKCVRMRGKERPSMDKV 785
+ + ++ ++R ++
Sbjct: 256 SPEAKDFIK------NLLQKEPRKRLTVHDA 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (398), Expect = 1e-43
Identities = 67/284 (23%), Positives = 111/284 (39%), Gaps = 27/284 (9%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLL 575
E +G G S V+ L+ VAVK + F E + LNH ++
Sbjct: 11 LGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 70
Query: 576 NLLGYCEE----GRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIE 631
+ E G +V E++ +L +H + + R + + A + +
Sbjct: 71 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALN 125
Query: 632 YLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL-LGPADSSSPLAELPAGTLGYLD 690
+ H +IHRD+K +NI+I + +V DFG++ + + +S GT YL
Sbjct: 126 FSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 691 PEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750
PE R + +SDVYS G +L E+L+G F + V A D
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP----FTGDSPVSVAY-QHVREDPIPPSAR 237
Query: 751 VLKLPSDLDALKRIANVACKCVRMRGKERP-SMDKVTTALERAL 793
L +DLDA+ K + + R + ++ L R
Sbjct: 238 HEGLSADLDAV------VLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (394), Expect = 2e-42
Identities = 51/329 (15%), Positives = 121/329 (36%), Gaps = 34/329 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
E++G+G F V++ V K + + E+ +L+ H ++L+
Sbjct: 9 IAEDLGRGEFGIVHRCVETSSKKTYMAKF---VKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L E E ++++EF++ + + ++ +L+ V+ Q +++LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLH-- 119
Query: 637 ACPPVIHRDIKSSNILIDEEHNARV--ADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
+ H DI+ NI+ ++ + +FG + + L Y PE +
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVH 175
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754
+ ++T +D++S G L+ +LSG F + + I + + T + ++
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGINP----FLAETNQQ-IIENIMNAEYTFDEEAFKEI 230
Query: 755 PSDLDALKRIANVACKCVRMRGKERPSMDKV------TTALERALAQLMGSPCSEQPILP 808
+ + + K R + + +ER +++ + +
Sbjct: 231 SIEAMDFVD------RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTL-KHRRYYH 283
Query: 809 TEVVLGSNRMHKKSSQRSSNRSTSETDVA 837
T + N + + S+ V+
Sbjct: 284 TLIKKDLNMVVSAARISCGGAIRSQKGVS 312
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 8e-42
Identities = 55/272 (20%), Positives = 103/272 (37%), Gaps = 27/272 (9%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
F++ +G G+FS V + +VA+K IA + E+ +L ++ H +++
Sbjct: 13 FRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHPNIVA 71
Query: 577 LLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY 636
L E G L+ + ++ G L + K + Q ++YLH
Sbjct: 72 LDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-----YTERDASRLIFQVLDAVKYLH-- 124
Query: 637 ACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
++HRD+K N+L DE+ ++DFGLS + + + GT GY+ PE
Sbjct: 125 -DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEV 180
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753
+ D +S GV+ +L G F + N + I +
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPP----FYDENDAKLFE-QILKAEYEFDSPYWDD 235
Query: 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
+ R + ++R + ++
Sbjct: 236 ISDSAKDFIR------HLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 152 bits (384), Expect = 8e-42
Identities = 61/284 (21%), Positives = 111/284 (39%), Gaps = 39/284 (13%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKK-------AIATSDRQKNSKEFHTELDLLSRL 569
KE +G+G S V + + AVK + + + Q+ + E+D+L ++
Sbjct: 7 PKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 66
Query: 570 N-HAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAAR 628
+ H +++ L E LV++ M G L +L K L I
Sbjct: 67 SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLE 121
Query: 629 GIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLG 687
I LH ++HRD+K NIL+D++ N ++ DFG S L P + + GT
Sbjct: 122 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV----CGTPS 174
Query: 688 YLDPEYYRL------HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKS 741
YL PE + D++S GV++ +L+G F + +I S
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP----FWHRKQMLMLR-MIMS 229
Query: 742 GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
G+ + L + + ++ ++R + ++
Sbjct: 230 GNYQFGSPEWDDYSDTVKDL------VSRFLVVQPQKRYTAEEA 267
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 149 bits (377), Expect = 7e-40
Identities = 56/275 (20%), Positives = 103/275 (37%), Gaps = 30/275 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLKD-GTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHA 572
+G+G F VY D G + A+K K I + + L L+S +
Sbjct: 8 VHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCP 67
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
++ + + + + M G LH HL + + + A + G+E+
Sbjct: 68 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-----YAAEIILGLEH 122
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
+H V++RD+K +NIL+DE + R++D GL+ D S GT GY+ PE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLA----CDFSKKKPHASVGTHGYMAPE 175
Query: 693 YYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751
+ + +D +S G +L ++L G F + + L
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLRGH----SPFRQHKTKDKHEIDRM------TLTMA 225
Query: 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVT 786
++LP + ++ ++ R
Sbjct: 226 VELPDSFS--PELRSLLEGLLQRDVNRRLGCLGRG 258
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 145 bits (366), Expect = 3e-39
Identities = 46/291 (15%), Positives = 97/291 (33%), Gaps = 31/291 (10%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA-HLL 575
+G+GSF +++G L + VA+K R+ ++ + E L +
Sbjct: 9 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFE----PRRSDAPQLRDEYRTYKLLAGCTGIP 64
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
N+ + +EG +LV + + + A Q ++ +H
Sbjct: 65 NVYYFGQEGLHNVLVIDLLGPSLEDLL-----DLCGRKFSVKTVAMAAKQMLARVQSIH- 118
Query: 636 YACPPVIHRDIKSSNILIDEEHN-----ARVADFGLSLLGPADSSS-----PLAELPAGT 685
+++RDIK N LI ++ V DFG+ + + +GT
Sbjct: 119 --EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 686 LGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745
Y+ + + + D+ + G + + L G + Q + + I +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGS--LPWQGLKAATNKQKYERIGEKKQS 234
Query: 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796
P+ +L + + + P D + + L +L
Sbjct: 235 ---TPLRELCAGFP--EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (363), Expect = 2e-38
Identities = 56/273 (20%), Positives = 111/273 (40%), Gaps = 30/273 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLL 575
+G GSF V+ + +G A+K R K + + E +LS + H ++
Sbjct: 8 ILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFII 67
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
+ G ++ ++ ++ +++ G L L + A + +EYLH
Sbjct: 68 RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-----PNPVAKFYAAEVCLALEYLH- 121
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
+I+RD+K NIL+D+ + ++ DFG + P + + GT Y+ PE
Sbjct: 122 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVVS 174
Query: 696 LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755
D +SFG+L+ E+L+G F + N ++ IL+ L+ P
Sbjct: 175 TKPYNKSIDWWSFGILIYEMLAGYTP----FYDSNTMKT---------YEKILNAELRFP 221
Query: 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788
+ + + ++ + + +R + T
Sbjct: 222 PFFN--EDVKDLLSRLITRDLSQRLGNLQNGTE 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (360), Expect = 2e-38
Identities = 49/289 (16%), Positives = 89/289 (30%), Gaps = 29/289 (10%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLN 576
++G GSF +Y G + G VA+K + + H E + + +
Sbjct: 11 LGRKIGSGSFGDIYLGTDIAAGEEVAIKL----ECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 577 LLGYC-EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
+ +C EG ++V E + K + +A Q IEY+H
Sbjct: 67 TIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRK-----FSLKTVLLLADQMISRIEYIHS 121
Query: 636 YACPPVIHRDIKSSNILI---DEEHNARVADFGLSLLGPADSSS-----PLAELPAGTLG 687
IHRD+K N L+ + + + DFGL+ + + GT
Sbjct: 122 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 178
Query: 688 YLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747
Y + + + D+ S G +L+ G + +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA-----ATKRQKYERISEKKM 233
Query: 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796
P+ L A C +R ++P + +
Sbjct: 234 STPIEVLCKGYP--SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 6e-38
Identities = 60/268 (22%), Positives = 101/268 (37%), Gaps = 28/268 (10%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKK-AIATSDRQKNSKEFHTELDLLSR-LNHAHL 574
+ +GKGSF V+ K A+K + + E +LS H L
Sbjct: 6 LHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 65
Query: 575 LNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLH 634
++ + V E++ G L H+ K D R A + G+++LH
Sbjct: 66 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLH 120
Query: 635 GYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYY 694
+++RD+K NIL+D++ + ++ADFG+ + GT Y+ PE
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEIL 175
Query: 695 RLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754
D +SFGVLL E+L G+ F + E +I
Sbjct: 176 LGQKYNHSVDWWSFGVLLYEMLIGQSP----FHGQDEEEL---------FHSIRMDNPFY 222
Query: 755 PSDLDALKRIANVACKCVRMRGKERPSM 782
P L+ K ++ K ++R +
Sbjct: 223 PRWLE--KEAKDLLVKLFVREPEKRLGV 248
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 62/277 (22%), Positives = 106/277 (38%), Gaps = 41/277 (14%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKK----AIATSDRQKNSKEFHTELDLLSRLNHA 572
+G G F VY G+ + D VA+K I+ N E+ LL +++
Sbjct: 8 VGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG 67
Query: 573 H--LLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
++ LL + E +L+ E + AL+E+L + Q +
Sbjct: 68 FSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL----ARSFFWQVLEAV 123
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEE-HNARVADFGLSLLGPADSSSPLAELPAGTLGYL 689
+ H V+HRDIK NILID ++ DFG L + GT Y
Sbjct: 124 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD----GTRVYS 176
Query: 690 DPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748
PE+ R H Y + V+S G+LL +++ G + FE I+
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGD----IPFEHDE---------------EII 217
Query: 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
+ + ++ C+ +R +RP+ +++
Sbjct: 218 RGQVFFRQRVS--SECQHLIRWCLALRPSDRPTFEEI 252
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 138 bits (348), Expect = 7e-37
Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 25/281 (8%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLG 579
E++G+G++ VYK G A+KK + + E+ +L L H++++ L
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 580 YCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACP 639
+ +LV+E + + L+ V + +Q GI Y H
Sbjct: 68 VIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHD---R 119
Query: 640 PVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR-LHY 698
V+HRD+K N+LI+ E ++ADFGL+ E+ TL Y P+
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV--TLWYRAPDVLMGSKK 177
Query: 699 LTTKSDVYSFGVLLLEILSGR------------KAIDMQFEEGNIVEWA-VPLIKSGDIT 745
+T D++S G + E+++G I N W V + D
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 746 AILDPVLKLPSDLDALKRIA-NVACKCVRMRGKERPSMDKV 785
+ L S L L ++ K +++ +R + +
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 7e-37
Identities = 57/277 (20%), Positives = 106/277 (38%), Gaps = 31/277 (11%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVK----KAIATSDRQKNSKEFHTELDLLSRLNHA 572
EE+G G F+ V K K G A K + +S R + ++ E+ +L + H
Sbjct: 14 TGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 73
Query: 573 HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
+++ L E + +L+ E +A G L L KE L Q G+ Y
Sbjct: 74 NVITLHEVYENKTDVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYY 128
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNAR----VADFGLSLLGPADSSSPLAELPAGTLGY 688
LH + H D+K NI++ + + + + DFGL+ + GT +
Sbjct: 129 LH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NIFGTPEF 182
Query: 689 LDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748
+ PE L ++D++S GV+ +LSG G+ + + + + +
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPF-----LGDTKQETLANVSAVNYEFED 237
Query: 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
+ + R + + K+R ++
Sbjct: 238 EYFSNTSALAKDFIR------RLLVKDPKKRMTIQDS 268
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 9e-37
Identities = 57/284 (20%), Positives = 100/284 (35%), Gaps = 28/284 (9%)
Query: 520 EEVGKGSFSCVYKGVLK-DGTVVAVK---KAIATSDRQKNSKEFHTELDLLSRLNHAHLL 575
+ +G+G F+ VYK K +VA+K + + ++ E+ LL L+H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
LL LV++FM L + +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYMLMTLQGLEYLHQ 118
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
+ ++HRD+K +N+L+DE ++ADFGL+ S + T Y PE
Sbjct: 119 H---WILHRDLKPNNLLLDENGVLKLADFGLA--KSFGSPNRAYTHQVVTRWYRAPELLF 173
Query: 696 -LHYLTTKSDVYSFGVLLLEILSGR------------KAIDMQFEEGNIVEWAVPLIKSG 742
D+++ G +L E+L I +W
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233
Query: 743 DITAILDPVLKLPSDLDALKRIA-NVACKCVRMRGKERPSMDKV 785
+T P + L A ++ R + +
Sbjct: 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 2e-36
Identities = 60/286 (20%), Positives = 107/286 (37%), Gaps = 28/286 (9%)
Query: 520 EEVGKGSFSCVYKGVLK--DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL---NHAHL 574
E+G+G++ V+K G VA+K+ + + E+ +L L H ++
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 575 LNLLGYCEEGRERLLVYEFMAHGSLHQ-HLHGKSKALKEQLDWVRRVTIAVQAARGIEYL 633
+ L C R + + Q K + + + Q RG+++L
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132
Query: 634 HGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEY 693
H V+HRD+K NIL+ ++ADFGL+ S TL Y PE
Sbjct: 133 H---SHRVVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMALTSVVVTLWYRAPEV 186
Query: 694 YRLHYLTTKSDVYSFGVLLLEILSGR---KAIDMQFEEGNIVEWA-----------VPLI 739
T D++S G + E+ + + + G I++ V L
Sbjct: 187 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246
Query: 740 KSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKV 785
+ + P+ K +D+D L + ++ KC+ +R S
Sbjct: 247 RQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRISAYSA 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-36
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+G++ VYK K G VVA+KK ++ + E+ LL LNH +++ LL
Sbjct: 8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
+ LV+EF+ + + Q +G+ + H
Sbjct: 68 DVIHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLAFCH---S 120
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE-YYRLH 697
V+HRD+K N+LI+ E ++ADFGL+ + E TL Y PE
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE--VVTLWYRAPEILLGCK 178
Query: 698 YLTTKSDVYSFGVLLLEILSGR 719
Y +T D++S G + E+++ R
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRR 200
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 7e-36
Identities = 56/336 (16%), Positives = 111/336 (33%), Gaps = 43/336 (12%)
Query: 519 KEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLN 576
+ +G G V + + A+K ++ + E++L R H++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVR 69
Query: 577 LLGYCE----EGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
++ E + L+V E + G L + + + I I+Y
Sbjct: 70 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQY 126
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHN---ARVADFGLSLLGPADSSSPLAELPAGTLGYL 689
LH + HRD+K N+L + ++ DFG + + +S P T Y+
Sbjct: 127 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYTPYYV 180
Query: 690 DPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749
PE D++S GV++ +L G I I+ G
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN-HGLAISPGMKTRIRMGQYEFPNP 239
Query: 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSPCSEQPILPT 809
++ ++ L R ++ +R ++ + M P Q
Sbjct: 240 EWSEVSEEVKMLIR------NLLKTEPTQRMTIT-----------EFMNHPWIMQSTKVP 282
Query: 810 EVVLGSNRMHKKSSQRSSNRSTSETDVAEAEDQRFE 845
+ L ++R+ K+ +R + T +E
Sbjct: 283 QTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYE 318
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 3e-35
Identities = 55/254 (21%), Positives = 98/254 (38%), Gaps = 42/254 (16%)
Query: 474 SQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKG 533
S+ T +P Q + + D K+ +G GSF VY+
Sbjct: 1 SKVTTVVATPGQGPDRPQEVSYTDTKV---------------------IGNGSFGVVYQA 39
Query: 534 VLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRER----- 587
L D G +VA+KK + ++ + + EL ++ +L+H +++ L + E+
Sbjct: 40 KLCDSGELVAIKKVL------QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93
Query: 588 -LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDI 646
LV +++ H K+ L + Q R + Y+H + HRDI
Sbjct: 94 LNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDI 148
Query: 647 KSSNILIDEE-HNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDV 705
K N+L+D + ++ DFG + P + T+ DV
Sbjct: 149 KPQNLLLDPDTAVLKLCDFGSA--KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 706 YSFGVLLLEILSGR 719
+S G +L E+L G+
Sbjct: 207 WSAGCVLAELLLGQ 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 57/295 (19%), Positives = 114/295 (38%), Gaps = 37/295 (12%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
++G+G+F V+K K G VA+KK + ++++ E+ +L L H +++NL+
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 579 GYCEEGRER--------LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
C LV++F H + K L ++RV + +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML-----L 127
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELP--AGTLGY 688
L+ ++HRD+K++N+LI + ++ADFGL+ +S TL Y
Sbjct: 128 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187
Query: 689 LDPEYYR-LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE----------GNIVEWAVP 737
PE D++ G ++ E+ + + E+ G+I P
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247
Query: 738 LIKSGDITAILDPVLKLPSDLDALKRIA-------NVACKCVRMRGKERPSMDKV 785
+ + ++ L+ V + + ++ K + + +R D
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-35
Identities = 47/203 (23%), Positives = 86/203 (42%), Gaps = 9/203 (4%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
+G+G++ V + VA+KK I+ + Q + E+ +L R H +++ +
Sbjct: 14 SYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHENIIGIN 72
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
+ ++ + L+ K + L Q RG++Y+H
Sbjct: 73 DIIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIH---S 127
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLS-LLGPADSSSPLAELPAGTLGYLDPEY-YRL 696
V+HRD+K SN+L++ + ++ DFGL+ + P + T Y PE
Sbjct: 128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 187
Query: 697 HYLTTKSDVYSFGVLLLEILSGR 719
T D++S G +L E+LS R
Sbjct: 188 KGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 1e-34
Identities = 58/271 (21%), Positives = 98/271 (36%), Gaps = 27/271 (9%)
Query: 518 FKEEVGKGSFSCVYKGVLK-DGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLL 575
+ + +GKG+F V K G A+K + TE +L H L
Sbjct: 9 YLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLT 68
Query: 576 NLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG 635
L + V E+ G L HL + R + +EYLH
Sbjct: 69 ALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLH- 122
Query: 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR 695
V++RDIK N+++D++ + ++ DFGL G +D ++ + GT YL PE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLE 178
Query: 696 LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755
+ D + GV++ E++ GR F + IL ++ P
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLP----FYNQDHERL---------FELILMEEIRFP 225
Query: 756 SDLDALKRIANVACKCVRMRGKERPSMDKVT 786
L ++ ++ K+R
Sbjct: 226 RTLS--PEAKSLLAGLLKKDPKQRLGGGPSD 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-34
Identities = 49/282 (17%), Positives = 102/282 (36%), Gaps = 25/282 (8%)
Query: 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
E++G+G++ V+K + +VA+K+ D + E+ LL L H +++ L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 579 GYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC 638
++ LV+EF LD + Q +G+ + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCH---S 119
Query: 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHY 698
V+HRD+K N+LI+ ++A+FGL+ + +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLFGAKL 178
Query: 699 LTTKSDVYSFGVLLLEILSGR------KAIDMQFEEGNIVEWAVPLIKSGDITAILD--P 750
+T D++S G + E+ + +D Q + + + +T + D P
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238
Query: 751 VLKLPSDLDALKRIANVA-------CKCVRMRGKERPSMDKV 785
P+ + + + ++ +R S ++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 7e-33
Identities = 50/222 (22%), Positives = 92/222 (41%), Gaps = 17/222 (7%)
Query: 506 FTYEELERATGGFK------EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKE 558
F +E+ + + + VG G++ V V + G VA+KK + +K
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 559 FHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVR 618
+ EL LL + H +++ LL +F GK E+L R
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDR 122
Query: 619 RVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPL 678
+ Q +G+ Y+H HRD+K N+ ++E+ ++ DFGL+ ++ + +
Sbjct: 123 IQFLVYQMLKGLRYIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV 179
Query: 679 AELPAGTLGYLDPEYYR-LHYLTTKSDVYSFGVLLLEILSGR 719
T Y PE T D++S G ++ E+++G+
Sbjct: 180 -----VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 125 bits (314), Expect = 8e-32
Identities = 53/253 (20%), Positives = 93/253 (36%), Gaps = 20/253 (7%)
Query: 469 GKASKSQKTNGAGSPYQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFS 528
G A+ ++K + S + + ++ + + +G GSF
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFD-----RIKTLGTGSFG 55
Query: 529 CVYKGV-LKDGTVVAVKK-AIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRE 586
V + G A+K + K + E +L +N L+ L ++
Sbjct: 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115
Query: 587 RLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDI 646
+V E++A G + HL + A Q EYLH +I+RD+
Sbjct: 116 LYMVMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHSL---DLIYRDL 167
Query: 647 KSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVY 706
K N+LID++ +V DFG + + + GT L PE D +
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDWW 222
Query: 707 SFGVLLLEILSGR 719
+ GVL+ E+ +G
Sbjct: 223 ALGVLIYEMAAGY 235
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 5e-30
Identities = 60/278 (21%), Positives = 109/278 (39%), Gaps = 29/278 (10%)
Query: 518 FKEEVGKGSFSCVYKGVL----KDGTVVAVK--KAIATSDRQKNSKEFHTELDLLSRLNH 571
+ +G G++ V+ G + A+K K + K ++ TE +L +
Sbjct: 28 LLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 572 A-HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGI 630
+ L+ L + + L+ +++ G L HL + + + +
Sbjct: 88 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLAL 142
Query: 631 EYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLD 690
E+LH +I+RDIK NIL+D + + DFGLS AD + A GT+ Y+
Sbjct: 143 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIEYMA 198
Query: 691 PEYYRLH--YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748
P+ R D +S GVL+ E+L+G + E+ + E + IL
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS---------RRIL 249
Query: 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVT 786
P ++ AL ++ + + K+R
Sbjct: 250 KSEPPYPQEMSAL--AKDLIQRLLMKDPKKRLGCGPRD 285
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 8e-30
Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 21/207 (10%)
Query: 520 EEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLL 578
+ +G G+ V VA+KK Q ++K + EL L+ +NH ++++LL
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 579 GYC------EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEY 632
EE ++ LV E M +LD R + Q GI++
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKH 134
Query: 633 LHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPE 692
LH IHRD+K SNI++ + ++ DFGL+ +S + T Y PE
Sbjct: 135 LHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPE 188
Query: 693 YYRLHYLTTKSDVYSFGVLLLEILSGR 719
D++S G ++ E++ +
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 117 bits (293), Expect = 4e-29
Identities = 41/242 (16%), Positives = 90/242 (37%), Gaps = 30/242 (12%)
Query: 484 YQKDNGKIRPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVA 542
Y N ++ D + + ++ + ++G+G +S V++ + + + V
Sbjct: 10 YTDVNTHRPREYWDYESHVVEWGNQDDYQ-----LVRKLGRGKYSEVFEAINITNNEKVV 64
Query: 543 VKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRERL--LVYEFMAHGSL 599
VK + K+ E+ +L L +++ L ++ R LV+E + +
Sbjct: 65 VKIL-----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 119
Query: 600 HQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEE-HN 658
Q L + + ++Y H ++HRD+K N++ID E
Sbjct: 120 KQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRK 168
Query: 659 ARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYR-LHYLTTKSDVYSFGVLLLEILS 717
R+ D+GL+ + + + PE D++S G +L ++
Sbjct: 169 LRLIDWGLAEFYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 718 GR 719
+
Sbjct: 226 RK 227
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 3e-28
Identities = 52/234 (22%), Positives = 93/234 (39%), Gaps = 24/234 (10%)
Query: 492 RPDFDDLKIRRAQMFTYEELERATGGFKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATS 550
RP F ++ + +E ER VG G++ V K G VAVKK
Sbjct: 1 RPTFYRQELNKTI---WEVPERYQ--NLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 55
Query: 551 DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR-----ERLLVYEFMAHGSLHQHLHG 605
++K + EL LL + H +++ LL R + + + L+ +
Sbjct: 56 QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK- 114
Query: 606 KSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665
++L + Q RG++Y+H HRD+K SN+ ++E+ ++ DFG
Sbjct: 115 -----CQKLTDDHVQFLIYQILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFG 166
Query: 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
L+ + + A + D++S G ++ E+L+GR
Sbjct: 167 LARHTDDEMTGY----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (274), Expect = 2e-26
Identities = 45/215 (20%), Positives = 80/215 (37%), Gaps = 18/215 (8%)
Query: 518 FKEEVGKGSFSCVYKGV-LKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA---- 572
++G G FS V+ + + T VA+K + ++ E+ LL R+N A
Sbjct: 17 LVRKLGWGHFSTVWLAKDMVNNTHVAMKI---VRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 573 -------HLLNLLGYCEEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQ 625
H+L LL + + + L K + + I+ Q
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 626 AARGIEYLHGYACPPVIHRDIKSSNILIDEE-HNARVADFGLSLLGPADSSSPLAELPAG 684
G++Y+H +IH DIK N+L++ + ++ LG A
Sbjct: 134 LLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 685 TLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR 719
T Y PE +D++S L+ E+++G
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 79.8 bits (196), Expect = 1e-17
Identities = 29/213 (13%), Positives = 57/213 (26%), Gaps = 45/213 (21%)
Query: 520 EEVGKGSFSCVYKGVLKDGTVVAVKK--------AIATSDRQKNSKEFHTELDLLSRLNH 571
+ +G+G S V+ + VK R F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 572 AHLLNLLGYCE----EGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAA 627
L L G ++ E + L++ +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV------------RVENPDEVLDMIL 113
Query: 628 RGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLG 687
+ + ++H D+ N+L+ E + DF S+ +
Sbjct: 114 EEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV----EVGEEGWR------E 159
Query: 688 YLDP------EYYRLHYLTTKSDVYSFGVLLLE 714
L+ Y+ Y T+ D+ S +L+
Sbjct: 160 ILERDVRNIITYFSRTY-RTEKDINSAIDRILQ 191
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 56.7 bits (135), Expect = 3e-09
Identities = 49/285 (17%), Positives = 82/285 (28%), Gaps = 40/285 (14%)
Query: 65 VTCYGSNSAIIYGTPAHFPFIGLTAGDGFVCG----LLLDSNQPYCWGSSGYIQMGVPQP 120
V +G N+ A P + D G L L + WG++ Q+ +P
Sbjct: 6 VVAWGGNN---DWGEATVPAEAQSGVDAIAGGYFHGLALKGGKVLGWGANLNGQLTMPAA 62
Query: 121 IIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFDGQIESISAG-SE 179
G I+AG+YH V WG N + S +
Sbjct: 63 TQSG--VDAIAAGNYHSL---------ALKDGEVIAWGGNEDGQTTVPAEARSGVDAIAA 111
Query: 180 FNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRS 239
++ + S ++ + GG + ++
Sbjct: 112 GAWASYALKDGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTALAVKNGGVIAWGDNYF 171
Query: 240 LDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPT 299
G +P + D VI WG T VPT
Sbjct: 172 --------------GQTTVPAEAQSGVDDVAGGIFHSLALKDGKVIAWGDNRYKQTTVPT 217
Query: 300 GI--KVYEIAAGNYFTCGVLAEKSMLPVCWGTGF--PTSLPLAVS 340
V IA+G +++ + K+ + WG+ P+S+ VS
Sbjct: 218 EALSGVSAIASGEWYSLAL---KNGKVIAWGSSRTAPSSVQSGVS 259
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 45.5 bits (106), Expect = 1e-05
Identities = 22/86 (25%), Positives = 33/86 (38%), Gaps = 11/86 (12%)
Query: 99 LDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWG 158
L + WG + Y Q VP + G I++G+++ L+ GK V WG
Sbjct: 197 LKDGKVIAWGDNRYKQTTVPTEALSGV--SAIASGEWYSLALK---NGK------VIAWG 245
Query: 159 YNMTKNYVFDGQIESISAGSEFNCGL 184
+ T + SI AG L
Sbjct: 246 SSRTAPSSVQSGVSSIEAGPNAAYAL 271
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 43.6 bits (101), Expect = 6e-05
Identities = 27/200 (13%), Positives = 54/200 (27%), Gaps = 15/200 (7%)
Query: 190 TVFCWGDESSSRVISLIPKEM-KFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSV 248
+V WG + ++ + +A G +H + G + WG +
Sbjct: 5 SVVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLALKGG---KVLGWGAN--------- 52
Query: 249 AYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAA 308
+ Q + + +I G +H+ +K + + + P V IAA
Sbjct: 53 -LNGQLTMPAATQSGVDAIAAGNYHSLALKDGEVIAWGGNEDGQTTVPAEARSGVDAIAA 111
Query: 309 GNYFTCGVLAEKSMLPVCWGTGFPTSLPLAVSPGLCKMTPCAPGYYEASQENAPCKSPNA 368
G + + + K + G T G+ + N
Sbjct: 112 GAWASYALKDGKVIAWGDDSDGQTTVPAE-AQSGVTALDGGVYTALAVKNGGVIAWGDNY 170
Query: 369 HVCITCSNGCPVEMYQTAEC 388
T + A
Sbjct: 171 FGQTTVPAEAQSGVDDVAGG 190
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} Length = 273 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Score = 41.3 bits (95), Expect = 3e-04
Identities = 23/177 (12%), Positives = 45/177 (25%), Gaps = 23/177 (12%)
Query: 102 NQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNM 161
+ + G G + V G + ++ D +
Sbjct: 119 LKDGKVIAWGDDSDGQTTVPAEAQSGVTALDGGVYTA----LAVKNGGVIAWGDNYFGQT 174
Query: 162 TKNYVFDGQIESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQKVAAGGYH 221
T ++ ++ G + L + V WGD + +A+G ++
Sbjct: 175 TVPAEAQSGVDDVAGGIFHSLALK--DGKVIAWGDNRYKQTTVPTEALSGVSAIASGEWY 232
Query: 222 VCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIK 278
+ G + WG S + SI G A +K
Sbjct: 233 SLALKNG---KVIAWGSS--------------RTAPSSVQSGVSSIEAGPNAAYALK 272
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.6 bits (106), Expect = 2e-05
Identities = 40/307 (13%), Positives = 69/307 (22%), Gaps = 23/307 (7%)
Query: 38 GSMSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGTPAHFPFIGLTAGDGFVCGL 97
G M ++ +S ++G V+ +D L + + + G
Sbjct: 55 GGMHTVCLS--KSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTA 112
Query: 98 LLDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCW 157
L + S GV + + + + + + +
Sbjct: 113 ALTDDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVP--VVKVASGNDHLVMLTAD 170
Query: 158 GYNMTKNYVFDGQIESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQKVAA 217
G T GQ+ + G R + SR ++FQ
Sbjct: 171 GDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSR---GHVRFQDAFC 227
Query: 218 GGYHVCGIL-EGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACG 276
G Y I EG + Q S G H
Sbjct: 228 GAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTV 287
Query: 277 IKSYDRGVICWGFI-------------IKPSTPVPTGIKVYEIAAGNYFTCGVLAEKSML 323
+ G T + V +A G V + +
Sbjct: 288 CMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVTKDGRV- 346
Query: 324 PVCWGTG 330
WG G
Sbjct: 347 -FAWGMG 352
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} Length = 401 | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.7 bits (96), Expect = 3e-04
Identities = 27/245 (11%), Positives = 57/245 (23%), Gaps = 22/245 (8%)
Query: 97 LLLDSNQPYCWGSSGYIQMG---------VPQPIIKGAQYVEISAGDYHLCGLRKPLTGK 147
+ G Q+G P + V+ AG H L K +G+
Sbjct: 10 HSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSK--SGQ 67
Query: 148 WRNYSYVDCWGYN-----MTKNYVFDGQIESISAGSEFNCGLFSQNRTVFCWGDESSSRV 202
V +G N V ++ + S + +
Sbjct: 68 ------VYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDGRVF 121
Query: 203 ISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDLPPSD 262
+ ++ + + + + V +
Sbjct: 122 LWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVMLTADGDLYTLGCGEQ 181
Query: 263 PMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGNYFTCGVLAEKSM 322
L V F G + ++ ++ S ++ + G YFT + E +
Sbjct: 182 GQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAISHEGHV 241
Query: 323 LPVCW 327
Sbjct: 242 YGFGL 246
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 914 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1a12a_ | 401 | Regulator of chromosome condensation RCC1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1jtdb_ | 273 | beta-lactamase inhibitor protein-II, BLIP-II {Stre | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1jtdb_ | 273 | beta-lactamase inhibitor protein-II, BLIP-II {Stre | 100.0 | |
| d1a12a_ | 401 | Regulator of chromosome condensation RCC1 {Human ( | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.73 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.61 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.0 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.94 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.95 | |
| d1emoa1 | 43 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 86.23 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=393.07 Aligned_cols=261 Identities=28% Similarity=0.494 Sum_probs=209.0
Q ss_pred CCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEECC
Q ss_conf 13121028665349999998089599999922036332064989999999981069852321020111876899996579
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.+.||+|+||.||+|+++ ..||||++..........+.|.+|+.++.+++|||||++++++.+ ...+|||||++
T Consensus 10 ~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~ 86 (276)
T d1uwha_ 10 ITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCE 86 (276)
T ss_dssp CCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCC
T ss_pred EEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEECCC
T ss_conf 899889830788589999999--989999997346998999999999999984799878645679715-58999996589
Q ss_pred CCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 99977863039520001355566898999999999996416999822058876426874999499943587545999999
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~~ 675 (914)
+|+|.++++... ..+++..++.|+.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 87 ~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 87 GSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp EEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred CCCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCCC
T ss_conf 988899985235----78999999999999999988875099---95161478997981899788750022133355677
Q ss_pred CCCCCCCCCCCCCCCHHHHHCC---CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 9975578886776694523018---9998200788999999999099886543456417897886652298432236534
Q 002512 676 SPLAELPAGTLGYLDPEYYRLH---YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 676 ~~~~~~~~Gt~~Y~aPE~l~~~---~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~ 752 (914)
........||+.|||||++... .++.++|||||||+||||+||+.||........+.. .+..+.....+.
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~----~~~~~~~~p~~~--- 232 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF----MVGRGYLSPDLS--- 232 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHH----HHHHTSCCCCGG---
T ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHHCCCCCCCCH---
T ss_conf 6312566557431799999505689999531516359999999978899899896999999----996588898600---
Q ss_pred CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 8999988999999999981101999999978999999999998
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~ 795 (914)
..+.+.+..+.+|+.+||..+|++||||.++++.|+.+.+.
T Consensus 233 --~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 233 --KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp --GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --HCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf --03655549999999997588976892999999999999970
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=392.01 Aligned_cols=257 Identities=25% Similarity=0.473 Sum_probs=207.5
Q ss_pred CCCCCCCCCCCCEEEEEEEECC-C---CEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEE
Q ss_conf 1312102866534999999808-9---59999992203633206498999999998106985232102011187689999
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD-G---TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
+.+.+.||+|+||.||+|.++. + ..||||++.... .....++|.+|+.+|++++|||||+++|++.+.+..++||
T Consensus 28 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 28 VKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred CEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 278569802788299999995799788999999978445-9899999999999998579988861899996288779999
Q ss_pred EECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 65799997786303952000135556689899999999999641699982205887642687499949994358754599
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~ 671 (914)
||+++|+|.+++..... .+++..++.++.|+++||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 107 Ey~~~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp ECCTTEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCEEEECCCCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECC
T ss_conf 72279853002104567----9999999999999999889885279---8357615044898899919988844315756
Q ss_pred CCCCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 9999997---557888677669452301899982007889999999990-998865434564178978866522984322
Q 002512 672 ADSSSPL---AELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 672 ~~~~~~~---~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i 747 (914)
....... .....||+.|||||.+....++.++||||||++||||+| |+.||...... .+. ..+..+
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-~~~----~~i~~~----- 249 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-DVI----NAIEQD----- 249 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHH----HHHHTT-----
T ss_pred CCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH-HHH----HHHHCC-----
T ss_conf 7777653650256668830038788836997861214453578999986799999999999-999----999737-----
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 36534899998899999999998110199999997899999999999
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 748 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~ 794 (914)
.+.+.+.+.+..+.+|+.+||+.+|++||||.||++.|+++++
T Consensus 250 ----~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 250 ----YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf ----8899974226999999999758797689299999999999841
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.28 Aligned_cols=255 Identities=27% Similarity=0.430 Sum_probs=208.4
Q ss_pred CCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEECC
Q ss_conf 13121028665349999998089599999922036332064989999999981069852321020111876899996579
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+.+.+.||+|+||.||+|.+++++.||||++.... ...++|.+|+.++++++|||||+++|++.+.+..++||||++
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred CEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 58888982088829999998899999999987886---768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 99977863039520001355566898999999999996416999822058876426874999499943587545999999
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~~ 675 (914)
+|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.......
T Consensus 84 ~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 84 HGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp TCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred CCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC
T ss_conf 991899752013----47889999999999999877653164---31044315326666887768655321002368873
Q ss_pred CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 99755788867766945230189998200788999999999099886543456417897886652298432236534899
Q 002512 676 SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 676 ~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~~~ 755 (914)
. ......||..|||||++....++.++||||||+++|||+|+..|+........+.. .+..+.. ..
T Consensus 157 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~----~i~~~~~---------~~ 222 (263)
T d1sm2a_ 157 T-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE----DISTGFR---------LY 222 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHH----HHHHTCC---------CC
T ss_pred E-EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHHCCC---------CC
T ss_conf 3-50430017666785786079998403321059999999878988877899999999----9980688---------89
Q ss_pred CCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 998899999999998110199999997899999999999
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~ 794 (914)
.+...+.++.+|+.+||+.+|++||||+++++.|++++.
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 954367999999999765797689199999999999985
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.27 Aligned_cols=265 Identities=28% Similarity=0.423 Sum_probs=212.0
Q ss_pred HHHHHHCCCCCCCCCCCCEEEEEEEECC-C-----CEEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCEEEEECEEE
Q ss_conf 9999851312102866534999999808-9-----5999999220363320649899999999810-6985232102011
Q 002512 510 ELERATGGFKEEVGKGSFSCVYKGVLKD-G-----TVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCE 582 (914)
Q Consensus 510 el~~~t~~f~~~lG~G~fg~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~ 582 (914)
|+......+.+.||+|+||.||+|++.. + ..||+|++..... ......|.+|+.++.++ +|||||++++++.
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 577899397019830788199999985788554204999999663358-7899999999999997158996868778886
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCC------------------HHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECC
Q ss_conf 187689999657999977863039520------------------00135556689899999999999641699982205
Q 002512 583 EGRERLLVYEFMAHGSLHQHLHGKSKA------------------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHR 644 (914)
Q Consensus 583 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHr 644 (914)
+.+..+|||||+++|+|.++|+..... ....+++..++.++.|++.||+|||+++ |+||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHR 188 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 188 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred ECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEC
T ss_conf 2995899997279995999998625777510221000012220012577899999999999999999997399---0505
Q ss_pred CCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCC
Q ss_conf 8876426874999499943587545999999997557888677669452301899982007889999999990-998865
Q 002512 645 DIKSSNILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAID 723 (914)
Q Consensus 645 DIKp~NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELlt-G~~p~~ 723 (914)
||||+|||++.++.+||+|||+|+...............||+.|||||++....++.++|||||||+||||+| |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCC
T ss_conf 27032144345982898514222204577861562343578765783887279999633030003999999838999999
Q ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHH
Q ss_conf 43456417897886652298432236534899998899999999998110199999997899999999
Q 002512 724 MQFEEGNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 724 ~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~ 791 (914)
.......+.. .+..+ .+.+.+...+.++.+|+.+||+.+|++|||++||++.|.-
T Consensus 269 ~~~~~~~~~~----~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 269 GIPVDANFYK----LIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp TCCCSHHHHH----HHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CCCHHHHHHH----HHHCC---------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9898999999----98569---------9899887678999999999758896689399999999748
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.37 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=207.9
Q ss_pred HHHCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEE
Q ss_conf 98513121028665349999998089599999922036332064989999999981069852321020111876899996
Q 002512 513 RATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 513 ~~t~~f~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
...+.+.+.||+|+||.||+|.+++++.||||++.... ...++|.+|+.++++++|||||++++++.+ +..+||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEE
T ss_conf 89938867981079828999999999999999986476---888999999999986799988578731045-97699999
Q ss_pred ECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 57999977863039520001355566898999999999996416999822058876426874999499943587545999
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~ 672 (914)
|+++|+|.+++.... ...+++..+++|+.||++||.|||+.+ |+||||||+||||++++.+||+|||+|+....
T Consensus 88 y~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ECCCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCC
T ss_conf 578982888875147---898878899999999999999997489---54675642251562024404234101477358
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 99999755788867766945230189998200788999999999099886543456417897886652298432236534
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~ 752 (914)
... .......||+.|||||++....++.++||||||++||||+||..|+........+.. .+..+.
T Consensus 162 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~----~i~~~~--------- 227 (272)
T d1qpca_ 162 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ----NLERGY--------- 227 (272)
T ss_dssp SCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHTTC---------
T ss_pred CCC-CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHHCC---------
T ss_conf 864-420356774444582898379998245645257999999968988888889999999----997068---------
Q ss_pred CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 899998899999999998110199999997899999999999
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~ 794 (914)
+.+.+...+.++.+|+.+||+.+|++||||++|++.|+..+.
T Consensus 228 ~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 888965571999999999758897689399999998611321
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=386.43 Aligned_cols=260 Identities=28% Similarity=0.449 Sum_probs=210.9
Q ss_pred HHHHHHCCCCCCCCCCCCEEEEEEEECC-CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEE
Q ss_conf 9999851312102866534999999808-959999992203633206498999999998106985232102011187689
Q 002512 510 ELERATGGFKEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 510 el~~~t~~f~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 588 (914)
|+....+.+.++||+|+||.||+|+++. ++.||||++... ....++|.+|+.++++++|||||++++++.+.+..+
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT---CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred EECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEE
T ss_conf 74579939865982088808999999999969999997776---103999999999998679998826775274578547
Q ss_pred EEEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 99965799997786303952000135556689899999999999641699982205887642687499949994358754
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~ 668 (914)
|||||+++|+|.+++..... ..+++..++.|+.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++
T Consensus 90 iv~E~~~~g~l~~~l~~~~~---~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~ 163 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSR 163 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTT
T ss_pred EEEECCCCCCHHHHHHHCCC---CCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf 87631467606777530355---41579999999999999788898789---3057604576899899928983244546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 59999999975578886776694523018999820078899999999909988654345641789788665229843223
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 748 (914)
........ ......|++.|||||++....++.++||||||+++|||+++..|+........+.+ .+..+
T Consensus 164 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~----~i~~~------ 232 (287)
T d1opja_ 164 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE----LLEKD------ 232 (287)
T ss_dssp TCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHTT------
T ss_pred ECCCCCCE-EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHHCC------
T ss_conf 53788722-10355665466692787279998104302178999999867998877425999999----98558------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHH
Q ss_conf 65348999988999999999981101999999978999999999
Q 002512 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 749 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~ 792 (914)
.+.+.+...+.++.+|+.+||+.||++|||+.++++.|+.+
T Consensus 233 ---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 233 ---YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ---CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf ---88888743309999999997577976893999999999999
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.01 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=206.2
Q ss_pred CCCCCCCCEEEEEEEECC---CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEECCC
Q ss_conf 102866534999999808---95999999220363320649899999999810698523210201118768999965799
Q 002512 520 EEVGKGSFSCVYKGVLKD---GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 520 ~~lG~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
++||+|+||.||+|.+++ ++.||||++..........++|.+|+.++++++|||||+++++|.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99778630395200013555668989999999999964169998220588764268749994999435875459999999
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~~~ 676 (914)
|+|.++++... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCC
T ss_conf 96899975225-----7899999999999999976687479---556777611310235675123413453313432344
Q ss_pred -CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf -97557888677669452301899982007889999999990-9988654345641789788665229843223653489
Q 002512 677 -PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 677 -~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~~ 754 (914)
.......||+.|||||.+....++.++||||||+++|||+| |+.||...... .+ ...+..+.. .
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~-~~----~~~i~~~~~---------~ 229 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS-EV----TAMLEKGER---------M 229 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-HH----HHHHHTTCC---------C
T ss_pred CCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHH-HH----HHHHHCCCC---------C
T ss_conf 322445677842039166537999843443034031328965899999998999-99----999982899---------9
Q ss_pred CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 999889999999999811019999999789999999999987
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~~ 796 (914)
+.+...+.++.+|+.+||+.+|++|||+++|++.|+....+.
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHC
T ss_conf 998656799999999975889768909899999852887504
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.35 Aligned_cols=260 Identities=25% Similarity=0.440 Sum_probs=209.0
Q ss_pred CCC-CCCCCCCEEEEEEEEC---CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEE
Q ss_conf 121-0286653499999980---895999999220363320649899999999810698523210201118768999965
Q 002512 518 FKE-EVGKGSFSCVYKGVLK---DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 518 f~~-~lG~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+ +||+|+||.||+|.++ ++..||||++.... .....++|.+|++++++++|||||++++++.+ +..+|||||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~ 89 (285)
T d1u59a_ 12 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEM 89 (285)
T ss_dssp EEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEEC
T ss_pred ECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEEEEE
T ss_conf 8784873060809999999608976899999988203-97899999999999986799888068656036-807999980
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 79999778630395200013555668989999999999964169998220588764268749994999435875459999
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~ 673 (914)
+++|+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 90 ~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 90 AGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp CTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred CCCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 78996899752125----69999999999999999878998688---105767646604546885420331342115543
Q ss_pred CCC-CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 999-97557888677669452301899982007889999999990-9988654345641789788665229843223653
Q 002512 674 SSS-PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 674 ~~~-~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 751 (914)
... .......||+.|||||++....++.++||||||+++|||+| |+.||..... .++. ..+..+...
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~~----~~i~~~~~~------ 231 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEVM----AFIEQGKRM------ 231 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHHH----HHHHTTCCC------
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH-HHHH----HHHHCCCCC------
T ss_conf 43211356211374335868872799995412322017899999389999999799-9999----999818999------
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHCCCC
Q ss_conf 4899998899999999998110199999997899999999999870999
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMGSP 800 (914)
Q Consensus 752 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~~~~~~ 800 (914)
+.+...+.++.+|+.+||..+|++||||.+|++.|+.....+..+.
T Consensus 232 ---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~~ 277 (285)
T d1u59a_ 232 ---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 277 (285)
T ss_dssp ---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHHCC
T ss_conf ---9997678999999999757797689099999999999999854111
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.01 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=203.5
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEEC
Q ss_conf 131210286653499999980-8959999992203633206498999999998106985232102011187689999657
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||.||+++++ +++.||+|++..... ....++|.+|+.++++++|||||++++++.+.+..||||||+
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 85 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYC 85 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECC
T ss_conf 0899897217480999999999997999999845664-127999999999998579988846965404674367988645
Q ss_pred CCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99997786303952000135556689899999999999641699982205887642687499949994358754599999
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~ 674 (914)
++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 86 ~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 86 SGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp TTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 8980899975379-----9999999999999999999999759---8357546899788789987983231422404688
Q ss_pred CCCCCCCCCCCCCCCCHHHHHCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 9997557888677669452301899-982007889999999990998865434564178978866522984322365348
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYL-TTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 675 ~~~~~~~~~Gt~~Y~aPE~l~~~~~-s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~ 753 (914)
.........||+.|||||++.+..+ +.++|||||||+||||+||+.||............ ...... .
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~----~~~~~~--------~ 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKT--------Y 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH----HHTTCT--------T
T ss_pred CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHH----HHCCCC--------C
T ss_conf 6531113255747428728618999997101617379999998299788889859999999----863888--------7
Q ss_pred CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 9999889999999999811019999999789999
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
.+.....+.++.+|+.+||+.||++|||++|+++
T Consensus 226 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8864469999999999976799668909999961
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.32 Aligned_cols=257 Identities=25% Similarity=0.456 Sum_probs=207.9
Q ss_pred CCCCCCCCCCCEEEEEEEECCC-----CEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEE
Q ss_conf 3121028665349999998089-----59999992203633206498999999998106985232102011187689999
Q 002512 517 GFKEEVGKGSFSCVYKGVLKDG-----TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVY 591 (914)
Q Consensus 517 ~f~~~lG~G~fg~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~ 591 (914)
.+.+.||+|+||.||+|.++.. ..||||++.... ......+|.+|+.++++++|||||+++|++.+.+..++||
T Consensus 10 ~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEE
T ss_conf 861598117790999999968998787999999988445-9689999999999998568987832367783388038999
Q ss_pred EECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 65799997786303952000135556689899999999999641699982205887642687499949994358754599
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGP 671 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~ 671 (914)
||+.+++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 89 e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 89 EYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp ECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EECCCCCCHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf 7213574022210234----54208999999999998541212123---4257656442788899849984551030035
Q ss_pred CCCCC-CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99999-97557888677669452301899982007889999999990998865434564178978866522984322365
Q 002512 672 ADSSS-PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 672 ~~~~~-~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 750 (914)
..... .......||+.|||||++....++.++||||||+++|||+++..|+........+.. .+..+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~----~i~~~-------- 229 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK----AINDG-------- 229 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHHTT--------
T ss_pred CCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHH----HHHCC--------
T ss_conf 787652674267777343488887049999735563448989999967988655689999999----98635--------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 34899998899999999998110199999997899999999999
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 751 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~ 794 (914)
.+.+.+.+.+..+.+|+.+||+.+|++||+|.||++.|+.+++
T Consensus 230 -~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 230 -FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -7899850457999999999776797689399999999999866
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.27 Aligned_cols=247 Identities=22% Similarity=0.336 Sum_probs=202.3
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEEC
Q ss_conf 131210286653499999980-8959999992203633206498999999998106985232102011187689999657
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.++||+|+||.||+++.+ +++.||+|++.... ....+.+.+|+.++++++|||||++++++.+.+..||||||+
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 388789812858299999998999899999984301--727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99997786303952000135556689899999999999641699982205887642687499949994358754599999
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~ 674 (914)
++|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 100 AGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp TTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 798089886415------9999999999999999999999879---7226776888688789968642515641321366
Q ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 99975578886776694523018999820078899999999909988654345641789788665229843223653489
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKL 754 (914)
Q Consensus 675 ~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~~ 754 (914)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||........+ ........ . ..
T Consensus 171 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~~~~~~~-~-------~~ 236 (293)
T d1yhwa1 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----YLIATNGT-P-------EL 236 (293)
T ss_dssp C--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----HHHHHHCS-C-------CC
T ss_pred C--CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHH----HHHHHCCC-C-------CC
T ss_conf 6--444444477736826644799880120313729999980488998997999999----99985799-9-------88
Q ss_pred CCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 999889999999999811019999999789999
Q 002512 755 PSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 755 ~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
+.+...+..+.+|+.+||..||.+|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 885537999999999986699668909999964
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.22 Aligned_cols=248 Identities=27% Similarity=0.442 Sum_probs=197.6
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEEC----CCEEEEEE
Q ss_conf 31210286653499999980-89599999922036332064989999999981069852321020111----87689999
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE----GRERLLVY 591 (914)
Q Consensus 517 ~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~----~~~~~LV~ 591 (914)
.|.++||+|+||.||++.++ +++.||+|++..........+.|.+|++++++++|||||++++++.+ ....+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEEC-CCCCEEEEECCCCCCC
Q ss_conf 657999977863039520001355566898999999999996416999822058876426874-9994999435875459
Q 002512 592 EFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID-EEHNARVADFGLSLLG 670 (914)
Q Consensus 592 Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~-~~~~~kI~DFGla~~~ 670 (914)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ ++|+||||||+|||++ +++.+||+|||+++..
T Consensus 92 E~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp ECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred ECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEEC
T ss_conf 5789894899975135-----5469999999999999999999789-979968767435116679998898005765423
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99999997557888677669452301899982007889999999990998865434564178978866522984322365
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 750 (914)
... ......||+.|||||++.. .++.++|||||||++|||++|+.||........+. ..+..+......
T Consensus 166 ~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~----~~i~~~~~~~~~-- 234 (270)
T d1t4ha_ 166 RAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIY----RRVTSGVKPASF-- 234 (270)
T ss_dssp CTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHH----HHHTTTCCCGGG--
T ss_pred CCC----CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHH----HHHHCCCCCCCC--
T ss_conf 687----6677553813008988478-99986711007999999987889998765599999----999738998656--
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 3489999889999999999811019999999789999
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
+.....++.+|+.+||+.||++|||++|+++
T Consensus 235 ------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 235 ------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ------7557899999999976379758929999967
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.75 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=207.3
Q ss_pred CCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEECCC
Q ss_conf 31210286653499999980895999999220363320649899999999810698523210201118768999965799
Q 002512 517 GFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMAH 596 (914)
Q Consensus 517 ~f~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~~ 596 (914)
.|.++||+|+||+||+|++++++.||||++..... ..++|.+|+.++++++||||++++|++.+.+..++||||+++
T Consensus 7 ~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred EEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCCC
T ss_conf 99689820788399999988998999999874757---789999999999966898601588998507816999970489
Q ss_pred CCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99778630395200013555668989999999999964169998220588764268749994999435875459999999
Q 002512 597 GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSSS 676 (914)
Q Consensus 597 gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~~~ 676 (914)
|+|.+++.... ..+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 84 g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 84 GCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE
T ss_conf 93888641024----67768999999999999999875468---434665413588769984798861442023578722
Q ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 97557888677669452301899982007889999999990-99886543456417897886652298432236534899
Q 002512 677 PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLKLP 755 (914)
Q Consensus 677 ~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~~~ 755 (914)
......||+.|+|||.+....++.++||||||+++|||+| |+.||...... ++. ..+..+. +.+
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~-~~~----~~i~~~~---------~~~ 221 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-ETA----EHIAQGL---------RLY 221 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-HHH----HHHHTTC---------CCC
T ss_pred -EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHH-HHH----HHHHHCC---------CCC
T ss_conf -5246578877578078637998852103364324673975599998899999-999----9998079---------789
Q ss_pred CCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHH
Q ss_conf 998899999999998110199999997899999999
Q 002512 756 SDLDALKRIANVACKCVRMRGKERPSMDKVTTALER 791 (914)
Q Consensus 756 ~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~ 791 (914)
.+...+.++.+|+.+||+.+|++|||++++++.|.+
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 965465999999999766897689399999987418
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.88 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=209.4
Q ss_pred HCCCCCCCCCCCCEEEEEEEECCC----CEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEEC-CCEEEE
Q ss_conf 513121028665349999998089----599999922036332064989999999981069852321020111-876899
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKDG----TVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE-GRERLL 589 (914)
Q Consensus 515 t~~f~~~lG~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~L 589 (914)
+.+|.++||+|+||+||+|.+.++ ..||||++.... .....++|.+|++++++++||||++++|++.+ +...++
T Consensus 28 ~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 28 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEE
T ss_pred EECCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 5526669813688099999997799879999999988436-978999999999999867899986786789806994389
Q ss_pred EEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99657999977863039520001355566898999999999996416999822058876426874999499943587545
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~ 669 (914)
||||+++|+|.++++.... .+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 107 v~E~~~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~ 179 (311)
T d1r0pa_ 107 VLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD 179 (311)
T ss_dssp EEECCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCC
T ss_pred EEEEEECCCHHHHHCCCCC----CCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHH
T ss_conf 9987406741442101345----4048999999999887652003367---62577668757677999889910652322
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 99999999--7557888677669452301899982007889999999990998865434564178978866522984322
Q 002512 670 GPADSSSP--LAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 670 ~~~~~~~~--~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i 747 (914)
........ ......||+.|+|||.+....++.++||||||+++|||+|++.||........+... +..+...
T Consensus 180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~----i~~g~~~-- 253 (311)
T d1r0pa_ 180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY----LLQGRRL-- 253 (311)
T ss_dssp TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH----HHTTCCC--
T ss_pred CCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHCCCCC--
T ss_conf 5566555310025655564556768874379997457466199999999789999888999999999----9808988--
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 3653489999889999999999811019999999789999999999987
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 748 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~~ 796 (914)
..+...+..+.+|+.+||+.||++||+|.||++.|+.++...
T Consensus 254 -------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 254 -------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf -------996447599999999976889768939999999999999752
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.29 Aligned_cols=245 Identities=26% Similarity=0.414 Sum_probs=202.6
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECC-CCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEE
Q ss_conf 131210286653499999980-89599999922036-3320649899999999810698523210201118768999965
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.+.||+|+||.||+++++ +++.||+|++.... ......+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEE
T ss_conf 69988985177858999999899949999998168856768999999999999856888888599999989998999850
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 79999778630395200013555668989999999999964169998220588764268749994999435875459999
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~ 673 (914)
+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 ~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 88 APLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp CTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred CCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 47985898875048-----9999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 99997557888677669452301899982007889999999990998865434564178978866522984322365348
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~ 753 (914)
......||+.|||||++.+..++.++|||||||+||||++|+.||....... ....+..... .
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-----~~~~i~~~~~--------~ 222 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-----TYKRISRVEF--------T 222 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHTTCC--------C
T ss_pred ----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHCCCC--------C
T ss_conf ----5235578876349999758998931440467599999832999988899999-----9999971899--------9
Q ss_pred CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 9999889999999999811019999999789999
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
.+...++++.+|+.+||+.||++|||++|+++
T Consensus 223 --~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 223 --FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --98668999999999976479768909999971
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.20 Aligned_cols=257 Identities=25% Similarity=0.413 Sum_probs=207.3
Q ss_pred CCCCCCCCCCCCEEEEEEEECC-CC----EEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEE
Q ss_conf 1312102866534999999808-95----999999220363320649899999999810698523210201118768999
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD-GT----VVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
+.+.+.||+|+||.||+|.+.. ++ .||+|++... ......++|.+|+.++++++|||||+++++|.+. ..+++
T Consensus 11 y~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp EEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEEE
T ss_conf 978319820899299999995899889899999996513-4979999999999999867998881589999619-83699
Q ss_pred EEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 96579999778630395200013555668989999999999964169998220588764268749994999435875459
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~ 670 (914)
+||+.+|+|.+++.... ..+++..+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEECCCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEEC
T ss_conf 98426874010111334----57999999999999999999998769---504762120311679987586025522233
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 99999997557888677669452301899982007889999999990-99886543456417897886652298432236
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 749 (914)
.............||+.|||||++....++.++||||||++||||+| |++||..... ..+.. .+..+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-~~~~~----~i~~~~------ 230 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISS----ILEKGE------ 230 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-GGHHH----HHHHTC------
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHH----HHHCCC------
T ss_conf 5444532236510586446708874699983565440799999999779999999998-99999----997599------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 5348999988999999999981101999999978999999999998
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 750 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~ 795 (914)
+.+.+...+..+.+|+.+||+.+|.+|||+.|++..|+.....
T Consensus 231 ---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 231 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ---8999855689999999984789934691999999999998758
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.97 Aligned_cols=256 Identities=27% Similarity=0.456 Sum_probs=207.3
Q ss_pred HHCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEE
Q ss_conf 85131210286653499999980895999999220363320649899999999810698523210201118768999965
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 514 ~t~~f~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
..+.+.+.||+|+||.||+|++++++.||||++.... ...+.|.+|+.++++++|||||++++++.+ +..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEE
T ss_conf 9979846993079809999999999999999988044---888999999999986666788689999823-975999994
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 79999778630395200013555668989999999999964169998220588764268749994999435875459999
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~ 673 (914)
+++|+|..++.... ...++|..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 93 ~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred CCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCC
T ss_conf 47994354200003---553059999999999999999875411---433531230799989992998442555425688
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 99997557888677669452301899982007889999999990998865434564178978866522984322365348
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~ 753 (914)
.. .......||+.|+|||++....++.++||||||+++|||+||..|+........... .+..+. +
T Consensus 167 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~----~i~~~~---------~ 232 (285)
T d1fmka3 167 EY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD----QVERGY---------R 232 (285)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHTTC---------C
T ss_pred CC-EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHH----HHHHCC---------C
T ss_conf 73-352454556654580898379989177413235899999868999998888999999----998268---------9
Q ss_pred CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9999889999999999811019999999789999999999
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l 793 (914)
.+.+...++++.+|+.+||+.+|++||+|++|++.|+..+
T Consensus 233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 9998323799999999975669758919999999876662
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.24 Aligned_cols=249 Identities=22% Similarity=0.307 Sum_probs=200.0
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEEC
Q ss_conf 131210286653499999980-8959999992203633206498999999998106985232102011187689999657
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||.||+++++ +++.||+|++.... ....+.|.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 14 Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 14 WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 598479930778199999999999399999987289--999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99997786303952000135556689899999999999641699982205887642687499949994358754599999
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~ 674 (914)
++|+|.+++.... ..+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~ 164 (288)
T d2jfla1 92 AGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 164 (288)
T ss_dssp TTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred CCCCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC
T ss_conf 9981889998628----99999999999999999999999889---8871407003148789998997161230357786
Q ss_pred CCCCCCCCCCCCCCCCHHHHH-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 999755788867766945230-----189998200788999999999099886543456417897886652298432236
Q 002512 675 SSPLAELPAGTLGYLDPEYYR-----LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 675 ~~~~~~~~~Gt~~Y~aPE~l~-----~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 749 (914)
.......||+.|||||++. ...++.++|||||||++|||+||+.||........+.. +.......
T Consensus 165 --~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~-----i~~~~~~~--- 234 (288)
T d2jfla1 165 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK-----IAKSEPPT--- 234 (288)
T ss_dssp --HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----HHHSCCCC---
T ss_pred --CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH-----HHCCCCCC---
T ss_conf --41001025626479999832025788888066578789999998208899999899999999-----97079987---
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 53489999889999999999811019999999789999
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 750 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
...+...+.++.+|+.+||+.||++|||++|+++
T Consensus 235 ----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 ----LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ----7765669999999999976699668919999962
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=363.53 Aligned_cols=250 Identities=21% Similarity=0.331 Sum_probs=202.2
Q ss_pred HCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEE
Q ss_conf 5131210286653499999980-895999999220363320649899999999810698523210201118768999965
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 515 t~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
.+.+.+.||+|+||.||+++++ +++.||+|++...... .....+.+|+.++++++|||||++++++.+.+..||||||
T Consensus 10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH-HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 669988994065839999999999989999998157731-2899999999999867998999198999989988898852
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEEC---CCCCEEEEECCCCCCC
Q ss_conf 7999977863039520001355566898999999999996416999822058876426874---9994999435875459
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID---EEHNARVADFGLSLLG 670 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~---~~~~~kI~DFGla~~~ 670 (914)
+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 89 ~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 89 VSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred CCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf 68984888653036-----7887899999999999987524130---556870463001104688824998315435872
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99999997557888677669452301899982007889999999990998865434564178978866522984322365
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 750 (914)
.... ......||+.|||||++.+..++.++|||||||+||||++|+.||....... +. ..+......
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~----~~i~~~~~~----- 227 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LF----EQILKAEYE----- 227 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH----HHHHTTCCC-----
T ss_pred CCCC---EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HH----HHHHCCCCC-----
T ss_conf 5897---0440032842259188737999807873451599999985979999989999-99----998616877-----
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 3489999889999999999811019999999789999
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
...+.....+.++.+|+.+||..||++|||++|+++
T Consensus 228 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 228 -FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -787666678999999999976089757918999862
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=362.33 Aligned_cols=250 Identities=22% Similarity=0.319 Sum_probs=201.7
Q ss_pred HCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEE
Q ss_conf 5131210286653499999980-895999999220363320649899999999810698523210201118768999965
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 515 t~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
.+.+.+.||+|+||.||+++.+ +++.||||++..... ...+.+.+|+.++++++|||||++++++.+.+..+|||||
T Consensus 27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 75898898407681999999889998999999845243--1699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECC--CCCEEEEECCCCCCCC
Q ss_conf 79999778630395200013555668989999999999964169998220588764268749--9949994358754599
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE--EHNARVADFGLSLLGP 671 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~--~~~~kI~DFGla~~~~ 671 (914)
+++|+|.+++.... ..+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+++...
T Consensus 105 ~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~ 177 (350)
T d1koaa2 105 MSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD 177 (350)
T ss_dssp CCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECC
T ss_pred CCCCCHHHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECC
T ss_conf 79988999997623----78999999999999999999997569---760001546736416889869995452104425
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99999975578886776694523018999820078899999999909988654345641789788665229843223653
Q 002512 672 ADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPV 751 (914)
Q Consensus 672 ~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~ 751 (914)
... ......||+.|||||++.+..++.++|||||||++|||++|+.||....... .. ..+.......
T Consensus 178 ~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~----~~i~~~~~~~----- 244 (350)
T d1koaa2 178 PKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TL----RNVKSCDWNM----- 244 (350)
T ss_dssp TTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HH----HHHHHTCCCS-----
T ss_pred CCC---CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HH----HHHHHCCCCC-----
T ss_conf 654---3200068624218899758998726765546599999985989989979999-99----9998478898-----
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 489999889999999999811019999999789999
Q 002512 752 LKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 752 ~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
........++.+.+|+.+||..||++|||++|+++
T Consensus 245 -~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 -DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp -CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -94223589999999999975689667908999862
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=366.82 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=209.8
Q ss_pred HCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEE
Q ss_conf 5131210286653499999980------8959999992203633206498999999998106985232102011187689
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 515 t~~f~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 588 (914)
.+.+.+.||+|+||.||+|+.+ +++.||||++.... .....++|.+|+.++++++||||+++++++.+....+
T Consensus 14 ~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 92 (301)
T d1lufa_ 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMC 92 (301)
T ss_dssp GCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred HCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC-CHHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCCCEE
T ss_conf 938867982078839999998887657788299999988210-8579999999999999668997655246660598038
Q ss_pred EEEEECCCCCHHHHHHCCCC-------------------CHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCC
Q ss_conf 99965799997786303952-------------------00013555668989999999999964169998220588764
Q 002512 589 LVYEFMAHGSLHQHLHGKSK-------------------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSS 649 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~ 649 (914)
+||||+++|+|.++++.... .....+++..++.|+.|++.||+|||+.+ |+||||||+
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~ 169 (301)
T d1lufa_ 93 LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATR 169 (301)
T ss_dssp EEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EEEEEECCC
T ss_conf 99981589929999985275542100001110012103467889899999999999999855413578---685488401
Q ss_pred CEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCC-CCCCCCCC
Q ss_conf 26874999499943587545999999997557888677669452301899982007889999999990998-86543456
Q 002512 650 NILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRK-AIDMQFEE 728 (914)
Q Consensus 650 NILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~-p~~~~~~~ 728 (914)
|||++.++.+||+|||+++...............|++.|+|||.+....++.++||||||+++|||+++.. ||... ..
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~-~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM-AH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CH
T ss_pred CEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCC-CH
T ss_conf 16898999289833144211367764111577776767679899726889805630252362999980689999998-99
Q ss_pred CCHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHH
Q ss_conf 41789788665229843223653489999889999999999811019999999789999999999
Q 002512 729 GNIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERAL 793 (914)
Q Consensus 729 ~~l~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l 793 (914)
..+. ..+..+.... .+...+.++.+|+.+||+.+|++||||.||++.|+++.
T Consensus 249 ~e~~----~~v~~~~~~~---------~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 249 EEVI----YYVRDGNILA---------CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp HHHH----HHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HHHH----HHHHCCCCCC---------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 9999----9997399788---------87325299999999974889657939999999999842
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.99 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=205.1
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEEC--CCEEEEEEE
Q ss_conf 131210286653499999980-89599999922036332064989999999981069852321020111--876899996
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE--GRERLLVYE 592 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~--~~~~~LV~E 592 (914)
+.+.+.||+|+||.||+++.+ +++.||+|++......+...+.|.+|++++++++|||||++++++.+ ....|||||
T Consensus 6 y~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmE 85 (269)
T d2java1 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85 (269)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 79967983088919999999999979999998746579799999999999999778999824899999178998999995
Q ss_pred ECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCEECCCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 5799997786303952000135556689899999999999641699--98220588764268749994999435875459
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYAC--PPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~--~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~ 670 (914)
|+++|+|.+++..... ....+++..++.++.|++.||.|||+.+. .+|+||||||+|||++.++.+||+|||+++..
T Consensus 86 y~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~ 164 (269)
T d2java1 86 YCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164 (269)
T ss_dssp CCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC
T ss_pred CCCCCCHHHHHHHCCC-CCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEEC
T ss_conf 6899938999985154-578999999999999999999999971677887885867654257478885798001000322
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99999997557888677669452301899982007889999999990998865434564178978866522984322365
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 750 (914)
..... ......||+.|||||++.+..++.++||||||+++|||+||+.||...... . ....+..+....+
T Consensus 165 ~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~-~----~~~~i~~~~~~~~--- 234 (269)
T d2java1 165 NHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK-E----LAGKIREGKFRRI--- 234 (269)
T ss_dssp -------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH-H----HHHHHHHTCCCCC---
T ss_pred CCCCC--CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH-H----HHHHHHCCCCCCC---
T ss_conf 45777--556677882327999983999993898875278999980188998998999-9----9999971899889---
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 3489999889999999999811019999999789999
Q 002512 751 VLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
+...+.++.+|+.+||+.||.+|||++|+++
T Consensus 235 ------~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 235 ------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ------7435999999999976799557918999972
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.88 Aligned_cols=268 Identities=25% Similarity=0.351 Sum_probs=211.2
Q ss_pred HHHHHCCCCCCCCCCCCEEEEEEEECC------CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCEEEEECEEEC
Q ss_conf 999851312102866534999999808------95999999220363320649899999999810-69852321020111
Q 002512 511 LERATGGFKEEVGKGSFSCVYKGVLKD------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEE 583 (914)
Q Consensus 511 l~~~t~~f~~~lG~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~ 583 (914)
+.+..+.+.++||+|+||.||+|.+.. ++.||||++..... ....+.|.+|...+.++ +|+||+.+++++.+
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCCCEEEEEEEEECC
T ss_conf 16799798449841678399999986777555783999999860017-17899999999998861499849974115404
Q ss_pred C-CEEEEEEEECCCCCHHHHHHCCCCC-----------HHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCE
Q ss_conf 8-7689999657999977863039520-----------001355566898999999999996416999822058876426
Q 002512 584 G-RERLLVYEFMAHGSLHQHLHGKSKA-----------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 651 (914)
Q Consensus 584 ~-~~~~LV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NI 651 (914)
. ...++||||+++|+|.++|+..... ....+++..++.++.||++||.|||+++ |+||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCE
T ss_conf 797579999845899299999853666665322202332146899999999999999999887379---71786773106
Q ss_pred EECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCC
Q ss_conf 87499949994358754599999999755788867766945230189998200788999999999099-88654345641
Q 002512 652 LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR-KAIDMQFEEGN 730 (914)
Q Consensus 652 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~-~p~~~~~~~~~ 730 (914)
|+++++.+||+|||+|+...............||+.|||||.+.+..++.++||||||+++|||+|+. .||........
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred EECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHH
T ss_conf 57799828984575200113566522247516672102036864688996632213678999998688999989998999
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 78978866522984322365348999988999999999981101999999978999999999998
Q 002512 731 IVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 731 l~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~ 795 (914)
+. ..+..+.... .+...+.++.+++.+||+.||++|||+.|+++.|+++++.
T Consensus 246 ~~----~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 FC----RRLKEGTRMR---------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp HH----HHHHHTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH----HHHHCCCCCC---------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 99----9996389888---------8865789999999997677966791999999999799867
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.01 Aligned_cols=250 Identities=20% Similarity=0.299 Sum_probs=206.0
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECC-CCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEE
Q ss_conf 131210286653499999980-89599999922036-3320649899999999810698523210201118768999965
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.+.||+|+||.||+++.+ +++.||||++.... ......+.+.+|+.++++++||||+++++++.+.+..||||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEC
T ss_conf 78988985087909999999899979999998657755777899999999999876888861799999989988999970
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 79999778630395200013555668989999999999964169998220588764268749994999435875459999
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~ 673 (914)
+++|+|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 90 ~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 90 AKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred CCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 48987777653159-----9999999999999999997621650---884767741236688853886032102422567
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 99997557888677669452301899982007889999999990998865434564178978866522984322365348
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~ 753 (914)
..........||+.|||||++.+..++.++|||||||+||||++|+.||...... +. ...+..... .
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~~-~~~i~~~~~--------~ 228 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY----LI-FQKIIKLEY--------D 228 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH----HH-HHHHHTTCC--------C
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHH----HH-HHHHHCCCC--------C
T ss_conf 7643335556775525844002689896662304569999980388998995999----99-999971899--------9
Q ss_pred CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHH
Q ss_conf 99998899999999998110199999997899999
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTA 788 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~ 788 (914)
. +.....++.+|+.+||+.||++|||++|++..
T Consensus 229 ~--p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 229 F--PEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp C--CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred C--CCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCC
T ss_conf 9--85479999999999855797689197897377
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.69 Aligned_cols=264 Identities=23% Similarity=0.293 Sum_probs=202.0
Q ss_pred HCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEE
Q ss_conf 5131210286653499999980-895999999220363320649899999999810698523210201118768999965
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 515 t~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
.+.+.++||+|+||.||+++++ +++.||+|++.... .....+.+.+|+.+|++++|||||++++++.+....+|||||
T Consensus 7 ~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 8889789712778099999998999699999987540-978999999999999867999999499999989999999976
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCC-CCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 7999977863039520001355566898999999999996416-999822058876426874999499943587545999
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGY-ACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~-~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~ 672 (914)
+++|+|.+++.+.. .+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||+|+....
T Consensus 86 ~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 79986899874249-----99999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHC-----------
Q ss_conf 999997557888677669452301899982007889999999990998865434564178978866522-----------
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKS----------- 741 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~----------- 741 (914)
.. .....||+.|||||++.+..++.++|||||||++|||++|+.||...................
T Consensus 158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC----CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 86----21113771411946875899894888998999999999888998998878999999887517754577421233
Q ss_pred --------------CCCCCCCCCCCC----CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH--HHHH
Q ss_conf --------------984322365348----9999889999999999811019999999789999--9999
Q 002512 742 --------------GDITAILDPVLK----LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT--ALER 791 (914)
Q Consensus 742 --------------~~~~~i~d~~~~----~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~--~L~~ 791 (914)
....+..+.... .......+.++.+|+.+||+.||.+|||++|+++ .+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCC
T ss_conf 3221111222354134778876650268766764448999999999986899467908999960986476
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=359.84 Aligned_cols=249 Identities=21% Similarity=0.319 Sum_probs=202.0
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEEC
Q ss_conf 131210286653499999980-8959999992203633206498999999998106985232102011187689999657
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+.+.+.||+|+||.||+++.+ +++.||+|++..... ...+.+.+|+.++++++|||||++++++.+.+..||||||+
T Consensus 31 Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 31 YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf 5998999317782999999989997999999887264--67999999999998679979891999999899999999828
Q ss_pred CCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEEC--CCCCEEEEECCCCCCCCC
Q ss_conf 999977863039520001355566898999999999996416999822058876426874--999499943587545999
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID--EEHNARVADFGLSLLGPA 672 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~--~~~~~kI~DFGla~~~~~ 672 (914)
++|+|.+++.... ..+++.....|+.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|.....
T Consensus 109 ~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 109 SGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCHHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC
T ss_conf 9980888898638----99899999999999999999999779---2651314455311346788489952563034378
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 99999755788867766945230189998200788999999999099886543456417897886652298432236534
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~ 752 (914)
.. ......||+.|||||++.+..++.++|||||||+||||+||+.||........+ ..+.......
T Consensus 182 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~-----~~i~~~~~~~------ 247 (352)
T d1koba_ 182 DE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-----QNVKRCDWEF------ 247 (352)
T ss_dssp TS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH-----HHHHHCCCCC------
T ss_pred CC---CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH-----HHHHHCCCCC------
T ss_conf 87---201004764534899974799897633389899999999688998997999999-----9998478898------
Q ss_pred CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 89999889999999999811019999999789999
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
........+.++.+|+.+||..||.+|||+.|+++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 93002479999999999975699668918999960
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=362.31 Aligned_cols=246 Identities=23% Similarity=0.303 Sum_probs=198.4
Q ss_pred HCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEE
Q ss_conf 5131210286653499999980-895999999220363-32064989999999981069852321020111876899996
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 515 t~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
.+...++||+|+||.||+++.+ +++.||||++..... .....+.|.+|+.++++++|||||++++++.+.+..|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 57999977863039520001355566898999999999996416999822058876426874999499943587545999
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~ 672 (914)
|+++|+|..++... ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ECCCCCHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf 06999457899737-----99999999999999999999998689---76667884217987999789844365334677
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 999997557888677669452301---89998200788999999999099886543456417897886652298432236
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRL---HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~Y~aPE~l~~---~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 749 (914)
. ....||+.|||||++.+ ..++.++|||||||++|||++|+.||....... .... +........
T Consensus 168 ~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~----~~~~-i~~~~~~~~-- 234 (309)
T d1u5ra_ 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS----ALYH-IAQNESPAL-- 234 (309)
T ss_dssp B------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH----HHHH-HHHSCCCCC--
T ss_pred C------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHH-HHHCCCCCC--
T ss_conf 8------73134766368899834678886721454558999999987889999979999----9999-982899988--
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 53489999889999999999811019999999789999
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 750 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
.+...++.+.+|+.+||..||.+|||++|+++
T Consensus 235 ------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 235 ------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp ------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ------87888999999999977379657918999971
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.23 Aligned_cols=268 Identities=25% Similarity=0.391 Sum_probs=214.1
Q ss_pred HHHHHCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCEEEEECEEEC
Q ss_conf 99985131210286653499999980------895999999220363320649899999999810-69852321020111
Q 002512 511 LERATGGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEE 583 (914)
Q Consensus 511 l~~~t~~f~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~ 583 (914)
+....+.+.+.||+|+||.||+|++. .++.||||++.... ......+|.+|+.++.++ +|||||++++++.+
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
T ss_conf 7789969854982068829999998066447788699999987424-877999999999998762699988789989831
Q ss_pred CCEEEEEEEECCCCCHHHHHHCCCCC-------------HHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCC
Q ss_conf 87689999657999977863039520-------------00135556689899999999999641699982205887642
Q 002512 584 GRERLLVYEFMAHGSLHQHLHGKSKA-------------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSN 650 (914)
Q Consensus 584 ~~~~~LV~Ey~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~N 650 (914)
.+..+|||||+++|+|.++++..... ....+++..++.++.||+.||+|||+++ ++||||||+|
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~N 175 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARN 175 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCC
T ss_conf 9978999973799879999985356654444453322233458899999999999999999887579---2666241021
Q ss_pred EEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC-C
Q ss_conf 687499949994358754599999999755788867766945230189998200788999999999099886543456-4
Q 002512 651 ILIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEE-G 729 (914)
Q Consensus 651 ILl~~~~~~kI~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~-~ 729 (914)
||++.++.+||+|||+++...............||+.|+|||.+....++.++||||||+++|||+|+..|+...... .
T Consensus 176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~ 255 (311)
T d1t46a_ 176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (311)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred CCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 00002575210234010233678861586201359687677886179999740010258999999858998877899899
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 178978866522984322365348999988999999999981101999999978999999999998
Q 002512 730 NIVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 730 ~l~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~ 795 (914)
.+.. .+..+. +...+...+..+.+|+.+||+.||++||||.+++++|++.+.+
T Consensus 256 ~~~~----~i~~~~---------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 KFYK----MIKEGF---------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHH----HHHHTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHH----HHHCCC---------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 9999----986689---------8898543659999999997577965792999999999876534
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.15 Aligned_cols=266 Identities=26% Similarity=0.390 Sum_probs=213.8
Q ss_pred HHHHCCCCCCCCCCCCEEEEEEEECC--------CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCEEEEECEEE
Q ss_conf 99851312102866534999999808--------95999999220363320649899999999810-6985232102011
Q 002512 512 ERATGGFKEEVGKGSFSCVYKGVLKD--------GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCE 582 (914)
Q Consensus 512 ~~~t~~f~~~lG~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~ 582 (914)
....+.+.+.||+|+||.||+++... +..||||++.... ......++.+|...+.++ +|||||+++++|.
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHHHHCCCCEEEECCCCCC
T ss_conf 58996970098516782899999857875556675499999988112-86889999999999998139996973465220
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCC-----------HHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCE
Q ss_conf 187689999657999977863039520-----------001355566898999999999996416999822058876426
Q 002512 583 EGRERLLVYEFMAHGSLHQHLHGKSKA-----------LKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNI 651 (914)
Q Consensus 583 ~~~~~~LV~Ey~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NI 651 (914)
+....++||||+++|+|.++|...... ....+++..+++++.|++.||+|||+.+ |+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCE
T ss_conf 188689999736999099999860677643222334574346799999999999999998766379---78630221022
Q ss_pred EECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCC
Q ss_conf 874999499943587545999999997557888677669452301899982007889999999990-9988654345641
Q 002512 652 LIDEEHNARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGN 730 (914)
Q Consensus 652 Ll~~~~~~kI~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELlt-G~~p~~~~~~~~~ 730 (914)
|++.++.+||+|||+++...............|++.|+|||.+....++.++||||||+++|||++ |.+||..... ..
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-~~ 245 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-EE 245 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HH
T ss_pred EECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH-HH
T ss_conf 45478976762211101135555543146678884663266751798882555477588888740179898999999-99
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 78978866522984322365348999988999999999981101999999978999999999998
Q 002512 731 IVEWAVPLIKSGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 731 l~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~ 795 (914)
....+..+.. .+.+...+..+.+|+.+||+.+|.+|||+.||++.|+++++.
T Consensus 246 ----~~~~i~~~~~---------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~ 297 (299)
T d1fgka_ 246 ----LFKLLKEGHR---------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297 (299)
T ss_dssp ----HHHHHHTTCC---------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----HHHHHHCCCC---------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ----9999972888---------898743529999999997667976793999999999888604
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.10 Aligned_cols=259 Identities=30% Similarity=0.476 Sum_probs=206.1
Q ss_pred CCCCCCCCCCCEEEEEEEECC-CC--EEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCEEEEECEEECCCEEEEEEE
Q ss_conf 312102866534999999808-95--999999220363320649899999999810-69852321020111876899996
Q 002512 517 GFKEEVGKGSFSCVYKGVLKD-GT--VVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 517 ~f~~~lG~G~fg~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
.+.+.||+|+||.||+|++++ +. .||||++..... ....++|.+|+++|.++ +|||||++++++.+.+..++|||
T Consensus 13 ~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 13 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp EEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred EEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
T ss_conf 88779820788289999998999699999999782338-57999999999999862289988367888841873699998
Q ss_pred ECCCCCHHHHHHCCCC-----------CHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEE
Q ss_conf 5799997786303952-----------00013555668989999999999964169998220588764268749994999
Q 002512 593 FMAHGSLHQHLHGKSK-----------ALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARV 661 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI 661 (914)
|+++|+|.++|+.... .....+++..++.++.||++||.|||+.+ |+||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEE
T ss_pred ECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCEEE
T ss_conf 02898699998640355555123101234578999999999999999987663089---545550520489868876387
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 43587545999999997557888677669452301899982007889999999990998865434564178978866522
Q 002512 662 ADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKS 741 (914)
Q Consensus 662 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~ 741 (914)
+|||+++....... .....||..|+|||.+....++.++||||||+++|||++|..|+........+.. .+..
T Consensus 169 ~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~----~i~~ 241 (309)
T d1fvra_ 169 ADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KLPQ 241 (309)
T ss_dssp CCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HGGG
T ss_pred CCCCCCCCCCCCCC---CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHH----HHHH
T ss_conf 43443224442234---5530137755553875269999622153138899999836899999999999999----9982
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 984322365348999988999999999981101999999978999999999998
Q 002512 742 GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 742 ~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~ 795 (914)
+. +.+.+...+.++.+|+.+||..+|++||||.|+++.|++++.+
T Consensus 242 ~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 242 GY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp TC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CC---------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 68---------8888766789999999997678966894999999999999861
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.70 Aligned_cols=259 Identities=24% Similarity=0.393 Sum_probs=207.6
Q ss_pred HHHCCCCCCCCCCCCEEEEEEEECC----CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEE
Q ss_conf 9851312102866534999999808----959999992203633206498999999998106985232102011187689
Q 002512 513 RATGGFKEEVGKGSFSCVYKGVLKD----GTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERL 588 (914)
Q Consensus 513 ~~t~~f~~~lG~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~ 588 (914)
+..+.+.+.||+|+||.||+|.+.. +..||+|++.... .....+.|.+|+.++++++|||||++++++.+ +..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEE
T ss_conf 899698779930788299999993699644999999936566-87999999999999986899998569889953-7479
Q ss_pred EEEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 99965799997786303952000135556689899999999999641699982205887642687499949994358754
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~ 668 (914)
+||||+++|+|.+++.... ..+++..++.++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEECCCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHE
T ss_conf 9998406980776542247----89999999999999987752302267---4414102655320678967876503421
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 5999999997557888677669452301899982007889999999990-998865434564178978866522984322
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAI 747 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i 747 (914)
....... .......||+.|+|||.+....++.++||||||+++|||+| |.+||...... .+.. .+..+...
T Consensus 157 ~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~-~~~~----~i~~~~~~-- 228 (273)
T d1mp8a_ 157 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-DVIG----RIENGERL-- 228 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHH----HHHTTCCC--
T ss_pred ECCCCCC-EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH-HHHH----HHHCCCCC--
T ss_conf 3367762-33054005831032667516998874524442478999982699998889999-9999----99818999--
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 365348999988999999999981101999999978999999999998
Q 002512 748 LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQ 795 (914)
Q Consensus 748 ~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~ 795 (914)
+.+...+..+.+|+.+||..||++|||+.||++.|+.++.+
T Consensus 229 -------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 -------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf -------89877799999999997687976892999999999999778
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.22 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=201.3
Q ss_pred HCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCC----CCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEE
Q ss_conf 5131210286653499999980-895999999220363----32064989999999981069852321020111876899
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD----RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLL 589 (914)
Q Consensus 515 t~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~L 589 (914)
.+.+.+.||+|+||.||+++.+ +++.||+|++..... .....+.|.+|+.++++++|||||++++++.+.+..||
T Consensus 11 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (293)
T d1jksa_ 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVIL 90 (293)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEE
T ss_conf 77982798117895999999999998999999875663213406899999999999986799899938899997998999
Q ss_pred EEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCC----CEEEEECC
Q ss_conf 99657999977863039520001355566898999999999996416999822058876426874999----49994358
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH----NARVADFG 665 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~----~~kI~DFG 665 (914)
||||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 v~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 91 ILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEECCCCCCCCCHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 998677864310010356-----4215578999999999987666254---22113330127982589866646964334
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 75459999999975578886776694523018999820078899999999909988654345641789788665229843
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 745 (914)
++....... ......||+.|+|||++....++.++|||||||++|||++|+.||........ ...+......
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-----~~~i~~~~~~ 234 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-----LANVSAVNYE 234 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-----HHHHHTTCCC
T ss_pred HHHHCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHH-----HHHHHHCCCC
T ss_conf 421057776---31224777743099998189999766522140999999708899889999999-----9999816888
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 223653489999889999999999811019999999789999
Q 002512 746 AILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 746 ~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
. ..+. ....+..+.+|+.+||..||++|||++|+++
T Consensus 235 ~-~~~~-----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 235 F-EDEY-----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C-CHHH-----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-CCHH-----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8-7010-----4788999999999986389668919999961
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.39 Aligned_cols=247 Identities=24% Similarity=0.298 Sum_probs=201.4
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEE
Q ss_conf 131210286653499999980-895999999220363-320649899999999810698523210201118768999965
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.+.||+|+||.||+++.+ +++.||+|++.+... .....+.+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey 86 (337)
T d1o6la_ 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86 (337)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCEEC
T ss_conf 28988983176849999999899989999998156544979999999999999867999887787640356421110003
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 79999778630395200013555668989999999999964169998220588764268749994999435875459999
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~ 673 (914)
+++|+|.+++.... .++......++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 87 ~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 87 ANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp CTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred CCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 57986055553256-----7759999999999965211343159---622464777847658998888205652003567
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 99997557888677669452301899982007889999999990998865434564178978866522984322365348
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~ 753 (914)
. .......||+.|||||++.+..++.++|||||||++|||++|+.||...... .+ ...+..... .
T Consensus 159 ~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~-~~----~~~i~~~~~--------~ 223 (337)
T d1o6la_ 159 G--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-RL----FELILMEEI--------R 223 (337)
T ss_dssp T--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HH----HHHHHHCCC--------C
T ss_pred C--CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHH-HH----HHHHHCCCC--------C
T ss_conf 8--6205510088996666504898883331022306788998789999996999-99----999852899--------8
Q ss_pred CCCCHHHHHHHHHHHHHHHHCCCCCCCC-----HHHHHH
Q ss_conf 9999889999999999811019999999-----789999
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPS-----MDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~ev~~ 787 (914)
. +...+.++.+|+.+||+.||.+||+ ++|+++
T Consensus 224 ~--p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 224 F--PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C--CTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C--CCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf 9--866899999999866638934422565234999972
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.88 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=199.5
Q ss_pred HCCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCC----EEEEE
Q ss_conf 51312102866534999999808959999992203633206498999999998106985232102011187----68999
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR----ERLLV 590 (914)
Q Consensus 515 t~~f~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~----~~~LV 590 (914)
++.+.+.||+|+||.||+|++. ++.||||++.... .....+..|+..+.+++||||+++++++.+.+ ..+||
T Consensus 4 ~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 4 TIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred EEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 8999889820788199999999-9899999987200---46799999999996279986832688998379860489999
Q ss_pred EEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCC-----CCCEECCCCCCCCEEECCCCCEEEEECC
Q ss_conf 96579999778630395200013555668989999999999964169-----9982205887642687499949994358
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYA-----CPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~-----~~~iiHrDIKp~NILl~~~~~~kI~DFG 665 (914)
|||+++|+|.++|++. .++|..+++++.|++.||+|||+.. .++|+||||||+|||+++++.+||+|||
T Consensus 80 ~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EECCCCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECC
T ss_conf 9646698989998658------9998999999999999999988766520468986615317313578688776887638
Q ss_pred CCCCCCCCCC--CCCCCCCCCCCCCCCHHHHHCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC--------
Q ss_conf 7545999999--99755788867766945230189------9982007889999999990998865434564--------
Q 002512 666 LSLLGPADSS--SPLAELPAGTLGYLDPEYYRLHY------LTTKSDVYSFGVLLLEILSGRKAIDMQFEEG-------- 729 (914)
Q Consensus 666 la~~~~~~~~--~~~~~~~~Gt~~Y~aPE~l~~~~------~s~ksDVySlGviL~ELltG~~p~~~~~~~~-------- 729 (914)
+++....... ........||+.|||||++.... ++.++||||||++||||+||..|+.......
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
T ss_conf 66234677762001355250354767822105654546777675012201599999996289988766311241012255
Q ss_pred --CHHHHHHHHHHCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf --17897886652298432236534-89999889999999999811019999999789999999999987
Q 002512 730 --NIVEWAVPLIKSGDITAILDPVL-KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQL 796 (914)
Q Consensus 730 --~l~~~~~~~~~~~~~~~i~d~~~-~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~~ 796 (914)
............... +|.+ ......+.+..+.+|+.+||+.||++|||+.||++.|+++..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCC----CCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 64309999998750246----8887765577689999999999976069858959999999999888865
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.92 Aligned_cols=249 Identities=29% Similarity=0.452 Sum_probs=202.9
Q ss_pred CCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECC-CEEEEEEEEC
Q ss_conf 131210286653499999980895999999220363320649899999999810698523210201118-7689999657
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG-RERLLVYEFM 594 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~LV~Ey~ 594 (914)
..|.+.||+|+||.||+|+++ +..||||++... ...++|.+|+.++++++||||++++|++.+. +..+|||||+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred EEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH----HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECC
T ss_conf 488579820798089999999-909999998857----779999999999986789898549878872389289999636
Q ss_pred CCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99997786303952000135556689899999999999641699982205887642687499949994358754599999
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~ 674 (914)
++|+|.++|+... ...+++..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp TTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCHHHHHHHCC---CCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCC-
T ss_conf 9998999987457---888899999999999985232113376---553666567601468997763245600344787-
Q ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 9997557888677669452301899982007889999999990-998865434564178978866522984322365348
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 675 ~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~ 753 (914)
.....++..|+|||++.+..++.++||||||+++|||+| |+.|+... ...++... +..+. +
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~-~~~~~~~~----i~~~~---------~ 218 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPR----VEKGY---------K 218 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS-CGGGHHHH----HTTTC---------C
T ss_pred ----CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHH----HHCCC---------C
T ss_conf ----765566646778178727988858877757999999997899999999-99999999----98089---------9
Q ss_pred CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 99998899999999998110199999997899999999999
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALA 794 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~ 794 (914)
.+.+...+.++.+|+.+||..||.+||||.++++.|+++..
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99976579999999999756697689399999999999986
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=349.62 Aligned_cols=244 Identities=21% Similarity=0.307 Sum_probs=200.1
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECC-CCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEE
Q ss_conf 131210286653499999980-89599999922036-3320649899999999810698523210201118768999965
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.+.||+|+||.||+++++ +++.||+|++.... ......+.+.+|+.++++++|||||++++++.+.+..|+||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEEEE
T ss_conf 08888972076808999999899979999998457754889999999999999863696753303568528800567650
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 79999778630395200013555668989999999999964169998220588764268749994999435875459999
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~ 673 (914)
+++|+|..++.... .+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 ~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 86 IEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred CCCCCCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 37863223432222-----1110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 99997557888677669452301899982007889999999990998865434564178978866522984322365348
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~ 753 (914)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...... +... .+..+.. .
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~----~~~~-~i~~~~~--------~ 219 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM----KTYE-KILNAEL--------R 219 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHH-HHHHCCC--------C
T ss_pred -----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHH----HHHH-HHHCCCC--------C
T ss_conf -----64345763435999983899980430465333689997598999996999----9999-9970898--------8
Q ss_pred CCCCHHHHHHHHHHHHHHHHCCCCCCC-----CHHHHHH
Q ss_conf 999988999999999981101999999-----9789999
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERP-----SMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~ev~~ 787 (914)
. +...+.++.+++.+||..+|.+|| +++++++
T Consensus 220 ~--p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 F--PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp C--CTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C--CCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf 9--977899999999999544997666431021999981
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.78 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=203.9
Q ss_pred CCCCCCCCCCCCEEEEEEEECC--C--CEEEEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEE
Q ss_conf 1312102866534999999808--9--5999999220363-320649899999999810698523210201118768999
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKD--G--TVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
+.+.+.||+|+||.||+|++.. + ..||||++..... .....++|.+|+.++++++||||++++|++.+. ..++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEE
T ss_pred EEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEEC-CHHEE
T ss_conf 19978980388839999999889990799999999835557989999999999999868999987898777401-00114
Q ss_pred EEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 96579999778630395200013555668989999999999964169998220588764268749994999435875459
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~ 670 (914)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf 65423861254442126----89999999999999999998752178---752056688815655654332561155530
Q ss_pred CCCCCC-CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 999999-97557888677669452301899982007889999999990-9988654345641789788665229843223
Q 002512 671 PADSSS-PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILS-GRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748 (914)
Q Consensus 671 ~~~~~~-~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELlt-G~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 748 (914)
...... .......|+..|+|||.+....++.++||||||+++|||+| |+.||...... .... .....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~-~~~~---~i~~~~------ 231 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-QILH---KIDKEG------ 231 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-HHHH---HHHTSC------
T ss_pred CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHH---HHHHCC------
T ss_conf 358875265476325731079999837999942156614899999996899999996999-9999---998479------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHH
Q ss_conf 65348999988999999999981101999999978999999999
Q 002512 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 749 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~ 792 (914)
.+.+.+...+..+.+|+.+||..||++||||.+|.+.|+++
T Consensus 232 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 ---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf ---99998544539999999997688966792999999999964
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.30 Aligned_cols=261 Identities=24% Similarity=0.398 Sum_probs=207.7
Q ss_pred HHCCCCCCCCCCCCEEEEEEEEC------CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEE
Q ss_conf 85131210286653499999980------895999999220363320649899999999810698523210201118768
Q 002512 514 ATGGFKEEVGKGSFSCVYKGVLK------DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRER 587 (914)
Q Consensus 514 ~t~~f~~~lG~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 587 (914)
....+.++||+|+||.||+|.++ ++..||||++.... .......|.+|+.++++++||||+++++++......
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 9918835982078818999998786447789689999987012-868999999999999976999884125478428810
Q ss_pred EEEEEECCCCCHHHHHHCCCCCH-----HCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEE
Q ss_conf 99996579999778630395200-----0135556689899999999999641699982205887642687499949994
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKAL-----KEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVA 662 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~~-----~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~ 662 (914)
++||||+++|+|.++++...... ...+++..+++++.|+++||.|||+++ |+||||||+|||+++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEEE
T ss_conf 6777604899889998750332113444688799999999999999999876479---6543286775403599649994
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 358754599999999755788867766945230189998200788999999999099-8865434564178978866522
Q 002512 663 DFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGR-KAIDMQFEEGNIVEWAVPLIKS 741 (914)
Q Consensus 663 DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~-~p~~~~~~~~~l~~~~~~~~~~ 741 (914)
|||+++...............||+.|+|||.+.+..++.++||||||+++|||+|+. +||... ..... ...+..
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~-~~~~~----~~~i~~ 250 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL-SNEQV----LRFVME 250 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS-CHHHH----HHHHHT
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-CHHHH----HHHHHH
T ss_conf 2454202357763031340231632378888736998833344437899999996899999998-99999----999980
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHH
Q ss_conf 984322365348999988999999999981101999999978999999999
Q 002512 742 GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERA 792 (914)
Q Consensus 742 ~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~ 792 (914)
+.... .+...+..+.+|+.+||+.+|++||||.+|++.|++.
T Consensus 251 ~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 251 GGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp TCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred CCCCC---------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf 88888---------8633539999999997577965893999999997876
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=346.24 Aligned_cols=248 Identities=20% Similarity=0.259 Sum_probs=192.8
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCC-CCCCHHHHHHH---HHHHHHCCCCCEEEEECEEECCCEEEEE
Q ss_conf 131210286653499999980-895999999220363-32064989999---9999810698523210201118768999
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTE---LDLLSRLNHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E---~~~l~~l~HpnIv~l~g~~~~~~~~~LV 590 (914)
+.+.+.||+|+||.||+++.+ +++.||+|++..... .......+.+| +.+++.++|||||++++++.+.+..|+|
T Consensus 6 y~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~iv 85 (364)
T d1omwa3 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85 (364)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
T ss_conf 85101884288909999999999979999998458754266799999999999998508998588999999989988999
Q ss_pred EEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 96579999778630395200013555668989999999999964169998220588764268749994999435875459
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~ 670 (914)
|||+++|+|.++|.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+..
T Consensus 86 mE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 86 LDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp ECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 99148983899987325-----5327899999999999999999779---622044422167858896798220102333
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 99999997557888677669452301-89998200788999999999099886543456417897886652298432236
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD 749 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d 749 (914)
.... .....||+.|||||++.. ..++.++|||||||+||||+||+.||....... ... ........
T Consensus 158 ~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~-~~~~~~~~------- 224 (364)
T d1omwa3 158 SKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHE-IDRMTLTM------- 224 (364)
T ss_dssp SSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-HHH-HHHHSSSC-------
T ss_pred CCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH-HHH-HHHHCCCC-------
T ss_conf 7886----4331134554216876038999844104677899999985999888899899-999-99860468-------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-----HHHHHH
Q ss_conf 53489999889999999999811019999999-----789999
Q 002512 750 PVLKLPSDLDALKRIANVACKCVRMRGKERPS-----MDKVTT 787 (914)
Q Consensus 750 ~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~ev~~ 787 (914)
... .+...+.++.+|+.+||..||.+||| ++|+++
T Consensus 225 -~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 -AVE--LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -CCC--CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCC--CCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf -887--8877899999999998566988808874357999974
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=348.35 Aligned_cols=244 Identities=22% Similarity=0.263 Sum_probs=200.4
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECC-CCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEE
Q ss_conf 131210286653499999980-89599999922036-3320649899999999810698523210201118768999965
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.+.||+|+||.||+++++ +++.||+|++.... ......+.+.+|+.+|++++|||||++++++.+....++||||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf 08988961176808999999899989999998267745889999999999999974877274034444322222322223
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 79999778630395200013555668989999999999964169998220588764268749994999435875459999
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPAD 673 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~ 673 (914)
+.+|+|.+++.... .+++.....++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 123 ~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp CTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 34662266675158-----9899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 99997557888677669452301899982007889999999990998865434564178978866522984322365348
Q 002512 674 SSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVLK 753 (914)
Q Consensus 674 ~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~~ 753 (914)
.....||+.|||||++.+..++.++|||||||+||||+||+.||..... .. ....+..... .
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~-~~~~i~~~~~--------~ 256 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQ-IYEKIVSGKV--------R 256 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHHHHHCCC--------C
T ss_pred -----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH----HH-HHHHHHCCCC--------C
T ss_conf -----6433676356788997179988533114500789999758899899599----99-9999861798--------8
Q ss_pred CCCCHHHHHHHHHHHHHHHHCCCCCCC-----CHHHHHH
Q ss_conf 999988999999999981101999999-----9789999
Q 002512 754 LPSDLDALKRIANVACKCVRMRGKERP-----SMDKVTT 787 (914)
Q Consensus 754 ~~~~~~~~~~l~~l~~~Cl~~dp~~RP-----s~~ev~~ 787 (914)
.+...+.++.+++.+||..||.+|+ +++++++
T Consensus 257 --~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 --FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf --9766899999999998340998606553454999971
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=349.30 Aligned_cols=259 Identities=23% Similarity=0.290 Sum_probs=206.5
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCC-CCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCC----EEEE
Q ss_conf 131210286653499999980-895999999220363-3206498999999998106985232102011187----6899
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSD-RQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR----ERLL 589 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~----~~~L 589 (914)
+.+.+.||+|+||.||++++. +++.||+|++..... .....+.|.+|+.++++++||||+++++++...+ ..||
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEEEE
T ss_conf 69868996089929999999999989999998556646989999999999999856999887311435432688766999
Q ss_pred EEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99657999977863039520001355566898999999999996416999822058876426874999499943587545
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~ 669 (914)
||||+++++|.+++.... .+++...+.++.|++.||+|||+++ |+||||||+|||++.++..+|+|||.+..
T Consensus 89 vmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEECCCCCEEHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHHH
T ss_conf 997788987101120358-----9999999999999999999998579---52763467556657543201003444322
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 999999-9975578886776694523018999820078899999999909988654345641789788665229843223
Q 002512 670 GPADSS-SPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAIL 748 (914)
Q Consensus 670 ~~~~~~-~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~ 748 (914)
...... ........||+.|||||++.+..++.++||||||+++|||+||+.||...... +.....+......
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~----~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV----SVAYQHVREDPIP--- 233 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHCCCCC---
T ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHH----HHHHHHHHCCCCC---
T ss_conf 123544333346425762436999983999996632026528999997697998996999----9999998469999---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC-CHHHHHHHHHHHH
Q ss_conf 65348999988999999999981101999999-9789999999999
Q 002512 749 DPVLKLPSDLDALKRIANVACKCVRMRGKERP-SMDKVTTALERAL 793 (914)
Q Consensus 749 d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RP-s~~ev~~~L~~~l 793 (914)
+.. .....+..+.+++.+||..||.+|| |++++++.|.++.
T Consensus 234 -~~~---~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -PSA---RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -GGG---TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -CCH---HCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf -710---034789999999999866797677739999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.47 Aligned_cols=243 Identities=18% Similarity=0.261 Sum_probs=193.9
Q ss_pred CCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCEEEEECEEEC----CCEEEEEEEE
Q ss_conf 10286653499999980-895999999220363320649899999999810-69852321020111----8768999965
Q 002512 520 EEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEE----GRERLLVYEF 593 (914)
Q Consensus 520 ~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~----~~~~~LV~Ey 593 (914)
+.||+|+||.||+++++ +++.||||++.. ...+.+|+.++.++ +|||||++++++.+ ....||||||
T Consensus 18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy 90 (335)
T d2ozaa1 18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD-------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMEC 90 (335)
T ss_dssp EEEEECSSCEEEEEEETTTCCEEEEEEEEC-------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEEC
T ss_pred EEEEECCCEEEEEEEECCCCCEEEEEEECC-------CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEEEEC
T ss_conf 796545486999999889998999999897-------4779999999998669999782989995034689789999977
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECC---CCCEEEEECCCCCCC
Q ss_conf 79999778630395200013555668989999999999964169998220588764268749---994999435875459
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE---EHNARVADFGLSLLG 670 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~---~~~~kI~DFGla~~~ 670 (914)
+++|+|.++|..... ..+++.....++.|++.||+|||+.+ |+||||||+|||+++ ++.+||+|||+++..
T Consensus 91 ~~gg~L~~~i~~~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~ 164 (335)
T d2ozaa1 91 LDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 164 (335)
T ss_dssp CCSEEHHHHHHSCSC---CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred CCCCCHHHHHHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEEC
T ss_conf 899849999986278---77579999999999999999999769---864441002201135555663113545512333
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99999997557888677669452301899982007889999999990998865434564178978866522984322365
Q 002512 671 PADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDP 750 (914)
Q Consensus 671 ~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~ 750 (914)
.... ......||+.|||||++.+..++.++|||||||+||||+||+.||........... ... .+...
T Consensus 165 ~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~-~~~--------~i~~~ 232 (335)
T d2ozaa1 165 TSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKT--------RIRMG 232 (335)
T ss_dssp CCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------CCCSC
T ss_pred CCCC---CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHH-HHH--------HHHCC
T ss_conf 6888---64322677563792777489888888887645167788658899889887788999-999--------98538
Q ss_pred CCCCCCC--HHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 3489999--889999999999811019999999789999
Q 002512 751 VLKLPSD--LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 751 ~~~~~~~--~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
....+.+ ...+.++.+|+.+||+.||++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 888898543469999999999975699657909999970
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.98 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=199.9
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECC-CCCCCHHHHHHHHHHHH-HCCCCCEEEEECEEECCCEEEEEEE
Q ss_conf 131210286653499999980-89599999922036-33206498999999998-1069852321020111876899996
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATS-DRQKNSKEFHTELDLLS-RLNHAHLLNLLGYCEEGRERLLVYE 592 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~f~~E~~~l~-~l~HpnIv~l~g~~~~~~~~~LV~E 592 (914)
+.+.+.||+|+||+||+++.+ +++.||||++.... ......+.+..|..++. .++|||||++++++.+.+..|||||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEEEE
T ss_conf 18865894087828999999999989999998055533848999999999999984799968789889704983167775
Q ss_pred ECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 57999977863039520001355566898999999999996416999822058876426874999499943587545999
Q 002512 593 FMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPA 672 (914)
Q Consensus 593 y~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~ 672 (914)
|+++|+|.++++... .++......++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 84 y~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp CCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred ECCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 037980899864047-----8999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 99999755788867766945230189998200788999999999099886543456417897886652298432236534
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~ 752 (914)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+..+..
T Consensus 156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-----~~~~i~~~~~-------- 220 (320)
T d1xjda_ 156 GD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-----LFHSIRMDNP-------- 220 (320)
T ss_dssp TT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHCCC--------
T ss_pred CC--CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHCCCC--------
T ss_conf 65--33454578777689999827998832320112278989873889999989999-----9999971899--------
Q ss_pred CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHH-HHHH
Q ss_conf 8999988999999999981101999999978-9999
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMD-KVTT 787 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~-ev~~ 787 (914)
..+...+.++.+|+.+||..||.+||++. ++++
T Consensus 221 --~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 --FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp --CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred --CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf --8975679999999999654489878388999980
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=340.13 Aligned_cols=250 Identities=24% Similarity=0.312 Sum_probs=201.1
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCC-------CCHHHHHHHHHHHHHCC-CCCEEEEECEEECCCE
Q ss_conf 131210286653499999980-89599999922036332-------06498999999998106-9852321020111876
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQ-------KNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRE 586 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~-------~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~ 586 (914)
+.+.+.||+|+||+||+++.+ +++.+|||++....... ...+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCC
T ss_conf 88852884176849999999999989999999624464114788899999999999999985079974799762146760
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCC
Q ss_conf 89999657999977863039520001355566898999999999996416999822058876426874999499943587
Q 002512 587 RLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGL 666 (914)
Q Consensus 587 ~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGl 666 (914)
.||||||+++|+|.++|.... .+++..+..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEEECCCCCHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 599997689866899998659-----9999999999999999999998759---94323462548986899838712403
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHHC------CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 545999999997557888677669452301------89998200788999999999099886543456417897886652
Q 002512 667 SLLGPADSSSPLAELPAGTLGYLDPEYYRL------HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIK 740 (914)
Q Consensus 667 a~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~------~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~ 740 (914)
++...... ......||..|+|||++.. ..++.++||||+|++||||++|+.||....... ....+.
T Consensus 157 a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-----~~~~i~ 228 (277)
T d1phka_ 157 SCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-----MLRMIM 228 (277)
T ss_dssp CEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHH
T ss_pred EEECCCCC---CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH-----HHHHHH
T ss_conf 16726887---2134524678889888605344567889923318565602310322888988999999-----999998
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 29843223653489999889999999999811019999999789999
Q 002512 741 SGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 741 ~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
.+... ...+.....++++.+|+.+||+.+|++|||++|+++
T Consensus 229 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 229 SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HCCCC------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 18988------898543468999999999976589668919999973
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.70 Aligned_cols=248 Identities=18% Similarity=0.257 Sum_probs=198.9
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEEC
Q ss_conf 131210286653499999980-8959999992203633206498999999998106985232102011187689999657
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
|.+.+.||+|+||.||++.++ +++.||+|.+..... ....+.+|+.+|.+++|||||++++++++.+..||||||+
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 5887898317783999999989996999999757866---5999999999998579979890989998899889999538
Q ss_pred CCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECC--CCCEEEEECCCCCCCCC
Q ss_conf 9999778630395200013555668989999999999964169998220588764268749--99499943587545999
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE--EHNARVADFGLSLLGPA 672 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~--~~~~kI~DFGla~~~~~ 672 (914)
++|+|.+++.... ..+++.....++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++....
T Consensus 84 ~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 84 SGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf 9980889987538----99999999999999999999998769---9751355444344378851899764411100346
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 99999755788867766945230189998200788999999999099886543456417897886652298432236534
Q 002512 673 DSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILDPVL 752 (914)
Q Consensus 673 ~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d~~~ 752 (914)
.. ......+|+.|+|||.+....++.++|||||||++|||++|+.||........ ...+...... ...+..
T Consensus 157 ~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~-----~~~i~~~~~~-~~~~~~ 227 (321)
T d1tkia_ 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI-----IENIMNAEYT-FDEEAF 227 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-----HHHHHHTCCC-CCHHHH
T ss_pred CC---CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHHCCCC-CCHHHC
T ss_conf 77---53212233222340210487778401130279999999828999999899999-----9999838999-880223
Q ss_pred CCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 89999889999999999811019999999789999
Q 002512 753 KLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 753 ~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
...+.++.+|+.+||..||.+|||++|+++
T Consensus 228 -----~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 228 -----KEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp -----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----678999999999986699668909999963
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.33 Aligned_cols=258 Identities=21% Similarity=0.234 Sum_probs=195.6
Q ss_pred CCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCC---CCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEEC
Q ss_conf 210286653499999980-89599999922036332---06498999999998106985232102011187689999657
Q 002512 519 KEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQ---KNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 519 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
.+.||+|+||+||+++++ +++.||||++....... ...+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99997786303952000135556689899999999999641699982205887642687499949994358754599999
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~ 674 (914)
.++++..++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~~~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred CCHHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCC
T ss_conf 4507765541266-----7789999999999999998863163---5503577625885377841146576100057875
Q ss_pred CCCCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC----
Q ss_conf 9997557888677669452301-89998200788999999999099886543456417897886652298432236----
Q 002512 675 SSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITAILD---- 749 (914)
Q Consensus 675 ~~~~~~~~~Gt~~Y~aPE~l~~-~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~i~d---- 749 (914)
. ......||+.|+|||++.. ..++.++|||||||++|||++|+.||........+... .............+
T Consensus 155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i-~~~~~~~~~~~~~~~~~~ 231 (299)
T d1ua2a_ 155 R--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI-FETLGTPTEEQWPDMCSL 231 (299)
T ss_dssp C--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHHHCCCCTTTSSSTTSS
T ss_pred C--CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHH-HHHCCCCCHHHCCCHHCC
T ss_conf 5--4330204733363999726778880564363042899998596999999999999999-985189972545210002
Q ss_pred ----CCCCC-CCC-----HHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf ----53489-999-----889999999999811019999999789999
Q 002512 750 ----PVLKL-PSD-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 750 ----~~~~~-~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
..... ..+ ....+++.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 134430347898867856568999999999976389456908999967
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.14 Aligned_cols=262 Identities=23% Similarity=0.318 Sum_probs=197.7
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEEC
Q ss_conf 131210286653499999980-8959999992203633206498999999998106985232102011187689999657
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+...+.||+|+||.||++++. +++.||+|++......+...+.+.+|++++++++|||||++++++.+....|+||||+
T Consensus 4 Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~ 83 (298)
T d1gz8a_ 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83 (298)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEEC
T ss_conf 77651772376809999999999979999998022257589999999999998679983887445332243203788623
Q ss_pred CCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99997786303952000135556689899999999999641699982205887642687499949994358754599999
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~ 674 (914)
.+ ++.+++.... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~-~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 84 HQ-DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp SE-EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred CC-CHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 77-4455544202---568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCC------CCCCC
Q ss_conf 99975578886776694523018-999820078899999999909988654345641789788665229------84322
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSG------DITAI 747 (914)
Q Consensus 675 ~~~~~~~~~Gt~~Y~aPE~l~~~-~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~------~~~~i 747 (914)
. ......||+.|+|||.+... .++.++||||||+++|||++|+.||........+..... ..... .....
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR-TLGTPDEVVWPGVTSM 233 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCCCCTTTSTTGGGS
T ss_pred C--CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHH-HCCCCCHHHCCCCCCC
T ss_conf 4--100103652154112213665777422103333134279668799898899999999998-3289833314442224
Q ss_pred CCCCCCC----CCC-----HHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 3653489----999-----889999999999811019999999789999
Q 002512 748 LDPVLKL----PSD-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 748 ~d~~~~~----~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
.+..... ... .....++.+|+.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 2124345432222044416678999999999976399557918999967
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=335.88 Aligned_cols=261 Identities=20% Similarity=0.270 Sum_probs=201.1
Q ss_pred CCCCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEECC
Q ss_conf 13121028665349999998089599999922036332064989999999981069852321020111876899996579
Q 002512 516 GGFKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFMA 595 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~~ 595 (914)
+...++||+|+||+||++++++++.||||++......+...+.|.+|+.+|++++||||+++++++.+.+..+++|||+.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred CEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEEEH
T ss_conf 63431872277818999996899999999981232685899999999999986799868766012046773158997400
Q ss_pred CCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 99977863039520001355566898999999999996416999822058876426874999499943587545999999
Q 002512 596 HGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADSS 675 (914)
Q Consensus 596 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~~ 675 (914)
++.+..+.... ..++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 84 QDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp EEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred HHHHHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 45678998604-----77514456899999999999860574---88267877505686899787323664301146765
Q ss_pred CCCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC------CCCC-
Q ss_conf 997557888677669452301-89998200788999999999099886543456417897886652298------4322-
Q 002512 676 SPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD------ITAI- 747 (914)
Q Consensus 676 ~~~~~~~~Gt~~Y~aPE~l~~-~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~------~~~i- 747 (914)
......+++.|+|||.+.. ..++.++||||||+++|||++|+.||........+..... ...... ....
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR-ILGTPNSKNWPNVTELP 232 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCCCCTTTSTTGGGST
T ss_pred --CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHH-HHCCCCHHHCCCHHHHH
T ss_conf --410102431101378871788888410021117589999779799898898999999998-63899711042123332
Q ss_pred -----CCCCCC---CCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf -----365348---9999889999999999811019999999789999
Q 002512 748 -----LDPVLK---LPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 748 -----~d~~~~---~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
...... ..........+.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 214333335676466651258999999999986689668909999856
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.10 Aligned_cols=259 Identities=21% Similarity=0.268 Sum_probs=193.5
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-C-CCEEEEEEEEECCCCCCCHHHHHHHHHHHHHC---CCCCEEEEECEEEC-----CC
Q ss_conf 131210286653499999980-8-95999999220363320649899999999810---69852321020111-----87
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-D-GTVVAVKKAIATSDRQKNSKEFHTELDLLSRL---NHAHLLNLLGYCEE-----GR 585 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l---~HpnIv~l~g~~~~-----~~ 585 (914)
+.+.++||+|+||.||++++. + ++.||+|++............+.+|+.+++.| +||||+++++++.. ..
T Consensus 9 Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~ 88 (305)
T d1blxa_ 9 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88 (305)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEE
T ss_pred EEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 79888992155869999999888998999999802324516799999999999987425898802366322146666674
Q ss_pred EEEEEEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECC
Q ss_conf 68999965799997786303952000135556689899999999999641699982205887642687499949994358
Q 002512 586 ERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFG 665 (914)
Q Consensus 586 ~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFG 665 (914)
..+++|||+.++++........ ..+++.....++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~~e~~~~~~~~~~~~~~~----~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 89 KLTLVFEHVDQDLTTYLDKVPE----PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp EEEEEEECCSCBHHHHHHHSCT----TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred EEEEEEEECCCCCHHHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCHH
T ss_conf 6999997405871444443037----89998999999999999999997588---9835798627898589975421000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 75459999999975578886776694523018999820078899999999909988654345641789788665229843
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT 745 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~ 745 (914)
+++...... ......||+.|||||++.+..++.++|||||||++|||++|+.||........+..... ........
T Consensus 162 ~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~-~~~~~~~~ 237 (305)
T d1blxa_ 162 LARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD-VIGLPGEE 237 (305)
T ss_dssp SCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH-HHCCCCGG
T ss_pred HHHHHCCCC---CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHH-HHCCCCHH
T ss_conf 101100234---57776548511483100179888111000328999999878799899898999999998-40799611
Q ss_pred C---------------CCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 2---------------23653489999889999999999811019999999789999
Q 002512 746 A---------------ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 746 ~---------------i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
. ...+... ......+.+.+|+.+||+.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 238 DWPRDVALPRQAFHSKSAQPIEK--FVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGG--TCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCCCCHHHHHCCCCCCCHHH--CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 05321111033302234564544--04458999999999987489667918999966
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.81 Aligned_cols=258 Identities=21% Similarity=0.239 Sum_probs=187.7
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECC------CEEE
Q ss_conf 131210286653499999980-895999999220363320649899999999810698523210201118------7689
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG------RERL 588 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~------~~~~ 588 (914)
++..++||+|+||+||+++++ +++.||||++.... ..+.+|+.+|++++||||+++++++... .+.+
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS------SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCC------HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf 675169821768399999999999799999988160------68999999998668989873878997447657731899
Q ss_pred EEEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCC-CEEEEECCCC
Q ss_conf 999657999977863039520001355566898999999999996416999822058876426874999-4999435875
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-NARVADFGLS 667 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kI~DFGla 667 (914)
|||||++++.+....+.. .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++
T Consensus 96 lv~Ey~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a 170 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 170 (350)
T ss_dssp EEEECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred EEEECCCCCCHHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCH
T ss_conf 998416886078888631--03689999999999999999999998668---7645788603787358971167336605
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHH----------
Q ss_conf 45999999997557888677669452301-8999820078899999999909988654345641789788----------
Q 002512 668 LLGPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV---------- 736 (914)
Q Consensus 668 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~---------- 736 (914)
+...... ......|+..|+|||.+.. ..++.++||||||+++|||++|+.||........+.....
T Consensus 171 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 171 KQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 247 (350)
T ss_dssp EECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred HHCCCCC---CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHH
T ss_conf 4404776---5320025555568277640468882100024652778550287998987999999999997489817765
Q ss_pred HHHH----CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 6652----29843223653489999889999999999811019999999789999
Q 002512 737 PLIK----SGDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 737 ~~~~----~~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
.... ......................++.+|+.+||..||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 4306210110355445674444315689999999999976589557929999966
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=320.94 Aligned_cols=262 Identities=18% Similarity=0.210 Sum_probs=204.8
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCEEEEECEEECCCEEEEEEEE
Q ss_conf 131210286653499999980-89599999922036332064989999999981069-8523210201118768999965
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNH-AHLLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.+.||+|+||.||+|++. +++.||+|....... ...+.+|++.+..+.| +|++.+++++.+....++||||
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 6997998417882999999988997999999750258----299999999999964899987799996018811799996
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECC-----CCCEEEEECCCCC
Q ss_conf 79999778630395200013555668989999999999964169998220588764268749-----9949994358754
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE-----EHNARVADFGLSL 668 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~-----~~~~kI~DFGla~ 668 (914)
+ +++|.+++..... .+++.....++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~-~~~l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 83 L-GPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp C-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred C-CCCHHHHHHHHCC----CHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf 4-8887999975203----1106899999999999999999779---662667713152347543447956872366057
Q ss_pred CCCCCCCC-----CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHH--HHHHHHC
Q ss_conf 59999999-----9755788867766945230189998200788999999999099886543456417897--8866522
Q 002512 669 LGPADSSS-----PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEW--AVPLIKS 741 (914)
Q Consensus 669 ~~~~~~~~-----~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~--~~~~~~~ 741 (914)
........ .......||+.|||||++.+..++.++||||||+++|||+||+.||............ .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCC
T ss_conf 71467665411102467627751026798964888886999898319999998698767885302199999999705679
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHCC
Q ss_conf 984322365348999988999999999981101999999978999999999998709
Q 002512 742 GDITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLMG 798 (914)
Q Consensus 742 ~~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~~~~ 798 (914)
....++ . ...++++.+++..|+..+|++||+++.+.+.|++++.+...
T Consensus 235 ~~~~~l-----~----~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 235 TPLREL-----C----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp SCHHHH-----T----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CCHHHH-----C----CCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCC
T ss_conf 995896-----5----79989999999998439930085999999999999997599
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.23 Aligned_cols=262 Identities=21% Similarity=0.272 Sum_probs=195.8
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECC--------CEE
Q ss_conf 31210286653499999980-895999999220363320649899999999810698523210201118--------768
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG--------RER 587 (914)
Q Consensus 517 ~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~--------~~~ 587 (914)
.+.++||+|+||+||+|+++ +++.||||++......+...+.+.+|+.+|++++||||+++++++... ...
T Consensus 13 ~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~ 92 (318)
T d3blha1 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI 92 (318)
T ss_dssp EEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CE
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCCCEE
T ss_conf 89999722748299999998999799999984222463789999999999998359996606765402465444457638
Q ss_pred EEEEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99996579999778630395200013555668989999999999964169998220588764268749994999435875
Q 002512 588 LLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLS 667 (914)
Q Consensus 588 ~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla 667 (914)
++||||+.++.+..+.... ..++......++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 93 ~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 93 YLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp EEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEECCCCCCCCHHHHCC-----CCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECCEE
T ss_conf 9998535787410122203-----44330899999999999998852299---885676722203668996876313500
Q ss_pred CCCCCCCCC--CCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC-
Q ss_conf 459999999--975578886776694523018-9998200788999999999099886543456417897886652298-
Q 002512 668 LLGPADSSS--PLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD- 743 (914)
Q Consensus 668 ~~~~~~~~~--~~~~~~~Gt~~Y~aPE~l~~~-~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~- 743 (914)
+........ .......||+.|+|||.+... .++.++||||||+++|||++|+.||........+.. .........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~-i~~~~~~~~~ 243 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL-ISQLCGSITP 243 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH-HHHHHCCCCT
T ss_pred EECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHH-HHHHCCCCCH
T ss_conf 223554443211356602497874289970799989178700678646617448799899899999999-9984189982
Q ss_pred ----------CCCCCCCCCCCCCCH-H------HHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf ----------432236534899998-8------9999999999811019999999789999
Q 002512 744 ----------ITAILDPVLKLPSDL-D------ALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 744 ----------~~~i~d~~~~~~~~~-~------~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
............... + ....+.+|+.+||+.||++|||++|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 5534432034443320133445550334044459989999999987389658909999974
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=320.00 Aligned_cols=261 Identities=20% Similarity=0.216 Sum_probs=198.1
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCC-EEEEECEEECCCEEEEEEEE
Q ss_conf 131210286653499999980-8959999992203633206498999999998106985-23210201118768999965
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAH-LLNLLGYCEEGRERLLVYEF 593 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hpn-Iv~l~g~~~~~~~~~LV~Ey 593 (914)
+.+.+.||+|+||.||+|++. +++.||||....... ..++..|++++++++|+| |+.+.++..+.+..++||||
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred EEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEE
T ss_conf 9996898507880999999988998999999721005----888999999999703899601799999519877899987
Q ss_pred CCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEEC---CCCCEEEEECCCCCCC
Q ss_conf 7999977863039520001355566898999999999996416999822058876426874---9994999435875459
Q 002512 594 MAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILID---EEHNARVADFGLSLLG 670 (914)
Q Consensus 594 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~---~~~~~kI~DFGla~~~ 670 (914)
+ +++|.+.+.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+..
T Consensus 85 ~-~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 85 L-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp C-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred C-CCCHHHHHHHCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEEC
T ss_conf 3-871333244306----88768999999999999999999799---442667876606433577761565046751342
Q ss_pred CCCCCC-----CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHH--HHHHCCC
Q ss_conf 999999-----975578886776694523018999820078899999999909988654345641789788--6652298
Q 002512 671 PADSSS-----PLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAV--PLIKSGD 743 (914)
Q Consensus 671 ~~~~~~-----~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~--~~~~~~~ 743 (914)
...... .......||+.|||||.+.+..++.++||||||+++|||+||+.||.............. .......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred CCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCC
T ss_conf 55445541000135776787353299999189989832188617789999849876655305779999998523567898
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHC
Q ss_conf 432236534899998899999999998110199999997899999999999870
Q 002512 744 ITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTTALERALAQLM 797 (914)
Q Consensus 744 ~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~~L~~~l~~~~ 797 (914)
... +. ...+.++.+++..||+.+|++||++.++.+.|+..+....
T Consensus 237 ~~~-----~~----~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 237 IEV-----LC----KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp HHH-----HT----TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred HHH-----HC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf 357-----53----4788999999999843995579199999999999999769
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.19 Aligned_cols=240 Identities=24% Similarity=0.357 Sum_probs=191.9
Q ss_pred HCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCC----CCHHHHHHHHHHHHHCC--CCCEEEEECEEECCCEE
Q ss_conf 5131210286653499999980-89599999922036332----06498999999998106--98523210201118768
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQ----KNSKEFHTELDLLSRLN--HAHLLNLLGYCEEGRER 587 (914)
Q Consensus 515 t~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~f~~E~~~l~~l~--HpnIv~l~g~~~~~~~~ 587 (914)
.+.+.+.||+|+||.||+++.. +++.||||++....... ....++.+|+.++++++ |||||++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred EEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEE
T ss_conf 37996798408783999999999997999999856884433455679999999999997435898812799998309968
Q ss_pred EEEEEECCC-CCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECC-CCCEEEEECC
Q ss_conf 999965799-99778630395200013555668989999999999964169998220588764268749-9949994358
Q 002512 588 LLVYEFMAH-GSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDE-EHNARVADFG 665 (914)
Q Consensus 588 ~LV~Ey~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~-~~~~kI~DFG 665 (914)
++||||+.+ +++.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEECCCCCHHHHHHHCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 99998336862289998615-----89999999999999999999998779---75566761114774478848977546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCC
Q ss_conf 7545999999997557888677669452301899-982007889999999990998865434564178978866522984
Q 002512 666 LSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYL-TTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDI 744 (914)
Q Consensus 666 la~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~-s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~ 744 (914)
+++..... ......||+.|||||++....+ +.++|||||||++|||++|+.||.... . +.....
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~---~--------i~~~~~ 221 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---E--------IIRGQV 221 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH---H--------HHHCCC
T ss_pred CCEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH---H--------HHHCCC
T ss_conf 53532444----55665658774799998489978865332554034536756889988736---7--------761544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 3223653489999889999999999811019999999789999
Q 002512 745 TAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 745 ~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
. .+...+.++.+|+.+||..||++|||++|+++
T Consensus 222 --------~--~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 222 --------F--FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp --------C--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --------C--CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf --------7--78779999999999976089758939999853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.05 Aligned_cols=256 Identities=21% Similarity=0.288 Sum_probs=194.3
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCC------EEE
Q ss_conf 131210286653499999980-8959999992203633206498999999998106985232102011187------689
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR------ERL 588 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~------~~~ 588 (914)
+.+.++||+|+||.||++.++ +++.||||++..........+.+.+|+.+|++++|||||++++++...+ ..+
T Consensus 20 Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 99 (346)
T d1cm8a_ 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99 (346)
T ss_dssp EEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCEEE
T ss_conf 89988980177819999999999989999998522259699999999999998668987547999863576555541599
Q ss_pred EEEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 99965799997786303952000135556689899999999999641699982205887642687499949994358754
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~ 668 (914)
|||||+ +.+|..+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 100 lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 100 LVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp EEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEECC-CCCHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCEE
T ss_conf 998405-52189998740------2269999999999999999987378---7645668511112100122113431022
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH-------HH
Q ss_conf 5999999997557888677669452301-899982007889999999990998865434564178978866-------52
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRL-HYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPL-------IK 740 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~-------~~ 740 (914)
..... .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........+....... ..
T Consensus 170 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (346)
T d1cm8a_ 170 QADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ 244 (346)
T ss_dssp ECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred CCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHHHHH
T ss_conf 06876-----3102455333588998178789965010300389999997869988897689999998503788488886
Q ss_pred CC----------CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 29----------843223653489999889999999999811019999999789999
Q 002512 741 SG----------DITAILDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 741 ~~----------~~~~i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
.. .........+. .........+.+|+.+||..||.+|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 245 RLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp TCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHCCHHHHHHHCCCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 53000344331157866655667-755689999999999977299557929999963
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.20 Aligned_cols=260 Identities=20% Similarity=0.270 Sum_probs=193.5
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCC----EEEEE
Q ss_conf 131210286653499999980-8959999992203633206498999999998106985232102011187----68999
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGR----ERLLV 590 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~----~~~LV 590 (914)
+.+.++||+|+||+||+++.+ +++.||||++.... .....+.+.+|+.+|++++||||+++++++.... ..+++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l 88 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC-CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEE
T ss_conf 599789940648099999999999499999980310-9589999999999999768989885888995056455414999
Q ss_pred EEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 96579999778630395200013555668989999999999964169998220588764268749994999435875459
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLG 670 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~ 670 (914)
++|+.+|+|.+++... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 89 ~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 89 VTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEECCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 9962598656644058------9999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCC-CCCCCCCCCCCCCCCHHHHH-CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC---
Q ss_conf 99999-99755788867766945230-18999820078899999999909988654345641789788665229843---
Q 002512 671 PADSS-SPLAELPAGTLGYLDPEYYR-LHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDIT--- 745 (914)
Q Consensus 671 ~~~~~-~~~~~~~~Gt~~Y~aPE~l~-~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~--- 745 (914)
..... ........||+.|+|||.+. ...++.++||||+|+++|||++|+.||............ ..........
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI-LGILGSPSQEDLN 238 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCSCCHHHHH
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHH-HHHCCCCCHHHHH
T ss_conf 477764101011026520003878604788874101004670133776697997888889999987-6520699756642
Q ss_pred --------C-C-CCCCCCCCCC-----HHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf --------2-2-3653489999-----889999999999811019999999789999
Q 002512 746 --------A-I-LDPVLKLPSD-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 746 --------~-i-~d~~~~~~~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
. . ..+.. ...+ .....++.+|+.+||..||.+|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHK-NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp TCCCHHHHHHHHTSCCC-CCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHCCCCCCCCC-CCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 34332222024467755-778777837899999999999976489567908999861
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.79 Aligned_cols=262 Identities=19% Similarity=0.231 Sum_probs=201.2
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECCCEEEEEEEEC
Q ss_conf 131210286653499999980-8959999992203633206498999999998106985232102011187689999657
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEGRERLLVYEFM 594 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~~~~~LV~Ey~ 594 (914)
+...++||+|+||+||+++++ +++.||||++............+.+|+.++++++||||+++++++.+....++|+|++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEEC
T ss_conf 78626971286819999999999969999998032178689999999999998567578882135444443115886302
Q ss_pred CCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 99997786303952000135556689899999999999641699982205887642687499949994358754599999
Q 002512 595 AHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLLGPADS 674 (914)
Q Consensus 595 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~~~~~~ 674 (914)
.+++|..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.+..+||+|||.++......
T Consensus 84 ~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 84 DQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp SEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred CCCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 3322211212356-----5403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC---C---CCC
Q ss_conf 99975578886776694523018-9998200788999999999099886543456417897886652298---4---322
Q 002512 675 SSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD---I---TAI 747 (914)
Q Consensus 675 ~~~~~~~~~Gt~~Y~aPE~l~~~-~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~---~---~~i 747 (914)
. ......++..|+|||.+... .++.++||||||+++|||++|+.||..................... . ...
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 R--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp S--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred C--CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf 5--10010344310146675069888804440265418899851899998899999999999861189973551344322
Q ss_pred --------CC-CCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf --------36-53489999889999999999811019999999789999
Q 002512 748 --------LD-PVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 748 --------~d-~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
.. ..............+.+|+.+||+.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 2113344454431043306568999999999986499668909999964
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=314.49 Aligned_cols=254 Identities=17% Similarity=0.281 Sum_probs=191.8
Q ss_pred HCCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEEECEEEC--CCEEEEE
Q ss_conf 5131210286653499999980-8959999992203633206498999999998106-9852321020111--8768999
Q 002512 515 TGGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEE--GRERLLV 590 (914)
Q Consensus 515 t~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~--~~~~~LV 590 (914)
.+.+.++||+|+||+||+|+++ +++.||+|++... ..+++.+|+.+|.+++ ||||+++++++.. ....++|
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEE
T ss_conf 718978983174819999998899979999998889-----999999999999851579987679999981687712688
Q ss_pred EEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCC-CEEEEECCCCCC
Q ss_conf 9657999977863039520001355566898999999999996416999822058876426874999-499943587545
Q 002512 591 YEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEH-NARVADFGLSLL 669 (914)
Q Consensus 591 ~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~-~~kI~DFGla~~ 669 (914)
|||+++++|..+.+ .++...+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+|+.
T Consensus 111 ~e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 111 FEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEECCCCCHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEE
T ss_conf 86317985899746--------8999999999999999998876433---443456441237748998366415654266
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH---------HH
Q ss_conf 9999999975578886776694523018-9998200788999999999099886543456417897886---------65
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVP---------LI 739 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~---------~~ 739 (914)
...... .....+|..|+|||.+... .++.++||||+|+++|||++|+.||............... ..
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 180 YHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHH
T ss_conf 468874---44322486424761026888888452323354555876048899988760189999999987884155555
Q ss_pred HCCC------CCCC--------CCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf 2298------4322--------3653489999889999999999811019999999789999
Q 002512 740 KSGD------ITAI--------LDPVLKLPSDLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 740 ~~~~------~~~i--------~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
.... .... ...............++.+|+.+||..||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 42254447430000033343311211552112448999999999986699568908999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=320.37 Aligned_cols=252 Identities=23% Similarity=0.301 Sum_probs=198.5
Q ss_pred CCCCCCCCCCCCEEEEEEEEC----CCCEEEEEEEEECCC--CCCCHHHHHHHHHHHHHCCC-CCEEEEECEEECCCEEE
Q ss_conf 131210286653499999980----895999999220363--32064989999999981069-85232102011187689
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK----DGTVVAVKKAIATSD--RQKNSKEFHTELDLLSRLNH-AHLLNLLGYCEEGRERL 588 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~f~~E~~~l~~l~H-pnIv~l~g~~~~~~~~~ 588 (914)
+.+.++||+|+||.||+++.. +++.||+|.+..... .....+.+.+|+.++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCEE
T ss_conf 59998983287839999998765887948999998367721016899999999999986467983999620002487300
Q ss_pred EEEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 99965799997786303952000135556689899999999999641699982205887642687499949994358754
Q 002512 589 LVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 589 LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~ 668 (914)
+||||+.+|+|.+++.... .+.......++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 106 ~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEECCCCCHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 1231234117999987304-----5437888888999999998851499---8965477320124699988874132022
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 59999999975578886776694523018--9998200788999999999099886543456417897886652298432
Q 002512 669 LGPADSSSPLAELPAGTLGYLDPEYYRLH--YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGDITA 746 (914)
Q Consensus 669 ~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~~~~ 746 (914)
....... .......|++.|++||.+... .++.++|||||||+||||++|+.||................... .
T Consensus 178 ~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~-~--- 252 (322)
T d1vzoa_ 178 EFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-E--- 252 (322)
T ss_dssp ECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC-C---
T ss_pred HHCCCCC-CCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCC-C---
T ss_conf 2034444-3221222333331068760577688713251777799999976899988887777999999833568-9---
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC-----HHHHHH
Q ss_conf 23653489999889999999999811019999999-----789999
Q 002512 747 ILDPVLKLPSDLDALKRIANVACKCVRMRGKERPS-----MDKVTT 787 (914)
Q Consensus 747 i~d~~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs-----~~ev~~ 787 (914)
.+.+.....++.+++.+||..+|.+||| ++|+++
T Consensus 253 -------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 253 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf -------988654799999999997445898819997450999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.74 Aligned_cols=257 Identities=21% Similarity=0.230 Sum_probs=195.2
Q ss_pred CCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEEC------CCEEEE
Q ss_conf 31210286653499999980-89599999922036332064989999999981069852321020111------876899
Q 002512 517 GFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEE------GRERLL 589 (914)
Q Consensus 517 ~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~------~~~~~L 589 (914)
.+.++||+|+||+||+|+++ +++.||||++...........++.+|+.++++++||||+++++++.. ....|+
T Consensus 20 ~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~i 99 (355)
T d2b1pa1 20 QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYL 99 (355)
T ss_dssp EEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEE
T ss_pred EEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCEEEE
T ss_conf 99889621758599999999999899999988233697999999999999986489876489989702564345762699
Q ss_pred EEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99657999977863039520001355566898999999999996416999822058876426874999499943587545
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~ 669 (914)
||||+.++ |.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++.
T Consensus 100 v~Ey~~~~-l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 100 VMELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEECCCHH-HHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHHC
T ss_conf 98414467-7876503-------8999999999999999998865221---12456776321136544313201023211
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHH--------------
Q ss_conf 999999997557888677669452301899982007889999999990998865434564178978--------------
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWA-------------- 735 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~-------------- 735 (914)
..... ......+|+.|+|||++.+..++.++||||+|+++|||++|+.||.............
T Consensus 169 ~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 169 AGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred CCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHH
T ss_conf 46665---533221465555813314777787743335662578986598998889778899999972058987999876
Q ss_pred ----HHHHHCC-C-----CCCCCCCCCCCCC---CHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf ----8665229-8-----4322365348999---9889999999999811019999999789999
Q 002512 736 ----VPLIKSG-D-----ITAILDPVLKLPS---DLDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 736 ----~~~~~~~-~-----~~~i~d~~~~~~~---~~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
....... . ............. .......+.+|+.+||..||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 56677776417543566642126433354321013337999999999987699457908999966
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=305.39 Aligned_cols=262 Identities=18% Similarity=0.212 Sum_probs=204.5
Q ss_pred CEEEEEEECCCEEEEECCCCCCCCCCCCCC-------------CCEEEEECCCCEEEEEEECCCCEEECCCCCCCCCC--
Q ss_conf 369899608935488247888865688999-------------78799941797047998089950532887898889--
Q 002512 52 PVFCGLKSDRSHLVTCYGSNSAIIYGTPAH-------------FPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMG-- 116 (914)
Q Consensus 52 ~~~c~~~~~~~~~v~cwg~n~~~~~~~~~~-------------~~~~~i~~G~~~~ca~~~~~~~~~cWG~n~~gqlg-- 116 (914)
.|+|++..+|.+ |+||.|+.||||.+.+ ..+++|++|..|+||| +++|.|||||.|.+||||
T Consensus 6 ~h~~~~~~~G~v--y~wG~n~~GqLG~g~~~~~~~~P~~v~~~~~i~~ia~G~~h~~al-~~~G~vy~wG~n~~GQLG~g 82 (401)
T d1a12a_ 6 SHRSHSTEPGLV--LTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCL-SKSGQVYSFGCNDEGALGRD 82 (401)
T ss_dssp CCTTCCCCCBEE--EEEEECTTSTTCSCTTCCEEEEEEEECCSSCEEEEEECSSEEEEE-ETTSCEEEEECCTTSTTCSC
T ss_pred EEEEEECCCCEE--EEEECCCCCCCCCCCCCCEECCCEEECCCCCEEEEEECCCEEEEE-ECCCEEEEEECCCCCCCCCC
T ss_conf 678999789889--999699988889999886503577908999929999189889999-67998999958999887744
Q ss_pred --------CCCCCCCCCEEEEEEECCCEEEEEECCCCCCCCCCCEEEECCCCCCCCCC-----------------CCCCE
Q ss_conf --------87322379708999707961342111789854779508980358998876-----------------89957
Q 002512 117 --------VPQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYV-----------------FDGQI 171 (914)
Q Consensus 117 --------~p~~~~~~~~~~~i~~G~~h~cal~~~~~~~~~~~g~v~cWG~n~~gql~-----------------~~~~~ 171 (914)
.|..+.....+++|++|..|+|++ +++|.|+|||.|..++.+ ....+
T Consensus 83 ~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~--------~~~g~v~~wG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 154 (401)
T d1a12a_ 83 TSVEGSEMVPGKVELQEKVVQVSAGDSHTAAL--------TDDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPV 154 (401)
T ss_dssp CCSTTGGGSCEECCCCSCEEEEEECSSEEEEE--------ETTSCEEEEECEEETTEEEESSBBTBCEEEEEEECCSSCE
T ss_pred CCCCCCCCCCCCCCCCCCEEEECCCCCCEEEC--------CCCCCCEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCE
T ss_conf 65566423554235422002201110010100--------0345311202145655544666775431001100168850
Q ss_pred EEEEECCCCEEEEEECCCEEEEECCCCCCCEEE---------------------C-------CCCCCCEEEEEECCCCEE
Q ss_conf 999624981467352599089915799985010---------------------3-------778741899974286136
Q 002512 172 ESISAGSEFNCGLFSQNRTVFCWGDESSSRVIS---------------------L-------IPKEMKFQKVAAGGYHVC 223 (914)
Q Consensus 172 ~~ia~G~~~~cal~~~~g~v~cWG~~~~g~~~~---------------------~-------~~~~~~~~~i~aG~~h~c 223 (914)
..|++|..|++++ +.+|.+|+||.|.++|+.. . ......+.+|++|..|+|
T Consensus 155 ~~i~~g~~~~~~~-~~~g~~~~~G~n~~gqlg~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~i~~v~~g~~~~~ 233 (401)
T d1a12a_ 155 VKVASGNDHLVML-TADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTF 233 (401)
T ss_dssp EEEEECSSEEEEE-ETTSCEEEEECCTTSTTCSCGGGTSSSCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETTEEE
T ss_pred EEEEECCCCEEEE-ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEEEEEECCCEEE
T ss_conf 6998203522565-037850034668766228887534456775554433565200003567777843999993687699
Q ss_pred EEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCC----CCCCCEEEEECCCCEEEEEEECCCCEEEEEECCCCCCCC--
Q ss_conf 97757996189863689986211111125665678----999990674158717876653497147762104899877--
Q 002512 224 GILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDL----PPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPV-- 297 (914)
Q Consensus 224 ~l~~~~~g~v~cWG~n~~~~~g~~~~~~~~~~~~~----~~~~~~~sia~g~~htcg~~~~~g~v~CwG~n~~gq~~i-- 297 (914)
+|+ .+|.+|+||.|.+++++.+.......+..+ .....++.+++|..|++++ ..+|.++|||.|.+||+..
T Consensus 234 ~l~--~~g~v~~~g~n~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~i~~g~~~~~~l-~~~g~v~~wG~n~~gqlG~g~ 310 (401)
T d1a12a_ 234 AIS--HEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCM-DSEGKAYSLGRAEYGRLGLGE 310 (401)
T ss_dssp EEE--TTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCTTCCEEEEEECSSEEEEE-ETTSCEEEEECCGGGTTCSCT
T ss_pred EEE--CCCEEEEECCCCEECCCCCCCCCCEECCCCCCCCCCCEEEEEEEEECCCEEEE-CCCCCEEEECCCCCCCCCCCC
T ss_conf 995--59818651222102035456631000001012355403699985101201356-148978884033467567886
Q ss_pred -----------CCCCCEEEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf -----------899517999965721101003678753245899
Q 002512 298 -----------PTGIKVYEIAAGNYFTCGVLAEKSMLPVCWGTG 330 (914)
Q Consensus 298 -----------p~g~~~~~i~~g~~~~Ca~l~e~~~~~~~wg~~ 330 (914)
+....+..|++|..|++++. +++.+ ++||.+
T Consensus 311 ~~~~~~~P~~i~~~~~i~~Is~G~~hs~alt-~dG~v-~~WG~n 352 (401)
T d1a12a_ 311 GAEEKSIPTLISRLPAVSSVACGASVGYAVT-KDGRV-FAWGMG 352 (401)
T ss_dssp TCCCEEEEEECCSSSSEEEEEECSSEEEEEE-TTSCE-EEEECC
T ss_pred CCCCCCCCEECCCCCCEEEEEEECCEEEEEE-CCCEE-EEEECC
T ss_conf 2333558888579998299993088799994-89969-999259
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=308.75 Aligned_cols=257 Identities=21% Similarity=0.284 Sum_probs=192.9
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEEEECEEECC-----CEEEE
Q ss_conf 131210286653499999980-895999999220363320649899999999810698523210201118-----76899
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAHLLNLLGYCEEG-----RERLL 589 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~HpnIv~l~g~~~~~-----~~~~L 589 (914)
+...++||+|+||+||++++. +++.||||++..........+.+.+|+.+|++++|||+|++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCEEE
T ss_conf 18888983178839999999999979999998820028689999999999998668987425999996346456686499
Q ss_pred EEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99657999977863039520001355566898999999999996416999822058876426874999499943587545
Q 002512 590 VYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 590 V~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~~ 669 (914)
++||+.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++..
T Consensus 100 i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp EEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred EEEEECCCCHHHHCCCC------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHCC
T ss_conf 99962588623200224------5309999999999999999997388---76516677633455432200132100012
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC-----
Q ss_conf 9999999975578886776694523018-9998200788999999999099886543456417897886652298-----
Q 002512 670 GPADSSSPLAELPAGTLGYLDPEYYRLH-YLTTKSDVYSFGVLLLEILSGRKAIDMQFEEGNIVEWAVPLIKSGD----- 743 (914)
Q Consensus 670 ~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~~s~ksDVySlGviL~ELltG~~p~~~~~~~~~l~~~~~~~~~~~~----- 743 (914)
... ......|+..|+|||.+... .++.++||||||+++|||++|+.||............ ........
T Consensus 171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i-~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI-LRLVGTPGAELLK 244 (348)
T ss_dssp CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHHHCCCCHHHHT
T ss_pred CCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-HHHCCCCCHHHHH
T ss_conf 575-----4444345435558355337756785512432058999997688997889889999999-9730799757732
Q ss_pred ------CCCCCCCCCCCC-CC-----HHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
Q ss_conf ------432236534899-99-----889999999999811019999999789999
Q 002512 744 ------ITAILDPVLKLP-SD-----LDALKRIANVACKCVRMRGKERPSMDKVTT 787 (914)
Q Consensus 744 ------~~~i~d~~~~~~-~~-----~~~~~~l~~l~~~Cl~~dp~~RPs~~ev~~ 787 (914)
...........+ .. ......+.+|+.+||..||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 00102445444303557875556626789999999999977588345938999855
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Probab=100.00 E-value=1.1e-44 Score=280.29 Aligned_cols=239 Identities=21% Similarity=0.296 Sum_probs=168.3
Q ss_pred CEEEEEECCCCCEEEEEEECCCEEEEECCCCCCCCCCCCCCC--CEEEEECCCCEEEEEEECCCCEEECCCCCCCCCCCC
Q ss_conf 404443079983698996089354882478888656889997--879994179704799808995053288789888987
Q 002512 41 SSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGTPAHF--PFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVP 118 (914)
Q Consensus 41 ~~~~~~~g~~~~~~c~~~~~~~~~v~cwg~n~~~~~~~~~~~--~~~~i~~G~~~~ca~~~~~~~~~cWG~n~~gqlg~p 118 (914)
...+++.|.. |+|++. ||.+ ||||.|..||++.|... .+.+|++|..|+|+| + ++.++|||.|.+||++.|
T Consensus 27 ~i~~va~G~~--h~~al~-dG~v--~~wG~N~~GQlG~~~~~~~~v~~v~~G~~~~~al-~-dg~v~~wG~~~~gq~~~~ 99 (273)
T d1jtdb_ 27 GVDAIAGGYF--HGLALK-GGKV--LGWGANLNGQLTMPAATQSGVDAIAAGNYHSLAL-K-DGEVIAWGGNEDGQTTVP 99 (273)
T ss_dssp SEEEEEECSS--EEEEEE-TTEE--EEEECCTTSTTSCCGGGGSCCCEEEECSSEEEEE-E-TTEEEEEECCTTSTTCCC
T ss_pred CCEEEECCCC--EEEEEE-CCEE--EEEECCCCCCEEEEECCCCCCEEEECCCCCEEEE-E-EEEEECCCCCCCEEECCC
T ss_conf 8599985679--899998-9989--9985899986002002346645996599725514-3-201302688730010223
Q ss_pred CCCCCCCEEEEEEECCCEEEEEECCCCCCCCCCCEEEECCCCCCCCCCCC----CCEEEEEECCCCEEEEEECCCEEEEE
Q ss_conf 32237970899970796134211178985477950898035899887689----95799962498146735259908991
Q 002512 119 QPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFD----GQIESISAGSEFNCGLFSQNRTVFCW 194 (914)
Q Consensus 119 ~~~~~~~~~~~i~~G~~h~cal~~~~~~~~~~~g~v~cWG~n~~gql~~~----~~~~~ia~G~~~~cal~~~~g~v~cW 194 (914)
...... +..|++|..|+|++ .+|+++|||.+..++.... ..+..++ +..|+|++ ..+|.++||
T Consensus 100 ~~~~~~--~~~i~~~~~~~~~~---------~dg~v~~~g~~~~~~~~~~~~~~~~v~~~~-~~~~~~~~-~~~g~~~~~ 166 (273)
T d1jtdb_ 100 AEARSG--VDAIAAGAWASYAL---------KDGKVIAWGDDSDGQTTVPAEAQSGVTALD-GGVYTALA-VKNGGVIAW 166 (273)
T ss_dssp GGGGSS--CCEEEEETTEEEEE---------ETTEEEEEECCTTSTTSCCGGGGSSEEEEE-ECSSEEEE-EETTEEEEE
T ss_pred CCCCCC--EEEEEEECCCCCCC---------CCCCCEECCCCCCCCEEEECCCCCEEEEEE-CCCEEEEE-ECCCCEEEE
T ss_conf 334420--14786301111111---------233200001279883434035773178875-03225645-236641675
Q ss_pred CCCCCCCEEECCCCCCCEEEEEECCCCEEEEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCEE
Q ss_conf 57999850103778741899974286136977579961898636899862111111256656789999906741587178
Q 002512 195 GDESSSRVISLIPKEMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHA 274 (914)
Q Consensus 195 G~~~~g~~~~~~~~~~~~~~i~aG~~h~c~l~~~~~g~v~cWG~n~~~~~g~~~~~~~~~~~~~~~~~~~~sia~g~~ht 274 (914)
|.+.++|+.........+++|++|..|+|+| +||+|||||.|.++|++... .....+.+|++|..|+
T Consensus 167 G~~~~g~~~~~~~~~~~v~~Is~G~~h~~~l---~dG~v~~WG~n~~Gql~~~~----------~~~~~v~~I~~G~~~~ 233 (273)
T d1jtdb_ 167 GDNYFGQTTVPAEAQSGVDDVAGGIFHSLAL---KDGKVIAWGDNRYKQTTVPT----------EALSGVSAIASGEWYS 233 (273)
T ss_dssp ECCTTSTTSCCGGGSSSEEEEEECSSEEEEE---ETTEEEEEECCTTSTTCCCG----------GGGSSCCEEEECSSCE
T ss_pred ECCCCCCCCCCCCCCCCCCCEECCCEEEEEE---ECCCEEECCCCCCCCCCCCC----------CCCCCCEEEEECCCEE
T ss_conf 2135786553332467741110302036788---56848983799989607870----------5789958999590569
Q ss_pred EEEEECCCCEEEEEECCCCCCCCCCCCCEEEEEECCCCCEEE
Q ss_conf 766534971477621048998778995179999657211010
Q 002512 275 CGIKSYDRGVICWGFIIKPSTPVPTGIKVYEIAAGNYFTCGV 316 (914)
Q Consensus 275 cg~~~~~g~v~CwG~n~~gq~~ip~g~~~~~i~~g~~~~Ca~ 316 (914)
|++ + +|.++|||.|.++|..++.+ +..+.++..|.+|+
T Consensus 234 ~~l-~-~g~v~~WG~~~~~~~~~~~~--~~~i~~~~~~~~al 271 (273)
T d1jtdb_ 234 LAL-K-NGKVIAWGSSRTAPSSVQSG--VSSIEAGPNAAYAL 271 (273)
T ss_dssp EEE-E-TTEEEEESTTCCCCGGGSSC--EEEEEECSSCEEEE
T ss_pred EEE-E-CCEEEEECCCCCCCCCCCCC--CEEEEECCCEEEEE
T ss_conf 999-8-99999978997789888898--23487375418995
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-44 Score=279.66 Aligned_cols=259 Identities=21% Similarity=0.259 Sum_probs=185.0
Q ss_pred CCCCCCCCCCCCEEEEEEEEC-CCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-----------CCCEEEEECEEEC
Q ss_conf 131210286653499999980-8959999992203633206498999999998106-----------9852321020111
Q 002512 516 GGFKEEVGKGSFSCVYKGVLK-DGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-----------HAHLLNLLGYCEE 583 (914)
Q Consensus 516 ~~f~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-----------HpnIv~l~g~~~~ 583 (914)
+.+.++||+|+||.||+|+.+ +++.||||++.... ...+.+.+|+.++++++ |+||+++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 799899750778189999999999799999983431---33689999999999840145555542276764789987631
Q ss_pred C--CEEEEEEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCEECCCCCCCCEEECCCC---
Q ss_conf 8--768999965799997786303952000135556689899999999999641-6999822058876426874999---
Q 002512 584 G--RERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG-YACPPVIHRDIKSSNILIDEEH--- 657 (914)
Q Consensus 584 ~--~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~-~~~~~iiHrDIKp~NILl~~~~--- 657 (914)
. ...+++++++..+.......... ....++...+..++.|++.||.|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCC
T ss_conf 25652023432000354200000122--34678689999999999999888764058---64656770570563057656
Q ss_pred ---CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCC--C--
Q ss_conf ---499943587545999999997557888677669452301899982007889999999990998865434564--1--
Q 002512 658 ---NARVADFGLSLLGPADSSSPLAELPAGTLGYLDPEYYRLHYLTTKSDVYSFGVLLLEILSGRKAIDMQFEEG--N-- 730 (914)
Q Consensus 658 ---~~kI~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~~s~ksDVySlGviL~ELltG~~p~~~~~~~~--~-- 730 (914)
.++++|||.+...... .....||+.|+|||++....++.++||||+|++++||++|+.||....... .
T Consensus 167 ~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred CCCEEEEEECCCCCCCCCC-----CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHH
T ss_conf 4430567531442123445-----42236652105713214667776432012378999998788998987554321026
Q ss_pred --HHHHHH-----------------HHHHCCCCCCCCCC----------CCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf --789788-----------------66522984322365----------3489999889999999999811019999999
Q 002512 731 --IVEWAV-----------------PLIKSGDITAILDP----------VLKLPSDLDALKRIANVACKCVRMRGKERPS 781 (914)
Q Consensus 731 --l~~~~~-----------------~~~~~~~~~~i~d~----------~~~~~~~~~~~~~l~~l~~~Cl~~dp~~RPs 781 (914)
+..... .............. .............+.+|+.+||..||.+|||
T Consensus 242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt 321 (362)
T d1q8ya_ 242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 321 (362)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC
T ss_conf 89999999837998788624532200013201220243235776444210001567435899999999987799457908
Q ss_pred HHHHHH
Q ss_conf 789999
Q 002512 782 MDKVTT 787 (914)
Q Consensus 782 ~~ev~~ 787 (914)
++|+++
T Consensus 322 a~e~L~ 327 (362)
T d1q8ya_ 322 AGGLVN 327 (362)
T ss_dssp HHHHHT
T ss_pred HHHHHC
T ss_conf 999966
|
| >d1jtdb_ b.69.5.2 (B:) beta-lactamase inhibitor protein-II, BLIP-II {Streptomyces exfoliatus [TaxId: 1905]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: beta-lactamase inhibitor protein-II, BLIP-II domain: beta-lactamase inhibitor protein-II, BLIP-II species: Streptomyces exfoliatus [TaxId: 1905]
Probab=100.00 E-value=3.7e-43 Score=271.16 Aligned_cols=233 Identities=23% Similarity=0.358 Sum_probs=187.1
Q ss_pred EEECCCCCC-CCCCCCCC--CCEEEEECCCCEEEEEEECCCCEEECCCCCCCCCCCCCCCCCCCEEEEEEECCCEEEEEE
Q ss_conf 882478888-65688999--787999417970479980899505328878988898732237970899970796134211
Q 002512 65 VTCYGSNSA-IIYGTPAH--FPFIGLTAGDGFVCGLLLDSNQPYCWGSSGYIQMGVPQPIIKGAQYVEISAGDYHLCGLR 141 (914)
Q Consensus 65 v~cwg~n~~-~~~~~~~~--~~~~~i~~G~~~~ca~~~~~~~~~cWG~n~~gqlg~p~~~~~~~~~~~i~~G~~h~cal~ 141 (914)
|+|||.|+. ++..+|.. ..+.+|++|..|+|+| . +|.+||||.|.+||||.|..... .+++|++|..|+|+|
T Consensus 6 v~~WG~~~~~~~~~~~~~~~~~i~~va~G~~h~~al-~-dG~v~~wG~N~~GQlG~~~~~~~--~v~~v~~G~~~~~al- 80 (273)
T d1jtdb_ 6 VVAWGGNNDWGEATVPAEAQSGVDAIAGGYFHGLAL-K-GGKVLGWGANLNGQLTMPAATQS--GVDAIAAGNYHSLAL- 80 (273)
T ss_dssp EEEESSCCSSSTTCCCGGGSSSEEEEEECSSEEEEE-E-TTEEEEEECCTTSTTSCCGGGGS--CCCEEEECSSEEEEE-
T ss_pred EEEECCCCCCCCEECCCCCCCCCEEEECCCCEEEEE-E-CCEEEEEECCCCCCEEEEECCCC--CCEEEECCCCCEEEE-
T ss_conf 999799988992440356789859998567989999-8-99899985899986002002346--645996599725514-
Q ss_pred CCCCCCCCCCCEEEECCCCCCCCCCCC----CCEEEEEECCCCEEEEEECCCEEEEECCCCCCCEEECCCCCCCEEEEEE
Q ss_conf 178985477950898035899887689----9579996249814673525990899157999850103778741899974
Q 002512 142 KPLTGKWRNYSYVDCWGYNMTKNYVFD----GQIESISAGSEFNCGLFSQNRTVFCWGDESSSRVISLIPKEMKFQKVAA 217 (914)
Q Consensus 142 ~~~~~~~~~~g~v~cWG~n~~gql~~~----~~~~~ia~G~~~~cal~~~~g~v~cWG~~~~g~~~~~~~~~~~~~~i~a 217 (914)
.+|+++|||.|.+||++.. ..+..|++|..|+|++ .||.++|||.+..++..........+..+++
T Consensus 81 --------~dg~v~~wG~~~~gq~~~~~~~~~~~~~i~~~~~~~~~~--~dg~v~~~g~~~~~~~~~~~~~~~~v~~~~~ 150 (273)
T d1jtdb_ 81 --------KDGEVIAWGGNEDGQTTVPAEARSGVDAIAAGAWASYAL--KDGKVIAWGDDSDGQTTVPAEAQSGVTALDG 150 (273)
T ss_dssp --------ETTEEEEEECCTTSTTCCCGGGGSSCCEEEEETTEEEEE--ETTEEEEEECCTTSTTSCCGGGGSSEEEEEE
T ss_pred --------EEEEEECCCCCCCEEECCCCCCCCCEEEEEEECCCCCCC--CCCCCEECCCCCCCCEEEECCCCCEEEEEEC
T ss_conf --------320130268873001022333442014786301111111--2332000012798834340357731788750
Q ss_pred CCCCEEEEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCEEEEECCCCEEEEEEECCCCEEEEEECCCCCCCC
Q ss_conf 28613697757996189863689986211111125665678999990674158717876653497147762104899877
Q 002512 218 GGYHVCGILEGLDSRTRCWGRSLDLEEEVSVAYSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICWGFIIKPSTPV 297 (914)
Q Consensus 218 G~~h~c~l~~~~~g~v~cWG~n~~~~~g~~~~~~~~~~~~~~~~~~~~sia~g~~htcg~~~~~g~v~CwG~n~~gq~~i 297 (914)
+. |+|+++ .+|.++|||.|..+|+.. +.+....+.+|++|..|+|++ + +|.|+|||.|.+||+.+
T Consensus 151 ~~-~~~~~~--~~g~~~~~G~~~~g~~~~----------~~~~~~~v~~Is~G~~h~~~l-~-dG~v~~WG~n~~Gql~~ 215 (273)
T d1jtdb_ 151 GV-YTALAV--KNGGVIAWGDNYFGQTTV----------PAEAQSGVDDVAGGIFHSLAL-K-DGKVIAWGDNRYKQTTV 215 (273)
T ss_dssp CS-SEEEEE--ETTEEEEEECCTTSTTSC----------CGGGSSSEEEEEECSSEEEEE-E-TTEEEEEECCTTSTTCC
T ss_pred CC-EEEEEE--CCCCEEEEECCCCCCCCC----------CCCCCCCCCCEECCCEEEEEE-E-CCCEEECCCCCCCCCCC
T ss_conf 32-256452--366416752135786553----------332467741110302036788-5-68489837999896078
Q ss_pred CC--CCCEEEEEECCCCCEEEECCCCCCCCCCCCC
Q ss_conf 89--9517999965721101003678753245899
Q 002512 298 PT--GIKVYEIAAGNYFTCGVLAEKSMLPVCWGTG 330 (914)
Q Consensus 298 p~--g~~~~~i~~g~~~~Ca~l~e~~~~~~~wg~~ 330 (914)
|. ...+..|+++..|+|++ . ++.+ .|||.+
T Consensus 216 ~~~~~~~v~~I~~G~~~~~~l-~-~g~v-~~WG~~ 247 (273)
T d1jtdb_ 216 PTEALSGVSAIASGEWYSLAL-K-NGKV-IAWGSS 247 (273)
T ss_dssp CGGGGSSCCEEEECSSCEEEE-E-TTEE-EEESTT
T ss_pred CCCCCCCCEEEEECCCEEEEE-E-CCEE-EEECCC
T ss_conf 705789958999590569999-8-9999-997899
|
| >d1a12a_ b.69.5.1 (A:) Regulator of chromosome condensation RCC1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: 7-bladed beta-propeller superfamily: RCC1/BLIP-II family: Regulator of chromosome condensation RCC1 domain: Regulator of chromosome condensation RCC1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=267.15 Aligned_cols=264 Identities=15% Similarity=0.168 Sum_probs=215.5
Q ss_pred CCEEEEEECCCCCEEEEEEECCCEEEEECCCCCCCCCCCCCC--------------CCEEEEECCCCEEEEEEECCCCEE
Q ss_conf 440444307998369899608935488247888865688999--------------787999417970479980899505
Q 002512 40 MSSIAISYGENGPVFCGLKSDRSHLVTCYGSNSAIIYGTPAH--------------FPFIGLTAGDGFVCGLLLDSNQPY 105 (914)
Q Consensus 40 ~~~~~~~~g~~~~~~c~~~~~~~~~v~cwg~n~~~~~~~~~~--------------~~~~~i~~G~~~~ca~~~~~~~~~ 105 (914)
..++.+++|.. |+|+|..+|.+ ||||.|..||+|.+.. ..+++|++|..|+|++ .+++.+|
T Consensus 47 ~~i~~ia~G~~--h~~al~~~G~v--y~wG~n~~GQLG~g~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~-~~~g~v~ 121 (401)
T d1a12a_ 47 EDVVQAEAGGM--HTVCLSKSGQV--YSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAAL-TDDGRVF 121 (401)
T ss_dssp SCEEEEEECSS--EEEEEETTSCE--EEEECCTTSTTCSCCCSTTGGGSCEECCCCSCEEEEEECSSEEEEE-ETTSCEE
T ss_pred CCEEEEEECCC--EEEEEECCCEE--EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCEEEC-CCCCCCE
T ss_conf 99299991898--89999679989--9995899988774465566423554235422002201110010100-0345311
Q ss_pred ECCCCCCCCCC--C---------CCCCCCCCEEEEEEECCCEEEEEECCCCCCCCCCCEEEECCCCCCCCCCCC------
Q ss_conf 32887898889--8---------732237970899970796134211178985477950898035899887689------
Q 002512 106 CWGSSGYIQMG--V---------PQPIIKGAQYVEISAGDYHLCGLRKPLTGKWRNYSYVDCWGYNMTKNYVFD------ 168 (914)
Q Consensus 106 cWG~n~~gqlg--~---------p~~~~~~~~~~~i~~G~~h~cal~~~~~~~~~~~g~v~cWG~n~~gql~~~------ 168 (914)
|||.+.+++++ . +........+..|++|..|++++ +.+|.+|+||.|.+||++..
T Consensus 122 ~wG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~g~~~~~~~--------~~~g~~~~~G~n~~gqlg~~~~~~~~ 193 (401)
T d1a12a_ 122 LWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVML--------TADGDLYTLGCGEQGQLGRVPELFAN 193 (401)
T ss_dssp EEECEEETTEEEESSBBTBCEEEEEEECCSSCEEEEEECSSEEEEE--------ETTSCEEEEECCTTSTTCSCGGGTSS
T ss_pred ECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCEEEEEECCCCEEEE--------ECCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 2021456555446667754310011001688506998203522565--------03785003466876622888753445
Q ss_pred --------------------------CCEEEEEECCCCEEEEEECCCEEEEECCCCCCCEEEC--------------CCC
Q ss_conf --------------------------9579996249814673525990899157999850103--------------778
Q 002512 169 --------------------------GQIESISAGSEFNCGLFSQNRTVFCWGDESSSRVISL--------------IPK 208 (914)
Q Consensus 169 --------------------------~~~~~ia~G~~~~cal~~~~g~v~cWG~~~~g~~~~~--------------~~~ 208 (914)
..+.+|++|..|+|+| +.+|.+|+||.|.++++... ...
T Consensus 194 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~i~~v~~g~~~~~~l-~~~g~v~~~g~n~~g~~g~~~~~~~~~~~~~~~~~~~ 272 (401)
T d1a12a_ 194 RGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAI-SHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNS 272 (401)
T ss_dssp SCGGGGHHHHHSCEECCCBCSSCCSBCCEEEEEEETTEEEEE-ETTCCEEEEECCTTSTTSCSSCSCEEEEEECGGGCCT
T ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCEEEEEEECCCEEEEE-ECCCEEEEECCCCEECCCCCCCCCCEECCCCCCCCCC
T ss_conf 677555443356520000356777784399999368769999-5598186512221020354566310000010123554
Q ss_pred CCCEEEEEECCCCEEEEEECCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCEEEEECCCCEEEEEEECCCCEEEE
Q ss_conf 74189997428613697757996189863689986211111-12566567899999067415871787665349714776
Q 002512 209 EMKFQKVAAGGYHVCGILEGLDSRTRCWGRSLDLEEEVSVA-YSRQGNVDLPPSDPMLSIVGGKFHACGIKSYDRGVICW 287 (914)
Q Consensus 209 ~~~~~~i~aG~~h~c~l~~~~~g~v~cWG~n~~~~~g~~~~-~~~~~~~~~~~~~~~~sia~g~~htcg~~~~~g~v~Cw 287 (914)
...++.+++|..|++++. .+|.|||||.|.++|+|.+.. .....|..++....+++|++|..|+|++ +.+|.|+||
T Consensus 273 ~~~~~~i~~g~~~~~~l~--~~g~v~~wG~n~~gqlG~g~~~~~~~~P~~i~~~~~i~~Is~G~~hs~al-t~dG~v~~W 349 (401)
T d1a12a_ 273 TKSWVGFSGGQHHTVCMD--SEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAV-TKDGRVFAW 349 (401)
T ss_dssp TCCEEEEEECSSEEEEEE--TTSCEEEEECCGGGTTCSCTTCCCEEEEEECCSSSSEEEEEECSSEEEEE-ETTSCEEEE
T ss_pred CEEEEEEEEECCCEEEEC--CCCCEEEECCCCCCCCCCCCCCCCCCCCEECCCCCCEEEEEEECCEEEEE-ECCCEEEEE
T ss_conf 036999851012013561--48978884033467567886233355888857999829999308879999-489969999
Q ss_pred EECCCCCCCC----------------CCCCCEEEEEECCCCCEEEECCC
Q ss_conf 2104899877----------------89951799996572110100367
Q 002512 288 GFIIKPSTPV----------------PTGIKVYEIAAGNYFTCGVLAEK 320 (914)
Q Consensus 288 G~n~~gq~~i----------------p~g~~~~~i~~g~~~~Ca~l~e~ 320 (914)
|.|.+||+.. +.+.++..|++|..|+|+++.+.
T Consensus 350 G~n~~GQLG~G~~~~~~~P~~v~~~~~~~~~v~~v~~G~~hs~~l~~d~ 398 (401)
T d1a12a_ 350 GMGTNYQLGTGQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLLVKDK 398 (401)
T ss_dssp ECCTTSTTCSSSCSCEEEEEECCSTTTTTEEEEEEEECSSEEEEEEEEC
T ss_pred ECCCCCCCCCCCCCCEECCEEEECCCCCCCEEEEEEECCCEEEEEEECC
T ss_conf 2599887789999888607896435789988999997524399999799
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=6.3e-26 Score=168.59 Aligned_cols=165 Identities=16% Similarity=0.168 Sum_probs=118.3
Q ss_pred CCCCCCCCCCEEEEEEEECCCCEEEEEEEEECCCC----------------CCCHHHHHHHHHHHHHCCCCCEEEEECEE
Q ss_conf 12102866534999999808959999992203633----------------20649899999999810698523210201
Q 002512 518 FKEEVGKGSFSCVYKGVLKDGTVVAVKKAIATSDR----------------QKNSKEFHTELDLLSRLNHAHLLNLLGYC 581 (914)
Q Consensus 518 f~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~f~~E~~~l~~l~HpnIv~l~g~~ 581 (914)
+.++||+|+||.||+|.+.+++.||||........ ......+..|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred HCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEC
T ss_conf 27780248565999999799999999998604434666556563000888999999778999999981699914499862
Q ss_pred ECCCEEEEEEEECCCCCHHHHHHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEECCCCCCCCEEECCCCCEEE
Q ss_conf 11876899996579999778630395200013555668989999999999964169998220588764268749994999
Q 002512 582 EEGRERLLVYEFMAHGSLHQHLHGKSKALKEQLDWVRRVTIAVQAARGIEYLHGYACPPVIHRDIKSSNILIDEEHNARV 661 (914)
Q Consensus 582 ~~~~~~~LV~Ey~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~~~~~~iiHrDIKp~NILl~~~~~~kI 661 (914)
. .+++|||+++..+.+ ++......++.|++++|.|||+.+ |+||||||+|||++++ .++|
T Consensus 84 ~----~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 84 G----NAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp T----TEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred C----CEEEEEEECCCCCCC------------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEE
T ss_conf 8----889999504565420------------015789999999999999982688---8983689036114289-8999
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCH------HHHHCCCCCCCCHHHHHHHHHH
Q ss_conf 435875459999999975578886776694------5230189998200788999999
Q 002512 662 ADFGLSLLGPADSSSPLAELPAGTLGYLDP------EYYRLHYLTTKSDVYSFGVLLL 713 (914)
Q Consensus 662 ~DFGla~~~~~~~~~~~~~~~~Gt~~Y~aP------E~l~~~~~s~ksDVySlGviL~ 713 (914)
+|||+|........ ..|... +.+ .+.++.++|+||..--++
T Consensus 144 iDFG~a~~~~~~~~----------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 144 IDFPQSVEVGEEGW----------REILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCCTTCEETTSTTH----------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred EECCCCCCCCCCCC----------HHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 87788430899870----------999987799999997-578998446899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.94 E-value=1.1e-08 Score=65.94 Aligned_cols=132 Identities=17% Similarity=0.114 Sum_probs=86.3
Q ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCEEEEECEEECCCEEEEEEEECCCCCHHHH
Q ss_conf 66534999999808959999992203633206498999999998106-98523210201118768999965799997786
Q 002512 524 KGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN-HAHLLNLLGYCEEGRERLLVYEFMAHGSLHQH 602 (914)
Q Consensus 524 ~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~LV~Ey~~~gsL~~~ 602 (914)
.++...||+... +++.+++|+..... ......+.+|...+..+. +--+++++.+..+.+..++||+++++.++.+.
T Consensus 24 G~s~~~v~rv~~-~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 24 GMSPAKVYKLVG-ENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CCSSSEEEEEEC-SSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCCCCEEEEEE-CCCEEEEEECCCCC--CCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCCCCCCC
T ss_conf 998771899990-89869999848876--532556999999999876069987289997508964999986043343543
Q ss_pred HHCCCCCHHCCCCHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q ss_conf 303952000135556689899999999999641-----------------------------------------------
Q 002512 603 LHGKSKALKEQLDWVRRVTIAVQAARGIEYLHG----------------------------------------------- 635 (914)
Q Consensus 603 l~~~~~~~~~~l~~~~~~~i~~qia~gL~yLH~----------------------------------------------- 635 (914)
...... ...++.++++.|..||+
T Consensus 101 ~~~~~~----------~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (263)
T d1j7la_ 101 YEDEQS----------PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp TTTCSC----------HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHH
T ss_pred CCCCCC----------HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
T ss_conf 344026----------9999998999999985568421435764465655577899877655554303323200579999
Q ss_pred ------C---CCCCEECCCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf ------6---99982205887642687499949994358754
Q 002512 636 ------Y---ACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 636 ------~---~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~ 668 (914)
. ..+.++|+|+.|.|||++++....|+||+.+.
T Consensus 171 ~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp HHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCC
T ss_conf 999984498678178986004764236499659996023144
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.73 E-value=7.1e-08 Score=61.07 Aligned_cols=141 Identities=20% Similarity=0.163 Sum_probs=82.8
Q ss_pred CCCCC-CEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCC--CCCEEEEECEEECCCEEEEEEEECCCCC
Q ss_conf 28665-34999999808959999992203633206498999999998106--9852321020111876899996579999
Q 002512 522 VGKGS-FSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLN--HAHLLNLLGYCEEGRERLLVYEFMAHGS 598 (914)
Q Consensus 522 lG~G~-fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~--HpnIv~l~g~~~~~~~~~LV~Ey~~~gs 598 (914)
+..|. ...||+....++..+++|..... ....+..|+..++.+. .-.+++++.+..+.+..++||||++|-+
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~-----~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred CCCCCCCCEEEEEEECCCCEEEEEECCCC-----CHHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCC
T ss_conf 67865477589999389878999958966-----7768999999999998659998861322245661599987441355
Q ss_pred HHHH-----------------HHCCCCCHHCCCCHH--HHHH--------------------HHHHHHHHHHHHHC----
Q ss_conf 7786-----------------303952000135556--6898--------------------99999999999641----
Q 002512 599 LHQH-----------------LHGKSKALKEQLDWV--RRVT--------------------IAVQAARGIEYLHG---- 635 (914)
Q Consensus 599 L~~~-----------------l~~~~~~~~~~l~~~--~~~~--------------------i~~qia~gL~yLH~---- 635 (914)
+.+. ||..... ...+.+. ..+. ........+..+..
T Consensus 93 ~~~~~~~~~~~~~~l~~~la~LH~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 93 LLSSHLAPAEKVSIMADAMRRLHTLDPA-TCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp TTTSCCCHHHHHHHHHHHHHHHTTSCGG-GCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHCCCCHH-HCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCC
T ss_conf 4322126899999999999987368854-488755412468899999987541101134011213799999999871876
Q ss_pred CCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 699982205887642687499949994358754
Q 002512 636 YACPPVIHRDIKSSNILIDEEHNARVADFGLSL 668 (914)
Q Consensus 636 ~~~~~iiHrDIKp~NILl~~~~~~kI~DFGla~ 668 (914)
...+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCCCEEEECCCCCCCEEEECCCEEEEEECHHCC
T ss_conf 579567867888763577379658999853326
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.61 E-value=4.1e-07 Score=56.53 Aligned_cols=79 Identities=16% Similarity=0.199 Sum_probs=51.2
Q ss_pred CCCCCCCCCEEEEEEEECC-CCEEEEEEEEECC-----CCCCCHHHHHHHHHHHHHC-CC--CCEEEEECEEECCCEEEE
Q ss_conf 2102866534999999808-9599999922036-----3320649899999999810-69--852321020111876899
Q 002512 519 KEEVGKGSFSCVYKGVLKD-GTVVAVKKAIATS-----DRQKNSKEFHTELDLLSRL-NH--AHLLNLLGYCEEGRERLL 589 (914)
Q Consensus 519 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~f~~E~~~l~~l-~H--pnIv~l~g~~~~~~~~~L 589 (914)
.+.||.|....||+....+ ++.+++|...... .......+...|...|..+ .+ ..+++++.+. .+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEEC--CCCCEE
T ss_conf 998079852768999957998489996177130346777888778999999999986505798855289985--988779
Q ss_pred EEEECCCCCH
Q ss_conf 9965799997
Q 002512 590 VYEFMAHGSL 599 (914)
Q Consensus 590 V~Ey~~~gsL 599 (914)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.00 E-value=3.2e-05 Score=45.27 Aligned_cols=138 Identities=12% Similarity=0.040 Sum_probs=75.2
Q ss_pred CEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCC--EEEEEC-----EEECCCEEEEEEEECCCCCH
Q ss_conf 34999999808959999992203633206498999999998106985--232102-----01118768999965799997
Q 002512 527 FSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHAH--LLNLLG-----YCEEGRERLLVYEFMAHGSL 599 (914)
Q Consensus 527 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hpn--Iv~l~g-----~~~~~~~~~LV~Ey~~~gsL 599 (914)
--.||+...++|+.+++|..... ....+++..|...+..|.... ++..+. ........+.++++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~---~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE---RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT---TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCEEEEEECCCCCEEEEEEECCC---CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 20269998389997999984787---788999999999999998559987875206898056653479999865277688
Q ss_pred HH-----H---------HHC----CCCCHHCCCCH-------------------HHHHHHHHHHHHHHHHHH----CCCC
Q ss_conf 78-----6---------303----95200013555-------------------668989999999999964----1699
Q 002512 600 HQ-----H---------LHG----KSKALKEQLDW-------------------VRRVTIAVQAARGIEYLH----GYAC 638 (914)
Q Consensus 600 ~~-----~---------l~~----~~~~~~~~l~~-------------------~~~~~i~~qia~gL~yLH----~~~~ 638 (914)
.. + +|. .....+..+++ ..+-.+...+.+.++.+. +...
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEECCCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 9822058876426874999499943587545
Q 002512 639 PPVIHRDIKSSNILIDEEHNARVADFGLSLL 669 (914)
Q Consensus 639 ~~iiHrDIKp~NILl~~~~~~kI~DFGla~~ 669 (914)
..++|+|+.+.|||++++ ..++||+-+..
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.94 E-value=0.00012 Score=41.94 Aligned_cols=73 Identities=12% Similarity=0.120 Sum_probs=47.9
Q ss_pred CCCCCCCCEEEEEEEECCC--------CEEEEEEEEECCCCCCCHHHHHHHHHHHHHC-CCCCEEEEECEEECCCEEEEE
Q ss_conf 1028665349999998089--------5999999220363320649899999999810-698523210201118768999
Q 002512 520 EEVGKGSFSCVYKGVLKDG--------TVVAVKKAIATSDRQKNSKEFHTELDLLSRL-NHAHLLNLLGYCEEGRERLLV 590 (914)
Q Consensus 520 ~~lG~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l-~HpnIv~l~g~~~~~~~~~LV 590 (914)
+.|..|-.-.+|+....++ +.+.++.. .. .....+..+|..+++.+ .+.-.+++++++.+ .+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~-g~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVY-FN---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEE-CS---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEEC-CC---CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEE
T ss_conf 99178533434899968877544578981799965-99---61165899999999999757999808998189----569
Q ss_pred EEECCCCCHH
Q ss_conf 9657999977
Q 002512 591 YEFMAHGSLH 600 (914)
Q Consensus 591 ~Ey~~~gsL~ 600 (914)
+||+++.+|.
T Consensus 120 ~efi~g~~l~ 129 (395)
T d1nw1a_ 120 EEYIPSRPLS 129 (395)
T ss_dssp ECCCCEEECC
T ss_pred EEEECCCCCC
T ss_conf 9973455488
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.95 E-value=0.007 Score=31.32 Aligned_cols=141 Identities=11% Similarity=0.001 Sum_probs=70.3
Q ss_pred CCCCCCEEEEEEEECCCCEEEEEEEEECCCCCCCHHHHHHHHHHHHHCCCC--CEEEEECE------EECCCEEEEEEEE
Q ss_conf 286653499999980895999999220363320649899999999810698--52321020------1118768999965
Q 002512 522 VGKGSFSCVYKGVLKDGTVVAVKKAIATSDRQKNSKEFHTELDLLSRLNHA--HLLNLLGY------CEEGRERLLVYEF 593 (914)
Q Consensus 522 lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~f~~E~~~l~~l~Hp--nIv~l~g~------~~~~~~~~LV~Ey 593 (914)
|..|---+.|+....+++ +++|+..... ..++...|+.++..|... .++..+-. .........++.+
T Consensus 26 i~~G~~N~ny~v~t~~g~-yVLri~~~~~----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~ 100 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKDP-LILTLYEKRV----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 100 (316)
T ss_dssp ECC---EEEEEEEESSCC-EEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred CCCCCCCCEEEEEECCCC-EEEEECCCCC----CHHHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEEEEE
T ss_conf 788852673899978972-8999807899----98899999999875430255545564104897621341255024531
Q ss_pred CCCCCHHHH--------------HHC----CC--CCHHC----------------CCCHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf 799997786--------------303----95--20001----------------3555668989999999999964169
Q 002512 594 MAHGSLHQH--------------LHG----KS--KALKE----------------QLDWVRRVTIAVQAARGIEYLHGYA 637 (914)
Q Consensus 594 ~~~gsL~~~--------------l~~----~~--~~~~~----------------~l~~~~~~~i~~qia~gL~yLH~~~ 637 (914)
..+...... ++. .. ..... ..........+..+...+...+...
T Consensus 101 ~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 180 (316)
T d2ppqa1 101 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 180 (316)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCCCCC
T ss_conf 14655333204678888899876454443202453101110120024567777653114127999999987642048554
Q ss_pred -CCCEECCCCCCCCEEECCCCCEEEEECCCC
Q ss_conf -998220588764268749994999435875
Q 002512 638 -CPPVIHRDIKSSNILIDEEHNARVADFGLS 667 (914)
Q Consensus 638 -~~~iiHrDIKp~NILl~~~~~~kI~DFGla 667 (914)
...+||+|+.+.||+++.+...-|.||+.+
T Consensus 181 L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 181 LPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred CCCCCCCCCCCHHHHHCCCCCCEEEECCCCC
T ss_conf 5450333786365640204541267422212
|
| >d1emoa1 g.3.11.1 (A:2124-2166) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.23 E-value=0.18 Score=22.93 Aligned_cols=29 Identities=14% Similarity=0.305 Sum_probs=19.3
Q ss_pred CCCCCCCCCCCC---CC-CCCCCCCCCCCCCCCCC
Q ss_conf 312367522368---87-66667765567878667
Q 002512 388 CTLKSDRVCEYN---CS-SCFSAECYKNCSSQFSD 418 (914)
Q Consensus 388 C~~~~~~~C~~~---C~-~C~nt~g~~~C~~~~~~ 418 (914)
|.|| +||..+ |. .|.|++|+|.|.++.+.
T Consensus 2 CvDi--dEC~~~~~~~~~~C~Nt~Gsy~C~C~~Gy 34 (43)
T d1emoa1 2 AVDM--DECKEPDVCKHGQCINTDGSYRCECPFGY 34 (43)
T ss_dssp CCCC--CSSSSTTSCSSSCCCCCSSCCCCCCCTTE
T ss_pred CCCE--ECCCCCCCCCCCEEECCCCCEEEECCCCC
T ss_conf 7616--24589697988886888999486799995
|